Citrus Sinensis ID: 012214
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C9L5 | 792 | Wall-associated receptor | yes | no | 0.735 | 0.434 | 0.601 | 1e-121 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.897 | 0.561 | 0.492 | 1e-119 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.677 | 0.422 | 0.619 | 1e-116 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.745 | 0.442 | 0.602 | 1e-116 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.709 | 0.436 | 0.599 | 1e-116 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.675 | 0.432 | 0.617 | 1e-115 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.741 | 0.451 | 0.587 | 1e-114 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.743 | 0.476 | 0.584 | 1e-114 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.700 | 0.455 | 0.604 | 1e-113 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.698 | 0.428 | 0.604 | 1e-113 |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 434 bits (1117), Expect = e-121, Method: Compositional matrix adjust.
Identities = 214/356 (60%), Positives = 282/356 (79%), Gaps = 12/356 (3%)
Query: 93 SGYGRLILIATIITSLVFLRIIRKKRMDIKLTEKFFKQNGGLLLQQMLNSYDGSVIDRFK 152
+ +G LI + I + + I+K+R + +KFFK+NGGLLLQQ L S G ++++
Sbjct: 379 ASFGSLIFVVGI---YLLYKFIKKQR-KLNQKKKFFKRNGGLLLQQQLISTVG-MVEKTI 433
Query: 153 LFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFI 212
+FSS+EL+KAT +F++NRILGQGGQGTVYKGML DGRI+AVKKSK+ +D KLEEFI
Sbjct: 434 VFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDED----KLEEFI 489
Query: 213 NEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRL 272
NE+VILSQINHRN+VKLLGCCLET+VP+LVYEFIPNG L++HLHD +E TW +RL
Sbjct: 490 NEVVILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEF-DENIMATWNIRL 548
Query: 273 RIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK 332
RIA ++AGAL+YLHS+ SSPIYHRD+KSTNI+LD++YRAKV+DFGTS+ + +D TH+TT
Sbjct: 549 RIAIDIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTV 608
Query: 333 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVH 392
+ GT GY+DPEY QSSQ TDKSDVYSFGVVLVEL+TG+K I + SQEN +LA YF+
Sbjct: 609 VSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFL--RSQENRTLATYFIL 666
Query: 393 SMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448
+M++N+L DI+D ++ + +Q+ A +A++CL+L G+KRP+M EVSMEL+ IR
Sbjct: 667 AMKENKLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 429 bits (1102), Expect = e-119, Method: Compositional matrix adjust.
Identities = 232/471 (49%), Positives = 323/471 (68%), Gaps = 51/471 (10%)
Query: 14 GWYQLPFMFAMENPQDGEGLNLTNSRDFQDAEGIRKLNI------GFSHR----SSRRYK 63
GW+ F + +D + ++ N+ D + + GFS+R +S YK
Sbjct: 239 GWF-----FDTSDSRDTQPISCKNASDTTPYTSDTRCSCSYGYFSGFSYRDCYCNSPGYK 293
Query: 64 GSRKEYLSG-----DFSDLGVGSSSTGSQDSLACSGY-----------GRLILIATIITS 107
G+ +L G D L +G + Q + G+ R+I I ++
Sbjct: 294 GN--PFLPGGCVDVDECKLDIGRNQCKDQSCVNLPGWFDCQPKKPEQLKRVIQGVLIGSA 351
Query: 108 LVFL--------RIIRKKRMDIKLTEKFFKQNGGLLLQQMLNSYDGSVIDRFKLFSSKEL 159
L+ + ++K+R I++ KFF++NGG+LL+Q L +G+V + ++FSS EL
Sbjct: 352 LLLFAFGIFGLYKFVQKRRKLIRM-RKFFRRNGGMLLKQQLARKEGNV-EMSRIFSSHEL 409
Query: 160 DKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILS 219
+KAT++FN NR+LGQGGQGTVYKGML DGRI+AVK+SK +D ++EEFINE+V+L+
Sbjct: 410 EKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDED----RVEEFINEVVVLA 465
Query: 220 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVA 279
QINHRN+VKLLGCCLETEVP+LVYEF+PNG L + LHD +++++ +TWE+RL IA E+A
Sbjct: 466 QINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHD--ESDDYTMTWEVRLHIAIEIA 523
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 339
GAL+YLHSA S PIYHRDIK+TNILLD+R RAKV+DFGTS+ + +DQTH+TT++ GTFGY
Sbjct: 524 GALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGY 583
Query: 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399
+DPEY QSS+ T+KSDVYSFGVVLVELLTG+KP + S+EN LAA+FV ++++NR+
Sbjct: 584 VDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPS--SRVRSEENRGLAAHFVEAVKENRV 641
Query: 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450
DI+DD++ +Q+M+ ANLA+RCL+ GKKRP M EVS+EL IR S
Sbjct: 642 LDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 420 bits (1080), Expect = e-116, Method: Compositional matrix adjust.
Identities = 202/326 (61%), Positives = 264/326 (80%), Gaps = 9/326 (2%)
Query: 127 FFKQNGGLLLQQMLNSYDGSVIDRFKLFSSKELDKATNHFNANRILGQGGQGTVYKGMLE 186
FFK+NGGLLL+Q L + G+V K+FSSKEL+KAT++FN NR+LGQGGQGTVYKGML
Sbjct: 383 FFKRNGGLLLKQQLTTRGGNV-QSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLV 441
Query: 187 DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFI 246
DGRI+AVK+SK+ +D K+EEFINE+ +LSQINHRN+VKL+GCCLETEVP+LVYE I
Sbjct: 442 DGRIVAVKRSKVLDED----KVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHI 497
Query: 247 PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD 306
PNG L++ LH H ++++ +TW++RLRI+ E+AGALAYLHSA S+P+YHRD+K+TNILLD
Sbjct: 498 PNGDLFKRLH--HDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLD 555
Query: 307 QRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVEL 366
++YRAKV+DFGTS+ I +DQTH+TT + GTFGYLDPEY Q+SQ TDKSDVYSFGVVLVEL
Sbjct: 556 EKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVEL 615
Query: 367 LTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRC 426
+TG+KP ++ +EN L ++F +M++NR+ DI+D ++ + Q++ A LA+RC
Sbjct: 616 ITGEKP--FSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAKLARRC 673
Query: 427 LDLNGKKRPTMEEVSMELNGIRGSSK 452
L L GKKRP M EVS+EL IR S +
Sbjct: 674 LSLKGKKRPNMREVSVELERIRSSPE 699
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 418 bits (1075), Expect = e-116, Method: Compositional matrix adjust.
Identities = 215/357 (60%), Positives = 272/357 (76%), Gaps = 8/357 (2%)
Query: 94 GYGRLILIATIITSLVFLRIIRKKRMDIKLTEKFFKQNGGLLLQQMLNSYDGSVIDRFKL 153
G G I ++ + +LR KKR K KFFK+NGGLLLQQ LN+ G+V ++ ++
Sbjct: 380 GVGSAFGILVLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNV-EKTRI 438
Query: 154 FSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFIN 213
FSS+EL+KAT++F+ +RILGQGGQGTVYKGML DGR +AVKKSK+ +D KLEEFIN
Sbjct: 439 FSSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDED----KLEEFIN 494
Query: 214 EIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLR 273
E+VILSQINHR+VVKLLGCCLETEVP LVYEFIPNG L+QH+H+ +++++ TW MRLR
Sbjct: 495 EVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHE--ESDDYTKTWGMRLR 552
Query: 274 IATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
IA ++AGAL+YLHSA SSPIYHRDIKSTNILLD++YR KV+DFGTS+ + +D TH TT I
Sbjct: 553 IAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVI 612
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393
GT GY+DPEY+ SSQ TDKSDVYSFGVVLVEL+TG+KP+ N SQE LA +F +
Sbjct: 613 SGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSN-SQEIRGLADHFRVA 671
Query: 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450
M++NR +I+D ++ Q+M ANLA+RCL+ GKKRP M +V +L I S
Sbjct: 672 MKENRFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILAS 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 417 bits (1072), Expect = e-116, Method: Compositional matrix adjust.
Identities = 205/342 (59%), Positives = 270/342 (78%), Gaps = 10/342 (2%)
Query: 112 RIIRKKRMDIKLTEKFFKQNGGLLLQQMLNSYDGSVIDRFKLFSSKELDKATNHFNANRI 171
+ I+K+R ++ FF++NGG+LL+Q L +G+V + K+FSS EL+KAT++FN NR+
Sbjct: 372 KFIKKQRRSSRM-RVFFRRNGGMLLKQQLARKEGNV-EMSKIFSSNELEKATDNFNTNRV 429
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231
LGQGGQGTVYKGML DGRI+AVK+SK +D K+EEFINE+V+L+QINHRN+VKLLG
Sbjct: 430 LGQGGQGTVYKGMLVDGRIVAVKRSKAMDED----KVEEFINEVVVLAQINHRNIVKLLG 485
Query: 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSS 291
CCLETEVP+LVYEF+PNG L + L D + +++ +TWE+RL IA E+AGAL+YLHSA S
Sbjct: 486 CCLETEVPVLVYEFVPNGDLCKRLRD--ECDDYIMTWEVRLHIAIEIAGALSYLHSAASF 543
Query: 292 PIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 351
PIYHRDIK+TNILLD++Y+ KV+DFGTS+ + +DQTH+TT++ GTFGY+DPEY QSS+ T
Sbjct: 544 PIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFT 603
Query: 352 DKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLG 411
DKSDVYSFGVVLVEL+TGK P + S+EN AA+FV ++++NR DI+D+++
Sbjct: 604 DKSDVYSFGVVLVELITGKNPS--SRVQSEENRGFAAHFVAAVKENRFLDIVDERIKDEC 661
Query: 412 VKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKK 453
+Q+M A LAKRCL+ GKKRP M EVS+EL IR SS K
Sbjct: 662 NLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRSSSYK 703
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 414 bits (1063), Expect = e-115, Method: Compositional matrix adjust.
Identities = 202/327 (61%), Positives = 263/327 (80%), Gaps = 11/327 (3%)
Query: 126 KFFKQNGGLLLQQMLNSYDGSVIDRFKLFSSKELDKATNHFNANRILGQGGQGTVYKGML 185
KFFK+NGGLLL+Q L + DGSV + K+FSS+EL+KAT++F+ +R+LGQGGQGTVYK ML
Sbjct: 389 KFFKRNGGLLLKQQLTTKDGSV-EMSKIFSSRELEKATDNFSIDRVLGQGGQGTVYKRML 447
Query: 186 EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEF 245
DG I+AVK+SK+ +D K+EEFINEIV+LSQINHRN+VKLLGCCLETEVP+LVYE+
Sbjct: 448 VDGSIVAVKRSKVVDED----KMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEY 503
Query: 246 IPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL 305
IPNG L++ LHD + +++ +TWE+RLRIA E+AGAL+Y+HSA S PI+HRDIK+TNILL
Sbjct: 504 IPNGDLFKRLHDEY--DDYMMTWEVRLRIAVEIAGALSYMHSAASFPIFHRDIKTTNILL 561
Query: 306 DQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVE 365
D++YRAK++DFGTS+ +A DQTH+TT + GTFGY+DPEY SSQ T KSDVYSFGVVLVE
Sbjct: 562 DEKYRAKISDFGTSRSVATDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVE 621
Query: 366 LLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKR 425
L+TG+KP+ + S+E + LA YF+ +M++NR DI+D ++ Q+M A LA+R
Sbjct: 622 LITGEKPM--SRVRSEEGIGLATYFLEAMKENRAVDIIDIRIKD--ESKQVMAVAKLARR 677
Query: 426 CLDLNGKKRPTMEEVSMELNGIRGSSK 452
CL+ G KRP M EVS++L IR S K
Sbjct: 678 CLNRKGNKRPNMREVSIKLERIRSSPK 704
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 413 bits (1061), Expect = e-114, Method: Compositional matrix adjust.
Identities = 212/361 (58%), Positives = 283/361 (78%), Gaps = 14/361 (3%)
Query: 93 SGYGRLILIATIITSLVFLRIIRKKRMDIKLTEKFFKQNGGLLLQQMLNSYDGSVIDRFK 152
+ + L+ I I F+R R++R++ K +KFFK+NGGLLLQQ L + +G+V D +
Sbjct: 365 TSFSTLVFIGGIYWLYKFIR--RQRRLNQK--KKFFKRNGGLLLQQQLTTTEGNV-DSTR 419
Query: 153 LFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFI 212
+F+S+EL+KAT +F+ RILG+GGQGTVYKGML DGRI+AVKKSK+ +D KLEEFI
Sbjct: 420 VFNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDED----KLEEFI 475
Query: 213 NEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLT-WEMR 271
NE+VILSQINHRN+VKLLGCCLET+VP+LVYEFIPNG L++HLHD ++++ +T WE+R
Sbjct: 476 NEVVILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHD--DSDDYTMTTWEVR 533
Query: 272 LRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTT 331
LRIA ++AGAL+YLHSA SSPIYHRDIKSTNI+LD+++RAKV+DFGTS+ + +D TH+TT
Sbjct: 534 LRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTT 593
Query: 332 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391
+ GT GY+DPEY QSSQ TDKSDVYSFGVVL EL+TG+K + + SQE +LA YF
Sbjct: 594 VVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFL--RSQEYRTLATYFT 651
Query: 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451
+M++NRL DI+D ++ NQ+ A +A++CL++ G+KRP+M +VSMEL IR S
Sbjct: 652 LAMKENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYS 711
Query: 452 K 452
+
Sbjct: 712 E 712
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 410 bits (1055), Expect = e-114, Method: Compositional matrix adjust.
Identities = 210/359 (58%), Positives = 280/359 (77%), Gaps = 11/359 (3%)
Query: 96 GRLILIATII--TSLVFLRIIRKKRMDIKLTEKFFKQNGGLLLQQMLNSYDGSVIDRFKL 153
G LI ++ ++ L +L + KKR +I ++KFFK+NGGLLL+Q L + DG+V + K+
Sbjct: 358 GILIGLSGLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNV-EMSKI 416
Query: 154 FSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFIN 213
FSSKEL KAT++F+ +R+LGQGGQGTVYKGML DG I+AVK+SK+ +D K+EEFIN
Sbjct: 417 FSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDED----KMEEFIN 472
Query: 214 EIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLR 273
EIV+LSQINHRN+VKLLGCCLETEVP+LVYE+IPNG L++ LHD +++++ +TWE+RLR
Sbjct: 473 EIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHD--ESDDYTMTWEVRLR 530
Query: 274 IATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
IA E+AGAL Y+HSA S PI+HRDIK+TNILLD++YRAKV+DFGTS+ + +DQTH+TT +
Sbjct: 531 IAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLV 590
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393
GTFGY+DPEY SSQ T KSDVYSFGVVLVEL+TG+KP+ S+E LA +F+ +
Sbjct: 591 AGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRV--RSEEGRGLATHFLEA 648
Query: 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452
M++NR+ DI+D ++ Q+M A LA++CL+ GK RP M+EVS EL IR S +
Sbjct: 649 MKENRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSSPE 707
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 409 bits (1050), Expect = e-113, Method: Compositional matrix adjust.
Identities = 205/339 (60%), Positives = 263/339 (77%), Gaps = 11/339 (3%)
Query: 116 KKRMDIKLTEKFFKQNGGLLLQQMLNSYDGSVIDRFKLFSSKELDKATNHFNANRILGQG 175
+KR K KFF++NGGLLLQQ + GSV +R K+FSS +L+ AT+ FNA+RILGQG
Sbjct: 341 RKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSV-NRTKVFSSNDLENATDRFNASRILGQG 399
Query: 176 GQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE 235
GQGTVYKGMLEDG I+AVKKSK ++ LEEFINEI++LSQINHRNVVK+LGCCLE
Sbjct: 400 GQGTVYKGMLEDGMIVAVKKSKALKEE----NLEEFINEIILLSQINHRNVVKILGCCLE 455
Query: 236 TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYH 295
TEVP+LVYEFIPN L+ HLH+ +E+FP++WE+RL IA EVA AL+YLHSA S PIYH
Sbjct: 456 TEVPILVYEFIPNRNLFDHLHN--PSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYH 513
Query: 296 RDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSD 355
RD+KSTNILLD+++RAKV+DFG S+ +A+D TH+TT +QGT GY+DPEY QS+ T KSD
Sbjct: 514 RDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSD 573
Query: 356 VYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQ 415
VYSFGV+L+ELLTG+KP+ QE L AYF+ +MR +RLH+ILD ++ + + +
Sbjct: 574 VYSFGVLLIELLTGEKPVSLL--RRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDREE 631
Query: 416 IMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKK 454
++ A LA+RCL LN + RPTM +V +EL+ R SK+K
Sbjct: 632 VLAVAKLARRCLSLNSEHRPTMRDVFIELD--RMQSKRK 668
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 408 bits (1048), Expect = e-113, Method: Compositional matrix adjust.
Identities = 203/336 (60%), Positives = 259/336 (77%), Gaps = 9/336 (2%)
Query: 112 RIIRKKRMDIKLTEKFFKQNGGLLLQQMLNSYDGSVIDRFKLFSSKELDKATNHFNANRI 171
+++RK+RM + KFFK+NGGLLLQQ LN+ G V ++ KLFSS+EL+KAT++FN NR+
Sbjct: 402 KLLRKRRMTNR-KRKFFKRNGGLLLQQQLNTTQGRV-EKTKLFSSRELEKATDNFNDNRV 459
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231
+GQGGQGTVYKGML DGR +AVKKS + +D KL+EFINE++ILSQINHR+VVKLLG
Sbjct: 460 IGQGGQGTVYKGMLVDGRSVAVKKSNVVDED----KLQEFINEVIILSQINHRHVVKLLG 515
Query: 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSS 291
CCLETEVP+LVYEFIPNG L+QHLH+ +++ W +R+RIA +++GA +YLH+A S
Sbjct: 516 CCLETEVPILVYEFIPNGNLFQHLHEEF--DDYTALWGVRMRIAVDISGAFSYLHTAACS 573
Query: 292 PIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 351
PIYHRDIKSTNILLD++YRAKV+DFGTS+ +++D TH TT I GT GY+DPEY+ SS T
Sbjct: 574 PIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFT 633
Query: 352 DKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLG 411
+KSDVYSFGVVLVEL+TG+KP+ T QE LA YF +MR+NRL +I+D ++
Sbjct: 634 EKSDVYSFGVVLVELITGEKPVITLSET-QEITGLADYFRLAMRENRLFEIIDARIRNDC 692
Query: 412 VKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
Q++ ANLA RCL GK RP M EVS L I
Sbjct: 693 KLEQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | ||||||
| 359475622 | 867 | PREDICTED: wall-associated receptor kina | 0.773 | 0.417 | 0.650 | 1e-133 | |
| 147852023 | 413 | hypothetical protein VITISV_028337 [Viti | 0.715 | 0.811 | 0.689 | 1e-133 | |
| 359475620 | 822 | PREDICTED: wall-associated receptor kina | 0.745 | 0.424 | 0.662 | 1e-133 | |
| 147765961 | 679 | hypothetical protein VITISV_007744 [Viti | 0.722 | 0.497 | 0.674 | 1e-130 | |
| 255545828 | 694 | kinase, putative [Ricinus communis] gi|2 | 0.700 | 0.472 | 0.679 | 1e-130 | |
| 224075946 | 729 | predicted protein [Populus trichocarpa] | 0.732 | 0.470 | 0.677 | 1e-130 | |
| 255545824 | 727 | kinase, putative [Ricinus communis] gi|2 | 0.700 | 0.451 | 0.679 | 1e-129 | |
| 225455808 | 718 | PREDICTED: wall-associated receptor kina | 0.702 | 0.458 | 0.680 | 1e-128 | |
| 297734146 | 1029 | unnamed protein product [Vitis vinifera] | 0.702 | 0.319 | 0.680 | 1e-127 | |
| 359475624 | 376 | PREDICTED: wall-associated receptor kina | 0.683 | 0.851 | 0.696 | 1e-127 |
| >gi|359475622|ref|XP_003631717.1| PREDICTED: wall-associated receptor kinase-like 10-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 483 bits (1242), Expect = e-133, Method: Compositional matrix adjust.
Identities = 242/372 (65%), Positives = 294/372 (79%), Gaps = 10/372 (2%)
Query: 77 LGVGSSSTGSQDSLACSGYGRLILIATIITSLVFLRIIRKKRMDIKLTEKFFKQNGGLLL 136
L G T S + A G L + ++ + +L I+ K+R IK EK F +NGGLLL
Sbjct: 286 LPQGCQGTQSIEDCAVITIGALGTLLLVLCAW-WLYIVLKRRKKIKYKEKCFNRNGGLLL 344
Query: 137 QQMLNSYDGSVIDRFKLFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKS 196
+Q L+S +G+ ID+ KLF+SKEL+KAT+ +N NR++GQGG+GTVYKGML DGRI+AVKK
Sbjct: 345 EQQLSSTEGN-IDKTKLFTSKELEKATDRYNENRVIGQGGEGTVYKGMLMDGRIVAVKKL 403
Query: 197 KLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLH 256
K+ D KLE+FINE+VIL QINHRNVVKLLGCCLETEVPLLVYEFIPNGTL +H+H
Sbjct: 404 KIMSDS----KLEQFINEVVILCQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIH 459
Query: 257 DRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316
QNEEFP+TWE+RLRIATEVAGAL+YLHSA S PIYHRDIKSTNILLD +YRAKVADF
Sbjct: 460 G--QNEEFPITWEIRLRIATEVAGALSYLHSAASVPIYHRDIKSTNILLDDKYRAKVADF 517
Query: 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWA 376
G SKF+A+DQTH+TT++QGTFGYLDPEY QSSQ T+KSDVYSFG+VL+ELLTGKKPI
Sbjct: 518 GISKFVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPIL-- 575
Query: 377 GNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT 436
S+E SLA+YF+ SM ++RL D+LD Q++K K +I A LA+RC++LNGKKRPT
Sbjct: 576 STASEEGKSLASYFILSMNEDRLSDLLDAQVVKESRKEEINAIAFLARRCINLNGKKRPT 635
Query: 437 MEEVSMELNGIR 448
M EV+MEL IR
Sbjct: 636 MMEVAMELERIR 647
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147852023|emb|CAN82287.1| hypothetical protein VITISV_028337 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 482 bits (1241), Expect = e-133, Method: Compositional matrix adjust.
Identities = 238/345 (68%), Positives = 290/345 (84%), Gaps = 10/345 (2%)
Query: 104 IITSLVFLRIIRKKRMDIKLTEKFFKQNGGLLLQQMLNSYDGSVIDRFKLFSSKELDKAT 163
+I + + R+++++R IK EK FK+NGGLLL+Q L+S +G+V D+ KLF+SKEL+KAT
Sbjct: 23 VICAWLLYRVLKRRR-KIKHKEKCFKRNGGLLLEQQLSSSEGNV-DKTKLFTSKELEKAT 80
Query: 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
+ +N NR++GQGGQGTVYKGML DGRI+AVKK K+ D KLE+FINE+VILSQINH
Sbjct: 81 DRYNENRVIGQGGQGTVYKGMLMDGRIVAVKKLKIVGDG----KLEQFINEVVILSQINH 136
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
RNVVKLLGCCLE EVPLLVYE+IPNGTL +H+HD QNEEFP+TW+MRL+IATEVAGAL+
Sbjct: 137 RNVVKLLGCCLEIEVPLLVYEYIPNGTLSEHIHD--QNEEFPITWKMRLQIATEVAGALS 194
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
YLHSA S PIYHRDIKSTNILLD +YRAKVADFGTSK +A+DQTH+TTK+QGTFGYLDPE
Sbjct: 195 YLHSAASIPIYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHLTTKVQGTFGYLDPE 254
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403
Y QSSQ T+KSDVYSFG+VL+ELLTGKKPI G S E SLA+YF+ SM+++RL D+L
Sbjct: 255 YFQSSQFTEKSDVYSFGIVLIELLTGKKPILSIG--SGEGKSLASYFIMSMKEDRLSDLL 312
Query: 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448
D +++K G K +I A LAKRC++LNGKKRPTM EV+MEL IR
Sbjct: 313 DARVVKEGRKEEINAIAFLAKRCINLNGKKRPTMMEVAMELERIR 357
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 480 bits (1235), Expect = e-133, Method: Compositional matrix adjust.
Identities = 240/362 (66%), Positives = 294/362 (81%), Gaps = 13/362 (3%)
Query: 93 SGYGRLILIATIITSLVFLRIIRKKRMDIKLTEKFFKQNGGLLLQQMLNSYDGSVIDRFK 152
+G G L+L+ I + +++ K+R IK EK FK+NGGLLL+Q L+S +G+V D+ K
Sbjct: 461 AGVGTLLLV---ICAWWLYKVL-KRRQKIKYKEKCFKRNGGLLLEQQLSSSEGNV-DKTK 515
Query: 153 LFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFI 212
LF+SKEL+KAT+ +N NR++GQGGQGTVYKGML DGRI+AVKK K+ D K+E+FI
Sbjct: 516 LFTSKELEKATDRYNENRVIGQGGQGTVYKGMLMDGRIVAVKKLKIVGDG----KVEQFI 571
Query: 213 NEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRL 272
NE+VILSQINHRNVVKLLGCCLET VPLLVYEFIPNGTL +H+HD QNEEFP+TWEMRL
Sbjct: 572 NEVVILSQINHRNVVKLLGCCLETAVPLLVYEFIPNGTLSEHIHD--QNEEFPITWEMRL 629
Query: 273 RIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK 332
RIA EVAGAL+YLHSA S PIYHRDIKSTNILLD +YRAKVADFGTSK +A+DQTH+TT+
Sbjct: 630 RIAIEVAGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHLTTQ 689
Query: 333 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVH 392
+QGTFGYLDPEY QSSQ T+KSDVYSFG+VL+ELLTGKKPI S+E SLA+YF+
Sbjct: 690 VQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPIL--STASEEGKSLASYFIL 747
Query: 393 SMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452
SM ++RL D+LD Q++K G K +I A LA+RC++LNGKKRPTM EV+MEL ++
Sbjct: 748 SMNEDRLSDLLDAQVVKEGKKEEINAIAFLARRCINLNGKKRPTMMEVAMELEILKTKKM 807
Query: 453 KK 454
+K
Sbjct: 808 QK 809
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147765961|emb|CAN70207.1| hypothetical protein VITISV_007744 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1213), Expect = e-130, Method: Compositional matrix adjust.
Identities = 234/347 (67%), Positives = 279/347 (80%), Gaps = 9/347 (2%)
Query: 110 FLRIIRKKRMDIKLTEKFFKQNGGLLLQQMLNSYDGSVIDRFKLFSSKELDKATNHFNAN 169
+L I K+R IK EK F +NGGLLL+Q L+S +G+ ID+ KLF+SKEL+KAT+ +N N
Sbjct: 303 WLYIXLKRRKKIKYKEKCFNRNGGLLLEQQLSSSEGN-IDKTKLFTSKELEKATDRYNEN 361
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
R++GQG QGT YKGML DGRI+AVKK K+ D KLE+FINE+VIL QINHRNVVKL
Sbjct: 362 RVIGQGXQGTXYKGMLMDGRIVAVKKLKIMSDS----KLEQFINEVVILCQINHRNVVKL 417
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
LGCCLETEVPLLVYEFIPNGTL +H+H QNEEFP+TWEMRLRIATEV GAL+YLHS
Sbjct: 418 LGCCLETEVPLLVYEFIPNGTLSEHIHG--QNEEFPITWEMRLRIATEVXGALSYLHSXA 475
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 349
S PIYHRDIKSTNILLB +YRAKVADFG SKF+A+DQTH+TT++QGTFGYLDPEY QSSQ
Sbjct: 476 SIPIYHRDIKSTNILLBDKYRAKVADFGISKFVAIDQTHLTTQVQGTFGYLDPEYFQSSQ 535
Query: 350 LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMK 409
T+KSDVYSFG+VL+ELLTGKKPI S+E SLA+YF+ SM ++RL D+LD Q++K
Sbjct: 536 FTEKSDVYSFGIVLIELLTGKKPIL--SIASEEGKSLASYFILSMNEDRLSDLLDAQVVK 593
Query: 410 LGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKRA 456
K +I A LA+RC++LNGKKRPTM EV+MEL IR RA
Sbjct: 594 ESRKEEINAIAFLARRCINLNGKKRPTMMEVAMELERIRKCQGDFRA 640
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 470 bits (1210), Expect = e-130, Method: Compositional matrix adjust.
Identities = 229/337 (67%), Positives = 287/337 (85%), Gaps = 9/337 (2%)
Query: 114 IRKKRMDIKLTEKFFKQNGGLLLQQMLNSYDGSVIDRFKLFSSKELDKATNHFNANRILG 173
I K+R +KL + FFK+NGGLLL+Q L+S + + +++ K+F+SKEL+KAT+ ++ NRILG
Sbjct: 349 IIKRRRAMKLKQNFFKRNGGLLLEQQLSSTE-NYVEQTKVFTSKELEKATDDYHTNRILG 407
Query: 174 QGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC 233
QGGQGTVYKGML DGR++A+KKSK+ +D KL++FINE+VILSQINHRNVVKL+GCC
Sbjct: 408 QGGQGTVYKGMLIDGRVVAIKKSKVVDED----KLDQFINEVVILSQINHRNVVKLIGCC 463
Query: 234 LETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPI 293
LETEVPLLVYEFIPNGTLYQ++H+ NEEFP+TWEMRLRIATEVAGALAYLH+A S PI
Sbjct: 464 LETEVPLLVYEFIPNGTLYQYIHN--PNEEFPVTWEMRLRIATEVAGALAYLHAAASMPI 521
Query: 294 YHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDK 353
YHRDIKS+NILLD++YRAKVADFGTSK I++DQTHVTT++QGTFGYLDPEY QSSQ T+K
Sbjct: 522 YHRDIKSSNILLDEKYRAKVADFGTSKSISIDQTHVTTRVQGTFGYLDPEYFQSSQFTEK 581
Query: 354 SDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVK 413
SDVYSFGVVLVELLTG+KPI + S E SLA YF+ +M ++RL +ILD +++K G +
Sbjct: 582 SDVYSFGVVLVELLTGQKPI--SSYRSVEERSLATYFLMTMEESRLFEILDARVLKEGGR 639
Query: 414 NQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450
+I+ A LA++CL+LNGKKRP M+ V++EL GIR S
Sbjct: 640 EEIIAMAKLAEKCLNLNGKKRPKMKTVAIELEGIRSS 676
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075946|ref|XP_002304841.1| predicted protein [Populus trichocarpa] gi|222842273|gb|EEE79820.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 469 bits (1208), Expect = e-130, Method: Compositional matrix adjust.
Identities = 239/353 (67%), Positives = 289/353 (81%), Gaps = 10/353 (2%)
Query: 98 LILIATIITSLV---FLRIIRKKRMDIKLTEKFFKQNGGLLLQQMLNSYDGSVIDRFKLF 154
+++IA I++ L +L + KKR +I+L KFFK+NGGLLLQQ L+S GSV + K+F
Sbjct: 324 VVVIAGILSLLAGISWLYKLAKKRKNIELKRKFFKRNGGLLLQQQLSSNHGSV-QKTKIF 382
Query: 155 SSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINE 214
+SKEL+ AT+ FN NRILGQGGQGTVYKGMLEDGRI+AVK+S T+ EE KLEEFINE
Sbjct: 383 TSKELETATDRFNENRILGQGGQGTVYKGMLEDGRIVAVKRS--TIVGEE--KLEEFINE 438
Query: 215 IVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI 274
+VILSQINHRNVVKL GCCLETEVPLLVYEFI NG L+Q+LH+ +QNE+F L+WEMRL+I
Sbjct: 439 VVILSQINHRNVVKLFGCCLETEVPLLVYEFISNGNLFQYLHNFYQNEDFILSWEMRLQI 498
Query: 275 ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ 334
A EVAGAL+YLHSA S PIYHRDIKS NILLD +YRAKV+DFG+S+ +A+DQTH+TT +Q
Sbjct: 499 AIEVAGALSYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGSSRSMAIDQTHLTTNVQ 558
Query: 335 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394
GTFGYLDPEY QSSQ TDKSDVYSFGVVLVELL+GKKPI +TSQE SLA +F+ M
Sbjct: 559 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLVELLSGKKPII--SSTSQETRSLATHFIVLM 616
Query: 395 RKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
+NRL DILD Q+ + ++ +IM ANLAKRCL+++ K RPTM+EVS EL I
Sbjct: 617 EENRLFDILDVQVKEDCLEEEIMAVANLAKRCLNVSRKHRPTMKEVSAELERI 669
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545824|ref|XP_002513972.1| kinase, putative [Ricinus communis] gi|223547058|gb|EEF48555.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 467 bits (1201), Expect = e-129, Method: Compositional matrix adjust.
Identities = 229/337 (67%), Positives = 285/337 (84%), Gaps = 9/337 (2%)
Query: 114 IRKKRMDIKLTEKFFKQNGGLLLQQMLNSYDGSVIDRFKLFSSKELDKATNHFNANRILG 173
I K+R KL +KFFK+NGGLLL+Q L+S + S +++ K+F+SKEL+KAT++++ +RILG
Sbjct: 344 IIKRRRATKLKQKFFKRNGGLLLEQQLSSTE-SHVEQTKVFTSKELEKATDNYHTSRILG 402
Query: 174 QGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC 233
QGGQGTVYKGML DGR++A+KKSKL +D KL++FINE+VILSQINHRNVVKL GCC
Sbjct: 403 QGGQGTVYKGMLTDGRVVAIKKSKLVDED----KLDQFINEVVILSQINHRNVVKLTGCC 458
Query: 234 LETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPI 293
LETEVPLLVYEFIPNGTL+Q++ + N+EFP+TWEMRLRIATEVAGALAYLHSA S PI
Sbjct: 459 LETEVPLLVYEFIPNGTLFQYIQN--PNKEFPITWEMRLRIATEVAGALAYLHSAASMPI 516
Query: 294 YHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDK 353
YHRDIKS+NILLD++YRAKVADFGTSK IA++QTHVTT +QGTFGYLDPEY QSSQ T+K
Sbjct: 517 YHRDIKSSNILLDEKYRAKVADFGTSKSIAIEQTHVTTLVQGTFGYLDPEYFQSSQFTEK 576
Query: 354 SDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVK 413
SDVYSFGVVLVELLTG+KPI + S E SLA YF+ +M +NRL +ILD +++K G +
Sbjct: 577 SDVYSFGVVLVELLTGQKPI--SSLRSVEERSLATYFLMTMEENRLFEILDARVLKEGGR 634
Query: 414 NQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450
+I+ A +A++CL+LNGKKRP M+ V++EL GIR S
Sbjct: 635 EEIIAMAKMAEKCLNLNGKKRPKMKTVAIELEGIRSS 671
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455808|ref|XP_002274809.1| PREDICTED: wall-associated receptor kinase-like 9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 464 bits (1194), Expect = e-128, Method: Compositional matrix adjust.
Identities = 230/338 (68%), Positives = 285/338 (84%), Gaps = 9/338 (2%)
Query: 114 IRKKRMDIKLTEKFFKQNGGLLLQQMLNSYDGSVIDRFKLFSSKELDKATNHFNANRILG 173
+ +K++DI++ ++FFK+NGGLLLQQ ++S D ++ K+F+S EL+KAT++FN NRILG
Sbjct: 336 VVRKQLDIRVKKRFFKRNGGLLLQQQISS-DKIAFEKTKIFTSDELEKATDNFNKNRILG 394
Query: 174 QGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC 233
QGGQGTVYKGML DGRI+AVKKSK+ VD+ +L E FINEIVILSQINHRNVV +LGCC
Sbjct: 395 QGGQGTVYKGMLNDGRIVAVKKSKI-VDENQL---EHFINEIVILSQINHRNVVGILGCC 450
Query: 234 LETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPI 293
LETEVPLLVYEFI NGTL+Q +HD QN EFPL+WEMRLRIA EV+GAL+YLHSA S PI
Sbjct: 451 LETEVPLLVYEFISNGTLFQLIHD--QNSEFPLSWEMRLRIALEVSGALSYLHSACSIPI 508
Query: 294 YHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDK 353
YHRDIKSTNILLD +Y+AKV+DFGTS+ I++DQTH+TT +QGTFGYLDPEY QSSQ T+K
Sbjct: 509 YHRDIKSTNILLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGTFGYLDPEYFQSSQFTEK 568
Query: 354 SDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVK 413
SDVYSFGVVLVELLTG+KPI + S E SLA +F+ S++++RL DILD +++K G K
Sbjct: 569 SDVYSFGVVLVELLTGQKPI--SSTRSPEEKSLATHFILSLQESRLFDILDARVVKEGRK 626
Query: 414 NQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451
IMTFA LA RCL+LNG+KRPTM+EV+ E++ IR S+
Sbjct: 627 EDIMTFAKLAGRCLNLNGRKRPTMKEVTTEIDNIRVSA 664
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297734146|emb|CBI15393.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 461 bits (1187), Expect = e-127, Method: Compositional matrix adjust.
Identities = 230/338 (68%), Positives = 285/338 (84%), Gaps = 9/338 (2%)
Query: 114 IRKKRMDIKLTEKFFKQNGGLLLQQMLNSYDGSVIDRFKLFSSKELDKATNHFNANRILG 173
+ +K++DI++ ++FFK+NGGLLLQQ ++S D ++ K+F+S EL+KAT++FN NRILG
Sbjct: 216 VVRKQLDIRVKKRFFKRNGGLLLQQQISS-DKIAFEKTKIFTSDELEKATDNFNKNRILG 274
Query: 174 QGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC 233
QGGQGTVYKGML DGRI+AVKKSK+ VD+ +L E FINEIVILSQINHRNVV +LGCC
Sbjct: 275 QGGQGTVYKGMLNDGRIVAVKKSKI-VDENQL---EHFINEIVILSQINHRNVVGILGCC 330
Query: 234 LETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPI 293
LETEVPLLVYEFI NGTL+Q +HD QN EFPL+WEMRLRIA EV+GAL+YLHSA S PI
Sbjct: 331 LETEVPLLVYEFISNGTLFQLIHD--QNSEFPLSWEMRLRIALEVSGALSYLHSACSIPI 388
Query: 294 YHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDK 353
YHRDIKSTNILLD +Y+AKV+DFGTS+ I++DQTH+TT +QGTFGYLDPEY QSSQ T+K
Sbjct: 389 YHRDIKSTNILLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGTFGYLDPEYFQSSQFTEK 448
Query: 354 SDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVK 413
SDVYSFGVVLVELLTG+KPI + S E SLA +F+ S++++RL DILD +++K G K
Sbjct: 449 SDVYSFGVVLVELLTGQKPI--SSTRSPEEKSLATHFILSLQESRLFDILDARVVKEGRK 506
Query: 414 NQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451
IMTFA LA RCL+LNG+KRPTM+EV+ E++ IR S+
Sbjct: 507 EDIMTFAKLAGRCLNLNGRKRPTMKEVTTEIDNIRVSA 544
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475624|ref|XP_002267548.2| PREDICTED: wall-associated receptor kinase-like 9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 460 bits (1184), Expect = e-127, Method: Compositional matrix adjust.
Identities = 229/329 (69%), Positives = 270/329 (82%), Gaps = 9/329 (2%)
Query: 128 FKQNGGLLLQQMLNSYDGSVIDRFKLFSSKELDKATNHFNANRILGQGGQGTVYKGMLED 187
F +NGGLLL+Q L+S G+V D+ KLF+SKEL+KAT+ +N NR++GQGGQGTVYKGML D
Sbjct: 40 FNRNGGLLLEQQLSSSKGNV-DKTKLFTSKELEKATDRYNENRVIGQGGQGTVYKGMLMD 98
Query: 188 GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 247
GRI+AVKK K+ D KLE+FINE+VIL QINHRNVVKLLGCCLETEVPLLVYEFIP
Sbjct: 99 GRIVAVKKLKIMSDS----KLEQFINEVVILCQINHRNVVKLLGCCLETEVPLLVYEFIP 154
Query: 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ 307
NGTL +H+H QNEEFP+TWEMRL+IATEVA AL+YLHSA S PIYHRDIKSTNILLD
Sbjct: 155 NGTLSEHIHG--QNEEFPITWEMRLQIATEVAKALSYLHSAASIPIYHRDIKSTNILLDD 212
Query: 308 RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELL 367
+YRAKVADFGTSKF ++DQTH+TT++QGTFGYLDPEY QSSQ T+KSDVYSFGVVL+ELL
Sbjct: 213 KYRAKVADFGTSKFFSIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLIELL 272
Query: 368 TGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCL 427
TGKKPI S+E SLA YF SM+++ L D+LD +++K G+K I A LA+RC+
Sbjct: 273 TGKKPIL--STRSEERKSLALYFKISMKEDHLSDLLDARVVKEGMKEDINEIAFLARRCI 330
Query: 428 DLNGKKRPTMEEVSMELNGIRGSSKKKRA 456
+LNGKKRPTM EV+MEL IR RA
Sbjct: 331 NLNGKKRPTMMEVAMELERIRKCQGDFRA 359
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | ||||||
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.735 | 0.434 | 0.581 | 7.5e-105 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.728 | 0.455 | 0.583 | 8.6e-104 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.739 | 0.449 | 0.569 | 1.8e-103 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.767 | 0.455 | 0.566 | 9.8e-103 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.705 | 0.439 | 0.582 | 9.8e-103 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.739 | 0.473 | 0.568 | 3.3e-102 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.739 | 0.440 | 0.563 | 2.1e-100 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.739 | 0.436 | 0.563 | 5.6e-100 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.700 | 0.455 | 0.581 | 2.2e-98 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.698 | 0.428 | 0.577 | 1.5e-97 |
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1038 (370.5 bits), Expect = 7.5e-105, P = 7.5e-105
Identities = 207/356 (58%), Positives = 276/356 (77%)
Query: 93 SGYGRLILIATIITSLVFLRIIRKKRMDIKLTEKFFKXXXXXXXXXXXXSYDGSVIDRFK 152
+ +G LI + I L++ + I+K+R + +KFFK S G ++++
Sbjct: 379 ASFGSLIFVVGIY--LLY-KFIKKQRK-LNQKKKFFKRNGGLLLQQQLISTVG-MVEKTI 433
Query: 153 LFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFI 212
+FSS+EL+KAT +F++NRILGQGGQGTVYKGML DGRI+AVKKSK+ VD++ KLEEFI
Sbjct: 434 VFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKV-VDED---KLEEFI 489
Query: 213 NEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRL 272
NE+VILSQINHRN+VKLLGCCLET+VP+LVYEFIPNG L++HLHD +E TW +RL
Sbjct: 490 NEVVILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEF-DENIMATWNIRL 548
Query: 273 RIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK 332
RIA ++AGAL+YLHS+ SSPIYHRD+KSTNI+LD++YRAKV+DFGTS+ + +D TH+TT
Sbjct: 549 RIAIDIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTV 608
Query: 333 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVH 392
+ GT GY+DPEY QSSQ TDKSDVYSFGVVLVEL+TG+K I + SQEN +LA YF+
Sbjct: 609 VSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFL--RSQENRTLATYFIL 666
Query: 393 SMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448
+M++N+L DI+D ++ + +Q+ A +A++CL+L G+KRP+M EVSMEL+ IR
Sbjct: 667 AMKENKLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1028 (366.9 bits), Expect = 8.6e-104, P = 8.6e-104
Identities = 206/353 (58%), Positives = 275/353 (77%)
Query: 98 LILIATIITSLVFLRIIRKKRMDIKLTEKFFKXXXXXXXXXXXXSYDGSVIDRFKLFSSK 157
L+L A I L + ++K+R I++ KFF+ +G+V + ++FSS
Sbjct: 352 LLLFAFGIFGLY--KFVQKRRKLIRM-RKFFRRNGGMLLKQQLARKEGNV-EMSRIFSSH 407
Query: 158 ELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVI 217
EL+KAT++FN NR+LGQGGQGTVYKGML DGRI+AVK+SK VD++ ++EEFINE+V+
Sbjct: 408 ELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSK-AVDED---RVEEFINEVVV 463
Query: 218 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATE 277
L+QINHRN+VKLLGCCLETEVP+LVYEF+PNG L + LHD +++++ +TWE+RL IA E
Sbjct: 464 LAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHD--ESDDYTMTWEVRLHIAIE 521
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF 337
+AGAL+YLHSA S PIYHRDIK+TNILLD+R RAKV+DFGTS+ + +DQTH+TT++ GTF
Sbjct: 522 IAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTF 581
Query: 338 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397
GY+DPEY QSS+ T+KSDVYSFGVVLVELLTG+KP + S+EN LAA+FV ++++N
Sbjct: 582 GYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPS--SRVRSEENRGLAAHFVEAVKEN 639
Query: 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450
R+ DI+DD++ +Q+M+ ANLA+RCL+ GKKRP M EVS+EL IR S
Sbjct: 640 RVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1025 (365.9 bits), Expect = 1.8e-103, P = 1.8e-103
Identities = 206/362 (56%), Positives = 277/362 (76%)
Query: 93 SGYGRLILIATIITSLVFLRIIRKKRMDIKLTEKFFKXXXXXXXXXXXXSYDGSVIDRFK 152
+ + L+ I I F+R R++R++ K +KFFK + +G+V D +
Sbjct: 365 TSFSTLVFIGGIYWLYKFIR--RQRRLNQK--KKFFKRNGGLLLQQQLTTTEGNV-DSTR 419
Query: 153 LFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFI 212
+F+S+EL+KAT +F+ RILG+GGQGTVYKGML DGRI+AVKKSK+ VD++ KLEEFI
Sbjct: 420 VFNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKV-VDED---KLEEFI 475
Query: 213 NEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLT-WEMR 271
NE+VILSQINHRN+VKLLGCCLET+VP+LVYEFIPNG L++HLHD ++++ +T WE+R
Sbjct: 476 NEVVILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHD--DSDDYTMTTWEVR 533
Query: 272 LRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTT 331
LRIA ++AGAL+YLHSA SSPIYHRDIKSTNI+LD+++RAKV+DFGTS+ + +D TH+TT
Sbjct: 534 LRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTT 593
Query: 332 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391
+ GT GY+DPEY QSSQ TDKSDVYSFGVVL EL+TG+K + + SQE +LA YF
Sbjct: 594 VVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFL--RSQEYRTLATYFT 651
Query: 392 HSMRKNRLHDILDDQLMKLGVK-NQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450
+M++NRL DI+D ++ G K NQ+ A +A++CL++ G+KRP+M +VSMEL IR
Sbjct: 652 LAMKENRLSDIIDARIRD-GCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSY 710
Query: 451 SK 452
S+
Sbjct: 711 SE 712
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1018 (363.4 bits), Expect = 9.8e-103, P = 9.8e-103
Identities = 209/369 (56%), Positives = 270/369 (73%)
Query: 85 GSQDSLACSGYGRLILIATIITSLVFLRIIRKKRMDIKLTEKFFKXXXXXXXXXXXXSYD 144
G++ + G G I ++ + +LR KKR K KFFK +
Sbjct: 371 GNKTRVTMIGVGSAFGILVLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNK 430
Query: 145 GSVIDRFKLFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEE 204
G+V ++ ++FSS+EL+KAT++F+ +RILGQGGQGTVYKGML DGR +AVKKSK+ VD++
Sbjct: 431 GNV-EKTRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKV-VDED- 487
Query: 205 LLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEF 264
KLEEFINE+VILSQINHR+VVKLLGCCLETEVP LVYEFIPNG L+QH+H+ +++++
Sbjct: 488 --KLEEFINEVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHE--ESDDY 543
Query: 265 PLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324
TW MRLRIA ++AGAL+YLHSA SSPIYHRDIKSTNILLD++YR KV+DFGTS+ + +
Sbjct: 544 TKTWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTI 603
Query: 325 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENV 384
D TH TT I GT GY+DPEY+ SSQ TDKSDVYSFGVVLVEL+TG+KP+ N SQE
Sbjct: 604 DHTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSN-SQEIR 662
Query: 385 SLAAYFVHSMRKNRLHDILDDQLMKLGVK-NQIMTFANLAKRCLDLNGKKRPTMEEVSME 443
LA +F +M++NR +I+D ++ G K Q+M ANLA+RCL+ GKKRP M +V +
Sbjct: 663 GLADHFRVAMKENRFFEIMDARIRD-GCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTD 721
Query: 444 LNGIRGSSK 452
L I S +
Sbjct: 722 LEKILASQE 730
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1018 (363.4 bits), Expect = 9.8e-103, P = 9.8e-103
Identities = 198/340 (58%), Positives = 263/340 (77%)
Query: 111 LRIIRKKRMDIKLTEKFFKXXXXXXXXXXXXSYDGSVIDRFKLFSSKELDKATNHFNANR 170
++ ++K+R I+ FFK + G+V K+FSSKEL+KAT++FN NR
Sbjct: 368 IKFVKKRRKIIR-KRMFFKRNGGLLLKQQLTTRGGNV-QSSKIFSSKELEKATDNFNMNR 425
Query: 171 ILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+LGQGGQGTVYKGML DGRI+AVK+SK+ DE+ K+EEFINE+ +LSQINHRN+VKL+
Sbjct: 426 VLGQGGQGTVYKGMLVDGRIVAVKRSKVL--DED--KVEEFINEVGVLSQINHRNIVKLM 481
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
GCCLETEVP+LVYE IPNG L++ LH H ++++ +TW++RLRI+ E+AGALAYLHSA S
Sbjct: 482 GCCLETEVPILVYEHIPNGDLFKRLH--HDSDDYTMTWDVRLRISVEIAGALAYLHSAAS 539
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 350
+P+YHRD+K+TNILLD++YRAKV+DFGTS+ I +DQTH+TT + GTFGYLDPEY Q+SQ
Sbjct: 540 TPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQF 599
Query: 351 TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKL 410
TDKSDVYSFGVVLVEL+TG+KP ++ +EN L ++F +M++NR+ DI+D ++ +
Sbjct: 600 TDKSDVYSFGVVLVELITGEKP--FSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEG 657
Query: 411 GVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450
Q++ A LA+RCL L GKKRP M EVS+EL IR S
Sbjct: 658 CTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSS 697
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1013 (361.7 bits), Expect = 3.3e-102, P = 3.3e-102
Identities = 203/357 (56%), Positives = 272/357 (76%)
Query: 96 GRLILIATII--TSLVFLRIIRKKRMDIKLTEKFFKXXXXXXXXXXXXSYDGSVIDRFKL 153
G LI ++ ++ L +L + KKR +I ++KFFK + DG+V + K+
Sbjct: 358 GILIGLSGLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNV-EMSKI 416
Query: 154 FSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFIN 213
FSSKEL KAT++F+ +R+LGQGGQGTVYKGML DG I+AVK+SK+ VD++ K+EEFIN
Sbjct: 417 FSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKV-VDED---KMEEFIN 472
Query: 214 EIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLR 273
EIV+LSQINHRN+VKLLGCCLETEVP+LVYE+IPNG L++ LHD +++++ +TWE+RLR
Sbjct: 473 EIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHD--ESDDYTMTWEVRLR 530
Query: 274 IATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
IA E+AGAL Y+HSA S PI+HRDIK+TNILLD++YRAKV+DFGTS+ + +DQTH+TT +
Sbjct: 531 IAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLV 590
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393
GTFGY+DPEY SSQ T KSDVYSFGVVLVEL+TG+KP+ + S+E LA +F+ +
Sbjct: 591 AGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPL--SRVRSEEGRGLATHFLEA 648
Query: 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450
M++NR+ DI+D ++ Q+M A LA++CL+ GK RP M+EVS EL IR S
Sbjct: 649 MKENRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSS 705
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 996 (355.7 bits), Expect = 2.1e-100, P = 2.1e-100
Identities = 201/357 (56%), Positives = 264/357 (73%)
Query: 91 ACSGYGRLILIATIITSLVFLRIIRKKRMDIKLTEKFFKXXXXXXXXXXXXSYDGSVIDR 150
A +G+G L+L+ + FL K+RM K +KFFK + G V+++
Sbjct: 374 AGTGFGVLVLVGGVWWLRKFLV---KRRM-AKRKKKFFKRNGGLLLQQELNTRQG-VVEK 428
Query: 151 FKLFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEE 210
++F+SKEL+KAT +F+ NR+LG GGQGTVYKGML DGR +AVKKSK+ +D++ KL+E
Sbjct: 429 ARIFTSKELEKATENFSENRVLGHGGQGTVYKGMLVDGRTVAVKKSKV-IDED---KLQE 484
Query: 211 FINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEM 270
FINE+VILSQINHR+VVKLLGCCLETEVP+LVYEFI NG L++H+H+ + +++ + W M
Sbjct: 485 FINEVVILSQINHRHVVKLLGCCLETEVPILVYEFIINGNLFKHIHEE-EADDYTMIWGM 543
Query: 271 RLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT 330
RLRIA ++AGAL+YLHSA SSPIYHRDIKSTNILLD++YRAKVADFGTS+ + +DQTH T
Sbjct: 544 RLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWT 603
Query: 331 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF 390
T I GT GY+DPEY++SSQ T+KSDVYSFGV+L EL+TG KP+ NT QE ++LA +F
Sbjct: 604 TVISGTVGYVDPEYYRSSQYTEKSDVYSFGVILAELITGDKPVIMVQNT-QEIIALAEHF 662
Query: 391 VHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
+M++ RL DI+D ++ Q+M ANLA +CL G+ RP M EV EL I
Sbjct: 663 RVAMKERRLSDIMDARIRDDSKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELERI 719
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 992 (354.3 bits), Expect = 5.6e-100, P = 5.6e-100
Identities = 201/357 (56%), Positives = 264/357 (73%)
Query: 91 ACSGYGRLILIATIITSLVFLRIIRKKRMDIKLTEKFFKXXXXXXXXXXXXSYDGSVIDR 150
A +G+G L+L+ L +LR KR K +KFFK + +G V ++
Sbjct: 383 AGTGFGVLVLVG----GLWWLRKFLIKRRITKRKKKFFKRNGGLLLLQELNTREGYV-EK 437
Query: 151 FKLFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEE 210
++F+S+EL+KAT +F+ NR+LG GGQGTVYKGML DGR +AVKKSK+ +D++ KL+E
Sbjct: 438 TRVFNSRELEKATENFSENRVLGHGGQGTVYKGMLVDGRTVAVKKSKV-IDED---KLQE 493
Query: 211 FINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEM 270
FINE+VILSQINHR+VVKLLGCCLETEVP+LVYEFI NG L++H+H+ +++++ + W M
Sbjct: 494 FINEVVILSQINHRHVVKLLGCCLETEVPMLVYEFIINGNLFKHIHEE-ESDDYTMLWGM 552
Query: 271 RLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT 330
RLRIA ++AGAL+YLHS+ SSPIYHRDIKSTNILLD++YRAKVADFGTS+ + +DQTH T
Sbjct: 553 RLRIAVDIAGALSYLHSSASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWT 612
Query: 331 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF 390
T I GT GY+DPEY+QSSQ T+KSDVYSFGV+L EL+TG KP+ NT QE V+LA +F
Sbjct: 613 TVISGTVGYVDPEYYQSSQYTEKSDVYSFGVILAELITGDKPVIMVQNT-QEIVALAEHF 671
Query: 391 VHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
+M++ RL DI+D ++ Q+M A +A +CL GKKRP M EV EL I
Sbjct: 672 RVAMKEKRLTDIIDARIRNDCKPEQVMAVAKVAMKCLSSKGKKRPNMREVFTELERI 728
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 977 (349.0 bits), Expect = 2.2e-98, P = 2.2e-98
Identities = 197/339 (58%), Positives = 253/339 (74%)
Query: 116 KKRMDIKLTEKFFKXXXXXXXXXXXXSYDGSVIDRFKLFSSKELDKATNHFNANRILGQG 175
+KR K KFF+ GSV +R K+FSS +L+ AT+ FNA+RILGQG
Sbjct: 341 RKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSV-NRTKVFSSNDLENATDRFNASRILGQG 399
Query: 176 GQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE 235
GQGTVYKGMLEDG I+AVKKSK ++ LEEFINEI++LSQINHRNVVK+LGCCLE
Sbjct: 400 GQGTVYKGMLEDGMIVAVKKSKALKEEN----LEEFINEIILLSQINHRNVVKILGCCLE 455
Query: 236 TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYH 295
TEVP+LVYEFIPN L+ HLH+ +E+FP++WE+RL IA EVA AL+YLHSA S PIYH
Sbjct: 456 TEVPILVYEFIPNRNLFDHLHN--PSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYH 513
Query: 296 RDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSD 355
RD+KSTNILLD+++RAKV+DFG S+ +A+D TH+TT +QGT GY+DPEY QS+ T KSD
Sbjct: 514 RDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSD 573
Query: 356 VYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQ 415
VYSFGV+L+ELLTG+KP+ QE L AYF+ +MR +RLH+ILD ++ + + +
Sbjct: 574 VYSFGVLLIELLTGEKPVSLLRR--QEVRMLGAYFLEAMRNDRLHEILDARIKEECDREE 631
Query: 416 IMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKK 454
++ A LA+RCL LN + RPTM +V +EL+ R SK+K
Sbjct: 632 VLAVAKLARRCLSLNSEHRPTMRDVFIELD--RMQSKRK 668
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 969 (346.2 bits), Expect = 1.5e-97, P = 1.5e-97
Identities = 194/336 (57%), Positives = 250/336 (74%)
Query: 112 RIIRKKRMDIKLTEKFFKXXXXXXXXXXXXSYDGSVIDRFKLFSSKELDKATNHFNANRI 171
+++RK+RM + KFFK + G V ++ KLFSS+EL+KAT++FN NR+
Sbjct: 402 KLLRKRRMTNR-KRKFFKRNGGLLLQQQLNTTQGRV-EKTKLFSSRELEKATDNFNDNRV 459
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231
+GQGGQGTVYKGML DGR +AVKKS + VD++ KL+EFINE++ILSQINHR+VVKLLG
Sbjct: 460 IGQGGQGTVYKGMLVDGRSVAVKKSNV-VDED---KLQEFINEVIILSQINHRHVVKLLG 515
Query: 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSS 291
CCLETEVP+LVYEFIPNG L+QHLH+ +++ W +R+RIA +++GA +YLH+A S
Sbjct: 516 CCLETEVPILVYEFIPNGNLFQHLHEEF--DDYTALWGVRMRIAVDISGAFSYLHTAACS 573
Query: 292 PIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 351
PIYHRDIKSTNILLD++YRAKV+DFGTS+ +++D TH TT I GT GY+DPEY+ SS T
Sbjct: 574 PIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFT 633
Query: 352 DKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLG 411
+KSDVYSFGVVLVEL+TG+KP+ T QE LA YF +MR+NRL +I+D ++
Sbjct: 634 EKSDVYSFGVVLVELITGEKPVITLSET-QEITGLADYFRLAMRENRLFEIIDARIRNDC 692
Query: 412 VKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
Q++ ANLA RCL GK RP M EVS L I
Sbjct: 693 KLEQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 468 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-51 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-31 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-28 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-28 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-26 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-24 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-24 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-21 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-16 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-14 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 5e-52
Identities = 89/273 (32%), Positives = 128/273 (46%), Gaps = 25/273 (9%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
R LG G GTVYK G+I+AVK K + + K + EI IL +++H N+V+
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSK--KDQTARREIRILRRLSHPNIVR 62
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
L+ + + LV E+ G L+ +L PL+ + +IA ++ L YLHS
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLS-----RGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 348
I HRD+K NILLD+ K+ADFG +K + + +TT GT Y+ PE
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGG 173
Query: 349 QL-TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407
K DV+S GV+L ELLTG KP F N + L +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTG-KPPFSGENILDQ---LQLIRRILGPPLEFDEPKWSSG 229
Query: 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ +L K+CL+ + KRPT EE+
Sbjct: 230 SE--------EAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 3e-51
Identities = 74/198 (37%), Positives = 105/198 (53%), Gaps = 14/198 (7%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
LG+GG GTVY + G+ +A+K K ++ LEE + EI IL ++NH N+VKL
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKK---EDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
G + LV E+ G+L L + E L+ + LRI ++ L YLH S
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLL----KENEGKLSEDEILRILLQILEGLEYLH---S 110
Query: 291 SPIYHRDIKSTNILLDQR-YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YHQSS 348
+ I HRD+K NILLD + K+ADFG SK + + I GT Y+ PE
Sbjct: 111 NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKG 169
Query: 349 QLTDKSDVYSFGVVLVEL 366
++KSD++S GV+L EL
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 9e-51
Identities = 76/272 (27%), Positives = 117/272 (43%), Gaps = 29/272 (10%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
LG+G G VY + G+++A+K K + E + EI IL ++ H N+V+
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK---DRERILREIKILKKLKHPNIVR 61
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
L + + LV E+ G L+ L R L+ + ++ AL YLHS
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-----RLSEDEARFYLRQILSALEYLHSK 116
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 348
I HRD+K NILLD+ K+ADFG ++ +D T GT Y+ PE
Sbjct: 117 G---IVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFVGTPEYMAPEVLLGK 171
Query: 349 QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLM 408
D++S GV+L ELLTG KP F + + + K
Sbjct: 172 GYGKAVDIWSLGVILYELLTG-KPPFPGDDQ-----------LLELFKKIGKPKPPFPPP 219
Query: 409 KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ + + +L ++ L + +KR T EE
Sbjct: 220 EWDISPE---AKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 1e-48
Identities = 79/278 (28%), Positives = 132/278 (47%), Gaps = 33/278 (11%)
Query: 169 NRILGQGGQGTVYKGMLEDG-----RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
+ LG+G G VYKG L+ +AVK K ++++ EEF+ E I+ +++H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI---EEFLREARIMRKLDH 60
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
N+VKLLG C E E ++V E++P G L +L N L+ L A ++A +
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK---NRPKELSLSDLLSFALQIARGME 117
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
YL S HRD+ + N L+ + K++DFG S+ + D + + ++ PE
Sbjct: 118 YLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE 174
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402
+ + T KSDV+SFGV+L E+ T G++P + G ++ E + Y R + +
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEP--YPGMSNAE---VLEYLKKGYRLPKPPNC 229
Query: 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ L +C + + RPT E+
Sbjct: 230 PPE-------------LYKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 4e-48
Identities = 78/278 (28%), Positives = 132/278 (47%), Gaps = 34/278 (12%)
Query: 169 NRILGQGGQGTVYKGMLED-----GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
+ LG+G G VYKG L+ +AVK K ++++ EEF+ E I+ +++H
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI---EEFLREARIMRKLDH 60
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
NVVKLLG C E E +V E++ G L +L L+ L A ++A +
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGME 116
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
YL S HRD+ + N L+ + K++DFG S+ + D + + ++ PE
Sbjct: 117 YLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE 173
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402
+ + T KSDV+SFGV+L E+ T G++P + G +++E + Y + R + +
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSNEE---VLEYLKNGYRLPQPPNC 228
Query: 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ +L +C + + RPT E+
Sbjct: 229 PPE-------------LYDLMLQCWAEDPEDRPTFSEL 253
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-46
Identities = 84/287 (29%), Positives = 137/287 (47%), Gaps = 43/287 (14%)
Query: 169 NRILGQGGQGTVYKGML-----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
+ LG+G G VYKG L +AVK K +EE EEF+ E I+ +++H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER---EEFLEEASIMKKLSH 60
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
N+V+LLG C + E +V E++P G L L + LT + L++A ++A +
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGME 116
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFG---YL 340
YL S HRD+ + N L+ + K++DFG S+ I D + G ++
Sbjct: 117 YLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWM 171
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399
PE + + T KSDV+SFGV+L E+ T G++P + G +++E + RL
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSNEE---VLELL---EDGYRL 223
Query: 400 --HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444
+ D+L ++M +C + + RPT E+ +L
Sbjct: 224 PRPENCPDEL------YELM------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 1e-45
Identities = 83/287 (28%), Positives = 131/287 (45%), Gaps = 38/287 (13%)
Query: 170 RILGQGGQGTVYKGMLEDG----RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
+ LG+G G VYKG L+ +AVK K +EE ++F+ E ++ ++ H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER---KDFLKEARVMKKLGHPN 57
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFP----LTWEMRLRIATEVAGA 281
VV+LLG C E E LV E++ G L +L P L+ + L A ++A
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GY 339
+ YL S HRD+ + N L+ + K++DFG S+ + D + G +
Sbjct: 118 MEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-GGKLPIRW 173
Query: 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRK-N 397
+ PE + T KSDV+SFGV+L E+ T G P + G +++E + +RK
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--YPGLSNEE-------VLEYLRKGY 224
Query: 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444
RL +++ L C L+ + RPT E+ L
Sbjct: 225 RL-------PKPEYCPDEL---YELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 6e-45
Identities = 84/275 (30%), Positives = 137/275 (49%), Gaps = 32/275 (11%)
Query: 170 RILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+LG+G G+VY + +D G ++AVK +L+ D EE +LE EI ILS + H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE--ELEALEREIRILSSLQHPNIVR 63
Query: 229 LLGCCL-ETEVPLLVY-EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATEVAGALAYL 285
G E + L ++ E++ G+L L + + P E +R ++ LAYL
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLK---KFGKLP---EPVIRKYTRQILEGLAYL 117
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA-MDQTHVTTKIQGTFGYLDPEY 344
HS I HRDIK NIL+D K+ADFG +K + ++ T ++GT ++ PE
Sbjct: 118 HSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 345 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404
+ + +D++S G ++E+ TGK P W S+ +AA + +I +
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPP--W----SELGNPMAALY-KIGSSGEPPEIPE 227
Query: 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
+ K+ + +CL + KKRPT +E
Sbjct: 228 HLSEEA--KDFLR-------KCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 6e-40
Identities = 84/273 (30%), Positives = 119/273 (43%), Gaps = 38/273 (13%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+GG G VYK G+ +A+K + E K E+ INEI IL + H N+VK
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKV----IKLESKEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT---EVAGALAYLHS 287
G L+ + +V EF G+L L +Q + IA E+ L YLHS
Sbjct: 64 GSYLKKDELWIVMEFCSGGSLKDLLKSTNQ--TLTESQ-----IAYVCKELLKGLEYLHS 116
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 347
I HRDIK+ NILL K+ DFG S ++ T + GT ++ PE
Sbjct: 117 NG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVING 171
Query: 348 SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407
K+D++S G+ +EL GK P E + A F I +
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPPYS-------ELPPMKALFK----------IATNGP 214
Query: 408 MKLGVKNQIMT-FANLAKRCLDLNGKKRPTMEE 439
L + F + K+CL N +KRPT E+
Sbjct: 215 PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 78/274 (28%), Positives = 122/274 (44%), Gaps = 30/274 (10%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+ +G+G G VY DG++ +K+ L+ E+ + E+ +NE+ IL ++NH N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK--EREDALNEVKILKKLNHPNIIK 63
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
E +V E+ G L Q + + + + P E L ++ AL YLHS
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGK-PFPEEQILDWFVQLCLALKYLHSR 122
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 348
I HRDIK NI L K+ DFG SK ++ T + GT YL PE Q+
Sbjct: 123 K---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNK 178
Query: 349 QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN--RLHDILDDQ 406
KSD++S G VL EL T K P F N L + ++ + +
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHP-FEGEN-------LLELALKILKGQYPPIPSQYSSE 230
Query: 407 LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
L NL L + ++RP++ ++
Sbjct: 231 L------------RNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 67/212 (31%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 165 HFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
++ ++G+G G VYKG+ LE G +A+K+ L EE L+ + EI +L + H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE--ALKSIMQEIDLLKNLKH 58
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATEVAGAL 282
N+VK +G ++ ++ E+ NG+L Q + + FP E + + +V L
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFP---ESLVAVYVYQVLQGL 112
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 342
AYLH + HRDIK+ NIL + K+ADFG + + D + + GT ++ P
Sbjct: 113 AYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAP 168
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
E + S + SD++S G ++ELLTG P +
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGNPPYY 200
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 78/275 (28%), Positives = 126/275 (45%), Gaps = 32/275 (11%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G G G VY + L+ G ++AVK+ ++ D + ++E +E+ +L + H N+VK
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRI--QDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
G + E + E+ GTL + L +E + ++ LAYLHS
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDE-----HVIRVYTLQLLEGLAYLHSHG- 119
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFG---YLDPEYHQS 347
I HRDIK NI LD K+ DFG + + + T + ++Q G Y+ PE
Sbjct: 120 --IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 348 SQLTDK---SDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404
+ +D++S G V++E+ TGK+P W+ +N + V + K + D
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP--WSE---LDNEFQIMFHVGAGHKPPIPD--S 230
Query: 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
QL G + RCL+ + KKRPT E
Sbjct: 231 LQLSPEGK--------DFLDRCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-30
Identities = 83/280 (29%), Positives = 134/280 (47%), Gaps = 34/280 (12%)
Query: 165 HFNANRILGQG--GQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
H+ R+LG+G G+ T+Y+ ED ++ K+ LT E+ + +NEIVILS +
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDA--LNEIVILSLLQ 57
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQN--EEFPLTWEMRLRIATEVAG 280
H N++ ++ L+ E+ GTLY + + EE + W + ++
Sbjct: 58 HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL-----FQIVS 112
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 340
A++Y+H A I HRDIK+ NI L + K+ DFG SK + + + T + GT Y+
Sbjct: 113 AVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYM 168
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400
PE Q + KSD+++ G VL ELLT K+ F A N V + ++ N
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLTLKR-TFDATNPLNLVVKI-------VQGNY-- 218
Query: 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ V + + +L L + +KRPT +EV
Sbjct: 219 ------TPVVSVYSSELI--SLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 71/273 (26%), Positives = 121/273 (44%), Gaps = 38/273 (13%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G VYK G+ +A+KK +L ++EL+ INEI+I+ H N+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI-----INEILIMKDCKHPNIVDYY 81
Query: 231 GCCLETEVPLLVYEFIPNGTL----YQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH 286
L + +V E++ G+L Q+ + + EV L YLH
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQN--------FVRMNEPQIAYVCREVLQGLEYLH 133
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 346
S + HRDIKS NILL + K+ADFG + + +++ + + GT ++ PE +
Sbjct: 134 SQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPEVIK 189
Query: 347 SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQ 406
K D++S G++ +E+ G+ P L A F + + + + +
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPPYL-------REPPLRALF--LITTKGIPPLKNPE 240
Query: 407 LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
F + +CL + +KRP+ EE
Sbjct: 241 KWS-------PEFKDFLNKCLVKDPEKRPSAEE 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 70/233 (30%), Positives = 110/233 (47%), Gaps = 35/233 (15%)
Query: 170 RILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
R LG+G G V+ G D ++AVK K T ++ ++F E +L+ H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND---ARKDFEREAELLTNFQH 67
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHL--HDRH-------QNEEFPLTWEMRLRI 274
N+VK G C E + P++V+E++ +G L + L H + LT L+I
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 275 ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTT--- 331
A ++A + YL S HRD+ + N L+ K+ DFG S+ + TT
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYY 178
Query: 332 KIQGT----FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNT 379
++ G ++ PE + T +SDV+SFGVVL E+ T GK+P + N
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (292), Expect = 5e-29
Identities = 81/285 (28%), Positives = 124/285 (43%), Gaps = 24/285 (8%)
Query: 165 HFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH- 223
+ R LG+G G VY D +++A+K ++ + +E F+ EI IL+ +NH
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKE-VERFLREIQILASLNHP 57
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
N+VKL + LV E++ G+L L + + L I ++ AL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE--ALFILAQILSALE 115
Query: 284 YLHSATSSPIYHRDIKSTNILLDQ-RYRAKVADFGTSKFIAMDQTHV-----TTKIQGTF 337
YLHS I HRDIK NILLD+ K+ DFG +K + + + GT
Sbjct: 116 YLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 338 GYLDPEYHQSSQL---TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394
GY+ PE L + SD++S G+ L ELLTG P + G + S + +
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP--FEGEKNSSATSQTLKIILEL 230
Query: 395 RKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
L L +L K ++L K+ L + K R +
Sbjct: 231 PTPSLASPLSPSNPELISKA----ASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-29
Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 10/202 (4%)
Query: 172 LGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G V+K + + D R+ A+K+ L+ + + EE I+E +L++++ +++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR--REREEAIDEARVLAKLDSSYIIRYY 65
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
L+ +V E+ NG L++ L + PL + R ++ LA+LHS
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGR---PLPEDQVWRFFIQILLGLAHLHS--- 119
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 350
I HRDIKS N+ LD K+ D G +K ++ D T+ I GT YL PE +
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 351 TDKSDVYSFGVVLVELLTGKKP 372
+KSDV++ GVVL E TGK P
Sbjct: 179 NEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 3e-28
Identities = 78/215 (36%), Positives = 108/215 (50%), Gaps = 20/215 (9%)
Query: 172 LGQGGQGTVYKGMLED-GRIIAVK---KSKLTVDDEELLKLEEFINEIVILSQINHRNVV 227
LG+G G V +D G++ A+K K K+ E E + E ILS+INH +V
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEV----EHTLTERNILSRINHPFIV 56
Query: 228 KLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH 286
KL +TE L LV E+ P G L+ HL ++E + E A E+ AL YLH
Sbjct: 57 KLH-YAFQTEEKLYLVLEYAPGGELFSHL-----SKEGRFSEERARFYAAEIVLALEYLH 110
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 346
S I +RD+K NILLD K+ DFG +K ++ + + T GT YL PE
Sbjct: 111 SLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLL 166
Query: 347 SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381
D +S GV+L E+LTGK P F+A + +
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPP-FYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-28
Identities = 79/289 (27%), Positives = 131/289 (45%), Gaps = 32/289 (11%)
Query: 170 RILGQGGQGTVYKGML--EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVV 227
+ILG+G G+V +G L +DG + V + +D ++EEF++E + +H NV+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 228 KLLGCCLETE------VPLLVYEFIPNGTLYQHL-HDRHQNEEFPLTWEMRLRIATEVAG 280
KL+G C E P+++ F+ +G L+ L + R L + L+ ++A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI-QGTFGY 339
+ YL ++ HRD+ + N +L + VADFG SK I + +I + +
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398
+ E T KSDV++FGV + E+ T G+ P + G EN + Y H R +
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP--YPG---VENHEIYDYLRHGNRLKQ 236
Query: 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
D LD+ +L C + K RPT ++ L I
Sbjct: 237 PEDCLDE-------------LYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 7e-28
Identities = 78/282 (27%), Positives = 125/282 (44%), Gaps = 40/282 (14%)
Query: 166 FNANRILGQGGQGTVYK-GMLEDGRIIAVKKSKL-TVDDEELLKLEEFINEIVILSQINH 223
F + LG+G G+VYK L D + A+K+ L ++ +E E+ +NEI IL+ +NH
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKER---EDAVNEIRILASVNH 58
Query: 224 RNVVK-----LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEV 278
N++ L G L +V E+ P G L + + R + + + + RI ++
Sbjct: 59 PNIISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRK-LIPEQEIWRIFIQL 112
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 338
L LH I HRD+KS NILL K+ D G SK + + T+I GT
Sbjct: 113 LRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISK--VLKKNMAKTQI-GTPH 166
Query: 339 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398
Y+ PE + + KSD++S G +L E+ T P + + Q+ Y V +
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP--FEARSMQD----LRYKVQRGKYPP 220
Query: 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ I L N + L + K RP +++
Sbjct: 221 IPPIYSQDL------------QNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 80/283 (28%), Positives = 119/283 (42%), Gaps = 38/283 (13%)
Query: 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
+ ++LGQG G VYK G+I A+KK + D+E +L E+ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCE 57
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
VVK G + +V E++ G+L D + + + IA ++ L
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSL----ADLLKKVG-KIPEPVLAYIARQILKGL 112
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI----AMDQTHVTTKIQGTFG 338
YLH T I HRDIK +N+L++ + K+ADFG SK + T V GT
Sbjct: 113 DYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVT 165
Query: 339 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398
Y+ PE Q + +D++S G+ L+E GK P G S F M+
Sbjct: 166 YMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---------FFELMQA-- 214
Query: 399 LHDILDDQLMKLGVKNQIMT--FANLAKRCLDLNGKKRPTMEE 439
I D L + + F + CL + KKRP+ E
Sbjct: 215 ---ICDGPPPSL--PAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 68/213 (31%), Positives = 110/213 (51%), Gaps = 21/213 (9%)
Query: 171 ILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDD-----EELLKLEEFINEIVILSQINHRN 225
+LG+G GTVY G+ G++IAVK+ +L + +E KL+E E+ +L + H N
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQE---EVDLLKSLKHVN 63
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
+V+ LG CL+ + EF+P G++ L N PL + + ++ +AYL
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSIL-----NRFGPLPEPVFCKYTKQILDGVAYL 118
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT-----TKIQGTFGYL 340
H ++ + HRDIK N++L K+ DFG ++ +A H T + GT ++
Sbjct: 119 H---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 373
PE S KSD++S G + E+ TGK P+
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 63/218 (28%), Positives = 113/218 (51%), Gaps = 27/218 (12%)
Query: 169 NRILGQGGQGTVYKGML----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
+++G G G V +G L + +A+K K D++ L +F+ E I+ Q +H
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL---DFLTEASIMGQFDHP 65
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
N+++L G ++ +++ E++ NG+L + L R + +F T + + +A + Y
Sbjct: 66 NIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKF--TVGQLVGMLRGIASGMKY 121
Query: 285 LHSATSSPIY-HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK-----IQGTFG 338
L S Y HRD+ + NIL++ KV+DFG S+ + + TTK I+ T
Sbjct: 122 L----SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT-- 175
Query: 339 YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFW 375
PE + T SDV+SFG+V+ E+++ G++P +W
Sbjct: 176 --APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP-YW 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 67/216 (31%), Positives = 108/216 (50%), Gaps = 18/216 (8%)
Query: 169 NRILGQGGQGTVYKGM---LEDGRI-IAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
R +G+G G VY+G+ E+ +I +AVK K E+F+ E I+ Q +H
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS---VREKFLQEAYIMRQFDHP 67
Query: 225 NVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
++VKL+G TE P+ +V E P G L +L Q ++ L + + +++ ALA
Sbjct: 68 HIVKLIGVI--TENPVWIVMELAPLGELRSYL----QVNKYSLDLASLILYSYQLSTALA 121
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
YL S HRDI + N+L+ K+ DFG S+++ + + +K + ++ PE
Sbjct: 122 YLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGN 378
+ T SDV+ FGV + E+L G KP N
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 79/286 (27%), Positives = 128/286 (44%), Gaps = 53/286 (18%)
Query: 166 FNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
F+ LG+G G+VYK + E G+++A+K + D +E++K EI IL Q +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK------EISILKQCDSP 58
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQ--HLHDRHQNEEFPLTWEMRLRIATEVAGA- 281
+VK G + +V E+ G++ + ++ EE IA +
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE---------EIAAILYQTL 109
Query: 282 --LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 339
L YLHS + HRDIK+ NILL++ +AK+ADFG S + T I GT +
Sbjct: 110 KGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFW 165
Query: 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF-VHSMR--- 395
+ PE Q +K+D++S G+ +E+ GK P Y +H MR
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP----------------YSDIHPMRAIF 209
Query: 396 --KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
N+ L D + F + K+CL + ++RP+ +
Sbjct: 210 MIPNKPPPTLSDP------EKWSPEFNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 63/199 (31%), Positives = 106/199 (53%), Gaps = 14/199 (7%)
Query: 172 LGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
LG G G VY+G+ + +AVK K E+ +++EEF+ E ++ +I H N+V+LL
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 231 GCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
G C E P ++ EF+ G L +L + ++ E + L +AT+++ A+ YL
Sbjct: 69 GVCTR-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLEKKN 124
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 349
HRD+ + N L+ + + KVADFG S+ + D + + PE ++
Sbjct: 125 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 181
Query: 350 LTDKSDVYSFGVVLVELLT 368
+ KSDV++FGV+L E+ T
Sbjct: 182 FSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 65/202 (32%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231
+G G G V+ G + R +A+K + E + E+FI E ++ +++H +V+L G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-----EGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSS 291
C E LV+EF+ +G L +L R Q +F + E L + +V +AYL S+
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYL--RAQRGKF--SQETLLGMCLDVCEGMAYLESSN-- 120
Query: 292 PIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 351
+ HRD+ + N L+ + KV+DFG ++F+ DQ +T + + PE S+ +
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 352 DKSDVYSFGVVLVELLT-GKKP 372
KSDV+SFGV++ E+ + GK P
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 170 RILGQGGQGTVYKGMLE-----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
+ LG+G G V + G +AVK L EE +F EI IL ++H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKS--LNHSGEEQ-HRSDFEREIEILRTLDHE 66
Query: 225 NVVKLLGCCLET--EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
N+VK G C + L+ E++P+G+L +L RH+++ + + L ++++ +
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQ---INLKRLLLFSSQICKGM 122
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGY 339
YL S HRD+ + NIL++ K++DFG +K + D+ + K G F Y
Sbjct: 123 DYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179
Query: 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLT 368
PE ++S+ + SDV+SFGV L EL T
Sbjct: 180 -APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 66/213 (30%), Positives = 108/213 (50%), Gaps = 19/213 (8%)
Query: 171 ILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLK-----LEEFINEIVILSQINHR 224
++G G G+VY GM G ++AVK+ +L L+ EI +L ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
N+V+ LG L+ + + E++P G++ L + + E L +I L Y
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVRNFVRQILK----GLNY 121
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK-----IQGTFGY 339
LH+ I HRDIK NIL+D + K++DFG SK + + T +QG+ +
Sbjct: 122 LHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
+ PE + + T K+D++S G ++VE+LTGK P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 68/239 (28%), Positives = 109/239 (45%), Gaps = 37/239 (15%)
Query: 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVK---KSKLTVDDEELLKLEEFINEIVILS 219
+ F +I+G+G TV E + A+K K +L + K++ E +L+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK----KVKYVKIEKEVLT 56
Query: 220 QIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEV 278
++N H ++KL + E V E+ PNG L Q++ ++ + + T R A E+
Sbjct: 57 RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCT---RF-YAAEI 111
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ---- 334
AL YLHS I HRD+K NILLD+ K+ DFGT+K + + + + K
Sbjct: 112 LLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 335 ---------------GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGN 378
GT Y+ PE SD+++ G ++ ++LTGK P F N
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP-FRGSN 226
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 16/219 (7%)
Query: 166 FNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
F R LG G G V++G+ ++ +A+K + ++LLK ++F E+ L ++ H++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIK----ILKSDDLLKQQDFQKEVQALKRLRHKH 63
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
++ L C E ++ E + G+L L E L + +A +VA +AYL
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRS---PEGQVLPVASLIDMACQVAEGMAYL 120
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMD-QTHVTTKIQGTFGYLDPEY 344
HRD+ + NIL+ + KVADFG ++ I D KI + + PE
Sbjct: 121 EEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEA 175
Query: 345 HQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
+ KSDV+SFG++L E+ T G+ P + G + E
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFTYGQVP--YPGMNNHE 212
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 87/279 (31%), Positives = 133/279 (47%), Gaps = 42/279 (15%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDD----EELLKLEEFINEIVILSQINHR 224
+LG G G+VY+G+ L+DG AVK+ L D E + +LE+ EI +LS++ H
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQ---EIALLSKLQHP 62
Query: 225 NVVKLLGCCLETEVPLLVY-EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATE-VAGAL 282
N+V+ LG E + L ++ E +P G+L + L +++ E +R+ T + L
Sbjct: 63 NIVQYLGTEREED-NLYIFLELVPGGSLAKLL------KKYGSFPEPVIRLYTRQILLGL 115
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGYLD 341
YLH HRDIK NIL+D K+ADFG +K + K +G+ ++
Sbjct: 116 EYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMA 169
Query: 342 PEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400
PE Q +D++S G ++E+ TGK P W+ E V AA F R L
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPP--WS---QLEGV--AAVF-KIGRSKELP 221
Query: 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
I D + K+ I+ +CL + RPT E
Sbjct: 222 PIPDH--LSDEAKDFIL-------KCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231
LG G G V+ G +A+K + E + ++FI E ++ +++H N+V+L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-----EGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSS 291
C + +V E++ NG L +L R + + E L + ++V A+ YL S
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYL--RERKGKLGT--EWLLDMCSDVCEAMEYLESNG-- 120
Query: 292 PIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 351
HRD+ + N L+ + KV+DFG ++++ DQ + + + PE S+ +
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 352 DKSDVYSFGVVLVELLT-GKKP 372
KSDV+SFGV++ E+ + GK P
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 82/276 (29%), Positives = 123/276 (44%), Gaps = 31/276 (11%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLK-LEEFINEIVILSQINHRNVV 227
++LGQG G VY ++ GR +AVK+ D E K + EI +L + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 228 KLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS 287
+ GC + E + E++P G++ L LT + + ++ + YLHS
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQL-----KAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK---FIAMDQTHVTTKIQGTFGYLDPEY 344
+ I HRDIK NIL D K+ DFG SK I T + + + GT ++ PE
Sbjct: 123 ---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEV 178
Query: 345 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404
K+DV+S G +VE+LT K P WA E ++AA F + + L
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP--WA-----EFEAMAAIF--KIATQPTNPQLP 229
Query: 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ N +R N KKRP+ EE+
Sbjct: 230 SHVSPDAR--------NFLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 71/278 (25%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231
+G+G G V G G+ +AVK K ++ + F+ E +++ + H N+V+LLG
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLK-----DDSTAAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSS 291
L+ +V E++ G+L +L R +T +L A +V + YL
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEEKN-- 122
Query: 292 PIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 351
HRD+ + N+L+ + AKV+DFG +K + Q ++ T PE + + +
Sbjct: 123 -FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFS 177
Query: 352 DKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH--DILDDQLMK 409
KSDV+SFG++L E I+ G + L H + R+ + ++ K
Sbjct: 178 TKSDVWSFGILLWE-------IYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYK 230
Query: 410 LGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
+ K C +L+ KRPT +++ +L I
Sbjct: 231 ------------VMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 73/211 (34%), Positives = 109/211 (51%), Gaps = 18/211 (8%)
Query: 170 RILGQGGQGTVYKGML--EDGRII--AVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
R++G+G G VY G L DG+ I AVK D EE+ E+F+ E +I+ +H N
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV---EQFLKEGIIMKDFSHPN 57
Query: 226 VVKLLGCCLETE-VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
V+ LLG CL +E PL+V ++ +G L + N T + + +VA + Y
Sbjct: 58 VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP----TVKDLIGFGLQVAKGMEY 113
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI---AMDQTHVTTKIQGTFGYLD 341
L S HRD+ + N +LD+ + KVADFG ++ I H T + ++
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 342 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
E Q+ + T KSDV+SFGV+L EL+T P
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 7e-24
Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 11/201 (5%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+G+G G VYKG+L+ +AVK + T+ + K F+ E IL Q +H N+VKL
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK---FLQEAEILKQYDHPNIVKL 57
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
+G C++ + +V E +P G+L L + ++ LT + L+++ + A + YL S
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFL----RKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI-QGTFGYLDPEYHQSS 348
HRD+ + N L+ + K++DFG S+ V+ + Q + PE
Sbjct: 114 C---IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 349 QLTDKSDVYSFGVVLVELLTG 369
+ T +SDV+S+G++L E +
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 9e-24
Identities = 67/209 (32%), Positives = 107/209 (51%), Gaps = 21/209 (10%)
Query: 172 LGQGGQGTVYKG--MLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
LG G G+V KG +++ G+ + V L + K +EF+ E +++Q++H +V+L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK-KEFLREASVMAQLDHPCIVRL 61
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
+G C E +LV E P G L ++L R + L +A +VA +AYL S
Sbjct: 62 IGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLES-- 113
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPE---Y 344
HRD+ + N+LL R++AK++DFG S+ + + G + + PE Y
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 345 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
+ S KSDV+S+GV L E + G KP
Sbjct: 173 GKFSS---KSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 1e-23
Identities = 83/290 (28%), Positives = 137/290 (47%), Gaps = 35/290 (12%)
Query: 170 RILGQGGQGTVYKGML-EDGRI--IAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNV 226
+ LG+G G+V +G L +D I +AVK K+ + ++E+F++E V + + +H NV
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRS--EMEDFLSEAVCMKEFDHPNV 62
Query: 227 VKLLGCCLETE------VPLLVYEFIPNGTLYQH-LHDRHQNEEFPLTWEMRLRIATEVA 279
++L+G CL+T P+++ F+ +G L+ L+ R + L +M ++ T++A
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI-QGTFG 338
+ YL +S HRD+ + N +L++ VADFG SK I + +I +
Sbjct: 123 SGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 339 YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKN 397
++ E T KSDV+SFGV + E+ T G+ P EN + Y R
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-----PGVENSEIYDYLRQGNRLK 234
Query: 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
+ D LD +L C LN K RP+ E + EL
Sbjct: 235 QPPDCLD-------------GLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 22/219 (10%)
Query: 172 LGQGGQGTVYKGMLED--GRII--AVKKSKLTVDDEELLK-LEEFINEIVILSQINHRNV 226
LG G G V +G G++I AVK + ++L +++F+ E I+ ++H N+
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVK----CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH 286
++L G L T ++V E P G+L L F ++ A ++A + YL
Sbjct: 59 IRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGH-FLIS--TLCDYAVQIANGMRYLE 114
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGT--FGYLDPEY 344
S HRD+ + NILL + K+ DFG + + ++ H + F + PE
Sbjct: 115 S---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 345 HQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAG-NTSQ 381
++ + SDV+ FGV L E+ T G++P WAG + SQ
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEP--WAGLSGSQ 208
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
R LG G G V+ G +AVK K + E F+ E I+ ++ H +V+
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLK-----PGTMSPEAFLQEAQIMKKLRHDKLVQ 65
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
L C E E +V E++ G+L L E L + +A ++A +AYL S
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKS---GEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQ--THVTTK--IQGTFGYLDPEY 344
HRD+ + NIL+ + K+ADFG ++ I D+ K I+ T PE
Sbjct: 123 N---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEA 175
Query: 345 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
+ T KSDV+SFG++L E++T G+ P
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 4e-23
Identities = 68/231 (29%), Positives = 116/231 (50%), Gaps = 29/231 (12%)
Query: 172 LGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKL-EEFINEIVILSQINHR 224
LG+G G VYKG L +A+K T+ + K+ +EF E ++S + H
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIK----TLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHL--HDRHQNEEF---------PLTWEMRLR 273
N+V LLG C + + +++E++ +G L++ L + H + L L
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 274 IATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI-AMDQTHVTTK 332
IA ++A + YL +S HRD+ + N L+ + K++DFG S+ I + D V +K
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 333 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
++ PE + T +SD++SFGVVL E+ + G +P + G ++QE
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY--GFSNQE 234
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 4e-23
Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 30/216 (13%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLK------LEEFINEIVILSQIN 222
++LG G GTVYKG+ + +G K K+ V + L + +E ++E +++ ++
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGE-----KVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
H +VV+LLG CL + L+ + +P G L ++ + H++ L ++A +
Sbjct: 68 HPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRN-HKDNIGSQYL---LNWCVQIAKGM 122
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK-----IQGTF 337
+YL + HRD+ + N+L+ K+ DFG +K + +D+ + I+
Sbjct: 123 SYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK--- 176
Query: 338 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
++ E T KSDV+S+GV + EL+T G KP
Sbjct: 177 -WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 4e-23
Identities = 76/277 (27%), Positives = 128/277 (46%), Gaps = 33/277 (11%)
Query: 171 ILGQGGQGTVYKGM-LEDGRIIAVKK---SKLTVDDEELLKLEEFINEIVILSQINHRNV 226
+G+G GTV K DG+I+ K+ +T +++ L ++E+ IL ++ H N+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL-----VSEVNILRELKHPNI 61
Query: 227 VKLLGCCL--ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
V+ + + +V E+ G L Q L + + E + E RI T++ AL
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 285 LH--SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 342
H S + + HRD+K NI LD K+ DFG +K + D + T + GT Y+ P
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSP 179
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402
E +KSD++S G ++ EL P F A N + LA+ + + R+
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPP-FTARN----QLQLASK-IKEGKFRRIPYR 233
Query: 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
+L N+++ K L+++ KRP+ EE
Sbjct: 234 YSSEL------NEVI------KSMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (245), Expect = 5e-23
Identities = 76/294 (25%), Positives = 124/294 (42%), Gaps = 49/294 (16%)
Query: 171 ILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
LG+G G VYK + G I+A+KK +L ++E + + EI +L ++ H N+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPS--TALREISLLKELKHPNIVKL 63
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
L LV+E+ L ++L R PL+ + I ++ LAY HS
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLDKRPG----PLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 349
I HRD+K NIL+++ K+ADFG ++ + T ++ T Y PE S+
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSK 174
Query: 350 LTDKS-DVYSFGVVLVELLTGKKPIFWA-GNTSQ----------------ENVSLAAYFV 391
+ D++S G + E++TG KP+F Q V+ +
Sbjct: 175 HYSTAVDIWSVGCIFAEMITG-KPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233
Query: 392 HSM---RKNRLHDI---LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
+ L + LD + +L + L N KR + +E
Sbjct: 234 PTFPKFPPKDLEKVLPRLDPEG------------IDLLSKMLQYNPAKRISAKE 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 5e-23
Identities = 68/220 (30%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
+ + ++G G VY + L + +A+K+ L + +E E+ +SQ N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV---DELRKEVQAMSQCN 57
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLY---QHLHDRHQNEEFPLTWEMRLRIAT--- 276
H NVVK + + LV ++ G+L + + R +E IAT
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI--------IATVLK 109
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA--MDQTHVTTK-I 333
EV L YLHS HRDIK+ NILL + K+ADFG S +A D+T K
Sbjct: 110 EVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF 166
Query: 334 QGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
GT ++ PE Q K+D++SFG+ +EL TG P
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-23
Identities = 86/365 (23%), Positives = 156/365 (42%), Gaps = 44/365 (12%)
Query: 90 LACSGYGRLILIATIITSLVFLRIIRKKRMDIKLTEKFFKQNGGLLLQQMLNSYDGSVID 149
+ C+ G +++A + VF+R + +++K E G Q +S
Sbjct: 632 ITCT-LGAFLVLALVAFGFVFIR--GRNNLELKRVE----NEDGTWELQFFDS------- 677
Query: 150 RFKLFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLE 209
K+ S ++ + ++ +G +G YKG + V K ++D +
Sbjct: 678 --KVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKE---INDVNSIPS- 731
Query: 210 EFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWE 269
+EI + ++ H N+VKL+G C + L++E+I L + L + L+WE
Sbjct: 732 ---SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWE 780
Query: 270 MRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHV 329
R +IA +A AL +LH S + ++ I++D + + + D
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCF 839
Query: 330 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAY 389
+ Y+ PE ++ +T+KSD+Y FG++L+ELLTGK P A + S+ +
Sbjct: 840 ISS-----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSP---ADAEFGVHGSIVEW 891
Query: 390 FVHSMRKNRLHDILDDQLMKLGV---KNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446
+ L D+ D ++ V +N+I+ NLA C + RP +V L
Sbjct: 892 ARYCYSDCHL-DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
Query: 447 IRGSS 451
SS
Sbjct: 951 ASRSS 955
|
Length = 968 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-22
Identities = 79/284 (27%), Positives = 131/284 (46%), Gaps = 39/284 (13%)
Query: 171 ILGQGGQGTVYKGM-LEDGRIIAVKKSKLTV-----DDEELLKLEEFIN-EIVILSQINH 223
++G+G G VY + + G ++AVK+ +L D + + + EI L ++H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 224 RNVVKLLGCCLETEVPLLVY-EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
N+V+ LG TE L ++ E++P G++ L + EE ++ +V L
Sbjct: 68 LNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-----QLVRFFTEQVLEGL 121
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK----FIAMDQTHVTTKIQGTFG 338
AYLHS I HRD+K+ N+L+D K++DFG SK DQ +QG+
Sbjct: 122 AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ---NMSMQGSVF 175
Query: 339 YLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396
++ PE S + K D++S G V++E+ G++P W S E A + + + R
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--W----SDEEAIAAMFKLGNKRS 229
Query: 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
I D M L + + + C +N RPT E+
Sbjct: 230 AP--PIPPDVSMNL---SPVA--LDFLNACFTINPDNRPTAREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 14/214 (6%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
R LG G G V++G+ + +AVK K D + +F+ E I+ ++ H +++L
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-----DFLAEAQIMKKLRHPKLIQL 66
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
C E +V E + G+L ++L L + +A +VA +AYL +
Sbjct: 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQN 123
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 349
HRD+ + N+L+ + KVADFG ++ I D + + PE ++
Sbjct: 124 ---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR 180
Query: 350 LTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
+ KSDV+SFG++L E++T G+ P + G T+ E
Sbjct: 181 FSIKSDVWSFGILLTEIVTYGRMP--YPGMTNAE 212
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 77/274 (28%), Positives = 130/274 (47%), Gaps = 35/274 (12%)
Query: 172 LGQGGQGTVYKGMLE--DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
LG G G V K +L G+I+AVK +L +++ ++ + E+ IL + N +V
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQI---LRELDILHKCNSPYIVGF 64
Query: 230 LGCCL-ETEVPLLVYEFIPNGTLYQHLHD-RHQNEEFPLTWEMRLRIATEVAGALAYLHS 287
G ++ + + E++ G+L + L + + + E L +IA V L YLH
Sbjct: 65 YGAFYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE 118
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLDPEYH 345
I HRD+K +NIL++ R + K+ DFG S + ++ +T V GT Y+ PE
Sbjct: 119 KHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERI 171
Query: 346 QSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDD 405
Q + + KSD++S G+ L+EL TG+ P EN F L I+++
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPY------PPENDPPDGIF------ELLQYIVNE 219
Query: 406 QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
+L F + CL + ++RP+ +E
Sbjct: 220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 77/300 (25%), Positives = 125/300 (41%), Gaps = 52/300 (17%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEF----INEIVILSQINHR 224
+G+G G VYK + G ++A+KK ++ ++E+ E F I EI +L ++ H
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRM--ENEK----EGFPITAIREIKLLQKLRHP 58
Query: 225 NVVKLLGCCLETEVP--LLVYEFIPNGTLYQHLHDR---HQNEEFPLTWEMRLRIATEVA 279
N+V+L +V+E++ HD + E T ++
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMD--------HDLTGLLDSPEVKFTESQIKCYMKQLL 110
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 339
L YLHS I HRDIK +NIL++ K+ADFG ++ + T T Y
Sbjct: 111 EGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWY 167
Query: 340 LDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE---------------- 382
PE +++ + D++S G +L EL G KPIF G+T E
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLG-KPIF-QGSTELEQLEKIFELCGSPTDEN 225
Query: 383 --NVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
VS +F + K L + L + +L + L L+ KKR + ++
Sbjct: 226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPS----ALDLLDKLLTLDPKKRISADQA 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 72/271 (26%), Positives = 118/271 (43%), Gaps = 36/271 (13%)
Query: 189 RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 248
++AVK + D E+F+ E+ ILS+++ N+ +LLG C ++ E++ N
Sbjct: 47 VLVAVKVLRPDASDNAR---EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103
Query: 249 GTLYQHLHDRHQNEE-------FPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKST 301
G L Q L +H E L++ L +AT++A + YL S HRD+ +
Sbjct: 104 GDLNQFLQ-KHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR 159
Query: 302 NILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGT----FGYLDPEYHQSSQLTDKSDVY 357
N L+ + Y K+ADFG S+ + + ++QG ++ E + T KSDV+
Sbjct: 160 NCLVGKNYTIKIADFGMSRNL---YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVW 216
Query: 358 SFGVVLVELLT-GKKPIFWAGNTSQ--ENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKN 414
+FGV L E+LT ++ + Q EN H R + L
Sbjct: 217 AFGVTLWEILTLCREQPYEHLTDQQVIENAG------HFFRDDGRQIYLP---RPPNCPK 267
Query: 415 QIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445
I L C + + RPT E+ + L
Sbjct: 268 DIY---ELMLECWRRDEEDRPTFREIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 9e-22
Identities = 86/296 (29%), Positives = 126/296 (42%), Gaps = 48/296 (16%)
Query: 158 ELDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIV 216
E + + +LG+G G VY L IA+K+ D + L E EI
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-DSRYVQPLHE---EIA 57
Query: 217 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTW-EMRLRIA 275
+ S + HRN+V+ LG E + E +P G+L L + PL E +
Sbjct: 58 LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG----PLKDNEQTIIFY 113
Query: 276 T-EVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA--KVADFGTSKFIAMDQTHVTTK 332
T ++ L YLH + I HRDIK N+L++ Y K++DFGTSK +A T
Sbjct: 114 TKQILEGLKYLH---DNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLA-GINPCTET 168
Query: 333 IQGTFGYLDPEYHQSSQLTDK--------SDVYSFGVVLVELLTGKKPIFWAGNTSQENV 384
GT Y+ PE + DK +D++S G +VE+ TGK P G
Sbjct: 169 FTGTLQYMAPE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---- 218
Query: 385 SLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
AA F M K +H + + L KN I RC + + KR + ++
Sbjct: 219 --AAMFKVGMFK--IHPEIPESL-SAEAKNFI-------LRCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 80/276 (28%), Positives = 133/276 (48%), Gaps = 31/276 (11%)
Query: 171 ILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+LG+G G V+KG L+D +AVK K + E LK++ F++E IL Q +H N+VKL+
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE--LKIK-FLSEARILKQYDHPNIVKLI 58
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
G C + + +V E +P G L R + +E L + ++ A + A +AYL S
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFL--RKKKDE--LKTKQLVKFALDAAAGMAYLESKNC 114
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI-QGTFGYLDPEYHQSSQ 349
HRD+ + N L+ + K++DFG S+ D + ++ + Q + PE +
Sbjct: 115 ---IHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGR 170
Query: 350 LTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLM 408
+ +SDV+S+G++L E + G P + G T+Q+ A V + D +
Sbjct: 171 YSSESDVWSYGILLWETFSLGVCP--YPGMTNQQ----AREQVEKGYRMSCPQKCPDDVY 224
Query: 409 KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444
K + +RC D + RP E+ EL
Sbjct: 225 K------------VMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 75/300 (25%), Positives = 135/300 (45%), Gaps = 36/300 (12%)
Query: 171 ILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH---RNV 226
++G+G G VY+G + GR++A+K L D+++ + E+ +LSQ+ N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV---SDIQREVALLSQLRQSQPPNI 64
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH 286
K G L+ ++ E+ G++ R + P+ + I EV AL Y+H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSV------RTLMKAGPIAEKYISVIIREVLVALKYIH 118
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 346
+ HRDIK+ NIL+ K+ DFG + + + + +T + GT ++ PE
Sbjct: 119 KV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVIT 174
Query: 347 SSQLTD-KSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDD 405
+ D K+D++S G+ + E+ TG P S + A + + RL D
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPY------SDVDAFRAMMLIPKSKPPRLEDNGYS 228
Query: 406 QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKRAMFSKIIKRL 465
+L++ CLD K+R + EE+ + I+ SK ++ ++I R
Sbjct: 229 KLLR-----------EFVAACLDEEPKERLSAEELL-KSKWIKAHSKTPVSILKELISRY 276
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 39/285 (13%)
Query: 170 RILGQGGQGTVYKGML-------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
R LGQG G VY+G+ + R+ A+K ++ + + EF+NE ++ + N
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRV-AIKT---VNENASMRERIEFLNEASVMKEFN 67
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEF-----PLTWEMRLRIATE 277
+VV+LLG + L+V E + G L +L R E P T + +++A E
Sbjct: 68 CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI-AMDQTHVTTKIQGT 336
+A +AYL + HRD+ + N ++ + K+ DFG ++ I D K
Sbjct: 128 IADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 337 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMR 395
++ PE + T KSDV+SFGVVL E+ T ++P + G +++E + FV
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP--YQGLSNEEVLK----FVIDGG 238
Query: 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
L + D+L++L M + C N K RPT E+
Sbjct: 239 HLDLPENCPDKLLEL------M------RMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 79/276 (28%), Positives = 117/276 (42%), Gaps = 38/276 (13%)
Query: 172 LGQGGQGTVYKG-MLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G G G VYK + G ++A+K KL D+ E EI +L + H N+V
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDD----FEIIQQEISMLKECRHPNIVAYF 66
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
G L + +V E+ G+L D +Q PL+ + E LAYLH
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSL----QDIYQVTRGPLSELQIAYVCRETLKGLAYLHE--- 119
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ---GTFGYLDPEYHQS 347
+ HRDIK NILL + K+ADFG S + T K + GT ++ PE
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFIGTPYWMAPEVAAV 175
Query: 348 SQLTD---KSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404
+ K D+++ G+ +EL + P+F +H MR L +
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPPMF---------------DLHPMRALFLISKSN 220
Query: 405 DQLMKLGVKNQ-IMTFANLAKRCLDLNGKKRPTMEE 439
KL K + F + K+CL + KKRPT +
Sbjct: 221 FPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATK 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-21
Identities = 76/288 (26%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 171 ILGQGGQGTVYKGML-----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
LG+G G V+ E G + + K+ DE L EF E+ + +++H+N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQ--SEFRRELDMFRKLSHKN 69
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEF----PLTWEMRLRIATEVAGA 281
VV+LLG C E E ++ E+ G L Q L +E PL+ + ++ + T++A
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 341
+ +L +A HRD+ + N L+ + KV+ SK + + + +L
Sbjct: 130 MDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLA 186
Query: 342 PEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRL- 399
PE Q + KSDV+SFGV++ E+ T G+ P + G + +E ++ ++ +L
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP--FYGLSDEE-------VLNRLQAGKLE 237
Query: 400 ---HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444
+ +L K +MT RC +N K RP+ E+ L
Sbjct: 238 LPVPEGCPSRLYK------LMT------RCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 82/295 (27%), Positives = 135/295 (45%), Gaps = 40/295 (13%)
Query: 172 LGQGGQGTVYK---GMLED--GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNV 226
LG+G G+V L+D G ++AVKK + + + L +F EI IL + H N+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH----LRDFEREIEILKSLQHDNI 67
Query: 227 VKLLGCCLETEVP--LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
VK G C LV E++P G+L +L + + L A+++ + Y
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL----LLYASQICKGMEY 123
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLD 341
L S HRD+ + NIL++ R K+ DFG +K + D+ + + G F Y
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA- 179
Query: 342 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401
PE S+ + SDV+SFGVVL EL T S ++ S A F+ M ++
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFT----------YSDKSCSPPAEFMRMMGNDKQGQ 229
Query: 402 ILDDQLMKLGVKNQ--------IMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448
++ L++L N + K C + + +RP+ E+++++ IR
Sbjct: 230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-21
Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 22/271 (8%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231
LG G G+V K + KK + K + + E+ I+ + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK--QILRELQIMHECRSPYIVSFYG 70
Query: 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSS 291
L + EF+ G+L DR + P+ E+ +IA V L YL++
Sbjct: 71 AFLNENNICMCMEFMDCGSL-----DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR- 124
Query: 292 PIYHRDIKSTNILLDQRYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLDPEYHQSSQ 349
I HRDIK +NIL++ R + K+ DFG S + ++ T V GT Y+ PE Q +
Sbjct: 125 -IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGK 178
Query: 350 LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMK 409
T KSDV+S G+ ++EL GK P +A + ++ + + L I+ + +
Sbjct: 179 YTVKSDVWSLGISIIELALGKFP--FAFSNIDDDGQDDPMGILDL----LQQIVQEPPPR 232
Query: 410 LGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
L + + CL + +RPT +++
Sbjct: 233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 9e-21
Identities = 75/273 (27%), Positives = 127/273 (46%), Gaps = 37/273 (13%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+GQG GTVY + + G+ +A+K+ L ++ K E INEI+++ + H N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNL----QQQPKKELIINEILVMRENKHPNIVNYL 82
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT---EVAGALAYLHS 287
L + +V E++ G+L + + +E +IA E AL +LHS
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG---------QIAAVCRECLQALEFLHS 133
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 347
+ + HRDIKS NILL K+ DFG I +Q+ +T + GT ++ PE
Sbjct: 134 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 189
Query: 348 SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407
K D++S G++ +E++ G+ P EN A Y + + L
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYL------NENPLRALYLIATNGTPELQ------- 236
Query: 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ F + RCL+++ +KR + +E+
Sbjct: 237 ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 83/298 (27%), Positives = 132/298 (44%), Gaps = 40/298 (13%)
Query: 166 FNANRILGQGGQGTVYKGML--EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
F R+LG+G G+V + L EDG V L D +EEF+ E + + +H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 224 RNVVKLLGCCLETE------VPLLVYEFIPNGTLYQHL-HDRHQNEEFPLTWEMRLRIAT 276
NV+KL+G L + +P+++ F+ +G L+ L R E F L + +R
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGT 336
++A + YL +S HRD+ + N +L++ VADFG SK I + QG
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR----QGC 173
Query: 337 FGYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYF 390
L ++ L D SDV++FGV + E++T G+ P +AG EN + Y
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP--YAG---VENSEIYNYL 228
Query: 391 VHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448
+ R + D L+D L +C K RP+ + + +L I
Sbjct: 229 IKGNRLKQPPDCLED-------------VYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 20/227 (8%)
Query: 165 HFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKL---TVDDEELLKLEEFINEIVILSQ 220
+ + LG G + Y+ ++ G ++AVK+ T ++E + +E EI ++++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEV-VEALRKEIRLMAR 59
Query: 221 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
+NH +++++LG E L E++ G++ L +E + + ++
Sbjct: 60 LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE-----AVIINYTEQLLR 114
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQR-YRAKVADFGTSKFIAMDQT---HVTTKIQGT 336
L+YLH + I HRD+K N+L+D R ++ADFG + +A T ++ GT
Sbjct: 115 GLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171
Query: 337 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQEN 383
++ PE + Q DV+S G V++E+ T K P W N
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP--W-NAEKHSN 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 25/226 (11%)
Query: 172 LGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
LG+G G V+ +D ++AVK K + +F E +L+ + H++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ----DFQREAELLTVLQHQH 68
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLH----DRHQNEEF------PLTWEMRLRIA 275
+V+ G C E L+V+E++ +G L + L D LT L IA
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 276 TEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI-AMDQTHVTTKIQ 334
+++A + YL S HRD+ + N L+ Q K+ DFG S+ I + D V +
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 335 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNT 379
++ PE + T +SD++SFGVVL E+ T GK+P + NT
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 69/225 (30%), Positives = 100/225 (44%), Gaps = 19/225 (8%)
Query: 170 RILGQGGQGTVYKG----MLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
R LG G G VY+G D + V L E +F+ E +I+S+ NH+N
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ-DESDFLMEALIMSKFNHQN 70
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHL-HDR-HQNEEFPLTWEMRLRIATEVAGALA 283
+V+L+G E ++ E + G L L +R LT + L A +VA
Sbjct: 71 IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 284 YLHSATSSPIYHRDIKSTNILLD----QRYRAKVADFGTSKFI-AMDQTHVTTKIQGTFG 338
YL HRDI + N LL R AK+ADFG ++ I +
Sbjct: 131 YLEENH---FIHRDIAARNCLLTCKGPGRV-AKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 339 YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
++ PE T K+DV+SFGV+L E+ + G P + G T+QE
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP--YPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G VYK G I+A+KK KL + E + K + EI +L ++NH N++KLL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA--LREIKLLKELNHPNIIKLL 64
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFP------LTWEMRLRIATEVAGALAY 284
LV+EF+ + LY+ + + + P +++ L+ LA+
Sbjct: 65 DVFRHKGDLYLVFEFM-DTDLYKLI--KDRQRGLPESLIKSYLYQL-LQ-------GLAF 113
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE- 343
HS I HRD+K N+L++ K+ADFG ++ T + T Y PE
Sbjct: 114 CHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPEL 169
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
+ D++S G + ELL+ +P+F
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSR-RPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 5e-20
Identities = 62/219 (28%), Positives = 116/219 (52%), Gaps = 18/219 (8%)
Query: 164 NHFNANRILGQGGQGTVYKGMLE-DGR---IIAVKKSKLTVDDEELLKLEEFINEIVILS 219
+H +++G G G V++G+L+ GR +A+K K +++ ++F++E I+
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR---QDFLSEASIMG 61
Query: 220 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVA 279
Q +H N+++L G + + +++ E++ NG L ++L D H E LR +A
Sbjct: 62 QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSYQLVGMLR---GIA 117
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMD--QTHVTTKIQGTF 337
+ YL HRD+ + NIL++ KV+DFG S+ + D T+ T+ +
Sbjct: 118 AGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174
Query: 338 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFW 375
+ PE + T SDV+SFG+V+ E+++ G++P +W
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP-YW 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 5e-20
Identities = 66/209 (31%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 165 HFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
HF R++G+G G V D + + K E + +NE IL ++NH
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATEVAGALA 283
+V L + E LV + + G L HL Q +F E +++ E+ AL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLS---QKVKFS---EEQVKFWICEIVLALE 114
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
YLHS I HRDIK NILLD++ + DF + + D +TT GT GY+ PE
Sbjct: 115 YLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPE 169
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
+ D +S GV E L GK+P
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-20
Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 30/231 (12%)
Query: 170 RILGQGGQGTVYKGM------LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
R LG+G G V+ +D ++AVK + D L ++F E +L+ + H
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVK----ALKDPTLAARKDFQREAELLTNLQH 66
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHL-------------HDRHQNEEFPLTWEM 270
++VK G C + + ++V+E++ +G L + L R E L+
Sbjct: 67 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS--Q 124
Query: 271 RLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI-AMDQTHV 329
L IA+++A + YL S HRD+ + N L+ K+ DFG S+ + + D V
Sbjct: 125 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 330 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNT 379
++ PE + T +SDV+SFGV+L E+ T GK+P F NT
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 7e-20
Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G V K G I+A+KK K + DDE++ K + E+ +L Q+ H N+V L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA--LREVKVLRQLRHENIVNLK 66
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFP--LTWEMRLRIATEVAGALAYLHSA 288
LV+E++ TL + L E P L + ++ A+AY HS
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELL------EASPGGLPPDAVRSYIWQLLQAIAYCHS- 118
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 348
I HRDIK NIL+ + K+ DFG ++ + T T Y PE
Sbjct: 119 --HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 349 QLTDKS-DVYSFGVVLVELLTGKKPIF 374
K DV++ G ++ ELL G +P+F
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDG-EPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 8e-20
Identities = 58/209 (27%), Positives = 109/209 (52%), Gaps = 16/209 (7%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLE-EFINEIVILSQINHRNVV 227
++LG G GTVYKG+ + +G + + + +++ K EF++E +I++ ++H ++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 228 KLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQN--EEFPLTWEMRLRIATEVAGALAYL 285
+LLG CL + LV + +P+G L ++H+ N + L W ++A + YL
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 125
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGYLDPEY 344
+ HRD+ + N+L+ K+ DFG ++ + D+ + ++ E
Sbjct: 126 EERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 345 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
+ T +SDV+S+GV + EL+T G KP
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 9e-20
Identities = 79/311 (25%), Positives = 131/311 (42%), Gaps = 53/311 (17%)
Query: 169 NRILGQGGQGTVYKGMLED--GR----IIAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
+ LG+G G V K GR +AVK K EL L ++E +L Q+N
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDL---LSEFNLLKQVN 61
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHL--------------------HDRHQNE 262
H +V+KL G C + LL+ E+ G+L L + + +E
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 263 EFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322
LT + A +++ + YL + HRD+ + N+L+ + + K++DFG S+ +
Sbjct: 122 R-ALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 323 AMDQTHVT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTS 380
+ ++V +K + ++ E T +SDV+SFGV+L E++T G P + G
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YPGIAP 235
Query: 381 QENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ RL ++L +N NL C KRPT ++
Sbjct: 236 E----------------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
Query: 441 SMELNGIRGSS 451
S EL + S
Sbjct: 280 SKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 9e-20
Identities = 70/220 (31%), Positives = 102/220 (46%), Gaps = 27/220 (12%)
Query: 166 FNANRILGQGGQGTVYKGML----EDGRIIAVKKSKLTVDDEELLKL---EEFINEIVIL 218
F + LG G G V ML G+ A+K + +++KL E +NE IL
Sbjct: 3 FEFIKTLGTGSFGRV---MLVRHKGSGKYYALK----ILSKAKIVKLKQVEHVLNEKRIL 55
Query: 219 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEV 278
I H +V L G + LV E++P G L+ HL ++ FP A +V
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR---KSGRFPEPVARFY--AAQV 110
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 338
AL YLHS I +RD+K N+LLD K+ DFG +K + +T+ + GT
Sbjct: 111 VLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTYT---LCGTPE 163
Query: 339 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGN 378
YL PE S D ++ G+++ E+L G P F+ N
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP-FFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 81/279 (29%), Positives = 121/279 (43%), Gaps = 26/279 (9%)
Query: 170 RILGQGGQGTV----YKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
R+LG+G G V Y + G ++AVK K + + EI IL + H
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK---RECGQQNTSGWKKEINILKTLYHE 66
Query: 225 NVVKLLGCCLET--EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
N+VK GCC E + L+ E++P G+L +L +H+ L L A ++ +
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHK-----LNLAQLLLFAQQICEGM 120
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGY 339
AYLHS HRD+ + N+LLD K+ DFG +K + + + G F Y
Sbjct: 121 AYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 177
Query: 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399
E + ++ + SDV+SFGV L ELLT +E + M RL
Sbjct: 178 A-VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQ---GQMTVVRL 233
Query: 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTME 438
++L+ + KN L K C + K RPT
Sbjct: 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 65/230 (28%), Positives = 111/230 (48%), Gaps = 31/230 (13%)
Query: 170 RILGQGGQGTVYK----GML--EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
R +GQG G V++ G+L E ++AVK K ++ +F E ++++ +H
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDH 67
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDR--HQNEEF---------------PL 266
N+VKLLG C + L++E++ G L + L R PL
Sbjct: 68 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 267 TWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI-AMD 325
+ +L IA +VA +AYL + HRD+ + N L+ + K+ADFG S+ I + D
Sbjct: 128 SCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 326 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIF 374
+ ++ PE ++ T +SDV+++GVVL E+ + G +P +
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 172 LGQGGQGTVYKG---MLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
LG G GTV KG M + + +AVK K +D L +E + E ++ Q+++ +V+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALK--DELLREANVMQQLDNPYIVR 60
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
++G C E E +LV E G L + L E +T + +V+ + YL
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-----ELVHQVSMGMKYLEE- 113
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPEYHQ 346
+ HRD+ + N+LL ++ AK++DFG SK + D+ + K G + + PE
Sbjct: 114 --TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171
Query: 347 SSQLTDKSDVYSFGVVLVELLT-GKKP 372
+ + KSDV+SFGV++ E + G+KP
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 80/278 (28%), Positives = 127/278 (45%), Gaps = 34/278 (12%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLK-LEEFINEIVILSQINHRNVV 227
++LGQG G VY ++ GR +A K+ + + E K + EI +L + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 228 KLLGCCLE-TEVPLLVY-EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
+ GC + E L ++ E++P G++ L LT + + ++ ++YL
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-----KAYGALTESVTRKYTRQILEGMSYL 122
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK---FIAMDQTHVTTKIQGTFGYLDP 342
HS + I HRDIK NIL D K+ DFG SK I M T + + + GT ++ P
Sbjct: 123 HS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSP 178
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402
E K+DV+S G +VE+LT K P WA E ++AA F
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPP--WA-----EYEAMAAIFK----------- 220
Query: 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ Q + + I A C+ + + RP+ EE+
Sbjct: 221 IATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-19
Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 17/213 (7%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEF--INEIVILSQINHRNV 226
R++G+G G V+ D +++ +K+ + E++ K E NE +L ++H N+
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQ----IPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH 286
++ LE + ++V E+ P GTL +++ R N + L ++ AL ++H
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLD--EDTILHFFVQILLALHHVH 118
Query: 287 SATSSPIYHRDIKSTNILLDQRYR-AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 345
+ I HRD+K+ NILLD+ K+ DFG SK ++ T + GT Y+ PE
Sbjct: 119 TKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELC 173
Query: 346 QSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGN 378
+ KSD+++ G VL EL + K+ F A N
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRA-FEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-19
Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 170 RILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
R LG+G G V+ +D ++AVK K D+ ++F E +L+ + H
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR----KDFHREAELLTNLQH 66
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDR--------HQNEEFPLTWEMRLRIA 275
++VK G C+E + ++V+E++ +G L + L N LT L IA
Sbjct: 67 EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 276 TEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI-AMDQTHVTTKIQ 334
++A + YL S HRD+ + N L+ + K+ DFG S+ + + D V
Sbjct: 127 QQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183
Query: 335 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGN 378
++ PE + T +SDV+S GVVL E+ T GK+P + N
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 5e-19
Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 38/217 (17%)
Query: 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+G G GTVYK + GR+ A+K +D + EI IL +NH NVVK
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT---VRRQICREIEILRDVNHPNVVK 136
Query: 229 LLGCCLET-----EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
C + E+ +L+ EF+ G+L H +E L +A ++ +A
Sbjct: 137 ----CHDMFDHNGEIQVLL-EFMDGGSL----EGTHIADEQFLA-----DVARQILSGIA 182
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA--MDQTHVTTKIQGTFGYLD 341
YLH I HRDIK +N+L++ K+ADFG S+ +A MD + + GT Y+
Sbjct: 183 YLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV---GTIAYMS 236
Query: 342 PEYHQSSQLTD------KSDVYSFGVVLVELLTGKKP 372
PE ++ L D++S GV ++E G+ P
Sbjct: 237 PE-RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 5e-19
Identities = 70/282 (24%), Positives = 129/282 (45%), Gaps = 37/282 (13%)
Query: 172 LGQGGQGTVYKGMLEDG--RIIAVKKSKLT------VDDEELLKLEEFINEIVIL-SQIN 222
LG G G VYK ++ ++A+K+ + E + + ++E+ I+ Q+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 223 HRNVVKLLGCCLETEVPLLVYEFI---PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVA 279
H N+V+ LE + +V + I P G + L ++ Q W + +++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 339
AL YLH I HRD+ NI+L + + + DFG +K T + GT Y
Sbjct: 125 -ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILY 179
Query: 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399
PE ++ +K+DV++FG +L ++ T +P F++ N +SLA V +
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYSTNM----LSLATKIV-----EAV 229
Query: 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVS 441
++ L + G+ ++ +T + CL + + RP + +VS
Sbjct: 230 YEPLPE-----GMYSEDVTD--VITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 6e-19
Identities = 74/229 (32%), Positives = 109/229 (47%), Gaps = 24/229 (10%)
Query: 170 RILGQGGQGTVYKGMLED------GRI-IAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
LG G G VY+G D G I +AVK + D+E +EF+ E ++S N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK---KEFLKEAHLMSNFN 57
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHD-RHQNEEFP-LTWEMRLRIATEVAG 280
H N+VKLLG CL E ++ E + G L +L D R + P LT + L I +VA
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 281 ALAYLHSATSSPIYHRDIKSTNILL-----DQRYRAKVADFGTSKFI-AMDQTHVTTKIQ 334
YL HRD+ + N L+ D K+ DFG ++ I D +
Sbjct: 118 GCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 335 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
++ PE + T +SDV+SFGV++ E+LT G++P + +QE
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP--YPALNNQE 221
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 6e-19
Identities = 74/278 (26%), Positives = 119/278 (42%), Gaps = 49/278 (17%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G VYK + +++A+K L ++E+ E+ EI LSQ + K
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI---EDIQQEIQFLSQCRSPYITKYY 65
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT---EVAGALAYLHS 287
G L+ ++ E+ G+ L +E + IA EV L YLH
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY---------IAFILREVLLGLEYLHE 116
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 347
HRDIK+ NILL + K+ADFG S + + T + GT ++ PE +
Sbjct: 117 EGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQ 172
Query: 348 SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR------KNRLHD 401
S +K+D++S G+ +EL G+ P L+ H MR KN
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPP-------------LSDL--HPMRVLFLIPKNNPPS 217
Query: 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
+ ++ K F + CL+ + K+RP+ +E
Sbjct: 218 LEGNKFSKP--------FKDFVSLCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 7e-19
Identities = 83/297 (27%), Positives = 136/297 (45%), Gaps = 33/297 (11%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
LG+G G+V K L++ +I K+ T + +L K + + E+ I +VK
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK--QILRELEINKSCKSPYIVKY 64
Query: 230 LGCCL---ETEVPLLVYEFIPNGTL---YQHLHDR-HQNEEFPLTWEMRLRIATEVAGAL 282
G L + + + + E+ G+L Y+ + R + E L +IA V L
Sbjct: 65 YGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVL-----GKIAESVLKGL 118
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS-KFI-AMDQTHVTTKIQGTFGYL 340
+YLHS I HRDIK +NILL ++ + K+ DFG S + + ++ T GT Y+
Sbjct: 119 SYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYM 170
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400
PE Q + SDV+S G+ L+E+ + P G + L +Y V +M L
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPELK 229
Query: 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKRAM 457
D + + F + K+CL+ + +RPT ++ +E I+ KKK M
Sbjct: 230 DEPGNGI------KWSEEFKDFIKQCLEKDPTRRPTPWDM-LEHPWIKAQMKKKVNM 279
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 7e-19
Identities = 73/270 (27%), Positives = 128/270 (47%), Gaps = 31/270 (11%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+GQG GTVY M + G+ +A+++ L ++ K E INEI+++ + + N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
L + +V E++ G+L + + +E + E AL +LHS
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHS--- 134
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 350
+ + HRDIKS NILL K+ DFG I +Q+ + + GT ++ PE
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAY 193
Query: 351 TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKL 410
K D++S G++ +E++ G+ P EN A Y + + L + ++L +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGTPELQN--PEKLSAI 245
Query: 411 GVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
F + RCLD++ +KR + +E+
Sbjct: 246 --------FRDFLNRCLDMDVEKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 8e-19
Identities = 74/228 (32%), Positives = 110/228 (48%), Gaps = 23/228 (10%)
Query: 170 RILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLK-LEEFINEIVILSQINHRNVV 227
++LG+G G VY D GR +AVK+ D +E K + EI +L + H +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 228 KLLGCCLE-TEVPLLVY-EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
+ GC + E L ++ E++P G++ L LT + R ++ ++YL
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-----KAYGALTENVTRRYTRQILQGVSYL 122
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK---FIAMDQTHVTTKIQGTFGYLDP 342
HS + I HRDIK NIL D K+ DFG SK I M T + + + GT ++ P
Sbjct: 123 HS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSP 178
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF 390
E K+DV+S +VE+LT K P WA E ++AA F
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP--WA-----EYEAMAAIF 219
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 60/211 (28%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 165 HFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
I+G+G G V +G G+ +AVK K V + F+ E ++++++H+
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDV------TAQAFLEETAVMTKLHHK 59
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
N+V+LLG L + +V E + G L L R + ++ L+ + +VA + Y
Sbjct: 60 NLVRLLGVILHNGL-YIVMELMSKGNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEY 115
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF--IAMDQTHVTTKIQGTFGYLDP 342
L S + HRD+ + NIL+ + AKV+DFG ++ + +D + + K + P
Sbjct: 116 LES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAP 166
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
E + + + KSDV+S+GV+L E+ + G+ P
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 13/204 (6%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+ LG G G V+ G +A+K E + E+FI E ++ +++H +V+L
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAIN-----EGAMSEEDFIEEAKVMMKLSHPKLVQL 64
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
G C + + +V EF+ NG L +L R L+ +M L + +V + YL
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK----LSKDMLLSMCQDVCEGMEYLE--- 117
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 349
+ HRD+ + N L+ KV+DFG ++++ D+ ++ + + PE S+
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 350 LTDKSDVYSFGVVLVELLT-GKKP 372
+ KSDV+SFGV++ E+ T GK P
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231
LG G G V G +A+K K E + +EFI E ++ +++H +V+L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSS 291
C + +V E++ NG L +L + + + EM +V +AYL S
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEM----CKDVCEGMAYLESKQ-- 120
Query: 292 PIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 351
HRD+ + N L+D + KV+DFG S+++ D+ + + + PE S+ +
Sbjct: 121 -FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFS 179
Query: 352 DKSDVYSFGVVLVELLT-GKKP 372
KSDV++FGV++ E+ + GK P
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 172 LGQGGQGTVYK-GMLEDGRIIAVKKSKLTVDDEELLKLEEFI-----NEIVILSQINHRN 225
+G+G G V+K E G +A+KK L +LE I EI L H
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALR-------RLEGGIPNQALREIKALQACQHPY 60
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
VVKLL +LV E++P+ L + ++EE PL + +AY+
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 345
H+ I HRD+K N+L+ K+ADFG ++ + ++ + + T Y PE
Sbjct: 116 HANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172
Query: 346 QSSQLTDKS-DVYSFGVVLVELLTGKKPIF 374
++ D D+++ G + ELL G P+F
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNG-SPLF 201
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDE-ELLKLEEFINEIVILSQINHRNVVKL 229
+G+G G V GR +AVKK L ELL NE+VI+ H N+V++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELL-----FNEVVIMRDYQHPNIVEM 81
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT---EVAGALAYLH 286
L + +V EF+ G L + NEE +IAT V AL++LH
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---------QIATVCLAVLKALSFLH 132
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEY 344
+ + HRDIKS +ILL R K++DFG F A V + + GT ++ PE
Sbjct: 133 A---QGVIHRDIKSDSILLTSDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPEV 186
Query: 345 HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
+ D++S G++++E++ G+ P F
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYF 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 170 RILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLE-EFINEIVILSQIN 222
R LGQG G VY+G+ E +A+K TV++ ++ EF+NE ++ + N
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIK----TVNEAASMRERIEFLNEASVMKEFN 67
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEE-----FPLTWEMRLRIATE 277
+VV+LLG + + L++ E + G L +L E P + + +++A E
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI-AMDQTHVTTKIQGT 336
+A +AYL+ ++ HRD+ + N ++ + + K+ DFG ++ I D K
Sbjct: 128 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 337 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 368
++ PE + T SDV+SFGVVL E+ T
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 13/216 (6%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
+F + +G+G VYK + L DGR++A+KK ++ + + ++ + EI +L Q+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQI-FEMMDAKARQDCLKEIDLLKQL 59
Query: 222 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHL-HDRHQNEEFP--LTWEMRLRIATEV 278
+H NV+K L +E +V E G L + + H + Q P W+ +++ +
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS-- 117
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 338
AL ++HS I HRDIK N+ + K+ D G +F + T + + GT
Sbjct: 118 --ALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 171
Query: 339 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
Y+ PE + KSD++S G +L E+ + P +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 3e-18
Identities = 70/270 (25%), Positives = 130/270 (48%), Gaps = 31/270 (11%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+GQG GTV+ + + G+ +A+K+ L ++ K E INEI+++ ++ + N+V L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINL----QKQPKKELIINEILVMKELKNPNIVNFL 82
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
L + +V E++ G+L + + +E + E AL +LH+
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTETCMDEA------QIAAVCRECLQALEFLHA--- 133
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 350
+ + HRDIKS N+LL K+ DFG I +Q+ +T + GT ++ PE
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 192
Query: 351 TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKL 410
K D++S G++ +E++ G+ P EN A Y + + L + ++L +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYL------NENPLRALYLIATNGTPELQN--PEKLSPI 244
Query: 411 GVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
F + RCL+++ +KR + +E+
Sbjct: 245 --------FRDFLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 86/297 (28%), Positives = 124/297 (41%), Gaps = 45/297 (15%)
Query: 159 LDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVI 217
L T F ++G+G G VYK + G+++A+K + D+EE +K E N +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE--YNILRK 58
Query: 218 LSQINHRNVVKLLGCCLETEVPL------LVYEFIPNGT---LYQHLHDRHQNEEFPLTW 268
S NH N+ G ++ P LV E G+ L + L + + L
Sbjct: 59 YS--NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK----RLKE 112
Query: 269 EMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH 328
E I E LAYLH + + HRDIK NILL + K+ DFG S +
Sbjct: 113 EWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169
Query: 329 VTTKIQGTFGYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFWAGNTSQEN 383
T I GT ++ PE + D +SDV+S G+ +EL GK P+
Sbjct: 170 RNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC--------- 219
Query: 384 VSLAAYFVHSMRKNRLHDILDDQLMKL-GVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
+H MR L I + L +N F + CL N ++RP MEE
Sbjct: 220 ------DMHPMRA--LFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEE 268
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 56/174 (32%), Positives = 76/174 (43%), Gaps = 19/174 (10%)
Query: 217 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIA 275
ILSQ VVKL + + L LV E++P G L L + +E ++
Sbjct: 46 ILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE-----DVARIYI 99
Query: 276 TEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHV------ 329
E+ AL YLHS I HRD+K NIL+D K+ DFG SK + +
Sbjct: 100 AEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156
Query: 330 -TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE 382
+I GT Y+ PE + D +S G +L E L G P G T +E
Sbjct: 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH--GETPEE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 4e-18
Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 34/215 (15%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFIN--EIVILSQIN-HRNVV 227
LG G G+VY E G ++A+KK K ++ EE +N E+ L ++N H N+V
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-----KKFYSWEECMNLREVKSLRKLNEHPNIV 61
Query: 228 KLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLR-IATEVAGALAYLH 286
KL E + V+E++ G LYQ + DR + + F E +R I ++ LA++H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDR-KGKPFS---ESVIRSIIYQILQGLAHIH 116
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE--- 343
+HRD+K N+L+ K+ADFG ++ I + T + T Y PE
Sbjct: 117 KHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILL 171
Query: 344 ----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
Y SS + D+++ G ++ EL T +P+F
Sbjct: 172 RSTSY--SSPV----DIWALGCIMAELYTL-RPLF 199
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 5e-18
Identities = 72/270 (26%), Positives = 128/270 (47%), Gaps = 31/270 (11%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+GQG GTVY + + G+ +A+K+ L ++ K E INEI+++ + + N+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 82
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
L + +V E++ G+L + + +E + E AL +LHS
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALDFLHS--- 133
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 350
+ + HRDIKS NILL K+ DFG I +Q+ +T + GT ++ PE
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 192
Query: 351 TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKL 410
K D++S G++ +E++ G+ P EN A Y + + L + ++L +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYL------NENPLRALYLIATNGTPELQN--PERLSAV 244
Query: 411 GVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
F + RCL+++ +R + +E+
Sbjct: 245 --------FRDFLNRCLEMDVDRRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 6e-18
Identities = 72/228 (31%), Positives = 110/228 (48%), Gaps = 23/228 (10%)
Query: 170 RILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLK-LEEFINEIVILSQINHRNVV 227
++LGQG G VY D GR +AVK+ + + E K + EI +L + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 228 KLLGCCLET-EVPLLVY-EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
+ GC + E L ++ E +P G++ L LT + + ++ ++YL
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-----LTENVTRKYTRQILEGVSYL 122
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK---FIAMDQTHVTTKIQGTFGYLDP 342
HS + I HRDIK NIL D K+ DFG SK I + T + + + GT ++ P
Sbjct: 123 HS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSP 178
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF 390
E K+D++S G +VE+LT K P WA E ++AA F
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP--WA-----EFEAMAAIF 219
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 172 LGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G V + GR +AVK +D + + E NE+VI+ H+NVV++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK----MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT---EVAGALAYLHS 287
L E ++ EF+ G L + NEE +IAT V AL YLHS
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQTRLNEE---------QIATVCESVLQALCYLHS 135
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 347
+ HRDIKS +ILL R K++DFG I+ D + + GT ++ PE
Sbjct: 136 ---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISR 191
Query: 348 SQLTDKSDVYSFGVVLVELLTGKKPIF 374
+ + D++S G++++E++ G+ P F
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGEPPYF 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 60/185 (32%), Positives = 97/185 (52%), Gaps = 14/185 (7%)
Query: 188 GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVPLLVYEF 245
G +AVK K + L++ EI IL + H N+VK G C E L+ EF
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 89
Query: 246 IPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL 305
+P+G+L ++L R++N+ + + +L+ A ++ + YL S HRD+ + N+L+
Sbjct: 90 LPSGSLKEYL-PRNKNK---INLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLV 142
Query: 306 DQRYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVL 363
+ ++ K+ DFG +K I D+ + T K + + PE S+ SDV+SFGV L
Sbjct: 143 ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTL 202
Query: 364 VELLT 368
ELLT
Sbjct: 203 YELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 68/216 (31%), Positives = 99/216 (45%), Gaps = 33/216 (15%)
Query: 172 LGQGGQGTVYKGML--EDGRIIAVKKSKLTVDDEE----LLKLEEFINEIVILSQINHRN 225
+G+G GTV K ML G I+AVK+ + TVD++E L+ L+ V++ +
Sbjct: 12 IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD------VVMRSSDCPY 64
Query: 226 VVKLLGCCLETEVPLLVYEF--IPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
+VK G + E I Y+++++ P E+ +IA AL
Sbjct: 65 IVKFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIP--EEILGKIAVATVKALN 121
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF----IAMDQTHVTTKIQGTFGY 339
YL I HRD+K +NILLD+ K+ DFG S IA T+ G Y
Sbjct: 122 YLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA------KTRDAGCRPY 173
Query: 340 LDPEYHQSSQLTD---KSDVYSFGVVLVELLTGKKP 372
+ PE S +SDV+S G+ L E+ TGK P
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 56/205 (27%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 172 LGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
LG G G V KG+ + + I V L ++E+ ++ +E + E I+ Q+++ +V+++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR-DEMMREAEIMHQLDNPYIVRMI 61
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
G C E E +LV E G L + L + +T + + +V+ + YL
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDE----ITVSNVVELMHQVSMGMKYLEGKN- 115
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPEYHQSS 348
HRD+ + N+LL ++ AK++DFG SK + D ++ + G + + PE
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 349 QLTDKSDVYSFGVVLVELLT-GKKP 372
+ + +SDV+S+G+ + E + G+KP
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 77/226 (34%), Positives = 118/226 (52%), Gaps = 27/226 (11%)
Query: 170 RILGQGGQGTVY---KGMLED-GRIIAVK---KSKLTVDDEELLKLEEFINEIVILSQIN 222
++LGQG G V+ K D G++ A+K K+ L V D K+E IL+++N
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMER-----DILAEVN 56
Query: 223 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWE-MRLRIATEVAG 280
H +VKL +TE L L+ +F+ G L+ L ++E T E ++ +A E+A
Sbjct: 57 HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLA-ELAL 109
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 340
AL +LHS I +RD+K NILLD+ K+ DFG SK ++D GT Y+
Sbjct: 110 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYM 165
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSL 386
PE T +D +SFGV++ E+LTG P + G +E +++
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLP--FQGKDRKETMTM 209
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 69/209 (33%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231
LG G G VYK ++ + A K +EEL E+F+ EI ILS+ H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL---EDFMVEIDILSECKHPNIVGLYE 69
Query: 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNE-EFPLTWEMRLR-IATEVAGALAYLHSAT 289
++ EF G L D E E LT E ++R + ++ AL +LHS
Sbjct: 70 AYFYENKLWILIEFCDGGAL-----DSIMLELERGLT-EPQIRYVCRQMLEALNFLHS-- 121
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTS-KFIAMDQTHVTTKIQGTFGYLDPEYHQSS 348
+ HRD+K+ NILL K+ADFG S K + Q T GT ++ PE
Sbjct: 122 -HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACE 178
Query: 349 QLTD-----KSDVYSFGVVLVELLTGKKP 372
D K+D++S G+ L+EL + P
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 31/221 (14%)
Query: 172 LGQGGQGTVY----KGMLE---------DGRIIAVKKSKLTVDDEELLKLEEFINEIVIL 218
LG+G G V+ +G+ E DG+ + V L D + + +F+ EI I+
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR-NDFLKEIKIM 71
Query: 219 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDR-------HQNEEFPLTWEMR 271
S++ + N+++LLG C+ + ++ E++ NG L Q L R H N ++
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 272 LRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTT 331
L +A ++A + YL S HRD+ + N L+ Y K+ADFG S+ + +
Sbjct: 132 LYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY--- 185
Query: 332 KIQG----TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 368
+IQG ++ E + T SDV++FGV L E+ T
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231
LG G G V+ G +A+K K + + E F+ E ++ Q+ H +V+L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-----QGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 232 CCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
T+ P+ ++ E++ NG+L L E LT + +A ++A +A++
Sbjct: 69 VV--TQEPIYIITEYMENGSLVDFLK---TPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 350
HRD+++ NIL+ + K+ADFG ++ I ++ + + PE
Sbjct: 124 ---IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 351 TDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
T KSDV+SFG++L E++T G+ P + G T+ E
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIP--YPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 69/230 (30%), Positives = 105/230 (45%), Gaps = 29/230 (12%)
Query: 153 LFSSKELDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEF 211
LFS + +K F R +G G G VY + ++A+KK + + K ++
Sbjct: 7 LFSKDDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYS-GKQSNEKWQDI 62
Query: 212 INEIVILSQINHRNVVKLLGCCLETEVPLLVYEF-IPNGTLYQHLHDRHQNEEFPLTWEM 270
I E+ L Q+ H N ++ GC L LV E+ + + + +H + E
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQE-------- 114
Query: 271 RLRIATEVAGAL---AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327
+ IA GAL AYLHS HRDIK+ NILL + K+ADFG++ ++ +
Sbjct: 115 -VEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS 170
Query: 328 HVTTKIQGTFGYLDPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
V GT ++ PE Q K DV+S G+ +EL K P+F
Sbjct: 171 FV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 61/234 (26%), Positives = 117/234 (50%), Gaps = 27/234 (11%)
Query: 172 LGQGGQGTVYKGML-----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNV 226
LG+ G +YKG L + +++A+K K D + EF E ++++++H N+
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK---DINNPQQWGEFQQEASLMAELHHPNI 69
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMR------------LRI 274
V LLG + + +++E++ G L++ L R + + + + L I
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 275 ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI-AMDQTHVTTKI 333
A ++A + YL +S H+D+ + NIL+ ++ K++D G S+ I + D V K
Sbjct: 130 AIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSL 386
++ PE + + SD++SFGVVL E+ + G +P + G ++QE + +
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY--GFSNQEVIEM 238
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231
LG G G VYK ++ +A K T +EEL E+++ EI IL+ NH +VKLLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPYIVKLLG 76
Query: 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSS 291
++ EF P G + + + + P ++++ I ++ AL YLHS
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHSMK-- 130
Query: 292 PIYHRDIKSTNILLDQRYRAKVADFGTS-KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 350
I HRD+K+ N+LL K+ADFG S K + Q GT ++ PE +
Sbjct: 131 -IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR--DSFIGTPYWMAPEVVMCETM 187
Query: 351 TD-----KSDVYSFGVVLVELLTGKKP 372
D K+D++S G+ L+E+ + P
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 74/278 (26%), Positives = 119/278 (42%), Gaps = 49/278 (17%)
Query: 172 LGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEE----LLKLEEFINEIVILSQINHRNV 226
+G G G VYK + G ++AVK+ + T + EE L+ L+ V+L + +
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD------VVLKSHDCPYI 76
Query: 227 VKLLGCCL-ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
VK G + +++V + E + T L R Q P+ ++ ++ + AL YL
Sbjct: 77 VKCYGYFITDSDV-FICMELM--STCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYL 130
Query: 286 ---HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 342
H + HRD+K +NILLD K+ DFG S + + T+ G Y+ P
Sbjct: 131 KEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAP 183
Query: 343 EYHQSSQLTDK----SDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398
E K +DV+S G+ LVEL TG+ P + ++ V
Sbjct: 184 ERIDPPDPNPKYDIRADVWSLGISLVELATGQFP--YKNCKTEFEV-------------- 227
Query: 399 LHDILDDQLMKL-GVKNQIMTFANLAKRCLDLNGKKRP 435
L IL ++ L + F + CL + +KRP
Sbjct: 228 LTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 65/204 (31%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 172 LGQGGQGTVYKGMLE-DGRIIAVKK-SKLTVDDEELLKLEEFI-NEIVILSQINHRNVVK 228
LG GG G V ++ R A+K K + + +E I +E IL + NH +VK
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE---TGQQEHIFSEKEILEECNHPFIVK 57
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
L + + ++ E+ G L+ L DR +E + R IA V A YLH+
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDE----YTARFYIAC-VVLAFEYLHNR 112
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 348
I +RD+K N+LLD K+ DFG +K + Q T GT Y+ PE +
Sbjct: 113 G---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEIILNK 167
Query: 349 QLTDKSDVYSFGVVLVELLTGKKP 372
D +S G++L ELLTG+ P
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231
LG G G V+ G +AVK K + E F+ E I+ ++ H +V+L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK-----PGTMSPESFLEEAQIMKKLRHDKLVQLYA 68
Query: 232 CCLETEVPLLVYEFIPNGTLYQHLHD-RHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
E + +V E++ G+L L D + + P +M A +VA +AY+
Sbjct: 69 VVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM----AAQVAAGMAYIERMN- 122
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 350
HRD++S NIL+ K+ADFG ++ I ++ + + PE +
Sbjct: 123 --YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 351 TDKSDVYSFGVVLVELLT-GKKP 372
T KSDV+SFG++L EL+T G+ P
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 63/209 (30%), Positives = 111/209 (53%), Gaps = 27/209 (12%)
Query: 170 RILGQGGQGTVYKGMLED--GRIIAVK--KSKLTVDDEELLKLEEFINEIVILSQINHRN 225
+ +G+G G V ML D G +AVK K+ T + F+ E +++Q+ H N
Sbjct: 12 QTIGKGEFGDV---MLGDYRGNKVAVKCIKNDATA--------QAFLAEASVMTQLRHSN 60
Query: 226 VVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
+V+LLG +E + L +V E++ G+L +L R ++ L + L+ + +V A+ Y
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEY 117
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 344
L + + HRD+ + N+L+ + AKV+DFG +K + Q ++ T PE
Sbjct: 118 LEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEA 170
Query: 345 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
+ + + KSDV+SFG++L E+ + G+ P
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 62/220 (28%), Positives = 112/220 (50%), Gaps = 30/220 (13%)
Query: 166 FNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKL------EEFINEIVIL 218
F ++LG G GTVYKG+ + +G +K K+ V +EL + +E ++E ++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEG-----EKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 219 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQN--EEFPLTWEMRLRIAT 276
+ +++ +V +LLG CL + V L + + +P G L ++ + N ++ L W
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 116
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTT---KI 333
++A + YL + HRD+ + N+L+ K+ DFG +K + D+ K+
Sbjct: 117 QIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
+ L+ H+ T +SDV+S+GV + EL+T G KP
Sbjct: 174 PIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 172 LGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G V ++ G+++AVKK +D + + E NE+VI+ H NVV++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKK----MDLRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
L + +V EF+ G L + NEE +IA L L +
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---------QIAAVCLAVLKALSVLHA 134
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQSS 348
+ HRDIKS +ILL R K++DFG F A V + + GT ++ PE
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPELISRL 191
Query: 349 QLTDKSDVYSFGVVLVELLTGKKPIF 374
+ D++S G++++E++ G+ P F
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPPYF 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFIN-----EIVILSQINHRN 225
LG+G VYK E GRI+A+KK KL E + ++ IN EI +L ++ H N
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKL----GERKEAKDGINFTALREIKLLQELKHPN 63
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLT------W-EMRLRIATEV 278
++ LL LV+EF+ L + + D+ LT + M LR
Sbjct: 64 IIGLLDVFGHKSNINLVFEFME-TDLEKVIKDK----SIVLTPADIKSYMLMTLR----- 113
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 338
L YLHS + I HRD+K N+L+ K+ADFG ++ +T ++ T
Sbjct: 114 --GLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRW 167
Query: 339 YLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
Y PE + D++S G + ELL P
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLR-VPFL 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-17
Identities = 68/260 (26%), Positives = 120/260 (46%), Gaps = 26/260 (10%)
Query: 166 FNANRILGQGGQGTVY--KGMLEDGR--IIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
+ + +G+G G +Y K + I + +K+ V ++E K E+++L+++
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK-----KEVILLAKM 56
Query: 222 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQ---NEEFPLTWEMRLRIATEV 278
H N+V E +V E+ G L + ++ + +E+ L+W ++
Sbjct: 57 KHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQI 110
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQRYR-AKVADFGTSKFIAMDQTHVTTKIQGTF 337
+ L ++H I HRDIKS NI L + AK+ DFG ++ + D + GT
Sbjct: 111 SLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTP 166
Query: 338 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397
YL PE Q+ +K+D++S G VL EL T K P F N Q + + + + N
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP-FEGNNLHQLVLKICQGYFAPISPN 225
Query: 398 RLHDI--LDDQLMKLGVKNQ 415
D+ L QL K+ +++
Sbjct: 226 FSRDLRSLISQLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 6e-17
Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKS-KLTVDDEELLKLEEFINEIVILSQINHRNVV 227
++LG G GTVYKG+ + DG + + + K+ ++ +E ++E +++ + V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 228 KLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQ--NEEFPLTWEMRLRIATEVAGALAYL 285
+LLG CL + V L V + +P G L ++ + + L W ++A ++YL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYL 125
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTT---KIQGTFGYLDP 342
+ HRD+ + N+L+ K+ DFG ++ + +D+T K+ + L+
Sbjct: 126 EEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
H+ + T +SDV+S+GV + EL+T G KP
Sbjct: 183 ILHR--RFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 78/288 (27%), Positives = 128/288 (44%), Gaps = 49/288 (17%)
Query: 170 RILGQGGQGTVYK----GMLEDGRII--AVKKSKLTVDDEELLKLEEFINEIVILSQI-N 222
+ LG G G V + G+ + ++ AVK K T E E ++E+ I+S + N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER---EALMSELKIMSHLGN 97
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
H N+V LLG C L++ E+ G L L + E LT E L + +VA +
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLR---RKRESFLTLEDLLSFSYQVAKGM 154
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGT----FG 338
A+L S HRD+ + N+LL K+ DFG ++ I D +V ++G
Sbjct: 155 AFLASKNC---IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPVK 208
Query: 339 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398
++ PE + T +SDV+S+G++L E IF G+ + + + F
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWE-------IFSLGSNPYPGMPVDSKFY------- 254
Query: 399 LHDILDDQLMKLGVKNQIMTFA-----NLAKRCLDLNGKKRPTMEEVS 441
+L+K G + A ++ K C D + KRPT +++
Sbjct: 255 -------KLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIV 295
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 7e-17
Identities = 69/276 (25%), Positives = 122/276 (44%), Gaps = 31/276 (11%)
Query: 172 LGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G V+ G L D +AVK + T+ + LK +F+ E IL Q +H N+V+L+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD--LK-AKFLQEARILKQYSHPNIVRLI 59
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
G C + + +V E + G L + E L + +++ A + YL S
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFL----RTEGPRLKVKELIQMVENAAAGMEYLESKHC 115
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQSS 348
HRD+ + N L+ ++ K++DFG S+ D + +T Q + PE
Sbjct: 116 ---IHRDLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 349 QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLM 408
+ + +SDV+SFG++L W E SL A ++ + + ++ +
Sbjct: 172 RYSSESDVWSFGILL-----------W------EAFSLGAVPYANLSNQQTREAIEQGVR 214
Query: 409 KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444
+ L +RC + + +RP+ V EL
Sbjct: 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 7e-17
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231
+G+G G V+KG+ D R V K+ +E ++E+ EI +LSQ + V K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT---EVAGALAYLHSA 288
L+ ++ E++ G+ L +E +IAT E+ L YLHS
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDE---------FQIATMLKEILKGLDYLHSE 120
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 348
HRDIK+ N+LL ++ K+ADFG + + Q T + GT ++ PE Q S
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176
Query: 349 QLTDKSDVYSFGVVLVELLTGKKP 372
K+D++S G+ +EL G+ P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 9e-17
Identities = 82/284 (28%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 166 FNANRILGQGGQGTVYKGMLEDGR---IIAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
F R +G G G VY D R ++A+KK + + K ++ I E+ L +I
Sbjct: 27 FTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYS-GKQSNEKWQDIIKEVKFLQRIK 83
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
H N ++ GC L LV E+ L + H+ PL + IA GAL
Sbjct: 84 HPNSIEYKGCYLREHTAWLVMEYCLGSA--SDLLEVHKK---PL---QEVEIAAITHGAL 135
Query: 283 ---AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 339
AYLHS + HRDIK+ NILL + + K+ADFG++ + + V GT +
Sbjct: 136 QGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYW 187
Query: 340 LDPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396
+ PE Q K DV+S G+ +EL K P+F N++ + H
Sbjct: 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF--------NMNAMSALYH---- 235
Query: 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
I ++ L F N CL + RPT EE+
Sbjct: 236 -----IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEEL 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 9e-17
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 170 RILGQGGQGTV----YKGMLEDGRIIAVK--KSKLTVDDEELLKLEEFINEIVILSQINH 223
++LG+G G V KG + AVK K + + D+++ E + E +L+
Sbjct: 1 KVLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDV---ECTMTEKRVLALAGK 54
Query: 224 RNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATEVAGA 281
+ L C +T+ L V E++ G L H+ + F E R R A E+
Sbjct: 55 HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR---FD---EPRARFYAAEIVLG 108
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYL 340
L +LH I +RD+K N+LLD K+ADFG K I T T+ GT Y+
Sbjct: 109 LQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYI 163
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
PE D ++ GV+L E+L G+ P
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231
+G+G G V+KG+ D R V K+ +E ++E+ EI +LSQ + V K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSS 291
L+ ++ E++ G+ L E PL I E+ L YLHS
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLHSEKK- 122
Query: 292 PIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 351
HRDIK+ N+LL + K+ADFG + + Q T + GT ++ PE + S
Sbjct: 123 --IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYD 179
Query: 352 DKSDVYSFGVVLVELLTGKKP 372
K+D++S G+ +EL G+ P
Sbjct: 180 SKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231
LGQG G V+ G +A+K K + E F+ E ++ ++ H +V+L
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSS 291
E + +V E++ G+L L L + +A ++A +AY+
Sbjct: 69 VVSEEPI-YIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVERMN-- 122
Query: 292 PIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 351
HRD+++ NIL+ + KVADFG ++ I ++ + + PE + T
Sbjct: 123 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 352 DKSDVYSFGVVLVELLT-GKKP 372
KSDV+SFG++L EL T G+ P
Sbjct: 182 IKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 32/229 (13%)
Query: 170 RILGQGGQGTVYKGMLED---GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNV 226
R++G+GG G VY D R +A+KK + + + LLK + F+ E I + + H +
Sbjct: 8 RLIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLK-KRFLREAKIAADLIHPGI 64
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMR------LRIATEVAG 280
V + C + + +I TL L Q E + L I ++
Sbjct: 65 VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH------------ 328
+ Y+HS + HRD+K NILL + D+G + F +++
Sbjct: 125 TIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 329 -----VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
+ KI GT Y+ PE ++ +D+Y+ GV+L ++LT P
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 72/253 (28%), Positives = 106/253 (41%), Gaps = 16/253 (6%)
Query: 170 RILGQGGQGTVY----KGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
R+LG G G V+ G + G++ A+K K ++ E E +L +
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 226 VVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
+ L +T+ L L+ +++ G L+ HL+ R E E+R+ IA E+ AL +
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES----EVRVYIA-EIVLALDH 120
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 344
LH I +RDIK NILLD + DFG SK ++ GT Y+ PE
Sbjct: 121 LHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 345 --HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAG-NTSQENVSLAAYFVHSMRKNRLHD 401
S D +S GV+ ELLTG P G SQ +S +
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA 237
Query: 402 ILDDQLMKLGVKN 414
D + KL K+
Sbjct: 238 EARDFIQKLLEKD 250
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 80/273 (29%), Positives = 121/273 (44%), Gaps = 33/273 (12%)
Query: 171 ILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
ILG G GTVYK L RI+AVK L + EL K + ++E+ IL + + ++
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQK--QIMSELEILYKCDSPYIIGF 64
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
G + EF+ G+L D ++ + RIA V L YL S
Sbjct: 65 YGAFFVENRISICTEFMDGGSL-----DVYRKIPEHVLG----RIAVAVVKGLTYLWSLK 115
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLDPEYHQS 347
I HRD+K +N+L++ R + K+ DFG S + ++ +T+V GT Y+ PE
Sbjct: 116 ---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISG 167
Query: 348 SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407
Q SDV+S G+ +EL G+ P + SL M L I+D+
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPYP---QIQKNQGSL-------MPLQLLQCIVDEDP 217
Query: 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
L V F + +C+ K+RP E +
Sbjct: 218 PVLPVGQFSEKFVHFITQCMRKQPKERPAPENL 250
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 170 RILGQGGQGTVYKGMLED---GRI---IAVKKSKLTVDDEELLKLE-EFINEIVILSQIN 222
R LGQG G VY+G D G +AVK TV++ L+ EF+NE ++
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVK----TVNESASLRERIEFLNEASVMKGFT 67
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEE-----FPLTWEMRLRIATE 277
+VV+LLG + + L+V E + +G L +L E P T + +++A E
Sbjct: 68 CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 127
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI-AMDQTHVTTKIQGT 336
+A +AYL+ + HRD+ + N ++ + K+ DFG ++ I D K
Sbjct: 128 IADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 337 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 368
++ PE + T SD++SFGVVL E+ +
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 172 LGQGGQGTVYKGMLEDGR-IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G VYKG+ + ++A+K L ++E+ E+ EI +LSQ + + +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEI---EDIQQEITVLSQCDSPYITRYY 68
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
G L+ ++ E++ G+ L E + T I E+ L YLHS
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIAT------ILREILKGLDYLHSERK 122
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 350
HRDIK+ N+LL ++ K+ADFG + + Q T + GT ++ PE + S
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178
Query: 351 TDKSDVYSFGVVLVELLTGKKP 372
K+D++S G+ +EL G+ P
Sbjct: 179 DFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 69/209 (33%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 170 RILGQGGQGTVYKG-MLEDGRIIAVKKSKLTV---DDEELLKLEEFINEIVILSQINHRN 225
R+LG+G G V + E GR+ AVK K V DD+ +E + E ILS +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDD----VECTMTEKRILSLARNHP 56
Query: 226 VVKLLGCCLET-EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATEVAGALA 283
+ L CC +T + V EF+ G L H+ + +E R R A E+ AL
Sbjct: 57 FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE------ARARFYAAEITSALM 110
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
+LH I +RD+K N+LLD K+ADFG K + T+ GT Y+ PE
Sbjct: 111 FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPE 166
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
Q D ++ GV+L E+L G P
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 58/214 (27%), Positives = 110/214 (51%), Gaps = 20/214 (9%)
Query: 171 ILGQGGQGTVYKGMLE-DGR---IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNV 226
++G G G V +G L+ G+ +A+K K +++ +F++E I+ Q +H N+
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHPNI 67
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH 286
+ L G ++ +++ EF+ NG L L R + +F + + + +A + YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVI--QLVGMLRGIAAGMKYLS 123
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH--VTTKIQGTFG--YLDP 342
HRD+ + NIL++ KV+DFG S+F+ D + T+ + G + P
Sbjct: 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFW 375
E + T SDV+S+G+V+ E+++ G++P +W
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP-YW 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 172 LGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G V + G+ +AVKK +D + + E NE+VI+ +H NVV +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKK----MDLRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT---EVAGALAYLHS 287
L + +V EF+ G L + NEE +IAT V AL+YLH+
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---------QIATVCLSVLRALSYLHN 136
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYH 345
+ HRDIKS +ILL R K++DFG F A V + + GT ++ PE
Sbjct: 137 ---QGVIHRDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPKRKSLVGTPYWMAPEVI 190
Query: 346 QSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
+ D++S G++++E++ G+ P F
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEMIDGEPPYF 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 73/234 (31%), Positives = 111/234 (47%), Gaps = 37/234 (15%)
Query: 164 NHFNANRILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEF----INEIVIL 218
+ F+ +G+G G VYK +D G ++A+KK +L D+E+ E F I EI IL
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL--DNEK----EGFPITAIREIKIL 60
Query: 219 SQINHRNVVKLLGCCLETEVPL----------LVYEFIPN---GTLYQHLHDRHQNEEFP 265
Q+NHRN+V L + + L LV+E++ + G L L ++
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 266 LTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMD 325
M+ ++ L Y H HRDIK +NILL+ + + K+ADFG ++ +
Sbjct: 121 F---MK-----QLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 326 QTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFWAGN 378
++ T T Y PE + + DV+S G +L EL T KKPIF A
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQ 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 25/217 (11%)
Query: 171 ILGQGGQGTVYKGML-----EDGRI-IAVKKSKLTVDDEELLKLEEFINEIVILSQI-NH 223
LG+G G V K + +AVK K +++L + ++E+ ++ I H
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS---DLVSEMEMMKMIGKH 75
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEF-----------PLTWEMRL 272
+N++ LLG C + +V E+ +G L L R E+ LT + +
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 273 RIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI-AMDQTHVTT 331
A +VA + +L S HRD+ + N+L+ + + K+ADFG ++ I +D TT
Sbjct: 136 SFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 332 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 368
+ ++ PE T +SDV+SFGV+L E+ T
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 55/225 (24%), Positives = 109/225 (48%), Gaps = 19/225 (8%)
Query: 152 KLFSSKELDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLK-LE 209
++ EL K ++LG G GTV+KG+ + +G I + + T+ D + +
Sbjct: 2 RILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ 54
Query: 210 EFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWE 269
E + ++ + ++H +V+LLG C + L V + P G+L H+ + L +
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDS----LDPQ 109
Query: 270 MRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI-AMDQTH 328
L ++A + YL + HR++ + NILL ++ADFG + + D+ +
Sbjct: 110 RLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166
Query: 329 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
++ + ++ E + T +SDV+S+GV + E+++ G +P
Sbjct: 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 81/287 (28%), Positives = 125/287 (43%), Gaps = 40/287 (13%)
Query: 166 FNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
F ++G G G VYKG ++ G++ A+K +T D+EE +K E IN + S +HR
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE--INMLKKYS--HHR 63
Query: 225 NVVKLLGCCLETEVP------LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEV 278
N+ G ++ P LV EF G++ + + N L E I E+
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT---LKEEWIAYICREI 120
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 338
L++LH + HRDIK N+LL + K+ DFG S + T I GT
Sbjct: 121 LRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPY 176
Query: 339 YLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393
++ PE + D KSD++S G+ +E+ G P+ +H
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC---------------DMHP 221
Query: 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
MR L I + +L K F + + CL N +RPT E++
Sbjct: 222 MRA--LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 170 RILGQGGQGTVY----KGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
++LG+G G V KG E + A+KK + +DD+ +E + E +L+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDD----VECTMVEKRVLALAWENP 56
Query: 226 VVKLLGCCLETEVPLL-VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
+ L C +T+ L V EF+ G L H+ D+ + + + T+ A E+ L +
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQF 111
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 344
LHS I +RD+K N++LD+ K+ADFG K +T GT Y+ PE
Sbjct: 112 LHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEI 167
Query: 345 HQSSQLTDKSDVYSFGVVLVELLTGKKP 372
Q + T D +SFGV+L E+L G+ P
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 8e-16
Identities = 51/170 (30%), Positives = 90/170 (52%), Gaps = 18/170 (10%)
Query: 210 EFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWE 269
+F+ EI I+S++ N+++LL C+ ++ ++ E++ NG L Q L RH+ +E +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFL-SRHEPQEAAEKAD 123
Query: 270 MR-------LRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322
+ + +AT++A + YL S HRD+ + N L+ + Y K+ADFG S+ +
Sbjct: 124 VVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 323 AMDQTHVTTKIQG----TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 368
+ +IQG ++ E + T SDV++FGV L E+LT
Sbjct: 181 YSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 76/289 (26%), Positives = 129/289 (44%), Gaps = 43/289 (14%)
Query: 171 ILGQGGQGTVYK-GMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
++G+G G V K E G+I+A+KK + DD+ + K+ + EI +L Q+ H N+V L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIA--MREIRMLKQLRHENLVNL 65
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
+ + LV+EF+ + L D + L + ++ + + HS
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 349
I HRDIK NIL+ Q K+ DFG ++ +A V T T Y PE
Sbjct: 121 ---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDT 176
Query: 350 LTDKS-DVYSFGVVLVELLTGKKPIFWA--------------GNTSQENVSLAAYFVHSM 394
++ D+++ G ++ E+LTG +P+F GN + +
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTG-EPLFPGDSDIDQLYHIIKCLGNLIPRHQEI-------F 228
Query: 395 RKN------RLHDILD-DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT 436
+KN RL ++ + + L K K + +LAK+CL ++ RP+
Sbjct: 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLV-LDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 9e-16
Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 171 ILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI---NHRNV 226
+G+G GTVYK L GR +A+KK ++ + +E + + EI +L Q+ H N+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPL--STLREIALLKQLESFEHPNI 63
Query: 227 VKLLGCC----LETEVPL-LVYEFIPNGTLYQHLH---DRHQNEEFP---LTWEMRLRIA 275
V+LL C + E+ L LV+E + Q L + P + MR
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVD-----QDLATYLSKCPKPGLPPETIKDLMR---- 114
Query: 276 TEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF--IAMDQTHVTTKI 333
++ + +LHS I HRD+K NIL+ + K+ADFG ++ M T V
Sbjct: 115 -QLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-- 168
Query: 334 QGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
T Y PE QSS T D++S G + EL ++P+F
Sbjct: 169 --TLWYRAPEVLLQSSYAT-PVDMWSVGCIFAELFR-RRPLF 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 53/170 (31%), Positives = 88/170 (51%), Gaps = 13/170 (7%)
Query: 206 LKLEEFI-NEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEF 264
LK E+ + NE +L +++H +++L + ++ E++P G L+ +L + +
Sbjct: 42 LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---- 97
Query: 265 PLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324
+ L A+E+ AL YLHS I +RD+K NILLD+ K+ DFG +K +
Sbjct: 98 -FSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-R 152
Query: 325 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
D+T + GT YL PE QS D ++ G+++ E+L G P F
Sbjct: 153 DRTWT---LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 70/277 (25%), Positives = 117/277 (42%), Gaps = 39/277 (14%)
Query: 177 QGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 236
G ++GM + ++ ++ T D++ L F+ E+ ++NH NV++ LG C+E+
Sbjct: 13 LGEAHRGMSKARVVVKELRASATPDEQLL-----FLQEVQPYRELNHPNVLQCLGQCIES 67
Query: 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHR 296
LLV EF P G L +L ++ R+A EVA L +LH A H
Sbjct: 68 IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHS 124
Query: 297 DIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLDPEYHQSSQ----- 349
D+ N L K+ D+G + + + TK +L PE +
Sbjct: 125 DLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLP 183
Query: 350 --LTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQ 406
T KS+++S GV + EL T +P + S E V L ++ +Q
Sbjct: 184 KDQTKKSNIWSLGVTMWELFTAADQPY---PDLSDEQV--------------LKQVVREQ 226
Query: 407 LMKLGVKNQIMTFANLAKRCLD---LNGKKRPTMEEV 440
+KL + +++ + L+ + RPT EEV
Sbjct: 227 DIKLPKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 13/214 (6%)
Query: 165 HFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
+F + +G+G VY+ L DG +A+KK ++ D + + I EI +L Q+NH
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQI-FDLMDAKARADCIKEIDLLKQLNH 61
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHL-HDRHQNEEFP--LTWEMRLRIATEVAG 280
NV+K +E +V E G L + + H + Q P W+ +++ +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS---- 117
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 340
AL ++HS + HRDIK N+ + K+ D G +F + +T + GT Y+
Sbjct: 118 ALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYM 173
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
PE + KSD++S G +L E+ + P +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 24/225 (10%)
Query: 169 NRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDE-ELLKLEEFINEIVILSQINHRNV 226
NRI G+G G VY+ G I+A+KK ++ D+E + + + + EI +L + H N+
Sbjct: 13 NRI-GEGTYGIVYRARDTTSGEIVALKKVRM--DNERDGIPISS-LREITLLLNLRHPNI 68
Query: 227 VKLL----GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
V+L G L++ LV E+ Q L N P + + ++ L
Sbjct: 69 VELKEVVVGKHLDS--IFLVMEYCE-----QDLASLLDNMPTPFSESQVKCLMLQLLRGL 121
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 342
YLH + I HRD+K +N+LL + K+ADFG ++ + +T K+ T Y P
Sbjct: 122 QYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAP 177
Query: 343 EYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFWAGNTSQENVSL 386
E + D+++ G +L ELL KP+ G + E + L
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAH-KPLL-PGKSEIEQLDL 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 68/213 (31%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 166 FNANRILGQGGQGTV----YKGMLEDGRIIAVKKSKLTVDDE-ELLKLEEFINEIVILSQ 220
F +LG+G G V YK E I A+KK + DE E L E+ I E +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETA--NS 58
Query: 221 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATEVA 279
H +V L C + V E+ G L H+H + F E R A V
Sbjct: 59 ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT----DVFS---EPRAVFYAACVV 111
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 339
L YLH + I +RD+K N+LLD K+ADFG K M T+ GT +
Sbjct: 112 LGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEF 167
Query: 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
L PE + T D + GV++ E+L G+ P
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 51/204 (25%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+ LG G G V+ G + +AVK K + ++ F+ E ++ + H +V+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLK-----PGTMSVQAFLEEANLMKTLQHDKLVRL 66
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
+ E ++ E++ G+L L +E + + + ++A +AY+
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLK---SDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 349
HRD+++ N+L+ + K+ADFG ++ I ++ + + PE
Sbjct: 124 ---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 350 LTDKSDVYSFGVVLVELLT-GKKP 372
T KSDV+SFG++L E++T GK P
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 69/209 (33%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 170 RILGQGGQGTVYKGMLE-DGRIIAVK--KSKLTVDDEELLKLEEFINEIVILSQINHRNV 226
+++G+G G V + DG+ AVK + K+ ++ +E + N V+L + H +
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERN--VLLKNVKHPFL 58
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATEVAGALAYL 285
V L TE V +F+ G L+ HL + FP E R R A E+A AL YL
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHLQ---RERSFP---EPRARFYAAEIASALGYL 112
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 345
HS I +RD+K NILLD + + DFG K + Q+ TT GT YL PE
Sbjct: 113 HSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVI 168
Query: 346 QSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
+ + D + G VL E+L G P +
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 83/275 (30%), Positives = 114/275 (41%), Gaps = 35/275 (12%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTV-DDEELLKLEEFINEIVILSQINHRNVVKL 229
+G G G VYK L G + AVK KL DD L++ EI ++ + H N+V
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ-----QEIFMVKECKHCNIVAY 71
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
G L E + E+ G+L H E + + R E LAYLHS
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSKG 126
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE---YHQ 346
HRDIK NILL K+ADFG + I + I GT ++ PE +
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEK 182
Query: 347 SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQ 406
+ D+++ G+ +EL + P+F +H MR L + Q
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPMF---------------DLHPMRALFLMSKSNFQ 227
Query: 407 LMKLGVKNQ-IMTFANLAKRCLDLNGKKRPTMEEV 440
KL K + TF N K L N KKRPT E +
Sbjct: 228 PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 60/189 (31%), Positives = 90/189 (47%), Gaps = 26/189 (13%)
Query: 197 KLTVDD--EELLKLEEFINEIVILSQINHRNVVKLL--GCCLETEVPLL--VYEFIPNGT 250
KL D EE + F E + +++ H N+V LL G E LL V+E++P T
Sbjct: 9 KLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSG---EAPPGLLFAVFEYVPGRT 65
Query: 251 LYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL---DQ 307
L + L + L R+ +V ALA H+ I HRD+K NI++
Sbjct: 66 LREVL----AADG-ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGV 117
Query: 308 RYRAKVADFGTSKFI----AMDQTHVT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGV 361
R AKV DFG + D +T T++ GT Y PE + +T SD+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 362 VLVELLTGK 370
+ +E LTG+
Sbjct: 178 IFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 81/287 (28%), Positives = 126/287 (43%), Gaps = 40/287 (13%)
Query: 166 FNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
F ++G G G VYKG ++ G++ A+K +T D+EE +KLE IN + S +HR
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLE--INMLKKYS--HHR 73
Query: 225 NVVKLLGCCLETEVP------LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEV 278
N+ G ++ P LV EF G++ + + N L + I E+
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA---LKEDWIAYICREI 130
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 338
LA+LH+ + HRDIK N+LL + K+ DFG S + T I GT
Sbjct: 131 LRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPY 186
Query: 339 YLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393
++ PE + D +SD++S G+ +E+ G P+ +H
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC---------------DMHP 231
Query: 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
MR L I + KL K F + + CL N RP+ E++
Sbjct: 232 MRA--LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQL 276
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 48/173 (27%), Positives = 84/173 (48%), Gaps = 18/173 (10%)
Query: 210 EFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRH---------- 259
+F+ E+ ILS++ N+++LLG C++ + ++ E++ NG L Q L H
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 260 ---QNEEFP-LTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315
P +++ L +A ++A + YL S HRD+ + N L+ + K+AD
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIAD 181
Query: 316 FGTSK-FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELL 367
FG S+ A D + + ++ E + T SDV++FGV L E+L
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231
LGQG G V+ G +A+K K + E F+ E I+ ++ H +V L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK-----PGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 232 CCLETEVPLLVYEFIPNGTLYQHLHDRH-QNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
E + +V EF+ G+L L + + + P +M A ++A +AY+
Sbjct: 69 VVSEEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM----AAQIADGMAYIERMN- 122
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 350
HRD+++ NIL+ K+ADFG ++ I ++ + + PE +
Sbjct: 123 --YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 351 TDKSDVYSFGVVLVELLT-GKKP 372
T KSDV+SFG++L EL+T G+ P
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G VYKG + G+I+A+KK +L ++E + I EI +L ++ H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA--IREISLLKELQHPNIVCLQ 65
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT-EVAGALAYLHSAT 289
++ L++EF+ + L ++L + + ++ ++ + + HS
Sbjct: 66 DVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDA---ELVKSYLYQILQGILFCHSRR 121
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 349
+ HRD+K N+L+D + K+ADFG ++ + V T T Y PE S
Sbjct: 122 ---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 350 L-TDKSDVYSFGVVLVELLTGKKPIF 374
+ D++S G + E+ T KKP+F
Sbjct: 178 RYSTPVDIWSIGTIFAEMAT-KKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 66/212 (31%), Positives = 96/212 (45%), Gaps = 28/212 (13%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231
LG G G VYK ++ ++A K T +EEL E+++ EI IL+ +H N+VKLL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL---EDYMVEIDILASCDHPNIVKLLD 69
Query: 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSS 291
++ EF G + + + E PLT + + AL YLH +
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLH---EN 122
Query: 292 PIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ------GTFGYLDPEYH 345
I HRD+K+ NIL K+ADFG S T IQ GT ++ PE
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVS-------AKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 346 QSSQLTD-----KSDVYSFGVVLVELLTGKKP 372
D K+DV+S G+ L+E+ + P
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-15
Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 16/216 (7%)
Query: 166 FNANRILGQG--GQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
+N R++G+G G+ + + + D + A+K+ +L + E+ E V+L+++ H
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAV---EDSRKEAVLLAKMKH 57
Query: 224 RNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
N+V E + L +V E+ G L Q + + + + FP + L+ ++ +
Sbjct: 58 PNIVAFKES-FEADGHLYIVMEYCDGGDLMQKIKLQ-RGKLFP--EDTILQWFVQMCLGV 113
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 342
++H + HRDIKS NI L Q + K+ DFG+++ + + T + GT Y+ P
Sbjct: 114 QHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPP 169
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGN 378
E ++ +KSD++S G +L EL T K P F A +
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHP-FQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G G G VY ++AVKK + + K ++ I E+ L Q+ H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYS-GKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 231 GCCLETEVPLLVYEF-IPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL---AYLH 286
GC L+ LV E+ + + + +H + E + IA GAL AYLH
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQE---------VEIAAITHGALQGLAYLH 138
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY-- 344
S + HRDIK+ NILL + + K+ADFG++ + + V GT ++ PE
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVIL 190
Query: 345 -HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
Q K DV+S G+ +EL K P+F
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLF 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLE-------EFINEIVILSQINHR 224
LG G G V K + +I +K L+ LE + I E+ +L + N
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARK---------LIHLEIKPAIRNQIIRELQVLHECNSP 63
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
+V G + E + G+L Q L + + E E+ +++ V LAY
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-----EILGKVSIAVLRGLAY 118
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLDP 342
L I HRD+K +NIL++ R K+ DFG S + +M + V GT Y+ P
Sbjct: 119 LRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSP 171
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 373
E Q + + +SD++S G+ LVEL G+ PI
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 62/223 (27%), Positives = 110/223 (49%), Gaps = 16/223 (7%)
Query: 170 RILGQGGQGTVYKGMLE--DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVV 227
+++G G G V G L+ R I V L E + +F++E I+ Q +H N++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIMGQFDHPNII 68
Query: 228 KLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS 287
L G +++ ++V E++ NG+L L R + +F T + + +A + YL
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQF--TVIQLVGMLRGIASGMKYL-- 122
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLDPEYH 345
+ HRD+ + NIL++ KV+DFG S+ + D T G + PE
Sbjct: 123 -SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 346 QSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLA 387
+ T SDV+S+G+V+ E+++ G++P +W S ++V A
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERP-YW--EMSNQDVIKA 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
R +G G G VY + + ++A+KK + + K ++ I E+ L ++ H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL---AYL 285
GC L LV E+ L + H+ PL + IA GAL AYL
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSA--SDLLEVHKK---PL---QEVEIAAVTHGALQGLAYL 131
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY- 344
HS + HRD+K+ NILL + K+ DFG++ +A V GT ++ PE
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 345 --HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
Q K DV+S G+ +EL K P+F
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 13/213 (6%)
Query: 166 FNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
F + +G+G VY+ L D + +A+KK ++ + + ++ + EI +L Q+NH
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQI-FEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHL-HDRHQNEEFP--LTWEMRLRIATEVAGA 281
NV+K L +E +V E G L Q + + + Q P W+ +++ + A
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS----A 118
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 341
+ ++HS + HRDIK N+ + K+ D G +F + +T + GT Y+
Sbjct: 119 VEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMS 174
Query: 342 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
PE + KSD++S G +L E+ + P +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 176 GQGTVYKGML----EDGRIIAVKK---SKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
G+G+ K +L EDG+ +K+ SK++ + E E E+ +LS + H N+V+
Sbjct: 9 GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE-----ESRKEVAVLSNMKHPNIVQ 63
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQ---NEEFPLTWEMRLRIATEVAGALAYL 285
E +V ++ G LY+ ++ + E+ L W +++ +A L ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHV 117
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 345
H I HRDIKS NI L + K+ DFG ++ + T I GT YL PE
Sbjct: 118 HD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEIC 173
Query: 346 QSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGN 378
++ +KSD+++ G VL E+ T K F AGN
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHA-FEAGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 170 RILGQGGQGTVY----KGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
++LG+G G V KG E I A+KK + DD+ +E + E +L+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDD----VECTMVERRVLALAWEHP 56
Query: 226 VVKLLGCCLETEVPLL-VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
+ L C +T+ L V E++ G L H+ + +E + A E+ L +
Sbjct: 57 FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-----YAAEIICGLQF 111
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 344
LH I +RD+K N+LLD+ K+ADFG K M+ + GT Y+ PE
Sbjct: 112 LHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNGEGKASTFCGTPDYIAPEI 167
Query: 345 HQSSQLTDKSDVYSFGVVLVELLTGKKP 372
+ + + D +SFGV+L E+L G+ P
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 65/301 (21%), Positives = 134/301 (44%), Gaps = 36/301 (11%)
Query: 146 SVIDRFKLFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEEL 205
++I R + K ++ + ++ + Q ++YKG+ + + + ++ K ++
Sbjct: 2 NIITRSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKV 60
Query: 206 LKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL----LVYEFIPNGTLYQHLHDRHQN 261
L ++ NEI L +I+ N++K+ G ++ L L+ E+ G L + L +
Sbjct: 61 L-IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-----D 114
Query: 262 EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321
+E L+++ +L +A + L L+ T+ P ++++ S + L+ + Y+ K+ G K
Sbjct: 115 KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKI 172
Query: 322 IAMDQTHVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNT 379
++ K Y + S+ T K D+YS GVVL E+ TGK P
Sbjct: 173 LSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF------ 222
Query: 380 SQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
EN++ + + KN + + L +I + + C + KRP ++E
Sbjct: 223 --ENLTTKEIYDLIINKN------NSLKLPLDCPLEI---KCIVEACTSHDSIKRPNIKE 271
Query: 440 V 440
+
Sbjct: 272 I 272
|
Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 69/232 (29%), Positives = 107/232 (46%), Gaps = 34/232 (14%)
Query: 171 ILGQGGQGTVYKGML-EDGRII--AVKKSK--LTVDDEELLKLEEFINEIVILSQIN-HR 224
++G+G G V K + +DG + A+K+ K + DD +F E+ +L ++ H
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-----DFAGELEVLCKLGHHP 68
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFP-----------LTWEMRLR 273
N++ LLG C L E+ P+G L L E P L+ + L
Sbjct: 69 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 274 IATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
A +VA + YL + HRD+ + NIL+ + Y AK+ADFG S+ Q K
Sbjct: 129 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKT 181
Query: 334 QGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
G ++ E S T SDV+S+GV+L E+++ G P + G T E
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCGMTCAE 231
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 13/205 (6%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G VYK G I+A+KK +L +DE + I EI +L ++NH N+V+LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA--IREISLLKELNHPNIVRLL 64
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
LV+EF+ + L +++ D L + ++ +AY HS
Sbjct: 65 DVVHSENKLYLVFEFL-DLDLKKYM-DSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR- 119
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YHQSSQ 349
+ HRD+K N+L+D+ K+ADFG ++ + T ++ T Y PE S Q
Sbjct: 120 --VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQ 176
Query: 350 LTDKSDVYSFGVVLVELLTGKKPIF 374
+ D++S G + E++ ++P+F
Sbjct: 177 YSTPVDIWSIGCIFAEMVN-RRPLF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 79/306 (25%), Positives = 129/306 (42%), Gaps = 52/306 (16%)
Query: 165 HFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLK--LEEFINEIVILSQI 221
+ + +G G G V + GR +A+KK DD K L E I +L +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE----IKLLRHL 56
Query: 222 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLY--QHL--HDRHQ--NEEFPLTWEMRLRIA 275
H N++ LL + P +F +Y L D H+ PLT +
Sbjct: 57 RHENIIGLL----DILRPPSPEDF---NDVYIVTELMETDLHKVIKSPQPLTDDHIQYFL 109
Query: 276 TEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT-------H 328
++ L YLHSA + HRD+K +NIL++ K+ DFG ++ + D+ +
Sbjct: 110 YQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 329 VTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFWAGNTSQENVSLA 387
V T+ Y PE SS K+ D++S G + ELLT KP+F G + ++L
Sbjct: 167 VVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPLF-PGRDYIDQLNLI 219
Query: 388 AYFVHSMRKNRLHDILDDQLMK----LGVK-----NQIMTFAN-----LAKRCLDLNGKK 433
+ + + L I ++ L K +++ A+ L ++ L + KK
Sbjct: 220 VEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKK 279
Query: 434 RPTMEE 439
R T +E
Sbjct: 280 RITADE 285
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 39/103 (37%), Positives = 57/103 (55%), Gaps = 9/103 (8%)
Query: 273 RIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS-KFI-AMDQTHVT 330
+I+ V L YL I HRD+K +NIL++ R K+ DFG S + I +M + V
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 159
Query: 331 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 373
GT Y+ PE Q + T +SD++S G+ LVE+ G+ PI
Sbjct: 160 ----GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 70/220 (31%), Positives = 106/220 (48%), Gaps = 25/220 (11%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEE----FINEIVILSQINHR 224
+++G+G G V DG+ AVK + + +LK +E V+L + H
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVK----VLQKKAILKKKEQKHIMAERNVLLKNVKHP 56
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEE-FPLTWEMRLRI-ATEVAGAL 282
+V L + V +++ G L+ HL Q E FP E R R A E+A AL
Sbjct: 57 FLVGLHYSFQTADKLYFVLDYVNGGELFFHL----QRERSFP---EPRARFYAAEIASAL 109
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 342
YLHS I +RD+K NILLD + + DFG K ++ + T+ GT YL P
Sbjct: 110 GYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAP 165
Query: 343 EYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFWAGNTSQ 381
E + Q D++ D + G VL E+L G P F++ +T++
Sbjct: 166 EVLR-KQPYDRTVDWWCLGAVLYEMLYGLPP-FYSRDTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 172 LGQGGQGTVYK----GMLED--GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHR 224
LG+G G V G+ ++ R+ V L D E L + I+E+ ++ I H+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGKHK 84
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRH-----------QNEEFPLTWEMRLR 273
N++ LLG C + ++ E+ G L ++L R Q E L+++ +
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 274 IATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI-AMDQTHVTTK 332
A +VA + YL S HRD+ + N+L+ + K+ADFG ++ I +D TT
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 333 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
+ ++ PE T +SDV+SFGV+L E+ T G P
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 53/196 (27%), Positives = 94/196 (47%), Gaps = 20/196 (10%)
Query: 191 IAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNG 249
+AVK K DD L + ++E+ ++ I H+N++ LLG C + ++ E+ G
Sbjct: 50 VAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 106
Query: 250 TLYQHLHDRHQNE-----------EFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDI 298
L ++L R + +T++ + +VA + YL S HRD+
Sbjct: 107 NLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDL 163
Query: 299 KSTNILLDQRYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 357
+ N+L+ + K+ADFG ++ + +D TT + ++ PE T +SDV+
Sbjct: 164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 223
Query: 358 SFGVVLVELLT-GKKP 372
SFGV++ E+ T G P
Sbjct: 224 SFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 57/234 (24%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 172 LGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
LG+ G VYKG L E + +A+K K D E EEF +E ++ S++ H N
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK---DKAEGPLREEFKHEAMMRSRLQHPN 69
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMR-----------LRI 274
+V LLG + + +++ + + L++ L R + + T + + + I
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 275 ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI-AMDQTHVTTKI 333
T++A + +L +S + H+D+ + N+L+ + K++D G + + A D +
Sbjct: 130 VTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSL 386
++ PE + + SD++S+GVVL E+ + G +P + G ++Q+ + +
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYSNQDVIEM 238
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 78/265 (29%), Positives = 117/265 (44%), Gaps = 28/265 (10%)
Query: 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEI----VILSQINHR 224
+++G+G G V + DG AVK + + +LK +E + + V+L + H
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVK----VLQKKTILKKKEQNHIMAERNVLLKNLKHP 56
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATEVAGALA 283
+V L E V +++ G L+ HL Q E L E R R A EVA A+
Sbjct: 57 FLVGLHYSFQTAEKLYFVLDYVNGGELFFHL----QRERCFL--EPRARFYAAEVASAIG 110
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
YLHS I +RD+K NILLD + + DFG K ++ T+ GT YL PE
Sbjct: 111 YLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPE 166
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENVSLAAYFVHSMRKNRLHD 401
+ D + G VL E+L G P F++ + SQ +N+ + + D
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPP-FYSRDVSQMYDNILHKPLQLPGGKTVAACD 225
Query: 402 IL-----DDQLMKLGVKNQIMTFAN 421
+L DQ +LG K + N
Sbjct: 226 LLVGLLHKDQRRRLGAKADFLEIKN 250
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+ LG G G V+ +AVK K + +E F+ E ++ + H +VK
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMK-----PGSMSVEAFLAEANVMKTLQHDKLVK 65
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
L + E ++ EF+ G+L L +++ PL + + ++A +A++
Sbjct: 66 L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLP--KLIDFSAQIAEGMAFIEQR 121
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 348
HRD+++ NIL+ K+ADFG ++ I ++ + + PE
Sbjct: 122 N---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 178
Query: 349 QLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
T KSDV+SFG++L+E++T G+ P + G ++ E
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIP--YPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 203 EELLKL---EEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRH 259
E+LK+ + E IL +++H +V ++ + + EF+ G L+ HL
Sbjct: 54 REILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR--- 110
Query: 260 QNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319
+ FP ++ E+ A YLHS I +RD+K N+LLD + KV DFG +
Sbjct: 111 KAGRFPN--DVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFA 165
Query: 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
K + T + GT YL PE QS D ++ GV+L E + G P F
Sbjct: 166 KKV----PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216
|
Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 80/265 (30%), Positives = 118/265 (44%), Gaps = 28/265 (10%)
Query: 170 RILGQGGQGTVYKGMLE-DGRIIAVK---KSKLTVDDEELLKLEEFINEIVILSQINHRN 225
+++G+G G V + + + AVK K + EE + E V+L + H
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSE---RNVLLKNVKHPF 57
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATEVAGALAY 284
+V L + V ++I G L+ HL Q E L E R R A E+A AL Y
Sbjct: 58 LVGLHFSFQTADKLYFVLDYINGGELFYHL----QRERCFL--EPRARFYAAEIASALGY 111
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 344
LHS I +RD+K NILLD + + DFG K ++ T+ GT YL PE
Sbjct: 112 LHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEV 167
Query: 345 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENV-----SLAAYFVHSMRKN 397
D + G VL E+L G P F++ NT++ +N+ L +S R +
Sbjct: 168 LHKQPYDRTVDWWCLGAVLYEMLYGLPP-FYSRNTAEMYDNILNKPLQLKPNITNSAR-H 225
Query: 398 RLHDILD-DQLMKLGVKNQIMTFAN 421
L +L D+ +LG K+ M N
Sbjct: 226 LLEGLLQKDRTKRLGAKDDFMEIKN 250
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 68/230 (29%), Positives = 104/230 (45%), Gaps = 18/230 (7%)
Query: 165 HFNANRILGQGGQGTVY-----KGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILS 219
+F ++LG G G V+ G + G++ A+K K ++ E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 220 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEV 278
I + L +T+ L L+ ++I G L+ HL R + +E E+++ E+
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ----EVQIYSG-EI 114
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 338
AL +LH I +RDIK NILLD + DFG SK D+ GT
Sbjct: 115 VLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 339 YLDPEYHQSSQLT-DKS-DVYSFGVVLVELLTGKKPIFWAGN-TSQENVS 385
Y+ P+ + DK+ D +S GV++ ELLTG P G SQ +S
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G VYK G ++A+KK +L + E + I EI +L ++NH N+VKLL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 65
Query: 231 GCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
+ TE L LV+EF+ + L + + D PL + ++ LA+ HS
Sbjct: 66 DV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLP--LIKSYLFQLLQGLAFCHSHR 120
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 349
+ HRD+K N+L++ K+ADFG ++ + T ++ T Y PE +
Sbjct: 121 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCK 176
Query: 350 L-TDKSDVYSFGVVLVELLTGK 370
+ D++S G + E++T +
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 58/197 (29%), Positives = 98/197 (49%), Gaps = 22/197 (11%)
Query: 191 IAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLLV-YEFIPN 248
+AVK K D++L L I+E+ ++ I H+N++ LLG C + E PL V E+
Sbjct: 47 VAVKMLKDNATDKDLADL---ISEMELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAK 102
Query: 249 GTLYQHLHDRH-----------QNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRD 297
G L + L R + E L+++ + A +VA + YL S HRD
Sbjct: 103 GNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC---IHRD 159
Query: 298 IKSTNILLDQRYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 356
+ + N+L+ + K+ADFG ++ + +D T+ + ++ PE T +SDV
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219
Query: 357 YSFGVVLVELLT-GKKP 372
+SFG+++ E+ T G P
Sbjct: 220 WSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 66/230 (28%), Positives = 111/230 (48%), Gaps = 30/230 (13%)
Query: 171 ILGQGGQGTVYKGMLE-DGRII--AVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNV 226
++G+G G V + M++ DG + A+K K + + +F E+ +L ++ +H N+
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH---RDFAGELEVLCKLGHHPNI 65
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFP-----------LTWEMRLRIA 275
+ LLG C + E+ P G L L E P LT + L+ A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 276 TEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQG 335
++VA + YL + HRD+ + N+L+ + +K+ADFG S+ ++ +V K G
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV-KKTMG 178
Query: 336 TFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
++ E S T KSDV+SFGV+L E+++ G P + G T E
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP--YCGMTCAE 226
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 15/227 (6%)
Query: 166 FNANRILGQGGQGTVY----KGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
F ++LG G G V+ + G++ A+K + ++ +E E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 222 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
+ L +TE L L+ +++ G ++ HL+ R E E+R E+
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED----EVRFYSG-EIIL 116
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 340
AL +LH I +RDIK NILLD + DFG SK ++ T GT Y+
Sbjct: 117 ALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 341 DPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFWAGN-TSQENVS 385
PE + K+ D +S G+++ ELLTG P G +Q VS
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 52/210 (24%), Positives = 102/210 (48%), Gaps = 11/210 (5%)
Query: 171 ILGQGGQGTVYKGMLEDGRIIAVKKS--KLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+L +G G ++ G+L D + ++ K D +++ + E +L ++H+N++
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 229 LLGCCLE-TEVPLLVYEFIPNGTLYQHLHD-RHQNEEFPLTWEMR--LRIATEVAGALAY 284
+L C+E E P ++Y ++ G L L R P + + +A ++A ++Y
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLDPE 343
LH + H+DI + N ++D+ + K+ D S+ MD + ++ E
Sbjct: 133 LHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALE 189
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
+ + + SDV+SFGV+L EL+T G+ P
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKK---SKLTVDDEELLKLEEFINEIVILSQI 221
F R+LG+GG G V + G++ A KK ++ E + L NE IL ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMAL----NEKQILEKV 57
Query: 222 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEE-FPLTWEMR-LRIATEV 278
N R VV L ET+ L LV + G L H++ H E F E R + A E+
Sbjct: 58 NSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY--HMGEAGFE---EGRAVFYAAEI 111
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 338
L LH I +RD+K NILLD +++D G + + QT + ++ GT G
Sbjct: 112 CCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVG 166
Query: 339 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
Y+ PE ++ + T D ++ G +L E++ G+ P
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 20/196 (10%)
Query: 191 IAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNG 249
+AVK K DD L + ++E+ ++ I H+N++ LLG C + ++ E+ G
Sbjct: 47 VAVKMLK---DDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKG 103
Query: 250 TLYQHLHDRH-----------QNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDI 298
L ++L R + E LT++ + A +VA + YL S HRD+
Sbjct: 104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDL 160
Query: 299 KSTNILLDQRYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 357
+ N+L+ + K+ADFG ++ + +D TT + ++ PE T +SDV+
Sbjct: 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 220
Query: 358 SFGVVLVELLT-GKKP 372
SFGV+L E+ T G P
Sbjct: 221 SFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-13
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 170 RILGQGGQGTVY----KGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
++LG+G G V+ KG + I A+KK + +DD+ +E + E +LS
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD----VECTMVEKRVLSLAWEHP 56
Query: 226 VVKLLGCCLETEVPLL-VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
+ L C +T+ L V E++ G L H+ H+ + T+ A E+ L +
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF-----YAAEIICGLQF 111
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 344
LHS I +RD+K NILLD K+ADFG K + T GT Y+ PE
Sbjct: 112 LHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEI 167
Query: 345 HQSSQLTDKSDVYSFGVVLVELLTGKKP 372
+ D +SFGV+L E+L G+ P
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 68/215 (31%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 170 RILGQGGQGTVY----KGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
++LG+G G V KG E I +KK + DD+ ++ + E IL+
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDD----VDCTMTEKRILALAAKHP 56
Query: 226 VVKLLGCCLETEVPLL-VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATEVAGALA 283
+ L CC +T+ L V E++ G L + + +E R R A EV AL
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDE------PRSRFYAAEVTLALM 110
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
+LH IY RD+K NILLD K+ADFG K + TT GT Y+ PE
Sbjct: 111 FLH--RHGVIY-RDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPE 166
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGN 378
Q + D ++ GV++ E++ G+ P F A N
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQPP-FEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 9e-13
Identities = 67/230 (29%), Positives = 108/230 (46%), Gaps = 30/230 (13%)
Query: 171 ILGQGGQGTVYKGMLE-DGRII--AVKKSKLTVDDEELLKLEEFINEIVILSQINHR-NV 226
++G+G G V K ++ DG + A+K+ K ++ +F E+ +L ++ H N+
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCKLGHHPNI 58
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFP-----------LTWEMRLRIA 275
+ LLG C L E+ P+G L L E P L+ + L A
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 276 TEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQG 335
+VA + YL + HRD+ + NIL+ + Y AK+ADFG S+ + +V K G
Sbjct: 119 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMG 171
Query: 336 TFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
++ E S T SDV+S+GV+L E+++ G P + G T E
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCGMTCAE 219
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G GTV+K E I+A+K+ +L DDE + + EI +L ++ H+N+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP--SSALREICLLKELKHKNIVRLY 65
Query: 231 GCCLETEVPLLVYEFIP----------NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
+ LV+E+ NG + D + F ++
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI-----DPEIVKSFMF----------QLLK 110
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 340
LA+ HS + HRD+K N+L+++ K+ADFG ++ + + ++ T Y
Sbjct: 111 GLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYR 166
Query: 341 DPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 374
P+ ++L S D++S G + EL +P+F
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 86/326 (26%), Positives = 136/326 (41%), Gaps = 107/326 (32%)
Query: 172 LGQGGQGTVYKGMLED---GRIIAVKKSKLTVDDEELLKLEEFIN---------EIVILS 219
LG+G G V+K + D ++A+KK + D F N EI+ L
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKK----IFDA-------FRNATDAQRTFREIMFLQ 61
Query: 220 QI-NHRNVVKLLGC--------------CLETEVPLLVYEFIPNGTLYQHLHDRHQNEEF 264
++ +H N+VKLL +ET++ + I L + +H R+
Sbjct: 62 ELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDL----HAVIRANIL-EDVHKRY----- 111
Query: 265 PLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA- 323
I ++ AL Y+HS + HRD+K +NILL+ R K+ADFG ++ ++
Sbjct: 112 ---------IMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159
Query: 324 MDQTH---VTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFWAGNT 379
+++ V T T Y PE S K D++S G +L E+L G KP+F +T
Sbjct: 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTST 218
Query: 380 --------------SQENV-SLAAYFVHSM-------RKNRLHDIL----DDQLMKLGVK 413
S E++ S+ + F +M + L ++L DD L
Sbjct: 219 LNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDAL------ 272
Query: 414 NQIMTFANLAKRCLDLNGKKRPTMEE 439
+L K+ L N KR T EE
Sbjct: 273 -------DLLKKLLVFNPNKRLTAEE 291
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 51/214 (23%), Positives = 82/214 (38%), Gaps = 19/214 (8%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+ + K ++AVKK L +E LKL EI+ Q+ H N++
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKL--LQQEIITSRQLQHPNILPY 64
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLR-IATEVAGALAYLHSA 288
+ + +V + G+ L H E P E+ + I +V AL Y+HS
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCED-LLKTHFPEGLP---ELAIAFILKDVLNALDYIHS- 119
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTS-KFIAMDQTHV-----TTKIQGTFGYLDP 342
HR +K+++ILL + ++ S I + +L P
Sbjct: 120 --KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 343 EYHQSSQL--TDKSDVYSFGVVLVELLTGKKPIF 374
E Q + +KSD+YS G+ EL G P
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 172 LGQGGQGTVYKGML--EDGRIIAVKKSKLTVDDEELLKLEEFINEI-VILSQINHRNVVK 228
LG+G G V K M G I+AVK+ + TV+ +E +L + ++ + + ++ V
Sbjct: 9 LGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRL---LMDLDISMRSVDCPYTVT 64
Query: 229 LLGC---------CLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVA 279
G C+E L +F + E+ +IA +
Sbjct: 65 FYGALFREGDVWICMEVMDTSL-DKFYKK----VYDKGLTIPEDI------LGKIAVSIV 113
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 339
AL YLHS S + HRD+K +N+L+++ + K+ DFG S ++ +D T G Y
Sbjct: 114 KALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDA-GCKPY 169
Query: 340 LDPEY---HQSSQLTD-KSDVYSFGVVLVELLTGKKP 372
+ PE + + D KSDV+S G+ ++EL TG+ P
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 65/228 (28%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 164 NHFNANRILGQGGQGTVYKGMLED-GRIIAVKK-SKLTVDDEELLKLEEFINEIVILSQI 221
F +GQGG G V+ +D G I+A+K+ K + +L ++ + E IL+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL--FKLNEVRHVLTERDILTTT 58
Query: 222 NHRNVVKLLGCCLETEVPLLVYEFIPNG---TLYQH---LHDRHQNEEFPLTWEMRLRIA 275
+VKLL + E L E++P G TL + L + H R +A
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA----------RFYMA 108
Query: 276 TEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK-FIAMDQTHVTTKIQ 334
E+ A+ LH HRD+K N L+D K+ DFG SK + + V
Sbjct: 109 -EMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV----- 159
Query: 335 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE 382
G+ Y+ PE + D +S G +L E L G P ++G+T E
Sbjct: 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP--FSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLE-------EFINEIVILSQINHR 224
LG G G V+K + +I +K L+ LE + I E+ +L + N
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARK---------LIHLEIKPAIRNQIIRELQVLHECNSP 63
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
+V G + E + G+L Q L + E ++ +++ V L Y
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-----QILGKVSIAVIKGLTY 118
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLDP 342
L I HRD+K +NIL++ R K+ DFG S + +M + V GT Y+ P
Sbjct: 119 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSP 171
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 373
E Q + + +SD++S G+ LVE+ G+ PI
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 172 LGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G VYK IA+KK +L +DE + I EI +L ++ H N+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGNIVRLQ 67
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
+ LV+E++ + L +H+ + +F + ++ +AY HS
Sbjct: 68 DVVHSEKRLYLVFEYL-DLDLKKHMD---SSPDFAKNPRLIKTYLYQILRGIAYCHSHR- 122
Query: 291 SPIYHRDIKSTNILLDQRYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YHQSS 348
+ HRD+K N+L+D+R A K+ADFG ++ + T ++ T Y PE S
Sbjct: 123 --VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSR 179
Query: 349 QLTDKSDVYSFGVVLVELLTGKKPIF 374
+ D++S G + E++ +KP+F
Sbjct: 180 HYSTPVDIWSVGCIFAEMVN-QKPLF 204
|
Length = 294 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 76/274 (27%), Positives = 111/274 (40%), Gaps = 33/274 (12%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G G G VYK + G + A+K KL ++ EI+++ H N+V
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGED----FAVVQQEIIMMKDCKHSNIVAYF 72
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
G L + + EF G+L H PL+ ++ E L YLHS
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE---YHQS 347
HRDIK NILL K+ADFG S I + I GT ++ PE +
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERK 183
Query: 348 SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407
D+++ G+ +EL + P+F +H MR L + Q
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMF---------------DLHPMRALFLMTKSNFQP 228
Query: 408 MKLGVKNQ-IMTFANLAKRCLDLNGKKRPTMEEV 440
KL K + +F + K L N KKRPT E++
Sbjct: 229 PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 35/219 (15%)
Query: 170 RILGQGGQGT---VYKGM-LEDGRIIAVKKSKLTVDD-EELLKLEEFINEIVILSQIN-H 223
+ILG+ G+GT V K + G+ A+K K E++ L EI L +++ H
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL----REIQALRRLSPH 57
Query: 224 RNVVKLLGCCLE--TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLR-IATEVAG 280
N+++L+ + T LV+E + + LY+ + R + PL E R++ ++
Sbjct: 58 PNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKR----PLP-EKRVKSYMYQLLK 111
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 340
+L ++H + I+HRDIK NIL+ K+ADFG+ + I + T+ T Y
Sbjct: 112 SLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY--TEYISTRWYR 165
Query: 341 DPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIF 374
PE LTD K D+++ G V E+L+ P+F
Sbjct: 166 APE----CLLTDGYYGPKMDIWAVGCVFFEILS-LFPLF 199
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 40/213 (18%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFI------NEIV-------IL 218
LG+G GTVY + K K V +E L L+E NE V +L
Sbjct: 8 LGKGSFGTVY-----------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLL 56
Query: 219 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEE-FP----LTWEMRLR 273
S+++H +VK LE + ++ E+ L L + + W ++L
Sbjct: 57 SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 274 IATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
+ Y+H I HRD+K+ NI L K+ DFG S+ + M + T
Sbjct: 117 LGVH------YMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTF 165
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVEL 366
GT Y+ PE + KSD++S G +L E+
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 61/237 (25%), Positives = 97/237 (40%), Gaps = 47/237 (19%)
Query: 169 NRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFIN----------EIVI 217
LG+G G V K G+I+A+KK K+ ++ K + + E+ I
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 218 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATE 277
+++I H N++ L+ +E + LV + I L + + + + LT I +
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVVDRKIR-----LTESQVKCILLQ 127
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG-------------TSKFIAM 324
+ L LH HRD+ NI ++ + K+ADFG SK M
Sbjct: 128 ILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 325 DQTHVTTKIQGTFGYLDPE-------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
+ T T Y PE YH + D++S G + ELLTG KP+F
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFA------VDMWSVGCIFAELLTG-KPLF 234
|
Length = 335 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 52/223 (23%), Positives = 102/223 (45%), Gaps = 18/223 (8%)
Query: 158 ELDKATNHFNANRILGQGGQGTVYKGMLE-DGR---IIAVKKSKLTVDDEELLKLEEFIN 213
ELD + RILG G G + +G L+ + +A+ + D++ F+
Sbjct: 1 ELDNKS--IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG---FLA 55
Query: 214 EIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLR 273
E + L Q +H N+V+L G ++V E++ NG L L +H+ + L +
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR-KHEGQ---LVAGQLMG 111
Query: 274 IATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
+ +A + YL + H+ + + +L++ K++ F + + + T
Sbjct: 112 MLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSG 168
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFW 375
+ + PE Q + SDV+SFG+V+ E+++ G++P +W
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP-YW 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 171 ILGQGGQGTVYKGMLED-GRIIAVK---KSKLTVDDEELLKLEEFINEIVILSQINHRNV 226
I+G+GG G VY D G++ A+K K ++ + E L L NE ++LS ++ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL----NERIMLSLVSTGDC 56
Query: 227 VKLLGCCLETEVP---LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
++ P + + + G L+ HL E EMR ATE+ L
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSE----KEMRF-YATEIILGLE 111
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
++H+ + +RD+K NILLD+ +++D G + + + H + GT GY+ PE
Sbjct: 112 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 165
Query: 344 YHQSSQLTDKS-DVYSFGVVLVELLTGKKP 372
Q D S D +S G +L +LL G P
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 24/223 (10%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVIL---SQINHRNVV 227
+G G GTVYK G +A+K ++ +E+ L L + E+ +L +H N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQ-TNEDGLPLST-VREVALLKRLEAFDHPNIV 65
Query: 228 KLLGCCL------ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGA 281
+L+ C ET+V L V+E + + L +L D+ P E + +
Sbjct: 66 RLMDVCATSRTDRETKVTL-VFEHV-DQDLRTYL-DKVPPPGLPA--ETIKDLMRQFLRG 120
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 341
L +LH+ + I HRD+K NIL+ + K+ADFG ++ + T + T Y
Sbjct: 121 LDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRA 175
Query: 342 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENV 384
PE S D++S G + E+ +KP+F GN+ + +
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLF-CGNSEADQL 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 33/225 (14%)
Query: 171 ILGQGGQGT---VYKGML---EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
I G G+GT VYK +DG+ A+KK K + + EI +L ++ H
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA-CREIALLRELKHE 62
Query: 225 NVVKLLGCCLETEVPL--LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
NVV L+ LE L++++ + L+Q + Q + + M + ++ +
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 283 AYLHSATSSPIYHRDIKSTNILL----DQRYRAKVADFGTS-KFIAMDQTHVT-TKIQGT 336
YLH S+ + HRD+K NIL+ +R K+ D G + F A + + T
Sbjct: 122 HYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178
Query: 337 FGYLDPE-------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
Y PE Y T D+++ G + ELLT +PIF
Sbjct: 179 IWYRAPELLLGARHY------TKAIDIWAIGCIFAELLT-LEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G V+K E G+I+A+KK + DD + K+ + EI +L Q+ H N+V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA--LREIRMLKQLKHPNLVNLI 66
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
LV+E+ + L + +++ + + +I + A+ + H
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVL--NELEKNPRG---VPEHLIKKIIWQTLQAVNFCHK--- 118
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH-QSSQ 349
HRD+K NIL+ ++ + K+ DFG ++ + T + T Y PE +Q
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQ 177
Query: 350 LTDKSDVYSFGVVLVELLTGKKPIFWAG 377
DV++ G V ELLTG +P+ W G
Sbjct: 178 YGPPVDVWAIGCVFAELLTG-QPL-WPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 66/227 (29%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEF----INEIVILSQINHRNV 226
LG+G G VYK ++ GR++A+KK + + +E+ + F + EI IL ++ H NV
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKK--ILMHNEK----DGFPITALREIKILKKLKHPNV 69
Query: 227 VKLLGCCLE-----TEVPLLVYEFIPNGTLYQHLHDRH---QNEEFPLTWEMRLRIATEV 278
V L+ +E VY P Y HD +N LT ++
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTP----YMD-HDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG----------TSKFIAMDQTH 328
+ YLH I HRDIK+ NIL+D + K+ADFG K T
Sbjct: 125 LEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 329 VTTKIQGTFGYLDPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
T + T Y PE + T D++ G V E+ T +PI
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPIL 227
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVK---KSKLTVDDEELLKLEEFINEIVILSQI 221
F R+LG+GG G V + G++ A K K ++ E + L NE IL ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL----NEKQILEKV 57
Query: 222 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMR-LRIATEVA 279
N R VV L ET+ L LV + G L H+++ N F E R + A E+
Sbjct: 58 NSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNM-GNPGFD---EERAVFYAAEIT 112
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 339
L LH I +RD+K NILLD +++D G + I +T + ++ GT GY
Sbjct: 113 CGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGY 167
Query: 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
+ PE ++ + T D + G ++ E++ GK P
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 67/250 (26%), Positives = 101/250 (40%), Gaps = 48/250 (19%)
Query: 166 FNANRILGQGGQGTVYKG-MLEDGRIIAVKKSKLTVDDEELLKLEE---FINEIVILSQI 221
F +++G+G G V+ + G++ A+K + +++K + E IL+
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLR----KSDMIKRNQIAHVRAERDILADA 58
Query: 222 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
+ +VKL + E L LV E++P G L L + FP R IA E+
Sbjct: 59 DSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDV---FPEET-ARFYIA-ELVL 112
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK-------------------F 321
AL +H HRDIK NIL+D K+ADFG K F
Sbjct: 113 ALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 322 IAMDQTHVTTKIQ---------GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
Q GT Y+ PE + + + D +S GV+L E+L G P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
Query: 373 IFWAGNTSQE 382
+ +T QE
Sbjct: 230 FY--SDTLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 7e-12
Identities = 54/187 (28%), Positives = 76/187 (40%), Gaps = 24/187 (12%)
Query: 190 IIAVKKSKLTVDDEEL-LKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 248
I +KKS + ++ +K E I ++ Q V KL + LV E++
Sbjct: 26 IKVLKKSDMIAKNQVTNVKAERAI----MMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81
Query: 249 G---TLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL 305
G +L + L P W + EV + LH I HRDIK N+L+
Sbjct: 82 GDCASLIKTLG------GLPEDWAKQY--IAEVVLGVEDLHQ---RGIIHRDIKPENLLI 130
Query: 306 DQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVE 365
DQ K+ DFG S+ ++ K GT YL PE SD +S G V+ E
Sbjct: 131 DQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFE 185
Query: 366 LLTGKKP 372
L G P
Sbjct: 186 FLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 8e-12
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 172 LGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEF---INEIVILSQINHRNVV 227
LG+GG G V ++ G++ A KK +D + L K + +NE IL +++ R +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK----LDKKRLKKRKGEQMALNEKKILEKVSSRFIV 56
Query: 228 KLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATEVAGALAYL 285
L ET+ L LV + G L H+++ FP E R A ++ L +L
Sbjct: 57 SL-AYAFETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFP---EARAIFYAAQIICGLEHL 111
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 345
H I +RD+K N+LLD +++D G + + + GT GY+ PE
Sbjct: 112 HQRR---IVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVL 166
Query: 346 QSSQLTDKSDVYSFGVVLVELLTGKKP 372
Q D ++ G L E++ G+ P
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 9e-12
Identities = 43/171 (25%), Positives = 79/171 (46%), Gaps = 14/171 (8%)
Query: 214 EIVILSQINHRNVVKLLGCCLETEVPLLVYEFIP--NGTLYQHLHDRHQNEEFPLTWEMR 271
E ++L +NH +V+++ + + +V +P + LY +L PL +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYL----TKRSRPLPIDQA 159
Query: 272 LRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTT 331
L I ++ L YLH+ I HRD+K+ NI ++ + + D G ++F + +
Sbjct: 160 LIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL-- 214
Query: 332 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE 382
+ GT PE + K+D++S G+VL E+L IF ++ E
Sbjct: 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265
|
Length = 357 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 9e-12
Identities = 60/234 (25%), Positives = 107/234 (45%), Gaps = 16/234 (6%)
Query: 170 RILGQGGQGTVYKGMLED-GRIIAVK--KSKLTVDDEELLKLEEFINEIVILSQINHRNV 226
R++G+G V L+ RI A+K K +L DDE++ ++ E + Q ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQ---TEKHVFEQASNHPF 57
Query: 227 VKLLGCCLETEVPLL-VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
+ L C +TE L V E++ G L H+ + + E E + E++ AL YL
Sbjct: 58 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE-----EHARFYSAEISLALNYL 112
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 345
H I +RD+K N+LLD K+ D+G K + T+ GT Y+ PE
Sbjct: 113 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEIL 168
Query: 346 QSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399
+ D ++ GV++ E++ G+ P G++ + + Y + + ++
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 21/215 (9%)
Query: 171 ILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEEL--LKLEEFINEIVILSQINHRNVV 227
+G+G G VYK G+++A+KK++L +D+E + L E I+ + +LS+ + +V
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALRE-ISLLQMLSESIY--IV 64
Query: 228 KLLGCCLETEVPL------LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGA 281
+LL E LV+E++ + L + + + PL + ++
Sbjct: 65 RLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 282 LAYLHSATSSPIYHRDIKSTNILLD-QRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 340
+A+ H + HRD+K N+L+D Q+ K+AD G + ++ T +I T Y
Sbjct: 123 VAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYR 178
Query: 341 DPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
PE S+ + D++S G + E+ K+P+F
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 172 LGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
LG+G G+VYK + G +A+K+ +L +D+ K + I E+ IL + +V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES---KFNQIIMELDILHKAVSPYIVDFY 65
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRL-RIATEVAGALAYLHSAT 289
G + E++ G+L + E P E L RI V L +L
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIP---EDVLRRITYAVVKGLKFLKEEH 122
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 349
+ I HRD+K TN+L++ + K+ DFG S + + T I G Y+ PE +S
Sbjct: 123 N--IIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNI-GCQSYMAPERIKSGG 177
Query: 350 LTD------KSDVYSFGVVLVELLTGKKP 372
+SDV+S G+ ++E+ G+ P
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 62/207 (29%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 172 LGQGGQGTVYKGMLEDGRII----AVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVV 227
+G+G G V + D + I ++K+ + E + + E +L+Q+N +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSE----VTHTLAERTVLAQVNCPFIV 56
Query: 228 KLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS 287
L E LV FI G L+ HL Q E R A E+ AL LH
Sbjct: 57 PLKFSFQSPEKLYLVLAFINGGELFHHL----QREGRFDLSRARFYTA-ELLCALENLHK 111
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 347
+ +RD+K NILLD + + DFG K + M T GT YL PE
Sbjct: 112 FN---VIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLG 167
Query: 348 SQLTDKSDVYSFGVVLVELLTGKKPIF 374
T D ++ GV+L E+LTG P +
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPPFY 194
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 67/214 (31%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 166 FNANRILGQGGQGTVY----KGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
FN +LG+G G V KG E I +KK + DD+ +E + E +L+
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDD----VECTMVEKRVLALP 57
Query: 222 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
+ L C +T L V E++ G L H+ + +E + A E+A
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE-----PHAVFYAAEIAI 112
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGY 339
L +LHS I +RD+K N++LD K+ADFG K TT+ GT Y
Sbjct: 113 GLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTFCGTPDY 167
Query: 340 LDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 372
+ PE + Q KS D ++FGV+L E+L G+ P
Sbjct: 168 IAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 28/224 (12%)
Query: 165 HFNANRILGQGGQGTV----YKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQ 220
+ + LGQG G V E+ + A+KK + L K + E+ +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETV-AIKKITNVFSKKILAK--RALRELKLLRH 57
Query: 221 I-NHRNVVKLLGCCLETEVPLLVYEFIPNGT-LYQHL--HDRHQ--NEEFPLTWEMRLRI 274
H+N+ C + ++ V+ N LY+ L D HQ PLT
Sbjct: 58 FRGHKNIT----CLYDMDI---VFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSF 110
Query: 275 ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ 334
++ L Y+HSA + HRD+K N+L++ K+ DFG ++ + + +
Sbjct: 111 IYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 335 G---TFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 374
T Y PE S Q K+ DV+S G +L ELL G+KP+F
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 172 LGQGGQGTVYKG--MLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN---HRNV 226
+G+G G V+K + GR +A+K+ ++ EE + L I E+ +L + H NV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLST-IREVAVLRHLETFEHPNV 66
Query: 227 VKLLGCCL------ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
V+L C ET++ L V+E + + L +L D+ P E + ++
Sbjct: 67 VRLFDVCTVSRTDRETKLTL-VFEHV-DQDLTTYL-DKVPEPGVPT--ETIKDMMFQLLR 121
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 340
L +LHS + HRD+K NIL+ + K+ADFG ++ + T + T Y
Sbjct: 122 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYR 176
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNT 379
PE S D++S G + E+ +KP+F G++
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLF-RGSS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 66/213 (30%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 166 FNANRILGQGGQGTVY----KGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
FN +LG+G G V KG E I +KK + DD+ +E + E +L+
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD----VECTMVEKRVLALS 57
Query: 222 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
+ L C +T L V E++ G L + + +E + A E+A
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKE-----PHAVFYAAEIAI 112
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGY 339
L +LHS I +RD+K N++LD K+ADFG K D VTTK GT Y
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDY 167
Query: 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
+ PE D ++FGV+L E+L G+ P
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 60/214 (28%), Positives = 109/214 (50%), Gaps = 16/214 (7%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
LG+G TVYKG G I+A+K+ L D E I EI ++ ++ H N+V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHL---DAEEGTPSTAIREISLMKELKHENIVRLH 64
Query: 231 GCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
+ TE L LV+E++ + L +++ D H L ++ +A+ H
Sbjct: 65 DV-IHTENKLMLVFEYM-DKDLKKYM-DTHGVRG-ALDPNTVKSFTYQLLKGIAFCHE-- 118
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 349
+ + HRD+K N+L+++R K+ADFG ++ + + ++ T Y P+ S+
Sbjct: 119 -NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSR 176
Query: 350 LTDKS-DVYSFGVVLVELLTGKKPIFWAGNTSQE 382
S D++S G ++ E++TG +P+F G +++
Sbjct: 177 TYSTSIDIWSVGCIMAEMITG-RPLF-PGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 68/232 (29%), Positives = 101/232 (43%), Gaps = 26/232 (11%)
Query: 157 KELDKATNHFNANRILGQGGQGTVYK-GMLEDGRIIAVKKSKLTVDDEELLKLEEFINEI 215
+ L T+ + +G+G G VYK +DG + AVK D +E ++ E I
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI--- 71
Query: 216 VILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGT---LYQHLHDRHQNEEFPLT 267
+ S NH NVVK G + + + LV E G+ L + L Q + +
Sbjct: 72 -LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM- 129
Query: 268 WEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327
I+ + GAL L ++ I HRD+K NILL K+ DFG S + +
Sbjct: 130 ------ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183
Query: 328 HVTTKIQGTFGYLDPEYHQSSQLTDKS-----DVYSFGVVLVELLTGKKPIF 374
T + GT ++ PE Q D S DV+S G+ +EL G P+F
Sbjct: 184 RRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 171 ILGQGGQGTVYKGMLED-GRIIAVK---KSKLTVDDEELLKLEEFINEIVILSQINHRNV 226
I+G+GG G VY D G++ A+K K ++ + E L L NE ++LS ++ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL----NERIMLSLVSTGDC 56
Query: 227 VKLLGCCLETEVP---LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
++ P + + + G L+ HL Q+ F EMR A E+ L
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEA-EMRF-YAAEIILGLE 111
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
++H+ + +RD+K NILLD+ +++D G + + + H + GT GY+ PE
Sbjct: 112 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 165
Query: 344 YHQSSQLTDKS-DVYSFGVVLVELLTGKKP 372
Q D S D +S G +L +LL G P
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 56/172 (32%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 211 FINEIVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWE 269
F E I++ N VV+L C + + L +V E++P G L + N + P W
Sbjct: 90 FWEERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLM----SNYDVPEKWA 144
Query: 270 MRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT-- 327
EV AL +HS + HRD+K N+LLD+ K+ADFGT + MD+T
Sbjct: 145 KFY--TAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGM 197
Query: 328 -HVTTKIQGTFGYLDPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIF 374
T + GT Y+ PE +S + D +S GV L E+L G P +
Sbjct: 198 VRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 166 FNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEE--FINEIVILSQINH 223
F+ +++G+G G V ++ V KL E + + + F E I++ N
Sbjct: 45 FDVIKVIGRGAFGEVQ--LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102
Query: 224 RNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
+V+L + + L +V E++P G L + N + P W R A EV AL
Sbjct: 103 EWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWA-RFYTA-EVVLAL 155
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT---HVTTKIQGTFGY 339
+HS HRD+K N+LLD+ K+ADFGT + MD T + GT Y
Sbjct: 156 DAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC--MKMDANGMVRCDTAV-GTPDY 209
Query: 340 LDPEYHQS----SQLTDKSDVYSFGVVLVELLTGKKPIF 374
+ PE +S + D +S GV L E+L G P +
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 170 RILGQGGQGTVYKGMLE-DGRIIAVK--KSKLTVDDEELLKLEEFINEIVILSQINHRNV 226
R++G+G V L+ + +I A+K K +L DDE++ ++ E + Q +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQ---TEKHVFEQASSNPF 57
Query: 227 VKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
+ L C +T L LV E++ G L H+ + + E E A E+ AL +L
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPE-----EHARFYAAEICIALNFL 112
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 345
H I +RD+K N+LLD K+ D+G K + T+ GT Y+ PE
Sbjct: 113 HE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 346 QSSQLTDKSDVYSFGVVLVELLTGKKP 372
+ + D ++ GV++ E++ G+ P
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKK---SKLTVDDEELLKLEEFINEIVILSQI 221
F R+LG+GG G V + G++ A KK ++ E + L NE IL ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL----NEKRILEKV 57
Query: 222 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMR-LRIATEVA 279
N R VV L ET+ L LV + G L H+++ N F E R + A E+
Sbjct: 58 NSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFD---EQRAIFYAAELC 112
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 339
L L I +RD+K NILLD R +++D G + I +T V ++ GT GY
Sbjct: 113 CGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGY 167
Query: 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
+ PE + + T D + G ++ E++ G+ P
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (157), Expect = 6e-11
Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 54/256 (21%)
Query: 210 EFINEIVILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGTLYQHLHDRHQN----EE 263
+ + E+ ++ ++ H+N+V+ + L + ++ EF G L +++ ++ EE
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 264 FPLTWEMRLRIATEVAGALAYLHSATSSP----IYHRDIKSTNILLDQRYR--------- 310
+ + I ++ ALAY H+ P + HRD+K NI L R
Sbjct: 118 HAI-----VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172
Query: 311 --------AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY--HQSSQLTDKSDVYSFG 360
AK+ DFG SK I ++ + GT Y PE H++ DKSD+++ G
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 361 VVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFA 420
++ EL +GK P A N SQ + +++ L +K +
Sbjct: 231 CIIYELCSGKTPFHKANNFSQ--------LISELKRGP----------DLPIKGKSKELN 272
Query: 421 NLAKRCLDLNGKKRPT 436
L K L+L+ K+RP+
Sbjct: 273 ILIKNLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 67/291 (23%), Positives = 122/291 (41%), Gaps = 52/291 (17%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKL---------EEFINEIVILSQIN 222
LGQG ++KG+ + V E LLK+ E F ++SQ++
Sbjct: 3 LGQGTFTKIFKGIRRE-----VGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS 57
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
H+++V G C+ + ++V E++ G+L +L ++W +L +A ++A AL
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN--LINISW--KLEVAKQLAWAL 113
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD- 341
+L + H ++ + N+LL R + G FI + ++ + L+
Sbjct: 114 HFLEDKG---LTHGNVCAKNVLL---IREEDRKTGNPPFIKLSDPGISITVLPKEILLER 167
Query: 342 -----PE-YHQSSQLTDKSDVYSFGVVLVELLTG-KKPIFWAGNTSQENVSLAAYFVHSM 394
PE L+ +D +SFG L E+ +G KP L+A S
Sbjct: 168 IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP-------------LSAL--DSQ 212
Query: 395 RKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445
+K + + +D+ +L ANL +C+D RP+ + +LN
Sbjct: 213 KKLQFY---EDRH-QLPAPKWT-ELANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 165 HFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
+ +G+G G V G +A+KK ++ + + + EI IL + H
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--ISPFEHQTFCQRT-LREIKILRRFKH 62
Query: 224 RNVVKLLGC----CLET--EVPLLVYEFIPNGTLY-----QHLHDRHQNEEFPLTWEMRL 272
N++ +L E+ +V +V E + LY QHL + H +++ L
Sbjct: 63 ENIIGILDIIRPPSFESFNDV-YIVQELMET-DLYKLIKTQHLSNDHIQY---FLYQI-L 116
Query: 273 RIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM--DQTHVT 330
R L Y+HSA + HRD+K +N+LL+ K+ DFG ++ D T
Sbjct: 117 R-------GLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166
Query: 331 TKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 374
T+ T Y PE +S+ K+ D++S G +L E+L+ +P+F
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 69/222 (31%), Positives = 100/222 (45%), Gaps = 32/222 (14%)
Query: 169 NRILGQGGQGTV-YKGMLEDGRIIAVKKSKLTVDDEELLKLEEFIN----EIVILSQINH 223
+R+LG G GTV + DG AVK VD E + + + N E+ L +
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVK----VVDMEGMSEAD--KNRAQAEVCCLLNCDF 90
Query: 224 RNVVKLLGCCLE------------TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMR 271
++VK C E + LV ++ G L Q + R + E
Sbjct: 91 FSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAG 146
Query: 272 LRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK-FIAMDQTHVT 330
L + +V A+ ++HS + HRDIKS NILL K+ DFG SK + A V
Sbjct: 147 L-LFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG 202
Query: 331 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
GT Y+ PE + + K+D++S GV+L ELLT K+P
Sbjct: 203 RTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 170 RILGQGGQGTVYKGMLE-DGRIIAVK--KSKLTVDDEEL--LKLEEFINEIVILSQINHR 224
R++G+G V L+ RI A+K K +L DDE++ ++ E+ + E + NH
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFE----TASNHP 56
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
+V L C V EF+ G L H+ + + E E + E++ AL +
Sbjct: 57 FLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPE-----EHARFYSAEISLALNF 111
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 344
LH I +RD+K N+LLD K+ D+G K + T+ GT Y+ PE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEI 167
Query: 345 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNT 379
+ D ++ GV++ E++ G+ P G +
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMS 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 172 LGQGGQGTVYK-GMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIV---ILSQINHRNVV 227
LG+GG G V M G++ A KK ++ + L K + + +V IL++++ R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKK----LNKKRLKKRKGYEGAMVEKRILAKVHSRFIV 56
Query: 228 KLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMR-LRIATEVAGALAYL 285
L +T+ L LV + G L H+++ +EE P E R ++ L +L
Sbjct: 57 SL-AYAFQTKTDLCLVMTIMNGGDLRYHIYN--VDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 345
H I +RD+K N+LLD +++D G + + Q+ T GT G++ PE
Sbjct: 114 HQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELL 169
Query: 346 QSSQLTDKSDVYSFGVVLVELLTGKKP 372
Q + D ++ GV L E++ + P
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 68/237 (28%), Positives = 125/237 (52%), Gaps = 33/237 (13%)
Query: 158 ELDKATNH-FNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFIN-E 214
+++++ N + I+G G G VY+ + ++ +A+KK +L+ ++ N E
Sbjct: 59 DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKK---------VLQDPQYKNRE 109
Query: 215 IVILSQINHRNVVKL-----LGCCLETEVPL---LVYEFIPNGTLYQHL-HDRHQNEEFP 265
++I+ +NH N++ L C + E + +V EFIP T+++++ H N P
Sbjct: 110 LLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALP 168
Query: 266 LTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR-YRAKVADFGTSKFIAM 324
L + ++L + ++ ALAY+HS I HRD+K N+L+D + K+ DFG++K +
Sbjct: 169 L-FLVKL-YSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223
Query: 325 DQTHVTTKIQGTFGYLDPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTS 380
Q V+ I F Y PE ++ T D++S G ++ E++ G PIF +G +S
Sbjct: 224 GQRSVSY-ICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YPIF-SGQSS 276
|
Length = 440 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 77/293 (26%), Positives = 128/293 (43%), Gaps = 46/293 (15%)
Query: 172 LGQGGQGTVYKGMLEDGRI---IAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+G G G V G + G + VK+ +++ +E +K F+ E + H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK---FLEEAQPYRSLQHSNLLQ 59
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEF---PLTWEMRLRIATEVAGALAYL 285
LG C E LLV EF P G L +L + E P T + R+A E+A L +L
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ---RMACEIALGLLHL 116
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK-------FIAMDQTHVTTKIQGTFG 338
H H D+ N LL K+ D+G S ++ DQ V ++
Sbjct: 117 HKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLRWIAP 171
Query: 339 YLDPEYHQSSQLTDK---SDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395
L E H + + D+ S+V+S GV + EL F G+ ++S +++R
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWEL-------FELGSQPYRHLSDEQVLTYTVR 224
Query: 396 KNRLHDILDDQLMKLGVKN---QIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445
+ +L L +KL + + ++M F L ++RP+ EEV + L+
Sbjct: 225 EQQLK--LPKPRLKLPLSDRWYEVMQFCWLQP-------EQRPSAEEVHLLLS 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 41/222 (18%)
Query: 169 NRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEF----INEIVILSQINH 223
NRI +G G VY+ + G I+A+KK K+ ++E E F + EI IL ++ H
Sbjct: 11 NRI-EEGTYGVVYRARDKKTGEIVALKKLKM---EKEK---EGFPITSLREINILLKLQH 63
Query: 224 RNVVKLLGCCLETEVPL--------LVYEFIPNG--TLYQHLHDRHQNEEFPLTWEMRLR 273
N+V + EV + +V E++ + +L + + E L
Sbjct: 64 PNIVTV------KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLS 117
Query: 274 IATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
+A+LH + I HRD+K++N+LL+ R K+ DFG ++ T++
Sbjct: 118 -------GVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQL 166
Query: 334 QGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
T Y PE + + + D++S G + ELLT KKP+F
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLF 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 65/247 (26%), Positives = 115/247 (46%), Gaps = 23/247 (9%)
Query: 170 RILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
R LG G G V+ + D + +AVKK LT + ++ + EI I+ +++H N+VK
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT----DPQSVKHALREIKIIRRLDHDNIVK 66
Query: 229 L---LGCCLETEVPLLVYEFIPNGTLY--QHLHD---RHQNEEFPLTWEMRLRIATEVAG 280
+ LG +++ V ++Y Q + + E+ PL+ E ++
Sbjct: 67 VYEVLGPS-GSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQR-YRAKVADFGTSKFIAMDQTHVTTKIQG--TF 337
L Y+HSA + HRD+K N+ ++ K+ DFG ++ + +H +G T
Sbjct: 126 GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 338 GYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396
Y P + T D+++ G + E+LTG KP+F AG E + L V +R+
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLF-AGAHELEQMQLILESVPVVRE 240
Query: 397 NRLHDIL 403
+++L
Sbjct: 241 EDRNELL 247
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 166 FNANRILGQGGQGTVY----KGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
FN +LG+G G V KG E I +KK + DD+ +E + E +L+
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD----VECTMVEKRVLALQ 57
Query: 222 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
+ + L C +T L V E++ G L H+ + +E + A E++
Sbjct: 58 DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE-----PQAVFYAAEISV 112
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGY 339
L +LH I +RD+K N++LD K+ADFG K +D VTT+ GT Y
Sbjct: 113 GLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDY 167
Query: 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
+ PE D +++GV+L E+L G+ P
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVK---KSKLTVDDEELLKLEEFINEIVILSQI 221
F R+LG+GG G V + G++ A K K ++ E + L NE IL ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMAL----NEKQILEKV 57
Query: 222 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGA 281
N + VV L + LV + G L H+++ N F E L A E+
Sbjct: 58 NSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGF--EEERALFYAAEILCG 114
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 341
L LH +RD+K NILLD +++D G + + + + GT GY+
Sbjct: 115 LEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMA 169
Query: 342 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
PE + + T D + G ++ E++ G+ P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 170 RILGQGGQGTV-YKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
R++G+G G V DG+ +KK L K E E +LSQ+ H N+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKHPNIVA 63
Query: 229 LLGCCLETEVPLL--VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH 286
E E LL V F G LY L ++ + + P + + ++A AL YLH
Sbjct: 64 YRES-WEGEDGLLYIVMGFCEGGDLYHKLKEQ-KGKLLPENQVVEWFV--QIAMALQYLH 119
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 346
I HRD+K+ N+ L + KV D G ++ + +Q + + + GT Y+ PE
Sbjct: 120 E---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELFS 175
Query: 347 SSQLTDKSDVYSFGVVLVELLTGK 370
+ KSDV++ G + E+ T K
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 166 FNANRILGQGGQGTVYKGMLEDGRI--IAVK---KSKLTVDDEELLKLEEFINEIVILSQ 220
FN R LG G G V ++ +A+K KSK+ + ++ +E IL+
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ----VDHVFSERKILNY 87
Query: 221 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
INH V L G + LV EF+ G + L +N+ FP ++ A ++
Sbjct: 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR---RNKRFPN--DVGCFYAAQIVL 142
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 340
YL S I +RD+K N+LLD+ K+ DFG +K + T + GT Y+
Sbjct: 143 IFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYI 195
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
PE + +D ++ G+ + E+L G P +
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPPFY 229
|
Length = 340 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 51/242 (21%)
Query: 171 ILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEF----INEIVILSQINHRN 225
+GQG G V+K + +I+A+KK + +++E+ E F + EI IL + H N
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKK--VLMENEK----EGFPITALREIKILQLLKHEN 72
Query: 226 VVKLLGCCLETEVP--------LLVYEFIPNGTLYQHLHD-----RHQNEEFPLTWEMRL 272
VV L+ C P LV+EF HD ++N +F L+ E++
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCE--------HDLAGLLSNKNVKFTLS-EIK- 122
Query: 273 RIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM---DQTHV 329
++ + L Y+H + I HRD+K+ NIL+ + K+ADFG ++ ++ + +
Sbjct: 123 KVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 330 TTKIQGTFGYLDPEYHQSSQLTDKS-----DVYSFGVVLVELLTGKKPIFWAGNTSQENV 384
T T Y PE L ++ D++ G ++ E+ T + PI GNT Q +
Sbjct: 180 YTNRVVTLWYRPPEL----LLGERDYGPPIDMWGAGCIMAEMWT-RSPIM-QGNTEQHQL 233
Query: 385 SL 386
+L
Sbjct: 234 TL 235
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 170 RILGQGGQGTVYKGMLEDG----RIIAVK---KSKLTVDDEELLKLEEFINEIVILSQIN 222
++LG+GG G V++ G +I A+K K+ + + ++ + N IL +
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERN---ILEAVK 58
Query: 223 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGA 281
H +V L+ +T L L+ E++ G L+ HL E + +E++ A
Sbjct: 59 HPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLE-----REGIFMEDTACFYLSEISLA 112
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 341
L +LH I +RD+K NILLD + K+ DFG K ++ + VT GT Y+
Sbjct: 113 LEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMA 168
Query: 342 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGN 378
PE S D +S G ++ ++LTG P F A N
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPP-FTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 176 GQGTVYKGML----EDGRIIAVK--KSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
G+GT K +L G+ A+K K ++ + +E+ + E +L H + L
Sbjct: 4 GKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEV---AHTLTESRVLQNTRHPFLTAL 60
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHL-HDRHQNEEFPLTWEMRLRI-ATEVAGALAYLHS 287
+ V E+ G L+ HL +R +E+ R R E+ AL YLHS
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-------RARFYGAEIVSALGYLHS 113
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 347
+ +RD+K N++LD+ K+ DFG K D + T GT YL PE +
Sbjct: 114 CD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLED 169
Query: 348 SQLTDKSDVYSFGVVLVELLTGKKPIF 374
+ D + GVV+ E++ G+ P +
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 172 LGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
LG+G TVYKG + +G+++A+K +L +EE I E +L + H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRL--QEEEGTPFTA-IREASLLKGLKHANIVLLH 69
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
E LV+E++ + L Q++ D+H P ++ L ++ L+Y+H
Sbjct: 70 DIIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLFL---FQLLRGLSYIHQRY- 123
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YHQSSQ 349
I HRD+K N+L+ K+ADFG ++ ++ +H + T Y P+ S++
Sbjct: 124 --ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 350 LTDKSDVYSFGVVLVELLTG 369
+ D++ G + VE++ G
Sbjct: 181 YSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 24/227 (10%)
Query: 164 NHFNANRILGQGGQGTVYKGMLED---GRIIAVK--KSKLTVDDEELLKLEEFINEIVIL 218
F+ ++G+G G V ++ + G I A+K K + + E + EE E IL
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEE---ERDIL 55
Query: 219 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEV 278
S N + +L + + LV E+ P G L L +R+++ +M E+
Sbjct: 56 SISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYED---QFDEDMAQFYLAEL 111
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 338
A+ HS HRDIK N+L+D+ K+ADFG++ + ++ + GT
Sbjct: 112 VLAI---HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD 168
Query: 339 YLDPEYHQSSQLTDKS------DVYSFGVVLVELLTGKKPIFWAGNT 379
Y+ PE + K D +S GV+ E++ G+ P F G +
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP-FHEGTS 214
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 52/165 (31%), Positives = 84/165 (50%), Gaps = 13/165 (7%)
Query: 213 NEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLT-WEMR 271
+E+ L+ +H +VK + LL+ E+ G L + + R + E P +E+
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK-EHLPFQEYEVG 172
Query: 272 LRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK----FIAMDQT 327
L + ++ AL +HS + HRD+KS NI L K+ DFG SK +++D
Sbjct: 173 L-LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD-- 226
Query: 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
V + GT YL PE + + + K+D++S GV+L ELLT +P
Sbjct: 227 -VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 65/217 (29%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 172 LGQGGQGTVYKGMLED-GRIIAVKK--SKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+G+G G VY+ +D RI A+K K V +E+ I E IL +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEV---AHTIGERNILVRTLLDESPF 57
Query: 229 LLGCCLETEVP---LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
++G + LV +++ G L+ HL + E + IA E+ AL +L
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE----DRAKFYIA-ELVLALEHL 112
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-Y 344
H I +RD+K NILLD + DFG SK + T GT YL PE
Sbjct: 113 HK---YDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 345 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381
T D +S GV++ E+ G P F+A +T Q
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSP-FYAEDTQQ 204
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 21/173 (12%)
Query: 213 NEIVILSQINHRNVVKL---LGCCLETEVPLLVYEFIPNGTLYQHLHDRH-QNEEFPLTW 268
NEI+ L ++NH N++K+ L T + Y+F LY ++D ++ PL
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLLK 267
Query: 269 EMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH 328
+ R I ++ A+ Y+H + HRDIK NI L+ + + DFGT+ ++
Sbjct: 268 QTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323
Query: 329 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT---------GKKP 372
GT PE + +D++S G++L+++L+ G KP
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376
|
Length = 501 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 64/302 (21%), Positives = 125/302 (41%), Gaps = 46/302 (15%)
Query: 166 FNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
+ +G G G V + G+ +A+KK D L K + E+ IL H
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAK--RTLRELKILRHFKHD 64
Query: 225 NVVKLLGCCLETEVPL-----LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVA 279
N++ + L +V + + + L+ +H PLT E ++
Sbjct: 65 NIIAIRDI-LRPPGADFKDVYVVMDLMES-DLHHIIHSDQ-----PLTEEHIRYFLYQLL 117
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA---MDQTHVTTKIQGT 336
L Y+HSA + HRD+K +N+L+++ ++ DFG ++ ++ + + T+ T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 337 FGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAY------ 389
Y PE S + T D++S G + E+L G++ +F G + L
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLF-PGKNYVHQLKLILSVLGSPS 232
Query: 390 --FVHSMRKNRLHDILDDQLMKLGVK-----NQIMTFA-----NLAKRCLDLNGKKRPTM 437
++ + +R+ + + L K ++I A +L + L + ++R T+
Sbjct: 233 EEVLNRIGSDRVRKYIQN----LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV 288
Query: 438 EE 439
E+
Sbjct: 289 EQ 290
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 64/218 (29%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQ 220
AT++ N + LG+G TVYKG+ +G+++A+K +++ EE + I E +L
Sbjct: 4 ATSYLNLEK-LGEGSYATVYKGISRINGQLVALKV--ISMKTEEGVPFTA-IREASLLKG 59
Query: 221 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
+ H N+V L E V+E++ + L Q++ +H P + +RL + + G
Sbjct: 60 LKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYM-IQHPGGLHP--YNVRLFMFQLLRG 115
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM-DQTHVTTKIQGTFGY 339
LAY+H I HRD+K N+L+ K+ADFG ++ ++ QT+ + + T Y
Sbjct: 116 -LAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWY 169
Query: 340 LDPEYHQSSQLTDKS---DVYSFGVVLVELLTGKKPIF 374
P+ + TD S D++ G + +E+L G +P F
Sbjct: 170 RPPDVLLGA--TDYSSALDIWGAGCIFIEMLQG-QPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 12/212 (5%)
Query: 164 NHFNANRILGQGGQGTVYK-GMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
N F ++G+G G V K E I+A+KK K + ++EE+ E + E+ +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVK--ETTLRELKMLRTLK 58
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
N+V+L LV+E++ L L + N P ++ + + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNML--ELLEEMPNGVPPE------KVRSYIYQLI 110
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 342
+H + I HRDIK N+L+ K+ DFG ++ ++ T+ T Y P
Sbjct: 111 KAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
E + D++S G +L EL G +P+F
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDG-QPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 44/136 (32%), Positives = 66/136 (48%), Gaps = 13/136 (9%)
Query: 241 LVYEFIPNGTLYQHL-HDRHQNEEFPLTWEMRLRI-ATEVAGALAYLHSATSSPIYHRDI 298
V E++ G L+ HL +R +E+ R R E+ AL YLHS I +RD+
Sbjct: 72 FVMEYVNGGELFFHLSRERVFSED-------RTRFYGAEIVSALDYLHSGK---IVYRDL 121
Query: 299 KSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYS 358
K N++LD+ K+ DFG K D + T GT YL PE + + D +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWG 180
Query: 359 FGVVLVELLTGKKPIF 374
GVV+ E++ G+ P +
Sbjct: 181 LGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 48/231 (20%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEF------------INEIVILS 219
LG+G TVYKG +SKLT + L+ L+E I E+ +L
Sbjct: 14 LGEGTYATVYKG-----------RSKLT---DNLVALKEIRLEHEEGAPCTAIREVSLLK 59
Query: 220 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHD-----RHQNEEFPLTWEMRLRI 274
+ H N+V L + LV+E++ + L Q+L D N + L +R
Sbjct: 60 DLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLR--- 115
Query: 275 ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ 334
L Y H + HRD+K N+L+++R K+ADFG ++ ++ + ++
Sbjct: 116 ------GLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV 166
Query: 335 GTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENV 384
T Y P+ S+ + + D++ G + E+ TG +P+F G+T +E +
Sbjct: 167 -TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG-RPLF-PGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 43/134 (32%), Positives = 62/134 (46%), Gaps = 9/134 (6%)
Query: 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKS 300
V E+ G L+ HL + E T E E+ AL YLHS + +RDIK
Sbjct: 72 FVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKL 123
Query: 301 TNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFG 360
N++LD+ K+ DFG K D + T GT YL PE + + D + G
Sbjct: 124 ENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 361 VVLVELLTGKKPIF 374
VV+ E++ G+ P +
Sbjct: 183 VVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 63/213 (29%), Positives = 87/213 (40%), Gaps = 21/213 (9%)
Query: 211 FINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEM 270
F E I++ N VV+L + +V E++P G L + N + P W
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWA- 144
Query: 271 RLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT 330
R A EV AL +HS HRD+K N+LLD+ K+ADFGT + +
Sbjct: 145 RFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200
Query: 331 TKIQGTFGYLDPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSL 386
GT Y+ PE +S + D +S GV L E+L G P F+A SL
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP-FYAD-------SL 252
Query: 387 AAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTF 419
+ M DD + KN I F
Sbjct: 253 VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAF 285
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 51/164 (31%), Positives = 73/164 (44%), Gaps = 14/164 (8%)
Query: 214 EIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT--LYQHLHDRHQNEEFPLTWEMR 271
EI IL I+HR ++ L+ +V +P L+ ++ DR PL E
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYV-DRSG----PLPLEQA 187
Query: 272 LRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS-KFIAMDQTHVT 330
+ I + ALAYLH I HRD+K+ NI LD+ A + DFG + K A T
Sbjct: 188 ITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244
Query: 331 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
GT PE K+D++S G+VL E+ +F
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288
|
Length = 392 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 43/136 (31%), Positives = 66/136 (48%), Gaps = 12/136 (8%)
Query: 241 LVYEFIPNGTLYQHL-HDRHQNEEFPLTWEMRLRI-ATEVAGALAYLHSATSSPIYHRDI 298
V E+ G L+ HL +R +E+ R R E+ AL YLHS + + +RD+
Sbjct: 72 FVMEYANGGELFFHLSRERVFSED-------RARFYGAEIVSALDYLHSEKN--VVYRDL 122
Query: 299 KSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYS 358
K N++LD+ K+ DFG K D + T GT YL PE + + D +
Sbjct: 123 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWG 181
Query: 359 FGVVLVELLTGKKPIF 374
GVV+ E++ G+ P +
Sbjct: 182 LGVVMYEMMCGRLPFY 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 62/249 (24%), Positives = 101/249 (40%), Gaps = 61/249 (24%)
Query: 154 FSSKELDKAT----NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKL 208
F +EL+K + + +G G G V + GR +A+KK K
Sbjct: 1 FYRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK- 59
Query: 209 EEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQ--------HLHD--- 257
E+ +L ++H NV+ LL F P +L HL
Sbjct: 60 -RTYRELRLLKHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADL 106
Query: 258 ----RHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKV 313
+ Q L+ + + ++ L Y+HSA I HRD+K +NI +++ K+
Sbjct: 107 NNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKI 159
Query: 314 ADFGTSKFIAMDQT-HVTTKIQGTFGYLDPE-------YHQSSQLTDKSDVYSFGVVLVE 365
DFG ++ + T +V T+ Y PE Y+Q+ D++S G ++ E
Sbjct: 160 LDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQT------VDIWSVGCIMAE 208
Query: 366 LLTGKKPIF 374
LLTG K +F
Sbjct: 209 LLTG-KTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 81/386 (20%), Positives = 152/386 (39%), Gaps = 113/386 (29%)
Query: 141 NSYDGSVIDRFKLFSSKELDKATNHFNANRILGQGGQGTVYK----GMLEDGRI--IAVK 194
N+Y + ID +L +++ + ++ + LG G G V + G+ ++ + +AVK
Sbjct: 17 NNY--TFIDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVK 74
Query: 195 KSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLG--------------CCL----- 234
K + +E E ++E+ ILS + H+N+V LLG CC
Sbjct: 75 MLKASAHTDER---EALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLN 131
Query: 235 ------ETEV-PLLVYEFIPNGTL-YQHLHDRHQ-------------------------- 260
ET + ++ I + Y+++ +
Sbjct: 132 FLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191
Query: 261 ------------NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR 308
+ +PL + LR +++VA + +L S HRD+ + N+LL
Sbjct: 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC---IHRDVAARNVLLTDG 248
Query: 309 YRAKVADFGTSKFIAMDQTHVTTKIQGT----FGYLDPEYHQSSQLTDKSDVYSFGVVLV 364
AK+ DFG ++ I D +V ++G ++ PE T +SDV+S+G++L
Sbjct: 249 RVAKICDFGLARDIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 305
Query: 365 ELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFA---- 420
E IF G + + + + F +++K G + FA
Sbjct: 306 E-------IFSLGKSPYPGILVNSKFY--------------KMVKRGYQMSRPDFAPPEI 344
Query: 421 -NLAKRCLDLNGKKRPTMEEVSMELN 445
++ K C +L +RPT ++S +
Sbjct: 345 YSIMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 66/230 (28%), Positives = 113/230 (49%), Gaps = 42/230 (18%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEF------------INEIVILS 219
LG+G TV+KG +SKLT E L+ L+E I E+ +L
Sbjct: 13 LGEGTYATVFKG-----------RSKLT---ENLVALKEIRLEHEEGAPCTAIREVSLLK 58
Query: 220 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT-E 277
+ H N+V L + TE L LV+E++ + L Q+L D N L ++I +
Sbjct: 59 NLKHANIVTLHDI-IHTERCLTLVFEYLDS-DLKQYL-DNCGN----LMSMHNVKIFMFQ 111
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF 337
+ L+Y H I HRD+K N+L++++ K+ADFG ++ ++ + ++ T
Sbjct: 112 LLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TL 167
Query: 338 GYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSL 386
Y P+ S++ + D++ G +L E+ TG +P+F G+T +E + L
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG-RPMF-PGSTVKEELHL 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 8e-09
Identities = 61/233 (26%), Positives = 108/233 (46%), Gaps = 48/233 (20%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEF------------INEIVILS 219
LG+G TV+KG +SKLT E L+ L+E I E+ +L
Sbjct: 14 LGEGTYATVFKG-----------RSKLT---ENLVALKEIRLEHEEGAPCTAIREVSLLK 59
Query: 220 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHD-----RHQNEEFPLTWEMRLRI 274
+ H N+V L + LV+E++ + L Q++ D N + L +R
Sbjct: 60 DLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILR--- 115
Query: 275 ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ 334
LAY H + HRD+K N+L+++R K+ADFG ++ ++ + ++
Sbjct: 116 ------GLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV 166
Query: 335 GTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSL 386
T Y P+ SS+ + + D++ G + E+ +G +P+F G+T ++ + L
Sbjct: 167 -TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG-RPLF-PGSTVEDELHL 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 45/158 (28%), Positives = 69/158 (43%), Gaps = 26/158 (16%)
Query: 222 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGA 281
++ N +KL + +L+ ++I +G L+ L + E E++ I ++ A
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL----KKEGKLSEAEVKK-IIRQLVEA 121
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQ-RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 340
L LH I H DIK N+L D+ + R + D+G K I + GT Y
Sbjct: 122 LNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYF 173
Query: 341 DPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
PE Y S D ++ GV+ ELLTGK P
Sbjct: 174 SPEKIKGHNYDVSF------DWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 42/242 (17%)
Query: 164 NHFNANRILGQGGQGTVYKGMLEDGRI-IAVKKSKLTVDDEELL---KLEEFINEIVILS 219
F +++ G G VY ++ R A+KK ++ + L+ ++++ E IL+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKK----INKQNLILRNQIQQVFVERDILT 56
Query: 220 QINHRNVVKLLGCCLETEVPL-LVYEFIPNG---TLYQHLHDRHQNEEFPLTWEM-RLRI 274
+ VV + C ET+ L +V E++ G TL +++ L +M R+
Sbjct: 57 FAENPFVVSMF-CSFETKRHLCMVMEYVEGGDCATLLKNIG--------ALPVDMARMYF 107
Query: 275 ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT------- 327
A E AL YLH+ I HRD+K N+L+ K+ DFG SK M T
Sbjct: 108 A-ETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGH 163
Query: 328 -------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTS 380
+ ++ GT Y+ PE D ++ G++L E L G P F G+T
Sbjct: 164 IEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF--GDTP 221
Query: 381 QE 382
+E
Sbjct: 222 EE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
TN + + +G G G V G+ +A+KK L K E+ +L +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAK--RTYRELKLLKHL 66
Query: 222 NHRNVVKLLGCCLE-TEVPLLVYEFIPNGT-LYQHLHDRHQNEEFPLTWEMRLRIATEVA 279
H N++ L + E V E + GT L++ L R PL + ++
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSR------PLEKQFIQYFLYQIL 118
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 339
L Y+HSA + HRD+K +NIL+++ K+ DFG ++ Q T T Y
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYY 171
Query: 340 LDPEYHQSSQLTD-KSDVYSFGVVLVELLTGKKPIF 374
PE + Q D + D++S G + E+L G KP+F
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 35/233 (15%)
Query: 221 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRL-RIATEVA 279
+ H N+++ LG C+E LLV+E+ G L +L + + + L R+A E+A
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYL--SQEQWHRRNSQLLLLQRMACEIA 109
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTT--KIQGTF 337
+ ++H H D+ N L KV D+G + ++ T
Sbjct: 110 AGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPL 165
Query: 338 GYLDPE----YHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF 390
+L PE +H +++ T S+V++ GV L EL EN A +
Sbjct: 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF--------------ENA--AQPY 209
Query: 391 VHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLD---LNGKKRPTMEEV 440
H + L+ ++ DQ +KL + ++ L L+ +KR T EEV
Sbjct: 210 SHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 44/165 (26%), Positives = 69/165 (41%), Gaps = 13/165 (7%)
Query: 212 INEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIP--NGTLYQHLHDRHQNEEFPLTWE 269
E IL INH ++++L G + L+ +P LY +L + + +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRN---IAIC-D 183
Query: 270 MRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHV 329
+ L I V A+ YLH + I HRDIK+ NI ++ + DFG + F +
Sbjct: 184 I-LAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239
Query: 330 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
GT PE D++S G+VL E+ T +F
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284
|
Length = 391 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 57/185 (30%), Positives = 81/185 (43%), Gaps = 39/185 (21%)
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT---TKIQGTF 337
AL Y+H+A ++HRD+K NIL + + K+ DFG ++ +A + T T T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATR 170
Query: 338 GYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIF--------------WAGNTSQ 381
Y PE S S+ T D++S G + E+LTG KP+F G S
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLITDLLGTPSP 229
Query: 382 ENVSL-----AAYFVHSMRKNRLHDILDDQLMKLGVK--NQIMTFANLAKRCLDLNGKKR 434
E +S A ++ SMRK Q + K N L +R L + K R
Sbjct: 230 ETISRVRNEKARRYLSSMRKK--------QPVPFSQKFPNADPLALRLLERLLAFDPKDR 281
Query: 435 PTMEE 439
PT EE
Sbjct: 282 PTAEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 72/302 (23%), Positives = 125/302 (41%), Gaps = 60/302 (19%)
Query: 172 LGQGGQGTVYKGML---------EDGRIIAVKKSKLTVDDEEL---LKLEE--------- 210
LGQG + +Y G L ED + + EL LK+ +
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 211 FINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEM 270
F ++SQ++H ++ + G C+ ++V EF+ +G L L R + P+ W++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL--RKEKGRVPVAWKI 120
Query: 271 RLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT 330
+A ++A AL+YL + H ++ + NILL R +A+ GTS FI + V+
Sbjct: 121 --TVAQQLASALSYLEDKN---LVHGNVCAKNILLA---RLGLAE-GTSPFIKLSDPGVS 171
Query: 331 TKIQG------TFGYLDPEYHQS-SQLTDKSDVYSFGVVLVEL-LTGKKPIFWAGNTSQE 382
++ PE + L+ +D +SFG L+E+ G+ P+ T E
Sbjct: 172 FTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL--KERTPSE 229
Query: 383 NVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442
F +K+RL + +L A L +CL +RP+ +
Sbjct: 230 K----ERFYE--KKHRLPEPSCKEL------------ATLISQCLTYEPTQRPSFRTILR 271
Query: 443 EL 444
+L
Sbjct: 272 DL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 69/291 (23%), Positives = 118/291 (40%), Gaps = 51/291 (17%)
Query: 172 LGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKL--------EEFINEIVILSQIN 222
LGQG +YKG+L + V + + +LK+ F ++SQ++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQ---EVSVVLKVLGSDHRDSLAFFETASLMSQLS 59
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
H+++VKL G C+ E ++V E++ G L LH N L W +L +A ++A AL
Sbjct: 60 HKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNN--VSLHW--KLDVAKQLASAL 114
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI------QGT 336
YL + H ++ NIL+ + + G FI + + +
Sbjct: 115 HYLEDKK---LVHGNVCGKNILVAR----YGLNEGYVPFIKLSDPGIPITVLSREERVER 167
Query: 337 FGYLDPEYHQ--SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394
++ PE + + LT +D +SFG L+E I G +S +
Sbjct: 168 IPWIAPECIRNGQASLTIAADKWSFGTTLLE-------ICSNGEEPLSTLSSSEKERFYQ 220
Query: 395 RKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445
++RL + D ANL +C + KRP+ + +LN
Sbjct: 221 DQHRL-PMPD-----------CAELANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 60/261 (22%), Positives = 102/261 (39%), Gaps = 71/261 (27%)
Query: 164 NHFNANRILGQGGQGTV-YKGMLEDGRIIAVKKSKLTVDDEELLKLEEFIN---EIVILS 219
+ F + +++G+G G V + G I A+KK + E+L+ E+ + E IL+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKK----LRKSEMLEKEQVAHVRAERDILA 56
Query: 220 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATE- 277
+ ++ VVKL + E L L+ E++P G + +T M+ TE
Sbjct: 57 EADNPWVVKLY-YSFQDENYLYLIMEYLPGGDM--------------MTLLMKKDTFTEE 101
Query: 278 -----VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK 332
+A + + S HRDIK N+LLD + K++DFG + ++H T
Sbjct: 102 ETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEF 159
Query: 333 IQ---------------------------------------GTFGYLDPEYHQSSQLTDK 353
+ GT Y+ PE + +
Sbjct: 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE 219
Query: 354 SDVYSFGVVLVELLTGKKPIF 374
D +S GV++ E+L G P
Sbjct: 220 CDWWSLGVIMYEMLVGYPPFC 240
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 65/217 (29%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVD-DEELLKLEEFINEIVILSQINHRNVVKL 229
+G+G G V+K + ++G AVK D DEE+ E N + LS +H NVVK
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI---EAEYNILKALS--DHPNVVKF 80
Query: 230 LGCCLETEVP-----LLVYEFIPNGT---LYQHLHDRHQNEEFPLTWEMRLRIATEVAGA 281
G + +V LV E G+ L + R + E P+ IA + A
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI-------IAYILHEA 133
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 341
L L + HRD+K NILL K+ DFG S + + T + GT ++
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMA 192
Query: 342 PEYHQSSQLTDKS-----DVYSFGVVLVELLTGKKPI 373
PE Q D + DV+S G+ +EL G P+
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 36/102 (35%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 341
L YLHSA I HRDIK N+L++ K+ DFG ++ D++ T+ T Y
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 342 PEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE 382
PE S+ T D++S G + ELL G++ +F A + Q+
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELL-GRRILFQAQSPIQQ 213
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 42/147 (28%), Positives = 64/147 (43%), Gaps = 14/147 (9%)
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDR-HQNEEFPLTWEMRLRIATEVAGALA 283
N+V L + + LV + G L+ H+ + EE W A E+ AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRW------AAEMVVALD 99
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
LH I RD+ NILLD R ++ F ++ ++ + ++ Y PE
Sbjct: 100 ALHR---EGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM--YCAPE 152
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLTGK 370
S+ T+ D +S G +L ELLTGK
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 5/102 (4%)
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF 337
+A + +HS HRDIK N+LLD ++ADFG+ + D T ++ GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167
Query: 338 GYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIF 374
Y+ PE Q+ + + D +S GV + E+L G+ P +
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 166 FNANRILGQGGQGTVYKGMLEDG-RIIAVKKSKLTVDDEELLKLEE---FINEIVILSQI 221
F +++G+G G V L++ ++ A+K ++ E+LK E F E +L
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMK----ILNKWEMLKRAETACFREERDVLVNG 58
Query: 222 NHRNVVKLLGCCLETEVPLLVYEFIPNG---TLYQHLHDRHQNEEFPLTWEMRLRIATEV 278
+++ + L + LV ++ G TL DR E+ + + IA +
Sbjct: 59 DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP-EDMARFYLAEMVIAIDS 117
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 338
L Y+H RDIK NIL+D ++ADFG+ + D T ++ GT
Sbjct: 118 VHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 168
Query: 339 YLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIF 374
Y+ PE Q+ + + D +S GV + E+L G+ P +
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 68/257 (26%), Positives = 107/257 (41%), Gaps = 59/257 (22%)
Query: 165 HFNANRILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELL---KLEEFINEIVILSQ 220
HF ++LG+G G V+ L+ G++ A+K +D +E++ K++ + E IL+
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALK----VLDKKEMIKRNKVKRVLTEQEILAT 57
Query: 221 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATEV 278
++H + L +TE L LV ++ P G L+ L R + E R A EV
Sbjct: 58 LDHPFLPTLY-ASFQTETYLCLVMDYCPGGELF-RLLQRQPGKCLS---EEVARFYAAEV 112
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ---- 334
AL YLH +Y RD+K NILL + ++DF SK + +K
Sbjct: 113 LLALEYLH--LLGIVY-RDLKPENILLHESGHIMLSDFDLSKQSD-VEPPPVSKALRKGS 168
Query: 335 -------------------------GTFGYLDPEY-----HQSSQLTDKSDVYSFGVVLV 364
GT Y+ PE H S+ D ++ G++L
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-----VDWWTLGILLY 223
Query: 365 ELLTGKKPIFWAGNTSQ 381
E+L G P F N +
Sbjct: 224 EMLYGTTP-FKGSNRDE 239
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 28/229 (12%)
Query: 154 FSSKELDKAT----NHFNANRILGQGGQGTV---YKGMLEDGRIIAVKKSKLTVDDEELL 206
F S E+ +T + + +G G QG V Y +LE R +A+KK ++
Sbjct: 10 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 207 KLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRH--QNEEF 264
K E+V++ +NH+N++ LL P E + + L D + Q +
Sbjct: 68 K--RAYRELVLMKCVNHKNIIGLL----NVFTPQKSLEEFQDVYIVMELMDANLCQVIQM 121
Query: 265 PLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA- 323
L E + ++ + +LHSA I HRD+K +NI++ K+ DFG ++
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178
Query: 324 --MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 370
M +V T+ Y PE + D++S G ++ E++ G
Sbjct: 179 SFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 32/211 (15%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G G G+V + G +AVKK L+ + ++ + E+ +L + H NV+ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFP---LTWEMRLRIATEVAGALAYLHS 287
+ P E + L HL N LT + + ++ L Y+HS
Sbjct: 83 ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 138
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPE--- 343
A I HRD+K +N+ +++ K+ DFG ++ + T +V T+ Y PE
Sbjct: 139 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIML 190
Query: 344 ----YHQSSQLTDKSDVYSFGVVLVELLTGK 370
Y+Q+ D++S G ++ ELLTG+
Sbjct: 191 NWMHYNQT------VDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 35/118 (29%), Positives = 60/118 (50%), Gaps = 11/118 (9%)
Query: 260 QNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319
+ +E L E L + +VA +++L S HRD+ + NILL K+ DFG +
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA 261
Query: 320 KFIAMDQTHVTTKIQGT----FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
+ I D +V ++G ++ PE + T +SDV+S+G++L E+ + G P
Sbjct: 262 RDIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 8e-07
Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 172 LGQGGQGTV---YKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+G G QG V Y +L+ R +A+KK ++ K E+V++ +NH+N++
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAK--RAYRELVLMKCVNHKNIIS 80
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRH--QNEEFPLTWEMRLRIATEVAGALAYLH 286
LL P E + L L D + Q + L E + ++ + +LH
Sbjct: 81 LL----NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 346
SA I HRD+K +NI++ K+ DFG ++ + + T T Y PE
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 347 SSQLTDKSDVYSFGVVLVELLTGK 370
+ D++S G ++ E++ K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 8e-07
Identities = 58/242 (23%), Positives = 104/242 (42%), Gaps = 40/242 (16%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEF---------INEIVILSQIN 222
+G+G G VYK +DG+ DE+ L++ EI +L ++
Sbjct: 9 VGRGTYGHVYKAKRKDGK------------DEKEYALKQIEGTGISMSACREIALLRELK 56
Query: 223 HRNVVKLLGCCLE--TEVPLLVYEFIPNGTLYQ---HLHDRHQNEEFPLTWEMRLRIATE 277
H NV+ L L L++++ + + H + + L M + +
Sbjct: 57 HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILL----DQRYRAKVADFGTSKFI--AMDQTHVTT 331
+ + YLH+ + + HRD+K NIL+ +R R K+AD G ++ +
Sbjct: 117 ILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 332 KIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF 390
+ TF Y PE ++ K+ D+++ G + ELLT +PIF + QE++ + F
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIF---HCRQEDIKTSNPF 229
Query: 391 VH 392
H
Sbjct: 230 HH 231
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 6/87 (6%)
Query: 295 HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-----SQ 349
HRDIK N+LLD+ ++ADFG+ + D T + GT Y+ PE Q+ +
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGR 184
Query: 350 LTDKSDVYSFGVVLVELLTGKKPIFWA 376
+ D +S GV + E+L G+ P F+A
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETP-FYA 210
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 172 LGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKL---EEFINEIVILSQINHRNVV 227
LG+GG G V +++ G++ A KK +D + L K + + E IL ++N +V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK----LDKKRLKKKSGEKMALLEKEILEKVNSPFIV 56
Query: 228 KLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH 286
L E++ L LV + G L H+++ + L E + + ++ + +LH
Sbjct: 57 NL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG---LEMERVIHYSAQITCGILHLH 112
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 346
S I +RD+K N+LLD + +++D G + + + T+ GT GY+ PE +
Sbjct: 113 SMD---IVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILK 167
Query: 347 SSQLTDKSDVYSFGVVLVELLTGKKP 372
+ D ++ G + E++ G+ P
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 36/110 (32%), Positives = 56/110 (50%), Gaps = 5/110 (4%)
Query: 265 PLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324
PLT E + + +VA + +L S HRD+ + NILL + K+ DFG ++ I
Sbjct: 170 PLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 325 DQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
D +V + ++ PE T +SDV+SFGV+L E+ + G P
Sbjct: 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+ +G G QG V + I V KL+ + + E+V+L +NH+N++ L
Sbjct: 27 KPIGSGAQGIVCAA-FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISL 85
Query: 230 LGCCL------ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
L E + LV E + + L Q +H L E + ++ +
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIH-------MELDHERMSYLLYQMLCGIK 137
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA---MDQTHVTTKIQGTFGYL 340
+LHSA I HRD+K +NI++ K+ DFG ++ M +V T+ Y
Sbjct: 138 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-----YR 189
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLTG 369
PE + D++S G ++ EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 341
L Y+HSA + HRD+K +N+LL+ K+ DFG ++ ++ T+ T Y
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRA 176
Query: 342 PE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
PE S+ T DV+S G + ELL G+KP+F
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 36/110 (32%), Positives = 56/110 (50%), Gaps = 5/110 (4%)
Query: 265 PLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324
PLT E + + +VA + +L S HRD+ + NILL + K+ DFG ++ I
Sbjct: 169 PLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 225
Query: 325 DQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
D +V + ++ PE T +SDV+SFGV+L E+ + G P
Sbjct: 226 DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 35/110 (31%), Positives = 55/110 (50%), Gaps = 5/110 (4%)
Query: 265 PLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324
LT E + + +VA + +L S HRD+ + NILL + K+ DFG ++ I
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 325 DQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
D +V + ++ PE T +SDV+SFGV+L E+ + G P
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 32/134 (23%), Positives = 58/134 (43%), Gaps = 13/134 (9%)
Query: 274 IATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT-TK 332
I ++ L Y+H I H DIK NI++D R + D+G + + H+ +K
Sbjct: 131 IMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187
Query: 333 IQ-----GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLA 387
Q GT Y + H + +T + D+ S G +++ + W G N+ A
Sbjct: 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW--AGIKLPWKGFGHNGNLIHA 245
Query: 388 AY--FVHSMRKNRL 399
A F+ + + ++
Sbjct: 246 AKCDFIKRLHEGKI 259
|
Length = 294 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 67/302 (22%), Positives = 117/302 (38%), Gaps = 70/302 (23%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEE--------------------F 211
LG+G + +Y G+L DDE+ E F
Sbjct: 3 LGRGTRTQIYAGILNYKD-----------DDEDDGYSYEKEIKVILKVLDPSHRDISLAF 51
Query: 212 INEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMR 271
++ Q++H+++V L G C+ ++V EF+ G L +H + LT +
Sbjct: 52 FETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD----VLTTPWK 107
Query: 272 LRIATEVAGALAYLHSATSSPIYHRDIKSTNILL-----DQRYRA--KVADFGTSKFIAM 324
++A ++A AL+YL + H ++ + NILL D K++D G +
Sbjct: 108 FKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS 164
Query: 325 DQTHVTTKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQEN 383
Q V ++ PE S L+ +D +SFG L E I + G ++
Sbjct: 165 RQECVE-----RIPWIAPECVEDSKNLSIAADKWSFGTTLWE-------ICYNGEIPLKD 212
Query: 384 VSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443
+LA K R + + Q M V A+L C++ + +RP + +
Sbjct: 213 KTLA-------EKERFY---EGQCML--VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260
Query: 444 LN 445
+N
Sbjct: 261 IN 262
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 59/252 (23%), Positives = 112/252 (44%), Gaps = 39/252 (15%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEE--LLKLE------EFINEIVILSQINH 223
+G+G G VYK +DG+ DD + L ++E EI +L ++ H
Sbjct: 9 VGRGTYGHVYKAKRKDGK-----------DDRDYALKQIEGTGISMSACREIALLRELKH 57
Query: 224 RNVVKLLGCCLE--TEVPLLVYEFIPNGTLYQ---HLHDRHQNEEFPLTWEMRLRIATEV 278
NV+ L L L++++ + + H + + L M + ++
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILL----DQRYRAKVADFGTSKFI--AMDQTHVTTK 332
+ YLH+ + + HRD+K NIL+ +R R K+AD G ++ +
Sbjct: 118 LDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 333 IQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391
+ TF Y PE ++ K+ D+++ G + ELLT +PIF + QE++ + +
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIF---HCRQEDIKTSNPYH 230
Query: 392 HSMRKNRLHDIL 403
H + +R+ +++
Sbjct: 231 HD-QLDRIFNVM 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 67/242 (27%), Positives = 106/242 (43%), Gaps = 59/242 (24%)
Query: 152 KLFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEF 211
KL + K+LDK LG+G TVYKG +SKLT +L+ L+E
Sbjct: 3 KLETYKKLDK----------LGEGSYATVYKG-----------RSKLT---GQLVALKEI 38
Query: 212 ------------INEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRH 259
I E +L + H N+V L + LV+E++ + L Q++ D
Sbjct: 39 RLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYM-DDC 96
Query: 260 QNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319
+RL + + G LAY H + HRD+K N+L+ +R K+ADFG +
Sbjct: 97 GGGLSMHN--VRLFLFQLLRG-LAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLA 150
Query: 320 KFIAMDQTHVTTKIQGTFGYLDP-------EYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
+ ++ + + T Y P EY S+ L D++ G + E+ TG +P
Sbjct: 151 RAKSV-PSKTYSNEVVTLWYRPPDVLLGSTEY--STSL----DMWGVGCIFYEMATG-RP 202
Query: 373 IF 374
+F
Sbjct: 203 LF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 32/111 (28%), Positives = 58/111 (52%), Gaps = 8/111 (7%)
Query: 261 NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320
NE L++ + + +VA + +L S HRD+ + N+L+ + K+ DFG ++
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKNC---VHRDLAARNVLICEGKLVKICDFGLAR 287
Query: 321 FIAMDQTHVTTKIQGTF---GYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 368
I D +++ TF ++ PE ++ T SDV+SFG++L E+ T
Sbjct: 288 DIMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 33/211 (15%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G G G+V + G +A+KK E K E+ +L + H NV+ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAK--RAYRELTLLKHMQHENVIGLL 80
Query: 231 GCCLETEVPLLVYEFIPNGTL---YQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS 287
+ + + + L Y D + PL+ + + ++ L Y+HS
Sbjct: 81 ----DVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS 135
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPE--- 343
A I HRD+K N+ +++ K+ DFG ++ + T +V T+ Y PE
Sbjct: 136 AG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVIL 187
Query: 344 ----YHQSSQLTDKSDVYSFGVVLVELLTGK 370
Y+Q+ D++S G ++ E+LTGK
Sbjct: 188 NWMHYNQT------VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 30/80 (37%), Positives = 41/80 (51%), Gaps = 8/80 (10%)
Query: 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKS 300
LV E++ G + LH +E EM ++ +EVA AL YLH I HRD+K
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDE-----EMAVKYISEVALALDYLHRHG---IIHRDLKP 132
Query: 301 TNILLDQRYRAKVADFGTSK 320
N+L+ K+ DFG SK
Sbjct: 133 DNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 13/157 (8%)
Query: 212 INEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIP--NGTLYQHLHDRHQNEEFPLTWE 269
++E +L +++H V+ LL + + LV +P LY +L R + PL
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLR----PLGLA 260
Query: 270 MRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI-AMDQTH 328
+A ++ A+ Y+H I HRDIK+ N+L++ + DFG + F T
Sbjct: 261 QVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317
Query: 329 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVE 365
I GT PE T D++S G+V+ E
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 8/100 (8%)
Query: 272 LRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTT 331
L +VA + +L S HRD+ + N+LL Q K+ DFG ++ I D +V+
Sbjct: 240 LSFTYQVARGMEFLASKNC---VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296
Query: 332 KIQGTF---GYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 368
TF ++ PE + T SDV+S+G++L E+ +
Sbjct: 297 G--STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 40/217 (18%)
Query: 170 RILGQGGQGTV---YKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNV 226
+ +G G QG V Y + G+ +A+KK L+ + + + E+V++ +NH+N+
Sbjct: 22 KPIGSGAQGIVCAAYDTVT--GQNVAIKK--LSRPFQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTL--YQHL--------HDRHQNEEFPLTWEMRLRIAT 276
+ LL F P +L +Q + + Q + L E +
Sbjct: 78 IGLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLY 125
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG---TSKFIAMDQTHVTTKI 333
++ + +LHSA I HRD+K +NI++ K+ DFG T+ M +V T+
Sbjct: 126 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 370
Y PE + D++S G ++ E++ G
Sbjct: 183 -----YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 65/241 (26%), Positives = 101/241 (41%), Gaps = 52/241 (21%)
Query: 154 FSSKELDKAT----NHFNANRILGQGGQGTVYKGMLEDGRI---IAVKKSKLTVDDEELL 206
F +EL+K + +G G G+V D R+ +AVKK L+ + L+
Sbjct: 1 FYRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAY--DTRLRQKVAVKK--LSRPFQSLI 56
Query: 207 KLEEFINEIVILSQINHRNVVKLL-----GCCLE--TEVPL---LVYEFIPNGTLYQHLH 256
E+ +L + H NV+ LL +E EV L L+ + N Q L
Sbjct: 57 HARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLS 116
Query: 257 DRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316
D H +F + +R L Y+HSA I HRD+K +N+ +++ ++ DF
Sbjct: 117 DEHV--QFLIYQLLR---------GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162
Query: 317 GTSKFIAMDQTHVTTKIQGTFGYLDPE-------YHQSSQLTDKSDVYSFGVVLVELLTG 369
G +A T T Y PE Y+Q+ D++S G ++ ELL G
Sbjct: 163 G----LARQADDEMTGYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLKG 212
Query: 370 K 370
K
Sbjct: 213 K 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 28/166 (16%)
Query: 164 NHFNANRILGQGGQGTV-YKGMLEDGRIIAVKKSKLTVDDEELLKLEEFIN---EIVILS 219
F+ +++G+G G V + G+I A+K T+ E+ K ++ + E +L+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK----TLLKSEMFKKDQLAHVKAERDVLA 56
Query: 220 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEM------RLR 273
+ + VV L + + L+ EF+P G L L + ++ R
Sbjct: 57 ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML----------IKYDTFSEDVTRFY 106
Query: 274 IATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319
+A E A+ +H HRDIK NIL+D+ K++DFG S
Sbjct: 107 MA-ECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 48/198 (24%), Positives = 72/198 (36%), Gaps = 50/198 (25%)
Query: 217 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT 276
IL++ ++ VVKL + + V ++IP G + L + F R IA
Sbjct: 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RLGIFEEDLA-RFYIA- 108
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG---------TSKFI----- 322
E+ A+ +H HRDIK NIL+D+ K+ DFG SK+
Sbjct: 109 ELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDH 165
Query: 323 ---------------------------AMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKS 354
+ GT Y+ PE + T
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225
Query: 355 DVYSFGVVLVELLTGKKP 372
D +S GV+L E+L G+ P
Sbjct: 226 DWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 39/218 (17%)
Query: 172 LGQGGQGTVYKGMLEDGRI---IAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+G G GTV + D R +A+KK E K E+ +L + H NV+
Sbjct: 23 VGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAK--RAYRELRLLKHMKHENVIG 78
Query: 229 LLGCCLETEVP------LLVYEFIPN--GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
LL LV F+ G L +H +F L ++M L+
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-LVYQM-LK------- 129
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQG---TF 337
L Y+H+A I HRD+K N+ +++ K+ DFG ++ +++ G T
Sbjct: 130 GLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVTR 179
Query: 338 GYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIF 374
Y PE + T D++S G ++ E+LTG KP+F
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 61/255 (23%), Positives = 99/255 (38%), Gaps = 52/255 (20%)
Query: 166 FNANRILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFIN---EIVILSQI 221
F + +++G+G G V +D G I A+K + ++L+ E+ + E IL +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMK----ILRKADMLEKEQVAHIRAERDILVEA 58
Query: 222 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGA 281
+ VVK+ + L+ EF+P G + L + L+ E E A
Sbjct: 59 DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT-----LSEEATQFYIAETVLA 113
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG------------------------ 317
+ +H HRDIK N+LLD + K++DFG
Sbjct: 114 IDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170
Query: 318 ------TSKFIA----MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELL 367
SK A ++ + GT Y+ PE + D +S GV++ E+L
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 368 TGKKPIFWAGNTSQE 382
G P + T QE
Sbjct: 231 IGYPP--FCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 32/154 (20%), Positives = 59/154 (38%), Gaps = 21/154 (13%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVV-- 227
++L G VY +D + +K + K + E+ IL + + +
Sbjct: 4 KLLKGGLTNRVYLLGTKDEDYV-LKINPSR------EKGADREREVAILQLLARKGLPVP 56
Query: 228 KLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS 287
K+L L+ E+I TL + ++ E + IA ++A LA LH
Sbjct: 57 KVLASGESDGWSYLLMEWIEGETLDE------------VSEEEKEDIAEQLAELLAKLHQ 104
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321
+ H D+ NIL+D + D+ + +
Sbjct: 105 LPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 61/252 (24%), Positives = 96/252 (38%), Gaps = 46/252 (18%)
Query: 166 FNANRILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
F + +++G+G G V +D G + A+K + D E ++ E IL + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-KADMLEKEQVGHIRAERDILVEADSL 61
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
VVK+ + L+ EF+P G + L + LT E E A+
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT-----LTEEETQFYIAETVLAIDS 116
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFG--------------------------- 317
+H HRDIK N+LLD + K++DFG
Sbjct: 117 IHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 318 ---TSKFIA----MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 370
SK A ++ + GT Y+ PE + D +S GV++ E+L G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 371 KPIFWAGNTSQE 382
P + T QE
Sbjct: 234 PP--FCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 36/107 (33%), Positives = 47/107 (43%), Gaps = 9/107 (8%)
Query: 189 RIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLV-YEFI 246
R +AVK K E L + E+ IL I +H NVV LLG C + PL+V E+
Sbjct: 38 RTVAVKMLKEGATASEYKAL---MTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYC 94
Query: 247 PNGTLYQHLHDRHQNEEFPLTWE--MRLRIATEVAGALAYLHSATSS 291
G L +L R + E F R R + G L S +SS
Sbjct: 95 KFGNLSNYL--RSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSS 139
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 53/204 (25%), Positives = 76/204 (37%), Gaps = 54/204 (26%)
Query: 217 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT 276
IL++ ++ VVKL + + V ++IP G + L + E FP R IA
Sbjct: 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMEVFPEVLA-RFYIA- 108
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG---------TSKF------ 321
E+ A+ +H HRDIK NIL+D K+ DFG SK+
Sbjct: 109 ELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSH 165
Query: 322 IAMD-------------------------------QTHVTTKIQGTFGYLDPEYHQSSQL 350
I D Q + + GT Y+ PE
Sbjct: 166 IRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY 225
Query: 351 TDKSDVYSFGVVLVELLTGKKPIF 374
T D +S GV+L E+L G+ P
Sbjct: 226 TQLCDWWSVGVILFEMLVGQPPFL 249
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.4 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.72 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.72 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.65 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.42 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.32 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.26 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.18 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.07 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.04 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.04 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.03 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.0 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.96 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.77 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.77 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.76 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.72 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.67 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.49 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.29 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.24 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.14 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.12 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.07 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.97 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.94 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.94 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.75 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.58 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.53 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.44 | |
| PLN02236 | 344 | choline kinase | 96.03 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.92 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.69 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.55 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.0 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.6 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.56 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.39 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.37 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.96 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.73 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.68 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.53 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.38 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 92.53 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 92.06 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 91.22 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-56 Score=440.60 Aligned_cols=291 Identities=47% Similarity=0.774 Sum_probs=252.7
Q ss_pred cccccCHHHHHHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeE
Q 012214 150 RFKLFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229 (468)
Q Consensus 150 ~~~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l 229 (468)
....|++.++..+|++|...+.||+|+||.||+|.+.+|+.||||++...... . ..+|.+|+.++.+++|||+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~---~-~~eF~~Ei~~ls~l~H~Nlv~L 136 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ---G-EREFLNEVEILSRLRHPNLVKL 136 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc---c-hhHHHHHHHHHhcCCCcCcccE
Confidence 45789999999999999999999999999999999999999999987764332 1 4569999999999999999999
Q ss_pred eeeeccCC-cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC
Q 012214 230 LGCCLETE-VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR 308 (468)
Q Consensus 230 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~ 308 (468)
+|||.+.+ ..+||||||++|||.+.|...... +++|.++++|+.++|+||+|||....++||||||||+|||||++
T Consensus 137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~ 213 (361)
T KOG1187|consen 137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED 213 (361)
T ss_pred EEEEecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence 99999988 599999999999999999874422 78999999999999999999999998899999999999999999
Q ss_pred CcEEEEecCCcccccC-CCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchH
Q 012214 309 YRAKVADFGTSKFIAM-DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLA 387 (468)
Q Consensus 309 ~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~ 387 (468)
+++||+|||+|+..+. ........ .||.+|+|||++..+..+.|+|||||||+|+||+||++|.+... ......+.
T Consensus 214 ~~aKlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--~~~~~~l~ 290 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--PRGELSLV 290 (361)
T ss_pred CCEEccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--CcccccHH
Confidence 9999999999976654 32222221 79999999999999999999999999999999999999876422 22333467
Q ss_pred HHHHHHhhccccchhcchHHh-hhchH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 388 AYFVHSMRKNRLHDILDDQLM-KLGVK-NQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
.+....+....+.+++|+.+. ...+. .....+..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 291 ~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 291 EWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 777778888899999999986 44443 6788899999999999999999999999999776644
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-50 Score=394.38 Aligned_cols=257 Identities=30% Similarity=0.448 Sum_probs=221.1
Q ss_pred CCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeee
Q 012214 166 FNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEF 245 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 245 (468)
+...+.||+|-||.||.|.++....||+|.++... ...++|.+|+.+|++++|+|||+++|+|..++..+|||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-----m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-----MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-----cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 34457799999999999999877799999987642 3346799999999999999999999999998899999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 012214 246 IPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMD 325 (468)
Q Consensus 246 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 325 (468)
|+.|+|.++|.. .....+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||+|+...++
T Consensus 283 m~~GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 283 MPKGSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred cccCcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 999999999987 23346889999999999999999999999 999999999999999999999999999977766
Q ss_pred CceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchhcc
Q 012214 326 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404 (468)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 404 (468)
..........+..|.|||.+..+.++.|||||||||+||||+| |+.|+.. ....+.+ +.++
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~--------msn~ev~----------~~le 418 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG--------MSNEEVL----------ELLE 418 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC--------CCHHHHH----------HHHh
Confidence 6666666778899999999999999999999999999999999 8888632 1222222 2233
Q ss_pred hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 405 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
...+.+.|..++..+.+++..||..+|++|||+..+...|+.+....
T Consensus 419 ~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 419 RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 33344457788999999999999999999999999999999887544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=382.51 Aligned_cols=261 Identities=35% Similarity=0.544 Sum_probs=211.8
Q ss_pred CCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC-cceeEee
Q 012214 166 FNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-VPLLVYE 244 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-~~~lV~E 244 (468)
+...+.||+|+||+||+|.+.....||||++......... .++|.+|+.++.+++|||||+++|+|.+.. ..++|||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~--~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES--RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH--HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 3444559999999999999975444999998765433322 678999999999999999999999999887 7899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC-cEEEEecCCccccc
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY-RAKVADFGTSKFIA 323 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~-~~kl~DfGla~~~~ 323 (468)
|+++|+|.+++... ....+++..++.|+.|||+||.|||+.+. ||||||||+|||++.++ ++||+|||+++...
T Consensus 121 y~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred eCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 99999999999874 23469999999999999999999999885 99999999999999997 99999999998665
Q ss_pred CCCceeeecccccCCccCccccc--cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQ--SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
... ...+...||+.|||||++. ...++.|+||||||+++|||+||+.||.... .......+........+
T Consensus 196 ~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~-----~~~~~~~v~~~~~Rp~~-- 267 (362)
T KOG0192|consen 196 ISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA-----PVQVASAVVVGGLRPPI-- 267 (362)
T ss_pred ccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhcCCCCCC--
Confidence 322 2234467999999999999 5699999999999999999999999985311 11111111111111111
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
+..+++.+..++.+||+.||..||++.+++..|+.+....
T Consensus 268 ----------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 268 ----------PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred ----------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 2235568999999999999999999999999999886643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-49 Score=404.16 Aligned_cols=267 Identities=28% Similarity=0.452 Sum_probs=226.2
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE 235 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~ 235 (468)
...+....+.||+|.||.||+|... +.+.||||.++..... +...+|.+|++++..++|||||+|+|+|.+
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~---~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN---QARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH---HHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3455667788999999999999842 3568999999876544 566899999999999999999999999999
Q ss_pred CCcceeEeeecCCCChhhHhhhcccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQNE---------EFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD 306 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~ 306 (468)
++..++|+|||..|+|.++|..+.... ..+++..+.+.||.|||.||.||.++. +|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceec
Confidence 999999999999999999998754322 234899999999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCCcccccCCCceeee-cccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchh
Q 012214 307 QRYRAKVADFGTSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENV 384 (468)
Q Consensus 307 ~~~~~kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~ 384 (468)
++..|||+|||+++.+...+++... ...-+++|||||.+..+++|++||||||||+|||+++ |+.|++...
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS------- 710 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS------- 710 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-------
Confidence 9999999999999987655555433 5567889999999999999999999999999999999 999985421
Q ss_pred chHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCc
Q 012214 385 SLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452 (468)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 452 (468)
.+.+...++.+.+ -..+.+++.+++.|+..||+.+|.+||+++||-..|+..-....
T Consensus 711 --n~EVIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 711 --NQEVIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred --hHHHHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 2334455555443 23467888899999999999999999999999999998765543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=364.10 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=206.5
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc-ceeEe
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV-PLLVY 243 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~-~~lV~ 243 (468)
++..+.||+|..|+||+++++ +++.+|+|.+...... ...+++.+|+++++..+||+||+++|.|..... ..++|
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~---~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDP---ALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCH---HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 344567999999999999976 6888999998654443 455789999999999999999999999998884 99999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS-ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||++|||++++... +.+++...-.|+.+|++||.|||+ ++ ||||||||+|||++..|.+||+|||.++.+
T Consensus 158 EYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred hhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 999999999999764 248999999999999999999996 66 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
... .....+||..|||||.+.+..|+.++||||||++++|+.+|+.|+...... .....+.+.... .+..+.+
T Consensus 230 vnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~---~~~~~~Ll~~Iv-~~ppP~l 302 (364)
T KOG0581|consen 230 VNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP---YLDIFELLCAIV-DEPPPRL 302 (364)
T ss_pred hhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC---CCCHHHHHHHHh-cCCCCCC
Confidence 543 445578999999999999999999999999999999999999998653111 111122211111 1111111
Q ss_pred cchHHhhhchH-HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVK-NQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~-~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+. ..+++++.++..||+.||.+|||+.|+++
T Consensus 303 ---------P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 303 ---------PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ---------CcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22 36678999999999999999999999987
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-47 Score=376.15 Aligned_cols=249 Identities=26% Similarity=0.420 Sum_probs=209.7
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.+|...+.||+|||+.+|.++. ..|..||+|++........ ...+...+|+++.++++|||||+++++|++.+..|+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~-~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP-KQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc-chHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 5688899999999999999997 7899999999876332221 3456788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
.|+|.+++|..+++.++ ++++.+++.++.||+.||.|||+++ |+|||||..|+||+++.++||+|||+|..+
T Consensus 97 LELC~~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred EEecCCccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeee
Confidence 99999999999998543 6999999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh-ccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR-KNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 401 (468)
..+.. .....+||+.|.|||++....++..+||||+||++|-|+.|++||.. ....+.+..... +..+
T Consensus 169 e~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet--------k~vkety~~Ik~~~Y~~-- 237 (592)
T KOG0575|consen 169 EYDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET--------KTVKETYNKIKLNEYSM-- 237 (592)
T ss_pred cCccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc--------chHHHHHHHHHhcCccc--
Confidence 65433 23457899999999999999999999999999999999999999942 111111111111 1111
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
|...+.+..+||.++|+.||.+|||+++|+.
T Consensus 238 ----------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 238 ----------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ----------ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2244457889999999999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=353.80 Aligned_cols=199 Identities=32% Similarity=0.515 Sum_probs=177.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.+|...+.||+|+||+||+|+++ ++..||||.+....-.. ...+-...|+.+|+.++|||||++++++..++..+||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~--k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNK--KLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCH--HHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 56888888999999999999965 68999999886643121 4456688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC------CcEEEEec
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR------YRAKVADF 316 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~------~~~kl~Df 316 (468)
||||++|+|.+|++.++ .+++.++..++.|||.||++||+++ ||||||||+||||+.. -.+||+||
T Consensus 88 MEyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 99999999999998854 4899999999999999999999999 9999999999999765 56899999
Q ss_pred CCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~ 374 (468)
|+|+.+.... .....+|++.|||||++...+|+.|+|+||+|+++||+++|+.||.
T Consensus 160 GfAR~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 160 GFARFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred chhhhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999886432 3445789999999999999999999999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=359.22 Aligned_cols=257 Identities=26% Similarity=0.364 Sum_probs=204.8
Q ss_pred HhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHH---HHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC
Q 012214 162 ATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEE---LLKLEEFINEIVILSQINHRNVVKLLGCCLETE 237 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 237 (468)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||++........ ........+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456788899999999999999984 5799999999865332211 112233569999999999999999999999999
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC---CcEEEE
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR---YRAKVA 314 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~---~~~kl~ 314 (468)
..|+||||++||.|.+.+-.+. .+.++.-..++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEec
Confidence 9999999999999999997744 3677777889999999999999999 9999999999999766 789999
Q ss_pred ecCCcccccCCCceeeecccccCCccCccccccCCC---CCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHH
Q 012214 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL---TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391 (468)
Q Consensus 315 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (468)
|||+|+... +...+...+||+.|.|||++.+... ..++|+||+||+||-+++|.+||... ....++.++
T Consensus 322 DFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~----~~~~sl~eQ-- 393 (475)
T KOG0615|consen 322 DFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE----YTDPSLKEQ-- 393 (475)
T ss_pred ccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc----cCCccHHHH--
Confidence 999999876 3445667899999999999987543 34789999999999999999999531 111112222
Q ss_pred HHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+..+.... ........+++..+||.+||..||++|||+.|+++
T Consensus 394 --I~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 394 --ILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred --HhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 11222111 11223455678899999999999999999999876
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=344.49 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=209.8
Q ss_pred cCCCCCceeeecCcEEEEEEE-ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEee-eeccCCc-ce
Q 012214 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG-CCLETEV-PL 240 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g-~~~~~~~-~~ 240 (468)
.+|++.++||.|+||.||++. ..+|..+|.|.+.-...+ ....+....|+.+|++++|||||++++ .+.++.. .+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md--~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD--AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc--HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 457888899999999999998 568999999988743322 255677899999999999999999998 4444444 89
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT-SSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
+|||++..|+|...++..+. +...+++.++++++.|++.||..+|+.- +..|+||||||.||+|+.+|.+||+|||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 99999999999999987653 3457999999999999999999999932 133999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
+.+....+. ....+|||.||+||.+.+.+|+.||||||+||++|||+.-+.||... +... ....+.....
T Consensus 176 r~l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~-L~~KI~qgd~ 245 (375)
T KOG0591|consen 176 RFLSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLS-LCKKIEQGDY 245 (375)
T ss_pred hHhcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHH-HHHHHHcCCC
Confidence 988765544 34578999999999999999999999999999999999999999642 1111 2222333333
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 444 (468)
+.+.+ ..++..+..|+..|+..||+.||+...++..+
T Consensus 246 ~~~p~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 246 PPLPD--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred CCCcH--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 32222 35677899999999999999999854444333
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=379.67 Aligned_cols=261 Identities=22% Similarity=0.385 Sum_probs=221.1
Q ss_pred cCCCCCceeeecCcEEEEEEEec----CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
+...+.+.||.|.||.||+|+++ ....||||.++..... .+..+|+.|+.+|-+++||||++|.|+.......
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte---kqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE---KQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH---HHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 45567889999999999999965 2457999999987655 5668999999999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
.+|.|||++|+|+.+|+.+- ..+++-++..++++||.||.||.+.+ +|||||.++|||++.|..+|++|||++
T Consensus 706 MIiTEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccce
Confidence 99999999999999998732 24899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCcee--eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 320 KFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 320 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
+.+.++.... +....-+.+|.|||.+...++|.+|||||||+++||.++ |.+|+..+. ....
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS--------NQdV------- 843 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--------NQDV------- 843 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc--------hHHH-------
Confidence 9876554222 223345689999999999999999999999999999877 999975321 1111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCc
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 452 (468)
...++...+-+.|.+++..|.+|++.|||+|-.+||++.+|+..|+++-.+..
T Consensus 844 ---IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 844 ---IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred ---HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 12223334445578899999999999999999999999999999998775543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=388.90 Aligned_cols=263 Identities=29% Similarity=0.464 Sum_probs=218.9
Q ss_pred cCCCCCceeeecCcEEEEEEEecC--Cc----EEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED--GR----IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 237 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~--g~----~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 237 (468)
.+....+.||+|.||.||.|...+ |. .||||.++..... +...+|++|+.+|+.++|||||+++|+|.+..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~---~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSE---QEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCH---HHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 344566789999999999999643 33 4899998875555 66789999999999999999999999999999
Q ss_pred cceeEeeecCCCChhhHhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQN--EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
..++++|||++|+|..+|++.+.. ....++..+.+.++.|||+|+.||++++ +|||||.++|+||+....+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999875322 2346899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCceeeecc-cccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHH
Q 012214 316 FGTSKFIAMDQTHVTTKI-QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
||+|+.+...+.+..... .-+..|||||.+..+.+|.|+|||||||++||++| |..||.. ....+.....
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~--------~~n~~v~~~~ 917 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS--------RSNFEVLLDV 917 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC--------cchHHHHHHH
Confidence 999996665555544333 55679999999999999999999999999999999 8888742 1111222223
Q ss_pred hhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 394 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
.+.+++ +.+..++..+++|+..||+.+|++||++..+++.+..+.+.
T Consensus 918 ~~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 918 LEGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred HhCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 333333 23778888999999999999999999999999988877654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=338.07 Aligned_cols=246 Identities=29% Similarity=0.398 Sum_probs=203.2
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|++.+.||+|+||+||.++.+ +++.+|+|+++....-.. ...+...+|..++..++||.||+++-.|.+.+.+||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 478999999999999999999954 588999999876543322 456778899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
|+||+.||.|...|.+.+ .++++.+.-.+..|+.||.|||+++ ||||||||+|||||.+|+++|+|||+++.
T Consensus 103 Vld~~~GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEeccCCccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchh
Confidence 999999999999997632 5899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
...... .+...+||+.|||||++.+..|+..+|.||||+++|||++|.+||.... .......... .++
T Consensus 175 ~~~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~--------~~~~~~~I~~-~k~-- 242 (357)
T KOG0598|consen 175 DLKDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED--------VKKMYDKILK-GKL-- 242 (357)
T ss_pred cccCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc--------HHHHHHHHhc-CcC--
Confidence 543322 3444789999999999999999999999999999999999999985411 1111111111 110
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT 436 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt 436 (468)
...+.-.+.+..+++.++|+.||++|..
T Consensus 243 -------~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 243 -------PLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred -------CCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 0112223447899999999999999974
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=329.17 Aligned_cols=266 Identities=24% Similarity=0.335 Sum_probs=203.6
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
+.|+...++|+|+||.||+++.+ +|+.||||++....++. .-.+-.++|+.++++++|+|+|.++++|......+||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~--~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDP--VVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccH--HHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 35677788999999999999966 59999999987654432 3445678999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||++. ++.+.|..... .++...+.+++.|++.|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+
T Consensus 80 FE~~dh-TvL~eLe~~p~----G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L 151 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPN----GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTL 151 (396)
T ss_pred eeecch-HHHHHHHhccC----CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhh
Confidence 999987 55556655332 3888999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHH--------HHH
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF--------VHS 393 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~--------~~~ 393 (468)
... ....+..+.|..|.|||.+.+ .+|...+||||+||++.||++|..-|.. ..+.+........ ...
T Consensus 152 ~~p-gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG--~SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 152 SAP-GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG--RSDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred cCC-cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC--cchHHHHHHHHHHHcccCHHHHHH
Confidence 642 233455678999999999988 7899999999999999999999987643 2222221111111 111
Q ss_pred hhcc------ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 394 MRKN------RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 394 ~~~~------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+..+ .+++.-+......--+..+.-+.+++..||+.||++|++-++++.
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111 111111111111111233446889999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=348.52 Aligned_cols=264 Identities=27% Similarity=0.394 Sum_probs=205.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEe------cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeecc
Q 012214 163 TNHFNANRILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLE 235 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~ 235 (468)
.++|.+.++||+|+||.||+|.. .++..||+|++...... .....+.+|+.++..+ +||||++++++|..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA---SEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch---HHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 46789999999999999999974 23567999998754322 3346789999999999 89999999998876
Q ss_pred CC-cceeEeeecCCCChhhHhhhcccC-----------------------------------------------------
Q 012214 236 TE-VPLLVYEFIPNGTLYQHLHDRHQN----------------------------------------------------- 261 (468)
Q Consensus 236 ~~-~~~lV~E~~~~gsL~~~l~~~~~~----------------------------------------------------- 261 (468)
.. ..++||||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 44 578999999999999998753210
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCcee-eeccccc
Q 012214 262 ----EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHV-TTKIQGT 336 (468)
Q Consensus 262 ----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt 336 (468)
...++++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......... .....++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 0235888999999999999999999999 9999999999999999999999999998654332221 2233467
Q ss_pred CCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHH
Q 012214 337 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQ 415 (468)
Q Consensus 337 ~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 415 (468)
..|+|||++.+..++.++|||||||++|||++ |..||...... ..+.......... ..+...
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--------~~~~~~~~~~~~~---------~~~~~~ 302 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--------EEFCQRLKDGTRM---------RAPENA 302 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--------HHHHHHHhcCCCC---------CCCCCC
Confidence 78999999999999999999999999999997 99998531110 0111111111111 012234
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 416 IMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 416 ~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
++.+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=345.65 Aligned_cols=262 Identities=25% Similarity=0.349 Sum_probs=207.0
Q ss_pred hcCCCCCceeeecCcEEEEEEE-ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccCC-cc
Q 012214 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETE-VP 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~-~~ 239 (468)
.++|...++||.|+||+||+|+ ...|..||||+++.....- ....-++|+.-|++++ ||||+++.+++.+.+ .+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~---ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW---EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH---HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 4678889999999999999999 4578999999998754431 1123468999999998 999999999999988 99
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++|||||+ .+|.++++.+ ..++++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|
T Consensus 86 ~fVfE~Md-~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 86 YFVFEFMD-CNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLA 157 (538)
T ss_pred eeeHHhhh-hhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccc
Confidence 99999996 4999999875 347999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc-
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN- 397 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 397 (468)
+.+..... .+..+.|..|.|||++.. +-|+.+.|+||+||+++|+.+-+.-|.... ..+.. -..-..+..+
T Consensus 158 Rev~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s--E~Dqi---~KIc~VLGtP~ 230 (538)
T KOG0661|consen 158 REVRSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS--EIDQI---YKICEVLGTPD 230 (538)
T ss_pred cccccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc--HHHHH---HHHHHHhCCCc
Confidence 97654333 456778999999997765 789999999999999999999887764321 11111 1111111111
Q ss_pred ----------------ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 398 ----------------RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 398 ----------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
.++......+....+ +++.+..+++.+|++.||.+|||+.|+++.
T Consensus 231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred cccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111222222222223 377789999999999999999999999873
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=334.27 Aligned_cols=263 Identities=25% Similarity=0.352 Sum_probs=211.2
Q ss_pred HhcCCCCCceeeecCcEEEEEEE-ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
..+.|.+.+.||.|..++||+|+ .+.+..||||++.....+ ...+++.+|+..++.++||||++++.+|..+...|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~---~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN---NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh---hhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 34789999999999999999999 457899999999876555 34688999999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||.||.+||+.+.++..-.. .+.+..+..|+.++++||.|||+++ .||||||+.||||+++|.|||+|||.+.
T Consensus 101 vVmpfMa~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred EeehhhcCCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeee
Confidence 999999999999999885443 3899999999999999999999999 9999999999999999999999999986
Q ss_pred cccCCCcee--e-ecccccCCccCcccccc--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 321 FIAMDQTHV--T-TKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 321 ~~~~~~~~~--~-~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
.+....... . ...+||+.|||||++.. ..|+.|+||||||++..||.+|..||... . ........+
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~-------p-PmkvLl~tL- 245 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY-------P-PMKVLLLTL- 245 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC-------C-hHHHHHHHh-
Confidence 654333221 1 34689999999998544 57999999999999999999999998421 1 111111111
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
++..+...-..+..+........+.+++..||+.||.+|||++++++
T Consensus 246 qn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 246 QNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11111111111222223445558999999999999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=342.08 Aligned_cols=264 Identities=27% Similarity=0.346 Sum_probs=208.0
Q ss_pred hcCCCCCceeeecCcEEEEEEE-ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC--Ccc
Q 012214 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVP 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~ 239 (468)
.+.|+..++||+|.||.||+++ ..+|+.||+|++....... .......+||.+|++++||||++|.+...+. ...
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~--~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE--GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC--cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 4567778889999999999999 5679999999987754332 3345678999999999999999999998876 688
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
|||+|||++ +|.-++... .-.|++.++..++.|++.||+|+|+.+ |+|||||.+|||||.+|.+||+|||||
T Consensus 194 YlVFeYMdh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLA 265 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLA 265 (560)
T ss_pred EEEEecccc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccce
Confidence 999999987 888777542 235999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc-
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN- 397 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 397 (468)
+++........+..+-|..|.|||.+.+ ..|+.+.|+||.||||.||++|+..|... .+......+......+
T Consensus 266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~-----tEveQl~kIfklcGSP~ 340 (560)
T KOG0600|consen 266 RFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR-----TEVEQLHKIFKLCGSPT 340 (560)
T ss_pred eeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc-----cHHHHHHHHHHHhCCCC
Confidence 9888777666777788999999999988 57999999999999999999999887431 1111111111111111
Q ss_pred --ccc--hhc-----------chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 --RLH--DIL-----------DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 --~~~--~~~-----------d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+. .+. ...+... ....++...+|+..+|..||.+|.|+.++++
T Consensus 341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 341 EDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred hhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 111 0111111 2233456789999999999999999999885
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=334.95 Aligned_cols=255 Identities=31% Similarity=0.452 Sum_probs=201.7
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC--cce
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE--VPL 240 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--~~~ 240 (468)
.++...+.||+|+||+||++... +|...|||........ ..+.+.+|+.+|.+++|||||+++|...... ..+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~----~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP----TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch----hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 45677788999999999999965 4899999988764221 1567889999999999999999999855444 588
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC-CCcEEEEecCCc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ-RYRAKVADFGTS 319 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~-~~~~kl~DfGla 319 (468)
+.|||+++|+|.+++.... . .+++..+...+.||++||+|||+++ |+|+||||+|||++. ++.+||+|||++
T Consensus 93 i~mEy~~~GsL~~~~~~~g---~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYG---G-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLA 165 (313)
T ss_pred eeeeccCCCcHHHHHHHcC---C-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccc
Confidence 9999999999999998743 2 5999999999999999999999999 999999999999999 799999999999
Q ss_pred ccccC--CCceeeecccccCCccCccccccCC-CCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 320 KFIAM--DQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 320 ~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
+.... ..........||+.|||||++..+. ...++|||||||++.||+||+.||..- .............
T Consensus 166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~ 238 (313)
T KOG0198|consen 166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGRE 238 (313)
T ss_pred cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhcc
Confidence 87653 1222234567999999999999643 335999999999999999999998431 1111111111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
...+. .+...+....+++.+|++.+|++|||+.++++.--
T Consensus 239 ~~~P~---------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 239 DSLPE---------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCCCC---------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 11221 22334557889999999999999999999998543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=340.44 Aligned_cols=253 Identities=28% Similarity=0.368 Sum_probs=207.4
Q ss_pred HhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcc
Q 012214 162 ATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~ 239 (468)
..++|...+.||+|+|++|++|+. +.++.+|||++.......+ ...+-...|-..|.+| .||.|++|+..|.++..+
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike-~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKE-KKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhh-cccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 347789999999999999999994 4689999999865433322 2334567888889999 899999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
|+|+||+++|+|.++|...+ .+++.....++.+|+.||+|||+.| ||||||||+|||||+|+++||+|||.|
T Consensus 150 YFvLe~A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence 99999999999999998854 4899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCce------------eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchH
Q 012214 320 KFIAMDQTH------------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLA 387 (468)
Q Consensus 320 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~ 387 (468)
+.+...... .....+||..|.+||++..+..+..+|+|+|||+||+|+.|.+||... .+.
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~-----Ney--- 293 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA-----NEY--- 293 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc-----cHH---
Confidence 987643221 114478999999999999999999999999999999999999999531 111
Q ss_pred HHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 388 AYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
-.|...+. +.-..++.-++.+.+|+.+.|..||.+|+|.++|-+
T Consensus 294 liFqkI~~-----------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 294 LIFQKIQA-----------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHHHHH-----------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 11111111 111223344457889999999999999999977755
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=342.66 Aligned_cols=265 Identities=25% Similarity=0.368 Sum_probs=215.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.+...+.++||+|-||.|.++....+..||||+++..... ....+|.+|+++|.+++||||++++|+|..++..++|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~---~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK---NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccch---hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 3556778899999999999999988899999999875544 4458899999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+|||++|+|..++..+... .+.-.....|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||+++.+
T Consensus 614 ~EYmEnGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHhcCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccc
Confidence 9999999999999875321 1344556679999999999999999 999999999999999999999999999966
Q ss_pred cCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh--CCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 323 AMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT--GKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 323 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
...+++ .....+-+++|||||.+..+++|+++|||+||+++||+++ ...||.. ..+....+........+..
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~-----lt~e~vven~~~~~~~~~~ 762 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQ-----LTDEQVVENAGEFFRDQGR 762 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhh-----hhHHHHHHhhhhhcCCCCc
Confidence 544444 4556678899999999999999999999999999999766 7778742 1122222222223332222
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
...+ ..|.-++..+.+++.+||..+.++|||++++...|++.
T Consensus 763 ~~~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 QVVL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ceec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2211 12556777899999999999999999999999888764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=313.91 Aligned_cols=264 Identities=25% Similarity=0.336 Sum_probs=204.3
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.+|...++||+|.||.||+|++ ++|+.||||+++.....+ .-....++|+..|+.++|+||+.+++++...+...||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd--Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD--GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc--CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence 4577778899999999999994 579999999998753332 1234678999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+|||+. +|...++... -.++...+..++.++++|++|||++. |+||||||+|+|++++|.+||+|||+|+.+
T Consensus 80 fEfm~t-dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFF 151 (318)
T ss_pred EEeccc-cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhcc
Confidence 999964 8988887643 36899999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc---cc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK---NR 398 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 398 (468)
......... .+.|..|.|||.+.+ ..|....|+||.||++.||+-|.+-|. +..+.+. + ......... ..
T Consensus 152 ~~p~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp--G~sDidQ--L-~~If~~LGTP~~~~ 225 (318)
T KOG0659|consen 152 GSPNRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP--GDSDIDQ--L-SKIFRALGTPTPDQ 225 (318)
T ss_pred CCCCccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC--CCchHHH--H-HHHHHHcCCCCccc
Confidence 755443333 367899999998887 579999999999999999998765442 2222221 1 111122211 11
Q ss_pred cch---hcchHHhh--------hchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 399 LHD---ILDDQLMK--------LGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 399 ~~~---~~d~~l~~--------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
+++ +.|-.-.. ..-..++....+|+.+|+.+||.+|+|++|++++
T Consensus 226 WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 226 WPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 211 11111100 0122345567999999999999999999999864
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=334.11 Aligned_cols=266 Identities=23% Similarity=0.362 Sum_probs=203.2
Q ss_pred cCCCCCceeeecCcEEEEEEEecC-----------------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCce
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED-----------------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNV 226 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni 226 (468)
++|.+.+.||+|+||.||++.+++ +..||+|.+...... ....+|.+|+.++.+++||||
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK---NARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH---HHHHHHHHHHHHHhhcCCCCe
Confidence 578889999999999999997532 346999988764333 345679999999999999999
Q ss_pred eeEeeeeccCCcceeEeeecCCCChhhHhhhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 012214 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQN--------------EEFPLTWEMRLRIATEVAGALAYLHSATSSP 292 (468)
Q Consensus 227 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 292 (468)
+++++++.+.+..++||||+++|+|.+++...... ....+++..++.++.||+.||.|||+.+
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--- 158 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--- 158 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---
Confidence 99999999999999999999999999998653211 1124788999999999999999999999
Q ss_pred EEecCCCCCCEEEcCCCcEEEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhC--
Q 012214 293 IYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTG-- 369 (468)
Q Consensus 293 iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG-- 369 (468)
|+||||||+|||+++++.+||+|||+++........ ......++..|+|||++.++.++.++||||||+++|||+++
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 999999999999999999999999999765433322 22234467889999999988999999999999999999874
Q ss_pred CCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 370 KKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 370 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
..||.. .... ................. ....+..++..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus 239 ~~p~~~--~~~~---~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 239 EQPYGE--LTDE---QVIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCc--CCHH---HHHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 455532 1111 11111111111110000 000122345578999999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=344.40 Aligned_cols=249 Identities=27% Similarity=0.450 Sum_probs=208.4
Q ss_pred cCCCCCceeeecCcEEEEEEE-ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
..|....+||+|+.|.||.+. ..+++.||||++..... ...+-.++|+.+|+..+|+|||.+++.+...+..++|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ----PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC----CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 457777889999999999998 44688999999876432 2334578999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
||||++|+|.+.+... .+++.++..|+..+++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+
T Consensus 349 MEym~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQI 419 (550)
T ss_pred EeecCCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecc
Confidence 9999999999998762 3899999999999999999999999 999999999999999999999999999887
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...... ....+||+.|||||++....|..|.||||||++++||+-|++||.. +....+.+.. ..+..+++
T Consensus 420 ~~~~~K-R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln------E~PlrAlyLI---a~ng~P~l 489 (550)
T KOG0578|consen 420 SEEQSK-RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN------ENPLRALYLI---ATNGTPKL 489 (550)
T ss_pred ccccCc-cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC------CChHHHHHHH---hhcCCCCc
Confidence 765553 3456799999999999999999999999999999999999999864 1111111111 12222222
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
-. +...+..+.+++.+||+.|+++||++.|+|+
T Consensus 490 k~-------~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 KN-------PEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CC-------ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 11 3455668999999999999999999999997
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=348.97 Aligned_cols=272 Identities=25% Similarity=0.448 Sum_probs=217.0
Q ss_pred ccCHHHHHHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeee
Q 012214 153 LFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGC 232 (468)
Q Consensus 153 ~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~ 232 (468)
..+.++.+...+.+.+...||+|.||+||+|.+-+ .||||+++...... ...+.|.+|+..+++-+|.||+-+.|+
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~--~qlqaFKnEVa~lkkTRH~NIlLFMG~ 456 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTP--EQLQAFKNEVAVLKKTRHENILLFMGA 456 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCH--HHHHHHHHHHHHHhhcchhhheeeehh
Confidence 33446666677778889999999999999999752 49999998866555 478899999999999999999999999
Q ss_pred eccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEE
Q 012214 233 CLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAK 312 (468)
Q Consensus 233 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~k 312 (468)
|..... .+|+.+|+|-+|+.+|+... ..+...+.+.|+.|||+||.|||.++ |||||||..|||+.+++.||
T Consensus 457 ~~~p~~-AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVk 528 (678)
T KOG0193|consen 457 CMNPPL-AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVK 528 (678)
T ss_pred hcCCce-eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEE
Confidence 998877 99999999999999998643 25899999999999999999999999 99999999999999999999
Q ss_pred EEecCCcccccCC-CceeeecccccCCccCcccccc---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH
Q 012214 313 VADFGTSKFIAMD-QTHVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 313 l~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~ 388 (468)
|+|||++..-..- .........|...|||||++.. .+|+..+||||||+++|||++|..||.. +. .+.
T Consensus 529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi--~~-~dq----- 600 (678)
T KOG0193|consen 529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI--QN-RDQ----- 600 (678)
T ss_pred EecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC--CC-hhh-----
Confidence 9999998643211 1111223457889999998874 5799999999999999999999999851 11 111
Q ss_pred HHHHHhhccc-cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 389 YFVHSMRKNR-LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 389 ~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
..-.+..+. .++.. ....+++.++.+|+..||.+++++||.+.+|+.+|+.+..+.
T Consensus 601 -IifmVGrG~l~pd~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 601 -IIFMVGRGYLMPDLS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred -eEEEecccccCccch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 111111111 11111 113356668999999999999999999999999888877643
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=350.24 Aligned_cols=267 Identities=27% Similarity=0.413 Sum_probs=212.8
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEecC--C--cE-EEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeec
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGMLED--G--RI-IAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL 234 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~--g--~~-vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~ 234 (468)
+...++-...++||+|+||.||+|.++. + .. ||||..+... ........+|++|++++++++|||||+++|++.
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 3344555666899999999999999653 2 23 8999887521 112266789999999999999999999999999
Q ss_pred cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 235 ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 235 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
.....++|||+|+||+|.++|..... .++..+.+.++.+.|.||+|||+++ +|||||.++|+|++.++.+||+
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeC
Confidence 99999999999999999999987432 5899999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHH
Q 012214 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 315 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
|||+++.... .........-+..|+|||.+..+.++.++|||||||++||+++ |..||.... .. .+...
T Consensus 305 DFGLs~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~-----~~----~v~~k 374 (474)
T KOG0194|consen 305 DFGLSRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK-----NY----EVKAK 374 (474)
T ss_pred ccccccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC-----HH----HHHHH
Confidence 9999875431 1111112246789999999999999999999999999999999 888874311 11 11122
Q ss_pred h-hccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCch
Q 012214 394 M-RKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKK 453 (468)
Q Consensus 394 ~-~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 453 (468)
+ ..+ .....+...+..+..++.+||..+|++||||.++.+.|+.+......
T Consensus 375 I~~~~---------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 375 IVKNG---------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHhcC---------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 2 111 11222335566888999999999999999999999999988876653
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=345.99 Aligned_cols=275 Identities=26% Similarity=0.414 Sum_probs=236.0
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEecC-CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
+-...+....++||-|.||.||.|.++. .-.||||.++... ..+++|+.|+.+|+.++|||+|+|+|+|..+..
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 3333556778899999999999999763 6679999887532 567899999999999999999999999999999
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.|+|+|||..|+|.+||++... ..++...++.++.||+.||+||..++ +|||||.++|+|+.++-.+|++|||+
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred eEEEEecccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccch
Confidence 9999999999999999987432 34777788999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
++++..+..........++.|.|||-+.-+.++.|+|||+|||+|||+.| |-.||.. .+ ..
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-----id-------------lS 473 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-----ID-------------LS 473 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-----cc-------------HH
Confidence 99988777766666678899999999999999999999999999999999 7777632 11 11
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCchhhhHHHHHHh
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKRAMFSKIIK 463 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~ 463 (468)
++..++....+.+.+..|++.+++|+..||+.+|.+||++.|+-+.++.|-++..-.++.+.+.-+
T Consensus 474 qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisdEV~keLgk 539 (1157)
T KOG4278|consen 474 QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISDEVQKELGK 539 (1157)
T ss_pred HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccHHHHHHHhh
Confidence 223444455566678899999999999999999999999999999999999888877777766543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=327.00 Aligned_cols=265 Identities=22% Similarity=0.331 Sum_probs=206.5
Q ss_pred ccccccCHHHHHHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceee
Q 012214 149 DRFKLFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228 (468)
Q Consensus 149 ~~~~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~ 228 (468)
...+.++.++++. .....||+|++|.||+|.. +|+.||||++...... .....+.|.+|+.++++++||||++
T Consensus 10 ~~~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~ 82 (283)
T PHA02988 10 NDIKCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKG-HKVLIDITENEIKNLRRIDSNNILK 82 (283)
T ss_pred CcceecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccc-cHHHHHHHHHHHHHHHhcCCCCEEE
Confidence 3445556666622 2235699999999999998 5889999998754222 1133577889999999999999999
Q ss_pred Eeeeecc----CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEecCCCCCCE
Q 012214 229 LLGCCLE----TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA-TSSPIYHRDIKSTNI 303 (468)
Q Consensus 229 l~g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLkp~NI 303 (468)
++|++.+ ....++||||+++|+|.+++... ..+++.....++.|++.||.|||+. + ++||||||+||
T Consensus 83 ~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~ni 154 (283)
T PHA02988 83 IYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSF 154 (283)
T ss_pred EeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhE
Confidence 9999876 34678999999999999999753 2488999999999999999999985 6 78999999999
Q ss_pred EEcCCCcEEEEecCCcccccCCCceeeecccccCCccCcccccc--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCcc
Q 012214 304 LLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381 (468)
Q Consensus 304 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~ 381 (468)
|+++++.+||+|||+++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 155 ll~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~----- 225 (283)
T PHA02988 155 LVTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL----- 225 (283)
T ss_pred EECCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC-----
Confidence 99999999999999987654321 22457889999999976 68999999999999999999999998531
Q ss_pred chhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 382 ENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
.. .............. ..+...+..+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 226 ~~---~~~~~~i~~~~~~~---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 226 TT---KEIYDLIINKNNSL---------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CH---HHHHHHHHhcCCCC---------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 11 11111111111100 0122345679999999999999999999999999998763
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=311.36 Aligned_cols=238 Identities=29% Similarity=0.386 Sum_probs=201.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|+..+.||.|+||.|.+++.+ +|..+|+|++.... --...+.+...+|..+|+.+.||.++++.+.+.+.+..++|
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~-vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK-VVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH-HHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 57888899999999999999965 68899999987642 22335677889999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||++||.|.+++++.+ .+++..+.-++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||+|+..
T Consensus 123 meyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred EeccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 99999999999998743 4899999999999999999999999 999999999999999999999999999977
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh-ccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR-KNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 401 (468)
... +-..+||+.|+|||.+...++..++|.|||||++|||+.|..||..... ...+..... .-..
T Consensus 195 ~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI~~~~v~f-- 260 (355)
T KOG0616|consen 195 SGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKILEGKVKF-- 260 (355)
T ss_pred cCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHHHhCcccC--
Confidence 543 4557899999999999999999999999999999999999999964111 111111111 1122
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCC
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKR 434 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~R 434 (468)
|...+..+.+|+.++|+.|-.+|
T Consensus 261 ----------P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 261 ----------PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----------CcccCHHHHHHHHHHHhhhhHhh
Confidence 22333478899999999999999
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=338.29 Aligned_cols=260 Identities=25% Similarity=0.329 Sum_probs=207.6
Q ss_pred HHhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHH-HHHHHHHHHHHHHHHhcC-CCceeeEeeeeccCC
Q 012214 161 KATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEE-LLKLEEFINEIVILSQIN-HRNVVKLLGCCLETE 237 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~ 237 (468)
...+.|.+.+.||+|+||+|+.|.. .++..||+|++........ ....+...+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999985 4689999997655311101 122345568999999998 999999999999999
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC-CcEEEEec
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR-YRAKVADF 316 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~-~~~kl~Df 316 (468)
..++||||+.+|+|.+++.... ++.+..+..++.|++.|++|||+.+ |+||||||+|||++.+ +++||+||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence 9999999999999999997732 5888999999999999999999999 9999999999999999 99999999
Q ss_pred CCcccccCCCceeeecccccCCccCccccccCC-CC-CcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ-LT-DKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
|++.... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||.. ......+....
T Consensus 166 G~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d--------~~~~~l~~ki~ 236 (370)
T KOG0583|consen 166 GLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD--------SNVPNLYRKIR 236 (370)
T ss_pred ccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--------ccHHHHHHHHh
Confidence 9998774 2222345568999999999999977 86 688999999999999999999953 11112222211
Q ss_pred h-ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 395 R-KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 395 ~-~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
. .-.++..+. +.++..|+.+||+.||.+|+|+.+++ .-.-++.
T Consensus 237 ~~~~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 237 KGEFKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred cCCccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 1 112222221 44789999999999999999999998 5444443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=328.58 Aligned_cols=256 Identities=21% Similarity=0.347 Sum_probs=204.4
Q ss_pred cCCCCCceeeecCcEEEEEEEec----CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
++|++.+.||+|+||.||+|.++ .+..||+|.++..... .....|.+|+.++++++||||+++++++......
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD---KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH---HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 56888999999999999999753 3668999998764333 3346789999999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.++++|||.+
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccc
Confidence 99999999999999997532 25899999999999999999999999 999999999999999999999999987
Q ss_pred ccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
...............++..|+|||.+.+..++.++|||||||++||+++ |..||.... .. . .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~-----~~---~-~~~~~~~~~ 225 (266)
T cd05064 155 QEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS-----GQ---D-VIKAVEDGF 225 (266)
T ss_pred ccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC-----HH---H-HHHHHHCCC
Confidence 6543222222222345678999999999999999999999999999775 999984311 00 1 111111111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
. ...+..++..+.+++.+||+.+|++|||+.++.+.|.++
T Consensus 226 ~---------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 R---------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred C---------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 011233456789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.67 Aligned_cols=262 Identities=27% Similarity=0.409 Sum_probs=204.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEe------cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeecc
Q 012214 163 TNHFNANRILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLE 235 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~ 235 (468)
.++|++.+.||+|+||.||++.. .++..||||+++..... ...+.+.+|+.++..+ +||||++++++|.+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL---TEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc---HHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 45789999999999999999963 23568999998754322 3346788999999999 89999999999999
Q ss_pred CCcceeEeeecCCCChhhHhhhcccC------------------------------------------------------
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQN------------------------------------------------------ 261 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------------------------ 261 (468)
....++||||+++|+|.+++......
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 99999999999999999998653210
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 012214 262 ----------------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMD 325 (468)
Q Consensus 262 ----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 325 (468)
....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 1125789999999999999999999999 999999999999999999999999999866433
Q ss_pred Ccee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 326 QTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 326 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
.... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... . ..+..........
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~----~----~~~~~~~~~~~~~--- 336 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV----D----SKFYKMIKEGYRM--- 336 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc----h----HHHHHHHHhCccC---
Confidence 3221 222345678999999999999999999999999999998 8888743110 0 1111111111100
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
..+...+.++.+|+.+||+.||++|||+.||+++|++.
T Consensus 337 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 ------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 01112234789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=342.53 Aligned_cols=263 Identities=27% Similarity=0.412 Sum_probs=205.6
Q ss_pred hcCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeecc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLE 235 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~ 235 (468)
.++|++.+.||+|+||.||+++.. ++..||+|++...... .....+.+|+.+++.+ +|+||++++++|.+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT---DEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH---HHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 457899999999999999998732 3457999998764333 3346788999999999 89999999999999
Q ss_pred CCcceeEeeecCCCChhhHhhhccc-------------------------------------------------------
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQ------------------------------------------------------- 260 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------- 260 (468)
....++||||+++|+|.+++.....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999999864221
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCcee-
Q 012214 261 ----------NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHV- 329 (468)
Q Consensus 261 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~- 329 (468)
....++++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 01135788999999999999999999999 9999999999999999999999999997654332221
Q ss_pred eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHh
Q 012214 330 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLM 408 (468)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 408 (468)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .. .......... .
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~----~~----~~~~~~~~~~---------~ 333 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV----NS----KFYKMVKRGY---------Q 333 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc----cH----HHHHHHHccc---------C
Confidence 222335678999999999999999999999999999997 9999853110 00 0111111110 0
Q ss_pred hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 409 KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 409 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
...+...+..+.+++.+||+.||++|||+.+++++|+++.
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0001122457899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=326.02 Aligned_cols=253 Identities=24% Similarity=0.299 Sum_probs=199.6
Q ss_pred CCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEee
Q 012214 166 FNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYE 244 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 244 (468)
|+..+.||+|+||.||++.. .+++.||+|.+....... ......+.+|+.+++.++|+||+++++++.+.+..++|+|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 67788999999999999985 478999999876432221 1233467899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
|+++|+|...+.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 999999998886522 235899999999999999999999999 99999999999999999999999999976543
Q ss_pred CCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcc
Q 012214 325 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404 (468)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 404 (468)
... .....||..|+|||++.+..++.++|||||||++|||++|+.||....... .............
T Consensus 155 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~------ 221 (285)
T cd05631 155 GET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-----KREEVDRRVKEDQ------ 221 (285)
T ss_pred CCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-----hHHHHHHHhhccc------
Confidence 222 233468999999999999999999999999999999999999985421110 0111111111110
Q ss_pred hHHhhhchHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 012214 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT-----MEEVSM 442 (468)
Q Consensus 405 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 442 (468)
...+...+..+.+|+.+||+.||.+||+ +.++++
T Consensus 222 ----~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 ----EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ----ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0112234457889999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=340.73 Aligned_cols=273 Identities=27% Similarity=0.436 Sum_probs=231.4
Q ss_pred cCCCCCceeeecCcEEEEEEEecC---C--cEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED---G--RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~---g--~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
......++||+|-||.||+|.+.+ | -.||||..+..... ...+.|+.|+.+|++++||||++++|+|.+ ..
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~---d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP---DDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh---hhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 344566789999999999999532 2 35899988775443 446789999999999999999999999976 56
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++|||.++-|.|..||..++. .++......++.||+.||+|||+.. +|||||..+|||+.+...+||+|||+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred eeEEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence 7999999999999999987443 5888999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
++.+.++..+..+...-++.|||||.+.-..+|.++|||.|||.+||++. |..||.+-.+ .
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN------------------s 599 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN------------------S 599 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc------------------c
Confidence 99998887777777778899999999999999999999999999999988 9999965222 2
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCchhhhHHHHHHhhh
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKRAMFSKIIKRL 465 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~~~ 465 (468)
.+.-.+...-+.+.|+++++.++.|+.+||.++|.+||++.|+...|..+++.++--...+.++.|+.
T Consensus 600 DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~Eq~r~~R~~ 667 (974)
T KOG4257|consen 600 DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSSEQLRRQRKV 667 (974)
T ss_pred ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhHHHHHhhhcc
Confidence 22222333334455788999999999999999999999999999999999998877777776666653
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=327.09 Aligned_cols=260 Identities=27% Similarity=0.431 Sum_probs=207.9
Q ss_pred cCCCCCceeeecCcEEEEEEEecC------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 237 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 237 (468)
++|++.+.||+|+||.||+|.... ...||+|.+...... .....|.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP---KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH---HHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 467888999999999999998542 257999988654332 34467899999999999999999999999988
Q ss_pred cceeEeeecCCCChhhHhhhcccCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEE-----------FPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD 306 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~ 306 (468)
..+++|||+++++|.+++........ ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVG 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEc
Confidence 99999999999999999976432111 45889999999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCCcccccCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchh
Q 012214 307 QRYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENV 384 (468)
Q Consensus 307 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~ 384 (468)
+++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.... .
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~--~---- 232 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS--N---- 232 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC--H----
Confidence 999999999999976543322 22233456788999999998899999999999999999998 999985311 0
Q ss_pred chHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 385 SLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
......+...... ..+..++.++.+|+.+||+.||.+|||+.||++.|+++
T Consensus 233 ---~~~~~~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 233 ---QEVIEMIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ---HHHHHHHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1111222222111 11234556899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=319.80 Aligned_cols=256 Identities=23% Similarity=0.409 Sum_probs=206.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.+....+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 36788899999999999999998888899999876432 2246788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 80 TEYMAKGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred EecCCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceec
Confidence 99999999999997632 235888999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
............++..|+|||++.+..++.++|||||||++|+|++ |..||... . ... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~--~---~~~----~~~~~~~~~~~- 223 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM--S---NSD----VMSALQRGYRM- 223 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC--C---HHH----HHHHHHcCCCC-
Confidence 5433222233346678999999998889999999999999999998 89887421 1 111 11111111000
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
......+..+.+++.+||+.+|++|||++++.+.|+.+
T Consensus 224 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 --------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 00112345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=333.42 Aligned_cols=248 Identities=28% Similarity=0.422 Sum_probs=210.1
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||+|+.+ +.+.||+|.+....... ..++...+|+++++.++||||+.++++|++..+.++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~--k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE--KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch--HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 56778888999999999999954 68899999876543332 5667889999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
.||+.+ +|..+|.... .++++.+..|+.+++.||.|||+.+ |+|||+||.|||++.++.+|++|||+|+..
T Consensus 80 te~a~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAM 150 (808)
T ss_pred ehhhhh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhc
Confidence 999976 9999997633 4999999999999999999999999 999999999999999999999999999977
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
.. .+.+.+.+.||+-|||||.+.+.+|+..+|.||+||++||+++|++||.. .+..+.+.....++..
T Consensus 151 ~~-~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a--------~si~~Lv~~I~~d~v~--- 218 (808)
T KOG0597|consen 151 ST-NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA--------RSITQLVKSILKDPVK--- 218 (808)
T ss_pred cc-CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH--------HHHHHHHHHHhcCCCC---
Confidence 65 45566778899999999999999999999999999999999999999853 1122222222222211
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+...+..+.+++...|+.||..|.|-.+++.
T Consensus 219 --------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 --------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred --------CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 13356668999999999999999999888765
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=324.46 Aligned_cols=249 Identities=36% Similarity=0.569 Sum_probs=193.4
Q ss_pred CceeeecCcEEEEEEEec-----CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 169 NRILGQGGQGTVYKGMLE-----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
.+.||.|.||.||+|.+. .+..|+||.++..... ...+.|.+|+..+++++||||++++|++......++|+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSE---EEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSH---HHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccc---ccceeeeecccccccccccccccccccccccccccccc
Confidence 467999999999999976 3678999999654333 34678999999999999999999999999888899999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++|+|.++|... ....+++..+..|+.||+.||+|||+.+ ++|+||+++||++++++.+||+|||++....
T Consensus 81 e~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp E--TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred ccccccccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 999999999999884 2235899999999999999999999999 9999999999999999999999999998763
Q ss_pred CCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 324 MDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 324 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.... ...........|+|||.+.+..++.++||||||+++|||++ |+.|+... ... . +...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----~~~---~-~~~~~~~~~~~~ 225 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-----DNE---E-IIEKLKQGQRLP 225 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-----CHH---H-HHHHHHTTEETT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccc---c-ccccccccccce
Confidence 2222 22333457789999999999999999999999999999999 67876321 111 1 111222211111
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 444 (468)
.+..++..+.+++..||+.+|++|||+.++++.|
T Consensus 226 ---------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ---------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1223345789999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=324.89 Aligned_cols=267 Identities=22% Similarity=0.249 Sum_probs=200.7
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||+++.+ +++.+|+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE--EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc--cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence 46889999999999999999975 57889999886543221 3345678999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||++++++..+... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 79 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 79 FEYVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNL 150 (287)
T ss_pred EecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence 999998766544322 125889999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH---------HHHHH
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA---------YFVHS 393 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~---------~~~~~ 393 (468)
............||..|+|||++.+..++.++|||||||++|||++|+.||.... ..+...... .....
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07848 151 SEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES--EIDQLFTIQKVLGPLPAEQMKLF 228 (287)
T ss_pred cccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhhCCCCHHHHHhh
Confidence 4433323334568999999999999889999999999999999999999985311 111000000 00000
Q ss_pred hhccccchhcch------HHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 394 MRKNRLHDILDD------QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 394 ~~~~~~~~~~d~------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...........+ ..........+..+.+|+.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000 0000111123457999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=320.14 Aligned_cols=256 Identities=24% Similarity=0.397 Sum_probs=206.1
Q ss_pred cCCCCCceeeecCcEEEEEEEecC----CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED----GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
++|++.+.||+|+||.||+|.... ...||+|.++..... ....+|.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD---KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh---HHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 578889999999999999998642 457999988754333 3456789999999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
+++|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 81 MIITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred EEEEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchh
Confidence 99999999999999996532 25899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCC-ceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 320 KFIAMDQ-THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 320 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
+...... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.... .. .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-----~~----~~~~~~~~~ 224 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-----NQ----DVIKAVEDG 224 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-----HH----HHHHHHHcC
Confidence 8775222 222223345678999999999999999999999999999998 998874211 11 111111111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
... ..+..++..+.+++.+||+.+|++||++.||++.|+++
T Consensus 225 ~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 YRL---------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 01223455789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=320.71 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=204.9
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
..|.+.+.||+|+||.||+|... .++.||+|.+.... ....++.+|+.+++.++|+||+++++++......+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 45778889999999999999965 58899999876432 2346788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~ 154 (263)
T cd05052 81 TEFMTYGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 154 (263)
T ss_pred EEeCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccc
Confidence 99999999999996532 235899999999999999999999998 999999999999999999999999999866
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
............++..|+|||.+.+..++.++|||||||++|||++ |..||... . . .... .......
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~--~---~---~~~~-~~~~~~~--- 222 (263)
T cd05052 155 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--D---L---SQVY-ELLEKGY--- 222 (263)
T ss_pred ccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--C---H---HHHH-HHHHCCC---
Confidence 5433222222334678999999999999999999999999999998 88887421 1 0 0111 1111110
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
....+...+..+.+++.+||+.+|++|||+.+++++|+.+
T Consensus 223 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 ------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0111223456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=302.77 Aligned_cols=268 Identities=23% Similarity=0.319 Sum_probs=213.1
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEE-ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC-
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE- 237 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~- 237 (468)
....++|.+.+.||+|||+-||.+. ..++..+|+|++.... . ...+..++|++..++++||||+++++++..+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~---~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-Q---EDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-h---HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 3445889999999999999999998 5678999999987654 2 45677899999999999999999999986544
Q ss_pred ----cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEE
Q 012214 238 ----VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKV 313 (468)
Q Consensus 238 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl 313 (468)
..|++++|...|||.+.+....... ..+++.+++.|+.+|++||.+||+.. ++++||||||.|||+.+.+.++|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEE
Confidence 4899999999999999998765333 36999999999999999999999987 68999999999999999999999
Q ss_pred EecCCcccccCCCcee--------eecccccCCccCccccc---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 012214 314 ADFGTSKFIAMDQTHV--------TTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE 382 (468)
Q Consensus 314 ~DfGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~ 382 (468)
.|||.++..+-.-... -....-|..|.|||.+. +..+++++|||||||+||+|+.|..||...-. ...
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~Gg 249 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGG 249 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCC
Confidence 9999987543211110 11234688999999875 46788999999999999999999999954211 111
Q ss_pred hhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 383 NVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
.. ...+...++..+.....++.+.+++.+|++.||.+||++.+++..++.+.
T Consensus 250 Sl--------------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 SL--------------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eE--------------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11 01112222222223336779999999999999999999999999998764
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=320.19 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=205.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.++|++.+.||+|++|.||++...+++.||+|.++.... ..+++.+|+.++++++|+||+++++++......+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 466888999999999999999987788899998865322 235688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++..
T Consensus 80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 80 TELMKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred eecccCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 99999999999997632 235899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.............+..|+|||++.+..++.++||||||+++|||++ |+.||... ... ............
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-----~~~---~~~~~~~~~~~~-- 223 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM-----TNA---EVLQQVDQGYRM-- 223 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-----CHH---HHHHHHHcCCCC--
Confidence 5332222222233467999999999999999999999999999999 88887421 111 111111111110
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
..+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 224 --------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 --------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11223445789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=330.18 Aligned_cols=249 Identities=27% Similarity=0.376 Sum_probs=206.6
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
..|...+.||+|.||.||+|.+ +.++.||+|++...... ..+++...|+.++.+++++||.+++|.+..+..++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~---deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE---DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc---hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 3466668899999999999995 46889999999876555 5567888999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
||||.+|++.+.|.... .+.+..+.-|+.++..|+.|||+++ .+|||||+.|||+..+|.+||+|||.+-..
T Consensus 90 Mey~~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql 161 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQL 161 (467)
T ss_pred HHHhcCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeee
Confidence 99999999999997632 3467777789999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
....... ...+||+-|||||++.+..|+.|+||||||++.+||++|.+|+..... .+..-+
T Consensus 162 ~~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP------------------mrvlfl 222 (467)
T KOG0201|consen 162 TNTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP------------------MRVLFL 222 (467)
T ss_pred echhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc------------------ceEEEe
Confidence 6544433 567899999999999998999999999999999999999999743111 000111
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+............+..+.+++..||+.||+.|||+.++++
T Consensus 223 Ipk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 223 IPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1111111112255667999999999999999999999986
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=324.34 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=199.7
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||.||++... +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV-IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 36888899999999999999965 688999998864321 1123456688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 80 MEYVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL 151 (291)
T ss_pred EeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence 99999999999997532 4889999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||.... .. ..... ......
T Consensus 152 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-----~~---~~~~~-i~~~~~--- 215 (291)
T cd05612 152 RDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN-----PF---GIYEK-ILAGKL--- 215 (291)
T ss_pred cCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HH---HHHHH-HHhCCc---
Confidence 432 123468999999999999889999999999999999999999985311 11 11111 111110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT-----MEEVSME 443 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 443 (468)
..+...+..+.+++.+||+.||.+||+ +.++++.
T Consensus 216 -------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 -------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011223447889999999999999995 7777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=337.57 Aligned_cols=251 Identities=30% Similarity=0.480 Sum_probs=206.1
Q ss_pred cccCHHHHHHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEee
Q 012214 152 KLFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231 (468)
Q Consensus 152 ~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g 231 (468)
..+++++|.. .+-||.|+.|.||+|++. ++.||||+++.-. ..+|.-|++|+|+||+.+.|
T Consensus 119 WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-----------ETdIKHLRkLkH~NII~FkG 179 (904)
T KOG4721|consen 119 WEIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-----------ETDIKHLRKLKHPNIITFKG 179 (904)
T ss_pred ccCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhhh-----------hhhHHHHHhccCcceeeEee
Confidence 4455666533 456999999999999996 6889999765311 14688899999999999999
Q ss_pred eeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcE
Q 012214 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA 311 (468)
Q Consensus 232 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~ 311 (468)
+|......++|||||..|-|...|+... +++......|..+||.||.|||.+. |||||||.-||||..+..+
T Consensus 180 VCtqsPcyCIiMEfCa~GqL~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~V 251 (904)
T KOG4721|consen 180 VCTQSPCYCIIMEFCAQGQLYEVLKAGR-----PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVV 251 (904)
T ss_pred eecCCceeEEeeeccccccHHHHHhccC-----ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceE
Confidence 9999999999999999999999997643 5888899999999999999999999 9999999999999999999
Q ss_pred EEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHH
Q 012214 312 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391 (468)
Q Consensus 312 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (468)
||+|||-++......+ .-..+||..|||||++.+.+.+.|+|||||||+||||+||..||..-.+. +.++
T Consensus 252 KIsDFGTS~e~~~~ST--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss--------AIIw 321 (904)
T KOG4721|consen 252 KISDFGTSKELSDKST--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS--------AIIW 321 (904)
T ss_pred EeccccchHhhhhhhh--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh--------eeEE
Confidence 9999999987654422 22367999999999999999999999999999999999999998531110 0000
Q ss_pred HHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
.+.. ..+....+..++..+.-|+++||+..|..||++.+++..|+-..
T Consensus 322 -GVGs--------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 322 -GVGS--------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred -eccC--------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 0011 11233346677788999999999999999999999999997543
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=315.47 Aligned_cols=251 Identities=28% Similarity=0.413 Sum_probs=201.3
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
++|.+.+.||+|+||.||++..+++..+|+|.+..... ..+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 45778889999999999999988888899998764322 2356889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||.++...
T Consensus 79 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 79 EFMENGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred EcCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 9999999999986532 24889999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...........++..|+|||++.+..++.++||||||+++|||++ |+.||... ... .............
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~-----~~~---~~~~~i~~~~~~~-- 221 (256)
T cd05114 152 DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK-----SNY---EVVEMISRGFRLY-- 221 (256)
T ss_pred CCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC-----CHH---HHHHHHHCCCCCC--
Confidence 333222233345678999999998889999999999999999999 88887431 111 1111111111100
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 444 (468)
.+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 222 --------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 --------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0112234789999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=327.56 Aligned_cols=250 Identities=25% Similarity=0.323 Sum_probs=201.3
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
..++|+..+.||+|+||.||+++.+ +|..+|+|+++.. .-....+++....|-.+|...++|.||+|+-.|.+.+.+|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS-~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKS-EMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHH-HHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 4588999999999999999999954 6999999999874 3334466788999999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
|||||++||++..+|.... .++++.+...+.+++-|+..||+.| +|||||||+|+|||..|++||+||||+.
T Consensus 218 LiMEylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccc
Confidence 9999999999999997633 5999999999999999999999999 9999999999999999999999999985
Q ss_pred cccC-----------------------CCc----ee-------------------eecccccCCccCccccccCCCCCcc
Q 012214 321 FIAM-----------------------DQT----HV-------------------TTKIQGTFGYLDPEYHQSSQLTDKS 354 (468)
Q Consensus 321 ~~~~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~s~ks 354 (468)
-+.. +.. .. ....+|||.|+|||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 3211 000 00 0124699999999999999999999
Q ss_pred cHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCC
Q 012214 355 DVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKR 434 (468)
Q Consensus 355 DVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~R 434 (468)
|.||||||+|||+.|.+||.. +.+.+...-...+...+..+ .....+.+..+||.+|+. ||++|
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s--~tp~~T~rkI~nwr~~l~fP-------------~~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCS--ETPQETYRKIVNWRETLKFP-------------EEVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHHHhhhccCC-------------CcCcccHHHHHHHHHHhc-CHHHh
Confidence 999999999999999999853 22221111111111111111 112233578899999999 99999
Q ss_pred CC
Q 012214 435 PT 436 (468)
Q Consensus 435 Pt 436 (468)
..
T Consensus 434 LG 435 (550)
T KOG0605|consen 434 LG 435 (550)
T ss_pred cC
Confidence 87
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=335.98 Aligned_cols=265 Identities=25% Similarity=0.349 Sum_probs=207.3
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeec
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCL 234 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~ 234 (468)
..++|.+.+.||+|+||.||+|... .+..||||++...... ...+.+.+|+.+++++. ||||++++++|.
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS---SEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh---HHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3578899999999999999999852 1346999998754333 33467999999999996 999999999999
Q ss_pred cCCcceeEeeecCCCChhhHhhhcccC-----------------------------------------------------
Q 012214 235 ETEVPLLVYEFIPNGTLYQHLHDRHQN----------------------------------------------------- 261 (468)
Q Consensus 235 ~~~~~~lV~E~~~~gsL~~~l~~~~~~----------------------------------------------------- 261 (468)
+....++||||+++|+|.+++......
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 999999999999999999988653210
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCE
Q 012214 262 --------------------------------------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNI 303 (468)
Q Consensus 262 --------------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NI 303 (468)
....+++..+..++.||+.||+|||+.+ |+|+||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence 0124788899999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 012214 304 LLDQRYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQ 381 (468)
Q Consensus 304 Ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~ 381 (468)
|+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-- 346 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-- 346 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--
Confidence 9999999999999999865433222 1222346788999999999999999999999999999997 88887431100
Q ss_pred chhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 382 ENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
..+......... ...+...+..+.+++.+||+.+|++|||+.+|.++|+.+..
T Consensus 347 ------~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 ------STFYNKIKSGYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ------HHHHHHHhcCCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 011111111100 01122345578999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=329.87 Aligned_cols=259 Identities=23% Similarity=0.417 Sum_probs=203.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCc----EEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGR----IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
++|+..+.||+|+||.||+|.+. ++. .||+|+++..... ...+++.+|+.+++.++||||++++|+|... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP---KANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 56889999999999999999853 333 4899988653332 3446788999999999999999999999764 5
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++++||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~ 155 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGL 155 (316)
T ss_pred ceeeeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccc
Confidence 789999999999999997632 24888999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 319 SKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 319 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||... .. . ........
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~---~~--~----~~~~~~~~ 226 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PA--S----EISSILEK 226 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---CH--H----HHHHHHhC
Confidence 98765433322 222334678999999999999999999999999999998 99987421 00 0 01111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
... ...+..++..+.+++.+||+.+|++|||+.+++..|..+....
T Consensus 227 ~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 227 GER---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 100 0011223447889999999999999999999999998776544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=317.43 Aligned_cols=269 Identities=27% Similarity=0.380 Sum_probs=203.3
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc--CCCceeeEeeeeccCC----
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI--NHRNVVKLLGCCLETE---- 237 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l--~h~niv~l~g~~~~~~---- 237 (468)
...+..+.||+|.||.||+|.+. ++.||||++.. ...+.|.+|-++.+.. +|+||+++++.-....
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~-------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE-------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH-------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 34455677999999999999986 59999999875 4456788888877664 8999999998765433
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCEEecCCCCCCEEEcCCCcE
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA------TSSPIYHRDIKSTNILLDQRYRA 311 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------~~~~iiH~DLkp~NILl~~~~~~ 311 (468)
..+||+||.+.|||.++|..+ .++|....+|+..+++||+|||+. .+++|+|||||.+||||..|+++
T Consensus 282 eywLVt~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 789999999999999999873 499999999999999999999965 36789999999999999999999
Q ss_pred EEEecCCcccccCCCce-eeecccccCCccCccccccC-CCC-----CcccHHHHHHHHHHHHhCCCCCCCCCCCccc--
Q 012214 312 KVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSS-QLT-----DKSDVYSFGVVLVELLTGKKPIFWAGNTSQE-- 382 (468)
Q Consensus 312 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s-----~ksDVwSlGvll~el~tG~~p~~~~~~~~~~-- 382 (468)
.|+|||+|..+...... .....+||.+|||||++.+. .+. .+.||||+|.+||||++...-++. +..+.-
T Consensus 356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yql 434 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQL 434 (534)
T ss_pred EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccC
Confidence 99999999987644332 23346799999999998873 222 257999999999999996544321 111111
Q ss_pred --------hhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 383 --------NVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 383 --------~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
...+.+.....++...-+.+.+.-..+ .....+++.+..||..||+.|.|+.=|.+++..+....
T Consensus 435 pfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 435 PFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred chhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 011122222222222223333333222 33457899999999999999999999999888776554
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=329.43 Aligned_cols=247 Identities=26% Similarity=0.351 Sum_probs=199.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||++... +++.||+|++..... ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI-LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 67888999999999999999965 588999998864321 1123456788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 97 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EcCCCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 99999999999997632 4788999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
.... ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... . .... .......+.
T Consensus 169 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~---~~~~-~~i~~~~~~-- 233 (329)
T PTZ00263 169 PDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-----P---FRIY-EKILAGRLK-- 233 (329)
T ss_pred CCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC-----H---HHHH-HHHhcCCcC--
Confidence 4322 23468999999999999999999999999999999999999984311 0 0111 111111110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT-----MEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 442 (468)
.+...+..+.+|+.+||+.||.+||+ +.+++.
T Consensus 234 --------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 234 --------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred --------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 01122346789999999999999997 566553
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=330.66 Aligned_cols=256 Identities=25% Similarity=0.299 Sum_probs=203.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||+|... +++.||+|++...... .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 46888999999999999999965 5889999998653211 123456788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 80 ~e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 80 MEYVPGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGI 151 (333)
T ss_pred EeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence 99999999999996532 4889999999999999999999999 999999999999999999999999999755
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..||... ...+ .......+.........
T Consensus 152 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~--~~~~---~~~~i~~~~~~~~~~~~ 222 (333)
T cd05600 152 VT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS--TPNE---TWENLKYWKETLQRPVY 222 (333)
T ss_pred cc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC--CHHH---HHHHHHhccccccCCCC
Confidence 33 223456899999999999999999999999999999999999998531 1111 11111111000000000
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
.+ .....+..+.+++.+||+.+|.+|||+.++++.
T Consensus 223 ~~------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 DD------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred Cc------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 012335578899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=327.22 Aligned_cols=244 Identities=24% Similarity=0.303 Sum_probs=195.5
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 248 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 248 (468)
+.||+|+||.||++... +|+.||+|++...... .......+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 6899999988653211 113446688999999999999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCce
Q 012214 249 GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH 328 (468)
Q Consensus 249 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 328 (468)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~ 150 (323)
T cd05571 80 GELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-A 150 (323)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-C
Confidence 9999998653 25899999999999999999999999 9999999999999999999999999987532221 1
Q ss_pred eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHh
Q 012214 329 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLM 408 (468)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 408 (468)
......||+.|+|||++.+..++.++|||||||++|||++|+.||... +.. ... ........
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-----~~~---~~~-~~~~~~~~--------- 212 (323)
T cd05571 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHE---KLF-ELILMEEI--------- 212 (323)
T ss_pred cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC-----CHH---HHH-HHHHcCCC---------
Confidence 223356999999999999999999999999999999999999998531 100 111 11111110
Q ss_pred hhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 409 KLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 409 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
..+...+..+.+++.+||+.||++|| ++.++++
T Consensus 213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 01223445788999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=321.21 Aligned_cols=259 Identities=27% Similarity=0.450 Sum_probs=206.1
Q ss_pred cCCCCCceeeecCcEEEEEEEecC------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 237 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 237 (468)
++|.+.+.||+|+||.||+|...+ +..||+|.+...... ...+.+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN---DARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH---HHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 457788899999999999998632 478999998764333 24468899999999999999999999999999
Q ss_pred cceeEeeecCCCChhhHhhhccc---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQ---------NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR 308 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~ 308 (468)
..++||||+++++|.+++..... .....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCC
Confidence 99999999999999999976431 22345889999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhch
Q 012214 309 YRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSL 386 (468)
Q Consensus 309 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~ 386 (468)
+.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-----~~- 232 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-----EE- 232 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HH-
Confidence 99999999998755332221 1223345788999999999999999999999999999998 9999743111 11
Q ss_pred HHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 387 AAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 387 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
............ .+...+..+.+++.+||+.||++|||+.||++.|++
T Consensus 233 ---~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 233 ---VIECITQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ---HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111111111111 112344578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=332.75 Aligned_cols=261 Identities=21% Similarity=0.285 Sum_probs=197.1
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||++... +++.||+|.... ..+.+|+.++++++||||+++++++......++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 367999999999999999999964 688999996432 246789999999999999999999999899999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
|+|++. ++|..++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 161 v~e~~~-~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred EEecCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 999985 68888886532 4889999999999999999999999 99999999999999999999999999975
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccc--hhchHHHHHHHhhcc--
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE--NVSLAAYFVHSMRKN-- 397 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~-- 397 (468)
.............||+.|+|||++.+..++.++|||||||++|||++|+.|+......... ...............
T Consensus 232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~ 311 (391)
T PHA03212 232 PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN 311 (391)
T ss_pred cccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence 4332222233457999999999999999999999999999999999999887532211110 000001111100000
Q ss_pred cc----chhcchHH---------------hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RL----HDILDDQL---------------MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~----~~~~d~~l---------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.. ...++... ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 00000000 00001134557899999999999999999999985
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=364.98 Aligned_cols=265 Identities=27% Similarity=0.436 Sum_probs=206.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
...|...+.||+|+||.||+|.. .++..||||++...... ...|+..+++++||||++++|+|.+....++
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI--------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc--------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence 45677888999999999999996 57899999988643221 1245788999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++|+|.+++.. ++|..+..|+.||++||+|||+.+.++|+||||||+||+++.++.+++. ||.+..
T Consensus 761 v~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 761 IHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred EEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 9999999999999953 8899999999999999999996655559999999999999999988876 666543
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.... ....+|..|+|||++.+..++.++|||||||++|||+||+.||..... .......+............
T Consensus 832 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~ 903 (968)
T PLN00113 832 LCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG---VHGSIVEWARYCYSDCHLDM 903 (968)
T ss_pred cccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC---CCCcHHHHHHHhcCccchhh
Confidence 3211 123578999999999999999999999999999999999999843211 11122222222222233333
Q ss_pred hcchHHhh--hchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCc
Q 012214 402 ILDDQLMK--LGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452 (468)
Q Consensus 402 ~~d~~l~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 452 (468)
+.++.+.. ..+.....++.+++.+||+.||++||||.|++++|+++.....
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 44443322 1234456678899999999999999999999999999876543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=320.86 Aligned_cols=261 Identities=26% Similarity=0.408 Sum_probs=204.3
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE 235 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~ 235 (468)
.+++|++.+.||+|+||.||+|... .+..||+|++...... ....++.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM---RERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4678999999999999999998753 2567999987643322 334578899999999999999999999999
Q ss_pred CCcceeEeeecCCCChhhHhhhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQN-----EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR 310 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~ 310 (468)
....++||||+++++|.+++...... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCC
Confidence 99999999999999999998753221 1234688899999999999999999998 999999999999999999
Q ss_pred EEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHH
Q 012214 311 AKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 311 ~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~ 388 (468)
++|+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||... .. .
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~--~~-------~ 228 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM--SN-------E 228 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--CH-------H
Confidence 9999999987654332221 122345778999999999899999999999999999999 67787431 11 1
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
............. .+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 229 ~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 229 QVLRFVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111111111111 112334578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=326.24 Aligned_cols=263 Identities=27% Similarity=0.388 Sum_probs=203.6
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|++.+.||+|+||.||++... ++..+|+|.+...... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH---HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 367899999999999999999965 6888999988754332 334678999999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA-TSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
||||+++++|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++.
T Consensus 81 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (331)
T ss_pred EeecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccc
Confidence 999999999999997532 488999999999999999999985 5 9999999999999999999999999987
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh---c-
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR---K- 396 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~---~- 396 (468)
...... .....||..|+|||.+.+..++.++|||||||++|||++|+.||..... ......+..... .
T Consensus 153 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~ 224 (331)
T cd06649 153 QLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-----KELEAIFGRPVVDGEEG 224 (331)
T ss_pred cccccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHhcccccccccC
Confidence 553321 2334689999999999999999999999999999999999999853211 000000000000 0
Q ss_pred --------------------------cccchhcchHH----hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 012214 397 --------------------------NRLHDILDDQL----MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444 (468)
Q Consensus 397 --------------------------~~~~~~~d~~l----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 444 (468)
....+..+... ........+..+.+|+.+||+.||++|||+.|+++.-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000000000 0001112456799999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=321.03 Aligned_cols=262 Identities=27% Similarity=0.394 Sum_probs=206.0
Q ss_pred CCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 165 HFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
+|++.+.||+|+||.||+|... ....+++|.+...... .....+.+|+.+++.++||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS---SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH---HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence 4678889999999999999853 2357899987754433 345678999999999999999999999999999
Q ss_pred ceeEeeecCCCChhhHhhhccc-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQ-------------------NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIK 299 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLk 299 (468)
.++++||+.+++|.+++..... ....++++..++.++.|++.||.|||+.+ ++|||||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dik 154 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLA 154 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhh
Confidence 9999999999999999865321 11235889999999999999999999999 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q 012214 300 STNILLDQRYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAG 377 (468)
Q Consensus 300 p~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~ 377 (468)
|+|||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~- 233 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI- 233 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC-
Confidence 999999999999999999997654332221 222345678999999988889999999999999999998 88887421
Q ss_pred CCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 378 NTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
.. ........... ....+...+..+.+++.+||+.+|++||++.++++.|+++..+
T Consensus 234 -~~-------~~~~~~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 234 -AP-------ERLFNLLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred -CH-------HHHHHHHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 11 11111111110 0111223445789999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=334.03 Aligned_cols=250 Identities=28% Similarity=0.402 Sum_probs=206.1
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.-|...+.||.|+-|.|-+|++ .+|+.+|||++.....- .......+.+|+.+|+.+.||||+++++++.+...+|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~-s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL-SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeecccccc-ccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 4577888999999999999995 57999999998764211 112334567899999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
.||+++|-|.+++..++ ++++.++.+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||+|.+.
T Consensus 91 lEyv~gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE 162 (786)
T ss_pred EEecCCchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc
Confidence 99999999999997754 5899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCceeeecccccCCccCccccccCCCC-CcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
..+.- ....+|.+.|.|||.+.+.+|. .++||||.||+||.|+||+.||+. .++.. ....++.+..+
T Consensus 163 ~~gkl--LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD--------dNir~-LLlKV~~G~f~- 230 (786)
T KOG0588|consen 163 VPGKL--LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD--------DNIRV-LLLKVQRGVFE- 230 (786)
T ss_pred cCCcc--ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC--------ccHHH-HHHHHHcCccc-
Confidence 54433 3346899999999999999886 589999999999999999999952 11111 11222222211
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
.|.+.+.+..+|+.+||..||+.|.|+.||++.
T Consensus 231 ---------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 231 ---------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---------CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 133445578999999999999999999999984
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=319.37 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=208.1
Q ss_pred HhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
...+|...+.||.|+||.||+|...++..+++|.+..... .....+.+|+.+++.++|+||+++++++.+....++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL----LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch----hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 3456888899999999999999988899999999875422 234568899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||.+..
T Consensus 80 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 80 ITELMEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARL 153 (261)
T ss_pred EEeecccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhh
Confidence 99999999999999763 2245899999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
...... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... .. ..+........
T Consensus 154 ~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-----~~---~~~~~~~~~~~-- 222 (261)
T cd05148 154 IKEDVY-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-----NH---EVYDQITAGYR-- 222 (261)
T ss_pred cCCccc-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-----HH---HHHHHHHhCCc--
Confidence 643322 2223346778999999998899999999999999999998 888874311 11 11111111100
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
...+...++.+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 223 --------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 --------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111233445789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=328.22 Aligned_cols=255 Identities=24% Similarity=0.304 Sum_probs=199.0
Q ss_pred CCCCCceeeecCcEEEEEEEe----cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcc
Q 012214 165 HFNANRILGQGGQGTVYKGML----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~ 239 (468)
+|++.+.||+|+||.||++.. .+++.||+|++............+.+..|+.++..+ +|+||+++++++.+....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 357899999886432222223445678899999999 599999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 99999999999999986532 4889999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
+..............||..|+|||++.+. .++.++|||||||++|||++|+.||........ ...+........
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~~~~~~~~~~ 227 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-----QSEVSRRILKCD 227 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-----HHHHHHHHhcCC
Confidence 86544333333345799999999998874 478899999999999999999999853221111 111111111100
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
...+...+..+.+++.+||+.||++|| +++++++
T Consensus 228 ----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 ----------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 001122344688999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=316.38 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=201.6
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
++|.+.+.||+|+||.||.+...++..+|+|.+..... ..++|.+|+.++++++||||+++++++.+....+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 45777889999999999999887777799998765322 2356889999999999999999999999988999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+.+++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||.++...
T Consensus 79 e~~~~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 79 EYMSNGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVL 151 (256)
T ss_pred EcCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecC
Confidence 9999999999987532 25899999999999999999999999 9999999999999999999999999988654
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||.... .. ..... .......
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----~~---~~~~~-~~~~~~~-- 220 (256)
T cd05113 152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-----NS---ETVEK-VSQGLRL-- 220 (256)
T ss_pred CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC-----HH---HHHHH-HhcCCCC--
Confidence 433222223345678999999998889999999999999999998 998874311 00 11111 1111100
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
..+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 221 -------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 -------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001123457899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=323.67 Aligned_cols=268 Identities=26% Similarity=0.359 Sum_probs=206.5
Q ss_pred ccCHHHHHHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHH----------HHHHHHHHHHHHHHHhc
Q 012214 153 LFSSKELDKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEE----------LLKLEEFINEIVILSQI 221 (468)
Q Consensus 153 ~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~----------~~~~~~~~~Ei~~l~~l 221 (468)
.+...+-.+..|+|.+.+.||+|.||.|-+++.. +++.||||++........ ...++...+|+.+|+++
T Consensus 86 ~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl 165 (576)
T KOG0585|consen 86 RYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL 165 (576)
T ss_pred eecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc
Confidence 4444455566799999999999999999999954 799999999865322110 11245788999999999
Q ss_pred CCCceeeEeeeecc--CCcceeEeeecCCCChhhHhhhcccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCC
Q 012214 222 NHRNVVKLLGCCLE--TEVPLLVYEFIPNGTLYQHLHDRHQNEEFP-LTWEMRLRIATEVAGALAYLHSATSSPIYHRDI 298 (468)
Q Consensus 222 ~h~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DL 298 (468)
+|||||+|+++..+ .+..|||+|||..|.+...=. ..+ +++.++++++.++..||+|||.++ ||||||
T Consensus 166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~------d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDI 236 (576)
T KOG0585|consen 166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP------DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDI 236 (576)
T ss_pred CCcCeeEEEEeecCcccCceEEEEEeccCCccccCCC------CcccccHHHHHHHHHHHHHHHHHHHhcC---eecccc
Confidence 99999999999865 468899999999887643321 223 899999999999999999999999 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCcccccCCCc----eeeecccccCCccCccccccCC----CCCcccHHHHHHHHHHHHhCC
Q 012214 299 KSTNILLDQRYRAKVADFGTSKFIAMDQT----HVTTKIQGTFGYLDPEYHQSSQ----LTDKSDVYSFGVVLVELLTGK 370 (468)
Q Consensus 299 kp~NILl~~~~~~kl~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlGvll~el~tG~ 370 (468)
||+|+||+++|++||+|||.+........ ......+||+.|+|||...++. ...+.||||+||+||.|+.|+
T Consensus 237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 99999999999999999999986632211 1123367999999999887743 234679999999999999999
Q ss_pred CCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 371 KPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 371 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
.||.. ......+. .++...+.....++..+.+.+||.+||+.||+.|.+..+|.....-
T Consensus 317 ~PF~~--------~~~~~l~~---------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 317 LPFFD--------DFELELFD---------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred CCccc--------chHHHHHH---------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 99853 11111121 2222222222233556789999999999999999999999876543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=320.84 Aligned_cols=262 Identities=21% Similarity=0.281 Sum_probs=197.2
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||+|... +++.||+|+++..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC---CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 56888999999999999999865 6889999988653222 2234577899999999999999999999998899999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||++ ++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 82 ~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 82 FEYLD-SDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAK 153 (288)
T ss_pred EeCCC-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeec
Confidence 99997 48988886532 24788999999999999999999999 999999999999999999999999998754
Q ss_pred cCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh------
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR------ 395 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~------ 395 (468)
..... ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||... ...+.. ........
T Consensus 154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~--~~~~~~---~~~~~~~~~~~~~~ 227 (288)
T cd07871 154 SVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS--TVKEEL---HLIFRLLGTPTEET 227 (288)
T ss_pred cCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHH---HHHHHHhCCCChHH
Confidence 33221 1223457899999998876 56899999999999999999999998531 111111 11111000
Q ss_pred ------ccccchhcchHHh----hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 396 ------KNRLHDILDDQLM----KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 396 ------~~~~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.........+... .......+.++.+|+.+||+.||.+|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000 0001123456889999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=318.42 Aligned_cols=268 Identities=29% Similarity=0.387 Sum_probs=201.9
Q ss_pred CCCCceeeecCcEEEEEEEe-----cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC--Cc
Q 012214 166 FNANRILGQGGQGTVYKGML-----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EV 238 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~ 238 (468)
|...+.||+|+||+||++.. .+++.||+|........ .....+.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ---QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 37889999999999988653 35778999988754322 3346788999999999999999999988653 35
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.+++|||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~ 153 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGL 153 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccc
Confidence 78999999999999998652 4899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCcee--eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 319 SKFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 319 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
++......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+........+.. .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~ 230 (283)
T cd05080 154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI---GPKQGQMTV 230 (283)
T ss_pred ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh---cccccccch
Confidence 98664332211 1223356679999999988999999999999999999999999743211000000 000000000
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
..+.+..+.......+...+..+.+++.+||+.+|++|||+++++++|+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0111111111111123344568999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=318.14 Aligned_cols=263 Identities=23% Similarity=0.327 Sum_probs=193.3
Q ss_pred cCCCCCceeeecCcEEEEEEEec--CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc---CCCceeeEeeeec----
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE--DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI---NHRNVVKLLGCCL---- 234 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~---- 234 (468)
++|.+.+.||+|+||.||++... +++.||+|.+....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC--CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 36888999999999999999863 46889999876533221 1223455677766665 6999999999885
Q ss_pred -cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEE
Q 012214 235 -ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKV 313 (468)
Q Consensus 235 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl 313 (468)
.....++|+||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl 151 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKL 151 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEE
Confidence 2456789999996 68999887532 235899999999999999999999999 999999999999999999999
Q ss_pred EecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH
Q 012214 314 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 314 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||..... . .........
T Consensus 152 ~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~--~---~~~~~i~~~ 224 (290)
T cd07862 152 ADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--V---DQLGKILDV 224 (290)
T ss_pred ccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH--H---HHHHHHHHH
Confidence 999999765433 223345689999999999998999999999999999999999999853211 1 111111111
Q ss_pred hhcc---ccch---hcchHH-------hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 394 MRKN---RLHD---ILDDQL-------MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 394 ~~~~---~~~~---~~d~~l-------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.... .+.. +....+ ........+..+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 225 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 1000 0000 000000 00001123456789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=343.33 Aligned_cols=269 Identities=25% Similarity=0.361 Sum_probs=221.1
Q ss_pred HHhcCCCCCceeeecCcEEEEEEEecCC-cEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeee-ecc--
Q 012214 161 KATNHFNANRILGQGGQGTVYKGMLEDG-RIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGC-CLE-- 235 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~-~~~-- 235 (468)
....++++.+.|.+|||+.||.+.+..+ ..+|+|++-.. +. ..++...+|+++|+.|. |+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de---~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DE---EALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CH---HHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 3445678889999999999999997665 99999998764 33 56788999999999996 9999999993 322
Q ss_pred ----CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcE
Q 012214 236 ----TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA 311 (468)
Q Consensus 236 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~ 311 (468)
.-..+|.||||.+|+|-++++.+... .|++.++++|+.|+++|+++||... +||||||||-+||||+.++..
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~ 185 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNY 185 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCE
Confidence 12567999999999999999986543 3999999999999999999999987 889999999999999999999
Q ss_pred EEEecCCcccccCCC-cee-------eecccccCCccCcccc---ccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCc
Q 012214 312 KVADFGTSKFIAMDQ-THV-------TTKIQGTFGYLDPEYH---QSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTS 380 (468)
Q Consensus 312 kl~DfGla~~~~~~~-~~~-------~~~~~gt~~y~aPE~~---~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~ 380 (468)
||||||.|.-..... ... .-....|+.|.|||++ .+.++++|+|||+|||+||-|+....||...+.
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-- 263 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-- 263 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--
Confidence 999999987543221 111 0112368999999976 468899999999999999999999999954221
Q ss_pred cchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCchhhhHH
Q 012214 381 QENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKRAMF 458 (468)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~ 458 (468)
..|++..........++..|.+||..||+.||++||++-+|++.+-.|........+.+
T Consensus 264 -------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 264 -------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred -------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 23444444444556788899999999999999999999999999999998887777666
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=311.81 Aligned_cols=264 Identities=22% Similarity=0.340 Sum_probs=209.3
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||+|... +++.||||.+...... +......+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM-DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC-CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 57888999999999999999954 6899999987542211 113456788999999999999999999999998999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 81 LELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 999999999998865322 2235888999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||....... . ..............
T Consensus 157 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~------~-~~~~~~~~~~~~~~ 228 (267)
T cd08228 157 SSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------F-SLCQKIEQCDYPPL 228 (267)
T ss_pred cchhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH------H-HHHHHHhcCCCCCC
Confidence 432221 223458889999999998889999999999999999999999985321110 1 11111111111111
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
.....+..+.+++.+||+.+|++|||+.+|++.|++++
T Consensus 229 --------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 --------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 11234457899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=323.59 Aligned_cols=242 Identities=26% Similarity=0.302 Sum_probs=192.4
Q ss_pred eeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCCCC
Q 012214 172 LGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 250 (468)
Q Consensus 172 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 250 (468)
||+|+||.||++... +++.||+|++...... .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 699999999999965 5889999988643211 12345678899999999999999999999999999999999999999
Q ss_pred hhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCceee
Q 012214 251 LYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT 330 (468)
Q Consensus 251 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 330 (468)
|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 80 L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 150 (312)
T cd05585 80 LFHHLQRE-----GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKT 150 (312)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccc
Confidence 99999653 24889999999999999999999999 9999999999999999999999999987543222 223
Q ss_pred ecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhh
Q 012214 331 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKL 410 (468)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 410 (468)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ....+...... .. .
T Consensus 151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~~-~~----------~ 211 (312)
T cd05585 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQE-PL----------R 211 (312)
T ss_pred ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcC-CC----------C
Confidence 34568999999999999999999999999999999999999985310 11111111111 10 1
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 411 GVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 411 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+...+..+.+++.+||+.||.+||++..+.+
T Consensus 212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence 12233457889999999999999986543333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=321.40 Aligned_cols=264 Identities=26% Similarity=0.390 Sum_probs=208.1
Q ss_pred HHhcCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeee
Q 012214 161 KATNHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCC 233 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~ 233 (468)
...++|+..+.||+|+||.||++... ....+|+|.+...... ....++.+|+.++..+ +|+||+++++++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH---HHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34467888999999999999999853 2367999988754333 3446788999999999 899999999999
Q ss_pred ccCCcceeEeeecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCC
Q 012214 234 LETEVPLLVYEFIPNGTLYQHLHDRHQ-----------NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTN 302 (468)
Q Consensus 234 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~N 302 (468)
......+++|||+++|+|.+++..... .....+++..++.++.|++.||+|||+.+ |+|+||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceee
Confidence 999999999999999999999975321 12346899999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 012214 303 ILLDQRYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTS 380 (468)
Q Consensus 303 ILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~ 380 (468)
|++++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--- 239 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--- 239 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC---
Confidence 999999999999999998664432221 222345678999999998899999999999999999998 888874210
Q ss_pred cchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 381 QENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
....+ ......... ..+...+..+.+|+.+||+.+|++|||+.|+++.|+.+.
T Consensus 240 -----~~~~~-~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 240 -----VEELF-KLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -----HHHHH-HHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111 111111110 112233457899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.52 Aligned_cols=264 Identities=21% Similarity=0.286 Sum_probs=196.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||+|... +++.||+|++...... .....+.+|+.+++.++||||+++++++.+....++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE---GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc---ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 367899999999999999999965 6889999998654322 222456789999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+. ++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 81 v~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 152 (303)
T cd07869 81 VFEYVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA 152 (303)
T ss_pred EEECCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCccee
Confidence 999995 68888876532 24888999999999999999999999 99999999999999999999999999875
Q ss_pred ccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc--
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR-- 398 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 398 (468)
...... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|..||....+. ...............
T Consensus 153 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~ 227 (303)
T cd07869 153 KSVPSH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI----QDQLERIFLVLGTPNED 227 (303)
T ss_pred ccCCCc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH----HHHHHHHHHHhCCCChh
Confidence 432221 1233457899999998875 45788999999999999999999998532110 000011100000000
Q ss_pred -c------chh--------cchHHhh-hchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 -L------HDI--------LDDQLMK-LGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 -~------~~~--------~d~~l~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+ ... ....+.. ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 000 0000000 000012346789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=314.07 Aligned_cols=251 Identities=26% Similarity=0.395 Sum_probs=200.4
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
.+|++.+.||+|+||.||++..+++..+|+|.+..... ....+.+|+.+++.++||||+++++++.+....++|+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 34778889999999999999987777899998764322 2246888999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++...
T Consensus 79 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 79 EYMANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVL 151 (256)
T ss_pred ecCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecc
Confidence 9999999999997532 25899999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...........++..|+|||.+.+..++.++||||||+++|||++ |..||.... . . ...........
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~---~---~~~~~~~~~~~---- 219 (256)
T cd05059 152 DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS--N---S---EVVESVSAGYR---- 219 (256)
T ss_pred cccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC--H---H---HHHHHHHcCCc----
Confidence 332222222234567999999999999999999999999999999 788874311 1 1 11111111100
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 444 (468)
...+...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 220 ------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 ------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 011223455799999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=318.97 Aligned_cols=263 Identities=27% Similarity=0.428 Sum_probs=207.4
Q ss_pred cCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 237 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 237 (468)
++|.+.+.||+|+||.||++... ++..+|+|.+.... . .....+.+|+.++++++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-D---NARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-H---HHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 56888899999999999999742 34568999876532 2 33467899999999999999999999999999
Q ss_pred cceeEeeecCCCChhhHhhhccc--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQ--------NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY 309 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~ 309 (468)
..++|+||+++++|.+++..... .....+++..++.++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence 99999999999999999975431 12235899999999999999999999999 99999999999999999
Q ss_pred cEEEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchH
Q 012214 310 RAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLA 387 (468)
Q Consensus 310 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~ 387 (468)
.++|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.... . .
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~--~------~ 229 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--N------N 229 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--H------H
Confidence 9999999999765433221 1223345778999999998899999999999999999998 888874311 0 0
Q ss_pred HHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 388 AYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
. ............. +...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 230 ~-~~~~i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 230 E-VIECITQGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred H-HHHHHHcCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 1 1111111111110 1123447899999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=326.68 Aligned_cols=248 Identities=25% Similarity=0.334 Sum_probs=198.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEecC--CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLED--GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
.++|.+.+.||+|+||.||+|.... +..||+|++...... .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 3578999999999999999998543 368999987543211 1134567889999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 108 lv~Ey~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 9999999999999997632 4889999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
..... .....||+.|+|||++.+..++.++|||||||++|||++|..||... ... ....... ....
T Consensus 180 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~-----~~~---~~~~~i~-~~~~- 245 (340)
T PTZ00426 180 VVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN-----EPL---LIYQKIL-EGII- 245 (340)
T ss_pred ecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC-----CHH---HHHHHHh-cCCC-
Confidence 65432 12346899999999999988999999999999999999999998531 111 1111111 1110
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
..+...+..+.+++.+||+.||++|+ |++++++
T Consensus 246 ---------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 246 ---------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ---------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 01122334678999999999999995 7888765
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=326.73 Aligned_cols=264 Identities=27% Similarity=0.383 Sum_probs=205.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeecc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLE 235 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~ 235 (468)
.++|++.+.||+|+||.||+|... .++.||+|++...... ...+.+..|+.++.++ +|+||++++++|..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA---SEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH---HHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 357899999999999999999632 3578999988754333 3346678899999999 89999999998864
Q ss_pred -CCcceeEeeecCCCChhhHhhhcccC-----------------------------------------------------
Q 012214 236 -TEVPLLVYEFIPNGTLYQHLHDRHQN----------------------------------------------------- 261 (468)
Q Consensus 236 -~~~~~lV~E~~~~gsL~~~l~~~~~~----------------------------------------------------- 261 (468)
+...++++||+++++|.+++......
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 45678999999999999998653210
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCcee-eecccccC
Q 012214 262 ---EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHV-TTKIQGTF 337 (468)
Q Consensus 262 ---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~ 337 (468)
...++++..+..++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||+++.+....... .....++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 0126899999999999999999999998 9999999999999999999999999998664332222 22344677
Q ss_pred CccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHH
Q 012214 338 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQI 416 (468)
Q Consensus 338 ~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 416 (468)
.|+|||++.+..++.++|||||||++|||++ |..||..... . ..+.......... ..+....
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~--~------~~~~~~~~~~~~~---------~~~~~~~ 302 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI--D------EEFCRRLKEGTRM---------RAPEYAT 302 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc--c------HHHHHHHhccCCC---------CCCccCC
Confidence 8999999999999999999999999999998 9988743110 0 1111111111110 0122334
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 417 MTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 417 ~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
+++.+++.+||+.+|++|||+.|++++|+.+.+
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=322.98 Aligned_cols=244 Identities=25% Similarity=0.309 Sum_probs=194.6
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 248 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 248 (468)
+.||+|+||.||++... +|+.||+|++...... .......+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 46999999999999864 6899999998653221 113456778899999999999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCce
Q 012214 249 GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH 328 (468)
Q Consensus 249 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 328 (468)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~- 150 (323)
T cd05595 80 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-
Confidence 99998886532 4899999999999999999999999 99999999999999999999999999875322221
Q ss_pred eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHh
Q 012214 329 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLM 408 (468)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 408 (468)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .. ........ ...
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~---~~~~~~~~-~~~--------- 212 (323)
T cd05595 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HE---RLFELILM-EEI--------- 212 (323)
T ss_pred ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC-----HH---HHHHHHhc-CCC---------
Confidence 1233568999999999999999999999999999999999999985311 00 11111111 100
Q ss_pred hhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 409 KLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 409 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
..+...++.+.+++.+||+.||.+|| ++.++++
T Consensus 213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 01223345788999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=312.84 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=202.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.++|++.+.||+|+||.||++..+++..+|+|.+...... .+.+.+|+.++++++|+|++++++++.+ ...+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-----PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC-----HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEE
Confidence 3568889999999999999999888888999988653322 2468899999999999999999998854 567999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++...
T Consensus 79 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 79 TEYMSKGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred EEecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeec
Confidence 9999999999999752 2235899999999999999999999999 999999999999999999999999999766
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
............++..|+|||.+.+..++.++||||||+++|+|++ |..||... ... ............
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-----~~~---~~~~~~~~~~~~-- 222 (260)
T cd05070 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-----NNR---EVLEQVERGYRM-- 222 (260)
T ss_pred cCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-----CHH---HHHHHHHcCCCC--
Confidence 4433222222345678999999988899999999999999999999 88887431 111 111111111010
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
..+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 223 --------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 --------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1122345579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=317.17 Aligned_cols=259 Identities=25% Similarity=0.429 Sum_probs=203.9
Q ss_pred cCCCCCceeeecCcEEEEEEEe-----cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 164 NHFNANRILGQGGQGTVYKGML-----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
+.|++.+.||+|+||.||+|.. .++..+++|.+...... .....+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP---QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH---HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 4577888999999999999984 24678999988754333 345678899999999999999999999999999
Q ss_pred ceeEeeecCCCChhhHhhhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQ------------NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD 306 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~ 306 (468)
.++||||+++++|.+++..... .....+++..++.++.|++.||+|||+.+ ++|+||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIG 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEc
Confidence 9999999999999999864321 01234788999999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCCcccccCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchh
Q 012214 307 QRYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENV 384 (468)
Q Consensus 307 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~ 384 (468)
+++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.... .
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-----~- 232 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-----N- 232 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----H-
Confidence 999999999999976543222 22233345778999999998889999999999999999998 888874311 0
Q ss_pred chHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 385 SLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
.............. .+...+..+.+++.+||+.||++||++.+++++|.+
T Consensus 233 ---~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 ---QEVIEMVRKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111111111 122344578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=313.34 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=203.7
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.+.|++.++||+|+||.||++..++++.+|+|.+...... ...+.+|+.+++.++|+|++++++++. .+..+++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc-----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 4678889999999999999999888999999988754322 356889999999999999999999874 4568999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++...
T Consensus 79 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 79 TEYMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred EEcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeec
Confidence 99999999999986532 235899999999999999999999999 999999999999999999999999999766
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
............++..|+|||++....++.++||||||+++|||++ |+.||.... .. ............
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~---~~~~~~~~~~~~-- 222 (260)
T cd05067 153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-----NP---EVIQNLERGYRM-- 222 (260)
T ss_pred CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC-----hH---HHHHHHHcCCCC--
Confidence 5333222233446778999999999899999999999999999999 999984311 00 111111111000
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
..+...+..+.+++.+||+.+|++|||++++++.|+.
T Consensus 223 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 --------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1112234579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=313.70 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=202.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.++|.+.++||+|+||.||+|...++..||+|++..... ..+.+.+|+.+++.++|+||+++++++.+ ...++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence 356889999999999999999987777899999875322 22468899999999999999999998754 567999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||.++..
T Consensus 79 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 79 TEYMSKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred EEcCCCCcHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeec
Confidence 99999999999997532 235789999999999999999999999 999999999999999999999999999766
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
............++..|+|||+..+..++.++||||||+++|||++ |..||... ... ............
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~--~~~------~~~~~~~~~~~~-- 222 (262)
T cd05071 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNR------EVLDQVERGYRM-- 222 (262)
T ss_pred cccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--ChH------HHHHHHhcCCCC--
Confidence 5433322223446778999999998899999999999999999999 77776421 110 001111111000
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
..+...+..+.+++.+|++.+|++|||+.++++.|+..
T Consensus 223 --------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 --------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=321.67 Aligned_cols=199 Identities=29% Similarity=0.437 Sum_probs=173.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|++.++||+|+||.||++... ++..+|+|.+...... .....+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH---HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 468999999999999999999965 6888999987654332 334678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA-TSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
||||+++++|.+++.... .+++..+..++.|++.||.|||+. + ++|+||||+|||+++++.+||+|||++.
T Consensus 81 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 152 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (333)
T ss_pred EEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcch
Confidence 999999999999996532 478899999999999999999974 5 9999999999999999999999999987
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFW 375 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~ 375 (468)
...... .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 153 QLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred hhhhhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 553221 2234689999999999998899999999999999999999999853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=315.31 Aligned_cols=265 Identities=28% Similarity=0.402 Sum_probs=204.7
Q ss_pred cCCCCCceeeecCcEEEEEEEecC-----------------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCce
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED-----------------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNV 226 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni 226 (468)
++|.+.+.||+|+||.||++...+ +..||+|.+...... ...+.+.+|+.++++++||||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD---NAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH---HHHHHHHHHHHHHHhcCCCCE
Confidence 578899999999999999988542 245899988764433 445778999999999999999
Q ss_pred eeEeeeeccCCcceeEeeecCCCChhhHhhhcccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCC
Q 012214 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNE------EFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKS 300 (468)
Q Consensus 227 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp 300 (468)
+++++++......++++|++++++|.+++....... ...+++..++.++.|++.||+|||+.+ ++|+||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp 158 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLAT 158 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccch
Confidence 999999999999999999999999999997644211 226899999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh--CCCCCCCCC
Q 012214 301 TNILLDQRYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT--GKKPIFWAG 377 (468)
Q Consensus 301 ~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t--G~~p~~~~~ 377 (468)
+||+++.++.++|+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ +..||...
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~- 237 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL- 237 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc-
Confidence 9999999999999999998765433222 2233456788999999998889999999999999999998 56665321
Q ss_pred CCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 378 NTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
. ..................... ..+...+.++.+++.+||+.||++|||+.||++.|+
T Consensus 238 -~---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 238 -T---DQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred -C---hHHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 111111111111111111000 012233457999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=307.77 Aligned_cols=264 Identities=24% Similarity=0.401 Sum_probs=210.3
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||.||+|... +|+.||+|.++...... ....+.+.+|+.++++++|+|++++++++.+.+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 57889999999999999999976 78999999876422211 13356788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 81 LELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeec
Confidence 99999999999986532 22335899999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... .... .............
T Consensus 157 ~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~-~~~~~~~~~~~~~ 228 (267)
T cd08224 157 SSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYS-LCKKIEKCDYPPL 228 (267)
T ss_pred cCCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHH-HHhhhhcCCCCCC
Confidence 432221 2234578899999999988899999999999999999999999853211 1111 1111111111111
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
.....+..+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 229 --------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 --------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11134457899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=321.73 Aligned_cols=245 Identities=27% Similarity=0.341 Sum_probs=194.0
Q ss_pred ceeeecCcEEEEEEEe----cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeee
Q 012214 170 RILGQGGQGTVYKGML----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEF 245 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 245 (468)
+.||+|+||.||++.. ..++.||+|++..............+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 357899999886532222223345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 012214 246 IPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMD 325 (468)
Q Consensus 246 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 325 (468)
+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 99999999986532 4788899999999999999999999 999999999999999999999999998754322
Q ss_pred CceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcch
Q 012214 326 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDD 405 (468)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 405 (468)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ......... ...
T Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-----~---~~~~~~~~~-~~~------ 217 (323)
T cd05584 154 GT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-----R---KKTIDKILK-GKL------ 217 (323)
T ss_pred CC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-----H---HHHHHHHHc-CCC------
Confidence 22 2233568999999999999889999999999999999999999985311 0 011111111 110
Q ss_pred HHhhhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 406 QLMKLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 406 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
..+...+..+.+++.+||+.+|++|| ++.++++
T Consensus 218 ----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 ----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 01122344788999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=322.83 Aligned_cols=245 Identities=24% Similarity=0.307 Sum_probs=195.5
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 248 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 248 (468)
+.||+|+||.||++... +++.||+|++...... .......+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII-AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 6899999998653211 113456788999999999999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCce
Q 012214 249 GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH 328 (468)
Q Consensus 249 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 328 (468)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 80 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~- 150 (328)
T cd05593 80 GELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA- 150 (328)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-
Confidence 9999888653 24899999999999999999999999 99999999999999999999999999875322211
Q ss_pred eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHh
Q 012214 329 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLM 408 (468)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 408 (468)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .. ... ........
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-----~~---~~~-~~~~~~~~--------- 212 (328)
T cd05593 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HE---KLF-ELILMEDI--------- 212 (328)
T ss_pred ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-----HH---HHH-HHhccCCc---------
Confidence 2233568999999999999999999999999999999999999985311 00 111 11110100
Q ss_pred hhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 012214 409 KLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSME 443 (468)
Q Consensus 409 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 443 (468)
..+...+..+.+++.+||+.||++|| ++.++++.
T Consensus 213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 -KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 01223345788999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=310.94 Aligned_cols=248 Identities=26% Similarity=0.387 Sum_probs=195.0
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 248 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 248 (468)
+.||+|+||.||++... +++.+|+|........ .....+.+|+.+++.++||||+++++++......++|+||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP---DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 35999999999999964 6889999987643322 3446789999999999999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCce
Q 012214 249 GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH 328 (468)
Q Consensus 249 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 328 (468)
++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 78 ~~L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 78 GDFLTFLRTEG----PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred CcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc
Confidence 99999986522 24889999999999999999999999 999999999999999999999999998754322111
Q ss_pred ee-ecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchhcchH
Q 012214 329 VT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQ 406 (468)
Q Consensus 329 ~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 406 (468)
.. .....+..|+|||.+.++.++.++||||||+++|||++ |..||... .... .........
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-----~~~~----~~~~~~~~~-------- 213 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-----SNQQ----TREAIEQGV-------- 213 (252)
T ss_pred ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc-----CHHH----HHHHHHcCC--------
Confidence 11 11123457999999999899999999999999999998 88887321 0000 111111100
Q ss_pred HhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 407 LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 407 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
....+...+..+.+++.+||+.+|++|||+.++.++|+
T Consensus 214 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 214 -RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 01112233457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=311.38 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=196.8
Q ss_pred eeeecCcEEEEEEEe---cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecC
Q 012214 171 ILGQGGQGTVYKGML---EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 171 ~LG~G~fG~Vy~~~~---~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
.||+|+||.||+|.+ .++..+|+|+++...... ...+++.+|+.+++.++||||+++++++. .+..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP--ALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcH--HHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence 589999999999974 357889999887543322 44577999999999999999999999885 456789999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 79 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~ 150 (257)
T cd05116 79 LGPLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150 (257)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCC
Confidence 999999996522 4889999999999999999999999 99999999999999999999999999987654333
Q ss_pred eee--ecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchhcc
Q 012214 328 HVT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404 (468)
Q Consensus 328 ~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 404 (468)
... ....++..|+|||.+....++.++|||||||++|||++ |..||.... ... ............
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~----~~~~i~~~~~~~--- 218 (257)
T cd05116 151 YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-----GNE----VTQMIESGERME--- 218 (257)
T ss_pred eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----HHH----HHHHHHCCCCCC---
Confidence 221 22234578999999988889999999999999999998 999984311 111 111122111111
Q ss_pred hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 405 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
.+...+..+.+++.+||+.||++||++.+|.+.|++.
T Consensus 219 ------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 ------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1223455789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=316.10 Aligned_cols=258 Identities=22% Similarity=0.376 Sum_probs=200.6
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCc----EEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGR----IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
++|++.+.||+|+||.||+|... +++ .+++|.+...... ....++..|+..+++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR---QTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccch---HHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 46778889999999999999863 344 4778876543222 344678888999999999999999999864 45
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++++||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||+
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~ 155 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGV 155 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcc
Confidence 789999999999999997532 25899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 319 SKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 319 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
++....... .......++..|+|||.+.++.++.++||||||+++|||++ |..||.... . .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~----~~~~~~~~~ 226 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-----P----HEVPDLLEK 226 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC-----H----HHHHHHHHC
Confidence 986643322 12233457788999999999999999999999999999998 998874311 0 011111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
..... .+..+...+.+++.+||+.+|++|||+.|+++.|..+...
T Consensus 227 ~~~~~---------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 227 GERLA---------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 11100 0111234678899999999999999999999999886643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=309.43 Aligned_cols=248 Identities=28% Similarity=0.418 Sum_probs=197.9
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCCC
Q 012214 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 249 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g 249 (468)
+.||+|+||.||+|...+++.+|+|.+...... .....+.+|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ---ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCH---HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 358999999999999888899999988764433 23356889999999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCcee
Q 012214 250 TLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHV 329 (468)
Q Consensus 250 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 329 (468)
+|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..........
T Consensus 78 ~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 150 (250)
T cd05085 78 DFLSFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS 150 (250)
T ss_pred cHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccccc
Confidence 9999986532 24789999999999999999999999 9999999999999999999999999987543322222
Q ss_pred eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHh
Q 012214 330 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLM 408 (468)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 408 (468)
.....++..|+|||++.++.++.++||||||+++|++++ |..||.... ... ...........
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~-----~~~----~~~~~~~~~~~-------- 213 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT-----NQQ----AREQVEKGYRM-------- 213 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC-----HHH----HHHHHHcCCCC--------
Confidence 222234678999999998899999999999999999998 888874311 000 01111111000
Q ss_pred hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 409 KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 409 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
..+...+..+.+++.+||+.+|++|||+.|++++|.
T Consensus 214 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 214 -SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 111233457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=308.68 Aligned_cols=259 Identities=29% Similarity=0.457 Sum_probs=198.9
Q ss_pred CCCCceeeecCcEEEEEEEecC-Cc--EEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC------
Q 012214 166 FNANRILGQGGQGTVYKGMLED-GR--IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET------ 236 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~~-g~--~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------ 236 (468)
|.+.+.||+|+||.||+|...+ +. .+|+|.++...... ...+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR--SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 3466789999999999999654 32 58999876543222 3457789999999999999999999987432
Q ss_pred CcceeEeeecCCCChhhHhhhcc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRH-QNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
...++++||+++|+|.+++.... ......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECC
Confidence 24689999999999999885422 122335899999999999999999999998 99999999999999999999999
Q ss_pred cCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHH
Q 012214 316 FGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 316 fGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
||+++......... .....++..|+|||...+..++.++||||||+++|||++ |+.||... ..... ...
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~~~----~~~ 226 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV-----ENSEI----YDY 226 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC-----CHHHH----HHH
Confidence 99998764433221 122345678999999999999999999999999999999 78887421 11111 111
Q ss_pred hhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 394 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
........ .+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 227 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 227 LRQGNRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111110 1123345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=315.34 Aligned_cols=259 Identities=27% Similarity=0.392 Sum_probs=202.4
Q ss_pred hcCCCCCceeeecCcEEEEEEEecC------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLED------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~ 236 (468)
+++|.+.+.||+|++|.||+|...+ +..||+|........ .....|.+|+.+++.++|+||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE---QDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4678899999999999999998653 567899987654333 3345789999999999999999999999998
Q ss_pred CcceeEeeecCCCChhhHhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC---cE
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQN--EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY---RA 311 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~---~~ 311 (468)
...++||||+++++|.+++...... ....+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++ .+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcce
Confidence 8999999999999999999764321 1235899999999999999999999999 99999999999998765 69
Q ss_pred EEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHH
Q 012214 312 KVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAY 389 (468)
Q Consensus 312 kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~ 389 (468)
||+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||... ... ....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~--~~~---~~~~- 232 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR--TNQ---EVME- 232 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--CHH---HHHH-
Confidence 999999998663322211 112233568999999999999999999999999999997 88887431 111 0111
Q ss_pred HHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 390 FVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
........ ..+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 233 --~~~~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 --FVTGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --HHHcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111111 112233457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=323.33 Aligned_cols=262 Identities=26% Similarity=0.355 Sum_probs=194.3
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC-----Cc
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET-----EV 238 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~ 238 (468)
+|++.+.||+|+||.||+|... +++.||||++....... .....+.+|+.+++.++||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV--SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc--hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 4778899999999999999964 68999999886432211 2345688999999999999999999988543 24
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~ 149 (338)
T cd07859 79 IYVVFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGL 149 (338)
T ss_pred EEEEEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcc
Confidence 799999995 6898888652 24899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCce--eeecccccCCccCcccccc--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 319 SKFIAMDQTH--VTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 319 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
++........ ......||..|+|||++.+ ..++.++|||||||++|||++|+.||..... ...........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-----~~~~~~~~~~~ 224 (338)
T cd07859 150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-----VHQLDLITDLL 224 (338)
T ss_pred ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHh
Confidence 9754322211 1233568999999999876 6789999999999999999999999853211 00000000000
Q ss_pred -----------hccccchhcchHHh------hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 395 -----------RKNRLHDILDDQLM------KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 395 -----------~~~~~~~~~d~~l~------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
........+..... .......++.+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000000000 0000123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=312.35 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=202.1
Q ss_pred CCCCceeeecCcEEEEEEEecC----CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc---
Q 012214 166 FNANRILGQGGQGTVYKGMLED----GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV--- 238 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~--- 238 (468)
|.+.+.||+|+||.||+|.... +..||+|+++...... ...+.+.+|+..++.++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY--SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 5677889999999999998642 3679999887543221 345679999999999999999999998876554
Q ss_pred ---ceeEeeecCCCChhhHhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 239 ---PLLVYEFIPNGTLYQHLHDRHQ-NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 239 ---~~lV~E~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
.++++||+++++|..++..... .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEEC
Confidence 7899999999999999865432 12236899999999999999999999998 9999999999999999999999
Q ss_pred ecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHH
Q 012214 315 DFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVH 392 (468)
Q Consensus 315 DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~ 392 (468)
|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.... .. ... .
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-----~~---~~~-~ 226 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-----NH---EIY-D 226 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----HH---HHH-H
Confidence 999998664433222 112235678999999988899999999999999999999 888874211 11 111 1
Q ss_pred HhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 393 SMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 393 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
........ ..+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 227 ~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 YLRHGNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHcCCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111111 01223455789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=322.80 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=192.3
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcceeEeeecC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
+.||+|+||.||++... +++.||+|+++..... .....+.+..|..++..+ +||||+++++++.+....++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 46999999999999965 6889999998753222 113446688899999888 79999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 150 (329)
T cd05588 80 GGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG- 150 (329)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-
Confidence 99999888653 25899999999999999999999999 9999999999999999999999999987432111
Q ss_pred eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
.......||..|+|||++.+..++.++|||||||++|+|++|+.||...+.......................
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 223 (329)
T cd05588 151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------- 223 (329)
T ss_pred CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC-------
Confidence 1223456899999999999999999999999999999999999999643222111111111111111111110
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCCC
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPT 436 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt 436 (468)
.+...+..+.+++.+||+.||.+|||
T Consensus 224 ---~p~~~~~~~~~li~~~L~~dP~~R~~ 249 (329)
T cd05588 224 ---IPRSLSVKASSVLKGFLNKDPKERLG 249 (329)
T ss_pred ---CCCCCCHHHHHHHHHHhccCHHHcCC
Confidence 12223447889999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=322.96 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=192.5
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcceeEeeecC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
+.||+|+||.||++... +++.+|+|+++..... .....+.+.+|+.++.++ +||||+++++++.+....++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 46999999999999965 5789999988753221 113445677888888777 89999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~ 151 (329)
T cd05618 80 GGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 151 (329)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence 99999888653 24899999999999999999999999 99999999999999999999999999875322211
Q ss_pred eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
......||..|+|||++.+..++.++|||||||++|||++|+.||...+......................
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-------- 222 (329)
T cd05618 152 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-------- 222 (329)
T ss_pred -ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--------
Confidence 12335689999999999999999999999999999999999999854222221111111122221111111
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCCCH
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTM 437 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 437 (468)
..+...+..+.+++.+||+.||++|||+
T Consensus 223 --~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 --RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 0122334578899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=314.11 Aligned_cols=254 Identities=25% Similarity=0.308 Sum_probs=199.6
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|+..+.||+|+||.||++... +++.||+|++....... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh-hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 4777889999999999999964 68899999886532221 123355788999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 80 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 80 TLMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred eccCCCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 9999999998886522 235899999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
.... .....|+..|+|||.+.+..++.++||||+||++|||++|+.||..... . .....+........
T Consensus 154 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~--~---~~~~~~~~~~~~~~----- 221 (285)
T cd05605 154 EGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE--K---VKREEVERRVKEDQ----- 221 (285)
T ss_pred CCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch--h---hHHHHHHHHhhhcc-----
Confidence 3222 1234689999999999998999999999999999999999999853111 0 01111111111100
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
...+...+..+.+|+.+||+.||++|| ++.++++
T Consensus 222 -----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 -----EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -----cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 011223455789999999999999999 6777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=316.04 Aligned_cols=263 Identities=22% Similarity=0.408 Sum_probs=208.6
Q ss_pred HhcCCCCCceeeecCcEEEEEEEecC-----CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc-
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLED-----GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE- 235 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~- 235 (468)
..++|.+.+.||+|+||.||+|...+ +..|++|++...... ...+.+.+|+.+++.++|+||+++++++.+
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE---IQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 34678889999999999999999765 688999987654332 445778999999999999999999998766
Q ss_pred CCcceeEeeecCCCChhhHhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEE
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQN---EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAK 312 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~k 312 (468)
....++++||+++++|.+++...... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEE
Confidence 46789999999999999999764321 1246899999999999999999999998 99999999999999999999
Q ss_pred EEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHH
Q 012214 313 VADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYF 390 (468)
Q Consensus 313 l~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~ 390 (468)
|+|||+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||... .... .
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~~~~----~ 228 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-----DPFE----M 228 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC-----CHHH----H
Confidence 99999998654333221 222346778999999999899999999999999999999 99997431 1111 1
Q ss_pred HHHhhcc-ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 391 VHSMRKN-RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 391 ~~~~~~~-~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
....... .+.. ....++.+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 229 ~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 229 AAYLKDGYRLAQ----------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHHHHcCCCCCC----------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111111 1110 11234578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=329.01 Aligned_cols=255 Identities=25% Similarity=0.289 Sum_probs=202.7
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||++... +++.||+|++...... .......+.+|+.++..++|+||+++++++.+....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 46888999999999999999965 6899999998653211 113346788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 151 (350)
T cd05573 80 MEYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKM 151 (350)
T ss_pred EcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence 9999999999999763 25899999999999999999999999 999999999999999999999999999866
Q ss_pred cCCC----------------------------ceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 012214 323 AMDQ----------------------------THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374 (468)
Q Consensus 323 ~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~ 374 (468)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence 4432 111233468999999999999999999999999999999999999985
Q ss_pred CCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 012214 375 WAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT-MEEVSME 443 (468)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~~ 443 (468)
... ..........+......+. ....++.+.+++.+|++ +|.+||+ +.++++.
T Consensus 232 ~~~-----~~~~~~~i~~~~~~~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 232 SDT-----LQETYNKIINWKESLRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCC-----HHHHHHHHhccCCcccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 311 1101111111000101110 11135578899999998 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=309.82 Aligned_cols=267 Identities=24% Similarity=0.357 Sum_probs=202.7
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc-----
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE----- 235 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----- 235 (468)
...+|...+.||+|+||.|+.+..+ +|..||||++....... ...++..+|+.+++.++|+||+.+.+.+..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~--~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQ--IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhch--HHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 4456776788999999999999854 68999999987544332 455778899999999999999999999865
Q ss_pred CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
-...|+|+|+| ..+|...++... .++.+.+..++.|+++||.|+|+.+ ++||||||.|+|++.+..+||+|
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecc
Confidence 34679999999 568888887632 4899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCC-CceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH
Q 012214 316 FGTSKFIAMD-QTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 316 fGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
||+|+..... .....+..+.|..|.|||.+.+ ..||.+.||||.||++.||++|+.-|.+... .+...+.......
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~--v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY--VHQLQLILELLGT 246 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch--HHHHHHHHHhcCC
Confidence 9999987543 1222466778999999997765 7899999999999999999999988754221 1111111111000
Q ss_pred hhccccchhcch---------------HHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 394 MRKNRLHDILDD---------------QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 394 ~~~~~~~~~~d~---------------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.....+..+-.. .+... -++..+...+|+.+||..||.+|+|++|.++
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~-fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSI-FPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHH-cCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000001111100 00111 1244557899999999999999999999987
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=334.71 Aligned_cols=253 Identities=25% Similarity=0.436 Sum_probs=209.4
Q ss_pred CCCceeeecCcEEEEEEEe-cCC----cEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 167 NANRILGQGGQGTVYKGML-EDG----RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 167 ~~~~~LG~G~fG~Vy~~~~-~~g----~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
...++||+|+||+||+|.+ ..| .+||||++...... ....++++|+-.|.+++|||+++++|+|.... +.|
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~---~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP---KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc---hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3457899999999999984 444 46899987654333 45578999999999999999999999998765 889
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
|++||+.|+|.++++..+. ++-.+..+.|..|||+||.|||.+. ++||||..+||||.+-..+||.|||+++.
T Consensus 775 vtq~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred HHHhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 9999999999999987543 5888899999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 322 IAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 322 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
...+.... .....-.+.|||-|.+....++.++|||||||++||++| |..|++.. ....+
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi------------------~~~eI 909 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI------------------PAEEI 909 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC------------------CHHHh
Confidence 86655443 333445678999999999999999999999999999999 99997431 11223
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
++++....+-..++.++-++..++.+||..|+..||+++++.+++..+-
T Consensus 910 ~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 910 PDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred hHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 3333333344457778889999999999999999999999998886543
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.51 Aligned_cols=267 Identities=23% Similarity=0.368 Sum_probs=209.4
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec--------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeee
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE--------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGC 232 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~ 232 (468)
..++|.+.+.||+|+||.||++... ++..||+|.+...... ....++.+|+.+++.+ +||||++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch---HHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 3567888999999999999999731 2457999987653222 3456788999999999 89999999999
Q ss_pred eccCCcceeEeeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCC
Q 012214 233 CLETEVPLLVYEFIPNGTLYQHLHDRHQN-----------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKST 301 (468)
Q Consensus 233 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~ 301 (468)
+......+++|||+++|+|.+++...... ....+++..+..++.||+.||.|||+.+ ++||||||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 166 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence 99999999999999999999999764321 1235788999999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC
Q 012214 302 NILLDQRYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNT 379 (468)
Q Consensus 302 NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~ 379 (468)
||++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||... .
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~ 244 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--P 244 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC--C
Confidence 9999999999999999998664433222 222345678999999998889999999999999999998 77776321 1
Q ss_pred ccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCc
Q 012214 380 SQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452 (468)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 452 (468)
... ........... ..+...+..+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus 245 ------~~~-~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 245 ------VEE-LFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred ------HHH-HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 111 11111111110 1122345578999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=326.26 Aligned_cols=255 Identities=25% Similarity=0.293 Sum_probs=202.3
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||++... +++.||+|+++..... .....+.+.+|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 46888999999999999999864 6889999998753221 113456688899999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 80 MEYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred ECCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 99999999999997632 25899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccc------cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQ------SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
............||+.|+|||++. ...++.++|||||||++|||++|+.||.... . ...+......
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--~------~~~~~~i~~~ 224 (330)
T cd05601 153 TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT--S------AKTYNNIMNF 224 (330)
T ss_pred CCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC--H------HHHHHHHHcC
Confidence 544443334456899999999986 4567899999999999999999999984311 0 1111111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
....... .....+..+.+|+.+||+ +|.+|||+.+++.
T Consensus 225 ~~~~~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 225 QRFLKFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCccCCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1111110 011234578899999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=314.57 Aligned_cols=265 Identities=25% Similarity=0.363 Sum_probs=200.8
Q ss_pred cCCCCCceeeecCcEEEEEEEecC---------------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceee
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED---------------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~---------------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~ 228 (468)
++|++.+.||+|+||.||++.... ...||+|.+...... .....|.+|++++++++|+|+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK---TARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH---HHHHHHHHHHHHHHhCCCCCcCe
Confidence 578899999999999999987532 235899988754333 34467899999999999999999
Q ss_pred EeeeeccCCcceeEeeecCCCChhhHhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCC
Q 012214 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQN-------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKST 301 (468)
Q Consensus 229 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~ 301 (468)
+++++......++||||+++++|.+++...... ....+++..++.++.|++.||+|||+.+ ++|+||||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~ 158 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATR 158 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChh
Confidence 999999999999999999999999998653211 1124788999999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh--CCCCCCCCCC
Q 012214 302 NILLDQRYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT--GKKPIFWAGN 378 (468)
Q Consensus 302 NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t--G~~p~~~~~~ 378 (468)
||++++++.+||+|||++.......... .....++..|+|||.+.++.++.++|||||||++|+|++ +..||.. .
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~--~ 236 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL--L 236 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc--c
Confidence 9999999999999999997654332221 222345778999999998899999999999999999998 4555532 1
Q ss_pred CccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 379 TSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
.... ................ ....+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 237 ~~~~---~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 237 SDEQ---VIENTGEFFRNQGRQI------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ChHH---HHHHHHHhhhhccccc------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111 1111111111000000 00011223457999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=316.87 Aligned_cols=262 Identities=25% Similarity=0.414 Sum_probs=207.1
Q ss_pred cCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 237 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 237 (468)
.+|.+.+.||+|+||.||++... ++..+++|.+..... ...+.+.+|+.+++.++|+||+++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL----AARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH----HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 45777889999999999999742 355689998765322 33457889999999999999999999999999
Q ss_pred cceeEeeecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQ-----------NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD 306 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~ 306 (468)
..++||||+++++|.+++..... .....+++..++.++.||+.||+|||+.+ ++||||||+||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEc
Confidence 99999999999999999976431 11234899999999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchh
Q 012214 307 QRYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENV 384 (468)
Q Consensus 307 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~ 384 (468)
.++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----~ 232 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-----T 232 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----H
Confidence 9999999999999765432221 1233446788999999999999999999999999999999 9998743110 0
Q ss_pred chHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 385 SLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
. ............ .+...+..+.+++.+||+.+|++|||+.+|+++|+++...
T Consensus 233 ---~-~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 233 ---E-VIECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ---H-HHHHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1 111122221111 1122345789999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=314.57 Aligned_cols=259 Identities=29% Similarity=0.400 Sum_probs=204.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEecC------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLED------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~ 236 (468)
.++|.+.+.||+|+||.||++.... +..||+|.+...... .....+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM---RERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH---HHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 3678889999999999999998642 468999998654332 3346788999999999999999999999999
Q ss_pred CcceeEeeecCCCChhhHhhhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcE
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNE-----EFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA 311 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~ 311 (468)
...++||||+++++|.+++....... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCE
Confidence 99999999999999999997643211 224789999999999999999999999 9999999999999999999
Q ss_pred EEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHH
Q 012214 312 KVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAY 389 (468)
Q Consensus 312 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~ 389 (468)
||+|||+++........ ......++..|+|||.+.++.++.++|||||||++||+++ |..||... ....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-----~~~~---- 229 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL-----SNEE---- 229 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC-----CHHH----
Confidence 99999998765433221 2233446789999999998889999999999999999998 88887421 1111
Q ss_pred HHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 390 FVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
............ .+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 230 ~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 230 VLKFVIDGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111111111 11223557899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=313.53 Aligned_cols=266 Identities=24% Similarity=0.373 Sum_probs=202.4
Q ss_pred cCCCCCceeeecCcEEEEEEEec-----------------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCce
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-----------------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNV 226 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-----------------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni 226 (468)
++|++.+.||+|+||.||++... ++..+|+|++...... .....+.+|+.+++.++|+||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK---NARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCc
Confidence 56899999999999999998532 2446899988754322 345678999999999999999
Q ss_pred eeEeeeeccCCcceeEeeecCCCChhhHhhhcccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCC
Q 012214 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNE------EFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKS 300 (468)
Q Consensus 227 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp 300 (468)
+++++++...+..++||||+++++|.+++....... ...+++..+..++.|++.||+|||+.+ ++|+||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp 158 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLAT 158 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCh
Confidence 999999999999999999999999999997643211 124788899999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh--CCCCCCCCC
Q 012214 301 TNILLDQRYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT--GKKPIFWAG 377 (468)
Q Consensus 301 ~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t--G~~p~~~~~ 377 (468)
+|||+++++.++|+|||+++.+....... .....++..|+|||...++.++.++|||||||++|||++ |..||...
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~- 237 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL- 237 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc-
Confidence 99999999999999999997654332221 222334678999999888899999999999999999998 66776321
Q ss_pred CCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 378 NTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
...+ ................. ...+..++..+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 238 -~~~~---~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 238 -SDEQ---VIENTGEFFRDQGRQVY------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -ChHH---HHHHHHHHHhhcccccc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111 11111111111000000 01122344678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=316.05 Aligned_cols=266 Identities=26% Similarity=0.376 Sum_probs=206.3
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE 235 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~ 235 (468)
..++|++.+.||+|+||.||+|..+ .+..||+|.+...... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL---RERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4578999999999999999999753 2457999987653322 233468899999999999999999999999
Q ss_pred CCcceeEeeecCCCChhhHhhhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQN-----EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR 310 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~ 310 (468)
....++||||+++|+|.+++...... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCc
Confidence 99999999999999999999763321 1234677889999999999999999999 999999999999999999
Q ss_pred EEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHH
Q 012214 311 AKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 311 ~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~ 388 (468)
++|+|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |..||... .. ..
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~--~~------~~ 229 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL--SN------EQ 229 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC--CH------HH
Confidence 9999999987654322211 122335678999999999899999999999999999998 67777421 00 01
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
............ .+...++.+.+++.+||+.+|++|||+.++++.|++.....
T Consensus 230 -~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~ 282 (288)
T cd05061 230 -VLKFVMDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282 (288)
T ss_pred -HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence 111111111111 11223457999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.17 Aligned_cols=265 Identities=26% Similarity=0.394 Sum_probs=204.7
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCc--EEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGR--IIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~--~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~ 239 (468)
++|++.+.||+|+||.||+|... ++. .+++|.+...... .....+.+|+.++.++ +|+||+++++++.+....
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH---HHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 57888899999999999999864 444 4577776543222 3446788999999999 899999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQN-----------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR 308 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~ 308 (468)
++|+||+++++|.+++...... ....+++..++.++.|++.||+|||+.+ ++||||||+|||++++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCC
Confidence 9999999999999999764321 1235889999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchH
Q 012214 309 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLA 387 (468)
Q Consensus 309 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~ 387 (468)
+.+||+|||++...... .......++..|+|||.+.+..++.++|||||||++|||+| |..||.... . .
T Consensus 161 ~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~---~--- 230 (303)
T cd05088 161 YVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--C---A--- 230 (303)
T ss_pred CcEEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC--h---H---
Confidence 99999999998632211 11112234668999999988889999999999999999998 999974211 0 0
Q ss_pred HHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCchh
Q 012214 388 AYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKK 454 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~ 454 (468)
..+.. ...... ...+...+..+.+++.+||+.+|++|||+.++++.|+.+....+..
T Consensus 231 ~~~~~-~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 231 ELYEK-LPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred HHHHH-HhcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 11111 111100 0011123447889999999999999999999999999887666543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=323.68 Aligned_cols=248 Identities=26% Similarity=0.370 Sum_probs=191.6
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|...+.||+|+||.||++... +++.||||++...... .....+.+|+.+++.++|+||+++++++.+....++||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED---TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH---HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 3556678999999999999965 6899999998653322 33467889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++++|.... ...+..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 152 e~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 152 EFMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred ecCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 999999985432 2466778899999999999999999 9999999999999999999999999998654
Q ss_pred CCCceeeecccccCCccCcccccc-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
.... ......||..|+|||++.. ...+.++|||||||++|||++|+.||...... + ..... .......
T Consensus 220 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~---~~~~~-~~~~~~~ 292 (353)
T PLN00034 220 QTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--D---WASLM-CAICMSQ 292 (353)
T ss_pred cccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--c---HHHHH-HHHhccC
Confidence 3211 1233468999999998753 22346899999999999999999998521111 0 00000 0000000
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
. ...+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 293 ~---------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 P---------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred C---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 01122344578999999999999999999999874
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=317.75 Aligned_cols=262 Identities=25% Similarity=0.383 Sum_probs=203.1
Q ss_pred cCCCCCceeeecCcEEEEEEEecC-Cc--EEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED-GR--IIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~--~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~ 239 (468)
++|++.+.||+|+||.||+|...+ +. .+++|.++..... ...+.+.+|+.++.++ +||||+++++++.+....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE---NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH---HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 468888999999999999998653 33 4788877643222 3346788999999999 799999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQN-----------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR 308 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~ 308 (468)
++++||+++++|.+++...... ....+++..++.++.|++.||+|||+.+ ++||||||+|||++++
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGEN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCC
Confidence 9999999999999999753211 1135889999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchH
Q 012214 309 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLA 387 (468)
Q Consensus 309 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~ 387 (468)
+.+||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||.... ..
T Consensus 156 ~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~-----~~--- 225 (297)
T cd05089 156 LASKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-----CA--- 225 (297)
T ss_pred CeEEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HH---
Confidence 99999999998643211 11111223567999999998899999999999999999997 999984311 11
Q ss_pred HHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 388 AYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
........ .. ....+...+..+.+++.+||+.+|.+|||+.++++.|+.+....
T Consensus 226 ~~~~~~~~-~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 226 ELYEKLPQ-GY---------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHHHhc-CC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111111 00 00112234457899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=309.14 Aligned_cols=247 Identities=24% Similarity=0.374 Sum_probs=195.2
Q ss_pred eeecCcEEEEEEEec---CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCC
Q 012214 172 LGQGGQGTVYKGMLE---DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 248 (468)
Q Consensus 172 LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 248 (468)
||+|+||.||+|.+. .+..||+|++...... ...+.+.+|+.++++++|+||+++++++. ....++||||+++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~---~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK---SVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccCh---HHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 899999999999753 3567999988764332 34467899999999999999999999985 4577999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCce
Q 012214 249 GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH 328 (468)
Q Consensus 249 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 328 (468)
++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 79 ~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 79 GPLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151 (257)
T ss_pred CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence 99999986522 25899999999999999999999999 999999999999999999999999999865443322
Q ss_pred ee--ecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchhcch
Q 012214 329 VT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDD 405 (468)
Q Consensus 329 ~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 405 (468)
.. ....++..|+|||.+.+..++.++||||||+++||+++ |..||.... .. ...........
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~----~~~~~~~~~~~------ 216 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK-----GP----EVMSFIEQGKR------ 216 (257)
T ss_pred eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC-----HH----HHHHHHHCCCC------
Confidence 21 12234578999999988889999999999999999996 999984311 11 11111111111
Q ss_pred HHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 406 QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 406 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
...+..+++++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 217 ---~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 ---LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 111233456889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=311.61 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=208.6
Q ss_pred hcCCCCCceeeecCcEEEEEEE-ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
..+|.+.+.||+|.||.|-++. ...|+.||||.++......+ +.+-.+.+|+++|+.++||||+.++.+|...+...+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkde-qDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDE-QDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccH-HHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 3568888899999999999998 46899999998876544433 566778999999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||..+|.|.+|+.+++ .+++.++..++.||..|+.|+|.++ ++|||||.+|||+|.|+++||+|||++.+
T Consensus 131 vMEYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhh
Confidence 999999999999998754 4999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCceeeecccccCCccCccccccCCCC-CcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
+..+.- ....+|++-|.+||.+.+.+|. +.+|-|||||+||-|+.|..||+. .+-. .....+..+...
T Consensus 203 y~~~kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-----~Dhk----~lvrQIs~GaYr 271 (668)
T KOG0611|consen 203 YADKKF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-----RDHK----RLVRQISRGAYR 271 (668)
T ss_pred hccccH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-----chHH----HHHHHhhccccc
Confidence 765432 3457899999999999998886 578999999999999999999964 1111 111111111111
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 444 (468)
.+..+....-||.|||..||+.|.|+.+|...-
T Consensus 272 -----------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 -----------EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -----------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 112223567899999999999999999998643
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=326.43 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=212.7
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc-cee
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV-PLL 241 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~-~~l 241 (468)
++|...+.+|+|+||.++..+.+ +++.+++|.+....... ...+...+|+.++++++|||||.+.+.+.+++. .++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~--~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE--PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc--hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 57888899999999999999865 67899999887654332 233467899999999999999999999999888 999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||+|++||+|.+.+.+.+ ...++++++..++.|++.|+.|||+.. |+|||||+.|||++.++.+||+|||+|+.
T Consensus 82 vm~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKI 155 (426)
T ss_pred EEeecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhh
Confidence 999999999999998854 346899999999999999999999888 99999999999999999999999999998
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
...+... .....||+.||.||.+.+.+|..|+|||||||++|||++-+++|... ..........+
T Consensus 156 l~~~~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~--------~m~~Li~ki~~------ 220 (426)
T KOG0589|consen 156 LNPEDSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS--------NMSELILKINR------ 220 (426)
T ss_pred cCCchhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc--------chHHHHHHHhh------
Confidence 8766533 34467999999999999999999999999999999999999998531 11111111111
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
......+..++.++..++..||+.+|+.||++.+++.+
T Consensus 221 ----~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 ----GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11233356677789999999999999999999999976
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=305.05 Aligned_cols=255 Identities=29% Similarity=0.412 Sum_probs=202.7
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccch-HHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDD-EELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
++|...+.||+|++|.||.+... +++.+|+|.+...... ......+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56889999999999999999854 6899999987653322 122345678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
|+||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 999999999999987532 4888999999999999999999999 99999999999999999999999999876
Q ss_pred ccCCCceee--ecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 322 IAMDQTHVT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 322 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
......... ....++..|+|||.+.+..++.++||||||+++|||++|+.||... +.. ............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~~---~~~~~~~~~~~~ 225 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF-----EAM---AAIFKIATQPTN 225 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc-----chH---HHHHHHhccCCC
Confidence 543221111 2345788999999999988999999999999999999999998431 110 111111111110
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
. ..+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus 226 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 P---------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred C---------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0 1122344578899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=337.24 Aligned_cols=263 Identities=25% Similarity=0.312 Sum_probs=206.4
Q ss_pred HHHHHHhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc
Q 012214 157 KELDKATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE 235 (468)
Q Consensus 157 ~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~ 235 (468)
.+.....++|.+.+.||+|+||+||++.. .+++.||||++....... .....+.+|+..+..++|+|++++++.+..
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~--~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~ 102 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE--ADKNRAQAEVCCLLNCDFFSIVKCHEDFAK 102 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH--HHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence 34445568999999999999999999985 468999999986543222 345678899999999999999999877643
Q ss_pred CC--------cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC
Q 012214 236 TE--------VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ 307 (468)
Q Consensus 236 ~~--------~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~ 307 (468)
.+ ..++||||+++|+|.+++..+.. ...++++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~ 178 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCS 178 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeC
Confidence 32 35799999999999999976432 2246899999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCCcccccCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhch
Q 012214 308 RYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSL 386 (468)
Q Consensus 308 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~ 386 (468)
++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... . .
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~---~ 250 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----N---M 250 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----C---H
Confidence 99999999999986543221 1233456999999999999999999999999999999999999998431 0 1
Q ss_pred HHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 387 AAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 387 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
...+.... ..... ..+...++.+.+++.+||+.||.+|||+.++++.
T Consensus 251 ~~~~~~~~-~~~~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 251 EEVMHKTL-AGRYD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHHh-cCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111111 11110 1123345578999999999999999999999763
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=329.81 Aligned_cols=257 Identities=23% Similarity=0.277 Sum_probs=200.9
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
..++|++.+.||+|+||.||++... +++.+|+|++...... .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 3468999999999999999999965 6889999988642111 1123345788999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 120 lv~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEecccee
Confidence 999999999999988652 3788889999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceeeecccccCCccCccccccC----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
..............||+.|+|||.+.+. .++.++|||||||++|||++|+.||.... . ...+......
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~---~~~~~~i~~~ 262 (370)
T cd05596 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----L---VGTYSKIMDH 262 (370)
T ss_pred eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-----H---HHHHHHHHcC
Confidence 6543332223345699999999988653 47889999999999999999999985311 0 1111111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKK--RPTMEEVSME 443 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 443 (468)
.....+. .....+..+.+++.+||+.+|.+ |||+.|+++.
T Consensus 263 ~~~~~~~-------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 263 KNSLTFP-------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCcCCCC-------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1000000 01123457889999999999987 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=311.94 Aligned_cols=250 Identities=22% Similarity=0.283 Sum_probs=195.3
Q ss_pred eeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCCCC
Q 012214 172 LGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 250 (468)
Q Consensus 172 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 250 (468)
||+|+||+||++... +++.+|+|++...... .....+.+..|+.+++.++|+||+++.+++.+....++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 699999999999864 6889999988643221 11344677889999999999999999999999999999999999999
Q ss_pred hhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCceee
Q 012214 251 LYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT 330 (468)
Q Consensus 251 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 330 (468)
|...+.... .....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++......... .
T Consensus 80 L~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~ 154 (280)
T cd05608 80 LRYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-T 154 (280)
T ss_pred HHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-c
Confidence 998875432 12246899999999999999999999999 999999999999999999999999999765433221 2
Q ss_pred ecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhh
Q 012214 331 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKL 410 (468)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 410 (468)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ............. .
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~----------~ 219 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-----NKELKQRILNDSV----------T 219 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-----HHHHHHhhcccCC----------C
Confidence 334689999999999999999999999999999999999999853221110 0001111101100 1
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 411 GVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 411 ~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
.+...+..+.+++.+||+.||++|| |+.++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 1223455788999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=308.64 Aligned_cols=264 Identities=23% Similarity=0.358 Sum_probs=209.1
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|++|.||++.. .++..+|||.+...... +.....++.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh-hHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 4677888999999999999995 47899999987643221 223456789999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 81 LELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 999999999999875322 2346899999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...... .....++..|+|||++.+..++.++||||||+++|+|++|..||...... ... ............
T Consensus 157 ~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~~- 227 (267)
T cd08229 157 SSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYS-LCKKIEQCDYPP- 227 (267)
T ss_pred ccCCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHH-HhhhhhcCCCCC-
Confidence 433221 22345888999999999988999999999999999999999998531110 001 111111111110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
......++.+.+++.+||+.+|++|||+.+|++++.++-
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 -------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 011234557999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=327.96 Aligned_cols=254 Identities=23% Similarity=0.309 Sum_probs=198.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||.||++... +++.||||++...... .......+.+|+.++..++||||+++++++.+....++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 46888999999999999999965 6899999998653211 113445688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 80 ~E~~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 80 MEYLPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred ECCCCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceec
Confidence 99999999999997532 4899999999999999999999999 999999999999999999999999998754
Q ss_pred cCCCce-------------------------------------eeecccccCCccCccccccCCCCCcccHHHHHHHHHH
Q 012214 323 AMDQTH-------------------------------------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVE 365 (468)
Q Consensus 323 ~~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~e 365 (468)
...... ......||+.|+|||++.+..++.++|||||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 231 (364)
T cd05599 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231 (364)
T ss_pred cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence 321100 0112358999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 012214 366 LLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT---MEEVSM 442 (468)
Q Consensus 366 l~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~ 442 (468)
|++|..||.... . ...............+. .....++.+.+++.+|+. +|.+|++ +.++++
T Consensus 232 l~~G~~Pf~~~~-----~---~~~~~~i~~~~~~~~~~-------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 232 MLVGYPPFCSDN-----P---QETYRKIINWKETLQFP-------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred hhcCCCCCCCCC-----H---HHHHHHHHcCCCccCCC-------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999985311 1 11111111100000000 011234477899999997 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=314.05 Aligned_cols=264 Identities=28% Similarity=0.448 Sum_probs=201.7
Q ss_pred cCCCCCceeeecCcEEEEEEEec-----CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc--C
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE--T 236 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~ 236 (468)
++|++.+.||+|+||.||++..+ ++..||+|.+.... . ...+.+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-A---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-H---HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 57888899999999999999742 57889999976532 2 345678899999999999999999998754 3
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...++|+||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~df 152 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDF 152 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCC
Confidence 46789999999999999996532 24899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCcee--eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 317 GTSKFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 317 Gla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
|++.......... .....++..|+|||++.+..++.++||||||+++|||++|..|+...... +....
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----------~~~~~ 222 (284)
T cd05081 153 GLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----------FMRMM 222 (284)
T ss_pred cccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----------hhhhc
Confidence 9998765433221 11222445699999999889999999999999999999987765321100 00000
Q ss_pred hccc--------cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 395 RKNR--------LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 395 ~~~~--------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
.... +.+.+........+...+..+.+++.+||+.+|++|||+.|+++.|+.++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 223 GNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred ccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 0000 00000000011112334567999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=307.91 Aligned_cols=259 Identities=29% Similarity=0.418 Sum_probs=205.7
Q ss_pred cCCCCCceeeecCcEEEEEEEecC----CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED----GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
++|.+.+.||+|+||.||+|...+ ...|++|........ ...+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP---SVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH---HHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 567888999999999999998643 246899987654333 345678999999999999999999999875 557
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCcee
Confidence 89999999999999997532 24899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
+..............++..|+|||.+....++.++||||||+++||+++ |..||.... .. ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~---~~~~~~~~~~~ 226 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK-----NN---DVIGRIENGER 226 (270)
T ss_pred eecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC-----HH---HHHHHHHcCCc
Confidence 8665443333333345568999999988889999999999999999986 999984311 11 11111111111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
+. .+...+..+.+++.+|+..+|++|||+.++++.|++++..+
T Consensus 227 ~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 227 LP----------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred CC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 10 12234457899999999999999999999999999988655
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=329.30 Aligned_cols=267 Identities=23% Similarity=0.358 Sum_probs=207.7
Q ss_pred HHHHhcCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEee
Q 012214 159 LDKATNHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLG 231 (468)
Q Consensus 159 i~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g 231 (468)
.+...++|.+.++||+|+||.||+|+.. .+..||+|+++..... ...+.+.+|+.++..+. ||||+++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS---SEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh---hHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 3444567888899999999999999853 3467999999764333 23457889999999997 999999999
Q ss_pred eeccCCcceeEeeecCCCChhhHhhhccc---------------------------------------------------
Q 012214 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQ--------------------------------------------------- 260 (468)
Q Consensus 232 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------- 260 (468)
+|......++|+||+++|+|.+++.....
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 99999999999999999999999975321
Q ss_pred ------------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCC
Q 012214 261 ------------------------------------------NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDI 298 (468)
Q Consensus 261 ------------------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DL 298 (468)
.....+++..++.++.||+.||+|||+.+ ++||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdl 265 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDL 265 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccC
Confidence 01124788889999999999999999988 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q 012214 299 KSTNILLDQRYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWA 376 (468)
Q Consensus 299 kp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~ 376 (468)
||+|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 266 AARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred CcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999865332211 1222346788999999999889999999999999999998 88887431
Q ss_pred CCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 377 GNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
. . ............ ....+...+..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 346 ~--~------~~~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 346 P--M------NEQFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred C--c------hHHHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 0 011111111110 00112233457999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.62 Aligned_cols=265 Identities=25% Similarity=0.366 Sum_probs=207.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEec--------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE--------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCC 233 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~ 233 (468)
.++|.+.+.||+|+||.||++... .+..+|+|.+...... ....++.+|+.+++.+ +|+||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE---KDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh---HHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 467899999999999999999742 2357999988754322 3346788999999999 799999999999
Q ss_pred ccCCcceeEeeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCC
Q 012214 234 LETEVPLLVYEFIPNGTLYQHLHDRHQN-----------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTN 302 (468)
Q Consensus 234 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~N 302 (468)
.+....++||||+++|+|.+++...... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence 9999999999999999999999764321 1235899999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 012214 303 ILLDQRYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTS 380 (468)
Q Consensus 303 ILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~ 380 (468)
|++++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.. ...
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~--~~~ 248 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--VPV 248 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc--CCH
Confidence 999999999999999987654322111 122234568999999999889999999999999999998 7777632 110
Q ss_pred cchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 381 QENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.. ........... ..+...+..+.+++.+||+.+|++|||+.++++.|+.+....
T Consensus 249 ------~~-~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 249 ------EE-LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred ------HH-HHHHHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 11 11111111111 112234457889999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=313.97 Aligned_cols=259 Identities=24% Similarity=0.407 Sum_probs=203.5
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCc----EEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGR----IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~----~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
++|...+.||+|+||+||+|.. .++. .||+|++...... ....++.+|+.++..++|+||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP---KANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH---HHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 5688889999999999999984 3444 4899988654333 334678899999999999999999999975 45
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++++||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCc
Confidence 789999999999999987532 25899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 319 SKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 319 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
++......... .....++..|+|||...+..++.++|||||||++|||++ |..||... .... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-----~~~~----~~~~~~~ 226 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-----PARE----IPDLLEK 226 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHHH----HHHHHHC
Confidence 98765333221 122335678999999999899999999999999999998 88887421 1111 1111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.... ..+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 227 ~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 227 GERL---------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CCcC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1100 011223457889999999999999999999999998887655
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=308.83 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=201.0
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
++|.+.+.||+|++|.||++...++..+|+|.+..... ..+.+.+|+.+++.++|+|++++++++. ....+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 56788889999999999999987777899998764322 2256888999999999999999999885 45688999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 80 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 80 EFMGKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIE 153 (260)
T ss_pred EcCCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEcc
Confidence 9999999999997632 235889999999999999999999999 9999999999999999999999999997654
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...........++..|+|||...+..++.++||||||+++|||++ |..||.... .. ... .........
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~------~~~-~~~~~~~~~-- 222 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--NR------EVL-EQVERGYRM-- 222 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--HH------HHH-HHHHcCCCC--
Confidence 332222223346678999999998899999999999999999999 888874311 10 111 111111000
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
..+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus 223 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 -------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122345578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=316.43 Aligned_cols=260 Identities=27% Similarity=0.388 Sum_probs=205.7
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeec
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCL 234 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~ 234 (468)
..++|.+.+.||+|+||.||++... .+..+|+|+++..... ...+.+.+|+.+++++ +|+||+++++++.
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS---SEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh---HHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 3467999999999999999999741 3457999988754332 3346789999999999 7999999999999
Q ss_pred cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 235 ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 235 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
..+..+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~ 183 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKIC 183 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEEC
Confidence 9999999999999999999997532 123899999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHH
Q 012214 315 DFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVH 392 (468)
Q Consensus 315 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~ 392 (468)
|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...+..
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--------~~~~~~ 255 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--------DSKFYK 255 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--------hHHHHH
Confidence 99999866443322 1222345778999999999999999999999999999998 8888743111 011111
Q ss_pred HhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 393 SMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 393 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
....... ...+...+..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 256 ~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 LIKEGYR---------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111100 001112345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=315.47 Aligned_cols=258 Identities=22% Similarity=0.332 Sum_probs=202.4
Q ss_pred CCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 165 HFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
+|.+.+.||+|+||.||+|... .++.||+|++...... ...+.+.+|+.++..++||||+++++++.+...
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG---PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH---HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 4666788999999999999853 2578999998754332 334668899999999999999999999999999
Q ss_pred ceeEeeecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQ-----------NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ 307 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~ 307 (468)
.++++||+++++|.+++..... .....+++..+..++.|++.||.|||+.+ |+||||||+||++++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecC
Confidence 9999999999999999853211 11235888999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCCcccccCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhc
Q 012214 308 RYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVS 385 (468)
Q Consensus 308 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~ 385 (468)
++.+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||... .
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--~------ 231 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--S------ 231 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--C------
Confidence 99999999999876543222 12233346788999999998889999999999999999998 77776321 0
Q ss_pred hHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 386 LAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
.. ............ ..+..++..+.+++.+||+.+|++||++.+|+..|+.
T Consensus 232 ~~-~~~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 232 NQ-DVIEMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH-HHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 01 111222221111 1123455578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=309.97 Aligned_cols=257 Identities=23% Similarity=0.434 Sum_probs=203.4
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CC---cEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DG---RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g---~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
.++|+..+.||+|+||.||+|... ++ ..+|+|........ ...+.+.+|+.+++.++|+|++++++++.+.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE---KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH---HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 357788899999999999999964 23 37999988654333 334678899999999999999999999999999
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcc
Confidence 999999999999999986532 25899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCceee--ecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 319 SKFIAMDQTHVT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 319 a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
+........... .....+..|+|||++.+..++.++|||||||++|||++ |..||.... .. . ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~-----~~---~-~~~~i~ 224 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS-----NH---E-VMKAIN 224 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC-----HH---H-HHHHHh
Confidence 876643322111 11223457999999998889999999999999999997 999984311 11 1 111111
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
... ....+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 225 ~~~---------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 225 DGF---------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred cCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 0001122345789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=326.92 Aligned_cols=254 Identities=21% Similarity=0.259 Sum_probs=195.2
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
.|...+.||+|+||+||++... +++.||+|++...... .......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 5788899999999999999854 6889999998653211 1134567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~ 152 (381)
T cd05626 81 DYIPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152 (381)
T ss_pred ecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence 9999999999987532 4888999999999999999999999 9999999999999999999999999976431
Q ss_pred CCCc----------------------------------------------eeeecccccCCccCccccccCCCCCcccHH
Q 012214 324 MDQT----------------------------------------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 357 (468)
Q Consensus 324 ~~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVw 357 (468)
.... .......||+.|+|||.+.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (381)
T cd05626 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232 (381)
T ss_pred cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence 1000 001234699999999999998999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHH--hhccCCCCCC
Q 012214 358 SFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKR--CLDLNGKKRP 435 (468)
Q Consensus 358 SlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~dp~~RP 435 (468)
||||++|||++|+.||.... . .........+....... .....+..+.+++.+ |+..++..||
T Consensus 233 SlG~il~elltG~~Pf~~~~--~---~~~~~~i~~~~~~~~~~----------~~~~~s~~~~dli~~ll~~~~~~~~R~ 297 (381)
T cd05626 233 SVGVILFEMLVGQPPFLAPT--P---TETQLKVINWENTLHIP----------PQVKLSPEAVDLITKLCCSAEERLGRN 297 (381)
T ss_pred ehhhHHHHHHhCCCCCcCCC--H---HHHHHHHHccccccCCC----------CCCCCCHHHHHHHHHHccCcccccCCC
Confidence 99999999999999985311 0 00000010000000010 011234467888888 4455666799
Q ss_pred CHHHHHH
Q 012214 436 TMEEVSM 442 (468)
Q Consensus 436 t~~evl~ 442 (468)
++.+++.
T Consensus 298 ~~~~~l~ 304 (381)
T cd05626 298 GADDIKA 304 (381)
T ss_pred CHHHHhc
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=309.95 Aligned_cols=256 Identities=23% Similarity=0.409 Sum_probs=203.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec----CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
.+|++.+.||+|+||.||+|... .+..+|+|.++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE---KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 56788899999999999999853 2347999988654333 3456789999999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+|||++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcc
Confidence 99999999999999997532 25899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeee--cccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 320 KFIAMDQTHVTT--KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 320 ~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
............ ...++..|+|||++.+..++.++||||||+++||+++ |..||..... ... ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-----~~~----~~~~~~ 224 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-----QDV----IKAIEE 224 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-----HHH----HHHHhC
Confidence 876543322221 2223568999999998899999999999999999886 9999743110 001 111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
..- ...+...+..+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 225 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 225 GYR---------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCc---------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 100 001123345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=333.66 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=200.7
Q ss_pred CCCCCceeeecCcEEEEEEEec-C-CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-D-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.|.+.+.||+|++|.||++... + +..||+|...... . .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~---~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-E---RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-H---HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 4888999999999999999853 3 6778888765432 1 3335677899999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++..... ...++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 144 ~E~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EECCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999999998865322 2346899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ......... ....
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----~---~~~~~~~~~-~~~~- 289 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-----Q---REIMQQVLY-GKYD- 289 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHHh-CCCC-
Confidence 43322 12334569999999999999999999999999999999999999984311 0 111111111 1110
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+...+..+.+++.+||+.||++|||+.+++.
T Consensus 290 --------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 --------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011233457899999999999999999999875
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=310.23 Aligned_cols=256 Identities=29% Similarity=0.436 Sum_probs=205.7
Q ss_pred HhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
..++|.+.+.||+|+||.||++..++++.+|+|.+..... ..+++.+|+.+++.++|+|++++++++.+....++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 3467899999999999999999988888999998875322 23568899999999999999999999998889999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++..
T Consensus 79 v~e~~~~~~L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~ 152 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARL 152 (261)
T ss_pred EEeccCCCCHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECcccccee
Confidence 999999999999997632 235899999999999999999999999 99999999999999999999999999876
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
..............+..|+|||.+.+..++.++||||||+++|+|++ |+.||... . ... ...........
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--~---~~~---~~~~~~~~~~~- 223 (261)
T cd05034 153 IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM--T---NRE---VLEQVERGYRM- 223 (261)
T ss_pred ccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--C---HHH---HHHHHHcCCCC-
Confidence 65332222222335668999999999899999999999999999998 89887421 1 111 11111111000
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
..+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 224 ---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 ---------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0112234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=307.38 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=203.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.++|++.+.||+|+||.||++... |+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+....++|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 357888999999999999999875 78899999875422 356789999999999999999999999998999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.++..
T Consensus 79 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 79 TEYMAKGSLVDYLRSRG---RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEA 152 (256)
T ss_pred EEecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccc
Confidence 99999999999997632 235899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
..... ....+..|+|||++.++.++.++||||||+++||+++ |..||... . . . ...........
T Consensus 153 ~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~-~--~----~~~~~~~~~~~-- 217 (256)
T cd05039 153 SQGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--P-L--K----DVVPHVEKGYR-- 217 (256)
T ss_pred ccccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC--C-H--H----HHHHHHhcCCC--
Confidence 32221 2335678999999998889999999999999999997 98887421 0 0 1 11111111100
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
...+...++.+.+++.+||+.+|++|||+.+++++|+.+
T Consensus 218 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 -------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 011223345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=320.89 Aligned_cols=244 Identities=24% Similarity=0.296 Sum_probs=193.9
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 248 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 248 (468)
+.||+|+||.||++... +++.||+|++...... .......+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999854 6889999988653211 113446678899999999999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 249 GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS-ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 249 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
|+|..++... ..+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 80 GELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151 (325)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence 9999888653 248999999999999999999997 67 99999999999999999999999999875332222
Q ss_pred eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .. . ..........
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-----~~---~-~~~~i~~~~~-------- 213 (325)
T cd05594 152 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HE---K-LFELILMEEI-------- 213 (325)
T ss_pred -ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC-----HH---H-HHHHHhcCCC--------
Confidence 1233468999999999999999999999999999999999999984311 00 0 0111111110
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
..+...+..+.+++.+||+.||++|+ ++.++++
T Consensus 214 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 214 --RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 01122344788999999999999997 8988875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=324.83 Aligned_cols=263 Identities=22% Similarity=0.280 Sum_probs=198.2
Q ss_pred CCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC-----c
Q 012214 165 HFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-----V 238 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-----~ 238 (468)
+|++.+.||+|+||.||++.. .+++.||+|++....... ...+.+.+|+.+++.++|+||+++++++.... .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL--VSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccch--HHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 478889999999999999996 468999999886532221 34467889999999999999999999998766 7
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++|+||+. ++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~ 149 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGL 149 (372)
T ss_pred EEEEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccc
Confidence 899999996 5788777542 25899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
++..............+|..|+|||.+.+. .++.++|||||||++|||++|+.||.... .. ............+
T Consensus 150 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~---~~~~~i~~~~g~~ 224 (372)
T cd07853 150 ARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS--PI---QQLDLITDLLGTP 224 (372)
T ss_pred eeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC--HH---HHHHHHHHHcCCC
Confidence 986544333333344678999999998874 57899999999999999999999985321 11 1111111111100
Q ss_pred ccchhc------------------chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 398 RLHDIL------------------DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 398 ~~~~~~------------------d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
...++. ............++.+.+|+.+||+.||++|||+.|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000 0000000112234578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=323.61 Aligned_cols=202 Identities=26% Similarity=0.358 Sum_probs=173.4
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|+..+.||+|+||+||++... +++.||+|++...... .......+.+|+.++..++|+||+++++++.+....++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 46888999999999999999864 5889999998653211 123446788899999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 80 MEFLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred EcCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 9999999999999753 25899999999999999999999999 999999999999999999999999998754
Q ss_pred cCCCc----------------------------------eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh
Q 012214 323 AMDQT----------------------------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 368 (468)
Q Consensus 323 ~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t 368 (468)
..... .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 231 (363)
T cd05628 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (363)
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence 32110 00123469999999999999999999999999999999999
Q ss_pred CCCCCC
Q 012214 369 GKKPIF 374 (468)
Q Consensus 369 G~~p~~ 374 (468)
|+.||.
T Consensus 232 G~~Pf~ 237 (363)
T cd05628 232 GYPPFC 237 (363)
T ss_pred CCCCCC
Confidence 999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=313.43 Aligned_cols=260 Identities=27% Similarity=0.424 Sum_probs=204.6
Q ss_pred hcCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~ 236 (468)
.++|++.+.||+|+||.||++... ++..+|+|.+...... ....++.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---DMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH---HHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 467888999999999999999853 4678999988754333 3446788999999999999999999999999
Q ss_pred CcceeEeeecCCCChhhHhhhccc-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCC
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQ-----------------NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIK 299 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLk 299 (468)
...++++||+++++|.+++..... .....+++..++.++.|++.||.|||+.+ ++|||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~ 157 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLA 157 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eeccccc
Confidence 999999999999999999975321 11235788999999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q 012214 300 STNILLDQRYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAG 377 (468)
Q Consensus 300 p~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~ 377 (468)
|+||++++++.++|+|||++.......... ......+..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999987553322211 122234667999999998899999999999999999998 877874210
Q ss_pred CCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 378 NTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
. . ............. .+...+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 238 ---~-----~-~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 ---H-----E-EVIYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---H-----H-HHHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 0 0 1111122111111 112334578999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=306.50 Aligned_cols=251 Identities=28% Similarity=0.414 Sum_probs=202.8
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|...+.||+|++|.||++... +++.|++|.+....... ...+.+.+|+.+++.++|||++++++++.+....++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR--REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH--HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence 4677889999999999999964 68899999876532221 34567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++...
T Consensus 79 e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 79 EYAENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS 152 (256)
T ss_pred EeCCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceecc
Confidence 9999999999997632 235899999999999999999999998 9999999999999999999999999988665
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
..... .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||.... .. .............
T Consensus 153 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~----~~~~~~~~~~~~~-- 220 (256)
T cd08529 153 DNTNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-----QG----ALILKIIRGVFPP-- 220 (256)
T ss_pred Cccch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----HH----HHHHHHHcCCCCC--
Confidence 43222 233457889999999999999999999999999999999999985311 11 1111111111111
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+...+..+.+++.+||+.+|++||++.++++
T Consensus 221 -------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 -------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred -------CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 11133457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=305.88 Aligned_cols=274 Identities=22% Similarity=0.297 Sum_probs=204.1
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCc-eeeEeeeeccCC----
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN-VVKLLGCCLETE---- 237 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~---- 237 (468)
..|...++||+|+||+||+|+. .+|+.||+|++......+ ..-....+|+.+++.++|+| |+++++++.+..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E--G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE--GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc--CCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 3455567799999999999995 478999999988754421 12245689999999999999 999999998877
Q ss_pred --cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 238 --VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 238 --~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
..++|+||++ -+|..++....... ..++...+..++.||+.||+|||+++ |+||||||+||||+++|.+||+|
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeec
Confidence 7889999995 59999998754321 34677889999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
||+|+...-.... .+..++|..|.|||++.+. .|++..||||+||++.||++++.-|... .. ...........
T Consensus 164 FGlAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~--se---~~ql~~If~~l 237 (323)
T KOG0594|consen 164 FGLARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGD--SE---IDQLFRIFRLL 237 (323)
T ss_pred cchHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCC--cH---HHHHHHHHHHc
Confidence 9999966533222 3445689999999999886 7999999999999999999987776431 11 11111111111
Q ss_pred hcc---ccchhc---chH----------HhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhcccC
Q 012214 395 RKN---RLHDIL---DDQ----------LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME--LNGIRGS 450 (468)
Q Consensus 395 ~~~---~~~~~~---d~~----------l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~~~ 450 (468)
..+ .++... +-. ......+.......+++.+||+.+|.+|.|++.++++ ++.+...
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 111 111111 000 0000011112467899999999999999999999986 6655433
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=326.78 Aligned_cols=255 Identities=23% Similarity=0.290 Sum_probs=196.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||++... +++.||+|++...... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 46888999999999999999854 6889999987643211 123456788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 80 ~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 80 MEFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999998653 24889999999999999999999999 999999999999999999999999998633
Q ss_pred cCCCce----------------------------------------------eeecccccCCccCccccccCCCCCcccH
Q 012214 323 AMDQTH----------------------------------------------VTTKIQGTFGYLDPEYHQSSQLTDKSDV 356 (468)
Q Consensus 323 ~~~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV 356 (468)
...... ......||+.|+|||++.+..++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 231 (377)
T cd05629 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence 210000 0012458999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCC--
Q 012214 357 YSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKR-- 434 (468)
Q Consensus 357 wSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~R-- 434 (468)
|||||++|||++|..||.... . ...+...........+.+ ....+..+.+++.+||+ +|.+|
T Consensus 232 wSlGvil~elltG~~Pf~~~~--~------~~~~~~i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~ 295 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCSEN--S------HETYRKIINWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLG 295 (377)
T ss_pred EecchhhhhhhcCCCCCCCCC--H------HHHHHHHHccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCC
Confidence 999999999999999984311 1 111111111000000000 11234478899999998 77765
Q ss_pred -CCHHHHHHH
Q 012214 435 -PTMEEVSME 443 (468)
Q Consensus 435 -Pt~~evl~~ 443 (468)
+|+.|+++.
T Consensus 296 r~~~~~~l~h 305 (377)
T cd05629 296 RGGAHEIKSH 305 (377)
T ss_pred CCCHHHHhcC
Confidence 599888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=308.13 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=204.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.++|.+.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|+.+++.++|+|++++++++.+ ...+++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 46788899999999999999997777889999876421 234678899999999999999999999887 778999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++...
T Consensus 79 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 79 TEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred EEeCCCCcHHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeec
Confidence 99999999999997632 235788999999999999999999998 999999999999999999999999999766
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
............++..|+|||++....++.++|+|||||++|++++ |..||.... ... ...........
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~----~~~~~~~~~~~- 222 (260)
T cd05073 153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-----NPE----VIRALERGYRM- 222 (260)
T ss_pred cCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC-----HHH----HHHHHhCCCCC-
Confidence 4433222233345678999999998889999999999999999999 888874211 000 11111111100
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
..+...+..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 223 --------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 223 --------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred --------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 11123345789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=308.51 Aligned_cols=265 Identities=26% Similarity=0.374 Sum_probs=203.4
Q ss_pred cCCCCCceeeecCcEEEEEEEe-----cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC--
Q 012214 164 NHFNANRILGQGGQGTVYKGML-----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET-- 236 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-- 236 (468)
..|++.+.||+|+||.||.+.. .++..||+|.++..... .....+.+|+.+++.++|||++++++++.+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG---NHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH---HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 4578889999999999999974 35788999998754333 3456789999999999999999999998765
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+||
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~df 153 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDF 153 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCC
Confidence 56789999999999999986532 25899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCce--eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccc------hhchHH
Q 012214 317 GTSKFIAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE------NVSLAA 388 (468)
Q Consensus 317 Gla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~------~~~~~~ 388 (468)
|+++........ ......++..|+|||++.+..++.++||||||+++|||++++.|.......... ......
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05079 154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT 233 (284)
T ss_pred ccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH
Confidence 999866433221 122345677899999999888999999999999999999987764321100000 000000
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
.......... ....+...+..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus 234 ~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 234 RLVRVLEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0111111110 0111223456899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=317.10 Aligned_cols=264 Identities=25% Similarity=0.376 Sum_probs=206.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEec--------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE--------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCC 233 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~ 233 (468)
.++|.+.+.||+|+||.||++... ....+|+|.+...... ....++.+|+.+++++ +||||+++++++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD---KDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh---HHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 367888999999999999999742 2457899988754333 3456788999999999 699999999999
Q ss_pred ccCCcceeEeeecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCC
Q 012214 234 LETEVPLLVYEFIPNGTLYQHLHDRHQ-----------NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTN 302 (468)
Q Consensus 234 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~N 302 (468)
.+....++++||+++|+|.+++..... .....+++..+..++.|++.||.|||+.+ ++|+||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccccee
Confidence 998899999999999999999976431 11235899999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 012214 303 ILLDQRYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTS 380 (468)
Q Consensus 303 ILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~ 380 (468)
||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||... ..
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~--~~ 242 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI--PV 242 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC--CH
Confidence 999999999999999998654322211 112234567999999999899999999999999999999 88887321 10
Q ss_pred cchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 381 QENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
.. ........... ..+...+..+.+++.+||+.+|++|||+.++++.|+++...
T Consensus 243 ------~~-~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 243 ------EE-LFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred ------HH-HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 01 11111111111 11223345788999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=325.30 Aligned_cols=257 Identities=24% Similarity=0.287 Sum_probs=198.8
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
..++|++.+.||+|+||.||++... +++.+|+|++...... .......+.+|+.+++.++||||+++++++.+....+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 4578999999999999999999965 5889999987542111 1123455788999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 120 lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence 999999999999998642 3788899999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceeeecccccCCccCccccccC----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
..............||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....+......
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~--------~~~~~~~i~~~ 262 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS--------LVGTYSKIMDH 262 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC
Confidence 6643333233445799999999998764 37889999999999999999999985311 11111111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCC--CCCCHHHHHHH
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGK--KRPTMEEVSME 443 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~--~RPt~~evl~~ 443 (468)
.....+. .....+..+.+++.+||+.++. .|||+.|+++.
T Consensus 263 ~~~~~~p-------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KNSLNFP-------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CcccCCC-------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1100100 0112345678899999985554 38899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=305.96 Aligned_cols=252 Identities=26% Similarity=0.374 Sum_probs=197.6
Q ss_pred CCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|+..+.||+|+||.||++.. .+++.+|+|........ ....++.+|+.++++++||||+++++++......++|+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV---ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh---HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 577888999999999999985 46889999988654322 33467899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 79 e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 79 EFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV 146 (279)
T ss_pred ecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence 999999986542 3678889999999999999999999 9999999999999999999999999987553
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
... .....+|..|+|||++.+..++.++||||||+++|+|++|+.||......... ...... ............
T Consensus 147 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~-~~~~~~~~~~~~- 220 (279)
T cd06619 147 NSI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS-LMPLQL-LQCIVDEDPPVL- 220 (279)
T ss_pred ccc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-cchHHH-HHHHhccCCCCC-
Confidence 321 23346899999999999989999999999999999999999998532111110 000111 111111110000
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 444 (468)
.....++.+.+++.+||+.+|++||++.|+++.-
T Consensus 221 -------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 221 -------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred -------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 0112344789999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=315.69 Aligned_cols=244 Identities=26% Similarity=0.310 Sum_probs=192.5
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCC-CceeeEeeeeccCCcceeE
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH-RNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~lV 242 (468)
+|.+.+.||+|+||.||+|... +++.||+|++...... .....+.+..|+.++..++| ++|+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 4778899999999999999965 5788999988653211 11345678889999999965 5688899999988999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 80 MEYVNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 99999999999986532 4889999999999999999999999 999999999999999999999999998643
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... .. ......... ...
T Consensus 152 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~-----~~---~~~~~~i~~-~~~--- 218 (324)
T cd05587 152 IFGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE-----DE---DELFQSIME-HNV--- 218 (324)
T ss_pred CCCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC-----CH---HHHHHHHHc-CCC---
Confidence 22211 223456899999999999999999999999999999999999998531 11 111111111 110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTM 437 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 437 (468)
..+...+..+.+++.+||+.||.+||+.
T Consensus 219 -------~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 -------SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0112234478899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=305.04 Aligned_cols=249 Identities=28% Similarity=0.406 Sum_probs=197.1
Q ss_pred ceeeecCcEEEEEEEecC----CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeee
Q 012214 170 RILGQGGQGTVYKGMLED----GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEF 245 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 245 (468)
++||+|+||.||+|.... +..+|+|.+...... ...+++.+|+.+++.++|+||+++++++. ....++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA---AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence 469999999999997432 268999988764332 34467899999999999999999999876 4567999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 012214 246 IPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMD 325 (468)
Q Consensus 246 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 325 (468)
+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.....
T Consensus 77 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 77 APLGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred CCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 99999999997632 5899999999999999999999999 999999999999999999999999999876543
Q ss_pred Cceee--ecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 326 QTHVT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 326 ~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||... .... +.........
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-----~~~~----~~~~~~~~~~--- 216 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-----KGAE----VIAMLESGER--- 216 (257)
T ss_pred CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-----CHHH----HHHHHHcCCc---
Confidence 33221 11224568999999999999999999999999999998 89997431 1111 1111111110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
...+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 217 ------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 ------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0112234457899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=315.22 Aligned_cols=241 Identities=25% Similarity=0.327 Sum_probs=188.3
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcceeEeeecC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
+.||+|+||.||++... +++.||+|+++...... ....+.+..|..++... +||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-DDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999965 57889999886532111 12344556677777654 89999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 80 gg~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~- 150 (316)
T cd05592 80 GGDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE- 150 (316)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-
Confidence 999999886532 4889999999999999999999999 9999999999999999999999999997543322
Q ss_pred eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ...+.. .....
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-----~---~~~~~~-i~~~~--------- 212 (316)
T cd05592 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-----E---DELFDS-ILNDR--------- 212 (316)
T ss_pred CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-----H---HHHHHH-HHcCC---------
Confidence 22334568999999999999999999999999999999999999985311 0 111111 11110
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e 439 (468)
...+...+..+.+++.+||+.||++||++.+
T Consensus 213 -~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 213 -PHFPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 0011223446789999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=315.61 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=192.4
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcceeEeeecC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
+.||+|+||.||++... +++.+|+|++...... .....+.+.+|+.++.++ +||||+++++++.+....++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 46999999999999964 5789999998753222 123456788999999888 69999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 151 (327)
T cd05617 80 GGDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD 151 (327)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence 99999888653 24899999999999999999999999 99999999999999999999999999875322111
Q ss_pred eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ................
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~-------- 220 (327)
T cd05617 152 -TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD--MNTEDYLFQVILEKPI-------- 220 (327)
T ss_pred -ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc--cccHHHHHHHHHhCCC--------
Confidence 22345689999999999999999999999999999999999999853221111 1111111111111110
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCCCHH
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTME 438 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 438 (468)
..+...+..+.+++.+||+.||.+||++.
T Consensus 221 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 --RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 01122334678999999999999999854
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=316.56 Aligned_cols=240 Identities=28% Similarity=0.360 Sum_probs=190.0
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcceeEeeecC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
+.||+|+||.||++..+ +++.||+|++...... .....+.+..|..++..+ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999965 5889999988643211 113445677888888876 79999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~ 151 (320)
T cd05590 80 GGDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151 (320)
T ss_pred CchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence 999999886532 4889999999999999999999999 99999999999999999999999999875422221
Q ss_pred eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... . .... ........
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~---~~~~-~~i~~~~~-------- 213 (320)
T cd05590 152 -TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-----E---DDLF-EAILNDEV-------- 213 (320)
T ss_pred -cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----H---HHHH-HHHhcCCC--------
Confidence 2233568999999999999999999999999999999999999985311 1 1111 11111111
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCCCHH
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTME 438 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 438 (468)
..+...+..+.+++.+||+.||.+||++.
T Consensus 214 --~~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 214 --VYPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 01112344788999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=316.17 Aligned_cols=247 Identities=26% Similarity=0.310 Sum_probs=191.4
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHH---HhcCCCceeeEeeeeccCCccee
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVIL---SQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l---~~l~h~niv~l~g~~~~~~~~~l 241 (468)
|.+.+.||+|+||.||++... +++.||||+++..... .....+.+.+|+.++ +.++||||+++++++.+....++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 567789999999999999865 6899999998653211 112344566666554 56789999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++++|...+.. ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 80 v~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 80 VMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred EEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 9999999999888753 24899999999999999999999999 99999999999999999999999999875
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
...... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||... .. . ..... ......
T Consensus 151 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~--~~---~---~~~~~-i~~~~~-- 218 (324)
T cd05589 151 GMGFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD--DE---E---EVFDS-IVNDEV-- 218 (324)
T ss_pred CCCCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC--CH---H---HHHHH-HHhCCC--
Confidence 322211 223456899999999999999999999999999999999999998531 10 0 11111 111110
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT-----MEEVSM 442 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 442 (468)
..+...+..+.+++.+||+.||.+||+ +.++++
T Consensus 219 --------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 --------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 012233457889999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=307.98 Aligned_cols=267 Identities=26% Similarity=0.339 Sum_probs=200.2
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC-----C
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET-----E 237 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~ 237 (468)
-.|...+.+|.|+||.||+|... ++..||||+....... --+|+.+|+.++|||||++.-++... -
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~--------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY--------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc--------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 34667788999999999999954 5789999987553222 12699999999999999998887432 1
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC-CcEEEEec
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR-YRAKVADF 316 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~-~~~kl~Df 316 (468)
...+|||||+. +|.+.++.... ....++...+.-++.||++||+|||+.+ |+||||||.|+|+|.+ |.+||+||
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDF 170 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDF 170 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccC
Confidence 44689999976 99999986322 2235777788889999999999999999 9999999999999977 99999999
Q ss_pred CCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
|.|+.+..++.... ..-|.-|.|||.+.+ ..|+.+.||||.||++.||+-|+.-|.. .+...........+.
T Consensus 171 GSAK~L~~~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-----~s~~dQL~eIik~lG 243 (364)
T KOG0658|consen 171 GSAKVLVKGEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-----DSSVDQLVEIIKVLG 243 (364)
T ss_pred CcceeeccCCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-----CCHHHHHHHHHHHhC
Confidence 99998876655433 335778999999887 6799999999999999999999988743 122222222333332
Q ss_pred ccccchhc----------chHHh-----hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhcccC
Q 012214 396 KNRLHDIL----------DDQLM-----KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGIRGS 450 (468)
Q Consensus 396 ~~~~~~~~----------d~~l~-----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i~~~ 450 (468)
.+.-.++. .+.+. .......+++..+|+.++|+++|.+|.++.|++. ..+.++..
T Consensus 244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 22111111 11111 1123445668999999999999999999999985 45555543
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=326.24 Aligned_cols=253 Identities=21% Similarity=0.254 Sum_probs=193.8
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|...+.||+|+||.||++... +++.+|+|++...... .......+.+|+.++++++|+||+++++++.+....++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 5888899999999999999964 6889999988643211 1234567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 81 E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~ 152 (382)
T cd05625 81 DYIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (382)
T ss_pred eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence 9999999999986532 4788999999999999999999999 9999999999999999999999999975321
Q ss_pred CCC----------------------------------------------ceeeecccccCCccCccccccCCCCCcccHH
Q 012214 324 MDQ----------------------------------------------THVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 357 (468)
Q Consensus 324 ~~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVw 357 (468)
... ........||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence 000 0001124689999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC-
Q 012214 358 SFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT- 436 (468)
Q Consensus 358 SlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt- 436 (468)
||||++|||++|+.||.... . .........+......+ .....++.+.+++.+|+ .+|.+|++
T Consensus 233 SlGvil~elltG~~Pf~~~~--~---~~~~~~i~~~~~~~~~p----------~~~~~s~~~~~li~~l~-~~p~~R~~~ 296 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQT--P---LETQMKVINWQTSLHIP----------PQAKLSPEASDLIIKLC-RGPEDRLGK 296 (382)
T ss_pred echHHHHHHHhCCCCCCCCC--H---HHHHHHHHccCCCcCCC----------CcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence 99999999999999985311 1 00001111100000000 01123346778888876 49999997
Q ss_pred --HHHHHH
Q 012214 437 --MEEVSM 442 (468)
Q Consensus 437 --~~evl~ 442 (468)
+.++++
T Consensus 297 ~~~~ei~~ 304 (382)
T cd05625 297 NGADEIKA 304 (382)
T ss_pred CCHHHHhc
Confidence 776654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=307.50 Aligned_cols=253 Identities=27% Similarity=0.409 Sum_probs=195.3
Q ss_pred ceeeecCcEEEEEEEecC-Cc--EEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcceeEeee
Q 012214 170 RILGQGGQGTVYKGMLED-GR--IIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVYEF 245 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~-g~--~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~ 245 (468)
+.||+|+||.||+|...+ +. .+++|.++..... ...+.+.+|+.++.++ +||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH---HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence 358999999999999653 43 4688887643222 3345788999999999 899999999999999999999999
Q ss_pred cCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 246 IPNGTLYQHLHDRHQN-----------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 246 ~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
+++++|.+++...... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEEC
Confidence 9999999999764311 1224789999999999999999999998 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHH
Q 012214 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 315 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
|||++...... ........+..|+|||++....++.++||||||+++|||++ |..||.... . ...+...
T Consensus 155 dfgl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~---~~~~~~~ 224 (270)
T cd05047 155 DFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----C---AELYEKL 224 (270)
T ss_pred CCCCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-----H---HHHHHHH
Confidence 99998532211 11112234567999999988889999999999999999997 999984311 0 0111111
Q ss_pred hhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 394 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
...... ..+...+..+.+++.+||+.+|.+|||+.++++.|+.|.
T Consensus 225 ~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 PQGYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred hCCCCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111010 011223447889999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=307.06 Aligned_cols=272 Identities=25% Similarity=0.367 Sum_probs=204.6
Q ss_pred HHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc--CCCceeeEeeeeccCC-
Q 012214 161 KATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI--NHRNVVKLLGCCLETE- 237 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l--~h~niv~l~g~~~~~~- 237 (468)
....+..+.+.||+|.||.||+|.+. |..||||++.... .+.+.+|.++.+.. +|+||+.+++.-..+.
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd-------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD-------ERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEecccc-------hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 34567788899999999999999996 8899999987532 14577888888765 9999999998865433
Q ss_pred ---cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCEEecCCCCCCEEEcCCC
Q 012214 238 ---VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS-----ATSSPIYHRDIKSTNILLDQRY 309 (468)
Q Consensus 238 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-----~~~~~iiH~DLkp~NILl~~~~ 309 (468)
.++||++|.++|||.+||.+. .++.+..++++..+|.||++||- +++|.|.|||||..||||..|+
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 678999999999999999762 58899999999999999999994 4789999999999999999999
Q ss_pred cEEEEecCCcccccCCCcee---eecccccCCccCccccccCC----C--CCcccHHHHHHHHHHHHhC----------C
Q 012214 310 RAKVADFGTSKFIAMDQTHV---TTKIQGTFGYLDPEYHQSSQ----L--TDKSDVYSFGVVLVELLTG----------K 370 (468)
Q Consensus 310 ~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~----~--s~ksDVwSlGvll~el~tG----------~ 370 (468)
.+.|+|+|+|.....+.... ....+||.+|||||++...- + -..+||||||.++||++-. +
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 99999999998765543322 33457999999999987632 1 1258999999999998752 4
Q ss_pred CCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 371 KPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 371 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
.||+...+.+. +..+ ....+-..++...++.. ....+....+.+++..||..||.-|-|+--+-+.|.++.++
T Consensus 434 ~Pyyd~Vp~DP---s~ee-MrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 434 LPYYDVVPSDP---SFEE-MRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCcccCCCCCC---CHHH-HhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 56643222111 1111 11111111111111111 11234556789999999999999999999999999998865
Q ss_pred Cch
Q 012214 451 SKK 453 (468)
Q Consensus 451 ~~~ 453 (468)
..+
T Consensus 507 ~ek 509 (513)
T KOG2052|consen 507 DEK 509 (513)
T ss_pred hhh
Confidence 433
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=316.30 Aligned_cols=244 Identities=25% Similarity=0.311 Sum_probs=192.5
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcceeEeeecC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
+.||+|+||.||+|... +++.||+|++...... .....+.+..|..++..+ +||||+++++++.+....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 35999999999999965 5789999988653211 113345677888888866 89999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+++|...+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 80 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 151 (321)
T cd05591 80 GGDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV 151 (321)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence 999998886532 4889999999999999999999999 99999999999999999999999999875432222
Q ss_pred eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+.........
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--------~~~~~~~i~~~~~~-------- 214 (321)
T cd05591 152 -TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--------EDDLFESILHDDVL-------- 214 (321)
T ss_pred -cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCC--------
Confidence 2234568999999999999999999999999999999999999985311 11111111111100
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCC-------CHHHHHH
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRP-------TMEEVSM 442 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-------t~~evl~ 442 (468)
.+...+..+.+++.+||+.||++|| ++.++++
T Consensus 215 ---~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 215 ---YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 0112334788999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=290.07 Aligned_cols=252 Identities=27% Similarity=0.336 Sum_probs=205.7
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|-||.||.|+.+ ++-.||+|++..... ....-..++.+|+++.+.++||||+++++++.+....||
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi-~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQI-LKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHH-HHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 377999999999999999999954 678899999865321 111234568899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
++||.++|+|...|.... ...+++.....++.|+|.||.|+|..+ +|||||||+|+|++.++.+||+|||-+..
T Consensus 100 ilEya~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EEEecCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceee
Confidence 999999999999998632 235888888999999999999999999 99999999999999999999999999865
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.+ .......+||..|.|||+..+..++.++|+|++|++.||++.|.+||.... ..+.+....+ - +
T Consensus 174 ~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--------~~etYkrI~k-~---~ 238 (281)
T KOG0580|consen 174 AP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--------HSETYKRIRK-V---D 238 (281)
T ss_pred cC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--------hHHHHHHHHH-c---c
Confidence 43 233455789999999999999999999999999999999999999985311 1111111111 0 1
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
-..+...+....++|.+|+..+|.+|.+..|+++.
T Consensus 239 -------~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 239 -------LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -------ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11123444578899999999999999999999753
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=300.60 Aligned_cols=264 Identities=23% Similarity=0.258 Sum_probs=202.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc--CCcc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE--TEVP 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~ 239 (468)
.+.|+..+.|++|+||.||+|+++ ++..||+|+++........ --..++|+.++.+++|||||.+..+... -+..
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GF--PItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGF--PITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCC--cchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 466888899999999999999965 6889999999875432211 1235799999999999999999888754 4568
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
|+|||||+. +|..++.... +++...++.-++.|+++|++|||+.. |+|||||++|+|++..|.+||+|||+|
T Consensus 153 y~VMe~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred eeeHHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchh
Confidence 999999987 8999987643 36889999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh---
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR--- 395 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 395 (468)
+.+..... ..+..+-|..|.|||.+.+ ..|++..|+||+||++.||+++++-|...+ +...+...+ ..+.
T Consensus 225 R~ygsp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s----E~dQl~~If-~llGtPt 298 (419)
T KOG0663|consen 225 REYGSPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS----EIDQLDKIF-KLLGTPS 298 (419)
T ss_pred hhhcCCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc----hHHHHHHHH-HHhCCCc
Confidence 98865422 3456678999999999888 579999999999999999999988764311 111111111 1111
Q ss_pred ccccchh--------------cchHHhhhchHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 396 KNRLHDI--------------LDDQLMKLGVKN-QIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 396 ~~~~~~~--------------~d~~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...++.+ ....+....... .++.-.+|+..+|..||.+|.|++|.++
T Consensus 299 e~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 299 EAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1111111 111122111111 3456789999999999999999999875
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=307.38 Aligned_cols=248 Identities=22% Similarity=0.291 Sum_probs=192.4
Q ss_pred eeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCCCC
Q 012214 172 LGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 250 (468)
Q Consensus 172 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 250 (468)
||+|+||.||++..+ +|+.+|+|.+........ .....+..|+.++++++||||+++++++.+....++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc-hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 699999999999864 689999998864221110 122345679999999999999999999999999999999999999
Q ss_pred hhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCceee
Q 012214 251 LYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT 330 (468)
Q Consensus 251 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 330 (468)
|.+.+.... ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++....... ..
T Consensus 80 L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~ 151 (277)
T cd05607 80 LKYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TI 151 (277)
T ss_pred HHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--ee
Confidence 998886532 235889999999999999999999999 9999999999999999999999999987654322 22
Q ss_pred ecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhh
Q 012214 331 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKL 410 (468)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 410 (468)
....|+..|+|||++.+..++.++|||||||++|||++|+.||..... ............ ..... .
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~----~~~~~~~~~~~~-~~~~~---------~ 217 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE----KVAKEELKRRTL-EDEVK---------F 217 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc----hhhHHHHHHHhh-ccccc---------c
Confidence 334689999999999998899999999999999999999999853111 011111111111 11100 0
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 411 GVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 411 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.....+..+.+++.+||+.||++||++.|+++
T Consensus 218 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 218 EHQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred ccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 01123457899999999999999999987753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=326.14 Aligned_cols=247 Identities=26% Similarity=0.318 Sum_probs=202.9
Q ss_pred HHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCc
Q 012214 161 KATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEV 238 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~ 238 (468)
...++|...+.||+|+||+|+++..+ +++.+|||+++....-.. ..++..+.|.+++... +||.++.++.++.+.++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~-d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQR-DEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecc-ccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 34578999999999999999999976 588999999987543221 4567788898888887 59999999999999999
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++||||+.||++....+. ..+++..+.-++..|+.||.|||+++ ||+||||.+|||||.+|.+||+|||+
T Consensus 444 l~fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred EEEEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccc
Confidence 9999999999994433332 25999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
++...... ..++..+||+.|||||++.+..|+..+|.|||||+||||+.|..||.. ++.. +.+......+
T Consensus 515 cKe~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g--ddEe------e~FdsI~~d~- 584 (694)
T KOG0694|consen 515 CKEGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG--DDEE------EVFDSIVNDE- 584 (694)
T ss_pred ccccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC--CCHH------HHHHHHhcCC-
Confidence 98654222 246678999999999999999999999999999999999999999853 1111 1122222111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTM 437 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 437 (468)
..+|...+.+..+++.++|..+|++|..+
T Consensus 585 ----------~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 ----------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12345556688999999999999999977
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=316.57 Aligned_cols=265 Identities=26% Similarity=0.356 Sum_probs=203.4
Q ss_pred hcCCCCCceeeecCcEEEEEEEe------cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeecc
Q 012214 163 TNHFNANRILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLE 235 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~ 235 (468)
.++|.+.+.||+|+||.||+|.. .+++.||||+++..... .....+.+|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh---HHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 36789999999999999999973 34788999998754332 3346788999999999 78999999998865
Q ss_pred C-CcceeEeeecCCCChhhHhhhcccC-----------------------------------------------------
Q 012214 236 T-EVPLLVYEFIPNGTLYQHLHDRHQN----------------------------------------------------- 261 (468)
Q Consensus 236 ~-~~~~lV~E~~~~gsL~~~l~~~~~~----------------------------------------------------- 261 (468)
. ...+++|||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 4678999999999999998653210
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCce-eee
Q 012214 262 ---------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH-VTT 331 (468)
Q Consensus 262 ---------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~ 331 (468)
....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 0124788899999999999999999999 999999999999999999999999998765332221 122
Q ss_pred cccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhh
Q 012214 332 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKL 410 (468)
Q Consensus 332 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 410 (468)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..............
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~--------- 302 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------EEFCRRLKEGTRMR--------- 302 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--------HHHHHHHhccCCCC---------
Confidence 2345678999999998899999999999999999997 88887431110 01111111111100
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 411 GVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 411 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
.+...++.+.+++.+||+.+|++|||+.|+++.|+.+.+.
T Consensus 303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0111234689999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=319.24 Aligned_cols=240 Identities=28% Similarity=0.315 Sum_probs=191.4
Q ss_pred ceeeecCcEEEEEEEe----cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeee
Q 012214 170 RILGQGGQGTVYKGML----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEF 245 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 245 (468)
+.||+|+||.||++.. .+|+.+|+|++...... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK--VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 5699999999999874 35789999988653211 12334577899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 012214 246 IPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMD 325 (468)
Q Consensus 246 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 325 (468)
+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 80 LRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 9999999998652 24899999999999999999999999 999999999999999999999999998765433
Q ss_pred CceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcch
Q 012214 326 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDD 405 (468)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 405 (468)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||... ... ..... ......
T Consensus 152 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-----~~~---~~~~~-i~~~~~------ 215 (318)
T cd05582 152 EK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK-----DRK---ETMTM-ILKAKL------ 215 (318)
T ss_pred CC-ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC-----CHH---HHHHH-HHcCCC------
Confidence 22 223456899999999999988999999999999999999999998531 111 11111 111110
Q ss_pred HHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 012214 406 QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439 (468)
Q Consensus 406 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e 439 (468)
..+...+..+.+++.+||+.||++|||+.+
T Consensus 216 ----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 ----GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 011223447889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=306.04 Aligned_cols=249 Identities=27% Similarity=0.420 Sum_probs=198.6
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeec-cCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL-ETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~-~~~~~~lV 242 (468)
++|.+.+.||+|+||.||++... |..+|+|...... ..+.+.+|+.++++++|+|++++++++. +....+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 46888899999999999999875 7789999876432 2356889999999999999999999764 45678999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 79 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 79 TEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred EECCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceec
Confidence 99999999999997632 235889999999999999999999999 999999999999999999999999998754
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.... .....+..|+|||++.+..++.++|||||||++|||++ |+.||... . ..... .........
T Consensus 153 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~---~~~~~-~~~~~~~~~- 218 (256)
T cd05082 153 SSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----P---LKDVV-PRVEKGYKM- 218 (256)
T ss_pred cccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----C---HHHHH-HHHhcCCCC-
Confidence 3221 12234568999999998899999999999999999998 88887421 1 11111 111111000
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
..+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 219 --------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 --------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11223445789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=302.93 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=192.4
Q ss_pred ceeeecCcEEEEEEEecC---CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeec
Q 012214 170 RILGQGGQGTVYKGMLED---GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFI 246 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 246 (468)
+.||+|+||.||+|...+ +..+|+|.+...... .....+.+|+.++++++||||+++++++.+....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV---QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence 358999999999998543 457899988664333 23357889999999999999999999999989999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 012214 247 PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQ 326 (468)
Q Consensus 247 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 326 (468)
++|+|.+++...........++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9999999997644333335677888899999999999999999 9999999999999999999999999987543332
Q ss_pred cee-eecccccCCccCccccccC-------CCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 327 THV-TTKIQGTFGYLDPEYHQSS-------QLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 327 ~~~-~~~~~gt~~y~aPE~~~~~-------~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
... .....++..|+|||++.+. .++.++||||||+++|||++ |+.||..... . ..... .....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~---~~~~~---~~~~~ 226 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--E---QVLTY---TVREQ 226 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh--H---HHHHH---Hhhcc
Confidence 221 2234577889999988642 35789999999999999996 9999843111 0 00011 11110
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
.....++.+ ....+..+.+++..|+ .+|++|||+.||+..|+
T Consensus 227 -~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 227 -QLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -cCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 011111111 1122346788999999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=326.58 Aligned_cols=255 Identities=21% Similarity=0.252 Sum_probs=195.6
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||.||++... +++.||+|++...... .......+.+|+.+++.++|+||+++++.+.+.+..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 36888999999999999999954 5889999988642211 112345688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 80 ~E~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 80 MDYIPGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred EeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999999996532 4788899999999999999999999 999999999999999999999999997532
Q ss_pred cCCC------------------------------------------ceeeecccccCCccCccccccCCCCCcccHHHHH
Q 012214 323 AMDQ------------------------------------------THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFG 360 (468)
Q Consensus 323 ~~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG 360 (468)
.... ........||+.|+|||++.+..++.++||||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 231 (376)
T cd05598 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231 (376)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence 1000 0001134699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCC---CH
Q 012214 361 VVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP---TM 437 (468)
Q Consensus 361 vll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~ 437 (468)
|++|||++|+.||.... .. ........+...... ......+..+.+++.+|+ .+|.+|+ |+
T Consensus 232 vilyell~G~~Pf~~~~--~~---~~~~~i~~~~~~~~~----------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~ 295 (376)
T cd05598 232 VILYEMLVGQPPFLADT--PA---ETQLKVINWETTLHI----------PSQAKLSREASDLILRLC-CGAEDRLGKNGA 295 (376)
T ss_pred ceeeehhhCCCCCCCCC--HH---HHHHHHhccCccccC----------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence 99999999999985321 10 000001000000000 001123446778888876 5999999 88
Q ss_pred HHHHHH
Q 012214 438 EEVSME 443 (468)
Q Consensus 438 ~evl~~ 443 (468)
.++++.
T Consensus 296 ~ell~h 301 (376)
T cd05598 296 DEIKAH 301 (376)
T ss_pred HHHhCC
Confidence 888753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=305.10 Aligned_cols=255 Identities=25% Similarity=0.455 Sum_probs=201.5
Q ss_pred cCCCCCceeeecCcEEEEEEEecC-C---cEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED-G---RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
+.|++.+.||+|+||.||+|.... + ..||+|.+...... ....+|..|+.+++.++||||+++++++.+....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE---KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH---HHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 457788899999999999999653 3 36999998754333 3456799999999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~ 153 (269)
T cd05065 81 MIITEFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLS 153 (269)
T ss_pred EEEEecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccc
Confidence 99999999999999987532 24889999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCcee--eecc--cccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHh
Q 012214 320 KFIAMDQTHV--TTKI--QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 320 ~~~~~~~~~~--~~~~--~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
.......... .... ..+..|+|||.+.+..++.++|||||||++||+++ |..||.... ... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-----~~~----~~~~i 224 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQD----VINAI 224 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-----HHH----HHHHH
Confidence 7654322211 1111 12457999999999999999999999999999886 999974311 111 11111
Q ss_pred hc-cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 395 RK-NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 395 ~~-~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
.. ..+. .+...+..+.+++.+||+.+|++||++.+++..|+++
T Consensus 225 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 EQDYRLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HcCCcCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 1110 1123445788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=314.63 Aligned_cols=244 Identities=25% Similarity=0.300 Sum_probs=192.9
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcceeE
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV 242 (468)
+|.+.+.||+|+||.||++... +++.||+|++....... ....+.+..|..++..+ +|++|+++++++.+.+..++|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 4778899999999999999865 57899999886532211 12345567788888777 689999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 80 ~E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~ 151 (323)
T cd05616 80 MEYVNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 151 (323)
T ss_pred EcCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceec
Confidence 99999999999886532 4889999999999999999999999 999999999999999999999999998754
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .. ........ ...
T Consensus 152 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-----~~---~~~~~i~~-~~~--- 218 (323)
T cd05616 152 MWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----ED---ELFQSIME-HNV--- 218 (323)
T ss_pred CCCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC-----HH---HHHHHHHh-CCC---
Confidence 32221 2234568999999999999999999999999999999999999985311 11 11111111 110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTM 437 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 437 (468)
..+...+..+.+++.+||+.+|++|++.
T Consensus 219 -------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0122334578899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=312.93 Aligned_cols=243 Identities=26% Similarity=0.333 Sum_probs=189.7
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcceeEeeecC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
+.||+|+||.||+|... +++.||+|+++...... ......+..|..++... +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 46999999999999965 57899999886532111 12334566777787764 99999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 80 ~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05619 80 GGDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA 151 (316)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence 99999998653 24888999999999999999999999 99999999999999999999999999875322221
Q ss_pred eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
......||..|+|||++.+..++.++|||||||++|||++|+.||.... .. . ..........
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~---~-~~~~i~~~~~-------- 213 (316)
T cd05619 152 -KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-----EE---E-LFQSIRMDNP-------- 213 (316)
T ss_pred -ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-----HH---H-HHHHHHhCCC--------
Confidence 1233568999999999999999999999999999999999999985311 11 1 1111111100
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTME-EVS 441 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-evl 441 (468)
..+...+..+.+++.+||+.||++||++. ++.
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 214 --CYPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred --CCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 00112334688999999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=301.67 Aligned_cols=253 Identities=29% Similarity=0.436 Sum_probs=192.9
Q ss_pred ceeeecCcEEEEEEEec----CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeec-cCCcceeEee
Q 012214 170 RILGQGGQGTVYKGMLE----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL-ETEVPLLVYE 244 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~-~~~~~~lV~E 244 (468)
+.||+|+||.||+|... +...+|+|.+...... ...+.+.+|+.+++.++||||+++++++. .+...++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL---EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH---HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence 35899999999999853 2457999987543222 34567889999999999999999999775 4556889999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
|+.+++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++....
T Consensus 78 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~ 150 (262)
T cd05058 78 YMKHGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYD 150 (262)
T ss_pred cCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccC
Confidence 999999999997532 23677888999999999999999998 99999999999999999999999999976543
Q ss_pred CCcee---eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 325 DQTHV---TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 325 ~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
..... .....++..|+|||.+.+..++.++|||||||++|||++|..|+... ........ .........
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~----~~~~~~~~---~~~~~~~~~- 222 (262)
T cd05058 151 KEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD----VDSFDITV---YLLQGRRLL- 222 (262)
T ss_pred CcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC----CCHHHHHH---HHhcCCCCC-
Confidence 22111 12334677899999998889999999999999999999965543221 11111111 111111100
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
.+...+..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 223 ---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 223 ---------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 011223478899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=316.30 Aligned_cols=240 Identities=26% Similarity=0.348 Sum_probs=187.9
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHH-HHHhcCCCceeeEeeeeccCCcceeEeeecC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIV-ILSQINHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
+.||+|+||+||++... +|+.||+|++....... .....++..|.. +++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 46999999999999965 68999999986532111 122344555654 5678999999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~- 150 (323)
T cd05575 80 GGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS- 150 (323)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-
Confidence 99999988652 25889999999999999999999999 9999999999999999999999999987532221
Q ss_pred eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......... ....
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~-~~~~------- 214 (323)
T cd05575 151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNILN-KPLR------- 214 (323)
T ss_pred CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHHc-CCCC-------
Confidence 12334568999999999999999999999999999999999999985311 0111111111 1100
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCCCHH
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTME 438 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 438 (468)
.+...+..+.+++.+||+.||.+||++.
T Consensus 215 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 ---LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0112345788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=322.76 Aligned_cols=261 Identities=24% Similarity=0.296 Sum_probs=200.8
Q ss_pred HHHHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC
Q 012214 158 ELDKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 236 (468)
Q Consensus 158 ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~ 236 (468)
++....++|.+.+.||+|+||.||++... +++.+|+|++...... .......+.+|+.+++.++||||+++++++.+.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 34445688999999999999999999965 5889999987542111 112345578899999999999999999999999
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...++||||+++|+|.+++... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999998652 3788889999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCceeeecccccCCccCccccccC----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHH
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVH 392 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 392 (468)
|+++..............||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....+..
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~ 258 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSK 258 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC--------HHHHHHH
Confidence 99987654333333456799999999998753 37889999999999999999999985311 1111222
Q ss_pred HhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 012214 393 SMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKK--RPTMEEVSME 443 (468)
Q Consensus 393 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 443 (468)
.........+.+ ....+..+.+++.+||+.++.+ ||++.++++.
T Consensus 259 i~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 259 IMNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHcCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 211111111111 1234457889999999843332 7788888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=310.00 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=201.3
Q ss_pred cCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 237 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 237 (468)
.+|...++||+|+||.||++... ++..+|+|.+.... . .....+.+|+.+++.++|+||+++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-E---SARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-H---HHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 45777889999999999999632 35678999876532 2 33467899999999999999999999999999
Q ss_pred cceeEeeecCCCChhhHhhhcccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQN----------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ 307 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~ 307 (468)
..++++||+++++|.+++...... ....+++..++.++.|++.|++|||+.+ ++|+||||+|||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcC
Confidence 999999999999999999764311 1135889999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhc
Q 012214 308 RYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVS 385 (468)
Q Consensus 308 ~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~ 385 (468)
++.+||+|||+++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.... ...
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~ 232 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS-----NTE 232 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC-----HHH
Confidence 9999999999987554322211 222335678999999999999999999999999999998 888874211 000
Q ss_pred hHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 386 LAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
. . ......... ..+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus 233 ~---~-~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 233 A---I-ECITQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred H---H-HHHHcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0 1 111111000 1112334578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=304.96 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=200.8
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
.+|++.+.||+|+||.||++...++..+|+|.+...... ...|.+|+.++++++|||++++++++......++|+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 467788899999999999999877888999988653322 246889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++++|.+++.... ..+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 79 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 79 EFMEHGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVL 151 (256)
T ss_pred EcCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecc
Confidence 9999999999986532 24789999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...........++.+|+|||.+.++.++.++||||||+++|||++ |..||.... .. . ......... ..
T Consensus 152 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~---~-~~~~~~~~~--~~ 220 (256)
T cd05112 152 DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-----NS---E-VVETINAGF--RL 220 (256)
T ss_pred cCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-----HH---H-HHHHHhCCC--CC
Confidence 332222222335678999999998899999999999999999998 888874211 01 1 111111110 00
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
. .+...+..+.+++.+||+.+|++|||+.+++++|.
T Consensus 221 ~-------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 221 Y-------KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred C-------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 0 01123357899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=318.12 Aligned_cols=265 Identities=25% Similarity=0.369 Sum_probs=207.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEec--------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE--------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCC 233 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~ 233 (468)
..+|.+.+.||+|+||.||++... .+..||+|........ ...+++.+|+.+++++ +||||+++++++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD---KDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH---HHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 356889999999999999999742 1236899987753322 3457889999999999 899999999999
Q ss_pred ccCCcceeEeeecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCC
Q 012214 234 LETEVPLLVYEFIPNGTLYQHLHDRHQ-----------NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTN 302 (468)
Q Consensus 234 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~N 302 (468)
......++++||+++|+|.+++..... .....+++..+..++.|++.||+|||+.+ ++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence 999999999999999999999976431 12235889999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 012214 303 ILLDQRYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTS 380 (468)
Q Consensus 303 ILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~ 380 (468)
||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||... .
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~- 241 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--P- 241 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC--C-
Confidence 999999999999999997654322221 222334567999999999999999999999999999998 78887421 1
Q ss_pred cchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 381 QENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
... ........... ..+...+..+.+++.+||+.+|++|||+.|+++.|+.+....
T Consensus 242 -----~~~-~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 242 -----VEE-LFKLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -----HHH-HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 111 11111111111 112233457889999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=300.64 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=201.5
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|++.+.||+|+||.||++... +++.+|+|.+...... ...+.+.+|+.+++.++|+||+++++++.+....++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS---SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch---HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence 4778899999999999999865 6889999987653322 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 78 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 78 EYCDGGDLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT 151 (255)
T ss_pred eeCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeec
Confidence 9999999999886522 235789999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
.... ......++..|+|||++.+..++.++|+||||+++|+|++|..||... .. .... ..........
T Consensus 152 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-----~~---~~~~-~~~~~~~~~~-- 219 (255)
T cd08219 152 SPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-----SW---KNLI-LKVCQGSYKP-- 219 (255)
T ss_pred cccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-----CH---HHHH-HHHhcCCCCC--
Confidence 3222 123356888999999999988999999999999999999999998431 10 0111 1111111111
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
.+...+..+.+++.+||+.||++|||+.+++..
T Consensus 220 -------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 -------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112234468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=300.87 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=198.0
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCCC
Q 012214 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 249 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g 249 (468)
++||+|+||.||++...+++.||+|........ .....+.+|+.++++++|+||+++++++.+....++|+||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP---DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 369999999999999777999999988764333 34467899999999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCcee
Q 012214 250 TLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHV 329 (468)
Q Consensus 250 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 329 (468)
+|.+++.... ..+++..+..++.+++.||+|||+.+ ++||||+|+||+++.++.++|+|||++..........
T Consensus 78 ~l~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 150 (251)
T cd05041 78 SLLTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV 150 (251)
T ss_pred cHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence 9999986532 24789999999999999999999999 9999999999999999999999999987654222211
Q ss_pred e-ecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 330 T-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 330 ~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
. .....+..|+|||.+.++.++.++|+||||+++|||++ |..||..... .. .........
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-----~~----~~~~~~~~~--------- 212 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-----QQ----TRERIESGY--------- 212 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-----HH----HHHHHhcCC---------
Confidence 1 11234567999999998899999999999999999999 7777743110 00 111111100
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
....+...+..+.+++.+||+.+|.+|||+.|+++.|++
T Consensus 213 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 001122334579999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=313.22 Aligned_cols=244 Identities=25% Similarity=0.319 Sum_probs=193.1
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcceeEeeecC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
+.||+|+||.||++... +++.||+|+++..... .......+..|..++..+ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999865 5789999988753211 113445677888888888 79999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+|+|..++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 80 ~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 151 (318)
T cd05570 80 GGDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151 (318)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence 999998886532 4899999999999999999999999 99999999999999999999999999865322221
Q ss_pred eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
......||..|+|||++.+..++.++|||||||++|+|++|+.||.... .. . ..........
T Consensus 152 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----~~---~-~~~~i~~~~~-------- 213 (318)
T cd05570 152 -TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----ED---E-LFQSILEDEV-------- 213 (318)
T ss_pred -cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----HH---H-HHHHHHcCCC--------
Confidence 1233468999999999999999999999999999999999999985311 11 1 1111111110
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTM-----EEVSM 442 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~ 442 (468)
..+...+..+.+++.+||+.||.+|||+ .++++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 --RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred --CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0112234578999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=326.93 Aligned_cols=266 Identities=23% Similarity=0.326 Sum_probs=194.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC-----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----- 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~----- 236 (468)
..+|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 467999999999999999999964 68899999875421 1234699999999999999998876321
Q ss_pred ---CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC-cEE
Q 012214 237 ---EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY-RAK 312 (468)
Q Consensus 237 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~-~~k 312 (468)
...++||||++ ++|.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+|
T Consensus 137 ~~~~~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vk 211 (440)
T PTZ00036 137 EKNIFLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLK 211 (440)
T ss_pred CCceEEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCcee
Confidence 24568999997 478777754321 2236899999999999999999999999 99999999999999665 799
Q ss_pred EEecCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHH
Q 012214 313 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391 (468)
Q Consensus 313 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (468)
|+|||+++....... .....+|+.|+|||++.+ ..++.++|||||||++|||++|..||.... ..+ ......
T Consensus 212 L~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~--~~~---~~~~i~ 284 (440)
T PTZ00036 212 LCDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS--SVD---QLVRII 284 (440)
T ss_pred eeccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHH---HHHHHH
Confidence 999999986643322 223467999999998876 468999999999999999999999985311 111 111111
Q ss_pred HHhhcc---------------ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhcc
Q 012214 392 HSMRKN---------------RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGIR 448 (468)
Q Consensus 392 ~~~~~~---------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i~ 448 (468)
.....+ .+..+....+....+...+.++.+|+.+||+.||.+|||+.|+++ .++.++
T Consensus 285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 111100 011111111222223344568899999999999999999999985 344443
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=312.12 Aligned_cols=243 Identities=26% Similarity=0.336 Sum_probs=189.6
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcceeEeeecC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
+.||+|+||.||++... +|+.||+|.++...... ......+..|..++... +||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 46999999999999965 58899999886532111 12334566787777754 89999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 150 (316)
T cd05620 80 GGDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD- 150 (316)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-
Confidence 99999988653 24889999999999999999999999 9999999999999999999999999987432211
Q ss_pred eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
.......||..|+|||++.+..++.++|||||||++|||++|+.||.... .. ... ........
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-----~~---~~~-~~~~~~~~-------- 213 (316)
T cd05620 151 NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-----ED---ELF-ESIRVDTP-------- 213 (316)
T ss_pred CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HH---HHH-HHHHhCCC--------
Confidence 12334568999999999999999999999999999999999999985311 11 111 11111100
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTME-EVS 441 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-evl 441 (468)
..+...+..+.+++.+||+.||++||++. +++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 --HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 00112334688999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=305.44 Aligned_cols=270 Identities=26% Similarity=0.367 Sum_probs=210.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|+..+.||.|++|.||++... +++.+|+|.+...... .....+.+|+.+++.++|+|++++++++.+....++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE---DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc---hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence 36788889999999999999965 6889999988754322 3446788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||+++++|.+++... ++++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++..
T Consensus 78 ~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 148 (274)
T cd06609 78 MEYCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQL 148 (274)
T ss_pred EEeeCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceee
Confidence 9999999999998652 5899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ... ............+
T Consensus 149 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~-----~~~----~~~~~~~~~~~~~ 218 (274)
T cd06609 149 TSTMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-----PMR----VLFLIPKNNPPSL 218 (274)
T ss_pred ccccc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc-----hHH----HHHHhhhcCCCCC
Confidence 54322 2233467889999999999889999999999999999999999984311 000 1111111111111
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCchhhhHHHHHHh
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKRAMFSKIIK 463 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~ 463 (468)
.. ...+..+.+++.+||+.+|++|||++++++.=-=.+...+..-.....+++
T Consensus 219 ~~--------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~~~~~~~~~ 271 (274)
T cd06609 219 EG--------NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTLLIERIK 271 (274)
T ss_pred cc--------cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcccHHHHHHHHHH
Confidence 10 114457899999999999999999999987432222333333444444443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=314.95 Aligned_cols=243 Identities=26% Similarity=0.338 Sum_probs=188.0
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHH-HHHHhcCCCceeeEeeeeccCCcceeEeeecC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEI-VILSQINHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei-~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
+.||+|+||.||++... +++.+|+|++........ .....+..|. .+++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 36999999999999965 578899998864321111 2223444454 45678899999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 80 GGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 999999986532 4778888999999999999999999 99999999999999999999999999875432211
Q ss_pred eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ...+..... ....
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~------~~~~~~i~~-~~~~------- 214 (325)
T cd05602 152 -TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--T------AEMYDNILN-KPLQ------- 214 (325)
T ss_pred -CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC--H------HHHHHHHHh-CCcC-------
Confidence 2334569999999999999999999999999999999999999985311 0 111111111 1110
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVS 441 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 441 (468)
.....+..+.+++.+||+.+|.+||++.+.+
T Consensus 215 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 215 ---LKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred ---CCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 1123345788999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=304.02 Aligned_cols=254 Identities=35% Similarity=0.507 Sum_probs=198.6
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEee
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYE 244 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 244 (468)
|++.+.||+|+||+||++... +++.+|+|.+....... .......+|+.++++++||||+++++++.+....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE--EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH--HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc--cccchhhhhhhcccccccccccccccccccccccccccc
Confidence 456788999999999999976 56789999987753332 223344569999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
++++++|.+++... ..+++..+..++.|+++||.+||+.+ ++|+||||+||+++.++.++|+|||.+....
T Consensus 79 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~- 149 (260)
T PF00069_consen 79 YCPGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS- 149 (260)
T ss_dssp EETTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-
T ss_pred cccccccccccccc-----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-
Confidence 99999999999832 24899999999999999999999999 9999999999999999999999999987542
Q ss_pred CCceeeecccccCCccCccccc-cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 325 DQTHVTTKIQGTFGYLDPEYHQ-SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
..........++..|+|||.+. +...+.++||||+|+++|+|++|..||... ................ ...
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~-----~~~~~~~~~~~~~~~~-~~~-- 221 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES-----NSDDQLEIIEKILKRP-LPS-- 221 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS-----SHHHHHHHHHHHHHTH-HHH--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cchhhhhhhhhccccc-ccc--
Confidence 2222344556899999999998 788999999999999999999999998532 0011111111111100 000
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...........+.+++.+||+.||++|||+.++++
T Consensus 222 ----~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 222 ----SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ----HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ----cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000011258999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=302.52 Aligned_cols=255 Identities=26% Similarity=0.341 Sum_probs=190.3
Q ss_pred eeeecCcEEEEEEEecC---CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecC
Q 012214 171 ILGQGGQGTVYKGMLED---GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 171 ~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
.||+|+||.||+|...+ ...+++|.+...... .....|.+|+..++.++|+||+++++.+.+....++||||++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP---DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCCh---HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 58999999999997543 456888877654332 334678899999999999999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+|+|.+++...........++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh
Confidence 999999997754332334578888999999999999999999 99999999999999999999999999865433222
Q ss_pred ee-eecccccCCccCcccccc-------CCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 328 HV-TTKIQGTFGYLDPEYHQS-------SQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 328 ~~-~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
.. .....++..|+|||++.. ..++.++|||||||++|||++ |..||... ... ...........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-----~~~---~~~~~~~~~~~ 227 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL-----SDE---QVLKQVVREQD 227 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC-----CHH---HHHHHHhhccC
Confidence 21 222345678999998643 456789999999999999999 77776421 111 11111111111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
..+..+.. +...+..+.+++..|+ .||++|||+++|++.|.
T Consensus 228 -~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 -IKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -ccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111111 1233446778888898 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=307.36 Aligned_cols=266 Identities=24% Similarity=0.389 Sum_probs=205.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec-----CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc--C
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE--T 236 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~ 236 (468)
.+|...+.||+|+||.||++... .+..+|+|.+...... ...+.|.+|+.+++.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 45677789999999999999853 3678999998764332 345679999999999999999999999877 5
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 153 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDF 153 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccc
Confidence 57899999999999999997632 24899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCcee--eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccc------hhchHH
Q 012214 317 GTSKFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE------NVSLAA 388 (468)
Q Consensus 317 Gla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~------~~~~~~ 388 (468)
|++.......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+......... ......
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05038 154 GLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233 (284)
T ss_pred ccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH
Confidence 9998765332211 11233556799999999889999999999999999999999987431111100 000011
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
.......... ....+..++..+.+++.+||+.+|++|||+.||+++|+.+.
T Consensus 234 ~~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 234 RLLELLKEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHHHHHcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1111111110 11112234467999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=314.44 Aligned_cols=262 Identities=23% Similarity=0.302 Sum_probs=196.1
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC---
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE--- 237 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--- 237 (468)
..++|++.+.||+|+||.||++... +|+.||+|++....... .....+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ--THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch--hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 4578999999999999999999864 58899999986543221 34467889999999999999999999986443
Q ss_pred ---cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 238 ---VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 238 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
..++||||+++ +|...+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~ 165 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 165 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEe
Confidence 46899999965 66666532 3788899999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 315 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
|||+++...... ......+|..|+|||.+.+..++.++|||||||++|+|++|+.||..... .+ .........
T Consensus 166 Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~--~~---~~~~~~~~~ 238 (359)
T cd07876 166 DFGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH--ID---QWNKVIEQL 238 (359)
T ss_pred cCCCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HH---HHHHHHHhc
Confidence 999997543221 22335689999999999999999999999999999999999999853211 00 000000000
Q ss_pred h--------------------ccccch-----hcchHH---hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 395 R--------------------KNRLHD-----ILDDQL---MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 395 ~--------------------~~~~~~-----~~d~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
. ...... ...... ........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 239 GTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred CCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000000 000000 000011124568899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=309.60 Aligned_cols=261 Identities=28% Similarity=0.421 Sum_probs=200.4
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||.||++... ++..+|+|.+...... .....+.+|++++.+++||||+++++++.+.+..++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP---AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence 46888999999999999999865 5788999987654322 3345688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS-ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++|+||||+|||+++++.+||+|||++..
T Consensus 78 ~ey~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (308)
T cd06615 78 MEHMDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 149 (308)
T ss_pred eeccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccc
Confidence 9999999999999753 248899999999999999999998 46 99999999999999999999999999875
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc---
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR--- 398 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 398 (468)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... .. ....+........
T Consensus 150 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~---~~~~~~~~~~~~~~~~ 221 (308)
T cd06615 150 LIDSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KE---LEAMFGRPVSEGEAKE 221 (308)
T ss_pred ccccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hh---HHHhhcCccccccccC
Confidence 43221 2234688999999999888899999999999999999999999853110 00 0000000000000
Q ss_pred -----------------cchhcchHHh----hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 399 -----------------LHDILDDQLM----KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 399 -----------------~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
..+..+.... .......+..+.+++.+||+.+|++|||+.++++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 00011234578999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=304.72 Aligned_cols=248 Identities=23% Similarity=0.281 Sum_probs=194.2
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEee
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYE 244 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 244 (468)
|+..+.||+|+||+||++... +++.+|+|.+....... ......+.+|+.+++.++|+|++++.+++.+.+..+++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK-RKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh-hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 566788999999999999864 68899999886532221 1233457889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 81 IMNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred eccCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 999999998886532 235899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcc
Q 012214 325 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404 (468)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 404 (468)
... .....|+..|+|||++.+..++.++|+||||+++|||++|..||..... ................
T Consensus 155 ~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~-----~~~~~~~~~~~~~~~~----- 222 (285)
T cd05632 155 GES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE-----KVKREEVDRRVLETEE----- 222 (285)
T ss_pred CCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhhhcccc-----
Confidence 221 2234689999999999998999999999999999999999999853111 0000111111111100
Q ss_pred hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCH
Q 012214 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTM 437 (468)
Q Consensus 405 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 437 (468)
..+...+..+.+|+.+||+.||++|||+
T Consensus 223 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05632 223 -----VYSAKFSEEAKSICKMLLTKDPKQRLGC 250 (285)
T ss_pred -----ccCccCCHHHHHHHHHHccCCHhHcCCC
Confidence 0112234468899999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=313.73 Aligned_cols=258 Identities=23% Similarity=0.289 Sum_probs=196.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||++... +++.||+|++..... ......+.+.+|+.++..++|+||+++++++.+....++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 46888999999999999999965 588999999864211 1113345688899999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 80 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 80 MDYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred EecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 99999999999996522 25889999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCceeeecccccCCccCcccccc-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
............||+.|+|||++.. ..++.++|||||||++|||++|+.||... .............
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~--------~~~~~~~~i~~~~ 224 (331)
T cd05597 153 LADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--------SLVETYGKIMNHK 224 (331)
T ss_pred CCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC--------CHHHHHHHHHcCC
Confidence 4433333333468999999999863 45788999999999999999999998431 0111111111111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCC--CCCCCHHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNG--KKRPTMEEVSME 443 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp--~~RPt~~evl~~ 443 (468)
....+.. .....+..+.+++.+|+..++ ..||++.++++.
T Consensus 225 ~~~~~~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 225 EHFQFPP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CcccCCC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1011000 011234577889998876533 347899888764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=324.32 Aligned_cols=250 Identities=24% Similarity=0.424 Sum_probs=206.3
Q ss_pred CCCceeeecCcEEEEEEEec--CCc--EEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 167 NANRILGQGGQGTVYKGMLE--DGR--IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 167 ~~~~~LG~G~fG~Vy~~~~~--~g~--~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
...++||+|.||.|++|.+. +|+ .||||.+...... ....+|++|+.+|.+++|+|+++|+|+..+ ....+|
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 34467999999999999865 344 5899999875544 467899999999999999999999999988 778899
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+|+++.|||.+.|+. .....|....+..++.|||.||.||.+++ +|||||..+|+||-....+||+|||+.+.+
T Consensus 189 ~ELaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hhhcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceecc
Confidence 999999999999987 23346888899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCce-ee-ecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 323 AMDQTH-VT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 323 ~~~~~~-~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
...+.. .+ ....-...|+|||.+....++.++|||+|||++|||+| |+.||..- .. ..+
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-----~g-------------~qI 324 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-----RG-------------IQI 324 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-----CH-------------HHH
Confidence 654332 22 23345778999999999999999999999999999999 88888431 00 111
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 444 (468)
.+.+|..-.-.-++.+++.+++++..||..+|++|||+..|.+.+
T Consensus 325 L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 325 LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 222333333334778899999999999999999999999998554
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=311.91 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=196.9
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||+|..+ +++.||+|.+...... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC---CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 56888999999999999999865 5788999988654322 2234577899999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++ +|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 83 ~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 83 FEYLDK-DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAK 154 (309)
T ss_pred EeCCCC-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceec
Confidence 999975 8888876532 24788999999999999999999999 999999999999999999999999998754
Q ss_pred cCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc---cc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK---NR 398 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 398 (468)
...... .....+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ..+... ........ ..
T Consensus 155 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~--~~~~~~---~~~~~~~~~~~~~ 228 (309)
T cd07872 155 SVPTKT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST--VEDELH---LIFRLLGTPTEET 228 (309)
T ss_pred CCCccc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHH---HHHHHhCCCCHHH
Confidence 332221 223457889999998865 568899999999999999999999985321 111110 01110000 00
Q ss_pred cchhc------chHHhh-------hchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHDIL------DDQLMK-------LGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~~~------d~~l~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+..+. +..... ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 000000 001123457889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=297.87 Aligned_cols=252 Identities=31% Similarity=0.462 Sum_probs=202.5
Q ss_pred ceeeecCcEEEEEEEecC----CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeee
Q 012214 170 RILGQGGQGTVYKGMLED----GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEF 245 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 245 (468)
+.||+|+||.||++.... +..+++|.+...... ...+.+.+|+..++.++|+|++++++++.+....++|+||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE---EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch---hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence 469999999999999653 788999998765443 2457789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 246 IPNGTLYQHLHDRHQN----EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 246 ~~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
+++++|.+++...... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccc
Confidence 9999999999774211 0246899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 322 IAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 322 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||... ... . ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~---~-~~~~~~~~~~ 225 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-----SNE---E-VLEYLRKGYR 225 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-----CHH---H-HHHHHHcCCC
Confidence 654332 12233457889999999998899999999999999999999 68887432 111 1 1111111110
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 226 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ---------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112233568999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=339.81 Aligned_cols=267 Identities=22% Similarity=0.352 Sum_probs=206.2
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.++||+|+||.||+|... +++.||+|++....... ....+.|.+|+.+++.++||||+++++++.+.+..++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~-e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN-PLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC-HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 57889999999999999999965 58999999986533221 13346799999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 243 YEFIPNGTLYQHLHDRHQN------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
|||+++++|.+++...... ....+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEec
Confidence 9999999999998752211 1124677888999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCc-----------------eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 012214 317 GTSKFIAMDQT-----------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNT 379 (468)
Q Consensus 317 Gla~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~ 379 (468)
|+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.....
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~- 236 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG- 236 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch-
Confidence 99986521110 011224689999999999999999999999999999999999999843110
Q ss_pred ccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhcccC
Q 012214 380 SQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-TMEEVSMELNGIRGS 450 (468)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~i~~~ 450 (468)
... ....... ++. ........+..+.+++.+||+.||++|| +++++++.|+...+.
T Consensus 237 --~ki----~~~~~i~--------~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 237 --RKI----SYRDVIL--------SPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred --hhh----hhhhhcc--------Chh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 000 0000000 000 0000123445788999999999999996 677788888776543
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=298.61 Aligned_cols=254 Identities=27% Similarity=0.478 Sum_probs=201.1
Q ss_pred CCCCCceeeecCcEEEEEEEecCCcEEEEEecccccch--HHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 165 HFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDD--EELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
+|...+.||+|+||.||+|...+++.+|+|.+...... ........+.+|+.++++++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788899999999999999878999999987653221 1223446688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||+++++|.+++.... ++++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 99999999999996532 4789999999999999999999999 999999999999999999999999998765
Q ss_pred cCCC-----ceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 323 AMDQ-----THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 323 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
.... ........++..|+|||++.+..++.++||||||+++|+|++|..||.... .. ...........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~--~~~~~~~~~~~ 225 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD-----RL--AAMFYIGAHRG 225 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC-----hH--HHHHHhhhccC
Confidence 3211 111223458899999999999889999999999999999999999984311 00 00000000001
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.... .+...+..+.+++.+||+.+|++|||+.++++
T Consensus 226 ~~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 LMPR---------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 12234457899999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=304.98 Aligned_cols=253 Identities=26% Similarity=0.313 Sum_probs=198.4
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEee
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYE 244 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 244 (468)
|+..+.||+|+||.||++... +++.+|+|.+....... ....+.+.+|+.++++++|+|++.+++.+.+.+..++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc-hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 667788999999999999865 68899999876432221 1233557789999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 81 LMNGGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred ecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 999999999886532 235889999999999999999999999 99999999999999999999999999876543
Q ss_pred CCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcc
Q 012214 325 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404 (468)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 404 (468)
... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||........ ..........
T Consensus 155 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-----~~~~~~~~~~-------- 219 (285)
T cd05630 155 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-----REEVERLVKE-------- 219 (285)
T ss_pred Ccc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-----HHHHHhhhhh--------
Confidence 222 1234689999999999999999999999999999999999999854211100 0001110000
Q ss_pred hHHhhhchHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 012214 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT-----MEEVSM 442 (468)
Q Consensus 405 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 442 (468)
.....+...+..+.+|+.+||+.||++||| +.|+++
T Consensus 220 --~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 220 --VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 000112223446889999999999999999 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=303.66 Aligned_cols=254 Identities=29% Similarity=0.390 Sum_probs=198.3
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++++++||||+++++++......++|
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG----DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc----chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 5688999999999999999996 4688999998865322 2234677899999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||+++++|.+++... .++++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 85 MEYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKI 156 (267)
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceee
Confidence 9999999999988642 24889999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCceeeecccccCCccCccccc---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
..... ......++..|+|||.+. ...++.++|||||||++|||++|+.||...... ... . .......
T Consensus 157 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~--~~~------~-~~~~~~~ 226 (267)
T cd06646 157 TATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--RAL------F-LMSKSNF 226 (267)
T ss_pred ccccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--hhh------e-eeecCCC
Confidence 32211 122345888999999874 355788999999999999999999998431110 000 0 0000000
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 444 (468)
. .+... .....+..+.+++.+||+.+|++|||+.++++.|
T Consensus 227 ~---~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 Q---PPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C---CCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 00000 0112345789999999999999999999998653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=322.70 Aligned_cols=262 Identities=23% Similarity=0.330 Sum_probs=197.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
...|.+.+.||+|+||.||++... .++.||||.... ..+.+|+.++++++|+||+++++++......++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 457999999999999999999965 578899995322 235689999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
|||++. ++|..++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 238 v~e~~~-~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~ 309 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACF 309 (461)
T ss_pred EEEccC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCcee
Confidence 999994 78888886532 25899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc----
Q 012214 322 IAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK---- 396 (468)
Q Consensus 322 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 396 (468)
....... ......||..|+|||++.+..++.++|||||||++|||++|..|+........... ....+...+..
T Consensus 310 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~-~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRP-YDAQILRIIRQAQVH 388 (461)
T ss_pred cccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCC-cHHHHHHHHHhhccc
Confidence 5432221 22345699999999999999999999999999999999998877643222111111 11111111111
Q ss_pred -cccchhcchHHhhh----------------c---hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 397 -NRLHDILDDQLMKL----------------G---VKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 397 -~~~~~~~d~~l~~~----------------~---~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
..........+... . .......+.+|+.+||+.||.+|||+.|+++.
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00110000000000 0 00122367899999999999999999999863
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=304.70 Aligned_cols=253 Identities=29% Similarity=0.425 Sum_probs=197.4
Q ss_pred ceeeecCcEEEEEEEecC-------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 170 RILGQGGQGTVYKGMLED-------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
+.||+|+||.||+|...+ ++.+|+|.+...... .....+.+|+.+++.++||||+++++++......++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD---QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch---hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 358999999999998642 257899987653222 3346788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC-----cEEEEe
Q 012214 243 YEFIPNGTLYQHLHDRHQN--EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY-----RAKVAD 315 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~-----~~kl~D 315 (468)
|||+++++|.+++...... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECC
Confidence 9999999999999764321 2234789999999999999999999998 99999999999999887 899999
Q ss_pred cCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHH
Q 012214 316 FGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 316 fGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |..||... ...... ..
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~-----~~~~~~----~~ 225 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL-----NNQEVL----QH 225 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc-----CHHHHH----HH
Confidence 99987654332211 222345678999999999999999999999999999998 99987421 111111 11
Q ss_pred hhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 394 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
....... ..+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 226 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 226 VTAGGRL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HhcCCcc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111100 1122345678999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=308.65 Aligned_cols=197 Identities=26% Similarity=0.392 Sum_probs=159.7
Q ss_pred CceeeecCcEEEEEEEec---CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc--CCcceeEe
Q 012214 169 NRILGQGGQGTVYKGMLE---DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE--TEVPLLVY 243 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~ 243 (468)
.++||+|+||.||+|... +++.+|+|.+...... ..+.+|+.++++++||||+++++++.. ....++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS------MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc------HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 357999999999999854 4678999988653222 346789999999999999999998854 45678999
Q ss_pred eecCCCChhhHhhhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE----cCCCcEEEEe
Q 012214 244 EFIPNGTLYQHLHDRHQ----NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL----DQRYRAKVAD 315 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl----~~~~~~kl~D 315 (468)
||+. ++|.+++..... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 9985 588887754221 11235899999999999999999999999 9999999999999 4567999999
Q ss_pred cCCcccccCCCce--eeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 012214 316 FGTSKFIAMDQTH--VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFW 375 (468)
Q Consensus 316 fGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~ 375 (468)
||+++........ ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 9999876433221 1234568999999999877 4588999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=297.56 Aligned_cols=252 Identities=30% Similarity=0.429 Sum_probs=203.3
Q ss_pred CCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|+..+.||+|+||.||.++. .+++.+++|.+....... .....+.+|+.++++++|+||+++++++.+....+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE--KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch--hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 578889999999999999884 468899999876543222 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 79 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 79 EYANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152 (256)
T ss_pred EecCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence 9999999999997632 235899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
.... ......++..|+|||.+.+..++.++||||||+++|||++|..||... . ......... .......
T Consensus 153 ~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--~------~~~~~~~~~-~~~~~~~- 221 (256)
T cd08221 153 SEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT--N------PLNLVVKIV-QGNYTPV- 221 (256)
T ss_pred cccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC--C------HHHHHHHHH-cCCCCCC-
Confidence 4332 223356889999999999888999999999999999999999997431 1 111111111 1111110
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 222 --------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 --------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred --------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 12334578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=292.09 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=204.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchH----HHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccC
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDE----ELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~----~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~ 236 (468)
-+.|...+.||.|..++|-++..+ +|+..|+|++....... .....++-.+|+.+++++ .||+|+.+.+++..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 456788889999999999988854 68889999876543221 122345567899999999 699999999999999
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...++|+|.|+.|.|.++|.+.- .+++.....|+.|+..|+.|||..+ ||||||||+|||+++|.++||+||
T Consensus 96 sF~FlVFdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 99999999999999999997643 5899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCceeeecccccCCccCcccccc------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHH
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS------SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF 390 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~ 390 (468)
|+|+.+..+.. ....+||++|+|||.+.. ..|+...|.||+||++|-|+.|..||.- ..... .
T Consensus 168 GFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-----RkQml----M 236 (411)
T KOG0599|consen 168 GFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-----RKQML----M 236 (411)
T ss_pred ceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-----HHHHH----H
Confidence 99998765543 456789999999997753 4578889999999999999999999842 11111 1
Q ss_pred HHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 391 VHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...+..+... ...+...+.+....+|+.+||+.||.+|.|++|++.
T Consensus 237 LR~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 237 LRMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1111111110 111112344557889999999999999999999986
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=300.10 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=203.1
Q ss_pred cCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 237 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 237 (468)
++|++.+.||+|+||.||+++.+ +.+.+++|.+...... ...+.+.+|+.++++++|+||+++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE---NLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch---HHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 56888899999999999999853 2467999987653222 34567899999999999999999999999989
Q ss_pred cceeEeeecCCCChhhHhhhcccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEE
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNE----EFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKV 313 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl 313 (468)
..++||||+++++|.+++....... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEE
Confidence 9999999999999999997643111 125899999999999999999999999 999999999999999999999
Q ss_pred EecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHH
Q 012214 314 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVH 392 (468)
Q Consensus 314 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~ 392 (468)
+|||++...............++..|+|||.+.+...+.++||||||+++|+|++ |..||.... . .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~-----~----~~~~~ 229 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS-----D----EEVLN 229 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----h----HHHHH
Confidence 9999987543322222233346778999999988888999999999999999999 777873211 0 11111
Q ss_pred HhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 393 SMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 393 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
......+.. ..+...+..+.+++.+||+.+|++|||+.|++..|.
T Consensus 230 ~~~~~~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 RLQAGKLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHcCCcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111111110 011233457899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=310.28 Aligned_cols=244 Identities=25% Similarity=0.307 Sum_probs=192.2
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccCCcceeE
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV 242 (468)
+|...+.||+|+||.||++... +++.||+|++...... .....+.+..|..++..+. |++|+++++++.+.+..++|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 3677789999999999999864 6889999988653211 1133456788888888885 67888899999998999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~Ey~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 80 MEYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccccccc
Confidence 99999999999886532 4899999999999999999999999 999999999999999999999999998754
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .. ........ ...
T Consensus 152 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-----~~---~~~~~i~~-~~~--- 218 (323)
T cd05615 152 MVDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED-----ED---ELFQSIME-HNV--- 218 (323)
T ss_pred CCCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC-----HH---HHHHHHHh-CCC---
Confidence 32221 2233568999999999999999999999999999999999999985311 11 11111111 110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTM 437 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 437 (468)
..+...+..+.+++.+||+.+|.+|++.
T Consensus 219 -------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0122334578899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=296.72 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=197.8
Q ss_pred ceeeecCcEEEEEEEecC--C--cEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeee
Q 012214 170 RILGQGGQGTVYKGMLED--G--RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEF 245 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~--g--~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 245 (468)
+.||+|++|.||++.+.+ + ..||+|.+...... ...+.+.+|+.++++++||||+++++.+.+ ...++|+||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence 358999999999998643 3 36899988765433 445789999999999999999999999988 888999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCC
Q 012214 246 IPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMD 325 (468)
Q Consensus 246 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 325 (468)
+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++.....
T Consensus 77 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 77 APLGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred cCCCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccc
Confidence 999999999976432 35899999999999999999999999 999999999999999999999999999876543
Q ss_pred Ccee--eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 326 QTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 326 ~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
.... .....++..|+|||++.+..++.++|||||||++|||++ |..||... .. ..............
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-----~~---~~~~~~~~~~~~~~-- 220 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-----SG---SQILKKIDKEGERL-- 220 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-----CH---HHHHHHHHhcCCcC--
Confidence 2221 123457789999999999899999999999999999998 99997421 00 11111111100000
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 221 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 -------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001223457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=304.62 Aligned_cols=262 Identities=22% Similarity=0.305 Sum_probs=190.7
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc---CCCceeeEeeeecc-----
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI---NHRNVVKLLGCCLE----- 235 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~----- 235 (468)
+|++.+.||+|+||.||++... +++.||+|.++...... .....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 4788899999999999999865 68899999886532221 1112345566666554 79999999998864
Q ss_pred CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
....++++||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 79 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~d 151 (288)
T cd07863 79 ETKVTLVFEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLAD 151 (288)
T ss_pred CceEEEEEcccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECc
Confidence 235789999997 48888886532 234899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
||+++....... .....+|..|+|||++.+..++.++|||||||++|+|++|+.||.... ..+ ..........
T Consensus 152 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~--~~~---~~~~~~~~~~ 224 (288)
T cd07863 152 FGLARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--EAD---QLGKIFDLIG 224 (288)
T ss_pred cCccccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC--HHH---HHHHHHHHhC
Confidence 999976543221 233457899999999999899999999999999999999999874311 110 1111111110
Q ss_pred c---cccchh-------cchH---HhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 396 K---NRLHDI-------LDDQ---LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 396 ~---~~~~~~-------~d~~---l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ..+... ..+. .........+..+.+++.+||+.||++|||+.|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000000 0000 000111234457889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=304.45 Aligned_cols=257 Identities=25% Similarity=0.417 Sum_probs=203.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCc----EEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGR----IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
.+|++.+.||+|+||.||+|..+ +|. .+|+|........ ....++.+|+.+++.++||||+++++++.. ..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP---KANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 56788899999999999999854 233 5899987654332 445678899999999999999999999987 78
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++|+||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~ 155 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGL 155 (279)
T ss_pred eEEEEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcc
Confidence 899999999999999997532 24899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 319 SKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 319 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
++......... .....++..|+|||.+....++.++|+||||+++||+++ |+.||... .. ..+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~~----~~~~~~~~~ 226 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-----PA----VEIPDLLEK 226 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-----CH----HHHHHHHhC
Confidence 98765332221 122234568999999988899999999999999999998 99997431 00 111111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
.... ..+..++..+.+++.+||..+|.+|||+.++++.|+.+..
T Consensus 227 ~~~~---------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 227 GERL---------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1100 0111233468899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=301.86 Aligned_cols=275 Identities=23% Similarity=0.316 Sum_probs=207.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||.||++... +++.+|+|.+...... .....+.+|+.++++++|+||+++++++......++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE---SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH---HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence 35788889999999999999965 6899999988654332 3346788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS-ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
+||+++++|..++.... ....+++..+..++.|++.||.|||+ .+ |+|+||||+||+++.++.++|+|||++..
T Consensus 78 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 152 (286)
T cd06622 78 MEYMDAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGN 152 (286)
T ss_pred EeecCCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence 99999999998886532 12358999999999999999999997 46 99999999999999999999999999875
Q ss_pred ccCCCceeeecccccCCccCccccccC------CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSS------QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
..... .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.... ........... .
T Consensus 153 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~-~ 223 (286)
T cd06622 153 LVASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-----YANIFAQLSAI-V 223 (286)
T ss_pred ccCCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-----hhhHHHHHHHH-h
Confidence 53221 2234578899999988654 35789999999999999999999984311 11111111111 1
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCchhhhHHHHHHhhh
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKRAMFSKIIKRL 465 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~~~ 465 (468)
..... ..+...+..+.+++.+||+.+|++||++.+++..-. +........++..++.+++
T Consensus 224 ~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~-~~~~~~~~~~~~~~~~~~~ 283 (286)
T cd06622 224 DGDPP---------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW-LVKYKNADVDMAEWVTGAL 283 (286)
T ss_pred hcCCC---------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh-hhhccCCccchHHHHHHHH
Confidence 11111 112234557899999999999999999999987321 1122222455555665554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=306.95 Aligned_cols=262 Identities=25% Similarity=0.366 Sum_probs=203.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||+||++... +++.+|+|++...... ...+.+.+|+.+++.++||||+++++++......++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS---SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc---hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 56777889999999999999854 6889999987654322 3346789999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS-ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
|||+++++|.+++... .++++..+..++.+++.||.|||+ ++ ++|+||+|+||++++++.++|+|||++..
T Consensus 82 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 82 MEFMDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGE 153 (284)
T ss_pred EecCCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccc
Confidence 9999999999988652 258999999999999999999997 46 99999999999999999999999999865
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccc---hhchHHHHHHHhhccc
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE---NVSLAAYFVHSMRKNR 398 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 398 (468)
..... .....++..|+|||++.+..++.++|||||||++|+|++|+.||......... .......+..... ..
T Consensus 154 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 229 (284)
T cd06620 154 LINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EP 229 (284)
T ss_pred hhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-cc
Confidence 43221 12346899999999998889999999999999999999999998642211110 0011111111111 11
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
...+ .....+..+.+++.+||+.||++|||+.|++++..-++
T Consensus 230 ~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 230 PPRL--------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred CCCC--------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 1110 01124457899999999999999999999998754433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=312.93 Aligned_cols=243 Identities=28% Similarity=0.362 Sum_probs=188.7
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHH-HHHhcCCCceeeEeeeeccCCcceeEeeecC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIV-ILSQINHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
+.||+|+||.||++... +|+.+|+|++....... ......+..|.. +++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 36999999999999854 68999999886432111 123345556654 5677899999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 80 GGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 99999888652 25899999999999999999999999 99999999999999999999999999875322111
Q ss_pred eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
......||+.|+|||++.+..++.++|||||||++|||++|..||.... ....+...... .+.
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~~~~~-~~~------- 214 (325)
T cd05604 152 -TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--------VAEMYDNILHK-PLV------- 214 (325)
T ss_pred -CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--------HHHHHHHHHcC-Ccc-------
Confidence 2234568999999999999999999999999999999999999985311 11111111111 100
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVS 441 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 441 (468)
.....+..+.+++.+||+.+|.+||++.+.+
T Consensus 215 ---~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 215 ---LRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred ---CCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 0112344678999999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=311.62 Aligned_cols=258 Identities=22% Similarity=0.275 Sum_probs=197.2
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.++||+|+||.||++..+ +++.+|+|++...... .......+.+|+.++..++|+||+++++++.+....++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 46888999999999999999965 4778999987542111 112345578899999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 80 ~ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 80 MDYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred EeccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheec
Confidence 99999999999997522 25889999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCceeeecccccCCccCccccc-----cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
............||+.|+|||++. ...++.++|||||||++|||++|+.||... . ............
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-----~---~~~~~~~i~~~~ 224 (332)
T cd05623 153 MEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-----S---LVETYGKIMNHK 224 (332)
T ss_pred ccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-----C---HHHHHHHHhCCC
Confidence 443333333456999999999886 346788999999999999999999998531 1 111111111111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCC--CCCCHHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGK--KRPTMEEVSME 443 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~--~RPt~~evl~~ 443 (468)
....+. ......+..+.+++.+|+..++. .|+++.|+++.
T Consensus 225 ~~~~~p------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 225 ERFQFP------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccccCC------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000000 00122345788899998865444 37889888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=314.10 Aligned_cols=265 Identities=21% Similarity=0.280 Sum_probs=196.5
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC----
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET---- 236 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~---- 236 (468)
..++|.+.+.||+|+||.||++... .++.||||++....... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh--HHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 4578999999999999999999854 58899999887543222 3446788999999999999999999988543
Q ss_pred --CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 237 --EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 237 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEe
Confidence 346899999965 67666643 3788899999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhc-hH------
Q 012214 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVS-LA------ 387 (468)
Q Consensus 315 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~-~~------ 387 (468)
|||+++..... .......+|..|+|||++.+..++.++|||||||++|+|++|+.||..... .+... ..
T Consensus 162 Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~ 237 (355)
T cd07874 162 DFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGTP 237 (355)
T ss_pred eCcccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCC
Confidence 99999754322 222345689999999999999999999999999999999999999853210 00000 00
Q ss_pred ---------HHHHHHhhc-cccc-----hhcchHH---hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 388 ---------AYFVHSMRK-NRLH-----DILDDQL---MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 388 ---------~~~~~~~~~-~~~~-----~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
......... .... ....... ...........+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 0000 0000000 000111234568899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=305.56 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=202.5
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEee
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYE 244 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 244 (468)
|+..+.||+|+||.||+|... ++..||+|.+...... ...+.+.+|+.+++.++||||+++++++......++|+|
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch---HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 555677999999999999864 5788999987654332 345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
|+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 83 YLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred ccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999999998853 24889999999999999999999998 99999999999999999999999999876543
Q ss_pred CCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcc
Q 012214 325 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404 (468)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 404 (468)
... ......++..|+|||++.+..++.++||||||+++|||++|+.|+.... . .. ...........
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~--~---~~----~~~~~~~~~~~---- 219 (277)
T cd06642 154 TQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH--P---MR----VLFLIPKNSPP---- 219 (277)
T ss_pred cch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc--h---hh----HHhhhhcCCCC----
Confidence 221 1223457889999999999899999999999999999999999974211 0 00 00011111100
Q ss_pred hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhcccCCchh
Q 012214 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGIRGSSKKK 454 (468)
Q Consensus 405 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i~~~~~~~ 454 (468)
......+..+.+++.+||+.+|++|||+.++++ .+..........
T Consensus 220 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~ 266 (277)
T cd06642 220 -----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFL 266 (277)
T ss_pred -----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhhHHHH
Confidence 011233457889999999999999999999998 344444333333
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=311.08 Aligned_cols=240 Identities=25% Similarity=0.346 Sum_probs=187.0
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHH-HHHhcCCCceeeEeeeeccCCcceeEeeecC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIV-ILSQINHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
+.||+|+||.||++... +++.||+|++........ .....+..|.. +++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKK-KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh-hHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999965 688999998864322111 22344555654 6788999999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+++|...+... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 150 (321)
T cd05603 80 GGELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE- 150 (321)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-
Confidence 99998888652 24788899999999999999999999 9999999999999999999999999987532221
Q ss_pred eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
.......||+.|+|||.+.+..++.++|||||||++|||++|..||... + .......... ...
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~---~~~~~~~i~~-~~~-------- 213 (321)
T cd05603 151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----D---VSQMYDNILH-KPL-------- 213 (321)
T ss_pred CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC-----C---HHHHHHHHhc-CCC--------
Confidence 1223456899999999999989999999999999999999999998531 1 1111111111 110
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCCCHH
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTME 438 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 438 (468)
..+...+..+.+++.+||+.+|.+||++.
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 --QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11223345788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=301.71 Aligned_cols=253 Identities=28% Similarity=0.419 Sum_probs=196.5
Q ss_pred HHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccC--
Q 012214 161 KATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET-- 236 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~-- 236 (468)
.+++.|+..+.||+|+||.||+|... +++.+|+|.+..... ....+.+|+.++..+ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 34677888899999999999999864 588899998865322 224677899999998 799999999998653
Q ss_pred ----CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEE
Q 012214 237 ----EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAK 312 (468)
Q Consensus 237 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~k 312 (468)
...+++|||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~ 151 (272)
T cd06637 78 PGMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 151 (272)
T ss_pred CCCCcEEEEEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEE
Confidence 35789999999999999997632 235899999999999999999999999 99999999999999999999
Q ss_pred EEecCCcccccCCCceeeecccccCCccCccccc-----cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchH
Q 012214 313 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLA 387 (468)
Q Consensus 313 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~ 387 (468)
|+|||++........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||.... .. .
T Consensus 152 l~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-----~~--~ 223 (272)
T cd06637 152 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-----PM--R 223 (272)
T ss_pred EccCCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-----HH--H
Confidence 999999876533221 223356889999999886 3467889999999999999999999984211 00 0
Q ss_pred HHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 388 AYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
... ... ....... .....+..+.+|+.+||+.+|.+|||+.++++
T Consensus 224 ~~~-~~~-~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 224 ALF-LIP-RNPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHH-HHh-cCCCCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 000 1111111 11223457899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=300.25 Aligned_cols=271 Identities=24% Similarity=0.320 Sum_probs=205.6
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC--Ccce
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVPL 240 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~ 240 (468)
++|...+.||.|++|.||++... +++.+|+|.+...... .....+.+|+++++.++||||+++++++.+. ...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP---DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch---HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 35778889999999999999974 5889999988754332 3446789999999999999999999988653 4679
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||+++++|.+++..... ....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 78 lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~ 153 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSG 153 (287)
T ss_pred EEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccc
Confidence 99999999999998765322 2335889999999999999999999999 9999999999999999999999999986
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
...... .....++..|+|||.+.+..++.++||||||+++|+|++|..||........... . ...........
T Consensus 154 ~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~-~~~~~~~~~~~ 226 (287)
T cd06621 154 ELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI---E-LLSYIVNMPNP 226 (287)
T ss_pred cccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChH---H-HHHHHhcCCch
Confidence 543221 1234578899999999999999999999999999999999999864322111111 1 11111111111
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhcccCC
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGIRGSS 451 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i~~~~ 451 (468)
.+.+. .......++.+.+++.+||+.+|++|||+.|+++ .+.....+.
T Consensus 227 ~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~ 276 (287)
T cd06621 227 ELKDE---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK 276 (287)
T ss_pred hhccC---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccch
Confidence 11100 0001234567899999999999999999999998 444444443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=311.56 Aligned_cols=258 Identities=19% Similarity=0.258 Sum_probs=193.1
Q ss_pred CCceeeec--CcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEee
Q 012214 168 ANRILGQG--GQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYE 244 (468)
Q Consensus 168 ~~~~LG~G--~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 244 (468)
+.++||+| +|++||++.. .+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+++..++|+|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN--EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 35679999 7899999985 478999999987643322 334567789999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+.....
T Consensus 80 ~~~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 80 FMAYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred ccCCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence 9999999999965321 24899999999999999999999999 99999999999999999999999986543321
Q ss_pred CCce------eeecccccCCccCcccccc--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 325 DQTH------VTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 325 ~~~~------~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
.... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ...... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~~~-~ 224 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--------MLLEKL-N 224 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--------HHHHHh-c
Confidence 1110 0112346778999999876 468899999999999999999999985321100 000000 0
Q ss_pred cccchhcc------------------------------------hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 012214 397 NRLHDILD------------------------------------DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440 (468)
Q Consensus 397 ~~~~~~~d------------------------------------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ev 440 (468)
.......+ ...........+..+.+++.+||+.||++|||+.|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~el 304 (327)
T cd08227 225 GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTL 304 (327)
T ss_pred CCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHH
Confidence 00000000 000011122345678999999999999999999999
Q ss_pred HH
Q 012214 441 SM 442 (468)
Q Consensus 441 l~ 442 (468)
++
T Consensus 305 l~ 306 (327)
T cd08227 305 LN 306 (327)
T ss_pred hc
Confidence 86
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=308.91 Aligned_cols=259 Identities=25% Similarity=0.441 Sum_probs=201.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCc----EEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGR----IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
++|+..+.||+|+||.||++... ++. .+|+|.+...... ....++.+|+.+++.++||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP---KANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 56778889999999999999853 343 5788887654332 3335688999999999999999999998754 4
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++++||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccc
Confidence 679999999999999987532 24889999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 319 SKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 319 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||.... . .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~------~~~~~~~~~ 226 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---T------REIPDLLEK 226 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---H------HHHHHHHHC
Confidence 98664332211 222345678999999999999999999999999999997 888874210 0 111111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.... ..+..++..+.+++.+||..+|++||++.++++.|+.+....
T Consensus 227 ~~~~---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 227 GERL---------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 1100 001123347889999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=318.69 Aligned_cols=254 Identities=23% Similarity=0.299 Sum_probs=194.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|+..+.||+|+||.||++... +++.||+|++...... .......+.+|+.++..++|+||+++++.+.+....++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 36888899999999999999865 6889999988642211 123456788899999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 80 ~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 80 MEFLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred EeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 99999999999996532 4889999999999999999999999 999999999999999999999999998754
Q ss_pred cCCCc----------------------------------eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh
Q 012214 323 AMDQT----------------------------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 368 (468)
Q Consensus 323 ~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t 368 (468)
..... .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t 231 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence 22110 00113468999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 012214 369 GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT---MEEVSM 442 (468)
Q Consensus 369 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~ 442 (468)
|+.||.... . ...............+. .....++.+.+++.+|+. ||.+|++ +.|+++
T Consensus 232 G~~Pf~~~~--~------~~~~~~i~~~~~~~~~p-------~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 232 GYPPFCSET--P------QETYRKVMNWKETLVFP-------PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCCC--H------HHHHHHHHcCCCceecC-------CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 999985311 1 01111111100000000 011133467888888774 9999996 455543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=319.90 Aligned_cols=249 Identities=22% Similarity=0.426 Sum_probs=198.4
Q ss_pred CCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc--ceeEe
Q 012214 167 NANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV--PLLVY 243 (468)
Q Consensus 167 ~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~--~~lV~ 243 (468)
....+||+|+|-+||+|.+. +|..||--.++...........+.|..|+.+|+.|+||||++++.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34456999999999999964 5777765444332222223556889999999999999999999999987665 67899
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC-CcEEEEecCCcccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR-YRAKVADFGTSKFI 322 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~-~~~kl~DfGla~~~ 322 (468)
|.|..|+|..|+++.+. ++...+..|++||++||.|||++. |||||||||-+||+|+.+ |.|||+|+|||...
T Consensus 123 EL~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred ecccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 99999999999988653 788899999999999999999987 899999999999999865 89999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... ..+.|||.|||||+.. ..|+..+||||||+.++||+|+..||. .+.........+.......-+..+
T Consensus 197 r~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs----EC~n~AQIYKKV~SGiKP~sl~kV 268 (632)
T KOG0584|consen 197 RKSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS----ECTNPAQIYKKVTSGIKPAALSKV 268 (632)
T ss_pred hcccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh----hhCCHHHHHHHHHcCCCHHHhhcc
Confidence 53322 2367999999999988 789999999999999999999999983 122222223333333333334444
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
-|+ ++.++|.+||.. .++|||+.|+++
T Consensus 269 ~dP------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 269 KDP------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CCH------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 443 688999999999 899999999986
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=299.44 Aligned_cols=254 Identities=23% Similarity=0.326 Sum_probs=187.0
Q ss_pred eeeecCcEEEEEEEecCC---cEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecC
Q 012214 171 ILGQGGQGTVYKGMLEDG---RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 171 ~LG~G~fG~Vy~~~~~~g---~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
.||+|+||.||++...++ ..+++|.+...... ...+.|.+|+.+++.++||||+++++.+.+....++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS---KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh---HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 599999999999975433 34566766543222 345689999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCC-
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQ- 326 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~- 326 (468)
+|+|.+++...... ....++..+..++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||++.......
T Consensus 79 ~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 79 LGDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 99999999764322 224677788899999999999999998 9999999999999999999999999986432111
Q ss_pred ceeeecccccCCccCcccccc-------CCCCCcccHHHHHHHHHHHHhC-CCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 327 THVTTKIQGTFGYLDPEYHQS-------SQLTDKSDVYSFGVVLVELLTG-KKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvll~el~tG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
........++..|+|||++.. ..++.++||||||+++|||+++ ..||... .. ...........
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-----~~---~~~~~~~~~~~- 225 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL-----SD---REVLNHVIKDQ- 225 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-----CH---HHHHHHHHhhc-
Confidence 111233457889999998753 2457899999999999999974 5565321 11 11111111111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
...+.++.+. ....+.+.+++..|| .+|++|||+.+|++.|.
T Consensus 226 ~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 226 QVKLFKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccccCCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1112222111 123446788999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=297.75 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=199.0
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc-CCcceeE
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE-TEVPLLV 242 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~lV 242 (468)
.|++.+.||+|++|.||++... +++.+|+|.+....... ...+.+.+|+.++++++|+|++++++.+.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR--RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH--HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 4788899999999999999965 57889999886532221 334568899999999999999999988764 4467899
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.... ..++++.++..++.|++.|+++||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~e~~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 79 MGFCEGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred ecccCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEe
Confidence 99999999999997632 235899999999999999999999999 999999999999999999999999999766
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... ......+++.|+|||.+.+..++.++||||||+++++|++|+.||... +. ....... ......
T Consensus 153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-----~~---~~~~~~~-~~~~~~-- 220 (257)
T cd08223 153 ENQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-----DM---NSLVYRI-IEGKLP-- 220 (257)
T ss_pred cccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CH---HHHHHHH-HhcCCC--
Confidence 43222 223345889999999999999999999999999999999999997421 10 0111111 111111
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+...+..+.+++.+||+.+|++|||+.++++
T Consensus 221 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 -------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 112234457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=295.61 Aligned_cols=249 Identities=28% Similarity=0.418 Sum_probs=201.4
Q ss_pred cCCCCCceeeecCcEEEEEEEecC-CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|+..+.||+|+||.||++...+ ++.+++|.+.... ..+++.+|+.+++.++|+||+++++++.+....+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 678889999999999999999764 7899999876531 156789999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 77 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 77 MEYCGAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQL 149 (256)
T ss_pred EecCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhc
Confidence 99999999999986522 35899999999999999999999999 999999999999999999999999998866
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... . . . ..........+
T Consensus 150 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--~-----~-~-~~~~~~~~~~~ 219 (256)
T cd06612 150 TDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--R-----A-I-FMIPNKPPPTL 219 (256)
T ss_pred ccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--h-----h-h-hhhccCCCCCC
Confidence 43322 222345788999999999989999999999999999999999998531110 0 0 0 00000000000
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+...+..+.+++.+||+.+|++|||+.|+++
T Consensus 220 -------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 -------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 012234457899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=297.60 Aligned_cols=258 Identities=24% Similarity=0.400 Sum_probs=201.5
Q ss_pred CCCCCceeeecCcEEEEEEEecC--CcEEEEEecccccch------HHHHHHHHHHHHHHHHHh-cCCCceeeEeeeecc
Q 012214 165 HFNANRILGQGGQGTVYKGMLED--GRIIAVKKSKLTVDD------EELLKLEEFINEIVILSQ-INHRNVVKLLGCCLE 235 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~~~~------~~~~~~~~~~~Ei~~l~~-l~h~niv~l~g~~~~ 235 (468)
+|++.+.||+|+||.||++.... ++.+|+|.+...... .......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778889999999999999764 688999987542211 111345667889988875 799999999999999
Q ss_pred CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS-ATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
.+..+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+ ++|+||+|+||++++++.++|+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEe
Confidence 9999999999999999998865321 22358999999999999999999996 56 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 315 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
|||++....... ......++..|+|||++.+..++.++||||||+++|+|++|+.||... ..... ....
T Consensus 157 dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-----~~~~~----~~~~ 225 (269)
T cd08528 157 DFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NMLSL----ATKI 225 (269)
T ss_pred cccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-----CHHHH----HHHH
Confidence 999997654432 233456889999999999988999999999999999999999997421 11111 1111
Q ss_pred hccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 395 RKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 395 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
........ .....+..+.+++.+||+.||++|||+.|+.++++
T Consensus 226 ~~~~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 VEAVYEPL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hhccCCcC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111110 01123457899999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=297.84 Aligned_cols=252 Identities=31% Similarity=0.477 Sum_probs=200.8
Q ss_pred CCCCceeeecCcEEEEEEEecC-----CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 166 FNANRILGQGGQGTVYKGMLED-----GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
|++.+.||.|+||.||++...+ +..||+|++...... ...+.+..|+.++..++|+||+++++++.+.+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE---QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh---HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 3567889999999999999653 378999998764332 24567889999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
++|||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~ 151 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSR 151 (258)
T ss_pred EEEeccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCce
Confidence 99999999999999976322 12899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
..............++..|+|||.+.+..++.++||||||+++++|++ |..||.. ... .... ........
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-----~~~---~~~~-~~~~~~~~ 222 (258)
T smart00219 152 DLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-----MSN---EEVL-EYLKKGYR 222 (258)
T ss_pred ecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-----CCH---HHHH-HHHhcCCC
Confidence 765543333223347789999999988889999999999999999998 7777632 111 1111 11111111
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 444 (468)
.. .+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 223 ~~---------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 LP---------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC---------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11 1122455789999999999999999999999765
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=303.71 Aligned_cols=264 Identities=24% Similarity=0.327 Sum_probs=196.4
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|++.+.||+|++|.||+|... +++.||+|++....... .....+.+|+.++++++||||+++++++.++...++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE--GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC--CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence 4778889999999999999965 68899999886532221 22356788999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||++ ++|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 79 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 79 EFLS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred ecCC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 9997 688888865322 235899999999999999999999999 9999999999999999999999999987553
Q ss_pred CCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh--cc---
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR--KN--- 397 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~--- 397 (468)
.... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... . ............ ..
T Consensus 153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd07861 153 IPVR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE--I--DQLFRIFRILGTPTEDVWP 227 (285)
T ss_pred CCcc-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH--H--HHHHHHHHHhCCCChhhhh
Confidence 3221 1223356889999998865 4578899999999999999999999853110 0 000000000000 00
Q ss_pred ----------ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 ----------RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ----------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.......... .......+.++.+++.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 228 GVTSLPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred cchhhHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0011224557889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=313.72 Aligned_cols=262 Identities=21% Similarity=0.276 Sum_probs=196.1
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC----
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET---- 236 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~---- 236 (468)
..++|.+.+.||+|+||.||++... .++.||||++....... .....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc--hhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 4578999999999999999999854 58899999987543221 3345688999999999999999999987543
Q ss_pred --CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 237 --EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 237 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
...++||||+++ +|...+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~ 168 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 168 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEE
Confidence 356899999964 77776643 3788899999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 315 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
|||+++...... ......+|..|+|||++.+..++.++|||||||++|+|++|+.||.... ..+ .........
T Consensus 169 DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~---~~~~~~~~~ 241 (364)
T cd07875 169 DFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD--HID---QWNKVIEQL 241 (364)
T ss_pred eCCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC--HHH---HHHHHHHhc
Confidence 999997653321 2233568999999999999999999999999999999999999985321 100 000000000
Q ss_pred h--------------------ccccchhcchHH--------hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 395 R--------------------KNRLHDILDDQL--------MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 395 ~--------------------~~~~~~~~d~~l--------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
. .+.........+ ...........+.+|+.+||+.||.+|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 000000000000 000011123468899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=310.79 Aligned_cols=257 Identities=22% Similarity=0.291 Sum_probs=196.9
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||++... +++.||+|++..... ........+.+|..++..++|+||+++++++.+.+..++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-LKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 46888999999999999999965 578899998764211 1113345678899999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 80 MDYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred EeCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 99999999999997532 25889999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCcccccc-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
............||+.|+|||++.+ +.++.++|||||||++|||++|+.||.... ............
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~ 224 (331)
T cd05624 153 NQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHE 224 (331)
T ss_pred cCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC--------HHHHHHHHHcCC
Confidence 5444333344569999999998875 567889999999999999999999985311 011111111111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKK--RPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~ 442 (468)
....+ .. .....++.+.+++.+|++.++.+ |+++.++++
T Consensus 225 ~~~~~-p~-----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 225 ERFQF-PS-----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CcccC-CC-----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 00000 00 01123457889999999865543 457777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=313.76 Aligned_cols=248 Identities=31% Similarity=0.446 Sum_probs=204.0
Q ss_pred CCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
.|+..+.||.|+||.||-+++ .+...||||++.-... .......+++.|+..|+++.|||++.+.||+..+...+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK-Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeecccccc-ccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 366677899999999999995 4688999999876432 23345678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||| -||-.+++.-.+ +++-+.++..|+.+.++||+|||+++ .||||||+.|||+++.|.|||+|||.|....
T Consensus 106 EYC-lGSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHH-hccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC
Confidence 999 568888886543 37899999999999999999999999 9999999999999999999999999997665
Q ss_pred CCCceeeecccccCCccCccccc---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
... ..+||+.|||||++. .+.|+-|+||||||++..||.-.++|++.+. ..+ +-+.......+.+.
T Consensus 178 PAn-----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-----AMS-ALYHIAQNesPtLq 246 (948)
T KOG0577|consen 178 PAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMS-ALYHIAQNESPTLQ 246 (948)
T ss_pred chh-----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-----HHH-HHHHHHhcCCCCCC
Confidence 443 357999999999875 4889999999999999999999999975421 111 11112222222222
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
..+++..+++++..||+.-|.+|||..+++..
T Consensus 247 -----------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 -----------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -----------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 34677789999999999999999999998874
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=299.29 Aligned_cols=249 Identities=27% Similarity=0.394 Sum_probs=201.1
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
..|+..+.||+|+||.||+|... ++..||+|.+...... .....+.+|+.+++.++|+||+++++++.+....++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 34667788999999999999965 5889999988754332 3456789999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.. .++++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 81 MEYLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred EecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceec
Confidence 999999999998854 24788899999999999999999998 999999999999999999999999999765
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... ......++..|+|||.+.+..++.++|+|||||++|||++|..||.... .. . ..........
T Consensus 152 ~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~--~~---~----~~~~~~~~~~--- 218 (277)
T cd06640 152 TDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH--PM---R----VLFLIPKNNP--- 218 (277)
T ss_pred cCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC--hH---h----HhhhhhcCCC---
Confidence 43322 1223457889999999998889999999999999999999999974311 00 0 0001111100
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
.......+..+.+++.+||+.+|++||++.+++..
T Consensus 219 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 ------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11123455678999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=296.14 Aligned_cols=255 Identities=28% Similarity=0.389 Sum_probs=197.6
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
+.+++++.....||+|+||.||+|... ++..|++|.+..... ...+.+.+|+.+++.++|+||+++++++...+.
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS----RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF 79 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH----HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence 445566666778999999999999954 577899998765422 234678899999999999999999999999999
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC-CCcEEEEe
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPL--TWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ-RYRAKVAD 315 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~-~~~~kl~D 315 (468)
.++|+||+++++|.+++.... .++ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~d 152 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISD 152 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEec
Confidence 999999999999999997532 124 78888999999999999999999 999999999999976 67999999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccCC--CCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
||++......... .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||....... .......
T Consensus 153 fg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~------~~~~~~~ 225 (268)
T cd06624 153 FGTSKRLAGINPC-TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ------AAMFKVG 225 (268)
T ss_pred chhheecccCCCc-cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh------hhHhhhh
Confidence 9998765432221 22235789999999987643 7889999999999999999999984321100 0000000
Q ss_pred hhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 394 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.. .. ....+....+.+.+++.+||+.+|.+|||+.|+++
T Consensus 226 ~~-~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 226 MF-KI---------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hh-cc---------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00 00 00112234457889999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=307.15 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=196.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||++... +++.||+|.+...... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc---CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 56888999999999999999865 5789999988653322 2234577899999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||++ ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||++...
T Consensus 83 ~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 83 FEYLD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAK 154 (301)
T ss_pred Eeccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence 99997 58988886532 25889999999999999999999999 999999999999999999999999998754
Q ss_pred cCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh---ccc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR---KNR 398 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 398 (468)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ..+. ......... ...
T Consensus 155 ~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~--~~~~---~~~~~~~~~~~~~~~ 228 (301)
T cd07873 155 SIPTKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST--VEEQ---LHFIFRILGTPTEET 228 (301)
T ss_pred CCCCCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC--HHHH---HHHHHHHcCCCChhh
Confidence 332211 122346889999998876 457889999999999999999999985321 1111 111111100 000
Q ss_pred cchhcch---------HHh----hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHDILDD---------QLM----KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~~~d~---------~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+..+.+. ... .......+..+.+|+.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1110000 000 0011123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=299.51 Aligned_cols=247 Identities=27% Similarity=0.444 Sum_probs=196.4
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
++|.+.+.||+|+||.||++.. +++.+|+|...... ..+.+.+|+.+++.++|||++++++++... ..+++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 4588889999999999999975 57889999876532 225688999999999999999999998654 579999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 78 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 78 ELMSKGNLVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred ECCCCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 9999999999997632 235889999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
... .....+..|+|||.+.++.++.++|+||||+++|||++ |+.||.... . .. ..........
T Consensus 152 ~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~---~~-~~~~~~~~~~--- 215 (254)
T cd05083 152 MGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----L---KE-VKECVEKGYR--- 215 (254)
T ss_pred ccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----H---HH-HHHHHhCCCC---
Confidence 211 12234567999999998899999999999999999998 888874311 0 01 1111111110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
...+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 216 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 ------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11122345578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=298.10 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=202.4
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|+..+.||+|++|.||++... +++.+|+|.+...... ....++.+|+.++++++||||+++++.+......+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE---AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh---HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 35777888999999999999975 6889999988765433 3456788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS-ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
+||+++++|.+++.... .++++..+..++.|++.||+|||+ .+ ++|+||+|+||++++++.++|+|||.+..
T Consensus 78 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~ 150 (265)
T cd06605 78 MEYMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQ 150 (265)
T ss_pred EEecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchh
Confidence 99999999999997632 358899999999999999999999 88 99999999999999999999999999875
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
....... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ........... .....
T Consensus 151 ~~~~~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~-~~~~~ 223 (265)
T cd06605 151 LVNSLAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD---GIFELLQYIVN-EPPPR 223 (265)
T ss_pred hHHHHhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc---cHHHHHHHHhc-CCCCC
Confidence 5332221 15688899999999999999999999999999999999999854221111 11111111111 11111
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+. ....+..+.+++.+||..+|++|||+.+++.
T Consensus 224 ~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 LP--------SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CC--------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 00 1114457899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=302.62 Aligned_cols=250 Identities=26% Similarity=0.437 Sum_probs=200.4
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.+|...+.||+|++|.||++.. .+++.+++|.+...... ..+.+.+|+.+++.++|+||+++++.+......++|
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~----~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc----hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 5788889999999999999985 46889999988653322 235688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++... .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 96 ~e~~~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 96 MEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred ecccCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 9999999999998541 4788999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||.... .. ........... ...
T Consensus 167 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~--~~------~~~~~~~~~~~-~~~ 236 (296)
T cd06654 167 TPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--PL------RALYLIATNGT-PEL 236 (296)
T ss_pred cccccc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC--HH------HhHHHHhcCCC-CCC
Confidence 432211 223458889999999999889999999999999999999999985311 10 00111111110 000
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
..+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 237 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 -------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0122344578899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=294.31 Aligned_cols=252 Identities=28% Similarity=0.473 Sum_probs=199.4
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchH-----HHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDE-----ELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
+|.+.+.||+|++|.||+|... +++.+|+|.+....... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999864 57899999876533221 11234678899999999999999999999999999
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++++||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCC
Confidence 99999999999999999653 24788999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCce-----eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH
Q 012214 319 SKFIAMDQTH-----VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 319 a~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
++........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.... .. .. ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~--~~-~~~~ 224 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT-----QL--QA-IFKI 224 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc-----HH--HH-HHHH
Confidence 8866432111 1122357889999999999889999999999999999999999985311 00 00 0000
Q ss_pred hhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 394 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..... ...+...+..+.+++.+||+.+|.+||++.++++
T Consensus 225 -~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 225 -GENAS---------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -hccCC---------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00000 0112234457899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=291.07 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=201.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
+++|++.+.||+|.|+.|+++.. .+|+.+|+|++....-.. ...+++.+|+.+.+.++||||+++.+...+....++
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 46678888899999999999874 478999999875432221 345678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC---CCcEEEEecCC
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ---RYRAKVADFGT 318 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~---~~~~kl~DfGl 318 (468)
|+|+|+|++|..-+-.+ ...++..+-..+.||+.+|.|+|..+ |||||+||+|+++-+ ..-+||+|||+
T Consensus 88 vFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGv 159 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGL 159 (355)
T ss_pred EEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccce
Confidence 99999999998777654 24788888899999999999999999 999999999999953 45699999999
Q ss_pred cccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
|..+. ....-....||++|||||++...+++..+|||+.||+||-|+.|..||.. ++...+.+......-+-
T Consensus 160 Ai~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-----~~~~rlye~I~~g~yd~- 231 (355)
T KOG0033|consen 160 AIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-----EDQHRLYEQIKAGAYDY- 231 (355)
T ss_pred EEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-----ccHHHHHHHHhccccCC-
Confidence 98776 23334456799999999999999999999999999999999999999853 11111111111111000
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.........++..+|+.+||..||.+|.|+.|.+.
T Consensus 232 ---------~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 232 ---------PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ---------CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 01112234457889999999999999999999875
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=296.15 Aligned_cols=259 Identities=29% Similarity=0.455 Sum_probs=198.7
Q ss_pred CCCCceeeecCcEEEEEEEec----CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC----
Q 012214 166 FNANRILGQGGQGTVYKGMLE----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 237 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~---- 237 (468)
|.+.+.||+|+||.||+|... .++.||+|++....... ...+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS--SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh--HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 556788999999999999853 36889999887643332 34567889999999999999999999886432
Q ss_pred --cceeEeeecCCCChhhHhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 238 --VPLLVYEFIPNGTLYQHLHDRHQ-NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 238 --~~~lV~E~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
..++++||+.+|+|..++..... .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEEC
Confidence 23688999999999988754321 22235789999999999999999999998 9999999999999999999999
Q ss_pred ecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHH
Q 012214 315 DFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVH 392 (468)
Q Consensus 315 DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~ 392 (468)
|||+++......... .....++..|++||.+.+..++.++||||||+++|||++ |+.||... ..... ...
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~-----~~~~~---~~~ 227 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV-----ENSEI---YNY 227 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC-----CHHHH---HHH
Confidence 999998654332211 222345678999999999889999999999999999999 78886421 11111 111
Q ss_pred HhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 393 SMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 393 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
........ .+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 228 ~~~~~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 228 LIKGNRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHcCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111110 0112345789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=303.73 Aligned_cols=196 Identities=26% Similarity=0.389 Sum_probs=158.7
Q ss_pred ceeeecCcEEEEEEEec---CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc--CCcceeEee
Q 012214 170 RILGQGGQGTVYKGMLE---DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE--TEVPLLVYE 244 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~E 244 (468)
.+||+|+||.||+|... ++..+|+|.+..... ...+.+|+.+++.++||||+++++++.. ....++|+|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 57999999999999864 357899998765322 1356789999999999999999998853 456789999
Q ss_pred ecCCCChhhHhhhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE----cCCCcEEEEec
Q 012214 245 FIPNGTLYQHLHDRHQ----NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL----DQRYRAKVADF 316 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl----~~~~~~kl~Df 316 (468)
|+. ++|.+++..... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 986 478777753211 12235889999999999999999999999 9999999999999 56789999999
Q ss_pred CCcccccCCCce--eeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 012214 317 GTSKFIAMDQTH--VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFW 375 (468)
Q Consensus 317 Gla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~ 375 (468)
|+++........ ......+|..|+|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 999876433221 1233568999999999876 4578999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=308.47 Aligned_cols=260 Identities=22% Similarity=0.294 Sum_probs=194.6
Q ss_pred HhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC----
Q 012214 162 ATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET---- 236 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~---- 236 (468)
..++|.+.+.||+|+||.||++.. .+++.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS--LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh--hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 457899999999999999999985 46789999988653222 23445678999999999999999999987543
Q ss_pred --CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 237 --EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 237 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
...++++|++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEc
Confidence 3468999988 7789887753 24899999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH
Q 012214 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 315 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
|||+++..... .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||..... ..........
T Consensus 161 Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~ 231 (343)
T cd07878 161 DFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-----IDQLKRIMEV 231 (343)
T ss_pred CCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHH
Confidence 99999865432 223468999999999877 5788999999999999999999999843110 0000111000
Q ss_pred hhccc------------------cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 394 MRKNR------------------LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 394 ~~~~~------------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
..... +.......+.. ......+.+.+|+.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hCCCCHHHHHhcchhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000000000 001123457899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=294.76 Aligned_cols=253 Identities=28% Similarity=0.401 Sum_probs=201.2
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|...+.||+|+||.||++... +++.+++|.+..... ...+.+.+|+.++++++||||+++++++.+....+++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG----DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch----hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 57888899999999999999964 578899998875322 2456788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 79 ~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 79 MEYCGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL 151 (262)
T ss_pred EeCCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhh
Confidence 99999999999887631 25889999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCceeeecccccCCccCccccccC---CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
..... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.... ... ... . ......
T Consensus 152 ~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~--~~~-----~~~-~-~~~~~~ 221 (262)
T cd06613 152 TATIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH--PMR-----ALF-L-ISKSNF 221 (262)
T ss_pred hhhhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC--HHH-----HHH-H-HHhccC
Confidence 43221 12334678899999998876 88999999999999999999999984311 000 000 0 011100
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.. .. .......+..+.+++.+||+.+|.+|||+++++.
T Consensus 222 ~~---~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 222 PP---PK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CC---cc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 00 0012344567999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=293.81 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=201.0
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|++.+.||+|+||.||++... +++.+|+|.+....... ...+++.+|+.+++.++||||+++++++.+....++|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP--KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh--HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence 4788899999999999999854 68899999876532221 33467889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 79 DYCEGGDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152 (256)
T ss_pred ecCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence 9999999999887532 224789999999999999999999998 9999999999999999999999999987654
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
.... ......++..|+|||++.+...+.++|+|||||++++|++|+.||... + ........... ...
T Consensus 153 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~---~~~~~~~~~~~-~~~--- 219 (256)
T cd08218 153 STVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----N---MKNLVLKIIRG-SYP--- 219 (256)
T ss_pred cchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----C---HHHHHHHHhcC-CCC---
Confidence 3221 122345788999999999989999999999999999999999998431 1 11111111111 110
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+...+..+.+++.+||+.+|++||++.+|++
T Consensus 220 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 ------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 112234457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=298.83 Aligned_cols=252 Identities=28% Similarity=0.394 Sum_probs=197.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||++... +++.||+|.++.... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG----EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 46777888999999999999854 688999998865422 2335678899999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 85 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 85 MEFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred EeccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 99999999999986532 4899999999999999999999999 999999999999999999999999998755
Q ss_pred cCCCceeeecccccCCccCccccc---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
... ........|+..|+|||++. ...++.++|||||||++|+|++|..||..... .. ............
T Consensus 157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~--~~-----~~~~~~~~~~~~ 228 (267)
T cd06645 157 TAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP--MR-----ALFLMTKSNFQP 228 (267)
T ss_pred cCc-ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc--hh-----hHHhhhccCCCC
Confidence 322 11223346899999999874 45688999999999999999999999743111 00 000000000000
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
....+ ....+..+.+++.+||+.+|++|||+.++++
T Consensus 229 ~~~~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 229 PKLKD-------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred Ccccc-------cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000 1123346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=292.57 Aligned_cols=251 Identities=27% Similarity=0.395 Sum_probs=200.1
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccch-HHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDD-EELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
+|+..+.||+|++|.||+|... ++..|++|.+...... ......+.+.+|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677888999999999999976 7899999987653211 1123456789999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999999652 24889999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCceeeecccccCCccCccccccCC-CCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.... . ...............
T Consensus 153 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-----~---~~~~~~~~~~~~~~~ 222 (258)
T cd06632 153 VEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-----G---VAAVFKIGRSKELPP 222 (258)
T ss_pred cccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-----H---HHHHHHHHhcccCCC
Confidence 4332 223455888999999988766 8999999999999999999999984311 0 111111111011111
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+......+.+++.+||+.+|++|||+.+++.
T Consensus 223 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 ---------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11223457889999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=314.54 Aligned_cols=261 Identities=24% Similarity=0.302 Sum_probs=196.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEec---CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE---DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
..+|.+.+.||+|+||.||++... .+..||+|.+... ..+.+|+.+++.++||||+++++++......
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 457999999999999999999753 3578999987542 1245799999999999999999999998999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
+++||++. ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 162 ~lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a 232 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232 (392)
T ss_pred EEEehhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccc
Confidence 99999985 6888888432 25899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 320 KFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 320 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
+........ ......||..|+|||++.+..++.++|||||||++|||++|+.||....... ....+.. .........
T Consensus 233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~-i~~~~~~~~ 310 (392)
T PHA03207 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRS-IIRCMQVHP 310 (392)
T ss_pred cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHH-HHHHhccCc
Confidence 765433222 2234569999999999999999999999999999999999999985422211 1111111 111110000
Q ss_pred c--ch-----hc------chHHhhh-------chHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 399 L--HD-----IL------DDQLMKL-------GVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 399 ~--~~-----~~------d~~l~~~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
. .. +. ....... ........+.+++.+||+.||++|||+.|++..
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00 00 0000000 001224567899999999999999999999864
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=309.94 Aligned_cols=192 Identities=24% Similarity=0.428 Sum_probs=164.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
..+|.+.+.||+|+||.||+|... +++.||+|..... ....|+.++++++|+||+++++++.+....++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 457999999999999999999965 4678999975432 23468999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
|+|++. ++|.+++.... .++++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 135 v~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred EEEccC-CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccc
Confidence 999995 68888886522 35899999999999999999999999 99999999999999999999999999875
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~ 374 (468)
..... ......||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 207 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 207 PVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 33221 1233568999999999999999999999999999999999766654
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=302.81 Aligned_cols=263 Identities=22% Similarity=0.307 Sum_probs=195.9
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|...+.||+|+||.||++... +|+.+|+|.+....... .....+.+|+.++++++|+||+++++++.+....++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc--cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence 4778889999999999999965 68899999886532221 22345778999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||++ ++|.+++.... ..+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 79 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 79 EYCD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred ecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 9996 58888776422 25899999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc------
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK------ 396 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 396 (468)
..... .....++..|+|||++.+. .++.++|||||||++|+|++|..|+....+ .... . .........
T Consensus 151 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~-~~~~--~-~~~~~~~~~~~~~~~ 225 (284)
T cd07839 151 IPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQ--L-KRIFRLLGTPTEESW 225 (284)
T ss_pred CCCCC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC-HHHH--H-HHHHHHhCCCChHHh
Confidence 32211 2234578899999988764 478999999999999999999999743221 1110 0 000000000
Q ss_pred ------cc---cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 397 ------NR---LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 397 ------~~---~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.. .................++.+.+++.+||+.||.+|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 00000000001111234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.82 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=198.4
Q ss_pred HHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc--CC
Q 012214 161 KATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE--TE 237 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~ 237 (468)
...++|.+.+.||+|+||+||++... .+..+|+|.+....... .....|..|+.++++++||||+++++++.+ ..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e--~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE--REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH--HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 34478999999999999999999965 57789999876533222 334678999999999999999999998854 45
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCEEecCCCCCCEEEcC------
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS----SPIYHRDIKSTNILLDQ------ 307 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~----~~iiH~DLkp~NILl~~------ 307 (468)
..++||||+++|+|.++|..... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 68999999999999999976332 12359999999999999999999998542 33999999999999964
Q ss_pred -----------CCcEEEEecCCcccccCCCceeeecccccCCccCcccccc--CCCCCcccHHHHHHHHHHHHhCCCCCC
Q 012214 308 -----------RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIF 374 (468)
Q Consensus 308 -----------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvll~el~tG~~p~~ 374 (468)
...+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 3458999999997654322 1234568999999999864 458899999999999999999999985
Q ss_pred CCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 375 WAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
... ..............+. ....+..+.+||..||+.+|.+|||+.|++.
T Consensus 245 ~~~-------~~~qli~~lk~~p~lp-----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 245 KAN-------NFSQLISELKRGPDLP-----------IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cCC-------cHHHHHHHHhcCCCCC-----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 311 1111111111111110 1123457899999999999999999999984
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=294.01 Aligned_cols=240 Identities=23% Similarity=0.380 Sum_probs=185.2
Q ss_pred ceeeecCcEEEEEEEecC-------------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC
Q 012214 170 RILGQGGQGTVYKGMLED-------------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 236 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~ 236 (468)
+.||+|+||.||+|.... ...|++|.+.... . .....|.+|+.+++.++||||+++++++.+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~---~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-R---DISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-h---hHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 358999999999998432 2358888765422 1 3345788899999999999999999999998
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc------
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR------ 310 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~------ 310 (468)
...++||||+++++|..++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~ 149 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGP 149 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCc
Confidence 89999999999999988886422 25899999999999999999999999 999999999999987664
Q ss_pred -EEEEecCCcccccCCCceeeecccccCCccCccccc-cCCCCCcccHHHHHHHHHHHH-hCCCCCCCCCCCccchhchH
Q 012214 311 -AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-SSQLTDKSDVYSFGVVLVELL-TGKKPIFWAGNTSQENVSLA 387 (468)
Q Consensus 311 -~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvll~el~-tG~~p~~~~~~~~~~~~~~~ 387 (468)
++++|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+.... ..
T Consensus 150 ~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~------ 216 (262)
T cd05077 150 FIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT--LA------ 216 (262)
T ss_pred eeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc--hh------
Confidence 899999998654322 2234778899999887 467899999999999999998 5777763211 00
Q ss_pred HHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 388 AYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
. ...... .... . .......+.+|+.+||+.||++||++.++++.|+
T Consensus 217 ~-~~~~~~-~~~~-~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 217 E-KERFYE-GQCM-L---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred H-HHHHHh-cCcc-C---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 000001 0000 0 1112346889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=298.06 Aligned_cols=251 Identities=26% Similarity=0.345 Sum_probs=196.4
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEee
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYE 244 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 244 (468)
|++.+.||+|+||.||++... ++..+++|.+.... . ...+.+.+|+.+++.++|||++++++++......++|+|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-E---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-H---HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 566788999999999999965 47788998875432 2 345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
|+++++|..++.... .++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 83 FCAGGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 155 (282)
T ss_pred ecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccc
Confidence 999999988876421 35899999999999999999999999 99999999999999999999999999875532
Q ss_pred CCceeeecccccCCccCccccc-----cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 325 DQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
... ......++..|+|||++. +..++.++|||||||++|||++|+.||.... .............
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~~- 225 (282)
T cd06643 156 TIQ-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSEP- 225 (282)
T ss_pred ccc-ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--------HHHHHHHHhhcCC-
Confidence 211 122345889999999874 3457889999999999999999999974210 1111111111100
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 444 (468)
... ..+...+..+.+++.+||+.+|++|||+.++++.-
T Consensus 226 ~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 226 PTL-------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred CCC-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 000 01122345789999999999999999999988543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=300.64 Aligned_cols=263 Identities=24% Similarity=0.317 Sum_probs=201.1
Q ss_pred CHHHHHHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeee
Q 012214 155 SSKELDKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGC 232 (468)
Q Consensus 155 ~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~ 232 (468)
..+.+..+.++|++.+.||+|+||.||++... +++.+|+|++..... ....+.+|+.+++.+ +||||++++++
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~ 83 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-----IDEEIEAEYNILKALSDHPNVVKFYGM 83 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-----hHHHHHHHHHHHHHHhcCCCeeeeeee
Confidence 34555667789999999999999999999864 578999998754221 124577899999999 79999999998
Q ss_pred ec-----cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC
Q 012214 233 CL-----ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ 307 (468)
Q Consensus 233 ~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~ 307 (468)
+. .+...++||||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~ 159 (286)
T cd06638 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTT 159 (286)
T ss_pred eeecccCCCCeEEEEEeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECC
Confidence 74 34568999999999999998865322 2235889999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCcccccCCCceeeecccccCCccCcccccc-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 012214 308 RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE 382 (468)
Q Consensus 308 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~ 382 (468)
++.++|+|||+++....... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||.....
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~---- 234 (286)
T cd06638 160 EGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP---- 234 (286)
T ss_pred CCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch----
Confidence 99999999999876543222 1223458999999998753 4578899999999999999999999853210
Q ss_pred hhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 383 NVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
....... .........+ +...+..+.+++.+||+.||++|||+.|+++.
T Consensus 235 ----~~~~~~~-~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 235 ----MRALFKI-PRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ----hHHHhhc-cccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0001110 0110001111 11233468899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=293.15 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=194.6
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccc-hHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc--CCcc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVD-DEELLKLEEFINEIVILSQINHRNVVKLLGCCLE--TEVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~ 239 (468)
.+|...+.||+|+||.||++... ++..|++|++..... .........+.+|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 588999998764322 1222345678899999999999999999998865 3567
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++++||+++++|.+++.... .+++...+.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 89999999999999996532 4788999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCCc--eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 320 KFIAMDQT--HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 320 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
........ .......++..|+|||++.+..++.++|||||||++|||++|+.||... .. ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~-----~~---~~~~~~~~~~~ 225 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY-----EA---MAAIFKIATQP 225 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc-----ch---HHHHHHHhcCC
Confidence 75532111 1112345788999999999988999999999999999999999998421 00 01111111111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
... ..+....+.+.+++ +||..+|++|||+.||++
T Consensus 226 ~~~---------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TNP---------QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCC---------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000 01122334566676 788899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=292.55 Aligned_cols=253 Identities=28% Similarity=0.431 Sum_probs=200.9
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|...+.||+|+||.||++... +++.+++|.++..... ....+.+.+|+.+++.++|+||+++++++.+.+..++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence 4788899999999999999864 6889999998764332 245678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 79 e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~ 150 (264)
T cd06626 79 EYCSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLK 150 (264)
T ss_pred ecCCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccC
Confidence 999999999998652 24788999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCceeee---cccccCCccCccccccCC---CCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 324 MDQTHVTT---KIQGTFGYLDPEYHQSSQ---LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 324 ~~~~~~~~---~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
........ ...++..|+|||++.+.. .+.++||||||+++|++++|+.||.... .... ...........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~----~~~~-~~~~~~~~~~~ 225 (264)
T cd06626 151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD----NEFQ-IMFHVGAGHKP 225 (264)
T ss_pred CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc----chHH-HHHHHhcCCCC
Confidence 43332211 345788999999998766 8899999999999999999999985311 0000 00000000111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.++. ....+..+.+++.+||+.+|.+|||+.+++.
T Consensus 226 ~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111 1122456789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=296.60 Aligned_cols=241 Identities=23% Similarity=0.370 Sum_probs=185.7
Q ss_pred ceeeecCcEEEEEEEecC--------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 170 RILGQGGQGTVYKGMLED--------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
+.||+|+||.||+|.... ...+++|.+.... ....+.+.+|+.+++.++||||+++++++......++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH----RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh----HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence 359999999999998532 2347778764321 1344678899999999999999999999999889999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc--------EEE
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR--------AKV 313 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~--------~kl 313 (468)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. +++
T Consensus 77 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l 149 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKL 149 (258)
T ss_pred EEecCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEe
Confidence 999999999999997632 25889999999999999999999999 999999999999987765 699
Q ss_pred EecCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHH
Q 012214 314 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVH 392 (468)
Q Consensus 314 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 392 (468)
+|||++...... ....++..|+|||++.+ ..++.++||||||+++|||++|..++... .+.. .....
T Consensus 150 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~----~~~~---~~~~~ 217 (258)
T cd05078 150 SDPGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA----LDSQ---KKLQF 217 (258)
T ss_pred cccccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh----ccHH---HHHHH
Confidence 999988644321 22457888999999987 45789999999999999999985443211 0000 00000
Q ss_pred HhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 393 SMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 393 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
......+ +......+.+++.+||+.+|++|||+.++++.|+
T Consensus 218 ~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 218 YEDRHQL------------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHccccC------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0011111 1122346899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=292.99 Aligned_cols=258 Identities=27% Similarity=0.399 Sum_probs=203.7
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||.|+||+||++... ++..+++|++...... ...+.+.+|+.+++.++|+|++++++.+......++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ---TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc---hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence 46888999999999999999954 6788999988653333 2456789999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+|++++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 78 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~ 152 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASL 152 (267)
T ss_pred EeccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence 999999999999976322 235899999999999999999999999 999999999999999999999999998766
Q ss_pred cCCCce---eeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 323 AMDQTH---VTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 323 ~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
...... ......++..|+|||.+... .++.++|+||||+++|+|++|+.||..... ...+........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~ 224 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP--------MKVLMLTLQNDP 224 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh--------hhhHHHHhcCCC
Confidence 543322 12334588999999998876 789999999999999999999999853111 011111111110
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...... ......+..+.+++.+||+.||++|||+.++++
T Consensus 225 -~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 -PSLETG----ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -CCcCCc----cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 001234567899999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=300.38 Aligned_cols=249 Identities=25% Similarity=0.443 Sum_probs=200.0
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.+|+..+.||.|++|.||++.. .+++.|++|.+..... ...+.+.+|+.+++.++|||++++++++.+....++|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ----PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC----chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 4688889999999999999985 4689999998865322 2345688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 95 ~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 95 MEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165 (296)
T ss_pred EEecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhc
Confidence 999999999998854 24899999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... . .. ........ ...+
T Consensus 166 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-----~--~~-~~~~~~~~-~~~~ 235 (296)
T cd06655 166 TPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----L--RA-LYLIATNG-TPEL 235 (296)
T ss_pred cccccc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H--HH-HHHHHhcC-Cccc
Confidence 433221 2234588899999999998899999999999999999999999843110 0 00 00111100 0000
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+...+..+.+++.+||+.+|++|||+.+++.
T Consensus 236 -------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 -------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 012233457889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=297.80 Aligned_cols=266 Identities=24% Similarity=0.327 Sum_probs=197.2
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|+..+.||+|++|.||++... +++.||+|++....... ...+.+.+|+.++++++|+|++++++++.+....++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP--VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc--cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence 46888899999999999999975 58999999876432221 2234578999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|..++... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 79 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07847 79 FEYCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARIL 150 (286)
T ss_pred EeccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceec
Confidence 9999998887776432 24899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH-HHHHH-------
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA-YFVHS------- 393 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~-~~~~~------- 393 (468)
..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .+...... .....
T Consensus 151 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 151 TGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD--VDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred CCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCChHHhhh
Confidence 44321 1223357788999999876 5678999999999999999999999853211 11100000 00000
Q ss_pred hhcccc-ch--hcchHH---hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 394 MRKNRL-HD--ILDDQL---MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 394 ~~~~~~-~~--~~d~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...... .. ..++.. ........+..+.+++.+||+.+|++|||+.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000 00 000000 00001123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=308.64 Aligned_cols=256 Identities=26% Similarity=0.393 Sum_probs=210.1
Q ss_pred HHhcCCCCCceeeecCcEEEEEEEecC-CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccCCc
Q 012214 161 KATNHFNANRILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEV 238 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~ 238 (468)
.....|.+.+.||+|.||.||+++.+. |+.+|+|.+........ ...+.+.+|+.+|+++. |||||.+.+++.+...
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~-~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK-EDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc-ccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 345678888999999999999999764 99999998866433211 23467889999999998 9999999999999999
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC----CcEEEE
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR----YRAKVA 314 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~----~~~kl~ 314 (468)
.++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.+ |+||||||+|+|+... +.+|++
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~ 181 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLI 181 (382)
T ss_pred EEEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEe
Confidence 99999999999999999874 2899999999999999999999999 9999999999999643 579999
Q ss_pred ecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 315 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
|||++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||...... .. +....
T Consensus 182 DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~----~~----~~~i~ 251 (382)
T KOG0032|consen 182 DFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF----EI----FLAIL 251 (382)
T ss_pred eCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh----HH----HHHHH
Confidence 9999998766 33456678999999999999999999999999999999999999998541110 10 11111
Q ss_pred hccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 395 RKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 395 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
...+ ..........+..+.+++..|+..||..|+|+.++++.
T Consensus 252 -~~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 252 -RGDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -cCCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1111 11122233456678999999999999999999999985
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=297.25 Aligned_cols=263 Identities=23% Similarity=0.292 Sum_probs=199.9
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|++.+.||+|++|.||+|... +|+.||+|++....... .....+.+|+.++++++|||++++++++.+....++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG--GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc--hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence 4778889999999999999964 68999999987643221 33467889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+ +++|.+++.... .++++..++.++.||+.||+|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 79 e~~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 79 EYM-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFS 150 (286)
T ss_pred ccc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence 999 999999987532 35899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc---c
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR---L 399 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 399 (468)
...........++..|+|||.+.+. .++.++||||+|++++||++|..||.. ... ............... +
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG--END---IEQLAIVFRTLGTPNEETW 225 (286)
T ss_pred CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC--CCH---HHHHHHHHHHcCCCChHHH
Confidence 4332222334688999999988754 468899999999999999999766632 111 111111111111000 0
Q ss_pred c---------hhcchH----HhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 400 H---------DILDDQ----LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 400 ~---------~~~d~~----l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. .+..+. .......+.+..+.+++.+||+.+|++|||++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 000000 000011233468999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=296.49 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=199.3
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
-|+..+.||+|+||.||+|... ++..+|+|........ .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 3667788999999999999854 6889999987643322 34467889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06641 82 EYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT 152 (277)
T ss_pred EeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecc
Confidence 99999999998854 24889999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
.... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.... .. .............
T Consensus 153 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-----~~----~~~~~~~~~~~~~-- 220 (277)
T cd06641 153 DTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH-----PM----KVLFLIPKNNPPT-- 220 (277)
T ss_pred cchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc-----hH----HHHHHHhcCCCCC--
Confidence 3221 1223457889999999988889999999999999999999999974210 00 0111111111110
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
.....+..+.+++.+||+.+|.+||++.++++.
T Consensus 221 -------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 -------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -------CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 112334578899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=293.26 Aligned_cols=256 Identities=24% Similarity=0.399 Sum_probs=200.4
Q ss_pred CCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchH--HHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 165 HFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDE--ELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
+|+..+.||+|++|.||++.. .+++.+|+|.+....... .....+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477888999999999999985 568999999886533211 11245778999999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC-cEEEEecCCcc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY-RAKVADFGTSK 320 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~-~~kl~DfGla~ 320 (468)
|+||+++++|.+++... .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++.
T Consensus 81 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 99999999999998653 25889999999999999999999999 99999999999998776 69999999987
Q ss_pred cccCCCce---eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 321 FIAMDQTH---VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 321 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
........ ......++..|+|||.+.+..++.++||||+|+++++|++|..||..... .. ............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~---~~~~~~~~~~~~ 227 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH--SN---HLALIFKIASAT 227 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--cc---hHHHHHHHhccC
Confidence 66433211 12234578899999999888899999999999999999999999843111 00 001110100000
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ....+...+..+.+++.+||+.+|++|||+.++++
T Consensus 228 ~---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 T---------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred C---------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0 01112334557889999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=299.27 Aligned_cols=259 Identities=27% Similarity=0.403 Sum_probs=199.8
Q ss_pred CHHHHHHHhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeee
Q 012214 155 SSKELDKATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGC 232 (468)
Q Consensus 155 ~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~ 232 (468)
+..++....+.|++.+.||+|+||.||+|.. .+++.+|+|...... ....++..|+.++..+ +|+||++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~ 81 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-----DEEEEIKLEINMLKKYSHHRNIATYYGA 81 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-----HHHHHHHHHHHHHHHhcCCCcEEEEeee
Confidence 4455555678899999999999999999996 468899999876532 2235678899999998 79999999999
Q ss_pred ecc------CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc
Q 012214 233 CLE------TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD 306 (468)
Q Consensus 233 ~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~ 306 (468)
+.. ....+++|||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++
T Consensus 82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~ 155 (282)
T cd06636 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLT 155 (282)
T ss_pred hhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC
Confidence 853 456799999999999999987632 235788889999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCCcccccCCCceeeecccccCCccCccccc-----cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCcc
Q 012214 307 QRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381 (468)
Q Consensus 307 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~ 381 (468)
+++.++|+|||++........ ......++..|+|||.+. ...++.++|||||||++|||++|..||.... ..
T Consensus 156 ~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~--~~ 232 (282)
T cd06636 156 ENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH--PM 232 (282)
T ss_pred CCCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC--HH
Confidence 999999999999875532211 122345888999999876 3467889999999999999999999984311 00
Q ss_pred chhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 382 ENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.... . ........ ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 233 -----~~~~-~-~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 233 -----RALF-L-IPRNPPPK--------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -----hhhh-h-HhhCCCCC--------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000 0 00000000 111234557999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=296.18 Aligned_cols=239 Identities=24% Similarity=0.386 Sum_probs=183.9
Q ss_pred eeeecCcEEEEEEEecC-------------------------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCc
Q 012214 171 ILGQGGQGTVYKGMLED-------------------------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225 (468)
Q Consensus 171 ~LG~G~fG~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n 225 (468)
.||+|+||.||+|.... ...|++|++..... ....+|.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR----DIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH----HHHHHHHHHHHHHhcCCCCC
Confidence 59999999999997421 13588888754211 33457889999999999999
Q ss_pred eeeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE
Q 012214 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL 305 (468)
Q Consensus 226 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl 305 (468)
|+++++++.+....++||||+++|+|..++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill 150 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILL 150 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEE
Confidence 9999999999999999999999999999886521 25889999999999999999999998 9999999999999
Q ss_pred cCCC-------cEEEEecCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHH-hCCCCCCCC
Q 012214 306 DQRY-------RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELL-TGKKPIFWA 376 (468)
Q Consensus 306 ~~~~-------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~-tG~~p~~~~ 376 (468)
+.++ .+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||...
T Consensus 151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 151 ARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred eccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 7644 4899999987543221 12346788999998876 56899999999999999985 688887431
Q ss_pred CCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 377 GNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
.. .+ ....+. ..... +......+.+++.+||+.+|++|||+.++++.|.
T Consensus 226 ~~--~~---~~~~~~---~~~~~------------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 226 TP--SE---KERFYE---KKHRL------------PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred Ch--HH---HHHHHH---hccCC------------CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11 10 001100 00011 1112236889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=299.80 Aligned_cols=263 Identities=25% Similarity=0.360 Sum_probs=198.2
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|+..+.||+|+||.||++..+ +++.+|+|++....... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK--MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc--hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence 46788899999999999999975 58899999876533221 2345688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||+++++|..+.... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 79 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07846 79 FEFVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL 150 (286)
T ss_pred EecCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence 9999998888776432 24899999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc-----
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK----- 396 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 396 (468)
..... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... .............
T Consensus 151 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07846 151 AAPGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-----IDQLYHIIKCLGNLIPRH 224 (286)
T ss_pred cCCcc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-----HHHHHHHHHHhCCCchhh
Confidence 43322 2233457889999998875 4578899999999999999999988743111 0000000100000
Q ss_pred ------c------ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 397 ------N------RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 397 ------~------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ..................+..+.+++.+||+.+|++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 000000000000011234567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=295.03 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=201.6
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc--CCccee
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE--TEVPLL 241 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~l 241 (468)
+|++.+.||.|+||.||++... +++.+|+|.+....... ...+.+.+|+.+++.++|+||+++++++.. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE--KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH--HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence 4778889999999999999854 67899999886533221 344678899999999999999999997754 446789
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH-----SATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-----~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
+|||+++++|.+++..... ...++++..++.++.||+.||.||| +.+ ++|+||+|+||++++++.+||+||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~ 154 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDF 154 (265)
T ss_pred EehhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecc
Confidence 9999999999999976432 2346899999999999999999999 666 999999999999999999999999
Q ss_pred CCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
|++......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... . .........
T Consensus 155 g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~----~~~~~~~~~ 224 (265)
T cd08217 155 GLAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----Q----LQLASKIKE 224 (265)
T ss_pred cccccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----H----HHHHHHHhc
Confidence 999876543321 223468899999999999889999999999999999999999985311 1 111122222
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
..... .+...+..+.+++.+||+.+|++|||+.+|++.
T Consensus 225 ~~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 GKFRR---------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCCC---------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 21111 122345578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=298.08 Aligned_cols=253 Identities=24% Similarity=0.385 Sum_probs=193.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHH-HHhcCCCceeeEeeeeccCCccee
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVI-LSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~-l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
++|++.+.||+|+||.||++... +|+.||+|+++...... ....+..|+.. ++..+||||+++++++......++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ---EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH---HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence 46888899999999999999965 68999999887543322 22345556654 666799999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA-TSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
++||++ ++|.+++...... ...+++..++.++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++.
T Consensus 78 v~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~ 152 (283)
T cd06617 78 CMEVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISG 152 (283)
T ss_pred Ehhhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999996 6888888653322 24689999999999999999999987 7 9999999999999999999999999987
Q ss_pred cccCCCceeeecccccCCccCcccccc----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQS----SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
...... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... .........
T Consensus 153 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~- 222 (283)
T cd06617 153 YLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-------FQQLKQVVE- 222 (283)
T ss_pred cccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-------HHHHHHHHh-
Confidence 653321 1223457889999998865 45688999999999999999999998421110 011111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.....+. ....+..+.+++.+||+.+|++|||+.++++
T Consensus 223 ~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 223 EPSPQLP--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred cCCCCCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111 1123457899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=299.59 Aligned_cols=247 Identities=26% Similarity=0.383 Sum_probs=206.0
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEee
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYE 244 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 244 (468)
|.+..+||+|+||.||++.++ .|+.+|||.+... ..+.+++.|+.++++.+.|++|+++|.+.....+++|||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 667788999999999999965 6999999998874 345789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
||.-||..+.++.+. ++++++++..++...++||+|||... =||||||+.|||++.+|.+||+|||.|-.+.+
T Consensus 109 YCGAGSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 109 YCGAGSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred hcCCCcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 999999999997644 47999999999999999999999988 79999999999999999999999999976543
Q ss_pred CCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcc
Q 012214 325 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404 (468)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 404 (468)
.. .....+.||+.|||||++..-.|+.++||||||++..||..|++|+....... ..-.+.....+-+
T Consensus 182 TM-AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------AIFMIPT~PPPTF-- 249 (502)
T KOG0574|consen 182 TM-AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------AIFMIPTKPPPTF-- 249 (502)
T ss_pred hH-HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------eeEeccCCCCCCC--
Confidence 22 22344679999999999999999999999999999999999999984211000 0000111111111
Q ss_pred hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 405 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+..++..+.+++.+||-.+|++|-|+.++++
T Consensus 250 -----~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 -----KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred -----CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 125667778999999999999999999999887
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=300.14 Aligned_cols=267 Identities=25% Similarity=0.305 Sum_probs=200.9
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|++|.||++... +++.||+|++....... ...+.+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE--DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc--cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence 36888899999999999999965 58899999886533221 3346788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||++++.+..+... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++...
T Consensus 79 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~ 150 (288)
T cd07833 79 FEYVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARAL 150 (288)
T ss_pred EecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence 999988666555433 124899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHH---------H
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV---------H 392 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~---------~ 392 (468)
............++..|+|||++.+. .++.++||||||+++|+|++|+.||..... .+......... .
T Consensus 151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD--IDQLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHhhh
Confidence 55443233345678899999999887 889999999999999999999998753111 11000000000 0
Q ss_pred Hhhcc-----ccchhcchH-HhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 393 SMRKN-----RLHDILDDQ-LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 393 ~~~~~-----~~~~~~d~~-l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..... ...+..+.. .....+...+..+.+++.+||+.+|++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 001111110 111122233678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=295.83 Aligned_cols=251 Identities=27% Similarity=0.362 Sum_probs=197.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
+.|++.+.||+|+||.||+|... +++.+++|.+.... . ...+.+.+|+.+++.++|+||+++++++..+...++|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-E---EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-H---HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 56888999999999999999965 58899999986532 2 3456788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|..++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 88 ~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 88 IEFCPGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred EecCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999988875422 25899999999999999999999998 999999999999999999999999998654
Q ss_pred cCCCceeeecccccCCccCccccc-----cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
.... .......++..|+|||++. ...++.++|||||||++|||++|..||.... . ..........
T Consensus 161 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~---~~~~~~~~~~- 230 (292)
T cd06644 161 VKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-----P---MRVLLKIAKS- 230 (292)
T ss_pred cccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-----H---HHHHHHHhcC-
Confidence 3221 1122345788999999885 3457889999999999999999999974311 0 1111111111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...... .+...+..+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 231 EPPTLS-------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCccCC-------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111100 12233447889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=303.33 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=200.2
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|+..+.||+|++|.||++... +++.+|+|.+....... ....+.+.+|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK-RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch-HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 36888899999999999999965 48999999887643221 13456788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 80 MDYCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred EEecCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 9999999999998752 2235899999999999999999999999 999999999999999999999999998754
Q ss_pred cCCCce----------------------------eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 012214 323 AMDQTH----------------------------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374 (468)
Q Consensus 323 ~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~ 374 (468)
...... ......||..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 322110 0112357889999999999889999999999999999999999985
Q ss_pred CCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 012214 375 WAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT----MEEVSM 442 (468)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt----~~evl~ 442 (468)
.... ...+....... .. .......+..+.+++.+||+.+|++||| +.|++.
T Consensus 234 ~~~~--------~~~~~~~~~~~-~~--------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 234 GSNR--------DETFSNILKKE-VT--------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCch--------HHHHHHHhcCC-cc--------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 3111 01111111111 00 0001114557999999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=296.01 Aligned_cols=255 Identities=26% Similarity=0.296 Sum_probs=204.0
Q ss_pred cCCCCCceeeecCcEEEEEEEecC-CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|+..+.||.|.-|+||++.+++ +..+|+|++....-. ......+...|-+||+.++||.+..|++.+..+...+++
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~-~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA-SRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh-hhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 557777889999999999999764 589999998764322 124456677899999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
||||+||+|..+++. +....+++..+.-.+..++-||+|||-.| ||.|||||+||||.++|++-|+||.++..+
T Consensus 156 meyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 999999999999987 33456999999999999999999999999 999999999999999999999999987543
Q ss_pred cCC---------------------------------Cc----------------------eeeecccccCCccCcccccc
Q 012214 323 AMD---------------------------------QT----------------------HVTTKIQGTFGYLDPEYHQS 347 (468)
Q Consensus 323 ~~~---------------------------------~~----------------------~~~~~~~gt~~y~aPE~~~~ 347 (468)
... .. ......+||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 210 00 01122469999999999999
Q ss_pred CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhh
Q 012214 348 SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCL 427 (468)
Q Consensus 348 ~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl 427 (468)
...+.++|+|+|||++|||+.|..||...+ .. ..+..++...+.-......+..+.+||.++|
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~--~~---------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSN--NK---------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCC--ch---------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence 999999999999999999999999996421 11 1112222222222222345567899999999
Q ss_pred ccCCCCCCC----HHHHHH
Q 012214 428 DLNGKKRPT----MEEVSM 442 (468)
Q Consensus 428 ~~dp~~RPt----~~evl~ 442 (468)
..||.+|.. +.||-+
T Consensus 373 vKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ccChhhhhccccchHHhhc
Confidence 999999998 666643
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=296.06 Aligned_cols=270 Identities=25% Similarity=0.417 Sum_probs=208.4
Q ss_pred CCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC---CCceeeEeeeeccCCcce
Q 012214 165 HFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN---HRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~ 240 (468)
.|+..+.||+|+||.||+|.. .+++.+|+|.+...... ....++.+|+.+++.++ |||++++++++.+....+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD---DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence 477788899999999999995 46899999988654333 33456888999999986 999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||+++++|.+++... ++++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 79 lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAA 149 (277)
T ss_pred EEEecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCcee
Confidence 999999999999988541 5899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
........ .....|+..|+|||.+.+ ..++.++||||||+++|+|++|..||..... . . ..........
T Consensus 150 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~------~-~~~~~~~~~~ 219 (277)
T cd06917 150 LLNQNSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--F------R-AMMLIPKSKP 219 (277)
T ss_pred ecCCCccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--h------h-hhhccccCCC
Confidence 66543322 233468889999998875 4568899999999999999999999843110 0 0 0011111111
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCchhhhHHHHHHhhh
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKRAMFSKIIKRL 465 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~~~ 465 (468)
..+. ....+..+.+++.+||+.||++|||+.++++. .=++.....+.....+++.++
T Consensus 220 ~~~~--------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~-~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd06917 220 PRLE--------DNGYSKLLREFVAACLDEEPKERLSAEELLKS-KWIKAHSKTPVSILKELISRY 276 (277)
T ss_pred CCCC--------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC-hHhhccccCchhhHHHHHHhh
Confidence 1111 11134578999999999999999999999863 333444444555555555543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=296.73 Aligned_cols=246 Identities=28% Similarity=0.376 Sum_probs=198.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|++|.||++... +++.+|+|++...... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 46888899999999999999965 6899999987643211 113456788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...
T Consensus 80 ~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 80 MEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred EecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999999763 25889999999999999999999999 999999999999999999999999999866
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
... .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||.... .. ....... ....
T Consensus 152 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~---~~~~~~~-~~~~--- 215 (290)
T cd05580 152 KGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PI---QIYEKIL-EGKV--- 215 (290)
T ss_pred CCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HH---HHHHHHh-cCCc---
Confidence 443 233468899999999988889999999999999999999999985311 00 1111111 1110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVS 441 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl 441 (468)
..+...+..+.+++.+||+.||.+|| ++.|++
T Consensus 216 -------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 216 -------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred -------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 01112245788999999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=322.17 Aligned_cols=276 Identities=19% Similarity=0.237 Sum_probs=191.0
Q ss_pred HHhcCCCCCceeeecCcEEEEEEEecC--CcEEEEEeccc-------------ccchHHHHHHHHHHHHHHHHHhcCCCc
Q 012214 161 KATNHFNANRILGQGGQGTVYKGMLED--GRIIAVKKSKL-------------TVDDEELLKLEEFINEIVILSQINHRN 225 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~-------------~~~~~~~~~~~~~~~Ei~~l~~l~h~n 225 (468)
...++|.+.+.||+|+||+||++..+. +...++|.... ............+.+|+.++++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999987532 22222221000 000001123456889999999999999
Q ss_pred eeeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE
Q 012214 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL 305 (468)
Q Consensus 226 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl 305 (468)
|+++++++.+.+..++|+|++. ++|.+++...............+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999984 57777775432222223446677889999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhc
Q 012214 306 DQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVS 385 (468)
Q Consensus 306 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~ 385 (468)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++........ ...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~-~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP-GKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH-HHH
Confidence 9999999999999987654433333446799999999999999999999999999999999998765433211111 011
Q ss_pred hHHHHHHHhh--ccccc-------hhcchH--------Hhh-hchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 386 LAAYFVHSMR--KNRLH-------DILDDQ--------LMK-LGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 386 ~~~~~~~~~~--~~~~~-------~~~d~~--------l~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.... ..... ...+. +.++.. +.. ......+..+.+++.+||+.||.+|||+.|++.
T Consensus 380 ~~~~-~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 380 LLKI-IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHH-HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1110 00000 00000 000000 000 000112345778899999999999999999986
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=289.96 Aligned_cols=252 Identities=28% Similarity=0.427 Sum_probs=205.1
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|++|.||++... +++.+++|++...... .....+.+|+..+..++|+|++++++++......++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE---EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence 46888899999999999999976 5899999988764332 3456789999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS-ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
+||+++++|.+++... .++++..++.++.|+++|+.|||+ .+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 78 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~ 149 (264)
T cd06623 78 LEYMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKV 149 (264)
T ss_pred EEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCcccee
Confidence 9999999999999763 358999999999999999999999 88 99999999999999999999999999886
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ....... ..........
T Consensus 150 ~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~-~~~~~~~~~~ 222 (264)
T cd06623 150 LENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELM-QAICDGPPPS 222 (264)
T ss_pred cccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHH-HHHhcCCCCC
Confidence 6433322 1234578899999999999999999999999999999999999854221 0111111 1111111111
Q ss_pred hcchHHhhhchHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 402 ILDDQLMKLGVKN-QIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 402 ~~d~~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+.. .+..+.+++.+||+.+|++|||+.++++
T Consensus 223 ---------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 223 ---------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred ---------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1112 4568999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=301.07 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=204.3
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.+|.+.+.||+|+||.||++.. .+++.||+|.+...... ..+.+.+|+.+++.++|+||+++++++......++|
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 6788999999999999999995 47899999988653322 235678999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 95 ~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 95 MEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred ecccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 999999999999864 24788999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...... .....+++.|+|||.+.+..++.++|||||||++|+|++|..||..... .... . ...... ...
T Consensus 166 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~--~~~~-----~-~~~~~~-~~~- 234 (297)
T cd06656 166 TPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--LRAL-----Y-LIATNG-TPE- 234 (297)
T ss_pred cCCccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc--chhe-----e-eeccCC-CCC-
Confidence 433221 2234588899999999998899999999999999999999999853111 0000 0 000000 000
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhcccCC
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGIRGSS 451 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i~~~~ 451 (468)
...+...+..+.+++.+||+.+|++|||+.++++ .++..+...
T Consensus 235 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 279 (297)
T cd06656 235 ------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS 279 (297)
T ss_pred ------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence 0012233456889999999999999999999997 455444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=318.85 Aligned_cols=267 Identities=20% Similarity=0.238 Sum_probs=190.8
Q ss_pred HHHHHHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC------CCceee
Q 012214 156 SKELDKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN------HRNVVK 228 (468)
Q Consensus 156 ~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~------h~niv~ 228 (468)
.+++...+++|.+.+.||+|+||+||++... .++.||||+++... ....++..|+.++..++ |.++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 195 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRDAKIEIQFMEKVRQADPADRFPLMK 195 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHHHHHHHHHHHHHhhcCcccCcceee
Confidence 3445556789999999999999999999864 57889999986421 11234455666666654 456888
Q ss_pred EeeeeccC-CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEecCCCCCCEEEc
Q 012214 229 LLGCCLET-EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS-ATSSPIYHRDIKSTNILLD 306 (468)
Q Consensus 229 l~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLkp~NILl~ 306 (468)
+++++... ...++|||++ +++|.+++... ..+++..+..|+.||+.||.|||+ .+ ||||||||+|||++
T Consensus 196 i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~ 266 (467)
T PTZ00284 196 IQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILME 266 (467)
T ss_pred eEEEEEcCCceEEEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEe
Confidence 98888654 4678999988 77898888653 258999999999999999999998 47 99999999999998
Q ss_pred CCC----------------cEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCC
Q 012214 307 QRY----------------RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 370 (468)
Q Consensus 307 ~~~----------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~ 370 (468)
.++ .+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~ 342 (467)
T PTZ00284 267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342 (467)
T ss_pred cCCcccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCC
Confidence 765 499999998754321 223457899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccchhchHHH--------HHHH---------hh-ccccchhcchHHh-------hhchHHHHHHHHHHHHH
Q 012214 371 KPIFWAGNTSQENVSLAAY--------FVHS---------MR-KNRLHDILDDQLM-------KLGVKNQIMTFANLAKR 425 (468)
Q Consensus 371 ~p~~~~~~~~~~~~~~~~~--------~~~~---------~~-~~~~~~~~d~~l~-------~~~~~~~~~~l~~li~~ 425 (468)
.||..... .+....... +... .. ...+....++... ..........+++|+.+
T Consensus 343 ~pf~~~~~--~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 420 (467)
T PTZ00284 343 LLYDTHDN--LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG 420 (467)
T ss_pred CCCCCCCh--HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHH
Confidence 99854211 111000000 0000 00 0000000000000 00001123467899999
Q ss_pred hhccCCCCCCCHHHHHH
Q 012214 426 CLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 426 cl~~dp~~RPt~~evl~ 442 (468)
||+.||++|||+.|+++
T Consensus 421 mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 421 LLHYDRQKRLNARQMTT 437 (467)
T ss_pred hCCcChhhCCCHHHHhc
Confidence 99999999999999987
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=297.17 Aligned_cols=263 Identities=27% Similarity=0.342 Sum_probs=201.8
Q ss_pred cCHHHHHHHhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEee
Q 012214 154 FSSKELDKATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLG 231 (468)
Q Consensus 154 ~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g 231 (468)
++..++..++++|.+.+.||+|+||.||++.. .+++.+|+|.+..... ....+.+|+.++.++ +|||++++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~~h~ni~~~~~ 86 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-----VDEEIEAEYNILQSLPNHPNVVKFYG 86 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-----HHHHHHHHHHHHHHhcCCCCeEEEEE
Confidence 44556666789999999999999999999996 4688999998764321 224567889999998 8999999999
Q ss_pred eeccC-----CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc
Q 012214 232 CCLET-----EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD 306 (468)
Q Consensus 232 ~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~ 306 (468)
++... ...++|+||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 87 ~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~ 162 (291)
T cd06639 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLT 162 (291)
T ss_pred EEEeccccCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEc
Confidence 98653 357999999999999998865321 2235899999999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCCcccccCCCceeeecccccCCccCccccccC-----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCcc
Q 012214 307 QRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-----QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381 (468)
Q Consensus 307 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~ 381 (468)
+++.+||+|||++........ ......++..|+|||.+... .++.++|||||||++|||++|+.||....
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~---- 237 (291)
T cd06639 163 TEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH---- 237 (291)
T ss_pred CCCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc----
Confidence 999999999999876543221 12234578899999987653 36889999999999999999999984311
Q ss_pred chhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 382 ENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ........+ .....+.+ +......+.+++.+||+.+|++||++.|+++
T Consensus 238 -~---~~~~~~~~~-~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 238 -P---VKTLFKIPR-NPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -H---HHHHHHHhc-CCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 011111111 11111111 1223447899999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=291.55 Aligned_cols=257 Identities=26% Similarity=0.388 Sum_probs=198.1
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccch------HHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDD------EELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 237 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 237 (468)
+|...+.||+|+||.||+|... +++.+|+|.+...... ......+.+.+|+.+++.++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999854 6889999987542111 11123456889999999999999999999999999
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG 317 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfG 317 (468)
..++|+||+++++|.+++... .++++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999999763 25889999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCCce-eeecccccCCccCccccccCC--CCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 318 TSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 318 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
+++........ ......++..|+|||.+.... ++.++|+||||+++|++++|..||.... . ... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-----~--~~~-~~~~~ 225 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE-----A--IAA-MFKLG 225 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc-----h--HHH-HHHhh
Confidence 98765432211 123345888999999987754 8899999999999999999999984211 0 001 11111
Q ss_pred hccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 395 RKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 395 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.......+. . ......+..+.+++.+||+.+|++|||+.++++
T Consensus 226 ~~~~~~~~~-~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 226 NKRSAPPIP-P----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccccCCcCC-c----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111000110 0 111223457899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=289.09 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=199.4
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|+..+.||+|++|.||++... +++.+|+|.+....... .....+.+|+.+++.++|||++++++.+......++|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK--DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc--HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 4778899999999999999854 68889999886543222 34567899999999999999999999999889999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC-CcEEEEecCCcccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR-YRAKVADFGTSKFI 322 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~-~~~kl~DfGla~~~ 322 (468)
||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++++ +.++|+|||++...
T Consensus 79 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 79 EYAPGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred ecCCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 9999999999997632 235899999999999999999999999 9999999999999865 46899999999866
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... . ......... .....
T Consensus 153 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-----~---~~~~~~~~~-~~~~~- 220 (256)
T cd08220 153 SSKSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-----L---PALVLKIMS-GTFAP- 220 (256)
T ss_pred CCCcc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-----h---HHHHHHHHh-cCCCC-
Confidence 43322 223457889999999998889999999999999999999999974311 0 011111111 11111
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+...+..+.+++.+||+.+|++|||+.|++.
T Consensus 221 --------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 --------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11223457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=290.86 Aligned_cols=238 Identities=26% Similarity=0.411 Sum_probs=186.3
Q ss_pred ceeeecCcEEEEEEEecCCc-----------EEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 170 RILGQGGQGTVYKGMLEDGR-----------IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
+.||+|+||.||+|...+.. .+++|.+..... . ...|.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----D-SLAFFETASLMSQLSHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----h-HHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence 35999999999999976432 477787654321 1 4678899999999999999999999988 77
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC-------cE
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY-------RA 311 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~-------~~ 311 (468)
.++|+||+++|+|.+++..... .+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++ .+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~ 147 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFI 147 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeE
Confidence 8999999999999999976332 5889999999999999999999999 99999999999999888 79
Q ss_pred EEEecCCcccccCCCceeeecccccCCccCccccccC--CCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHH
Q 012214 312 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS--QLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 312 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~ 388 (468)
||+|||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..|+.... ...
T Consensus 148 kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~--~~~------ 214 (259)
T cd05037 148 KLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS--SSE------ 214 (259)
T ss_pred EeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC--chh------
Confidence 9999999876533 1223466789999998876 78999999999999999999 466653211 100
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
........... +......+.+++.+||..+|++|||+.++++.|+
T Consensus 215 -~~~~~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 215 -KERFYQDQHRL-----------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -HHHHHhcCCCC-----------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00111111000 0011157889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=295.85 Aligned_cols=253 Identities=27% Similarity=0.357 Sum_probs=200.4
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||++... ++..+|+|...... . ...+.|.+|+.++++++|+||+++++.+.+....++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-E---EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-H---HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence 356888899999999999999964 68899999886532 2 345678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++++|.+++.... .++++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..
T Consensus 80 v~e~~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 80 LIEFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred EeeccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchh
Confidence 999999999999986532 25899999999999999999999999 99999999999999999999999999875
Q ss_pred ccCCCceeeecccccCCccCccccc-----cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
...... ......++..|+|||.+. ...++.++||||||+++|+|++|+.||.... . ........ .
T Consensus 153 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~-----~---~~~~~~~~-~ 222 (280)
T cd06611 153 NKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN-----P---MRVLLKIL-K 222 (280)
T ss_pred hccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC-----H---HHHHHHHh-c
Confidence 533221 123345889999999875 3457789999999999999999999984311 0 11111111 1
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
.....+ ..+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus 223 ~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 223 SEPPTL-------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCCCc-------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111000 0122334578899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=307.75 Aligned_cols=243 Identities=25% Similarity=0.276 Sum_probs=185.2
Q ss_pred eeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc---CCCceeeEeeeeccCCcceeEeeecC
Q 012214 172 LGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI---NHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 172 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
||+|+||+||++... +++.||+|++....... ......+..|..++... +||||+++++++.+....++||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 699999999999965 58999999875422111 12334556677777665 69999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 80 GGELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred CChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence 99999888652 24899999999999999999999999 99999999999999999999999999875432221
Q ss_pred eeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQ 406 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 406 (468)
......||..|+|||.+.+. .++.++|||||||++|+|++|+.||.... ....... ...... .+.
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--------~~~~~~~-i~~~~~-~~~--- 217 (330)
T cd05586 152 -TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--------TQQMYRN-IAFGKV-RFP--- 217 (330)
T ss_pred -CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--------HHHHHHH-HHcCCC-CCC---
Confidence 12345689999999998764 57899999999999999999999985311 0111111 111110 000
Q ss_pred HhhhchHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 012214 407 LMKLGVKNQIMTFANLAKRCLDLNGKKRPT----MEEVSM 442 (468)
Q Consensus 407 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt----~~evl~ 442 (468)
....+..+.+++.+||+.||.+||+ +.++++
T Consensus 218 -----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 -----KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -----CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0112346789999999999999995 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=297.52 Aligned_cols=258 Identities=24% Similarity=0.281 Sum_probs=200.4
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|...+.||+|+||.||++... .++.|++|.+..... ......+.+.+|+.+++.++||||+++++.+.+....++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 46888899999999999999965 578899998765321 1123456788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 80 ~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~ 151 (305)
T cd05609 80 MEYVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151 (305)
T ss_pred EecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence 99999999999996532 4899999999999999999999998 999999999999999999999999998642
Q ss_pred cCCCc--------------eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH
Q 012214 323 AMDQT--------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 323 ~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~ 388 (468)
..... .......++..|+|||.+.+..++.++|+||||+++|||++|..||... .. ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~--~~------~~ 223 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--TP------EE 223 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CH------HH
Confidence 11100 0111235788999999999888999999999999999999999998431 11 11
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
....... ..... +. .....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 224 ~~~~~~~-~~~~~---~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 224 LFGQVIS-DDIEW---PE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHHh-cccCC---CC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1111111 10000 00 011234578999999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=290.37 Aligned_cols=253 Identities=27% Similarity=0.388 Sum_probs=195.9
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccch-HHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC--Ccc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDD-EELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~ 239 (468)
++|.+.+.||+|+||.||.+... ++..||+|.+...... ......+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999864 5889999987532211 1123456788999999999999999999988763 467
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++++||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccc
Confidence 89999999999999986532 4788889999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCc--eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 320 KFIAMDQT--HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 320 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
........ .......++..|+|||.+.+..++.++|||||||++|||++|+.||... .. ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-----~~---~~~~~~~~~~~ 225 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF-----EA---MAAIFKIATQP 225 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc-----ch---HHHHHHHhcCC
Confidence 75432111 1122345888999999998888999999999999999999999998421 00 01111111111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.. ...+......+.+++.+|+. +|++|||++|+++
T Consensus 226 ~~---------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 TN---------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CC---------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00 11123344568889999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.94 Aligned_cols=268 Identities=24% Similarity=0.355 Sum_probs=217.1
Q ss_pred HHHHHhcCCCCCceeeecCcEEEEEEEec--------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceee
Q 012214 158 ELDKATNHFNANRILGQGGQGTVYKGMLE--------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVK 228 (468)
Q Consensus 158 ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~ 228 (468)
..+...++..+.+.||+|.||.|++|... ....||||+++..... ...+.+..|+.+++.+ +|+||+.
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~---~~~~~~~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS---SEKKDLMSELNVLKELGKHPNIVN 366 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc---HHHHHHHHHHHHHHHhcCCcchhh
Confidence 44455566667779999999999999843 1457999999876554 5567899999999999 6999999
Q ss_pred EeeeeccCCcceeEeeecCCCChhhHhhhcc---------cCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecC
Q 012214 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRH---------QNEE--FPLTWEMRLRIATEVAGALAYLHSATSSPIYHRD 297 (468)
Q Consensus 229 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~D 297 (468)
++|+|.+....++|.||+..|+|.++|+..+ .... ..++....+.++.|||.||+||++.. +||||
T Consensus 367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRD 443 (609)
T KOG0200|consen 367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRD 443 (609)
T ss_pred heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchh
Confidence 9999999999999999999999999999866 1111 23899999999999999999999999 99999
Q ss_pred CCCCCEEEcCCCcEEEEecCCcccccCCCceeeeccc--ccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 012214 298 IKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ--GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIF 374 (468)
Q Consensus 298 Lkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~ 374 (468)
|.++|||+.++..+||+|||+|+.............. -+..|||||.+....++.|+||||||++||||+| |..|+.
T Consensus 444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred hhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 9999999999999999999999977666555533333 3567999999999999999999999999999999 778863
Q ss_pred CCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 375 WAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
. ......+....+.+ .+...|..+..+++++++.||+.+|++||++.++.+.|+.+.
T Consensus 524 ~--------~~~~~~l~~~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 524 G--------IPPTEELLEFLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred C--------CCcHHHHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 2 11011112222222 222335666778999999999999999999999999999853
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=294.35 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=196.1
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|+..+.||+|++|.||++... +++.||||++....... .....+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE--GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc--ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence 4788899999999999999864 68899999886533221 22356889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+. ++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 79 e~~~-~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 79 EFLH-QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred eccc-cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 9995 68888886532 235899999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCceeeecccccCCccCccccccCC-CCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc-----
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN----- 397 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 397 (468)
..... .....++..|+|||.+.+.. ++.++||||||+++|||+||+.||.... +........ ......
T Consensus 152 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~----~~~~~~~~~-~~~~~~~~~~~ 225 (284)
T cd07860 152 VPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS----EIDQLFRIF-RTLGTPDEVVW 225 (284)
T ss_pred cCccc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHH-HHhCCCChhhh
Confidence 32211 22234678899999887644 6889999999999999999999985311 111111111 100000
Q ss_pred -----------ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 -----------RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 -----------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
............ .....+..+.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhHHHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 01123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=295.72 Aligned_cols=267 Identities=20% Similarity=0.281 Sum_probs=195.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCc---
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEV--- 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~--- 238 (468)
++|++.+.||+|+||.||++... +++.||+|+........ .....+.+|+.+++.+ +|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE--GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc--CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 46888899999999999999965 68999999876532221 2235678899999999 56999999999876665
Q ss_pred --ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC-CCcEEEEe
Q 012214 239 --PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ-RYRAKVAD 315 (468)
Q Consensus 239 --~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~-~~~~kl~D 315 (468)
.++||||+++ +|.+++..........+++..++.++.||+.||.|||+.+ |+||||+|+||+++. ++.+||+|
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEee
Confidence 7999999975 8988887643332346899999999999999999999999 999999999999998 89999999
Q ss_pred cCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
||+++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||..... . ..........
T Consensus 155 fg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~---~~~~~~~~~~ 228 (295)
T cd07837 155 LGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE--L---QQLLHIFKLL 228 (295)
T ss_pred cccceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH--H---HHHHHHHHHh
Confidence 999875532211 1122346788999998865 4578999999999999999999999853111 0 0000011110
Q ss_pred hccc---cchh---c--------chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 395 RKNR---LHDI---L--------DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 395 ~~~~---~~~~---~--------d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+. +... . .+.......+..+..+.+++.+||+.||.+|||+.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 0000 0 000000111234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=296.17 Aligned_cols=264 Identities=21% Similarity=0.281 Sum_probs=193.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
+++|.+.+.||+|+||.||+|... ++..+|+|.+...... .....+.+|+.+++.++|+||+++++++.+....++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE---GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC---CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 477899999999999999999864 6889999988654322 122356789999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
|+||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 81 v~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARA 152 (291)
T ss_pred EEeccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccc
Confidence 999995 67777765421 24788889999999999999999999 99999999999999999999999999875
Q ss_pred ccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc---
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN--- 397 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 397 (468)
....... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...... .............+
T Consensus 153 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~----~~~~~~~~~~~~~~~~~ 227 (291)
T cd07870 153 KSIPSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV----FEQLEKIWTVLGVPTED 227 (291)
T ss_pred cCCCCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH----HHHHHHHHHHcCCCChh
Confidence 4322111 122346889999999876 45788999999999999999999998532110 00000010000000
Q ss_pred ------ccchhcch--------HHhh-hchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 ------RLHDILDD--------QLMK-LGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ------~~~~~~d~--------~l~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.++..... .+.. .........+.+++.+|++.||++|||+.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000 0000 000012457889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=294.87 Aligned_cols=263 Identities=22% Similarity=0.312 Sum_probs=194.9
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|+..+.||+|++|.||++..+ +++.||+|.+...... .....+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 57888899999999999999965 6889999987653222 1223467899999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++ +|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++..
T Consensus 82 ~e~~~~-~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 82 FEYLDT-DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred EecCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 999974 8998886532 25889999999999999999999999 999999999999999999999999998754
Q ss_pred cCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc---c
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN---R 398 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~ 398 (468)
...... .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...... .+ ............ .
T Consensus 154 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~ 228 (291)
T cd07844 154 SVPSKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV-ED---QLHKIFRVLGTPTEET 228 (291)
T ss_pred CCCCcc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH-HH---HHHHHHHhcCCCChhh
Confidence 322111 122346788999998876 56889999999999999999999998532110 00 001011100000 0
Q ss_pred cch--------------hcchHHhhhc-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHD--------------ILDDQLMKLG-VKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~--------------~~d~~l~~~~-~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+.. .....+.... .......+.+++.+||+.+|++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0000000000 0111256789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=295.99 Aligned_cols=257 Identities=26% Similarity=0.341 Sum_probs=194.4
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccCCcceeE
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV 242 (468)
+|...+.||+|+||.||++... +++.+|+|.+...... .....+.+|+.++.++. |+||+++++++......+++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE---KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh---HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4455677999999999999864 5899999988754333 33467889999999996 99999999999988899999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA-TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
+||+. +++.++...........+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||++..
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 99985 4665544321112224689999999999999999999975 7 99999999999999999999999999876
Q ss_pred ccCCCceeeecccccCCccCccccccC---CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
...... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||.... ............ .
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~-~ 227 (288)
T cd06616 158 LVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKG-D 227 (288)
T ss_pred hccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCC-C
Confidence 543221 2233578899999998876 68999999999999999999999984311 111111111111 1
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
...+ ........+..+.+|+.+||+.+|++|||+.+|++.
T Consensus 228 ~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPIL-----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcC-----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 111112355679999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=294.52 Aligned_cols=250 Identities=30% Similarity=0.427 Sum_probs=196.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
..|...+.||+|+||.||++... +++.||+|.+...... ......++.+|+.+++.++||||+++++++.+....++|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 45888899999999999999864 6889999987543221 113446788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||++ |+|.+.+.... .++++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 94 ~e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 94 MEYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred HHhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceec
Confidence 99996 57777775422 25899999999999999999999999 999999999999999999999999998755
Q ss_pred cCCCceeeecccccCCccCccccc---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
... ....++..|+|||++. ...++.++||||||+++|||++|+.||.... .... . ........
T Consensus 166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-----~~~~---~-~~~~~~~~ 231 (307)
T cd06607 166 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSA---L-YHIAQNDS 231 (307)
T ss_pred CCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-----HHHH---H-HHHhcCCC
Confidence 332 2235788999999874 4568899999999999999999999974311 0000 0 00111111
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 444 (468)
.. ......+..+.+++.+||+.+|++|||+.+++...
T Consensus 232 ~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 PT--------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CC--------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 11 01223456789999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=295.45 Aligned_cols=263 Identities=19% Similarity=0.280 Sum_probs=185.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEecC----CcEEEEEecccccchH--HHHH-----HHHHHHHHHHHHhcCCCceeeEee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLED----GRIIAVKKSKLTVDDE--ELLK-----LEEFINEIVILSQINHRNVVKLLG 231 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~--~~~~-----~~~~~~Ei~~l~~l~h~niv~l~g 231 (468)
.++|.+.+.||+|+||.||+|...+ +..+|+|+........ +... ......+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999999654 3466777543321110 0000 012233445566778999999999
Q ss_pred eeccCC----cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC
Q 012214 232 CCLETE----VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ 307 (468)
Q Consensus 232 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~ 307 (468)
++.... ..++++|++. .++.+.+.... ..++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG 161 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 875543 3356777663 36666654321 2567888999999999999999999 999999999999999
Q ss_pred CCcEEEEecCCcccccCCCce------eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCcc
Q 012214 308 RYRAKVADFGTSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381 (468)
Q Consensus 308 ~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~ 381 (468)
++.++|+|||+|+.+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999876432211 11224699999999999999999999999999999999999999854221111
Q ss_pred chhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 382 ENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
........+......+.. .....+..+.+++..|++.+|++||++.++++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKI-----------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHHHhhhhhh-----------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 100001111111111110 11233567899999999999999999999998763
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=291.06 Aligned_cols=255 Identities=29% Similarity=0.414 Sum_probs=198.9
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCC--
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETE-- 237 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~-- 237 (468)
.+++|++.+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 4688999999999999999999975 578899998765322 235688999999999 7999999999997644
Q ss_pred ----cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEE
Q 012214 238 ----VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKV 313 (468)
Q Consensus 238 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl 313 (468)
..++||||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l 154 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKL 154 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEE
Confidence 47999999999999999875331 1236899999999999999999999999 999999999999999999999
Q ss_pred EecCCcccccCCCceeeecccccCCccCcccccc-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH
Q 012214 314 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 314 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~ 388 (468)
+|||++........ ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||.... .. .
T Consensus 155 ~d~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~---~ 225 (275)
T cd06608 155 VDFGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH-----PM---R 225 (275)
T ss_pred CCCccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc-----hH---H
Confidence 99999875543221 2233458889999998754 346789999999999999999999984211 00 0
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...... ......+. .+...+..+.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~~~-~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 226 ALFKIP-RNPPPTLK-------SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHHhh-ccCCCCCC-------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111 11111111 12234567899999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=292.54 Aligned_cols=255 Identities=30% Similarity=0.430 Sum_probs=198.1
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEee
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYE 244 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 244 (468)
|...+.||+|+||.||++... ++..+|+|++...... .......+.+|+.+++.++|+|++++++++.+....++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 667788999999999999954 6889999988643222 11344678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
|++ |+|.+.+.... .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 996 57877775422 35899999999999999999999999 99999999999999999999999999865432
Q ss_pred CCceeeecccccCCccCccccc---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 325 DQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
. ....++..|+|||++. .+.++.++|||||||++|||++|+.||... ..... ........ ..
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-----~~~~~---~~~~~~~~-~~- 242 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSA---LYHIAQNE-SP- 242 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc-----cHHHH---HHHHHhcc-CC-
Confidence 2 2345788999999874 467889999999999999999999997431 10000 11111111 00
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.......+..+.+++.+||+.+|.+|||+.++++.+..+....
T Consensus 243 -------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 243 -------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred -------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 0111234457899999999999999999999998665444333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=296.74 Aligned_cols=273 Identities=23% Similarity=0.302 Sum_probs=197.9
Q ss_pred CCCCCceeeecCcEEEEEEEec---CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC--Ccc
Q 012214 165 HFNANRILGQGGQGTVYKGMLE---DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVP 239 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~ 239 (468)
.|.+.+.||+|++|.||+|... +++.||+|.+...... .....+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ-YTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc-ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 3777889999999999999964 4789999988763211 112235577899999999999999999999887 789
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC----CCcEEEEe
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ----RYRAKVAD 315 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~----~~~~kl~D 315 (468)
++||||+++ +|.+.+..........+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECC
Confidence 999999964 7777776543333346899999999999999999999999 999999999999999 99999999
Q ss_pred cCCcccccCCCc--eeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchh----chHH
Q 012214 316 FGTSKFIAMDQT--HVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENV----SLAA 388 (468)
Q Consensus 316 fGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~----~~~~ 388 (468)
||+++....... .......++..|+|||.+.+ ..++.++||||||+++++|++|+.||........... ....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999986643322 11233457889999998776 4578999999999999999999999854222110000 0000
Q ss_pred HHHHHhhc------------cccch---------hcchHHhhhchH--HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 389 YFVHSMRK------------NRLHD---------ILDDQLMKLGVK--NQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 389 ~~~~~~~~------------~~~~~---------~~d~~l~~~~~~--~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.....+.. ..... .....+....+. ..+..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000 00000 000011111111 34457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=290.35 Aligned_cols=250 Identities=28% Similarity=0.337 Sum_probs=201.0
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|++.+.||+|+||.||++... +++.+|+|.+...... .....+.+.+|+.++++++||||+++++++.+....++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-chhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 4788899999999999999965 5889999988653211 1134578899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+.+++|.+++... .++++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 80 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~ 151 (258)
T cd05578 80 DLLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVT 151 (258)
T ss_pred eCCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence 999999999999663 35889999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ....+........
T Consensus 152 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~----- 218 (258)
T cd05578 152 PDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQETAD----- 218 (258)
T ss_pred CCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcccc-----
Confidence 332 223355888999999999888999999999999999999999998542211 1111111111100
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCH--HHHH
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTM--EEVS 441 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~--~evl 441 (468)
...+...+..+.+++.+||+.||.+||++ +|++
T Consensus 219 -----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 -----VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -----ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11122344688999999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=295.53 Aligned_cols=245 Identities=26% Similarity=0.397 Sum_probs=194.3
Q ss_pred CceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecC
Q 012214 169 NRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
...||+|+||.||++... ++..||||.+.... . ...+.+.+|+..++.++|+||+++++.+...+..++||||++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-Q---QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecch-H---HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 456999999999999864 68899999876422 1 344668899999999999999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 103 ~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 103 GGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred CCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 9999998753 14789999999999999999999999 99999999999999999999999999875543222
Q ss_pred eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
......++..|+|||.+.+..++.++||||||+++|||++|+.||.... .... . ...... ....+.
T Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~~~~---~-~~~~~~-~~~~~~--- 239 (292)
T cd06658 174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP-----PLQA---M-RRIRDN-LPPRVK--- 239 (292)
T ss_pred -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHH---H-HHHHhc-CCCccc---
Confidence 1223458899999999998889999999999999999999999985311 1000 0 011100 000000
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
.....+..+.+++.+||+.||.+|||+.++++.
T Consensus 240 ---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 ---DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ---cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011234468899999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=293.31 Aligned_cols=263 Identities=23% Similarity=0.275 Sum_probs=197.4
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC--Ccce
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVPL 240 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~ 240 (468)
++|+..+.||+|+||.||+|... +++.+++|.++...... .....+.+|+.++++++||||+++++++... ...+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE--GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc--cchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 56888899999999999999975 58899999886543221 2234567899999999999999999998776 8899
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+|+||++ ++|.+++.... ..+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 83 lv~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~ 154 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154 (293)
T ss_pred EEehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCcee
Confidence 9999997 59988886532 25899999999999999999999999 9999999999999999999999999988
Q ss_pred cccCCCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc---
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK--- 396 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 396 (468)
....... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... .. ...........
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~--~~---~~~~~~~~~~~~~~ 228 (293)
T cd07843 155 EYGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE--ID---QLNKIFKLLGTPTE 228 (293)
T ss_pred eccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh--HH---HHHHHHHHhCCCch
Confidence 6654321 12234578899999988764 468899999999999999999999853211 10 00000000000
Q ss_pred --------------cccchhcchHHhhhchHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 397 --------------NRLHDILDDQLMKLGVKN-QIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 397 --------------~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..........+....+.. .+..+.+++.+||+.+|++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000011111111111111 3567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=302.33 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=199.5
Q ss_pred HhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 240 (468)
....|++.++||+||.+.||++...+.+.+|+|++.....+ .+.+..|.+|+.+|.++ .|.+|+.|+++-..++..|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D--~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEAD--NQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcC--HHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 34678999999999999999999888888898877653332 36778899999999999 5999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||= ..+|...|..+... ...| .+..+..||+.++.++|+++ |||.||||.|+|+- .|.+||+|||+|.
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~---~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSI---DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIAN 507 (677)
T ss_pred EEeecc-cccHHHHHHhccCC---CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhc
Confidence 999986 45999999875431 2234 67788999999999999999 99999999999985 5699999999999
Q ss_pred cccCCCcee-eecccccCCccCccccccC-----------CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH
Q 012214 321 FIAMDQTHV-TTKIQGTFGYLDPEYHQSS-----------QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 321 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~ 388 (468)
.+..+.+.. ....+||+.||+||.+... +.+.++|||||||+||+|+.|+.||.. -....
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~-------~~n~~- 579 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ-------IINQI- 579 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-------HHHHH-
Confidence 887776654 4456799999999987642 256799999999999999999999831 11111
Q ss_pred HHHHHhhccccchhcchHHhhhchH-HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVK-NQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~-~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+..+.++.-.-+++. ....++.+++..||+.||.+|||..|+++
T Consensus 580 --------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 --------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 11223333321111111 11123899999999999999999999986
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=292.94 Aligned_cols=261 Identities=25% Similarity=0.291 Sum_probs=202.5
Q ss_pred CCCCCceeeecCcEEEEEEEe----cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcc
Q 012214 165 HFNANRILGQGGQGTVYKGML----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~ 239 (468)
+|++.+.||+|++|.||++.. .+++.+|||.++...........+.+.+|+.++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999874 357889999886432222223456788999999999 699999999999988999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccc
Confidence 9999999999999998652 24889999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCCceeeecccccCCccCccccccCC--CCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
+..............++..|+|||.+.+.. .+.++||||||+++|||++|..||........ ...........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~ 227 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-----QSEISRRILKS 227 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-----HHHHHHHHHcc
Confidence 765444333333456889999999987754 78899999999999999999999853211110 01111111000
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
. ...+...+..+.+++.+||+.+|++|||+.++.+.|+..-
T Consensus 228 ~----------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 228 K----------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred C----------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 0 0111223346889999999999999999999988877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=288.11 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=198.8
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|...+.||+|+||.||++..+ +|..+|+|.+....... ...+.+.+|+.+++.++|+||+++++.+.+....++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV--KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc--hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence 4778889999999999999965 58889999876532111 23456789999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC-cEEEEecCCcccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY-RAKVADFGTSKFI 322 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~-~~kl~DfGla~~~ 322 (468)
||+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++ .+||+|||.+...
T Consensus 79 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 79 EYCDGGDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred ecCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 9999999999987532 235799999999999999999999999 99999999999999885 4699999998766
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... ......|+..|+|||+..+..++.++|+||||+++|||++|..||.... ......... ......
T Consensus 153 ~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~~~- 221 (257)
T cd08225 153 NDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKIC-QGYFAP- 221 (257)
T ss_pred cCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHh-cccCCC-
Confidence 43222 2223458889999999988889999999999999999999999974210 111111111 111111
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.....+..+.+++.+||+.+|++|||+.+++.
T Consensus 222 --------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 --------ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11223457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=300.47 Aligned_cols=261 Identities=21% Similarity=0.299 Sum_probs=196.9
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC----
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET---- 236 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~---- 236 (468)
..++|+..+.||+|+||.||++... +++.||+|.+....... .....+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV--THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh--hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 4578999999999999999999964 68999999886532221 3345677899999999999999999988643
Q ss_pred --CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 237 --EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 237 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
...++|+||+. ++|.+.+.. .++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~ 160 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 160 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEc
Confidence 34689999995 588887754 2788899999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 315 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
|||+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... . ..........
T Consensus 161 Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~--~---~~~~~~~~~~ 233 (353)
T cd07850 161 DFGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH--I---DQWNKIIEQL 233 (353)
T ss_pred cCccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH--H---HHHHHHHHhc
Confidence 9999986543221 2234578899999999999999999999999999999999999853211 0 0000000000
Q ss_pred hc--------------------c-----ccchhcchHH----hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 395 RK--------------------N-----RLHDILDDQL----MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 395 ~~--------------------~-----~~~~~~d~~l----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.. . .+.+...... ....+...+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred CCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0 0000000000 00012234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=283.58 Aligned_cols=249 Identities=32% Similarity=0.455 Sum_probs=201.5
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
.|...+.||+|++|.||++... +++.+++|++..... .....+.+|+.+++.++|+|++++++++......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3677889999999999999975 688999999876432 24567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++++|.+++.... ..+++..+..++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+....
T Consensus 77 e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 77 EFCSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149 (253)
T ss_pred ecCCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccc
Confidence 9999999999987632 35899999999999999999999988 9999999999999999999999999987765
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
.... .....++..|+|||.+.+..++.++||||||+++++|++|+.||.... ........ .........
T Consensus 150 ~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~----~~~~~~~~~ 218 (253)
T cd05122 150 DTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP-----PMKALFKI----ATNGPPGLR 218 (253)
T ss_pred cccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc-----hHHHHHHH----HhcCCCCcC
Confidence 4432 233468889999999998889999999999999999999999985311 00000110 001111111
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ....+..+.+++.+||+.||++|||+.++++
T Consensus 219 ~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 N-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred c-------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 1112457899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=289.51 Aligned_cols=252 Identities=26% Similarity=0.440 Sum_probs=202.4
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
.++.|...+.||+|++|.||++... ++..+++|++..... ..+.+.+|+.+++.++|+|++++++++......+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 3466888889999999999999976 688999999875432 3456889999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+++||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred EEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhh
Confidence 9999999999999998743 25899999999999999999999998 9999999999999999999999999986
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||... ... ...... ......
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-----~~~---~~~~~~-~~~~~~ 234 (286)
T cd06614 165 QLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-----PPL---RALFLI-TTKGIP 234 (286)
T ss_pred hhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-----CHH---HHHHHH-HhcCCC
Confidence 5543221 122345788999999999888999999999999999999999997421 100 001111 111111
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...+ ....+..+.+++.+||+.+|.+|||+.++++
T Consensus 235 ~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 235 PLKN-------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCcc-------hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1111 1123457899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=290.46 Aligned_cols=262 Identities=24% Similarity=0.301 Sum_probs=197.3
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC--CcceeE
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVPLLV 242 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV 242 (468)
|.+.+.||+|++|.||++... +++.+|+|++....... .....+.+|+.+++.++|+|++++++++.+. ...++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE--GFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc--cchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 567788999999999999965 58899999987643111 2345688999999999999999999999887 789999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||+++ +|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 79 ~e~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~ 150 (287)
T cd07840 79 FEYMDH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPY 150 (287)
T ss_pred eccccc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeec
Confidence 999974 8888886532 35899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc---cc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK---NR 398 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 398 (468)
............++..|+|||.+.+ ..++.++||||||+++|||++|+.||.... ... ........... ..
T Consensus 151 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~--~~~---~~~~~~~~~~~~~~~~ 225 (287)
T cd07840 151 TKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST--ELE---QLEKIFELCGSPTDEN 225 (287)
T ss_pred cCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC--hHH---HHHHHHHHhCCCchhh
Confidence 5443222333456788999998765 467899999999999999999999985311 111 00111111000 00
Q ss_pred cch--------------hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHD--------------ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~--------------~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+.. .....+.......++..+.+++.+||+.+|++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 00011111111112567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=297.71 Aligned_cols=245 Identities=28% Similarity=0.411 Sum_probs=194.6
Q ss_pred CceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecC
Q 012214 169 NRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
...||+|+||.||++... +++.||+|.+..... ...+.+.+|+.+++.++|||++++++++......++++||++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 346999999999999864 688999998854322 233568899999999999999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+++|..++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 102 ~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 102 GGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred CCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 9999987754 24889999999999999999999999 99999999999999999999999999875543322
Q ss_pred eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
......++..|+|||++.+..++.++|||||||++|||++|+.||.... ... ... ..........
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~~~---~~~-~~~~~~~~~~----- 237 (297)
T cd06659 173 -KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS-----PVQ---AMK-RLRDSPPPKL----- 237 (297)
T ss_pred -cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHH---HHH-HHhccCCCCc-----
Confidence 1233568899999999998889999999999999999999999985311 110 011 1111100000
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
......+..+.+++.+||+.+|++|||+.++++.
T Consensus 238 --~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 --KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred --cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0011234468899999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=289.85 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=196.3
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEee
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYE 244 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 244 (468)
|...+.||+|++|.||++... +++.+++|++..... ...+.+.+|+.+++.++||||+++++++...+..++++|
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 444568999999999999854 688999998754322 234568899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
|+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||.+.....
T Consensus 97 ~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 97 FLEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred ccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 9999999998865 24889999999999999999999999 99999999999999999999999998875543
Q ss_pred CCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcc
Q 012214 325 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404 (468)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 404 (468)
... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... ...... ...........
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-----~~~~~~----~~~~~~~~~~~- 236 (285)
T cd06648 168 EVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-----PLQAMK----RIRDNLPPKLK- 236 (285)
T ss_pred CCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-----HHHHHH----HHHhcCCCCCc-
Confidence 322 1223458899999999998889999999999999999999999985311 110111 11111000000
Q ss_pred hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 405 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+...+..+.+++.+||+.+|++|||+.++++
T Consensus 237 ------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 ------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ------ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01123457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=308.00 Aligned_cols=244 Identities=30% Similarity=0.441 Sum_probs=198.0
Q ss_pred eeeecCcEEEEEEEecC-CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCCC
Q 012214 171 ILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 249 (468)
Q Consensus 171 ~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g 249 (468)
.||+|.||+||.|++.+ ...+|||.+..... ....-+..|+.+.++++|.|||+++|+|.+++..-+.||.++||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds----r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS----REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc----hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 49999999999999664 55789998765432 33456788999999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc-CCCcEEEEecCCcccccCCC
Q 012214 250 TLYQHLHDRHQNEEFPL--TWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD-QRYRAKVADFGTSKFIAMDQ 326 (468)
Q Consensus 250 sL~~~l~~~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~-~~~~~kl~DfGla~~~~~~~ 326 (468)
||.++|+..-. |+ .+.+.-....||++||.|||+.. |||||||-+||||+ -.|.+||+|||-++.+..-.
T Consensus 658 SLSsLLrskWG----PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin 730 (1226)
T KOG4279|consen 658 SLSSLLRSKWG----PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN 730 (1226)
T ss_pred cHHHHHHhccC----CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence 99999987432 45 77788889999999999999999 99999999999997 47899999999998765332
Q ss_pred ceeeecccccCCccCccccccC--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcc
Q 012214 327 THVTTKIQGTFGYLDPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404 (468)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 404 (468)
. .+....||.-|||||++..+ .|..++|||||||++.||.||++||...++.. ++.|.-.+-.-
T Consensus 731 P-~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq------AAMFkVGmyKv------- 796 (1226)
T KOG4279|consen 731 P-CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ------AAMFKVGMYKV------- 796 (1226)
T ss_pred c-cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh------Hhhhhhcceec-------
Confidence 2 24456799999999999875 47889999999999999999999996544332 12222211100
Q ss_pred hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 405 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
-.+.|.+.+++...+|.+|+.++|.+||+++++++
T Consensus 797 ---HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 797 ---HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ---CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11224566778899999999999999999999985
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=289.05 Aligned_cols=262 Identities=26% Similarity=0.331 Sum_probs=195.4
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEee
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYE 244 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 244 (468)
|++.+.||.|++|.||+|... +|+.||+|++....... .....+.+|+.+++.++|||++++++++.+....+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE--GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc--cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 567788999999999999864 79999999886543221 223567889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
|++ ++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 79 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 79 FLD-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGV 151 (283)
T ss_pred ccC-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence 995 689998876331 35899999999999999999999998 99999999999999999999999999876533
Q ss_pred CCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc------
Q 012214 325 DQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN------ 397 (468)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 397 (468)
.... .....++..|+|||++.+. .++.++||||||+++|+|++|+.||..... .......+ ......
T Consensus 152 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~-~~~~~~~~~~~~ 225 (283)
T cd07835 152 PVRT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE----IDQLFRIF-RTLGTPDEDVWP 225 (283)
T ss_pred Cccc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH-HHhCCCChHHhh
Confidence 2211 1223468899999987664 578899999999999999999999853211 00000100 000000
Q ss_pred ---ccchhcch------HHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 ---RLHDILDD------QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ---~~~~~~d~------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+.+.... ..........+..+.+++.+||+.+|++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 0000111233457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=281.99 Aligned_cols=252 Identities=29% Similarity=0.432 Sum_probs=203.8
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC--Cccee
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVPLL 241 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~l 241 (468)
+|...+.||+|++|.||+|... +++.+++|+....... ....+.+.+|+.++++++|+||+++++++.+. ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS--EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence 4677889999999999999976 6889999988764332 24457889999999999999999999999888 88999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
++||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 79 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 150 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKR 150 (260)
T ss_pred EEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence 999999999999997632 5899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 322 IAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 322 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
....... ......++..|+|||.+.+...+.++||||||+++++|++|..||.... ................
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~ 223 (260)
T cd06606 151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYKIGSSGEPP 223 (260)
T ss_pred cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHhccccCCCc
Confidence 6544321 1233468889999999998889999999999999999999999985422 0111111111101111
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. .+...+..+.+++.+|++.+|++||++.+++.
T Consensus 224 ~---------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 E---------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred C---------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1 12223558999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=288.31 Aligned_cols=251 Identities=27% Similarity=0.374 Sum_probs=203.0
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|++.+.||+|++|.||++... +++.+++|.+....... ....++.+|+.+++.++|+||+++++++.+....++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ--KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH--HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence 4778889999999999999854 67899999886533222 34467889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 79 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~ 154 (256)
T cd08530 79 EYAPFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLK 154 (256)
T ss_pred hhcCCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence 99999999999876432 2246899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... .. .............
T Consensus 155 ~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~~----~~~~~~~~~~~~~-- 220 (256)
T cd08530 155 KN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-----MQ----DLRYKVQRGKYPP-- 220 (256)
T ss_pred cC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HH----HHHHHHhcCCCCC--
Confidence 44 2223457889999999999889999999999999999999999984311 10 1111111122111
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+...+..+.+++.+||+.+|++|||+.++++
T Consensus 221 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 -------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 12234557899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=289.14 Aligned_cols=262 Identities=22% Similarity=0.330 Sum_probs=197.7
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|+..+.||+|++|.||+|... +|+.||+|++...... .....+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE---GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc---cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence 4788899999999999999975 6889999988754322 22356778999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++ +|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 78 e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 78 EYMDK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred ecCCc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 99975 88888865332 235899999999999999999999999 9999999999999999999999999987554
Q ss_pred CCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc------
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK------ 396 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 396 (468)
.... ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.... ..+. ..........
T Consensus 152 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~--~~~~---~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 152 IPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN--NEDQ---LLKIFRIMGTPTESTW 225 (284)
T ss_pred CCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--cHHH---HHHHHHHhCCCChhhH
Confidence 3221 1122346889999998866 457889999999999999999999985321 1110 0000000000
Q ss_pred ----------cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 397 ----------NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 397 ----------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.......+... .......+..+.+++.+|++.||.+|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHhcCchhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000001111 1111234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=303.98 Aligned_cols=196 Identities=30% Similarity=0.413 Sum_probs=167.6
Q ss_pred HhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-C-----CceeeEeeeec
Q 012214 162 ATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-H-----RNVVKLLGCCL 234 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h-----~niv~l~g~~~ 234 (468)
...+|.+.+.||+|+||.|.+|.+ .+++.||||+++... .-..+...|+.+|..++ | -|+|++++++.
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 344889999999999999999995 469999999998743 33456678999999996 3 39999999999
Q ss_pred cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC--CcEE
Q 012214 235 ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR--YRAK 312 (468)
Q Consensus 235 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~--~~~k 312 (468)
..++.|||+|.+. .+|.++++.+.. ..++...+..|+.||+.||.+||+.+ |||+||||+||||.+- ..+|
T Consensus 259 fr~HlciVfELL~-~NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vK 331 (586)
T KOG0667|consen 259 FRNHLCIVFELLS-TNLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIK 331 (586)
T ss_pred cccceeeeehhhh-hhHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCcee
Confidence 9999999999994 599999988443 35999999999999999999999999 9999999999999653 4799
Q ss_pred EEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCC
Q 012214 313 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 373 (468)
Q Consensus 313 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~ 373 (468)
|+|||.|+.....-. ...-+.-|.|||++.+.+|+.+.||||||||+.||++|.+-|
T Consensus 332 VIDFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf 388 (586)
T KOG0667|consen 332 VIDFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF 388 (586)
T ss_pred EEecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence 999999986543221 334567899999999999999999999999999999995544
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=290.49 Aligned_cols=255 Identities=26% Similarity=0.318 Sum_probs=196.5
Q ss_pred CCCCCceeeecCcEEEEEEEe----cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcc
Q 012214 165 HFNANRILGQGGQGTVYKGML----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~ 239 (468)
+|++.+.||+|+||.||.+.. .+|..||+|++............+.+.+|+.++.++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477888999999999999985 368899999886532222223346678899999999 699999999999988899
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++|+||+++++|.+++... .++++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccc
Confidence 9999999999999999753 24888999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCccccccC--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
...............|+..|+|||.+.+. .++.++||||||+++|+|++|..||...+.. ..............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~ 228 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK----NSQAEISRRILKSE 228 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc----ccHHHHHHHhhccC
Confidence 86644333223345588999999998753 4678999999999999999999998532111 11111111111100
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
. ..+...+..+.+++.+||+.+|++|| ++.+++.
T Consensus 229 ~-----------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 P-----------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred C-----------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 01222345788999999999999997 5566654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=291.93 Aligned_cols=264 Identities=26% Similarity=0.290 Sum_probs=196.9
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHH-HHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEE-LLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
+|...+.||+|++|.||+|... +++.||+|.+........ ......+..|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999964 689999999865432211 12234567899999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.++|+|||+++..
T Consensus 81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 899999996532 25899999999999999999999999 999999999999999999999999999866
Q ss_pred cCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc----
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN---- 397 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 397 (468)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|..||... ...+ ............
T Consensus 153 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~--~~~~---~~~~~~~~~~~~~~~~ 226 (298)
T cd07841 153 GSPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD--SDID---QLGKIFEALGTPTEEN 226 (298)
T ss_pred cCCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC--ccHH---HHHHHHHHcCCCchhh
Confidence 443221 222346788999998865 56788999999999999999997665321 1111 000110000000
Q ss_pred -----ccchhcchHH-----hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 -----RLHDILDDQL-----MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 -----~~~~~~d~~l-----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.......... ........+..+.+++.+||+.+|++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000000 00011233567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=293.03 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=199.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||++... +++.+++|.+..... ...+.+.+|+.+++.++|||++++++.+......++|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc----hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 67888999999999999999854 678899998754322 2346788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 95 ~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 95 MEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (293)
T ss_pred EecCCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence 9999999999998652 3788999999999999999999999 999999999999999999999999998755
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...... .....+++.|+|||.+.+..++.++||||||+++|++++|+.||...... .. ......... ..
T Consensus 166 ~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~--~~------~~~~~~~~~-~~- 234 (293)
T cd06647 166 TPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RA------LYLIATNGT-PE- 234 (293)
T ss_pred cccccc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--hh------eeehhcCCC-CC-
Confidence 433221 22345888999999998888999999999999999999999998532110 00 000000000 00
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
...+...+..+.+++.+||+.+|++||++.+++..
T Consensus 235 ------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 ------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00112234468899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=292.64 Aligned_cols=266 Identities=27% Similarity=0.345 Sum_probs=197.4
Q ss_pred HHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC--
Q 012214 161 KATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-- 237 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-- 237 (468)
...++|++.+.||+|+||.||+|... +++.||+|.+....... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE--GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc--CchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 45678999999999999999999975 58899999886543221 22245678999999999999999999987654
Q ss_pred --------cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC
Q 012214 238 --------VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY 309 (468)
Q Consensus 238 --------~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~ 309 (468)
..++|+||+++ ++...+... ...+++..+..++.||+.||+|||+.+ |+|+||+|+||++++++
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~ 153 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKG 153 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence 78999999975 777777542 235899999999999999999999999 99999999999999999
Q ss_pred cEEEEecCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH
Q 012214 310 RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 310 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~ 388 (468)
.+||+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ......
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~-----~~~~~~ 228 (302)
T cd07864 154 QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ-----ELAQLE 228 (302)
T ss_pred cEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHH
Confidence 99999999998665433222222346778999998765 457889999999999999999999985311 111111
Q ss_pred HHHHHhhccc---cchhcc--------------hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 389 YFVHSMRKNR---LHDILD--------------DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 389 ~~~~~~~~~~---~~~~~d--------------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+........ +..+.. ...... ....+..+.+++.+||+.+|++|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111111100 000000 000000 1123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=294.36 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=206.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
..-|...+.||+|-|..|-++++- .|..||||++..+.-+. .....++.|+..|+.++|||||+|+++..+....||
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~--~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT--LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch--hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 455777888999999999999843 79999999987653332 445678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc-CCCcEEEEecCCcc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD-QRYRAKVADFGTSK 320 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~-~~~~~kl~DfGla~ 320 (468)
|+|+-++|+|.+|+..+.. .+.++.+.+.+.||+.|+.|+|+.. +|||||||+||.+- .-|-+||+|||++.
T Consensus 95 iLELGD~GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred EEEecCCchHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccc
Confidence 9999999999999987542 4899999999999999999999999 99999999998764 56899999999997
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCC-cccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD-KSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~-ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
.+..... .+..+|+..|-|||.+.+..|+. ++|||||||+||-|++|+.||..+.+. +.+
T Consensus 168 kf~PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-----------------ETL 228 (864)
T KOG4717|consen 168 KFQPGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-----------------ETL 228 (864)
T ss_pred cCCCcch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----------------hhh
Confidence 6654433 34568999999999999998875 679999999999999999999542211 111
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..++|= +-..|...+.+..+||..||+.||.+|.|.+||+.
T Consensus 229 TmImDC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 229 TMIMDC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhhcc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 222221 12234556678999999999999999999999975
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=283.94 Aligned_cols=245 Identities=27% Similarity=0.292 Sum_probs=193.9
Q ss_pred eeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCCCC
Q 012214 172 LGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 250 (468)
Q Consensus 172 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 250 (468)
||.|++|.||++... +++.+|+|.+....... ....+.+.+|+.+++.++||||+++++.+.+....++++||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE-TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh-hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999975 48899999886533221 1334678999999999999999999999999999999999999999
Q ss_pred hhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCceee
Q 012214 251 LYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT 330 (468)
Q Consensus 251 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 330 (468)
|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~ 149 (262)
T cd05572 80 LWTILRDRG-----LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KT 149 (262)
T ss_pred HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cc
Confidence 999996532 4889999999999999999999998 9999999999999999999999999998665432 22
Q ss_pred ecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhh
Q 012214 331 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKL 410 (468)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 410 (468)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .............. ..
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~---------~~ 214 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED------PMEIYNDILKGNGK---------LE 214 (262)
T ss_pred ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC------HHHHHHHHhccCCC---------CC
Confidence 2345788999999998888999999999999999999999998542210 11111111110000 01
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 012214 411 GVKNQIMTFANLAKRCLDLNGKKRPT-----MEEVSM 442 (468)
Q Consensus 411 ~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 442 (468)
.+...+..+.+++.+||+.+|++||| +.|+++
T Consensus 215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11222457899999999999999999 566654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=288.68 Aligned_cols=247 Identities=22% Similarity=0.263 Sum_probs=192.1
Q ss_pred eeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCCCC
Q 012214 172 LGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 250 (468)
Q Consensus 172 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 250 (468)
||+|+||+||++... +|+.+|+|.+....... ......+.+|+.+++.++||||+++++.+...+..++|+||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK-RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh-hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 689999999999854 68899999876432111 1234457789999999999999999999999999999999999999
Q ss_pred hhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCceee
Q 012214 251 LYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT 330 (468)
Q Consensus 251 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 330 (468)
|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 80 L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~ 151 (277)
T cd05577 80 LKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KI 151 (277)
T ss_pred HHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cc
Confidence 9999976332 35899999999999999999999999 9999999999999999999999999987654321 12
Q ss_pred ecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhh
Q 012214 331 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKL 410 (468)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 410 (468)
....++..|+|||++.+..++.++||||||+++|+|++|+.||........ ........... ...
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~----------~~~ 216 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-----KEELKRRTLEM----------AVE 216 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-----HHHHHhccccc----------ccc
Confidence 234578899999999888899999999999999999999999854221100 00111110000 001
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 411 GVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 411 ~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
.+...++.+.+++.+||+.+|++|| ++.+++.
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 217 YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 1222355789999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=290.12 Aligned_cols=263 Identities=24% Similarity=0.333 Sum_probs=194.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|+..+.||+|++|.||+|... +++.||+|.+....... ...+.+.+|+.++++++|+||+++++++.+....++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE--GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc--cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 56888899999999999999965 68899999876532221 2335688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC-CCcEEEEecCCccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ-RYRAKVADFGTSKF 321 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~-~~~~kl~DfGla~~ 321 (468)
|||++ ++|.+.+.... ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++..
T Consensus 80 ~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~ 152 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (294)
T ss_pred Eeccc-ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccc
Confidence 99996 58888775422 224688889999999999999999998 999999999999985 56799999999976
Q ss_pred ccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc--
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR-- 398 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 398 (468)
...... ......++..|+|||++.+ ..++.++||||||+++|+|+||+.||..... .+ .... .......+.
T Consensus 153 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~--~~--~~~~-~~~~~~~~~~~ 226 (294)
T PLN00009 153 FGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE--ID--ELFK-IFRILGTPNEE 226 (294)
T ss_pred cCCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HH--HHHH-HHHHhCCCChh
Confidence 543211 1122356889999998876 4578999999999999999999999853111 10 0000 001100000
Q ss_pred -c------chh-------cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 -L------HDI-------LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 -~------~~~-------~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+ .+. ....+ .......++.+.+++.+|++.+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 227 TWPGVTSLPDYKSAFPKWPPKDL-ATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hccccccchhhhhhcccCCCCCH-HHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000 00000 0011233457899999999999999999999986
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=298.40 Aligned_cols=269 Identities=23% Similarity=0.315 Sum_probs=197.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC-----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----- 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~----- 236 (468)
+++|++.+.||+|+||.||+|... +|+.||+|.+...... .....+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ---TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc---hhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 478999999999999999999854 6899999988642222 3345678899999999999999999887543
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...++++||+. ++|.+.+.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~df 150 (336)
T cd07849 81 NDVYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDF 150 (336)
T ss_pred ceEEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcc
Confidence 35789999996 478777753 25899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCcee--eecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH
Q 012214 317 GTSKFIAMDQTHV--TTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 317 Gla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
|++.......... .....+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ...........
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~-----~~~~~~~~~~~ 225 (336)
T cd07849 151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD-----YLHQLNLILGV 225 (336)
T ss_pred cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHH
Confidence 9987654322211 123457899999998755 568899999999999999999999984311 00001111111
Q ss_pred hhccc---cchhcchHH--------------hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhccc
Q 012214 394 MRKNR---LHDILDDQL--------------MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME--LNGIRG 449 (468)
Q Consensus 394 ~~~~~---~~~~~d~~l--------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~~ 449 (468)
...+. +..+.+... ........+..+.+++.+||+.+|++|||+.|+++. ++....
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred cCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 11000 000000000 000011234578999999999999999999999985 555443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=286.54 Aligned_cols=260 Identities=23% Similarity=0.294 Sum_probs=191.3
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccC--Cccee
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLET--EVPLL 241 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~--~~~~l 241 (468)
|++.+.||+|+||.||++... +++.+|+|+++...... ......+|+.++.++. |+|++++++++.+. +..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL---EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc---hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 566788999999999999854 68899999886543221 1223457888888885 99999999999887 88999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
|+||++ ++|.+.+.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. +.+||+|||+++.
T Consensus 78 v~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~ 148 (282)
T cd07831 78 VFELMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRG 148 (282)
T ss_pred EEecCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccc
Confidence 999996 58888876532 35899999999999999999999999 999999999999999 9999999999986
Q ss_pred ccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchH--------HHHHH
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLA--------AYFVH 392 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~--------~~~~~ 392 (468)
....... ....++..|+|||.+.. +.++.++|||||||++|||++|..||.... ..+..... .....
T Consensus 149 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07831 149 IYSKPPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN--ELDQIAKIHDVLGTPDAEVLK 224 (282)
T ss_pred cccCCCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC--HHHHHHHHHHHcCCCCHHHHH
Confidence 6433221 22457889999997654 567889999999999999999999984311 11100000 00000
Q ss_pred Hhhccc-----cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 393 SMRKNR-----LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 393 ~~~~~~-----~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...... ........+. ......+..+.+++.+||+.+|++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 225 KFRKSRHMNYNFPSKKGTGLR-KLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hhcccccccccCcccccccHH-HHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000 0000000000 011234678999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=306.24 Aligned_cols=251 Identities=27% Similarity=0.395 Sum_probs=200.3
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCc-EEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGR-IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~-~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
+.|.++..||.|+||.||++..++.. ..|.|++... .. ..+++|+-|+.+|...+||+||+|++.|...+.++++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-se---EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SE---EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-ch---hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 34556667999999999999976544 4466665442 22 5678999999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
.|||.||-++..+-.-. .+++++++..++.|++.||.|||+.+ |||||||+.|||++-+|.++|+|||.+...
T Consensus 108 iEFC~GGAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred EeecCCchHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc
Confidence 99999999998887632 36999999999999999999999999 999999999999999999999999997532
Q ss_pred cCCCceeeecccccCCccCccccc-----cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
.. .........||+.|||||++. ..+|+.++||||||++|.||..+.+|- ...+......... ..
T Consensus 181 ~~-t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH--------helnpMRVllKia-KS 250 (1187)
T KOG0579|consen 181 KS-TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH--------HELNPMRVLLKIA-KS 250 (1187)
T ss_pred hh-HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc--------cccchHHHHHHHh-hc
Confidence 21 111234567999999999764 468999999999999999999999884 2222222222222 22
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+-++- |..++..+.+++.+||..||..||++.++++
T Consensus 251 ePPTLlq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 251 EPPTLLQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CCCcccC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 2222222 4567778999999999999999999999986
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=292.91 Aligned_cols=262 Identities=20% Similarity=0.294 Sum_probs=194.3
Q ss_pred eeeec--CcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecC
Q 012214 171 ILGQG--GQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 171 ~LG~G--~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
.||+| +||+||++... +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++...+..++|+||+.
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE--EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 46666 99999999964 78999999987543332 345778899999999999999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+........
T Consensus 83 ~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 83 YGSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred CCCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 9999999876432 24889999999999999999999998 99999999999999999999999986543321111
Q ss_pred ee------eecccccCCccCccccccC--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc--
Q 012214 328 HV------TTKIQGTFGYLDPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN-- 397 (468)
Q Consensus 328 ~~------~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 397 (468)
.. .....++..|+|||++.+. .++.++|||||||++|||++|+.||...... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--------~~~~~~~~~~~~ 228 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--------QMLLQKLKGPPY 228 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--------HHHHHHhcCCCC
Confidence 10 0112245679999998763 4789999999999999999999998531100 0000000000
Q ss_pred ----------------------------------ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH-
Q 012214 398 ----------------------------------RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM- 442 (468)
Q Consensus 398 ----------------------------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~- 442 (468)
......+..+........+..+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred CCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000111111112223446678999999999999999999999985
Q ss_pred -HHHhcc
Q 012214 443 -ELNGIR 448 (468)
Q Consensus 443 -~L~~i~ 448 (468)
.+..++
T Consensus 309 ~~~~~~~ 315 (328)
T cd08226 309 AFFKQVK 315 (328)
T ss_pred HHHHHHH
Confidence 344444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=280.38 Aligned_cols=275 Identities=23% Similarity=0.281 Sum_probs=202.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEec---C--CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc-C
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE---D--GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE-T 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~---~--g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~ 236 (468)
-..|+....||+|.||.||++.-+ + .+.+|+|+++....... -.....+|+.+++.++||||+++..++.+ +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG--iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG--ISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC--cCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 356888899999999999999632 2 34789999877533221 12357799999999999999999999987 7
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC----CcEE
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR----YRAK 312 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~----~~~k 312 (468)
...++++||.+. +|...++.++......++...+..|+.||+.|+.|||+.- |+||||||.|||+..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence 789999999977 8999998766555567999999999999999999999999 9999999999999877 9999
Q ss_pred EEecCCcccccCCCce--eeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccch-hchHH
Q 012214 313 VADFGTSKFIAMDQTH--VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQEN-VSLAA 388 (468)
Q Consensus 313 l~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~-~~~~~ 388 (468)
|+|||+++.+...-.. ....++.|..|.|||.+.+ ..||.+.||||.||++.||+|-++-|...+...... .....
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 9999999988643222 2345678999999999988 568889999999999999999887775322211111 11111
Q ss_pred H---HHHHhhcc---ccch---hcch-------H--------Hhhhc--hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 389 Y---FVHSMRKN---RLHD---ILDD-------Q--------LMKLG--VKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 389 ~---~~~~~~~~---~~~~---~~d~-------~--------l~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ....+..+ .++. ..+- . +.... ...-++...+|+.++|++||-+|.|+++.++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 1 11111111 1111 1110 0 00000 0011223678999999999999999999886
Q ss_pred H
Q 012214 443 E 443 (468)
Q Consensus 443 ~ 443 (468)
.
T Consensus 337 h 337 (438)
T KOG0666|consen 337 H 337 (438)
T ss_pred c
Confidence 3
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=284.06 Aligned_cols=253 Identities=30% Similarity=0.429 Sum_probs=204.1
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|.+.+.||.|++|.||++... +++.+++|++....... .....+.+|+++++.++|+|++++.+.+......++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE--KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCCh--HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence 4778889999999999999965 68899999987643321 34467889999999999999999999999989999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
|++++++|.+++..... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+....
T Consensus 79 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 154 (258)
T cd08215 79 EYADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154 (258)
T ss_pred EecCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecc
Confidence 99999999999977431 2246899999999999999999999998 9999999999999999999999999997665
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
... .......+++.|+|||...+..++.++|+||+|+++++|++|..||.... . ........ ......+
T Consensus 155 ~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~---~~~~~~~~-~~~~~~~- 223 (258)
T cd08215 155 STV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----L---LELALKIL-KGQYPPI- 223 (258)
T ss_pred cCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----H---HHHHHHHh-cCCCCCC-
Confidence 433 22333468889999999998889999999999999999999999984311 1 11111111 1111111
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+...+..+.+++.+||+.+|++|||+.++++
T Consensus 224 --------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 --------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1133457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=283.66 Aligned_cols=246 Identities=26% Similarity=0.248 Sum_probs=187.4
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHH-HHhcCCCceeeEeeeeccCCcceeEeeecC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVI-LSQINHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~-l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
+.||+|+||.||+|... +++.||+|.+....... ......+..|..+ ....+|+|++++++++.+.+..++|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 46899999999999864 58899999886532211 1223344455444 445589999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+++|.+++... .++++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 149 (260)
T cd05611 81 GGDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--- 149 (260)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc---
Confidence 99999999653 24889999999999999999999999 99999999999999999999999999875432
Q ss_pred eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHH
Q 012214 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407 (468)
Q Consensus 328 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 407 (468)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||... .. ...+ ..........
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--~~------~~~~-~~~~~~~~~~------ 212 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE--TP------DAVF-DNILSRRINW------ 212 (260)
T ss_pred --cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC--CH------HHHH-HHHHhcccCC------
Confidence 22345788999999998888899999999999999999999998431 11 0111 1111111000
Q ss_pred hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 012214 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444 (468)
Q Consensus 408 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 444 (468)
........+..+.+++.+||+.+|++|||+.++.+.|
T Consensus 213 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 0001112345789999999999999999876665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=287.73 Aligned_cols=245 Identities=22% Similarity=0.252 Sum_probs=185.4
Q ss_pred eeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHH---HHhcCCCceeeEeeeeccCCcceeEeeec
Q 012214 171 ILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVI---LSQINHRNVVKLLGCCLETEVPLLVYEFI 246 (468)
Q Consensus 171 ~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~---l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 246 (468)
.||+|+||.||++... +++.+|+|.+........ .....+.+|..+ +...+|||++.+++++.+.+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 3899999999999964 588999998764322211 111233444433 33447999999999999889999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 012214 247 PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQ 326 (468)
Q Consensus 247 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 326 (468)
++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++.......
T Consensus 80 ~~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 80 NGGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 999999988653 24899999999999999999999999 9999999999999999999999999987543322
Q ss_pred ceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcch
Q 012214 327 THVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDD 405 (468)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 405 (468)
.....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||........ ..........
T Consensus 152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~-------- 214 (279)
T cd05633 152 ---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK------HEIDRMTLTV-------- 214 (279)
T ss_pred ---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH------HHHHHHhhcC--------
Confidence 123458999999998864 5688999999999999999999999853211110 0011110000
Q ss_pred HHhhhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 012214 406 QLMKLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSME 443 (468)
Q Consensus 406 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 443 (468)
....+...+..+.+++.+||+.||++|| |++|+++.
T Consensus 215 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 --NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0011223455789999999999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=297.77 Aligned_cols=270 Identities=23% Similarity=0.297 Sum_probs=200.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC-----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----- 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~----- 236 (468)
.++|.+.+.||+|+||+||++... +++.||||.+....... .....+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR--IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc--chhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 457889999999999999999854 68999999876532221 2345677899999999999999999988654
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Df 152 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDF 152 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcC
Confidence 24799999995 6888888642 25899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
|+++...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.... .. ...........
T Consensus 153 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~---~~~~~~~~~~~ 226 (337)
T cd07858 153 GLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD--YV---HQLKLITELLG 226 (337)
T ss_pred ccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC--hH---HHHHHHHHHhC
Confidence 9998654332 12233457889999998765 568899999999999999999999985321 10 00111111000
Q ss_pred c---cccchhcc---------------hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhcccC
Q 012214 396 K---NRLHDILD---------------DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME--LNGIRGS 450 (468)
Q Consensus 396 ~---~~~~~~~d---------------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~~~ 450 (468)
. ..+..+.+ .... ......+..+.+++.+||+.+|++|||+.++++. +..+...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 227 SPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred CCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 0 00000000 0000 0112345678999999999999999999999975 6554433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=292.04 Aligned_cols=263 Identities=24% Similarity=0.307 Sum_probs=194.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC--Ccc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVP 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~ 239 (468)
.++|++.+.||+|+||.||+|... +|+.||+|.+....... .....+.+|+.++++++|+|++++++++.+. +..
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD--GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC--CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 467899999999999999999965 58999999886533221 1123456799999999999999999998654 467
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~ 155 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLA 155 (309)
T ss_pred EEEEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcccee
Confidence 99999996 48888886532 35899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||... .. .............+.
T Consensus 156 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~--~~---~~~~~~~~~~~~~~~ 229 (309)
T cd07845 156 RTYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK--SE---IEQLDLIIQLLGTPN 229 (309)
T ss_pred eecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC--CH---HHHHHHHHHhcCCCC
Confidence 86643321 1222345788999998876 56789999999999999999999998531 11 111111111111000
Q ss_pred ---cch-----------h---cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 ---LHD-----------I---LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ---~~~-----------~---~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+.. + ....+.. .....++.+.+++.+||+.||++|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 230 ESIWPGFSDLPLVGKFTLPKQPYNNLKH-KFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhchhhhcccccccccccCCCCCchHH-hccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0 0000000 00113557789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=284.85 Aligned_cols=261 Identities=25% Similarity=0.335 Sum_probs=198.3
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEee
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYE 244 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 244 (468)
|.+.+.||+|++|.||++... +++.+++|.+....... .....+.+|+.+++.++|+||+++++++......++|+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE--GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc--hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence 566788999999999999864 68899999886543221 234578889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
|+++ +|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 79 ~~~~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 79 FMDT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGS 150 (283)
T ss_pred ccCC-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence 9975 8888886632 35899999999999999999999999 99999999999999999999999999977654
Q ss_pred CCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc---cccc
Q 012214 325 DQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK---NRLH 400 (468)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 400 (468)
.. .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..... .+. .......... ..+.
T Consensus 151 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~ 224 (283)
T cd05118 151 PV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--IDQ---LFKIFRTLGTPDPEVWP 224 (283)
T ss_pred Cc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHH---HHHHHHHcCCCchHhcc
Confidence 43 112234577889999998876 789999999999999999999998743111 110 0001011000 0000
Q ss_pred hhcc-----------hH--HhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 401 DILD-----------DQ--LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 401 ~~~d-----------~~--l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+.+ .. .........+..+.+++.+||+.||.+||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 00 001112345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.96 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=204.4
Q ss_pred HhcCCCCCceeeecCcEEEEEEE-ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
.+-+++-..+||.|.||.||.+. .++|...|+|.++..... ........+|..++..++|||+|+++|+-...+..+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 34567778889999999999998 557999999987664433 244566789999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
|.||||++|+|.+.+...+. .++.....+..|++.|++|||+++ ||||||||.||+|+.+|.+|++|||.|.
T Consensus 1311 IFMEyC~~GsLa~ll~~gri-----~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRI-----EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHhccCcHHHHHHhcch-----hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccccee
Confidence 99999999999999976432 455555667899999999999999 9999999999999999999999999998
Q ss_pred cccCCCcee---eecccccCCccCccccccCC---CCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 321 FIAMDQTHV---TTKIQGTFGYLDPEYHQSSQ---LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 321 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
.+....... .....||+.|||||++.+.. .-.++||||+||++.||+||++||.. .+..-...+.....
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~-----~dne~aIMy~V~~g 1457 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAE-----LDNEWAIMYHVAAG 1457 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhh-----ccchhHHHhHHhcc
Confidence 775442111 22357999999999998743 45688999999999999999999953 12222333334444
Q ss_pred hccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 395 RKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 395 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
+.+++++ ..+.+-.+++.+||+.||..|.++.|+++.
T Consensus 1458 h~Pq~P~------------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 HKPQIPE------------RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCCCCch------------hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 4444443 244467899999999999999999988763
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=291.11 Aligned_cols=268 Identities=23% Similarity=0.304 Sum_probs=191.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 237 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~---- 237 (468)
.++|++.+.||+|+||.||++... +++.||+|.+....... .....+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC--CchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 357899999999999999999965 68899999876432221 12234568999999999999999999987654
Q ss_pred ----cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEE
Q 012214 238 ----VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKV 313 (468)
Q Consensus 238 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl 313 (468)
..++||||+. ++|.+.+.... ..+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl 160 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKL 160 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEE
Confidence 3499999996 48888775422 25899999999999999999999999 999999999999999999999
Q ss_pred EecCCcccccCCCce---eeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHH
Q 012214 314 ADFGTSKFIAMDQTH---VTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAY 389 (468)
Q Consensus 314 ~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~ 389 (468)
+|||++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.... ..........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~--~~~~~~~~~~ 238 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT--EQHQLTLISQ 238 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHH
Confidence 999999765432211 11233577889999988764 47889999999999999999999874311 1111111111
Q ss_pred HHHHhhccccchhc--------------chHHhh-hchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 390 FVHSMRKNRLHDIL--------------DDQLMK-LGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 390 ~~~~~~~~~~~~~~--------------d~~l~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.............. ...... .........+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000000000 000000 000012345779999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=277.48 Aligned_cols=249 Identities=27% Similarity=0.438 Sum_probs=201.4
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|++.+.||+|++|.||++... +++.+++|.+....... ...+.+.+|++++++++|+|++++++++.+....++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE--EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH--HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence 4778889999999999999865 57899999987653321 34567999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++....
T Consensus 79 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 150 (254)
T cd06627 79 EYAENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLN 150 (254)
T ss_pred ecCCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecC
Confidence 999999999998753 25899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
..... .....++..|+|||...+..++.++||||+|+++|+|++|+.||.... .. .. ...... .....
T Consensus 151 ~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-----~~--~~-~~~~~~-~~~~~-- 218 (254)
T cd06627 151 DVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-----PM--AA-LFRIVQ-DDHPP-- 218 (254)
T ss_pred CCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-----HH--HH-HHHHhc-cCCCC--
Confidence 43332 233457889999999988888999999999999999999999984311 10 11 111111 11110
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+...+..+.+++.+||+.+|++|||+.+++.
T Consensus 219 -------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 -------LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -------CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11223457889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=286.11 Aligned_cols=252 Identities=24% Similarity=0.382 Sum_probs=193.2
Q ss_pred cCCCCCceeeecCcEEEEEEEecC-CcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCccee
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 241 (468)
++|.+.+.||+|++|.||++..++ ++.||||.++..... ....++..|+.++... .|+||+++++++.+....++
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK---EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh---HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 668889999999999999999764 899999998754322 2335567777767666 49999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS-ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+|||+. ++|.+++.... .++++..+..++.|++.||+|||+ .+ |+||||+|+||++++++.+||+|||++.
T Consensus 92 v~e~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred EeeccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccch
Confidence 999985 47777765522 268999999999999999999997 47 9999999999999999999999999987
Q ss_pred cccCCCceeeecccccCCccCccccccCC----CCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQ----LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
....... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.... .. ..........
T Consensus 164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~---~~~~~~~~~~ 234 (296)
T cd06618 164 RLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK----TE---FEVLTKILQE 234 (296)
T ss_pred hccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch----hH---HHHHHHHhcC
Confidence 6543222 12335788999999987653 7889999999999999999999984311 00 1111111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
. ...... ....+.++.+++.+||+.||++|||+.++++.
T Consensus 235 ~-~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 235 E-PPSLPP-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-CCCCCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 111000 11234578999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=279.72 Aligned_cols=253 Identities=27% Similarity=0.382 Sum_probs=196.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccc-hHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC--Ccc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVD-DEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~ 239 (468)
.+|.+.+.||+|+||.||++... +++.+|+|.+..... .........+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999864 688999998753211 11224456788999999999999999999998654 457
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++++||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccc
Confidence 89999999999999986522 4788899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC--ceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 320 KFIAMDQ--THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 320 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
+...... ........++..|+|||++.+..++.++|+|||||++|+|++|+.||... . ...........+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~----~~~~~~~~~~~~ 225 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY----E----AMAAIFKIATQP 225 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc----C----HHHHHHHHHcCC
Confidence 7653211 11122345888999999999888999999999999999999999998421 0 011111111111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.. ...+....+.+.+++.+||+ +|..|||..+++.
T Consensus 226 ~~---------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 TK---------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CC---------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11 11133445578999999999 5799999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=295.33 Aligned_cols=264 Identities=20% Similarity=0.310 Sum_probs=196.6
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc----CC
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE----TE 237 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~ 237 (468)
.++|++.+.||+|++|.||++... +++.||+|++....... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP--TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc--cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 367889999999999999999954 68999999887543221 234567789999999999999999988753 34
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG 317 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfG 317 (468)
..++|+||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg 152 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFG 152 (334)
T ss_pred eEEEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccc
Confidence 6789999995 6888888542 24899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCce---eeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH
Q 012214 318 TSKFIAMDQTH---VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 318 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
++......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... . ........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~---~~~~~~~~ 227 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--H---QLKLILSV 227 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--H---HHHHHHHH
Confidence 98765432211 1223468889999998766 56889999999999999999999998532111 0 00000000
Q ss_pred hh-----------ccccchhcchH------HhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 394 MR-----------KNRLHDILDDQ------LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 394 ~~-----------~~~~~~~~d~~------l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.. ...+....+.. .........+..+.+++.+||+.+|++|||+.+++.
T Consensus 228 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00 00000000000 000011234567999999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=287.19 Aligned_cols=267 Identities=19% Similarity=0.230 Sum_probs=193.4
Q ss_pred CceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCC
Q 012214 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 248 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 248 (468)
.+.+|.|+++.|+++.. +++.||+|++....... ...+.+.+|+.+++.++|+||+++++++.+.+..+++|||+++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSK--EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccch--hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 33355555555555554 68999999987542221 4557799999999999999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc-
Q 012214 249 GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT- 327 (468)
Q Consensus 249 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~- 327 (468)
++|.+++..... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 84 GSCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 999999976422 24888999999999999999999999 99999999999999999999999998875432211
Q ss_pred -----eeeecccccCCccCcccccc--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh----hc
Q 012214 328 -----HVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM----RK 396 (468)
Q Consensus 328 -----~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~----~~ 396 (468)
.......++..|+|||.+.. ..++.++|||||||++|||++|..||..... ............ ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~ 233 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA----TQMLLEKVRGTVPCLLDK 233 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCcccccc
Confidence 01123346778999999876 3588999999999999999999999853111 000111100000 00
Q ss_pred cc-------cch----hcc----hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhcc
Q 012214 397 NR-------LHD----ILD----DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGIR 448 (468)
Q Consensus 397 ~~-------~~~----~~d----~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i~ 448 (468)
.. ... ..+ ..............+.+++.+||+.||++|||+.++++ .+..++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00 000 000 00111122344567889999999999999999999987 444444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=282.00 Aligned_cols=248 Identities=27% Similarity=0.326 Sum_probs=195.1
Q ss_pred eeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCCCC
Q 012214 172 LGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 250 (468)
Q Consensus 172 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 250 (468)
||+|+||.||++... +++.+++|.+...... .....+.+.+|+.++++++||||+++++++......++++||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI-RKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhh-hhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999976 4899999988653221 12445678899999999999999999999999999999999999999
Q ss_pred hhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc---
Q 012214 251 LYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT--- 327 (468)
Q Consensus 251 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~--- 327 (468)
|.+++.... .+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 80 L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 80 LASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 999997632 5899999999999999999999999 99999999999999999999999999875543221
Q ss_pred ----eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 328 ----HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 328 ----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
.......++..|+|||...+...+.++||||||+++|+|++|..||.... ....+..... ..... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~~-~ 221 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--------PEEIFQNILN-GKIEW-P 221 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhc-CCcCC-C
Confidence 12233457889999999988889999999999999999999999984311 1111111111 11100 0
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
.....+..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 222 -------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 -------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00012457899999999999999999966665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=279.75 Aligned_cols=245 Identities=24% Similarity=0.315 Sum_probs=187.4
Q ss_pred HHhcCCCCCcee--eecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccC
Q 012214 161 KATNHFNANRIL--GQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET 236 (468)
Q Consensus 161 ~~~~~f~~~~~L--G~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~ 236 (468)
...++|.+.+.+ |+|+||.||++..+ ++..+|+|......... .|+.....+ +|||++++++++...
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 334566666666 99999999999854 67889999876432110 122222222 799999999999999
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC-cEEEEe
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY-RAKVAD 315 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~-~~kl~D 315 (468)
+..++||||+++++|.+++.... ++++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++ .++|+|
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence 99999999999999999997532 5899999999999999999999999 99999999999999998 999999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
||++....... ...++..|+|||++.+..++.++||||||+++|||++|+.||..... +...... +....
T Consensus 154 fg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~---~~~~~~~-~~~~~- 223 (267)
T PHA03390 154 YGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED---EELDLES-LLKRQ- 223 (267)
T ss_pred CccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc---chhhHHH-HHHhh-
Confidence 99987654322 23578899999999998999999999999999999999999853211 1111111 11111
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT-MEEVSM 442 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~ 442 (468)
.... ......+..+.+++.+||+.+|.+||+ ++++++
T Consensus 224 ~~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 QKKL----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cccC----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1100 011234557899999999999999996 588773
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=318.88 Aligned_cols=256 Identities=31% Similarity=0.441 Sum_probs=191.3
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC--
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET-- 236 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-- 236 (468)
.+-.++|...+.||+||||.||+++.+ ||+.+|||++...... .......+|+.++++++|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~---~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASD---KLYSKILREVKLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHH---HHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence 445577888999999999999999966 8999999999886522 4556788999999999999999998533210
Q ss_pred --------------------------------------------------------------------------------
Q 012214 237 -------------------------------------------------------------------------------- 236 (468)
Q Consensus 237 -------------------------------------------------------------------------------- 236 (468)
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence
Q ss_pred -------------------------------------CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHH
Q 012214 237 -------------------------------------EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVA 279 (468)
Q Consensus 237 -------------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia 279 (468)
...|+=||||+..+|.+++..+.... ..+..+.++++|+
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREIL 707 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHH
Confidence 01256678887766666665532211 3577899999999
Q ss_pred HHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc------C-----------CCceeeecccccCCccCc
Q 012214 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA------M-----------DQTHVTTKIQGTFGYLDP 342 (468)
Q Consensus 280 ~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~------~-----------~~~~~~~~~~gt~~y~aP 342 (468)
.||+|+|+.+ ||||||||.||+++++..|||+|||+|+... . ......+..+||..|+||
T Consensus 708 EGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 708 EGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 9999999999 9999999999999999999999999998721 0 011123456799999999
Q ss_pred cccccC---CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHH
Q 012214 343 EYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTF 419 (468)
Q Consensus 343 E~~~~~---~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 419 (468)
|.+.+. .|+.|+|+|||||+++||+. ||. +..+. ......++.+.++.- .....+..+.-
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~----TsMER----a~iL~~LR~g~iP~~------~~f~~~~~~~e 847 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFG----TSMER----ASILTNLRKGSIPEP------ADFFDPEHPEE 847 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc---cCC----chHHH----HHHHHhcccCCCCCC------cccccccchHH
Confidence 998874 59999999999999999986 552 11221 223333344444332 00111222345
Q ss_pred HHHHHHhhccCCCCCCCHHHHHH
Q 012214 420 ANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 420 ~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+|.+|++.||++|||+.|++.
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhh
Confidence 78999999999999999999985
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=281.67 Aligned_cols=261 Identities=25% Similarity=0.333 Sum_probs=193.1
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc---CCCceeeEeeeeccCCc---
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI---NHRNVVKLLGCCLETEV--- 238 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~~~~--- 238 (468)
|++.+.||+|+||.||++... +++.+|+|++....... .....+.+|+.++.++ +|+|++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE--GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc--hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 567788999999999999976 48999999987543321 2234566787777666 69999999999987776
Q ss_pred --ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 239 --PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 239 --~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
.+++|||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+||
T Consensus 79 ~~~~l~~e~~~-~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~df 151 (287)
T cd07838 79 LKLTLVFEHVD-QDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADF 151 (287)
T ss_pred ceeEEEehhcc-cCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEecc
Confidence 899999996 48988886532 125899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
|++........ .....++..|+|||.+.+..++.++|+|||||++|||++|..||.... ..+ ....+......
T Consensus 152 g~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~--~~~---~~~~~~~~~~~ 224 (287)
T cd07838 152 GLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS--EAD---QLDKIFDVIGL 224 (287)
T ss_pred CcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC--hHH---HHHHHHHHcCC
Confidence 99877643322 122347889999999999999999999999999999999988874311 110 01111110000
Q ss_pred c---ccc-------hhcchH---HhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 397 N---RLH-------DILDDQ---LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 397 ~---~~~-------~~~d~~---l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. .+. ...... .........+..+.+++.+||+.||.+||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 225 PSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 000 000000 001111234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=293.03 Aligned_cols=272 Identities=25% Similarity=0.338 Sum_probs=199.3
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccC--C
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET--E 237 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~--~ 237 (468)
..++|.+.+.||+|+||.||+|... +++.+|+|++....... .....+.+|+.+++++ +|+||+++++++... .
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA--TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc--hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 3467888899999999999999965 58899999875432221 2335677899999999 999999999988643 3
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG 317 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfG 317 (468)
..++|+||++ ++|..++... .+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g 152 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFG 152 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeecc
Confidence 6799999997 5898888642 4788899999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCce----eeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHH
Q 012214 318 TSKFIAMDQTH----VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVH 392 (468)
Q Consensus 318 la~~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 392 (468)
++......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .+. ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~--~~~---~~~~~~ 227 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST--LNQ---LEKIIE 227 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh--HHH---HHHHHH
Confidence 99866433221 2223458889999998765 5678899999999999999999999843111 100 000000
Q ss_pred Hhh-----------ccccchhcc----hH--HhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhcccC
Q 012214 393 SMR-----------KNRLHDILD----DQ--LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME--LNGIRGS 450 (468)
Q Consensus 393 ~~~-----------~~~~~~~~d----~~--l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~~~ 450 (468)
... ......+++ .. .........+..+.+++.+||+.+|++|||+.++++. ++.....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred HhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 000 000000000 00 0000011245678999999999999999999999974 5555433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=284.22 Aligned_cols=251 Identities=27% Similarity=0.369 Sum_probs=200.4
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccCCccee
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~l 241 (468)
++|.+.+.||+|++|.||++... +++.+|+|+......... ...+.+.+|+.++++++ |+||+++++++...+..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccch-HHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 46888899999999999999965 689999998765322111 23467889999999998 9999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
|||++++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 80 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~ 151 (280)
T cd05581 80 VLEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKV 151 (280)
T ss_pred EEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccc
Confidence 999999999999997632 5899999999999999999999999 99999999999999999999999999876
Q ss_pred ccCCCc-------------------eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 012214 322 IAMDQT-------------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE 382 (468)
Q Consensus 322 ~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~ 382 (468)
...... .......++..|+|||.+.+..++.++||||||++++++++|+.||....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----- 226 (280)
T cd05581 152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN----- 226 (280)
T ss_pred cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-----
Confidence 543321 11223457889999999988889999999999999999999999985321
Q ss_pred hhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 012214 383 NVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTM----EEVSM 442 (468)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~----~evl~ 442 (468)
. ...+..... . ....+...++.+.+++.+||+.+|++|||+ .+++.
T Consensus 227 ~---~~~~~~~~~-~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 227 E---YLTFQKILK-L----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H---HHHHHHHHh-c----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 111111111 0 001122234578999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=288.29 Aligned_cols=252 Identities=23% Similarity=0.256 Sum_probs=203.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.+.|+.-++||+||||.||-++.+ +|+.+|.|++....... .....-.++|-.++..++.+.||.+--.+.+.+.+++
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-r~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-RKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-hhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 467888899999999999999854 69999999875533221 1233457789999999999999999989999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
|+..|+||+|.-.|..... ..+++..+.-.+.+|+.||++||... ||.|||||+|||+|+.|+++|+|+|+|..
T Consensus 263 VLtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEe
Confidence 9999999999998876432 45999999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
++...... ..+||.+|||||++.++.|+...|.|||||+||||+.|+.||..... ....+.+......
T Consensus 337 i~~g~~~~--~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke-----Kvk~eEvdrr~~~----- 404 (591)
T KOG0986|consen 337 IPEGKPIR--GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE-----KVKREEVDRRTLE----- 404 (591)
T ss_pred cCCCCccc--cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-----hhhHHHHHHHHhc-----
Confidence 87665543 34799999999999999999999999999999999999999853111 0000011111110
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTME 438 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 438 (468)
...+++..-+++..++....|+.||++|....
T Consensus 405 -----~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 405 -----DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred -----chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 01223445566788999999999999997543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=282.52 Aligned_cols=259 Identities=25% Similarity=0.364 Sum_probs=194.0
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccCCcceeEe
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~ 243 (468)
|.+.+.||+|++|.||+|... +++.|+||++...... .......+|+..+++++ |+|++++++++.+.+..++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc---hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence 567788999999999999975 5788999987654332 11223457899999998 999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+ +|+|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 78 e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~ 150 (283)
T cd07830 78 EYM-EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIR 150 (283)
T ss_pred ecC-CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceecc
Confidence 999 889999887632 235899999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc------
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK------ 396 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 396 (468)
.... .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..... .+. ..........
T Consensus 151 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~ 223 (283)
T cd07830 151 SRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE--IDQ---LYKICSVLGTPTKQDW 223 (283)
T ss_pred CCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh--HHH---HHHHHHhcCCCChhhh
Confidence 3222 223457889999998754 5678999999999999999999988743211 000 0000000000
Q ss_pred -------cccc----hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 397 -------NRLH----DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 397 -------~~~~----~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+. ......+. ......+..+.+++.+||+.+|++|||+.|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 224 PEGYKLASKLGFRFPQFAPTSLH-QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhHhhhhccccccccccccccHH-HHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000 00000000 001112467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=285.18 Aligned_cols=254 Identities=29% Similarity=0.420 Sum_probs=196.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
+.|...+.||+|+||.||+|+.. ++..+|+|.+....... .....++.+|+.+++.++|+|++++++++......++|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34666778999999999999964 57889999875421111 13446788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||+. |+|.+.+.... .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 94 ~e~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 94 MEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred EEccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceee
Confidence 99996 68877775422 25889999999999999999999998 999999999999999999999999998755
Q ss_pred cCCCceeeecccccCCccCccccc---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
... ....++..|+|||.+. ...++.++|||||||++|+|++|..||... ...... .. ......
T Consensus 166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~~~~~---~~-~~~~~~ 231 (308)
T cd06634 166 APA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSAL---YH-IAQNES 231 (308)
T ss_pred cCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc-----cHHHHH---HH-HhhcCC
Confidence 332 2345788999999874 356788999999999999999999997431 000000 01 111111
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
.. ......+..+.+++.+||+.+|++||++.++++.-.-+.
T Consensus 232 ~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 232 PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred CC--------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 11 011234457889999999999999999999998655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=289.26 Aligned_cols=264 Identities=24% Similarity=0.292 Sum_probs=192.1
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 237 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~---- 237 (468)
.++|.+.+.||+|+||.||++... +++.+|+|++....... .....+.+|+.+++.++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD--GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC--CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 478999999999999999999965 68899999875432221 11235678999999999999999999875433
Q ss_pred ----cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEE
Q 012214 238 ----VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKV 313 (468)
Q Consensus 238 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl 313 (468)
..++|+||+.+ +|...+... ...+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.++|
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l 156 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKI 156 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 45899999864 677766542 235899999999999999999999999 999999999999999999999
Q ss_pred EecCCcccccCCCce----------eeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 012214 314 ADFGTSKFIAMDQTH----------VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE 382 (468)
Q Consensus 314 ~DfGla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~ 382 (468)
+|||+++........ ..+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~---- 232 (311)
T cd07866 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD---- 232 (311)
T ss_pred CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH----
Confidence 999999765432211 1123356888999998765 4578999999999999999999999843111
Q ss_pred hhchHHHHHHHhhccc---------cchh--------cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 383 NVSLAAYFVHSMRKNR---------LHDI--------LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 383 ~~~~~~~~~~~~~~~~---------~~~~--------~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
............... +... ....+.. ......+.+.+++.+||+.||++|||+.|++.
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 233 -IDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred -HHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111111111111000 0000 0000000 01122357889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=301.67 Aligned_cols=271 Identities=28% Similarity=0.405 Sum_probs=203.8
Q ss_pred CCCCceeeecCcEEEEEEE-ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC------Cc
Q 012214 166 FNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET------EV 238 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~ 238 (468)
+...+.||+|+||.||+|+ ...|+.||||........ ...+...+|++++++++|+|||+++++-.+. ..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~---r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL---RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhccc---chHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 3445679999999999999 457999999988765433 4456788999999999999999999986553 35
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc--CCC--cEEEE
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD--QRY--RAKVA 314 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~--~~~--~~kl~ 314 (468)
..+|||||.+|||...|.+. .+...+++...+.++.+++.||.|||+++ |+||||||.||++- ++| ..||+
T Consensus 92 ~vlvmEyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred ceEEEeecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeee
Confidence 68999999999999999874 33446999999999999999999999999 99999999999984 223 47999
Q ss_pred ecCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH
Q 012214 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 315 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
|||.|+.++++. ......||..|++||.+.. +.|+..+|.|||||++|+.+||..||..-+..... ....+..
T Consensus 167 DfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~----~~~~~~~ 240 (732)
T KOG4250|consen 167 DFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN----KEIMWHI 240 (732)
T ss_pred cccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc----chhhhhh
Confidence 999999887655 4566789999999999984 88999999999999999999999999653332210 1111111
Q ss_pred hhccc-------------cchhcch-HHhhhchHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHhcccC
Q 012214 394 MRKNR-------------LHDILDD-QLMKLGVKNQIMTFANLAKRCLDLNGKKRP--TMEEVSMELNGIRGS 450 (468)
Q Consensus 394 ~~~~~-------------~~~~~d~-~l~~~~~~~~~~~l~~li~~cl~~dp~~RP--t~~evl~~L~~i~~~ 450 (468)
...+. ..++... .............+...+..+|..+|.+|. ...+....+..|...
T Consensus 241 ~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 241 ITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred hccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 11100 0000000 001112233444566788888899999999 777777777666543
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=292.55 Aligned_cols=264 Identities=22% Similarity=0.325 Sum_probs=194.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 237 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~---- 237 (468)
.++|...+.||+|+||.||+|... +|+.||+|++....... .....+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE--IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc--cchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 478999999999999999999954 68999999886532221 22356789999999999999999999986543
Q ss_pred --cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 238 --VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 238 --~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
..++|+||+.. +|..++. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~d 160 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILD 160 (342)
T ss_pred CceEEEEeccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEee
Confidence 35899999864 6665542 14889999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...........
T Consensus 161 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~ 231 (342)
T cd07879 161 FGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----LDQLTQILKVT 231 (342)
T ss_pred CCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhc
Confidence 9998754322 123356888999999876 5688999999999999999999999853110 00000000000
Q ss_pred -----------hccccchh-------cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhccc
Q 012214 395 -----------RKNRLHDI-------LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME--LNGIRG 449 (468)
Q Consensus 395 -----------~~~~~~~~-------~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~~ 449 (468)
........ ....+.. .....+..+.+++.+||+.||++|||+.+++.. ++..+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CCCCHHHHHHhcccchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000000 0000000 001234568899999999999999999999953 666554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=269.84 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=194.2
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcceeEe
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 243 (468)
.+....||.|+.|.|++++.+ .|...|||.+..+... ...+.++..+.++..- ++|+||+.+|+|..+...++.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk---ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK---EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH---HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 344456999999999999965 5899999999886555 4456777888777666 4999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
|.|. ..+..++.... .++++..+-++...+..||.||..+.. |+|||+||+|||+|+.|++|++|||++-.+-
T Consensus 171 elMs-~C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 171 ELMS-TCAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHH-HHHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceee
Confidence 9984 45666665422 369999999999999999999987543 9999999999999999999999999997765
Q ss_pred CCCceeeecccccCCccCcccccc---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
+... .+...|-+.|||||.+.- ..|+.++||||||+.++||.||+.||.. ...+. +....... +..
T Consensus 244 dSkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~----c~tdF---e~ltkvln-~eP- 312 (391)
T KOG0983|consen 244 DSKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG----CKTDF---EVLTKVLN-EEP- 312 (391)
T ss_pred cccc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC----CCccH---HHHHHHHh-cCC-
Confidence 4433 344568899999998874 4688899999999999999999999843 11111 11111111 111
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..++. ....+..+++++..||+.|+.+||...++++
T Consensus 313 P~L~~------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 313 PLLPG------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCc------ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11111 1224568999999999999999999999886
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=283.75 Aligned_cols=246 Identities=29% Similarity=0.423 Sum_probs=192.1
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEee
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYE 244 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 244 (468)
|...+.||+|+||.||+|+.. +++.+++|++...... .......+.+|+.+++.++|||++++++++.+....++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 556677999999999999864 6889999988643222 11344678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
|+. ++|.+++.... .++++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 102 ~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 102 YCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred cCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 995 57877775422 35899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCceeeecccccCCccCccccc---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 325 DQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.....++..|+|||++. .+.++.++||||||+++|+|++|..||.... ..... ..... .....
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-----~~~~~---~~~~~-~~~~~ 239 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSAL---YHIAQ-NDSPT 239 (313)
T ss_pred -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----hHHHH---HHHHh-cCCCC
Confidence 22345888999999874 4668889999999999999999999974311 11101 01111 11111
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.. ....+..+.+++.+||+.+|.+||++.+++.
T Consensus 240 ~~--------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 240 LQ--------SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 1123346889999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=292.13 Aligned_cols=270 Identities=26% Similarity=0.357 Sum_probs=203.0
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC-----c
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-----V 238 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-----~ 238 (468)
+|.+.+.||+|++|.||++... +++.+|+|++...... ....+.+.+|+.+++.++|+||+++++++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD--LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc--chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 5788899999999999999965 4899999988754321 134467889999999999999999999988765 7
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.+++|||+. ++|.+++.... ++++..+..++.|++.||+|||+.+ |+|+||||.|||++.++.++|+|||+
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~ 149 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGL 149 (330)
T ss_pred eEEEecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCc
Confidence 899999997 58888886422 5899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCc--eeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 319 SKFIAMDQT--HVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 319 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
+........ .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... .+ ..........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~--~~---~~~~i~~~~~ 224 (330)
T cd07834 150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY--ID---QLNLIVEVLG 224 (330)
T ss_pred eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH--HH---HHHHHHHhcC
Confidence 987654321 112334578899999999887 889999999999999999999999853211 00 0000111000
Q ss_pred cc-----------ccchhcch------HHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhcccC
Q 012214 396 KN-----------RLHDILDD------QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME--LNGIRGS 450 (468)
Q Consensus 396 ~~-----------~~~~~~d~------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~~~ 450 (468)
.. .....+.. .-........+..+.+++.+||+.+|++|||+.+++.. +++++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 00 00000000 00000112245678999999999999999999999973 6655543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=280.24 Aligned_cols=244 Identities=21% Similarity=0.244 Sum_probs=185.1
Q ss_pred eeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHH---HHHHhcCCCceeeEeeeeccCCcceeEeeec
Q 012214 171 ILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEI---VILSQINHRNVVKLLGCCLETEVPLLVYEFI 246 (468)
Q Consensus 171 ~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei---~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 246 (468)
.||+|+||.||++... +++.||+|.+........ .....+..|. ..++..+||||+++++++.+.+..++|+||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 3899999999999864 588999998765322211 1112233443 3444568999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 012214 247 PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQ 326 (468)
Q Consensus 247 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 326 (468)
++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 80 NGGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 999999888642 25899999999999999999999999 9999999999999999999999999987553322
Q ss_pred ceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcch
Q 012214 327 THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDD 405 (468)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 405 (468)
. ....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||......... ..........
T Consensus 152 ~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~------- 215 (278)
T cd05606 152 P---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH------EIDRMTLTMA------- 215 (278)
T ss_pred C---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH------HHHHHhhccC-------
Confidence 1 234689999999998754 6899999999999999999999998542111110 0111110000
Q ss_pred HHhhhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 406 QLMKLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 406 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
...+...+..+.+++.+||+.+|.+|| ++.++++
T Consensus 216 ---~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 216 ---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ---CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 001112345789999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=288.71 Aligned_cols=268 Identities=23% Similarity=0.301 Sum_probs=197.9
Q ss_pred HHHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC
Q 012214 159 LDKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 237 (468)
Q Consensus 159 i~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 237 (468)
+....++|++.+.||+|+||.||++... ++..||+|++....... .....+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE--LFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccch--HHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 3445678999999999999999999854 68999999886432221 33456889999999999999999999987554
Q ss_pred ------cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcE
Q 012214 238 ------VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA 311 (468)
Q Consensus 238 ------~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~ 311 (468)
..++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~ 157 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCEL 157 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCE
Confidence 348999998 6788888753 24899999999999999999999999 9999999999999999999
Q ss_pred EEEecCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHH-
Q 012214 312 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAY- 389 (468)
Q Consensus 312 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~- 389 (468)
+|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... . ......
T Consensus 158 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~--~--~~~~~~~ 229 (343)
T cd07880 158 KILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH--L--DQLMEIM 229 (343)
T ss_pred EEeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--H--HHHHHHH
Confidence 99999998755332 123357889999998876 4588899999999999999999999853211 0 000000
Q ss_pred ---------HHHHhhcccc-------chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhc
Q 012214 390 ---------FVHSMRKNRL-------HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGI 447 (468)
Q Consensus 390 ---------~~~~~~~~~~-------~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i 447 (468)
+......... .......+ .......+..+.+++.+|++.||++|||+.+++. .++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 230 KVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HhcCCCCHHHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0000000000 00000000 0011233456889999999999999999999984 44444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=283.41 Aligned_cols=243 Identities=26% Similarity=0.411 Sum_probs=193.0
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCC
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 248 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 248 (468)
.+||+|+||.||++... +++.||+|++..... ...+.+.+|+.+++.++|+|++++++++...+..++||||+++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccch----hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 56999999999999864 689999998754321 3346688999999999999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCce
Q 012214 249 GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH 328 (468)
Q Consensus 249 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 328 (468)
++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 102 ~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~- 171 (292)
T cd06657 102 GALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 171 (292)
T ss_pred CcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence 999987753 14789999999999999999999999 99999999999999999999999999876543221
Q ss_pred eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHh
Q 012214 329 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLM 408 (468)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 408 (468)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||... ............. ...+..
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~-----~~~~~~~~~~~~~-~~~~~~------- 238 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPLKAMKMIRDNL-PPKLKN------- 238 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhhC-CcccCC-------
Confidence 123345889999999998888999999999999999999999998431 1111011111000 000000
Q ss_pred hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 409 KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 409 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
....+..+.+++.+||+.+|.+||++.++++
T Consensus 239 ---~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 ---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ---cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 1123346889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.75 Aligned_cols=267 Identities=22% Similarity=0.302 Sum_probs=197.5
Q ss_pred CHHHHHHHhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeee
Q 012214 155 SSKELDKATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC 233 (468)
Q Consensus 155 ~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~ 233 (468)
...++...+++|.+.+.||+|+||.||++.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh--hHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 3455667789999999999999999999985 46889999988653222 13345688999999999999999999988
Q ss_pred ccC------CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC
Q 012214 234 LET------EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ 307 (468)
Q Consensus 234 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~ 307 (468)
... ...+++++++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~ 155 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 155 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcC
Confidence 543 3457788876 7899887754 24899999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhch
Q 012214 308 RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSL 386 (468)
Q Consensus 308 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~ 386 (468)
++.+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... . ..
T Consensus 156 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~--~---~~ 226 (345)
T cd07877 156 DCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--I---DQ 226 (345)
T ss_pred CCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H---HH
Confidence 999999999998754322 223457889999998876 5688899999999999999999999843111 0 00
Q ss_pred HHHHHHHhh--cccc-chhcch---H----Hhh-------hchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 387 AAYFVHSMR--KNRL-HDILDD---Q----LMK-------LGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 387 ~~~~~~~~~--~~~~-~~~~d~---~----l~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
......... ...+ ..+.+. . +.. ......+..+.+++.+||+.||.+|||+.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 011100000 0000 000000 0 000 000123456889999999999999999999886
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=277.07 Aligned_cols=254 Identities=21% Similarity=0.260 Sum_probs=193.6
Q ss_pred CCCCCceeeecCcEEEEEEEecC-CcEEEEEecccccch-HHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 165 HFNANRILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDD-EELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
+|.+.+.||+|+||.||++.... +..+++|.++..... ........+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998643 444555554432111 0012234566789999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.++|+|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeec
Confidence 999999999998875322 2236899999999999999999999999 999999999999975 56999999998765
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||... . .......... .....
T Consensus 156 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-----~---~~~~~~~~~~-~~~~~- 224 (260)
T cd08222 156 MGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-----N---FLSVVLRIVE-GPTPS- 224 (260)
T ss_pred CCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----c---HHHHHHHHHc-CCCCC-
Confidence 43222 223345788999999998888899999999999999999999997421 1 1111111111 11111
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+...+..+.+++.+||+.+|++||++.++++
T Consensus 225 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 --------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 12344568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=285.80 Aligned_cols=263 Identities=22% Similarity=0.294 Sum_probs=195.7
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc-CC
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE-TE 237 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~ 237 (468)
..++++|++.+.||+|+||.||++... +++.||+|++....... ...+.+.+|+.+++.++||||+++.+++.. ..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP--VLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc--chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 346788999999999999999999855 78999999875432221 234567789999999999999999998865 55
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG 317 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfG 317 (468)
..++++||+ +++|.+++.. .++++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg 153 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFG 153 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccc
Confidence 788999998 5688887753 24788888999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 318 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 318 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .............
T Consensus 154 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-----~~~~~~~~~~~~~ 224 (328)
T cd07856 154 LARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-----VNQFSIITDLLGT 224 (328)
T ss_pred cccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCC
Confidence 98754321 122356888999998766 5689999999999999999999999843111 0000111111000
Q ss_pred -----------cccchhcchH-Hhh-----hchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 397 -----------NRLHDILDDQ-LMK-----LGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 397 -----------~~~~~~~d~~-l~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
....++.... ... ......+..+.+++.+||+.+|++|||+.+++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 225 PPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 000 0011234678999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=278.53 Aligned_cols=260 Identities=27% Similarity=0.343 Sum_probs=196.6
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEee
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYE 244 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 244 (468)
|+..+.||+|++|.||+|... +++.+|+|.+....... ...+.+.+|+.+++.++|+|++++++++.+....++|+|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE--GIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccc--cccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence 456678999999999999965 58999999987643221 234567889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 79 ~~~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 79 YCD-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred CcC-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 997 59999997632 25899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh--------
Q 012214 325 DQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR-------- 395 (468)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 395 (468)
... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.... .. ...........
T Consensus 151 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07829 151 PLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS--EI---DQLFKIFQILGTPTEESWP 224 (282)
T ss_pred Ccc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc--HH---HHHHHHHHHhCCCcHHHHH
Confidence 322 12223457789999998776 88999999999999999999988874311 10 00000111000
Q ss_pred --------ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 396 --------KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 396 --------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
............. ......+..+.+++.+||+.+|++||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 225 GVTKLPDYKPTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred hhcccccccccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000000 001122557999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=287.04 Aligned_cols=264 Identities=23% Similarity=0.287 Sum_probs=194.0
Q ss_pred cCCC-CCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHH----------HHHHHHHHHHHHHhcCCCceeeEee
Q 012214 164 NHFN-ANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELL----------KLEEFINEIVILSQINHRNVVKLLG 231 (468)
Q Consensus 164 ~~f~-~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~----------~~~~~~~Ei~~l~~l~h~niv~l~g 231 (468)
++|. +.+.||+|+||.||++... +++.||+|++.......... ....+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 4567999999999999965 68999999876532221000 0124778999999999999999999
Q ss_pred eeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcE
Q 012214 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA 311 (468)
Q Consensus 232 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~ 311 (468)
++...+..++||||+. ++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence 9999999999999996 6899888652 24889999999999999999999999 9999999999999999999
Q ss_pred EEEecCCcccccCCC-------------ceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 012214 312 KVADFGTSKFIAMDQ-------------THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAG 377 (468)
Q Consensus 312 kl~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~ 377 (468)
+|+|||++....... ........++..|+|||.+.+. .++.++|||||||++|||++|..||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999997654111 1111223467889999998764 46889999999999999999999985321
Q ss_pred CCccchhchHHHHHHHhhccc---cchh------------cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 378 NTSQENVSLAAYFVHSMRKNR---LHDI------------LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~---~~~~------------~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ............... +... ...... ......+..+.+++.+||+.+|++|||+.|++.
T Consensus 239 ~-----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 E-----IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred H-----HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1 111111111111110 0000 000000 001223457889999999999999999999986
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=288.36 Aligned_cols=259 Identities=22% Similarity=0.310 Sum_probs=195.5
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc--
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV-- 238 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~-- 238 (468)
..++|.+.+.||+|++|.||+|... +++.||+|++....... ...+.+.+|+.+++.++|+|++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA--IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh--hHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 4678999999999999999999965 58899999876532221 234567889999999999999999998866554
Q ss_pred ----ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 239 ----PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 239 ----~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~ 160 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKIL 160 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEc
Confidence 89999998 6699888864 25899999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH
Q 012214 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 315 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.... ... ........
T Consensus 161 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~--~~~---~~~~i~~~ 231 (343)
T cd07851 161 DFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD--HID---QLKRIMNL 231 (343)
T ss_pred ccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--hHH---HHHHHHHh
Confidence 99998765432 223457888999998865 467889999999999999999999985311 110 00001010
Q ss_pred hh-----------ccccchhcch-------HHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 394 MR-----------KNRLHDILDD-------QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 394 ~~-----------~~~~~~~~d~-------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.. ......+... ... ......+..+.+++.+||+.+|++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFK-EVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cCCCCHHHHhhccchhHHHHHHhccccCCCCHH-HHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 0000000000 000 001123567899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=289.94 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=202.9
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
....|.+.+.||+|.|+.|.++++. .+..||||.+.....+. .....+.+|+.+|..++|||||+++.+......+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~--~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP--SKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh--HHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 3577999999999999999999954 68999999887654433 34455889999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||..+|.+.+++..... +.+..+..++.|+.+|++|||+++ |+|||||++||||+.+.++||+|||++.
T Consensus 132 lV~eya~~ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred EEEEeccCchhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccce
Confidence 99999999999999987543 555788889999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceeeecccccCCccCccccccCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh-ccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR-KNR 398 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 398 (468)
.+... ......+|++.|.|||++.+..+ .+.+|+||+|+++|-|+.|..||+...-.... ...+. .-+
T Consensus 204 ~~~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr--------~rvl~gk~r 273 (596)
T KOG0586|consen 204 FFDYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR--------PRVLRGKYR 273 (596)
T ss_pred eeccc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc--------chheeeeec
Confidence 77632 23445689999999999999765 46899999999999999999999631100000 00000 001
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+ +...+.+..++++++|-.+|.+|++++++.+
T Consensus 274 I------------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 274 I------------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred c------------cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 1 1122335778999999999999999999866
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=283.54 Aligned_cols=261 Identities=27% Similarity=0.392 Sum_probs=201.6
Q ss_pred hcCCCCCceeeecCcEEEEEEE-ecCCcEEEEEecccccchHHH---HHHHHHHHHHHHHHhcCCCceeeEeeeec-cCC
Q 012214 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEEL---LKLEEFINEIVILSQINHRNVVKLLGCCL-ETE 237 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~-~~~ 237 (468)
.++|-..++||+|||+.||++. +...+.||||+-.....+.+. .-.+...+|..+.+.++||.||++++++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 4567788899999999999998 556889999987654433321 12456789999999999999999999985 667
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC---CCcEEEE
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ---RYRAKVA 314 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~---~~~~kl~ 314 (468)
.++-|+|||+|.+|+-||+..+ .+++.++..|+.||+.||.||.... +||||-||||.|||+-. -|.+||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence 8899999999999999997644 4899999999999999999998876 88999999999999954 4789999
Q ss_pred ecCCcccccCCCce------eeecccccCCccCccccccC----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchh
Q 012214 315 DFGTSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENV 384 (468)
Q Consensus 315 DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~ 384 (468)
|||+++++..+... .+....||..|++||++.-+ .++.|+||||+||++|+.+.|++||.. +....
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh--nqsQQ-- 691 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH--NQSQQ-- 691 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC--chhHH--
Confidence 99999988765433 24567899999999987643 578899999999999999999999842 11111
Q ss_pred chHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 385 SLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+..+.+...-.-. .+.-+..+.+...+|.+||++.-++|....++..
T Consensus 692 -------dILqeNTIlkAtEVq--FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 -------DILQENTILKATEVQ--FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -------HHHhhhchhcceecc--CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111111111100 1111223446788999999999999999888764
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=284.24 Aligned_cols=261 Identities=23% Similarity=0.292 Sum_probs=189.6
Q ss_pred CCCCCceeeecCcEEEEEEEec-C--CcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccC----
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-D--GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET---- 236 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~--g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~---- 236 (468)
+|.+.+.||+|+||.||++... . +..+|+|++....... ...+.+.+|+.+++++ +||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK--ILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc--hhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 4677889999999999999964 3 7789999876532221 2345678899999999 599999999875432
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...++++|++. ++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Df 149 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDF 149 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcC
Confidence 45678888885 6898888542 25899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCce---eeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHH
Q 012214 317 GTSKFIAMDQTH---VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVH 392 (468)
Q Consensus 317 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 392 (468)
|+++........ ......||..|+|||.+.+ ..++.++||||||+++|+|++|..||..... .........
T Consensus 150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-----~~~~~~~~~ 224 (332)
T cd07857 150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-----VDQLNQILQ 224 (332)
T ss_pred CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-----HHHHHHHHH
Confidence 999865432211 1223468899999998766 5689999999999999999999998753210 000000000
Q ss_pred Hhh-----------ccccchhc-------chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 393 SMR-----------KNRLHDIL-------DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 393 ~~~-----------~~~~~~~~-------d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
... ........ ...+. ......+..+.+++.+||+.||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhCCCCHHHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00000000 00000 001112457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=268.04 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=196.8
Q ss_pred HhcCCCCC-ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeecc---
Q 012214 162 ATNHFNAN-RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLE--- 235 (468)
Q Consensus 162 ~~~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~--- 235 (468)
.+++|++. ++||-|-.|.|-.+..+ +|+.+|+|++... ....+|+++.-.. .|||||++++++..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds---------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS---------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC---------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 34555543 56999999999999865 6889999988642 2345788776655 69999999999864
Q ss_pred -CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc---CCCcE
Q 012214 236 -TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD---QRYRA 311 (468)
Q Consensus 236 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~---~~~~~ 311 (468)
...+.+|||.|+||.|...+.+++ ...+++.++-+|+.||+.|+.|||+.+ |.||||||+|+|.. .|..+
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~l 203 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPL 203 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcce
Confidence 446679999999999999998744 346999999999999999999999999 99999999999996 46789
Q ss_pred EEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHH
Q 012214 312 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391 (468)
Q Consensus 312 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (468)
||+|||+|+.-.. .......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||+...... ...-..
T Consensus 204 KLtDfGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-----ispgMk 276 (400)
T KOG0604|consen 204 KLTDFGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMK 276 (400)
T ss_pred EecccccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-----CChhHH
Confidence 9999999986433 222344578999999999999999999999999999999999999997522211 111112
Q ss_pred HHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..++.+.. ++.+ +-....++...++|+.+|..+|++|.|+.++..
T Consensus 277 ~rI~~gqy-~FP~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 277 RRIRTGQY-EFPE-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHhhccCc-cCCC-----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 22222221 1111 113455678889999999999999999999876
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=269.05 Aligned_cols=239 Identities=32% Similarity=0.370 Sum_probs=191.6
Q ss_pred eeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCCCC
Q 012214 172 LGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 250 (468)
Q Consensus 172 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 250 (468)
||+|+||.||++... +++.+|+|.+...... .....+.+.+|+.+++.++|+||+++++.+......++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII-KRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhc-chHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999965 5889999987654322 11345678899999999999999999999999999999999999999
Q ss_pred hhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCceee
Q 012214 251 LYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT 330 (468)
Q Consensus 251 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 330 (468)
|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 80 L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~ 150 (250)
T cd05123 80 LFSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRT 150 (250)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-Ccc
Confidence 999997632 4899999999999999999999988 9999999999999999999999999987654332 122
Q ss_pred ecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhh
Q 012214 331 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKL 410 (468)
Q Consensus 331 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 410 (468)
....++..|+|||...+...+.++|+||||+++|++++|..||.... . ...... ...... .
T Consensus 151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~---~~~~~~-~~~~~~----------~ 211 (250)
T cd05123 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED-----R---KEIYEK-ILKDPL----------R 211 (250)
T ss_pred cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----H---HHHHHH-HhcCCC----------C
Confidence 34457889999999998888999999999999999999999984311 1 111111 111110 0
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 012214 411 GVKNQIMTFANLAKRCLDLNGKKRPTMEE 439 (468)
Q Consensus 411 ~~~~~~~~l~~li~~cl~~dp~~RPt~~e 439 (468)
.+...+..+.+++.+||+.||++|||+.+
T Consensus 212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 212 FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11122457889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=270.94 Aligned_cols=265 Identities=23% Similarity=0.309 Sum_probs=200.7
Q ss_pred ccccCHHHHHHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceee
Q 012214 151 FKLFSSKELDKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVK 228 (468)
Q Consensus 151 ~~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~ 228 (468)
...|+.+.++. ...||.|+||+|++-.++ .|+..|||++...... ...++++.|.+...+- +.||||+
T Consensus 58 ~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~---keq~rll~e~d~~mks~~cp~IVk 127 (361)
T KOG1006|consen 58 LHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE---KEQKRLLMEHDTVMKSSNCPNIVK 127 (361)
T ss_pred ccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch---HHHHHHHHHHHHHHhhcCCcHHHH
Confidence 34555544433 456999999999999865 7999999999876554 4446788888765554 7999999
Q ss_pred EeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC
Q 012214 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR 308 (468)
Q Consensus 229 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~ 308 (468)
++|.+..+...++.||+|+ .||+.+...........+++..+-.|+.-...||.||...-+ |||||+||+|||++..
T Consensus 128 fyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~ 204 (361)
T KOG1006|consen 128 FYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRH 204 (361)
T ss_pred HhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecC
Confidence 9999999999999999995 588776654333334468999999999999999999987543 9999999999999999
Q ss_pred CcEEEEecCCcccccCCCceeeecccccCCccCcccccc--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhch
Q 012214 309 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSL 386 (468)
Q Consensus 309 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~ 386 (468)
|.+||+|||++-.+.. +...+...|-..|||||.+.. ..|+.+|||||||++|+|+.||..|+.. -.+.
T Consensus 205 G~vKLCDFGIcGqLv~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~-------w~sv 275 (361)
T KOG1006|consen 205 GDVKLCDFGICGQLVD--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK-------WDSV 275 (361)
T ss_pred CCEeeecccchHhHHH--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch-------HHHH
Confidence 9999999999875532 233444568888999998875 3489999999999999999999999743 1122
Q ss_pred HHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 387 AAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 387 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+++..... +..+.+..+ ....+.+..++.++.-||..|-++||...++.+
T Consensus 276 feql~~Vv~-gdpp~l~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 276 FEQLCQVVI-GDPPILLFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHHHHHc-CCCCeecCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 222222222 111211111 112345668999999999999999999999876
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=283.76 Aligned_cols=261 Identities=24% Similarity=0.323 Sum_probs=190.2
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC-----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----- 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~----- 236 (468)
..+|.+.+.||.|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 367899999999999999999964 688999998765432 2346688899999999999999999876543
Q ss_pred ---------CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc-
Q 012214 237 ---------EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD- 306 (468)
Q Consensus 237 ---------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~- 306 (468)
...++|+||++ ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~ 149 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINT 149 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcC
Confidence 34689999996 588887753 24889999999999999999999999 99999999999997
Q ss_pred CCCcEEEEecCCcccccCCCce--eeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccch
Q 012214 307 QRYRAKVADFGTSKFIAMDQTH--VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQEN 383 (468)
Q Consensus 307 ~~~~~kl~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~ 383 (468)
+++.+||+|||+++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ..
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--~~- 226 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE--LE- 226 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH--HH-
Confidence 4567899999998765322111 1122357889999997654 5678899999999999999999999853211 00
Q ss_pred hchHHHHHHHhhcc---ccchh---cchHHh----------hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 384 VSLAAYFVHSMRKN---RLHDI---LDDQLM----------KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 384 ~~~~~~~~~~~~~~---~~~~~---~d~~l~----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
............ ..... ...... .......+.++.+++.+||+.||.+|||+.+++.
T Consensus 227 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 227 --QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred --HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000000000 00000 000000 0001123457889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=274.31 Aligned_cols=266 Identities=23% Similarity=0.338 Sum_probs=210.7
Q ss_pred HHHHHhcCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEee
Q 012214 158 ELDKATNHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLG 231 (468)
Q Consensus 158 ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g 231 (468)
++.....+++....+-+|.||.||.|.+. +.+.|-+|.++..... -++..++.|..++..+.|||+..+.+
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~---iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ---IQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH---HHHHHHHHHHHHHhcCcCCCccceeE
Confidence 33444567888888999999999999643 3566778877665443 66778999999999999999999999
Q ss_pred eecc-CCcceeEeeecCCCChhhHhhhcc---cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC
Q 012214 232 CCLE-TEVPLLVYEFIPNGTLYQHLHDRH---QNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ 307 (468)
Q Consensus 232 ~~~~-~~~~~lV~E~~~~gsL~~~l~~~~---~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~ 307 (468)
++.+ ...++++|.++.-|+|..+|..-+ ....+.++..+...++.|++.|++|||+++ +||.||.++|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 9865 557889999999999999998322 122345777888999999999999999999 999999999999999
Q ss_pred CCcEEEEecCCcccccCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhc
Q 012214 308 RYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVS 385 (468)
Q Consensus 308 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~ 385 (468)
..++||+|=.+++.+-..+. ........+..||+||.+.+..|+.++|||||||++|||+| |+.|+.. . +...
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae--I---DPfE 506 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE--I---DPFE 506 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc--c---CHHH
Confidence 99999999999986543333 33344456789999999999999999999999999999999 8888632 1 1111
Q ss_pred hHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 386 LAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
...+... ..+-..|.+++.++..++.-||...|++||+.++++.-|.+.
T Consensus 507 m~~ylkd-------------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 507 MEHYLKD-------------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred HHHHHhc-------------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1111111 122223667888999999999999999999999999888754
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=266.59 Aligned_cols=252 Identities=25% Similarity=0.304 Sum_probs=202.4
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
..++|...+.||+|.||.|-+++-+ .++.+|+|+++....-.. ..+..-+.|-++|+..+||.+..+.-.+...+..+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak-dEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK-DEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh-HHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 4578999999999999999999954 799999999876543321 44566778889999999999999988899999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||..||.|.-.|.+. ..++++.....-..|..||.|||+.+ ||.||||.+|.|+|.+|++||+|||+++
T Consensus 245 FVMeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred EEEEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccch
Confidence 999999999999888653 25888888899999999999999999 9999999999999999999999999997
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
.-... ...+...+||+.|+|||++....|..++|.|.+||++|||++|+.||+.... ..+.+.. .+.+-+
T Consensus 317 E~I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-----~kLFeLI--l~ed~k-- 386 (516)
T KOG0690|consen 317 EEIKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-----EKLFELI--LMEDLK-- 386 (516)
T ss_pred hcccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-----hHHHHHH--Hhhhcc--
Confidence 53322 2235568999999999999999999999999999999999999999964211 1111100 001111
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC--HHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT--MEEVSM 442 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt--~~evl~ 442 (468)
.|...+++...|+..+|..||.+|.. ..++.+
T Consensus 387 ----------FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakE 420 (516)
T KOG0690|consen 387 ----------FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKE 420 (516)
T ss_pred ----------CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHH
Confidence 13344457788999999999999973 344443
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=303.42 Aligned_cols=259 Identities=26% Similarity=0.309 Sum_probs=209.7
Q ss_pred HHHHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC
Q 012214 158 ELDKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 236 (468)
Q Consensus 158 ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~ 236 (468)
++....++|.+.+.||+|+||.|..++.+ .++.+|.|++.... .-.......|..|-.+|..-+.+-|+.++-.|.+.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~e-MlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWE-MLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHH-HhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 44445678999999999999999999965 58889999886521 11112345688889999999999999999999999
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
.++|+|||||+||+|..++.... +++++.+...+..|+-||.-||+.| +|||||||+|||||.+|++||+||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999997632 5999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCceeeecccccCCccCcccccc-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHH
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (468)
|.+-.+..+..-.....+|||.|.+||++.. +.|...+|.||+||++|||+.|..||+. .++...+.
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa--------dslveTY~ 291 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA--------DSLVETYG 291 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH--------HHHHHHHH
Confidence 9998888777777888899999999998763 5788999999999999999999999953 23333344
Q ss_pred HHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC---HHHHH
Q 012214 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT---MEEVS 441 (468)
Q Consensus 392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl 441 (468)
..+.......+.+ ....++...+||++.+. +|+.|.. +.++-
T Consensus 292 KIm~hk~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 292 KIMNHKESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred HHhchhhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 4443322222221 23356678889988885 6777777 66554
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=298.82 Aligned_cols=148 Identities=29% Similarity=0.345 Sum_probs=130.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.++||+|+||.||+|... +++.||+|++...... .......+..|+.++..++|+||+++++++......++|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-NKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 67888999999999999999965 6889999998653221 113346788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
|||+.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999996532 4788999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=243.68 Aligned_cols=264 Identities=23% Similarity=0.333 Sum_probs=196.9
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
+|...++||+|.||+||+++.. .+..||+|++.....++ ..-...++|+-+++.++|.|||+++++...+...-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde--gvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC--CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 3455677999999999999954 58899999987754443 22346789999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
|||. .+|..+..+-. .-++.+.+..++.|+++||.++|+++ +.||||||.|.||+.||.+|++|||+++.+.
T Consensus 81 e~cd-qdlkkyfdsln----g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafg 152 (292)
T KOG0662|consen 81 EFCD-QDLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFG 152 (292)
T ss_pred HHhh-HHHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcC
Confidence 9995 48888876522 24889999999999999999999999 9999999999999999999999999999775
Q ss_pred CCCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH--hhcccc-
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS--MRKNRL- 399 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~- 399 (468)
-.-.. .+..+.|..|.+|.++.+. -|++..|+||-||++.|+....+|.....+ ..+ .+...++.. .....+
T Consensus 153 ipvrc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d-vdd--qlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 153 IPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDD--QLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred CceEe-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc-HHH--HHHHHHHHhCCCccccCC
Confidence 43322 2345678999999998884 578899999999999999997777643222 211 111112111 111111
Q ss_pred --chhcchHHhhh---------chHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 400 --HDILDDQLMKL---------GVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 400 --~~~~d~~l~~~---------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+.|-..... ..+.....=.+++++.+.-+|.+|.++++.++
T Consensus 229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11222111111 11122233468999999999999999988764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=283.57 Aligned_cols=239 Identities=23% Similarity=0.295 Sum_probs=191.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 240 (468)
+..|.....+|.|+|+.|-.+.. .+++..++|++.....+ -.+|+.++... +||||+++.+++.+....+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~--------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD--------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc--------cccccchhhhhcCCCcceeecceecCCceee
Confidence 56788888899999999988884 46888999998764222 23466555444 8999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE-cCCCcEEEEecCCc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL-DQRYRAKVADFGTS 319 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl-~~~~~~kl~DfGla 319 (468)
+|||.+.++-|.+.+..... +. ..+..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.+
T Consensus 393 ~v~e~l~g~ell~ri~~~~~-----~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a 463 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPE-----FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFW 463 (612)
T ss_pred eeehhccccHHHHHHHhcch-----hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechh
Confidence 99999999888777765321 23 677789999999999999999 9999999999999 68999999999999
Q ss_pred ccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
+....+ ....+-|..|.|||+.....++.++|+||||++||+|++|+.||...... ......+..+..
T Consensus 464 ~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--------~ei~~~i~~~~~ 531 (612)
T KOG0603|consen 464 SELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--------IEIHTRIQMPKF 531 (612)
T ss_pred hhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--------HHHHHhhcCCcc
Confidence 876554 22335688999999999999999999999999999999999998532111 112222222222
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ...+....+|+.+||+.||.+||+|.++..
T Consensus 532 s------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 532 S------------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred c------------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 2 344557889999999999999999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=264.05 Aligned_cols=222 Identities=23% Similarity=0.203 Sum_probs=175.3
Q ss_pred cCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCCCChhh
Q 012214 175 GGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQ 253 (468)
Q Consensus 175 G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 253 (468)
|.+|.||++... +++.+|+|++.... .+.+|...+....|||++++++++.+.+..++||||+++|+|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 899999999964 68899999886532 12344555556679999999999999999999999999999999
Q ss_pred HhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCceeeecc
Q 012214 254 HLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333 (468)
Q Consensus 254 ~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 333 (468)
++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++|||.+...... ....
T Consensus 75 ~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~ 142 (237)
T cd05576 75 HISKFL-----NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGE 142 (237)
T ss_pred HHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccC
Confidence 986532 4899999999999999999999999 999999999999999999999999987654322 1223
Q ss_pred cccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchH
Q 012214 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVK 413 (468)
Q Consensus 334 ~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 413 (468)
.++..|+|||.+.+..++.++||||+|+++|||++|+.|+....... ...... ..+.
T Consensus 143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~~~~~------------~~~~ 199 (237)
T cd05576 143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NTHTTL------------NIPE 199 (237)
T ss_pred CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------cccccc------------CCcc
Confidence 45678999999988889999999999999999999998863210000 000000 0112
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHH
Q 012214 414 NQIMTFANLAKRCLDLNGKKRPTMEEV 440 (468)
Q Consensus 414 ~~~~~l~~li~~cl~~dp~~RPt~~ev 440 (468)
..+..+.+++.+||+.||++|||+.+.
T Consensus 200 ~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 200 WVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred cCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 234478899999999999999997443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=286.09 Aligned_cols=264 Identities=19% Similarity=0.219 Sum_probs=168.8
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-C----CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeee----
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-D----GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGC---- 232 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~---- 232 (468)
..++|.+.+.||+|+||.||+|.+. + +..||+|++...... +.+..+ .+....+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~------e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV------EIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh------HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 4578999999999999999999965 4 689999987542211 111111 1112222222222111
Q ss_pred --eccCCcceeEeeecCCCChhhHhhhcccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEe
Q 012214 233 --CLETEVPLLVYEFIPNGTLYQHLHDRHQN---------------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYH 295 (468)
Q Consensus 233 --~~~~~~~~lV~E~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH 295 (468)
+.+....++|+||+.+++|.+++...... .........+..++.||+.||.|||+.+ |+|
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiH 278 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVH 278 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 24566789999999999999998753210 0001123446689999999999999999 999
Q ss_pred cCCCCCCEEEcC-CCcEEEEecCCcccccCCCceeeecccccCCccCccccccC----------------------CCCC
Q 012214 296 RDIKSTNILLDQ-RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS----------------------QLTD 352 (468)
Q Consensus 296 ~DLkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ 352 (468)
|||||+|||+++ ++.+||+|||+|+..............+|+.|+|||.+... .++.
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 999999999986 68999999999986654444444456789999999965432 2345
Q ss_pred cccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh-hccccchhcchH----Hhh--hchHHHHHHHHHHHHH
Q 012214 353 KSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM-RKNRLHDILDDQ----LMK--LGVKNQIMTFANLAKR 425 (468)
Q Consensus 353 ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~----l~~--~~~~~~~~~l~~li~~ 425 (468)
++|||||||++|||+++..|+.. ........+.... ....+.....+. +.. ...........+|+.+
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence 67999999999999997665321 1000000000000 000000000000 000 0000112235589999
Q ss_pred hhccCCCCCCCHHHHHH
Q 012214 426 CLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 426 cl~~dp~~RPt~~evl~ 442 (468)
||+.||++|||+.++++
T Consensus 433 mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 433 MMRFKGRQRISAKAALA 449 (566)
T ss_pred HccCCcccCCCHHHHhC
Confidence 99999999999999987
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=277.04 Aligned_cols=246 Identities=25% Similarity=0.333 Sum_probs=195.0
Q ss_pred CceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecC
Q 012214 169 NRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
.+.||+|-||+||-|+++ +|+.||||++....-.. .....+.+|+.+|++++||.||.+..-|++.+..++|||.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~--kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl- 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT--KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL- 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCC--chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-
Confidence 467999999999999964 79999999875432221 22366889999999999999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC---CcEEEEecCCcccccC
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR---YRAKVADFGTSKFIAM 324 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~---~~~kl~DfGla~~~~~ 324 (468)
+|+..+.+-. .+...+++..-..++.||+.||.|||.++ |+|+||||+|||+.+. ..+||+|||+|+++++
T Consensus 646 ~GDMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 646 HGDMLEMILS---SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred cchHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 5677776655 33346888888889999999999999999 9999999999999654 5799999999998875
Q ss_pred CCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcc
Q 012214 325 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404 (468)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 404 (468)
..- ....+||+.|+|||++.+..|...-|+||.||++|--++|..||...++.. ...+...-.+..+.
T Consensus 720 ksF--RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn----dQIQNAaFMyPp~P------ 787 (888)
T KOG4236|consen 720 KSF--RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN----DQIQNAAFMYPPNP------ 787 (888)
T ss_pred hhh--hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh----HHhhccccccCCCc------
Confidence 433 345689999999999999999999999999999999999999985321111 11111111111112
Q ss_pred hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 405 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+.++..++||...||..-.+|-|....+.
T Consensus 788 -------W~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 788 -------WSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred -------hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 2344457889999999999999999877654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=264.70 Aligned_cols=262 Identities=25% Similarity=0.339 Sum_probs=197.7
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC--CC----ceeeEeee
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN--HR----NVVKLLGC 232 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~----niv~l~g~ 232 (468)
+..+++|.+...+|+|.||.|-.+.+. .+..||||+++... .-.+..+-|++++.++. .| -+|.+.++
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-----KYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 344789999999999999999999854 47899999987632 22345677999999993 22 36667788
Q ss_pred eccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC-----
Q 012214 233 CLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ----- 307 (468)
Q Consensus 233 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~----- 307 (468)
+.-.++.++|+|.+ |-|+.++|.. +...+++...+..|+.|+++++++||+.+ ++|.||||+|||+.+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEE
Confidence 88889999999998 6699999987 33457899999999999999999999999 999999999999832
Q ss_pred ---------------CCcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCC
Q 012214 308 ---------------RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372 (468)
Q Consensus 308 ---------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p 372 (468)
+..++|+|||.|....... +..+.|..|.|||++.+-.++.++||||+||+|+|+.||..-
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 3468999999998655443 445679999999999999999999999999999999999998
Q ss_pred CCCCCCCccchhchHHHHHHHh-----------------hcccc--c---------hhcch----HHhhhchHHHHHHHH
Q 012214 373 IFWAGNTSQENVSLAAYFVHSM-----------------RKNRL--H---------DILDD----QLMKLGVKNQIMTFA 420 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~--~---------~~~d~----~l~~~~~~~~~~~l~ 420 (468)
|....+.. .+ +.....+ ..+.+ . ...+. .........+...|.
T Consensus 309 FqtHen~E----HL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 309 FQTHENLE----HL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred cccCCcHH----HH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 85422111 11 1110000 00000 0 00000 001111233445699
Q ss_pred HHHHHhhccCCCCCCCHHHHHH
Q 012214 421 NLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 421 ~li~~cl~~dp~~RPt~~evl~ 442 (468)
+|+.+||.+||.+|+|+.|++.
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHccCccccccHHHHhc
Confidence 9999999999999999999975
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=252.77 Aligned_cols=264 Identities=22% Similarity=0.341 Sum_probs=200.8
Q ss_pred HHHHHHHhcCCCCCceeeecCcEEEEEEE-ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeee
Q 012214 156 SKELDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCC 233 (468)
Q Consensus 156 ~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~ 233 (468)
++++.+.|+ +.||+|+|+.|-.++ +.+|..+|||++... .. .......+|++++.+. .|+||+.|++++
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~g---HsR~RvfREVe~f~~Cqgh~nilqLiefF 145 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PG---HSRSRVFREVETFYQCQGHKNILQLIEFF 145 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC-Cc---hHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence 455555554 459999999999887 678999999998764 22 4456788999999998 599999999999
Q ss_pred ccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC---Cc
Q 012214 234 LETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR---YR 310 (468)
Q Consensus 234 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~---~~ 310 (468)
.++...|||||.|.||+|...+..+. .+++.++..+..+|+.||.|||.++ |.||||||+|||.... .-
T Consensus 146 Edd~~FYLVfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsP 217 (463)
T KOG0607|consen 146 EDDTRFYLVFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSP 217 (463)
T ss_pred cccceEEEEEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCc
Confidence 99999999999999999999997754 4899999999999999999999999 9999999999999654 45
Q ss_pred EEEEecCCcccccCC------CceeeecccccCCccCccccc---c--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 012214 311 AKVADFGTSKFIAMD------QTHVTTKIQGTFGYLDPEYHQ---S--SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNT 379 (468)
Q Consensus 311 ~kl~DfGla~~~~~~------~~~~~~~~~gt~~y~aPE~~~---~--~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~ 379 (468)
+||+||.+..-+... .+......+|+..|||||++. + ..|+.++|.|||||+||-|++|..||......
T Consensus 218 vKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~ 297 (463)
T KOG0607|consen 218 VKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA 297 (463)
T ss_pred eeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC
Confidence 899999887543221 112233457889999999654 2 35788999999999999999999999642210
Q ss_pred -c-----cchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 380 -S-----QENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 380 -~-----~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ..-.......-..+.++.. ++.|.. ....+.+..+++..+|..++.+|.++.+++.
T Consensus 298 dCGWdrGe~Cr~CQ~~LFesIQEGkY-eFPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 298 DCGWDRGEVCRVCQNKLFESIQEGKY-EFPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCccCCCccHHHHHHHHHHHhccCC-cCChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0 0011222222333333221 222221 2234556788999999999999999988876
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=255.05 Aligned_cols=239 Identities=31% Similarity=0.393 Sum_probs=191.1
Q ss_pred CcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCCCChhhH
Q 012214 176 GQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQH 254 (468)
Q Consensus 176 ~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~ 254 (468)
+||.||++... +++.+++|++...... ...+.+.+|+..+++++|+|++++++++......++++|++++++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 58999999976 4899999998764332 1157889999999999999999999999998999999999999999999
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCceeeeccc
Q 012214 255 LHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ 334 (468)
Q Consensus 255 l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 334 (468)
+.... .+++..++.++.+++.++.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ......
T Consensus 78 ~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 147 (244)
T smart00220 78 LKKRG-----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFV 147 (244)
T ss_pred HHhcc-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--cccccc
Confidence 87532 2889999999999999999999998 9999999999999999999999999998765432 233455
Q ss_pred ccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHH
Q 012214 335 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKN 414 (468)
Q Consensus 335 gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 414 (468)
++..|++||.+.+..++.++||||||+++++|++|..||.... .. ................. ...
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~----~~----~~~~~~~~~~~~~~~~~-------~~~ 212 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD----QL----LELFKKIGKPKPPFPPP-------EWK 212 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----cH----HHHHHHHhccCCCCccc-------ccc
Confidence 7889999999998889999999999999999999999984311 10 11111111111110000 000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 415 QIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 415 ~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+..+.+++.+||..+|++||++.++++
T Consensus 213 ~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 213 ISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 3457899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-32 Score=276.47 Aligned_cols=270 Identities=19% Similarity=0.199 Sum_probs=181.5
Q ss_pred HhcCCCCCceeeecCcEEEEEEEe-----------------cCCcEEEEEecccccchHHH----------HHHHHHHHH
Q 012214 162 ATNHFNANRILGQGGQGTVYKGML-----------------EDGRIIAVKKSKLTVDDEEL----------LKLEEFINE 214 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~----------~~~~~~~~E 214 (468)
..++|.+.++||+|+||.||+|.. ..++.||||++......... ...+.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999963 23567999998653221100 011234457
Q ss_pred HHHHHhcCCCce-----eeEeeeecc--------CCcceeEeeecCCCChhhHhhhcccC-------------------C
Q 012214 215 IVILSQINHRNV-----VKLLGCCLE--------TEVPLLVYEFIPNGTLYQHLHDRHQN-------------------E 262 (468)
Q Consensus 215 i~~l~~l~h~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~-------------------~ 262 (468)
+.++.+++|.++ ++++++|.. ....++||||+++++|.+++...... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766654 667777653 34679999999999999998753110 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCceeeecccccCCccCc
Q 012214 263 EFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 342 (468)
Q Consensus 263 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP 342 (468)
...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 123577889999999999999999999 99999999999999999999999999976543322222223457899999
Q ss_pred cccccCC----------------------CCCcccHHHHHHHHHHHHhCCC-CCCCCCCCccchh--chHHHHHHHhhcc
Q 012214 343 EYHQSSQ----------------------LTDKSDVYSFGVVLVELLTGKK-PIFWAGNTSQENV--SLAAYFVHSMRKN 397 (468)
Q Consensus 343 E~~~~~~----------------------~s~ksDVwSlGvll~el~tG~~-p~~~~~~~~~~~~--~~~~~~~~~~~~~ 397 (468)
|.+.... ...+.||||+||++++|++|.. |+........+.. ......+......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875432 1235799999999999999875 5431100000000 0000000111111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCC---CCCCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNG---KKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp---~~RPt~~evl~ 442 (468)
.. + ............+|+.+||..+| .+|+|+.|+++
T Consensus 460 ~~-~-------~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 KY-D-------FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CC-C-------cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 10 0 00112234578899999999866 68999999985
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=278.54 Aligned_cols=254 Identities=28% Similarity=0.412 Sum_probs=203.9
Q ss_pred HHhcCCCCCceeeecCcEEEEEEE-ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeec----
Q 012214 161 KATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCL---- 234 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~---- 234 (468)
..++-|.+.+.||.|.+|.||+++ .++++.+|+|++......+ ++...|.++++.. +|||++.++|++.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-----EEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-----HHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 345778899999999999999999 4578999999987654442 4556788888888 7999999999985
Q ss_pred -cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEE
Q 012214 235 -ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKV 313 (468)
Q Consensus 235 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl 313 (468)
.++.++||||||.+||..++++... ...+.|..+..|+..++.|+.+||... ++|||||-.|||++.++.|||
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 3568899999999999999998754 446999999999999999999999998 999999999999999999999
Q ss_pred EecCCcccccCCCceeeecccccCCccCcccccc-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH
Q 012214 314 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 314 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~ 388 (468)
+|||++..+... ........||+.|||||++.. ..|+..+|+||||++..||.-|.+|+..+. ....
T Consensus 165 vDFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH-------Pmra 236 (953)
T KOG0587|consen 165 VDFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH-------PMRA 236 (953)
T ss_pred eeeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc-------hhhh
Confidence 999998765432 222344679999999998875 347778999999999999999999974311 0011
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.| ...+ +..+. ..-+..+..++.++|..||..|-+.||++.++++
T Consensus 237 LF-~IpR-NPPPk-------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 LF-LIPR-NPPPK-------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hc-cCCC-CCCcc-------ccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11 1111 11111 1226678889999999999999999999999886
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=256.26 Aligned_cols=267 Identities=25% Similarity=0.340 Sum_probs=197.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc-------
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE------- 235 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------- 235 (468)
+.|.-..+||+|.||.||+++.+ .|+.||+|+........ .--...++|+.++..+.|+|++.+++.|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe--GfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc--CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 34555677999999999999954 58889998764422211 112356789999999999999999998853
Q ss_pred -CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 236 -TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 236 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
....++|+.+|+. +|.-.|.... ..++..++.+++.++..||.|+|+.. |+|||+||.|+||+.++.+||+
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEee
Confidence 2357899999976 8888886532 35899999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCcee---eecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHH
Q 012214 315 DFGTSKFIAMDQTHV---TTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF 390 (468)
Q Consensus 315 DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~ 390 (468)
|||+++.+....... .+..+.|..|.+||.+.+ ..++++.|||.-||++.||+|+.+-+.. +.......+....
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg--nteqqql~~Is~L 244 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG--NTEQQQLHLISQL 244 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC--ChHHHHHHHHHHH
Confidence 999998765433222 344557999999998887 5789999999999999999998876532 2333333333333
Q ss_pred HHHhhccccchhcchHHhhhc-----h-------HHH------HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 391 VHSMRKNRLHDILDDQLMKLG-----V-------KNQ------IMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 391 ~~~~~~~~~~~~~d~~l~~~~-----~-------~~~------~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
-.....+.++....-.+.... + ++. ....++|+.+++..||.+|+++++++.
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 333333333333222222111 0 011 125789999999999999999999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-33 Score=271.09 Aligned_cols=245 Identities=24% Similarity=0.272 Sum_probs=199.3
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCc-EEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGR-IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~-~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.++...-.||-||||.|=++..+... .+|+|+++....- +..+.+....|-.+|...+.|.||+++..+.+....|+.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV-dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV-DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhcc-chhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 44555667999999999998875433 3788877654322 224557788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
||-|-||.|+..|+.+. .++..+...++..+.+|++|||+++ ||.|||||+|.+++.+|-+||.|||+|+.+
T Consensus 499 mEaClGGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred HHhhcCchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHh
Confidence 99999999999998754 4788888899999999999999999 999999999999999999999999999988
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... +-..+||+.|.|||.+.+...+.++|.||||+++|||++|.+||.. .+...........+..-
T Consensus 571 ~~g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-----~dpmktYn~ILkGid~i----- 638 (732)
T KOG0614|consen 571 GSGRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-----VDPMKTYNLILKGIDKI----- 638 (732)
T ss_pred ccCCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-----CchHHHHHHHHhhhhhh-----
Confidence 65544 3457899999999999999999999999999999999999999854 12222222222222211
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT 436 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt 436 (468)
..|........+|+.++...+|.+|..
T Consensus 639 -------~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 -------EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -------hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 223344456789999999999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-33 Score=284.08 Aligned_cols=247 Identities=28% Similarity=0.401 Sum_probs=187.1
Q ss_pred CCCCCceeeecCcEE-EEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcceeE
Q 012214 165 HFNANRILGQGGQGT-VYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV 242 (468)
-|...+.+|.|+.|+ ||+|... |+.||||++-.. ..+-..+|+..++.- +|||||++++.-.++...|++
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e-------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE-------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA 581 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH-------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence 356667799999986 6999985 789999987652 223466899999988 699999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC-----CCcEEEEecC
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ-----RYRAKVADFG 317 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~-----~~~~kl~DfG 317 (468)
.|.|. .+|.+++........ ...--..+.++.|++.||++||+.+ ||||||||.||||+. ...++|+|||
T Consensus 582 lELC~-~sL~dlie~~~~d~~-~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfg 656 (903)
T KOG1027|consen 582 LELCA-CSLQDLIESSGLDVE-MQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFG 656 (903)
T ss_pred ehHhh-hhHHHHHhccccchh-hcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccc
Confidence 99995 599999987411110 1111345678899999999999999 999999999999976 2579999999
Q ss_pred CcccccCCCcee--eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhC-CCCCCCCCCCccchhchHHHHHHHh
Q 012214 318 TSKFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTG-KKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 318 la~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG-~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
+++....+.... .....||.+|+|||++.....+.++||||+||++|..++| .+||.. ....+.+ +. .
T Consensus 657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd---~~~R~~N----Il--~ 727 (903)
T KOG1027|consen 657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD---SLERQAN----IL--T 727 (903)
T ss_pred cccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc---hHHhhhh----hh--c
Confidence 999887655433 3456799999999999998888899999999999998885 888832 1111000 00 0
Q ss_pred hccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 395 RKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 395 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
....+..+ .. ..++ +..+||.+|+.++|..||++.+|+.
T Consensus 728 ~~~~L~~L-----~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 728 GNYTLVHL-----EP--LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred Cccceeee-----cc--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 01111110 00 1111 6789999999999999999999975
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=260.23 Aligned_cols=246 Identities=27% Similarity=0.333 Sum_probs=195.1
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 240 (468)
..+|.....||+|+||.|.++..+ +...+|||+++....-++ ..++.-+.|-++|... +-|.++.++.++.+-+.+|
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 356888899999999999999865 466799999877544322 2334455677777766 5788999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||+.||+|-..+.... .+.+..+.-.+..||-||-+||+++ ||.||||.+|||+|.+|.+||+|||+++
T Consensus 427 FVMEyvnGGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eEEEEecCchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence 9999999999998887643 3666778889999999999999999 9999999999999999999999999997
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
.-..+.. .+...+||+.|+|||.+.-.+|...+|.|||||+||||+.|+.||+.. .+. +.+......+
T Consensus 499 Eni~~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe----DE~----elF~aI~ehn--- 566 (683)
T KOG0696|consen 499 ENIFDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE----DED----ELFQAIMEHN--- 566 (683)
T ss_pred ccccCCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC----CHH----HHHHHHHHcc---
Confidence 5433322 244578999999999999999999999999999999999999998541 111 1222222211
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTM 437 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 437 (468)
-.++...+.+...+....|...|.+|...
T Consensus 567 --------vsyPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 567 --------VSYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred --------CcCcccccHHHHHHHHHHhhcCCccccCC
Confidence 11244555678889999999999999743
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=236.38 Aligned_cols=208 Identities=25% Similarity=0.371 Sum_probs=171.7
Q ss_pred HHHHhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccC
Q 012214 159 LDKATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET 236 (468)
Q Consensus 159 i~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~ 236 (468)
++...+.......||+|++|.|=+.++ .+|+..|+|.+...... +..+..++|+.+..+. .+|.+|+++|....+
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~---q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS---QEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh---HHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 445555666667799999999988875 47999999999877665 4456788898876655 799999999999999
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...++.||.|+ .||..+..... .....+++..+-+|+..+.+||.|||++-. +||||+||+|||++.+|++|++||
T Consensus 118 gdvwIcME~M~-tSldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 118 GDVWICMELMD-TSLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred ccEEEeHHHhh-hhHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEccc
Confidence 99999999995 58888776543 233469999999999999999999999753 999999999999999999999999
Q ss_pred CCcccccCCCceeeecccccCCccCcccccc----CCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS----SQLTDKSDVYSFGVVLVELLTGKKPIFW 375 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwSlGvll~el~tG~~p~~~ 375 (468)
|++-.+.+.- ..+...|-..|||||.+.. ..|+-|+||||||+++.||.+++.|+..
T Consensus 194 GIsG~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 194 GISGYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ccceeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 9997664321 2233457788999998764 4789999999999999999999999854
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=249.57 Aligned_cols=263 Identities=24% Similarity=0.310 Sum_probs=197.4
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC-----cc
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-----VP 239 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-----~~ 239 (468)
.+..+.||.|+||.||.+.+. +|+.||.|++.... .....-+.+.+|+.++..++|.|++..++...... ..
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf--q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF--QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHH--HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 345677999999999999864 79999999987643 33355678999999999999999999988765432 45
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
|+++|.|. .+|...+-+ .++++.+.+.-++.||++||.|||+.+ |.||||||.|.|+++|..+||+|||++
T Consensus 133 YV~TELmQ-SDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 133 YVLTELMQ-SDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHHHHHH-hhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccc
Confidence 78899885 478777744 346888999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
+.-..++...++..+.|..|.|||.+.+ ..|+.+.||||.||++.||+..+.-|...+ .....+.....+..+.
T Consensus 204 Rvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~-----PiqQL~lItdLLGTPs 278 (449)
T KOG0664|consen 204 RTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG-----PIEQLQMIIDLLGTPS 278 (449)
T ss_pred cccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC-----hHHHHHHHHHHhCCCc
Confidence 9877666666777778999999999988 578999999999999999998777664311 1111222222222111
Q ss_pred cchhcch-------------------HHhh-hchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 012214 399 LHDILDD-------------------QLMK-LGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444 (468)
Q Consensus 399 ~~~~~d~-------------------~l~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 444 (468)
..+.-.. .+.. ..+.....+...+.++++.+||+.|.+..+.+..+
T Consensus 279 ~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 279 QEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1110000 0000 00112233567888999999999999998887644
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=248.19 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=198.4
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 240 (468)
-++|...+.||+|+|.+|..++++ +.+.+|+|+++....+++ ..++-...|-.+..+. +||.+|.+..|+.++...+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd-edidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc-ccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 367999999999999999999954 678899998876543322 3344455666666665 7999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+|.||+++|+|--.+...+ .++++.+......|+-||.|||+.+ ||.||||.+|+|+|..|.+||+|+|+++
T Consensus 328 fvieyv~ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEecCcceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhh
Confidence 9999999999977775532 4999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh-hcccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM-RKNRL 399 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 399 (468)
.--. ....++..+||+.|.|||.+.+..|....|.|+|||+++||+.|+.||+.-+....+.......+.-.+ ++-++
T Consensus 400 e~l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri 478 (593)
T KOG0695|consen 400 EGLG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI 478 (593)
T ss_pred cCCC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc
Confidence 5322 223355689999999999999999999999999999999999999999865544433222221121111 11122
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT 436 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt 436 (468)
+...+.....+++.-|..||.+|..
T Consensus 479 ------------prslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 479 ------------PRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ------------cceeehhhHHHHHHhhcCCcHHhcC
Confidence 2233335667889999999999864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=260.19 Aligned_cols=204 Identities=24% Similarity=0.334 Sum_probs=172.7
Q ss_pred hcCCCCCceeeecCcEEEEEEE-ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
...|..++.||-|+||.|.+++ .++...+|.|.+.... --....+.....|-.||...+.+-||+|+-.|.+.+.+|+
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaD-Vl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKAD-VLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHH-HHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 4678888999999999999998 4456678999876532 1122445678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||+|++||++-.+|.... -+.++.+...+..+..|+++.|..+ +|||||||+|||||.+|.+||+||||+.-
T Consensus 707 VMdYIPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred EEeccCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccc
Confidence 999999999999997643 3788889999999999999999999 99999999999999999999999999853
Q ss_pred cc---------CCCc-----------------e---------------eeecccccCCccCccccccCCCCCcccHHHHH
Q 012214 322 IA---------MDQT-----------------H---------------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFG 360 (468)
Q Consensus 322 ~~---------~~~~-----------------~---------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG 360 (468)
+. ..+. . .....+||+.|+|||++....++..+|.||.|
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g 858 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG 858 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence 31 1000 0 01125699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCC
Q 012214 361 VVLVELLTGKKPIFW 375 (468)
Q Consensus 361 vll~el~tG~~p~~~ 375 (468)
|+||||+.|+.||..
T Consensus 859 vil~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLA 873 (1034)
T ss_pred HHHHHHhhCCCCccC
Confidence 999999999999854
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=233.86 Aligned_cols=256 Identities=21% Similarity=0.331 Sum_probs=194.4
Q ss_pred hcCCCCCceeeecCcEEEEEEE-ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccC--Cc
Q 012214 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLET--EV 238 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~--~~ 238 (468)
.++|++.+++|+|.++.||.|. ..+.+.++||+++. ...+.+.+|+.++..+. ||||++++++..+. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 4678999999999999999998 55788999999876 33456889999999996 99999999998764 46
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC-CCcEEEEecC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ-RYRAKVADFG 317 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~-~~~~kl~DfG 317 (468)
+.||+||+++.+...+.. .++...+...+.+++.||.|+|+.| |+|||+||.|++||. .-.++|+|+|
T Consensus 110 paLiFE~v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred chhHhhhhccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecc
Confidence 789999999877766653 3777888999999999999999999 999999999999985 4679999999
Q ss_pred CcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHH-----H
Q 012214 318 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF-----V 391 (468)
Q Consensus 318 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~-----~ 391 (468)
+|-++........ .+.+.-|--||.+.. ..|+..-|+|||||++..|+..+.||+...++.......+... .
T Consensus 179 LAEFYHp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 179 LAEFYHPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred hHhhcCCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 9988765544322 234556788998876 5678888999999999999999999975444333222111110 0
Q ss_pred HHhh------cc------------ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 392 HSMR------KN------------RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 392 ~~~~------~~------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.-+. .+ .+..++.+...+ -.+++..+++.+.|..|-.+|||++|...
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~h----l~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQH----LVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccc----cCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0000 11 111111111111 12357889999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-29 Score=227.42 Aligned_cols=211 Identities=38% Similarity=0.583 Sum_probs=182.7
Q ss_pred eeecCcEEEEEEEecC-CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCCCC
Q 012214 172 LGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 250 (468)
Q Consensus 172 LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 250 (468)
||+|++|.||++...+ ++.+++|+........ ..+.+.+|+..++.+.|++++++++++......++++|++++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 6899999999999754 8999999987643321 34678899999999999999999999999899999999999999
Q ss_pred hhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC-CCcEEEEecCCcccccCCCcee
Q 012214 251 LYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ-RYRAKVADFGTSKFIAMDQTHV 329 (468)
Q Consensus 251 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~ 329 (468)
|.+++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 78 l~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~ 149 (215)
T cd00180 78 LKDLLKENE----GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-L 149 (215)
T ss_pred HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-h
Confidence 999987632 25889999999999999999999998 999999999999999 89999999999976544321 1
Q ss_pred eecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHh
Q 012214 330 TTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLM 408 (468)
Q Consensus 330 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 408 (468)
.....+...|++||..... ..+.++|+|++|+++++|
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------ 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------ 187 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence 2234577889999998887 888999999999999999
Q ss_pred hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 409 KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 409 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 267899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=236.42 Aligned_cols=131 Identities=27% Similarity=0.375 Sum_probs=110.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-----C---CceeeEeeeec
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-----H---RNVVKLLGCCL 234 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-----h---~niv~l~g~~~ 234 (468)
.+|.+.++||-|-|++||++.+. +.+.||+|+.+... .-.+..+.||.+|++++ | .+||+|++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 78999999999999999999854 67889999987532 33456789999999983 2 47999999985
Q ss_pred ----cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE
Q 012214 235 ----ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL 305 (468)
Q Consensus 235 ----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl 305 (468)
.+.+.++|+|++ |-+|..++.... ...++...+.+|+.||+.||.|||..+. |||.||||+|||+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 456889999999 678999987733 3358999999999999999999999875 9999999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-28 Score=223.78 Aligned_cols=199 Identities=36% Similarity=0.538 Sum_probs=170.7
Q ss_pred CCCCceeeecCcEEEEEEEecC-CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEee
Q 012214 166 FNANRILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYE 244 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 244 (468)
|...+.||+|++|.||++...+ ++.+++|........ ...+.+.+|+..++.++|+|++++++++......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence 4567789999999999999764 889999998764332 245678899999999999999999999998899999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
++++++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+.....
T Consensus 78 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~ 150 (225)
T smart00221 78 YCEGGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHR 150 (225)
T ss_pred ccCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence 9999999999976321 1788999999999999999999998 99999999999999999999999999987654
Q ss_pred CCceeeecccccCCccCcccc-ccCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 012214 325 DQTHVTTKIQGTFGYLDPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPIF 374 (468)
Q Consensus 325 ~~~~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlGvll~el~tG~~p~~ 374 (468)
..........++..|++||.+ ....++.++||||||+++++|++|+.||.
T Consensus 151 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 151 DLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 431122334577889999998 66778889999999999999999999983
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=229.93 Aligned_cols=262 Identities=22% Similarity=0.299 Sum_probs=192.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC-----
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----- 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~----- 236 (468)
..+|...+.+|.|.- .|..+.+ -.++.||+|++...... ....+...+|..++..+.|+|+++++.++.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n--~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN--QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc--CccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 356777788899987 5555553 25889999988665333 24557788999999999999999999998643
Q ss_pred -CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 237 -EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 237 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
...|+|||+|. .+|...+.- .++-.++..|..|++.|+.|||+.+ |+||||||+||++..++.+||.|
T Consensus 93 ~~e~y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~d 161 (369)
T KOG0665|consen 93 FQEVYLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILD 161 (369)
T ss_pred HHhHHHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeecc
Confidence 35689999995 588887763 2666788899999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhc----------
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVS---------- 385 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~---------- 385 (468)
||+|+....+ ...+..+.|.-|.|||++.+-.+.+.+||||+||++.||++|..-|.. ....+...
T Consensus 162 fg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g--~d~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 162 FGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG--KDHIDQWNKIIEQLGTPD 237 (369)
T ss_pred chhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC--chHHHHHHHHHHHhcCCC
Confidence 9999854433 566777889999999999998899999999999999999999887742 11111000
Q ss_pred ------hHHHHHHHhh-ccc-----cchhc-chHHh--hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 386 ------LAAYFVHSMR-KNR-----LHDIL-DDQLM--KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 386 ------~~~~~~~~~~-~~~-----~~~~~-d~~l~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+........+ .++ ..+.+ |.... .+.+......+.+++.+||..||++|.++++++.
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0000000000 000 00011 10000 1112223345789999999999999999999986
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=242.43 Aligned_cols=199 Identities=23% Similarity=0.345 Sum_probs=166.7
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHH-----HHHHHHHHHHHHhcC---CCceeeEeeeec
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLK-----LEEFINEIVILSQIN---HRNVVKLLGCCL 234 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~-----~~~~~~Ei~~l~~l~---h~niv~l~g~~~ 234 (468)
..|...+.+|+|+||.|+.+.++ +...|+||.+.....-.+ .. +-..-.|+++|..++ |+||++++++|+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~D-tWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVD-TWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhh-hhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 45888899999999999999976 466789998765332111 11 113457999999997 999999999999
Q ss_pred cCCcceeEeeec-CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEE
Q 012214 235 ETEVPLLVYEFI-PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKV 313 (468)
Q Consensus 235 ~~~~~~lV~E~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl 313 (468)
+++..||++|-. ++.+|.+++..+. .+++.++..|+.||+.|+++||+.+ |||||||-+|+.++.+|-+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEE
Confidence 999999999975 4668889997643 4899999999999999999999999 999999999999999999999
Q ss_pred EecCCcccccCCCceeeecccccCCccCccccccCCCCCc-ccHHHHHHHHHHHHhCCCCCC
Q 012214 314 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDK-SDVYSFGVVLVELLTGKKPIF 374 (468)
Q Consensus 314 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDVwSlGvll~el~tG~~p~~ 374 (468)
+|||.|.+.... .....+||.+|.|||++.+.+|--| -|||++|++||-++....||+
T Consensus 712 idfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999998765332 2334679999999999999888665 599999999999999888875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=238.40 Aligned_cols=209 Identities=23% Similarity=0.254 Sum_probs=174.2
Q ss_pred ccCHHHHHHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC------CCc
Q 012214 153 LFSSKELDKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN------HRN 225 (468)
Q Consensus 153 ~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~------h~n 225 (468)
.|.+.-.+..-++|.+....|+|-|++|..|.+. .|+.||||++..... ..+.=+.|+++|++|+ --|
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-----M~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-----MHKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-----HhhhhhHHHHHHHHhhccCchhhhH
Confidence 3444455667788999999999999999999854 588999999876432 2345568999999995 348
Q ss_pred eeeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE
Q 012214 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL 305 (468)
Q Consensus 226 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl 305 (468)
.++|+..|...+++|||+|-+ ..+|.+.|+..+.+- .+....+...+.|+.-||..|-..+ |+|.||||+|||+
T Consensus 496 clrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nv--GL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNV--GLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILV 569 (752)
T ss_pred HHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCccc--ceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEe
Confidence 899999999999999999987 569999999866544 3777888999999999999999999 9999999999999
Q ss_pred cCC-CcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 012214 306 DQR-YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFW 375 (468)
Q Consensus 306 ~~~-~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~ 375 (468)
++. ..+||||||.|........ +....+..|.|||.+.+-+|+...|+||+||.||||.||+..|..
T Consensus 570 NE~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred ccCcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 875 5789999999976654432 233455679999999999999999999999999999999988753
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=230.13 Aligned_cols=264 Identities=25% Similarity=0.373 Sum_probs=196.5
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec----CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccC
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET 236 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~ 236 (468)
..+.|...++||+|.|++||++.+. ....||+|.+...... ....+|+++|..+ -+.||+++.+++...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p------~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP------SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc------hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 4567889999999999999999843 4678999988765433 4578999999999 699999999999999
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC-CcEEEEe
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR-YRAKVAD 315 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~-~~~kl~D 315 (468)
+...+|+||+++....+++.. ++...+...+..+..||+++|..+ ||||||||.|+|.+.. +.-.|.|
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred CeeEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEe
Confidence 999999999999999888865 778889999999999999999999 9999999999999854 6789999
Q ss_pred cCCcccccCC-------C---------------------------ce---------eeecccccCCccCcccccc-CCCC
Q 012214 316 FGTSKFIAMD-------Q---------------------------TH---------VTTKIQGTFGYLDPEYHQS-SQLT 351 (468)
Q Consensus 316 fGla~~~~~~-------~---------------------------~~---------~~~~~~gt~~y~aPE~~~~-~~~s 351 (468)
||+|...... . .. ......||+||.|||++.. ...+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 9999721100 0 00 0112459999999998876 6788
Q ss_pred CcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh------hccc-----------cchhc--------chH
Q 012214 352 DKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM------RKNR-----------LHDIL--------DDQ 406 (468)
Q Consensus 352 ~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~-----------~~~~~--------d~~ 406 (468)
+++||||.||+++.+++++.||....++......+...+.... ..+. +.+.. ...
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence 9999999999999999999999764443322221111110000 0000 00000 000
Q ss_pred H-------hhh-chHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 407 L-------MKL-GVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 407 l-------~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ... .....+..+.+|+.+|+..||.+|.|+++.++
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0 000 01112336889999999999999999999886
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=246.45 Aligned_cols=253 Identities=29% Similarity=0.387 Sum_probs=199.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.....+|.|.||.||++++. .++..|+|+++....+ ...-...|+-+++..+||||+.++|.+...+..++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d----d~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD----DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc----cccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 367888899999999999999954 6899999998875433 33456689999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
+||||.+|+|.+..+.. .++++.++..+++...+|++|||+.+ =+|||||-.|||+++.|.+|++|||.+-.
T Consensus 90 cMEycgggslQdiy~~T-----gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaq 161 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQ 161 (829)
T ss_pred EEEecCCCcccceeeec-----ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhh
Confidence 99999999999887652 36999999999999999999999999 79999999999999999999999999865
Q ss_pred ccCCCceeeecccccCCccCccccc---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
+..- ........||+.|||||+.. .+.|..++|||++|+...|+---+.|.+. .......+.-..-..+
T Consensus 162 itat-i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd-------lhpmr~l~LmTkS~~q 233 (829)
T KOG0576|consen 162 ITAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD-------LHPMRALFLMTKSGFQ 233 (829)
T ss_pred hhhh-hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc-------cchHHHHHHhhccCCC
Confidence 5321 11234467999999999653 47899999999999999999887777431 1111111111111111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+.+-| .....+.+.++++.|+-.+|.+|||+..++.
T Consensus 234 pp~lkD-------k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PPTLKD-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCcccC-------CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111112 2345668999999999999999999988765
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=261.56 Aligned_cols=194 Identities=20% Similarity=0.204 Sum_probs=136.4
Q ss_pred cCC-CceeeEeeee-------ccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 012214 221 INH-RNVVKLLGCC-------LETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSP 292 (468)
Q Consensus 221 l~h-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 292 (468)
++| +||+++++.+ .+....++++|++ +++|.++|... ...+++.+++.++.||++||+|||+++
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 344 5777777776 2334667888987 56999999642 235899999999999999999999999
Q ss_pred EEecCCCCCCEEEcCC-------------------CcEEEEecCCcccccCCC---------------ceeeecccccCC
Q 012214 293 IYHRDIKSTNILLDQR-------------------YRAKVADFGTSKFIAMDQ---------------THVTTKIQGTFG 338 (468)
Q Consensus 293 iiH~DLkp~NILl~~~-------------------~~~kl~DfGla~~~~~~~---------------~~~~~~~~gt~~ 338 (468)
|+||||||+||||+.. +.+|++|||+++...... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 455666666665321100 000112357888
Q ss_pred ccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHH
Q 012214 339 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMT 418 (468)
Q Consensus 339 y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 418 (468)
|+|||++.+..++.++|||||||+||||++|..|+.. ...... . .... ...+.. ......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~-------~~~~~~---~-~~~~----~~~~~~-----~~~~~~ 240 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE-------KSRTMS---S-LRHR----VLPPQI-----LLNWPK 240 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh-------HHHHHH---H-HHHh----hcChhh-----hhcCHH
Confidence 9999999999999999999999999999998887531 000000 0 0000 011110 111234
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHH
Q 012214 419 FANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 419 l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...++.+||+.+|.+|||+.|+++
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhh
Confidence 568889999999999999999976
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=205.08 Aligned_cols=168 Identities=23% Similarity=0.269 Sum_probs=126.0
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCce
Q 012214 249 GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH 328 (468)
Q Consensus 249 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 328 (468)
|+|.+++..+. .++++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc--
Confidence 68999997532 35999999999999999999999876 999999999999999 99987654322
Q ss_pred eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHh
Q 012214 329 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLM 408 (468)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 408 (468)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..................
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~------- 128 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL----SAILEILLNGMPADDPRD------- 128 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh----cHHHHHHHHHhccCCccc-------
Confidence 25889999999999999999999999999999999999998432111 111111111111110000
Q ss_pred hhchHHHHH--HHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 409 KLGVKNQIM--TFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 409 ~~~~~~~~~--~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
......... .+.+++.+||+.+|.+|||+.|+++.+..+.
T Consensus 129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 001112222 6899999999999999999999999887664
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=211.16 Aligned_cols=249 Identities=20% Similarity=0.312 Sum_probs=180.7
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeee-ccCCcc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCC-LETEVP 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~-~~~~~~ 239 (468)
.+.|.+.+.||+|.||.+-++.++ ..+.+++|.++... ...++|.+|...--.+ .|.||+.-+++. .+.+..
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 467999999999999999999976 57789999877643 3357899998776666 699999887764 556677
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc--CCCcEEEEecC
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD--QRYRAKVADFG 317 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~--~~~~~kl~DfG 317 (468)
++++||++.|+|.+.+... .+.+.....++.|+++|+.|||+++ +||||||.+||||- +...+||+|||
T Consensus 98 vF~qE~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred EEeeccCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecc
Confidence 7899999999999888652 2667778889999999999999999 99999999999994 34589999999
Q ss_pred CcccccCCCceeeecccccCCccCcccccc---C--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHH
Q 012214 318 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQS---S--QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVH 392 (468)
Q Consensus 318 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 392 (468)
+.+..+. . .....-+..|.|||.... + ...+.+|||.||+++|.++||..||..+...+.. ...+..
T Consensus 169 ~t~k~g~---t-V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~----Y~~~~~ 240 (378)
T KOG1345|consen 169 LTRKVGT---T-VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP----YWEWEQ 240 (378)
T ss_pred cccccCc---e-ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch----HHHHHH
Confidence 9864321 1 111224557899996543 2 3466889999999999999999999643222221 111222
Q ss_pred Hhhc--cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 393 SMRK--NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 393 ~~~~--~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+... ..+++.+ ...++.+..+..+-|..+|++|--..++.+
T Consensus 241 w~~rk~~~~P~~F---------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 241 WLKRKNPALPKKF---------NPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred HhcccCccCchhh---------cccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 2211 1122211 122346778888999999999944444433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=205.60 Aligned_cols=262 Identities=23% Similarity=0.253 Sum_probs=194.0
Q ss_pred CCCCCceeeecCcEEEEEEEecCC--cEEEEEecccccchHHHHHHHHHHHHHHHHHhcC----CCceeeEeeee-ccCC
Q 012214 165 HFNANRILGQGGQGTVYKGMLEDG--RIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN----HRNVVKLLGCC-LETE 237 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~----h~niv~l~g~~-~~~~ 237 (468)
+|.+.+.||+|+||.||.+..... ..+|+|......... . ..+..|..++..+. .+++..+++.. ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---P-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---C-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 799999999999999999996543 478888765532221 1 14667888888876 26888899888 4777
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC-----CcEE
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR-----YRAK 312 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~-----~~~k 312 (468)
..++||+.+ |.+|.++..... ...++..+.+.|+.|++.+|.+||+.+ ++||||||.|+++... ..+.
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~ 167 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLY 167 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEE
Confidence 889999988 789999886643 346999999999999999999999999 9999999999999865 4699
Q ss_pred EEecCCcc--cccCCCce----e---eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccch
Q 012214 313 VADFGTSK--FIAMDQTH----V---TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQEN 383 (468)
Q Consensus 313 l~DfGla~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~ 383 (468)
|.|||+++ .+...... . .....||..|+++.+..+...+.+.|+||++.++.|+..|..||........
T Consensus 168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-- 245 (322)
T KOG1164|consen 168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-- 245 (322)
T ss_pred EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--
Confidence 99999998 43222211 1 1235599999999999999999999999999999999999999854221111
Q ss_pred hchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 384 VSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
...+........... .....+..+.++...+-..+..++|....+...|++.....
T Consensus 246 ---~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 246 ---KSKFEKDPRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ---HHHHHHHhhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 111111111111110 11223345666666666689999999999999887765543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=206.74 Aligned_cols=169 Identities=21% Similarity=0.155 Sum_probs=129.6
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEec--CCcEEEEEecccccch-HHHHHHHHHHHHHHHHHhcCCCceee-Eeeeecc
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGMLE--DGRIIAVKKSKLTVDD-EELLKLEEFINEIVILSQINHRNVVK-LLGCCLE 235 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~-l~g~~~~ 235 (468)
....++|.+.+.||+|+||+||+|... +++.+|||++...... ......+.|.+|+.++++++|+|++. +++.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345578999999999999999999864 5778899986532110 01133456899999999999999985 4432
Q ss_pred CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCC-CCCCEEEcCCCcEEEE
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDI-KSTNILLDQRYRAKVA 314 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DL-kp~NILl~~~~~~kl~ 314 (468)
...++||||+++++|.. +.. .. ...++.|+++||.|||+.+ |+|||| ||+|||++.++.+||+
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEE
Confidence 45799999999999962 210 11 1467889999999999999 999999 9999999999999999
Q ss_pred ecCCcccccCCCcee-------eecccccCCccCcccccc
Q 012214 315 DFGTSKFIAMDQTHV-------TTKIQGTFGYLDPEYHQS 347 (468)
Q Consensus 315 DfGla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 347 (468)
|||+|+.+....... .+...++..|+|||.+..
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999998765432111 134568889999998764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=195.53 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=190.4
Q ss_pred CCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeec
Q 012214 167 NANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFI 246 (468)
Q Consensus 167 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 246 (468)
....+|.+.-.|..|+|++. |..+++|++....... ...++|..|.-.++-+.||||+.++|.|.....+.++..||
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~--risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTA--RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhccCCCccccccccc-Ccchhhhhhhhhhcch--hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 34456889999999999986 4556778776532221 23356888888899899999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 012214 247 PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQ 326 (468)
Q Consensus 247 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 326 (468)
+.|||...|++ .....++-.++.+++.+||+|++|||+.. +-|.---|....+++|++.+++|+- +-++ .
T Consensus 270 p~gslynvlhe---~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~k-----f 339 (448)
T KOG0195|consen 270 PFGSLYNVLHE---QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTK-----F 339 (448)
T ss_pred cchHHHHHHhc---CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccce-----e
Confidence 99999999987 33345677889999999999999999987 3355557899999999999888752 1111 1
Q ss_pred ceeeecccccCCccCccccccCCCC---CcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 327 THVTTKIQGTFGYLDPEYHQSSQLT---DKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~s---~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
++......-.+.||+||.+...+-+ .++|+|||++++|||.|...||...... +-. ..+.
T Consensus 340 sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm--ecg---------------mkia 402 (448)
T KOG0195|consen 340 SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM--ECG---------------MKIA 402 (448)
T ss_pred eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch--hhh---------------hhhh
Confidence 2222223346789999999876544 4789999999999999999998532111 000 0111
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
-..++-..++..+..+..|+.-|+..||.+||.+..|+-.|+++.
T Consensus 403 leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 123334446667778999999999999999999999999998875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-21 Score=191.13 Aligned_cols=261 Identities=30% Similarity=0.406 Sum_probs=196.3
Q ss_pred CCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCC-ceeeEeeeeccCCcceeEee
Q 012214 166 FNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR-NVVKLLGCCLETEVPLLVYE 244 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~-niv~l~g~~~~~~~~~lV~E 244 (468)
|...+.||.|+||.||++... ..+++|.+........ .....+.+|+.++..+.|+ +++++.+++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS-KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch-hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 566778999999999999976 7789998876543321 2457799999999999888 79999999977777899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC-cEEEEecCCccccc
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY-RAKVADFGTSKFIA 323 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~-~~kl~DfGla~~~~ 323 (468)
++.++++.+++...... ..++......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.++...
T Consensus 79 ~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred cCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 99999999766553211 25888999999999999999999999 99999999999999998 79999999998654
Q ss_pred CCCce-----eeecccccCCccCcccccc---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 324 MDQTH-----VTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 324 ~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
..... ......||..|+|||.+.+ ...+...|+||+|++++++++|..|+...... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~ 228 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-----SATSQTLKIIL 228 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-----ccHHHHHHHHH
Confidence 43322 2355679999999999987 57888999999999999999999996432211 00111111111
Q ss_pred ccccc---hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 396 KNRLH---DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 396 ~~~~~---~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
..... ....... .......+.+++..|+..+|..|.++.+....
T Consensus 229 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 229 ELPTPSLASPLSPSN----PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred hcCCcccccccCccc----cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11100 0000000 01223467899999999999999999887753
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-22 Score=184.89 Aligned_cols=260 Identities=17% Similarity=0.245 Sum_probs=196.2
Q ss_pred HhcCCCCCceeeecCcEEEEEEE-ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcc
Q 012214 162 ATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~ 239 (468)
..-+|.+.++||+|+||.++.|. +-+++.||||.-...... -++..|....+.| ..++|...+-+..++.+-
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A------PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA------PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccCCc------chHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 34689999999999999999998 557999999976554322 3466788888887 578888888888888888
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC-----CCcEEEE
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ-----RYRAKVA 314 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~-----~~~~kl~ 314 (468)
.||+|++ |-||.+++.-.. ..++..++..||.|++.-++|+|++. +|.|||||+|+||.. ...+.|+
T Consensus 100 iLVidLL-GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEE
Confidence 9999998 779988886522 35999999999999999999999999 999999999999964 3468999
Q ss_pred ecCCcccccCCCcee------eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH
Q 012214 315 DFGTSKFIAMDQTHV------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 315 DfGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~ 388 (468)
|||+|+.+.+..+.. .....||.+||+-....+.+.+.+.|.-|||-+++..+-|..||........ -+
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-----K~ 246 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-----KE 246 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-----HH
Confidence 999999887665543 3346699999999999999999999999999999999999999965322211 11
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
.+...-...+... ......+.++++..-+.-.=..+-.+-|...-+...+..
T Consensus 247 kYeKIGe~Kr~T~------i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 247 KYEKIGETKRSTP------IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred HHHHhccccccCC------HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1111111111111 111123345566666666666677777887776665544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=182.24 Aligned_cols=264 Identities=18% Similarity=0.270 Sum_probs=198.8
Q ss_pred hcCCCCCceeeecCcEEEEEEE-ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCC-CceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH-RNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~ 240 (468)
.+.|.+.++||.|+||.+|.|. ..+|..||||+-...... ..+..|..+...+++ ..|..+..+..+...-.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h------pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH------PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC------cchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 4679999999999999999998 568999999986554322 346678888888864 67777788888889999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC---CcEEEEecC
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR---YRAKVADFG 317 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~---~~~kl~DfG 317 (468)
+||+.+ |.||.+++.-.. ..++..+++-++-|++.-++|+|.++ +|||||||+|+|..-+ ..+.++|||
T Consensus 88 lVMdLL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred eeeecc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEecc
Confidence 999998 789998886422 25889999999999999999999999 9999999999998643 468999999
Q ss_pred CcccccCCCcee------eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHH
Q 012214 318 TSKFIAMDQTHV------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391 (468)
Q Consensus 318 la~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (468)
+|+.+.+..+.. .....||.+|.+--...+...+...|+-|+|.+|...--|..||........ .+.+.
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-----~QKyE 234 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-----KQKYE 234 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-----HHHHH
Confidence 999875543322 3456799999999888888889999999999999999999999964221111 11111
Q ss_pred HHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
. +.+..+. ..........+.++.-.+.-|=..--++-|...-+.+.+.-+....
T Consensus 235 k-I~EkK~s-----~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 235 K-ISEKKMS-----TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred H-HHHhhcC-----CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 1 1110000 0011123344567888888888888888898887777666555443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-23 Score=218.17 Aligned_cols=257 Identities=22% Similarity=0.269 Sum_probs=186.6
Q ss_pred CCCceeeecCcEEEEEEEec-CCcEEEEEecccc--cchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 167 NANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLT--VDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 167 ~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
.....+|.|.+|.|+..... .....+.|..... ....+......+..|+.+-..++|+|++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45677999999988777632 3333444433210 11111122223778888888999999988887777766666669
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++ +|..++... ..++..++..++.|+..|+.|+|+.+ |.|||||++|+++..++.+||+|||.+..+.
T Consensus 401 E~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 999999763 24778888999999999999999999 9999999999999999999999999998765
Q ss_pred CCCc---eeeecccccCCccCccccccCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 324 MDQT---HVTTKIQGTFGYLDPEYHQSSQLTDK-SDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 324 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~k-sDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
.+.. ......+|+..|+|||.+.+..|.+. .||||.|+++..|++|+.||..+....... .......+.
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~~~~ 544 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYSDQR 544 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhcccccc
Confidence 4332 44566789999999999999999874 699999999999999999996533322211 000000000
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..... ........+.....++.+||+.+|.+|.|+.+|++
T Consensus 545 ~~~~~---~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 NIFEG---PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccC---hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000 01112234456788999999999999999999985
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-22 Score=210.06 Aligned_cols=255 Identities=24% Similarity=0.276 Sum_probs=184.2
Q ss_pred CCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEee
Q 012214 165 HFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYE 244 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 244 (468)
++...+.||++.|=+|.+++++.|. |+||++-.....-......+-+.|++ ....+|||.+.+.-+-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5666778999999999999998887 89998866544433333444445555 555699999999888888888899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc--c
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF--I 322 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~--~ 322 (468)
|..+ +|.+.+..+. -+..-+..-|+.|++.||.-+|..+ |+|+|||.+||||+.=.=+.|+||..-+- +
T Consensus 102 yvkh-nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHhh-hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 9866 8888886532 3667778889999999999999999 99999999999999888899999987653 3
Q ss_pred cCCCcee----eecccccCCccCccccccC----------C-CCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhch
Q 012214 323 AMDQTHV----TTKIQGTFGYLDPEYHQSS----------Q-LTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSL 386 (468)
Q Consensus 323 ~~~~~~~----~~~~~gt~~y~aPE~~~~~----------~-~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~ 386 (468)
+.++... -.....-.+|.|||.+... . .+++.||||+||+++||++ |++||.. .++
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L--------SQL 244 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL--------SQL 244 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--------HHH
Confidence 3333322 1122334579999976541 2 6778899999999999999 6777632 111
Q ss_pred HHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 387 AAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 387 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
..+ +.+. ......-+ ..-....+.+++..|++.||++|.++++.++.-.++.
T Consensus 245 ~aY-----r~~~-~~~~e~~L----e~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 245 LAY-----RSGN-ADDPEQLL----EKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred HhH-----hccC-ccCHHHHH----HhCcCccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 111 1110 00000000 1111226889999999999999999999998766654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=178.40 Aligned_cols=175 Identities=13% Similarity=0.143 Sum_probs=134.2
Q ss_pred HHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHH------HHHHHHHHHhcCCCceeeEeeeec
Q 012214 161 KATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEE------FINEIVILSQINHRNVVKLLGCCL 234 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~------~~~Ei~~l~~l~h~niv~l~g~~~ 234 (468)
...++|...+.||.|+||.||.... ++..+|+|.+.......+ ..... +.+|+..+.++.|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~-~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTE-RFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchH-HHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3468999999999999999999655 577899999875443322 22222 679999999999999999988855
Q ss_pred cC--------CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc
Q 012214 235 ET--------EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD 306 (468)
Q Consensus 235 ~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~ 306 (468)
.. ...+++|||++|.+|.++.. ++. ....+++.++..+|+.+ ++|+|++|.||+++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~ 169 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVS 169 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEe
Confidence 32 35789999999999977631 222 24569999999999999 99999999999999
Q ss_pred CCCcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHH
Q 012214 307 QRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELL 367 (468)
Q Consensus 307 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~ 367 (468)
+++ ++|+|||.......+... ..++....+..++|+||||+++.-..
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988 999999987644322111 11333445667999999999887654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-21 Score=192.20 Aligned_cols=234 Identities=24% Similarity=0.413 Sum_probs=171.2
Q ss_pred HHhcCCCceeeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecC
Q 012214 218 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRD 297 (468)
Q Consensus 218 l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~D 297 (468)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....+++.-...++.+|+.||+|||.-.- ..|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i--~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHNSPI--GYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhcCcc--eeeee
Confidence 3568899999999999999999999999999999999976 22358899999999999999999998661 39999
Q ss_pred CCCCCEEEcCCCcEEEEecCCcccccC-CCceeeecccccCCccCccccccC-------CCCCcccHHHHHHHHHHHHhC
Q 012214 298 IKSTNILLDQRYRAKVADFGTSKFIAM-DQTHVTTKIQGTFGYLDPEYHQSS-------QLTDKSDVYSFGVVLVELLTG 369 (468)
Q Consensus 298 Lkp~NILl~~~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDVwSlGvll~el~tG 369 (468)
|++.|+++|....+||+|||+...... ..........-..-|.|||.+.+. ..+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 999999999999999999999876542 111111222345679999988763 146679999999999999999
Q ss_pred CCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 370 KKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 370 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
+.||......... ......+.........+.+... . +..+.+..++..||..+|++||++.++-..++.+..
T Consensus 155 ~~~~~~~~~~~~~-~eii~~~~~~~~~~~rP~i~~~-----~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDP-DEIILRVKKGGSNPFRPSIELL-----N--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCCh-HHHHHHHHhcCCCCcCcchhhh-----h--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999653322222 1111111110111111111111 0 333478999999999999999999999999999888
Q ss_pred CCchhhhHHHHHHhhh
Q 012214 450 SSKKKRAMFSKIIKRL 465 (468)
Q Consensus 450 ~~~~~~~~~~~~~~~~ 465 (468)
..+......+.|.+++
T Consensus 227 ~~~~~~nl~D~m~~~l 242 (484)
T KOG1023|consen 227 GGSSKGNLMDSLFRML 242 (484)
T ss_pred cccccchhHHHHHHHH
Confidence 7653334555555544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-21 Score=173.73 Aligned_cols=143 Identities=18% Similarity=0.147 Sum_probs=107.4
Q ss_pred CceeeecCcEEEEEEEecCCcEEEEEecccccchHHH--------H--------------HHHHHHHHHHHHHhcCCCce
Q 012214 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEEL--------L--------------KLEEFINEIVILSQINHRNV 226 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~--------~--------------~~~~~~~Ei~~l~~l~h~ni 226 (468)
...||+|++|.||+|...+|+.||||+++........ . .......|+..+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3569999999999999878999999998654211000 0 01122458999999987776
Q ss_pred eeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCEEecCCCCCCEEE
Q 012214 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL-HSATSSPIYHRDIKSTNILL 305 (468)
Q Consensus 227 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~iiH~DLkp~NILl 305 (468)
........ ...++||||++++++....... .+++...+..++.|++.+|.++ |+.+ |+||||||+|||+
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 43332221 2348999999887766543221 2588899999999999999999 6888 9999999999999
Q ss_pred cCCCcEEEEecCCcccc
Q 012214 306 DQRYRAKVADFGTSKFI 322 (468)
Q Consensus 306 ~~~~~~kl~DfGla~~~ 322 (468)
+ ++.++|+|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 478999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-20 Score=168.49 Aligned_cols=145 Identities=22% Similarity=0.189 Sum_probs=110.8
Q ss_pred CceeeecCcEEEEEEEecCCcEEEEEecccccchH----------------------HHHHHHHHHHHHHHHHhcCCCce
Q 012214 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDE----------------------ELLKLEEFINEIVILSQINHRNV 226 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~----------------------~~~~~~~~~~Ei~~l~~l~h~ni 226 (468)
...||+|++|.||+|...+|+.||||++....... .......+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999997789999999987542110 00011234578999999999987
Q ss_pred eeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEecCCCCCCEEE
Q 012214 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS-ATSSPIYHRDIKSTNILL 305 (468)
Q Consensus 227 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLkp~NILl 305 (468)
.....+... ..++||||++++++....... ..++......++.|++.++.++|+ .+ |+||||||+|||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 554443322 248999999887654432221 246788899999999999999999 88 9999999999999
Q ss_pred cCCCcEEEEecCCcccccC
Q 012214 306 DQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 306 ~~~~~~kl~DfGla~~~~~ 324 (468)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 88999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=179.10 Aligned_cols=236 Identities=22% Similarity=0.255 Sum_probs=149.9
Q ss_pred CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCC----------CceeeEeeeec
Q 012214 166 FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH----------RNVVKLLGCCL 234 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h----------~niv~l~g~~~ 234 (468)
+...+.||.|+++.||.+++. +++.+|+|+..... .......+++.+|.-....+.+ -.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 344677999999999999976 58999999876554 3333456777777655554322 22222222221
Q ss_pred c---------C---C-----cceeEeeecCCCChhhHhhh---cccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEE
Q 012214 235 E---------T---E-----VPLLVYEFIPNGTLYQHLHD---RHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIY 294 (468)
Q Consensus 235 ~---------~---~-----~~~lV~E~~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ii 294 (468)
- . . ..+++|+-+ .++|.+++.. .... ...+....++.+..|+++.+++||+.+ ++
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 0 0 1 235678777 4688877543 2211 223455566788899999999999999 99
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCcccccCCCceeeecccccCCccCcccccc--------CCCCCcccHHHHHHHHHHH
Q 012214 295 HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS--------SQLTDKSDVYSFGVVLVEL 366 (468)
Q Consensus 295 H~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwSlGvll~el 366 (468)
|+||+|+|++++++|.++|+||+....... .... ...+..|.+||.... -.++.+.|.|+||+++|.|
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGT--RYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTE--EEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCc--eeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999987754332 1111 345678999996644 2578899999999999999
Q ss_pred HhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCC
Q 012214 367 LTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKR 434 (468)
Q Consensus 367 ~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~R 434 (468)
++|..||........... .-..+. +.++.+..||..+|+.||++|
T Consensus 244 WC~~lPf~~~~~~~~~~~----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW----------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG----------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc----------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999854211111000 111223 777889999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=162.79 Aligned_cols=189 Identities=15% Similarity=0.067 Sum_probs=138.1
Q ss_pred CCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccCCcceeEeee
Q 012214 167 NANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLLVYEF 245 (468)
Q Consensus 167 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~ 245 (468)
.+...|++|+||+||.+.. .+.+++.+.+.............-|.+|++++++++ |+++.+++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3456799999999997766 577788777665433211112235789999999994 5889999886 346899999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCC-CCCCEEEcCCCcEEEEecCCcccccC
Q 012214 246 IPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDI-KSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 246 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DL-kp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
+.|.+|...+.. ....++.|++.+|.++|+.+ |+|||| ||.|||++.++.++|+|||+|.....
T Consensus 80 I~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPPR------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhhh------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999888643311 11347789999999999999 999999 79999999999999999999985543
Q ss_pred CCce----e--------eecccccCCccCcccccc-CCCC-CcccHHHHHHHHHHHHhCCCCCCC
Q 012214 325 DQTH----V--------TTKIQGTFGYLDPEYHQS-SQLT-DKSDVYSFGVVLVELLTGKKPIFW 375 (468)
Q Consensus 325 ~~~~----~--------~~~~~gt~~y~aPE~~~~-~~~s-~ksDVwSlGvll~el~tG~~p~~~ 375 (468)
.... . ..-...++.|++|+...- ...+ ...+.++-|+-+|.++|++.+...
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 2210 0 001225677788874332 1223 466999999999999999988654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4e-20 Score=176.32 Aligned_cols=256 Identities=22% Similarity=0.303 Sum_probs=172.4
Q ss_pred hcCCCCCceeeecCcEEEEEEEecC-Cc-----------------------------------EEEEEeccccc-chHHH
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLED-GR-----------------------------------IIAVKKSKLTV-DDEEL 205 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~-----------------------------------~vavK~l~~~~-~~~~~ 205 (468)
.++|.+.+.||+|....||.++..+ |. +.|||++-.-. ...+.
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 3568999999999999999987532 10 24667553321 22222
Q ss_pred HHHHHHHHHHH------HH--------H-------h-cCCCceeeEeeeecc---------------------------C
Q 012214 206 LKLEEFINEIV------IL--------S-------Q-INHRNVVKLLGCCLE---------------------------T 236 (468)
Q Consensus 206 ~~~~~~~~Ei~------~l--------~-------~-l~h~niv~l~g~~~~---------------------------~ 236 (468)
.-++...+|.. ++ + + -.|||||++.++|.+ .
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 22333444421 11 1 1 259999999988753 2
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc--CC--CcEE
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD--QR--YRAK 312 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~--~~--~~~k 312 (468)
...|+||...+. +|..++-.+ ..+.....-|+.|+++|+.|||.++ |.|||+|.+|||+. +| ..+.
T Consensus 316 ~tlylvMkrY~~-tLr~yl~~~------~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LV 385 (598)
T KOG4158|consen 316 KTLYLVMKRYRQ-TLREYLWTR------HRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLV 385 (598)
T ss_pred ceEEEehhcchh-hHHHHHhcC------CCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEE
Confidence 345788887754 899998653 2556677789999999999999999 99999999999993 44 3578
Q ss_pred EEecCCcccccCC-----CceeeecccccCCccCccccccCC------CCCcccHHHHHHHHHHHHhCCCCCCCCCCCcc
Q 012214 313 VADFGTSKFIAMD-----QTHVTTKIQGTFGYLDPEYHQSSQ------LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381 (468)
Q Consensus 313 l~DfGla~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~ 381 (468)
|+|||.+-....- ........-|...-||||....-+ --.|+|.|+.|.+.||+++...||+..+....
T Consensus 386 vaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L 465 (598)
T KOG4158|consen 386 VADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL 465 (598)
T ss_pred EcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee
Confidence 9999987432210 001111234777899999876422 13589999999999999999999976333222
Q ss_pred chhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 382 ENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
+... +++.+++.+ +..+++.+.+|+...|+.||++|++..-....|+
T Consensus 466 ~~r~--------Yqe~qLPal---------p~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 466 DTRT--------YQESQLPAL---------PSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred chhh--------hhhhhCCCC---------cccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 2111 223333332 2345557899999999999999999876665553
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-20 Score=189.49 Aligned_cols=233 Identities=27% Similarity=0.266 Sum_probs=180.3
Q ss_pred eeecCcEEEEEEE----ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccCCcceeEeeec
Q 012214 172 LGQGGQGTVYKGM----LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLLVYEFI 246 (468)
Q Consensus 172 LG~G~fG~Vy~~~----~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~ 246 (468)
+|+|.||.|+++. .+.|..+|.|+++....... .......|..++...+ ||.+|++.-.+..+...++++++.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~--~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVR--DRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccc--cccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 7999999999875 33477788887765332211 1114556778888886 999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 012214 247 PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQ 326 (468)
Q Consensus 247 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 326 (468)
.+|.|...+.... .+.+.........++-+++++|+.+ |+|||+|++||+++.+|.+++.|||+++..-..+
T Consensus 80 rgg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 80 RGGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred ccchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 9999887775422 3667777778889999999999999 9999999999999999999999999998664433
Q ss_pred ceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchH
Q 012214 327 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQ 406 (468)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 406 (468)
.. +||..|||||.+. .....+|.||||++.+||+||..||.. ... ..++.
T Consensus 152 ~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~---------~~Il~-- 201 (612)
T KOG0603|consen 152 IA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTM---------KRILK-- 201 (612)
T ss_pred hc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHH---------HHHhh--
Confidence 22 7999999999998 567899999999999999999999842 000 11111
Q ss_pred HhhhchHHHHHHHHHHHHHhhccCCCCCCCH--HHHHHHH
Q 012214 407 LMKLGVKNQIMTFANLAKRCLDLNGKKRPTM--EEVSMEL 444 (468)
Q Consensus 407 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~--~evl~~L 444 (468)
.....+........+++..++..+|..|.-. ..+.+.+
T Consensus 202 ~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 202 AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 1122355566678899999999999999865 3444433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-19 Score=192.22 Aligned_cols=201 Identities=20% Similarity=0.289 Sum_probs=159.5
Q ss_pred HHHHHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC---CCceeeEeeee
Q 012214 157 KELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN---HRNVVKLLGCC 233 (468)
Q Consensus 157 ~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~ 233 (468)
.+.+.....|.+.+.||+|+||+||.|...+|+.||+|+-+..... +|.--.+++.+|+ -+.|..+..++
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-------EfYI~~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-------EFYICLQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-------eeeehHHHHHhhchhhhcchHHHHHHH
Confidence 3445566789999999999999999999888999999987765443 2222233444444 23344444455
Q ss_pred ccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc-------
Q 012214 234 LETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD------- 306 (468)
Q Consensus 234 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~------- 306 (468)
.-.+..+||+||.+.|+|.++++. ...++|.....++.|++..+..||..+ |||+||||+|+||.
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~ 835 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADS 835 (974)
T ss_pred ccCCcceeeeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCC
Confidence 566778999999999999999973 235899999999999999999999999 99999999999994
Q ss_pred CCCcEEEEecCCcccccC-CCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCC
Q 012214 307 QRYRAKVADFGTSKFIAM-DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372 (468)
Q Consensus 307 ~~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p 372 (468)
++..++|+|||-+..+.. .+...-...++|-.+-.+|+..|.+++..+|.|.++.+++-|+.|+..
T Consensus 836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 345799999999865432 122334556789999999999999999999999999999999998754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=158.08 Aligned_cols=136 Identities=17% Similarity=0.164 Sum_probs=103.6
Q ss_pred CCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-----CCCceeeEeeeeccCC---c
Q 012214 167 NANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-----NHRNVVKLLGCCLETE---V 238 (468)
Q Consensus 167 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-----~h~niv~l~g~~~~~~---~ 238 (468)
...+.||+|+||.||. ++.....+||+...... ...+.+.+|+.+++.+ +||||++++|++.++. .
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 3456799999999996 44333347898765322 2335789999999999 5799999999998764 3
Q ss_pred -ceeEeee--cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCEEecCCCCCCEEEcC----CCc
Q 012214 239 -PLLVYEF--IPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL-AYLHSATSSPIYHRDIKSTNILLDQ----RYR 310 (468)
Q Consensus 239 -~~lV~E~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL-~yLH~~~~~~iiH~DLkp~NILl~~----~~~ 310 (468)
..+|+|| +.+++|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~ 147 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVI 147 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCc
Confidence 2378999 5579999999652 24444 35678888777 9999999 999999999999974 348
Q ss_pred EEEEecCCc
Q 012214 311 AKVADFGTS 319 (468)
Q Consensus 311 ~kl~DfGla 319 (468)
++|+||+.+
T Consensus 148 ~~LiDg~G~ 156 (210)
T PRK10345 148 PVVCDNIGE 156 (210)
T ss_pred EEEEECCCC
Confidence 999995433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.9e-18 Score=155.20 Aligned_cols=138 Identities=22% Similarity=0.337 Sum_probs=113.5
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEecccccch----HHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeee
Q 012214 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDD----EELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEF 245 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~----~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 245 (468)
+.||+|++|.||+|.. +|..+++|+....... ........+.+|+.++..+.|+++.....++.+....+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5699999999999987 5778999976532211 1112235688999999999999988777777777788999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 246 IPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 246 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
+++++|.+++... .+ .+..++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988541 12 77889999999999999999 99999999999999 78999999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=3e-17 Score=150.60 Aligned_cols=148 Identities=21% Similarity=0.199 Sum_probs=111.7
Q ss_pred HHHHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHH------------------HHHHHHHHHHHHHHH
Q 012214 158 ELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEE------------------LLKLEEFINEIVILS 219 (468)
Q Consensus 158 ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~------------------~~~~~~~~~Ei~~l~ 219 (468)
++......|.+.+.||+|+||.||++..++|+.||||+......... ......+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 34444445777889999999999999988899999998654321100 001123677888899
Q ss_pred hcCCC--ceeeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecC
Q 012214 220 QINHR--NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRD 297 (468)
Q Consensus 220 ~l~h~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~D 297 (468)
.+.|+ .+...++. ...++||||+++++|...... .....++.+++.++.++|+.+ ++|+|
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~D 150 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGD 150 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence 88777 44444442 345899999999988665421 234578899999999999998 99999
Q ss_pred CCCCCEEEcCCCcEEEEecCCccccc
Q 012214 298 IKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 298 Lkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
|+|.||++++++.++|+|||++....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.3e-19 Score=175.17 Aligned_cols=173 Identities=24% Similarity=0.360 Sum_probs=131.4
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG 317 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfG 317 (468)
.+++.|++|...+|.++|..+.... ..++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e--~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGE--ERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCccc--ccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 5789999999999999998655443 36778889999999999999 66 8999999999999999999999999
Q ss_pred CcccccCCC-----ceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHH
Q 012214 318 TSKFIAMDQ-----THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFV 391 (468)
Q Consensus 318 la~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~ 391 (468)
+........ ....+...||..||+||.+.+..|+.|+||||||++|+|++. =..++. .....
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------------r~~t~ 469 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------------RIATL 469 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------------HHHhh
Confidence 987765544 223556679999999999999999999999999999999987 222210 01111
Q ss_pred HHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 012214 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439 (468)
Q Consensus 392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e 439 (468)
..++.+.++. ......+ .-..|+.+++.+.|.+||++.+
T Consensus 470 ~d~r~g~ip~----~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 470 TDIRDGIIPP----EFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hhhhcCCCCh----HHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 2223333331 1111111 3457999999999999994443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.3e-17 Score=153.27 Aligned_cols=147 Identities=18% Similarity=0.140 Sum_probs=110.7
Q ss_pred cCCCCCceeeecCcEEEEEEE--ecCCcEEEEEecccccchH-------------------H-HHHHHHHHHHHHHHHhc
Q 012214 164 NHFNANRILGQGGQGTVYKGM--LEDGRIIAVKKSKLTVDDE-------------------E-LLKLEEFINEIVILSQI 221 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~--~~~g~~vavK~l~~~~~~~-------------------~-~~~~~~~~~Ei~~l~~l 221 (468)
..|.+.+.||+|++|.||+|. ..+|+.||+|++....... . ......+..|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357788899999999999998 5689999999886532100 0 00112356899999999
Q ss_pred CCC--ceeeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCC
Q 012214 222 NHR--NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIK 299 (468)
Q Consensus 222 ~h~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLk 299 (468)
.+. .+.++++. ...++||||+++.+|....... ..+.......++.||+.++.+||+.+. ++|+|||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dik 176 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLS 176 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCC
Confidence 753 34444443 2358999999998886654221 235556678899999999999999874 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCcccc
Q 012214 300 STNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 300 p~NILl~~~~~~kl~DfGla~~~ 322 (468)
|+||+++ ++.++|+|||.+...
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999 889999999998643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.4e-17 Score=148.85 Aligned_cols=134 Identities=22% Similarity=0.349 Sum_probs=106.8
Q ss_pred eeeecCcEEEEEEEecCCcEEEEEecccccc-h---HHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeec
Q 012214 171 ILGQGGQGTVYKGMLEDGRIIAVKKSKLTVD-D---EELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFI 246 (468)
Q Consensus 171 ~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~-~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 246 (468)
.||+|++|.||+|.. ++..+++|....... . ......+.+.+|+.++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 578899998543221 1 11223467889999999998887655555555666779999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 247 PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 247 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
++++|.+.+.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875411 0 78999999999999999 99999999999999 88999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.6e-17 Score=170.88 Aligned_cols=141 Identities=23% Similarity=0.322 Sum_probs=112.2
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEec-ccccch---HHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKS-KLTVDD---EELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l-~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
...|...+.||+|+||.||++...+.. +++|+. ...... ......+.+.+|+.++..++|++++....++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344567889999999999999875443 444432 211111 111234578899999999999999988877777778
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|+|||+
T Consensus 411 ~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence 899999999999998885 24578999999999999999 9999999999999 678999999999
Q ss_pred ccc
Q 012214 319 SKF 321 (468)
Q Consensus 319 a~~ 321 (468)
++.
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.8e-16 Score=166.30 Aligned_cols=213 Identities=27% Similarity=0.345 Sum_probs=144.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEecC-CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|..++.|..|++|.||..+++. .+.+|.|+=+.+ . +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------l----ilRn--ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------L----ILRN--ILTFAGNPFVV-------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc------h----hhhc--cccccCCccee--------------
Confidence 4689999999999999999998763 567787532211 0 1110 22323344333
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
|+-...++.. .+++.+ ++.+++|||+.+ |+|||+||+|.+|+.-|.+|++|||+++.
T Consensus 136 -------gDc~tllk~~-----g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 -------GDCATLLKNI-----GPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred -------chhhhhcccC-----CCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhh
Confidence 3333333321 134432 278999999999 99999999999999999999999999875
Q ss_pred ccCCCc--------------eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchH
Q 012214 322 IAMDQT--------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLA 387 (468)
Q Consensus 322 ~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~ 387 (468)
.....+ .....++||+.|.|||++....|...+|+|++|+++||.+-|..||+. +.+++
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG--dtpee----- 265 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG--DTPEE----- 265 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC--CCHHH-----
Confidence 432211 123456899999999999999999999999999999999999999864 22221
Q ss_pred HHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 012214 388 AYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ev 440 (468)
.+...+.+. ....+.....+.+..+++.++|+.+|..|--....
T Consensus 266 -lfg~visd~--------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 266 -LFGQVISDD--------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred -HHhhhhhhh--------ccccccCcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence 121221111 00111122344578999999999999999844433
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-15 Score=137.60 Aligned_cols=138 Identities=23% Similarity=0.238 Sum_probs=98.0
Q ss_pred CceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHH---------------------HHHHHHHHHHhcCCC--c
Q 012214 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLE---------------------EFINEIVILSQINHR--N 225 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~---------------------~~~~Ei~~l~~l~h~--n 225 (468)
.+.||+|+||.||++...+++.||||+......... .... ....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFK-KRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchh-hhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999988899999998765322110 0000 113455666666433 3
Q ss_pred eeeEeeeeccCCcceeEeeecCCCChhhH-hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEecCCCCCCE
Q 012214 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQH-LHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS-ATSSPIYHRDIKSTNI 303 (468)
Q Consensus 226 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLkp~NI 303 (468)
+.+.+++ ...++||||++++++... +.... .. .....++.+++.++.++|+ .+ |+|+||||+||
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Ni 146 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNI 146 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhE
Confidence 4444443 245899999998654321 21100 11 5677899999999999999 88 99999999999
Q ss_pred EEcCCCcEEEEecCCcccc
Q 012214 304 LLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 304 Ll~~~~~~kl~DfGla~~~ 322 (468)
+++ ++.++|+|||.+...
T Consensus 147 li~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EEE-CCcEEEEECcccccc
Confidence 999 899999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=6e-15 Score=127.98 Aligned_cols=135 Identities=24% Similarity=0.233 Sum_probs=111.8
Q ss_pred CCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCC--CceeeEeeeeccCCcceeEeee
Q 012214 168 ANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH--RNVVKLLGCCLETEVPLLVYEF 245 (468)
Q Consensus 168 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~~~~~lV~E~ 245 (468)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++.+++++....+..++++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 35679999999999999854 7899998765322 3467889999999976 5899999988887889999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 246 IPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 246 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
++++++..+ +......++.++++++++||......++|+|++|+||++++.+.+++.|||.+..
T Consensus 75 ~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 988766433 4456677899999999999996444599999999999999999999999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1e-16 Score=168.93 Aligned_cols=258 Identities=21% Similarity=0.283 Sum_probs=185.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEecC--CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccCCcc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLED--GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVP 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~ 239 (468)
...|.+.+.||+|+|+.|-...... ...+|+|...... ......+....|..+-..+. |+|++++++...+.+..
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 4567788889999999998877532 3456666555432 11123344455777777776 99999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCEEecCCCCCCEEEcCCC-cEEEEecC
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH-SATSSPIYHRDIKSTNILLDQRY-RAKVADFG 317 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~iiH~DLkp~NILl~~~~-~~kl~DfG 317 (468)
++..++..++++.+.+.. ......+.......+.|+..++.|+| ..+ +.|+|+||+|.+++..+ ..+++|||
T Consensus 97 ~~~~~~s~g~~~f~~i~~---~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~ 170 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISH---PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFG 170 (601)
T ss_pred ccccCccccccccccccc---CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCch
Confidence 999999999999888832 11112455566778999999999999 777 99999999999999999 99999999
Q ss_pred CcccccC-C-Cceeeecccc-cCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH
Q 012214 318 TSKFIAM-D-QTHVTTKIQG-TFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 318 la~~~~~-~-~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
+|..+.. . ........+| ++.|+|||...+. -.....|+||.|+++.-+++|..|+......... +..+
T Consensus 171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-------~~~~ 243 (601)
T KOG0590|consen 171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-------YSSW 243 (601)
T ss_pred hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-------ceee
Confidence 9987765 2 2333444567 9999999998884 4456789999999999999999998653222211 1111
Q ss_pred hhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 394 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...... ..............+++.+++..+|+.|.+.+++..
T Consensus 244 ~~~~~~-------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 244 KSNKGR-------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccc-------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 111000 000011122235678899999999999999888753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.9e-14 Score=135.66 Aligned_cols=138 Identities=22% Similarity=0.304 Sum_probs=104.2
Q ss_pred ceee-ecCcEEEEEEEecCCcEEEEEecccccc-----hH----HHHHHHHHHHHHHHHHhcCCCce--eeEeeeeccCC
Q 012214 170 RILG-QGGQGTVYKGMLEDGRIIAVKKSKLTVD-----DE----ELLKLEEFINEIVILSQINHRNV--VKLLGCCLETE 237 (468)
Q Consensus 170 ~~LG-~G~fG~Vy~~~~~~g~~vavK~l~~~~~-----~~----~~~~~~~~~~Ei~~l~~l~h~ni--v~l~g~~~~~~ 237 (468)
..|| .||.|+||.+... +..+++|....... .. .......+.+|+.++..++|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4588 8999999999875 67789987743210 00 01223567889999999988775 66777644322
Q ss_pred ----cceeEeeecCC-CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEE
Q 012214 238 ----VPLLVYEFIPN-GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAK 312 (468)
Q Consensus 238 ----~~~lV~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~k 312 (468)
..++|+|++++ .+|.+++... +++.. .+.+|+.+|.+||+.+ |+|+||||.|||++.++.++
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 23599999997 6888887541 24443 3578999999999999 99999999999999999999
Q ss_pred EEecCCccc
Q 012214 313 VADFGTSKF 321 (468)
Q Consensus 313 l~DfGla~~ 321 (468)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.7e-14 Score=133.87 Aligned_cols=204 Identities=20% Similarity=0.298 Sum_probs=140.8
Q ss_pred HHHHhcCCCceeeEeeeeccCC-----cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 012214 216 VILSQINHRNVVKLLGCCLETE-----VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290 (468)
Q Consensus 216 ~~l~~l~h~niv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~ 290 (468)
.-+-++.|.|||+++.++.+.. ...++.|||..|++..+|++..... ..+......+|+.||..||.|||+..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 3455667999999999886533 4678999999999999998755333 35777778899999999999999976
Q ss_pred CCEEecCCCCCCEEEcCCCcEEEEecCCcccccC----CCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHH
Q 012214 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM----DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVEL 366 (468)
Q Consensus 291 ~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el 366 (468)
|+|+|+++.-+.|++..++-+|++-- ....... ..........+-++|.+||+=.....+..+|||+||+..+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 88999999999999999998887531 1111100 001112223467899999987777778899999999999999
Q ss_pred HhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 367 LTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 367 ~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
.-+..-.....+......... ..+..+-+. .=+.++.+|++..|..||+|.+++..
T Consensus 276 ailEiq~tnseS~~~~ee~ia---------~~i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIA---------NVIIGLENG------------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCCcceeehhhhhh---------hheeeccCc------------cccCcCcccccCCCCCCcchhhhhcC
Confidence 887654211111000000000 000000000 12357889999999999999998754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.6e-13 Score=135.82 Aligned_cols=145 Identities=19% Similarity=0.205 Sum_probs=101.4
Q ss_pred CceeeecCcEEEEEEEecCCcEEEEEecccccchHHHH------------------------------------HHHHHH
Q 012214 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELL------------------------------------KLEEFI 212 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~------------------------------------~~~~~~ 212 (468)
.+.||.|++|.||+|++++|+.||||+.+......-.. ..-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986532111000 001355
Q ss_pred HHHHHHHhcC----CCceeeEeeeec-cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 012214 213 NEIVILSQIN----HRNVVKLLGCCL-ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG-ALAYLH 286 (468)
Q Consensus 213 ~Ei~~l~~l~----h~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~-gL~yLH 286 (468)
+|+..+.++. |.+-+.+-.++. .....+|||||++|++|.+....... ..+ ...++.+++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CCC---HHHHHHHHHHHHHHHHH
Confidence 6666665552 322233333332 24457999999999999887653211 122 3456666665 467899
Q ss_pred hCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 287 ~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
..+ ++|+|++|.||++++++.+++.|||++..++
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 988 9999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.1e-13 Score=139.97 Aligned_cols=249 Identities=22% Similarity=0.238 Sum_probs=180.8
Q ss_pred cCCCCCceeee--cCcEEEEEEEe---cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCC
Q 012214 164 NHFNANRILGQ--GGQGTVYKGML---EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETE 237 (468)
Q Consensus 164 ~~f~~~~~LG~--G~fG~Vy~~~~---~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~ 237 (468)
..|.+.+.+|. |.+|.||.+.. .++..+|+|+-+...... .....-++|+.....+ .|+|.++....+.+.+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p--~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP--LDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc--cccccccchhhcccccCccccccccCcccccCC
Confidence 44667778999 99999999986 368889999855433321 1112334666666667 5999999999999999
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCEEecCCCCCCEEEcCC-CcEE
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG----ALAYLHSATSSPIYHRDIKSTNILLDQR-YRAK 312 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~----gL~yLH~~~~~~iiH~DLkp~NILl~~~-~~~k 312 (468)
..++-+|++. .+|..+...... .++...++.+..+..+ |+.++|+.+ ++|-|+||.||+..++ ...+
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred cceeeecccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceee
Confidence 9999999985 688777765332 3666777888888888 999999999 9999999999999999 8999
Q ss_pred EEecCCcccccCCCce----eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH
Q 012214 313 VADFGTSKFIAMDQTH----VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 313 l~DfGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~ 388 (468)
++|||+...+....-. ......|...|++||...+ -++.++|+||+|.++.+..++..+.....
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~----------- 331 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK----------- 331 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC-----------
Confidence 9999999887654421 1233367889999998765 57889999999999999999877643210
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVS 441 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 441 (468)
+..|....... +..+.......++..++..|++.+|-.|++.+.+.
T Consensus 332 -~~~W~~~r~~~------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 332 -NSSWSQLRQGY------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred -CCCcccccccc------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 00111111110 11112222333566699999999999999987765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.1e-11 Score=126.95 Aligned_cols=245 Identities=18% Similarity=0.189 Sum_probs=161.0
Q ss_pred ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCC
Q 012214 185 LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEF 264 (468)
Q Consensus 185 ~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~ 264 (468)
..++..|.|...+.... .......+-+..++.++||||+++++...+....|+|+|-+. .|..++.+
T Consensus 34 k~~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------- 100 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------- 100 (690)
T ss_pred eccCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------
Confidence 34677888887765432 122345567788999999999999999999999999999874 78888876
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCceeeecccccCCccCccc
Q 012214 265 PLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 344 (468)
Q Consensus 265 ~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~ 344 (468)
++.......+.||+.||.|||+.+. ++|++|..+.|+|+..|..||++|-++.....-.. .......-..|..|+.
T Consensus 101 -l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 101 -LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEE 176 (690)
T ss_pred -hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhh
Confidence 3345566778999999999987654 99999999999999999999999988754332211 1111112234666665
Q ss_pred cccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchh---chHHHHHHHhhccccchhcchHHhhhchHHHHHHHHH
Q 012214 345 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENV---SLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFAN 421 (468)
Q Consensus 345 ~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 421 (468)
+.... -..|.|-||++++|++.|..+-. ........ .....+.+..... +...+ ..+.
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng~~~~~--~~~~~~~~ipk~~~~~~~k~~~~~--------------~~~r~-n~~~ 237 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNGSLLTK--TDLSNTGKIPKALIELYCKKLGAT--------------ELKRP-NKLR 237 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCcccCcc--hhhhccCccchhHHHHHHHHhccc--------------ccccc-chhh
Confidence 44332 45699999999999999933211 00000000 0111110111000 01111 1567
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHhcccCCchhh-hHHHHHHhhh
Q 012214 422 LAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKR-AMFSKIIKRL 465 (468)
Q Consensus 422 li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~-~~~~~~~~~~ 465 (468)
++..|....+--|=..-++...|++++-.+.-.. ..+..+++++
T Consensus 238 ~~~~~~~~~gff~n~fvd~~~fLeel~lks~~eK~~Ff~~L~~~l 282 (690)
T KOG1243|consen 238 FILECRLLGGFFRNDFVDTLLFLEELRLKSVEEKQKFFSGLIDRL 282 (690)
T ss_pred HHHHHHhccccccchHHHHHHHHHhcccCcHHHHHHHHHHHHHHH
Confidence 8888888888888888999999998886654332 3334444433
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.31 E-value=9.3e-12 Score=129.10 Aligned_cols=149 Identities=17% Similarity=0.168 Sum_probs=96.2
Q ss_pred cCCCCCceeeecCcEEEEEEEecC-CcEEEEEecccccchH---H-----------------------HHHH--------
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDE---E-----------------------LLKL-------- 208 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~---~-----------------------~~~~-------- 208 (468)
..|+. +.||+|++|.||+|++++ |+.||||+.+...... + ....
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 689999999999999887 9999999987532110 0 0000
Q ss_pred --HHHHHHHHHHHhc----CCCceeeEeeeecc-CCcceeEeeecCCCChhhHh--hhcccCCCCCCCHHHHHHHHHHHH
Q 012214 209 --EEFINEIVILSQI----NHRNVVKLLGCCLE-TEVPLLVYEFIPNGTLYQHL--HDRHQNEEFPLTWEMRLRIATEVA 279 (468)
Q Consensus 209 --~~~~~Ei~~l~~l----~h~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~~~~~l~~~~~~~i~~qia 279 (468)
-+|.+|+..+.++ .+.+.+.+-.++.+ ....+|||||++|+++.+.- .... .....+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CCHHHHHHHHHHHHHHHH-
Confidence 1244555555444 24444444344433 45678999999999997742 2211 000113333333333443
Q ss_pred HHHHHHHhCCCCCEEecCCCCCCEEEcCCC----cEEEEecCCcccccC
Q 012214 280 GALAYLHSATSSPIYHRDIKSTNILLDQRY----RAKVADFGTSKFIAM 324 (468)
Q Consensus 280 ~gL~yLH~~~~~~iiH~DLkp~NILl~~~~----~~kl~DfGla~~~~~ 324 (468)
...+ ++|+|++|.||+++.++ .+++.|||++..++.
T Consensus 277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4567 99999999999999988 999999999977654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.6e-11 Score=107.99 Aligned_cols=129 Identities=22% Similarity=0.180 Sum_probs=94.1
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCcee-eEeeeeccCCcceeEeeecCC
Q 012214 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVV-KLLGCCLETEVPLLVYEFIPN 248 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~g~~~~~~~~~lV~E~~~~ 248 (468)
+.|+.|.++.||++... +..+++|....... ....+..|+.++..+.+.+++ +++.+.. ...++|||++++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence 56899999999999875 77899998654321 112356788888888654443 4555433 345899999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 249 GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT--SSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 249 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
.++... . . ....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 76 ~~l~~~--~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 76 SELLTE--D--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred Cccccc--c--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 877543 0 0 11245689999999999987 23359999999999999 6689999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.3e-10 Score=108.29 Aligned_cols=271 Identities=16% Similarity=0.169 Sum_probs=163.8
Q ss_pred CCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeee----e---ccCCc
Q 012214 167 NANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGC----C---LETEV 238 (468)
Q Consensus 167 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~----~---~~~~~ 238 (468)
...+.||+|+.+.+|..-.-.+ -+.|+......... . ..+..|... .||-+-.=+.+ . .....
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~----a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQ----A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchhhc--hhheeecCCCchHH----H---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 3456799999999996432212 23455544322211 1 112233333 56644331111 0 11222
Q ss_pred ceeEeeecCCC-ChhhHhhhc-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 239 PLLVYEFIPNG-TLYQHLHDR-HQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 239 ~~lV~E~~~~g-sL~~~l~~~-~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
.-+.|..+.+. ....++.-. +........|+-++.+++.++.+.+.||.++ .+-+|+.++|+|+.+++.+.|.|=
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 45677776553 333344322 1233345899999999999999999999999 899999999999999999999986
Q ss_pred CCcccccCCCceeeecccccCCccCccccc-----cCCCCCcccHHHHHHHHHHHHhC-CCCCCCCCCCccchhchH---
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTG-KKPIFWAGNTSQENVSLA--- 387 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvll~el~tG-~~p~~~~~~~~~~~~~~~--- 387 (468)
..-... .........+|...|.+||... +-.-+..+|.|.||+++++++.| ++||...-..........
T Consensus 162 Dsfqi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 162 DSFQIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred cceeec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 654333 2223334457889999999654 34567789999999999999886 899853211111111111
Q ss_pred --HHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccC--CCCCCCHHHHHHHHHhcccCCchh
Q 012214 388 --AYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLN--GKKRPTMEEVSMELNGIRGSSKKK 454 (468)
Q Consensus 388 --~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~d--p~~RPt~~evl~~L~~i~~~~~~~ 454 (468)
..+...... .......+ ......-.++.+..+..+|+... +.-|||++.++..|..++++.++=
T Consensus 240 a~g~f~ya~~~-~~g~~p~P--~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C 307 (637)
T COG4248 240 AHGRFAYASDQ-RRGLKPPP--RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC 307 (637)
T ss_pred hcceeeechhc-cCCCCCCC--CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence 111111110 00000000 01111223446788999999764 568999999999999998876653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.6e-10 Score=101.59 Aligned_cols=139 Identities=18% Similarity=0.149 Sum_probs=97.4
Q ss_pred ceeeecCcEEEEEEEecC-------CcEEEEEecccccch---H------H---------HHHHHH----HHHHHHHHHh
Q 012214 170 RILGQGGQGTVYKGMLED-------GRIIAVKKSKLTVDD---E------E---------LLKLEE----FINEIVILSQ 220 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~-------g~~vavK~l~~~~~~---~------~---------~~~~~~----~~~Ei~~l~~ 220 (468)
..||.|--+.||.|...+ +..+|||+.+..... . + ...... ..+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 478999976532100 0 0 000112 3388999988
Q ss_pred cCC--CceeeEeeeeccCCcceeEeeecCCCChhh-HhhhcccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCEEec
Q 012214 221 INH--RNVVKLLGCCLETEVPLLVYEFIPNGTLYQ-HLHDRHQNEEFPLTWEMRLRIATEVAGALAYL-HSATSSPIYHR 296 (468)
Q Consensus 221 l~h--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~iiH~ 296 (468)
+.. -++..++++ ...++||||+.+..+.. .+.. ..++......+..+++.+|..| |+.+ +||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 853 455666654 45689999997654322 2222 1244556677889999999998 8888 9999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 297 DIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 297 DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
||++.||+++ ++.+.|+|||.+...
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeC
Confidence 9999999997 468999999988543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.5e-09 Score=106.75 Aligned_cols=218 Identities=19% Similarity=0.262 Sum_probs=152.3
Q ss_pred cEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc----CCcceeEeeecCC-CC
Q 012214 177 QGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE----TEVPLLVYEFIPN-GT 250 (468)
Q Consensus 177 fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~~~lV~E~~~~-gs 250 (468)
..+.|++.. .||..+++|+++..... ....-..-++.++++.|+|+|++.+++.. +...++||+|.++ ++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~----~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQ----STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccccc----CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 357899884 48999999998432211 11112345778999999999999998863 4567899999875 67
Q ss_pred hhhHhhhcccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 251 LYQHLHDRHQN----------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 251 L~~~l~~~~~~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
|.++....... +....++..+|.++.|+..||.++|+.| +..+-|.|.+||++.+.+++|+..|...
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEeccccee
Confidence 77766543221 2235788999999999999999999999 9999999999999999999999999876
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
.+..+.. |.+.+ -.+-|.=.||.+++.|.||...-.. .+.. ....
T Consensus 442 vl~~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~-----~d~~--~~s~---------- 486 (655)
T KOG3741|consen 442 VLQEDPT---------------EPLES---QQQNDLRDLGLLLLALATGTENSNR-----TDST--QSSH---------- 486 (655)
T ss_pred eecCCCC---------------cchhH---HhhhhHHHHHHHHHHHhhccccccc-----ccch--HHHH----------
Confidence 5544331 11111 1256888999999999999665210 0000 0000
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 444 (468)
.......++.++.+++.-....++++ -++.+++.++
T Consensus 487 -------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 487 -------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred -------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 01112244557778888888888887 6788877654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.5e-10 Score=103.23 Aligned_cols=142 Identities=23% Similarity=0.276 Sum_probs=107.2
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCC--CceeeEeeeeccCC---cceeEee
Q 012214 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH--RNVVKLLGCCLETE---VPLLVYE 244 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~~---~~~lV~E 244 (468)
+.|+.|..+.||++...+|..+++|........ .....+..|+.++..+.+ .++.+++.+..... ..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 468999999999999876788999986543221 123467889999999865 34566777776542 5689999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT----------------------------------- 289 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~----------------------------------- 289 (468)
|+++.++.+.+.. ..++......++.+++++|..||+..
T Consensus 81 ~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (223)
T cd05154 81 RVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP 154 (223)
T ss_pred EeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence 9999888765531 13666777788888888888888531
Q ss_pred ------------------CCCEEecCCCCCCEEEcC--CCcEEEEecCCcc
Q 012214 290 ------------------SSPIYHRDIKSTNILLDQ--RYRAKVADFGTSK 320 (468)
Q Consensus 290 ------------------~~~iiH~DLkp~NILl~~--~~~~kl~DfGla~ 320 (468)
...++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 244899999999999998 6678999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.3e-09 Score=95.74 Aligned_cols=133 Identities=26% Similarity=0.328 Sum_probs=99.8
Q ss_pred eeeecCcEEEEEEEecCCcEEEEEe-cccccchHH---HHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeec
Q 012214 171 ILGQGGQGTVYKGMLEDGRIIAVKK-SKLTVDDEE---LLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFI 246 (468)
Q Consensus 171 ~LG~G~fG~Vy~~~~~~g~~vavK~-l~~~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 246 (468)
.+++|+-+.+|.+.+. |..+++|. .+......+ .-....-.+|+.++..+.--.|....=+..+.....++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 4789999999999764 44466663 222222211 123455778999999987666555555566677788999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 247 PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 247 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
++..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++.... +.++|||++.
T Consensus 82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred CChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccc
Confidence 998888888763 1356777888888999999 99999999999998765 9999999985
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.2e-11 Score=121.53 Aligned_cols=252 Identities=19% Similarity=0.222 Sum_probs=176.0
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEe--cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccC
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGML--EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET 236 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~ 236 (468)
.....+|..+..||.|.|+.|+.... .++..+++|.+........ .. ..-+.|+.+...+ .|.+++++...+...
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~-~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA-SD-IFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH-hh-hcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 33456788899999999999998774 3688899998765443321 11 1224555555555 588999988888888
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC-CcEEEEe
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR-YRAKVAD 315 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~-~~~kl~D 315 (468)
...++=-||++++++....... ..+....++.+..|++.++.++|+.. ++|+|+||+||++..+ +..+++|
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~ 410 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGD 410 (524)
T ss_pred ccccCchhhhcCcchhhhhHHH-----HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccc
Confidence 8888999999999887666321 24777888999999999999999998 9999999999999886 8889999
Q ss_pred cCCcccccCCCceeeecccccCCcc--CccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYL--DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
||.+..+.-. ......+-+++ +|+......+-.+.|++|||..+.+.+++..--.. +.. +..
T Consensus 411 ~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-~~~-----------~~~ 474 (524)
T KOG0601|consen 411 FGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-GVQ-----------SLT 474 (524)
T ss_pred ccccccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcc-ccc-----------cee
Confidence 9998642211 11111223344 55566667888999999999999999987653211 000 001
Q ss_pred hhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 394 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
.+.+..... ......+..+...++..++..||.+.++....+-.
T Consensus 475 i~~~~~p~~----------~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 475 IRSGDTPNL----------PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred eecccccCC----------CchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 111111111 11123567788889999999999988877655443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.3e-09 Score=92.05 Aligned_cols=147 Identities=20% Similarity=0.246 Sum_probs=104.9
Q ss_pred CCceeeecCcEEEEEEEecCCcEEEEEec-ccccchH---HHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 168 ANRILGQGGQGTVYKGMLEDGRIIAVKKS-KLTVDDE---ELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 168 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l-~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
....+-+|+-+.|+++... |+...||.- .....-. .......-.+|+..+.++.--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567999999999999885 677677742 2211111 1122346778999998886555554444556666778999
Q ss_pred eecCC-CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC---cEEEEecCCc
Q 012214 244 EFIPN-GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY---RAKVADFGTS 319 (468)
Q Consensus 244 E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~---~~kl~DfGla 319 (468)
||+++ .++.+++...-.. .........++.+|-+.+.-||..+ |||+||..+||++.+++ .+.+.|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 99976 4777888763322 1222333688999999999999999 99999999999997654 4589999998
Q ss_pred cc
Q 012214 320 KF 321 (468)
Q Consensus 320 ~~ 321 (468)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 53
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.2e-08 Score=92.11 Aligned_cols=129 Identities=26% Similarity=0.250 Sum_probs=83.1
Q ss_pred EEEEEEecCCcEEEEEecccccc----------------------hHHHHHHHHHHHHHHHHHhcCCC--ceeeEeeeec
Q 012214 179 TVYKGMLEDGRIIAVKKSKLTVD----------------------DEELLKLEEFINEIVILSQINHR--NVVKLLGCCL 234 (468)
Q Consensus 179 ~Vy~~~~~~g~~vavK~l~~~~~----------------------~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~g~~~ 234 (468)
.||.|...+|..+|+|..+.... ...........+|...|.++... ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988899999997653210 00111234567899999999765 456666542
Q ss_pred cCCcceeEeeecC--CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCEEecCCCCCCEEEcCCCcE
Q 012214 235 ETEVPLLVYEFIP--NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY-LHSATSSPIYHRDIKSTNILLDQRYRA 311 (468)
Q Consensus 235 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~y-LH~~~~~~iiH~DLkp~NILl~~~~~~ 311 (468)
...+||||++ +..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.||+++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 4579999998 55554433221 1123445677788885555 57888 9999999999999988 99
Q ss_pred EEEecCCcccc
Q 012214 312 KVADFGTSKFI 322 (468)
Q Consensus 312 kl~DfGla~~~ 322 (468)
.|+|||.+...
T Consensus 146 ~iIDf~qav~~ 156 (188)
T PF01163_consen 146 YIIDFGQAVDS 156 (188)
T ss_dssp EE--GTTEEET
T ss_pred EEEecCcceec
Confidence 99999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2e-10 Score=122.60 Aligned_cols=252 Identities=22% Similarity=0.239 Sum_probs=167.5
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
..+.+.+.+-+-+|.++.++...-. .|...++|.......- .....+....+-.++-..++|-+++..-.+.-....+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i-~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKI-RTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhh-ccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 4466777778889999999887632 2433444433221100 0011222233333333445677776665555667889
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
|+++|..+++|...|+... ..+.+-....+..+.++++|||+.. +.|+|++|.|+|...++..+++|||...
T Consensus 881 L~~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred hhhHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccc
Confidence 9999999999999987643 2444455566778889999999988 8999999999999999999999998432
Q ss_pred cccCC------------------------------CceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCC
Q 012214 321 FIAMD------------------------------QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 370 (468)
Q Consensus 321 ~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~ 370 (468)
....- +........+|+.|.+||...+......+|+|++|+.++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 22100 001122356899999999999999999999999999999999999
Q ss_pred CCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHH
Q 012214 371 KPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTME 438 (468)
Q Consensus 371 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 438 (468)
.||... .+ ...+.... ...+. ....+...+....+++...+..+|.+|-.+.
T Consensus 1033 pp~na~--tp------q~~f~ni~-~~~~~-------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAE--TP------QQIFENIL-NRDIP-------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCc--ch------hhhhhccc-cCCCC-------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 998431 11 11111111 00000 1112333445678899999999999998876
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.7e-08 Score=94.06 Aligned_cols=142 Identities=17% Similarity=0.119 Sum_probs=96.6
Q ss_pred eeecCcEEEEEEEecCCcEEEEEecccccchHHHHH-------HHHHHHHHHHHHhcCCCce--eeEeeeecc-----CC
Q 012214 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLK-------LEEFINEIVILSQINHRNV--VKLLGCCLE-----TE 237 (468)
Q Consensus 172 LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~-------~~~~~~Ei~~l~~l~h~ni--v~l~g~~~~-----~~ 237 (468)
+-......|.+... +|+.+.||.........-... ...+.+|...+..+...+| ..++++... ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 44334444666655 578899997644321100000 1136788888877743333 333444432 23
Q ss_pred cceeEeeecCCC-ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC-------CC
Q 012214 238 VPLLVYEFIPNG-TLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ-------RY 309 (468)
Q Consensus 238 ~~~lV~E~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~-------~~ 309 (468)
..++|+|++++. +|.+++.... ..+.+......++.+++..+.-||+.+ |+|+|+++.|||++. +.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 468999999875 7888885421 123556677889999999999999999 999999999999975 57
Q ss_pred cEEEEecCCcc
Q 012214 310 RAKVADFGTSK 320 (468)
Q Consensus 310 ~~kl~DfGla~ 320 (468)
.+.++||+.+.
T Consensus 183 ~~~LIDl~r~~ 193 (268)
T PRK15123 183 KLSVIDLHRAQ 193 (268)
T ss_pred eEEEEECCccc
Confidence 89999999874
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.4e-07 Score=87.86 Aligned_cols=138 Identities=22% Similarity=0.223 Sum_probs=96.9
Q ss_pred CCCCceeeecCcEEEEEEEecCCcEEEEEecccccchH-------H-----------HHHHHHHHHHHHHHHhcCCC--c
Q 012214 166 FNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDE-------E-----------LLKLEEFINEIVILSQINHR--N 225 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~-------~-----------~~~~~~~~~Ei~~l~~l~h~--n 225 (468)
..+.++||-|--+.||.|....|..+|||.-+.....- + ........+|...|..+... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45667899999999999999999999999543321100 0 01223467888999988655 6
Q ss_pred eeeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE
Q 012214 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL 305 (468)
Q Consensus 226 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl 305 (468)
|.+.+++ +...+|||++++-.|...- ++....-.++..|+.-+.-+-..+ |||+|+++-||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 6665543 5568999999886553322 112223345555555555555667 9999999999999
Q ss_pred cCCCcEEEEecCCcc
Q 012214 306 DQRYRAKVADFGTSK 320 (468)
Q Consensus 306 ~~~~~~kl~DfGla~ 320 (468)
++||.+.++||--+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999998764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.3e-09 Score=110.52 Aligned_cols=152 Identities=24% Similarity=0.284 Sum_probs=104.3
Q ss_pred HHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCcee--------eecccccCCccCccccc
Q 012214 275 ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHV--------TTKIQGTFGYLDPEYHQ 346 (468)
Q Consensus 275 ~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~ 346 (468)
+.+++.|+.|+|...+ +||++|.|++|.++.++..||+.|+.+.......... ..-......|.|||++.
T Consensus 105 l~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3456699999998654 9999999999999999999999999876543311111 11123456899999999
Q ss_pred cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHh
Q 012214 347 SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRC 426 (468)
Q Consensus 347 ~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~c 426 (468)
+...+.++|+||+|+++|-+..|..+.......... .. +.. . .+..-......+.+.++.+=+.++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~----~~~--~-------~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-YS----FSR--N-------LLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcch-hh----hhh--c-------ccccccccccccCcHHHHHHHHHH
Confidence 988899999999999999999666654321111110 00 000 0 000001111245566888999999
Q ss_pred hccCCCCCCCHHHHHH
Q 012214 427 LDLNGKKRPTMEEVSM 442 (468)
Q Consensus 427 l~~dp~~RPt~~evl~ 442 (468)
+..++.-||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 9999999998776643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.7e-07 Score=82.36 Aligned_cols=142 Identities=18% Similarity=0.132 Sum_probs=100.5
Q ss_pred eeecCcEEEEEEEecCCcEEEEEecccccchHH--HHHHHHHHHHHHHHHhcCC--CceeeEeeeecc----CCcceeEe
Q 012214 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEE--LLKLEEFINEIVILSQINH--RNVVKLLGCCLE----TEVPLLVY 243 (468)
Q Consensus 172 LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~--~~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~----~~~~~lV~ 243 (468)
-|+||.+.|+...+. |+.+-+|.........- ......|.+|...+.++.. ..+.++..+... .-..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 477999999997775 55788997642111100 0134579999999998853 234444422111 12357999
Q ss_pred eecCC-CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc--EEEEecCCcc
Q 012214 244 EFIPN-GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR--AKVADFGTSK 320 (468)
Q Consensus 244 E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~--~kl~DfGla~ 320 (468)
|-+++ .+|.+++.... ..+.+......++.++++.+.-||+.+ +.|+|+.+.|||++.++. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97753 58888875522 124567778899999999999999999 999999999999986666 9999998654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=7.5e-07 Score=82.09 Aligned_cols=105 Identities=25% Similarity=0.299 Sum_probs=80.0
Q ss_pred HHHHHHHHHHHhcCC--CceeeEeeeeccC----CcceeEeeecCCC-ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHH
Q 012214 209 EEFINEIVILSQINH--RNVVKLLGCCLET----EVPLLVYEFIPNG-TLYQHLHDRHQNEEFPLTWEMRLRIATEVAGA 281 (468)
Q Consensus 209 ~~~~~Ei~~l~~l~h--~niv~l~g~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~g 281 (468)
..+.+|...+..+.. -.+.+.+++.... ...++|+|++++. +|.+++..... .+......++.+++..
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALARL 130 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHHH
Confidence 356677777777643 3344555555432 2447999999874 78888865221 4556678899999999
Q ss_pred HHHHHhCCCCCEEecCCCCCCEEEcCCC---cEEEEecCCccc
Q 012214 282 LAYLHSATSSPIYHRDIKSTNILLDQRY---RAKVADFGTSKF 321 (468)
Q Consensus 282 L~yLH~~~~~~iiH~DLkp~NILl~~~~---~~kl~DfGla~~ 321 (468)
++-||+.+ |+|+|+++.|||++.+. .+.++||+-++.
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999 99999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.8e-06 Score=89.35 Aligned_cols=148 Identities=18% Similarity=0.216 Sum_probs=95.2
Q ss_pred CCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHH--------------------------HHH---------
Q 012214 165 HFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELL--------------------------KLE--------- 209 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~--------------------------~~~--------- 209 (468)
.|.. +-|+.++-|.||+|++++|+.||||+........-.. .++
T Consensus 127 eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 127 EFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred HcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 3443 5699999999999999999999999876543211000 011
Q ss_pred -HHHHHHHHHHhc----C-CCceeeEeeeec-cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHH-
Q 012214 210 -EFINEIVILSQI----N-HRNVVKLLGCCL-ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGA- 281 (468)
Q Consensus 210 -~~~~Ei~~l~~l----~-h~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~g- 281 (468)
++.+|+..+.++ + .+++ ++=.++. -.....|+|||++|-.+.+...-... .++... ++..++++
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~----g~d~k~---ia~~~~~~f 277 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA----GIDRKE---LAELLVRAF 277 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhc----CCCHHH---HHHHHHHHH
Confidence 234555444444 2 3443 3333333 35677899999999999887433211 244333 33333322
Q ss_pred HHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccC
Q 012214 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324 (468)
Q Consensus 282 L~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 324 (468)
+..+=..+ +.|.|..|.||+++.++.+.+.|||+...++.
T Consensus 278 ~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 278 LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 22223356 99999999999999999999999999876654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.1e-05 Score=75.29 Aligned_cols=141 Identities=17% Similarity=0.189 Sum_probs=82.2
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCc--eeeEeeeeccCCcceeEeeecC
Q 012214 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN--VVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~~~~~~~~~lV~E~~~ 247 (468)
..||+|..+.||+. .+..+++|........ ....+|.++++.+..-. +.+.+++....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~------~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDK------ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCCH------HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 45899999999984 2446778876543222 33567888888885433 4567777777777789999998
Q ss_pred CCC-hhhHhh--------------h----cccCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCCEEe
Q 012214 248 NGT-LYQHLH--------------D----RHQNEEFPLTWEMRLR-IAT----------EVAG-ALAYLHSA-TSSPIYH 295 (468)
Q Consensus 248 ~gs-L~~~l~--------------~----~~~~~~~~l~~~~~~~-i~~----------qia~-gL~yLH~~-~~~~iiH 295 (468)
|.+ +...+. . -............... +-. .+.. ...+|... ..+.++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 211110 0 0000000011111000 000 0011 12222211 2345799
Q ss_pred cCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 296 RDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 296 ~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+|+.|.||++++++ +.|.||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.9e-05 Score=71.01 Aligned_cols=155 Identities=22% Similarity=0.232 Sum_probs=99.8
Q ss_pred cCHHHHHHHhcCCCCCce---eeecCcEEEEEEEecCCcEEEEEecccccchHHH--------------------HHHHH
Q 012214 154 FSSKELDKATNHFNANRI---LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEEL--------------------LKLEE 210 (468)
Q Consensus 154 ~~~~ei~~~~~~f~~~~~---LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~--------------------~~~~~ 210 (468)
.+.+.+....++..+... |.+|--+.||+|...++..+|||+.+.....-.. ....-
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 344555555555555555 4566777899999888999999987653221100 00112
Q ss_pred HHHHHHHHHhcC--CCceeeEeeeeccCCcceeEeeecCCCC-hhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 012214 211 FINEIVILSQIN--HRNVVKLLGCCLETEVPLLVYEFIPNGT-LYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS 287 (468)
Q Consensus 211 ~~~Ei~~l~~l~--h~niv~l~g~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 287 (468)
...|..-|.++. +-.+.+.+++. .-.|||||+.... -.-.|.. .++.......+..++++.+.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHH
Confidence 245666666663 33444444433 3469999985431 1112221 223344677778888888888877
Q ss_pred -CCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 288 -ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 288 -~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
.+ +||+||+.-|||+. ++.+.|+|||-|...
T Consensus 185 ~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 185 EAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred hcC---cccccchhhheEEE-CCeEEEEECcccccc
Confidence 66 99999999999999 889999999988544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.18 E-value=4.4e-05 Score=69.86 Aligned_cols=140 Identities=16% Similarity=0.196 Sum_probs=90.1
Q ss_pred HhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHH------HHHHHHHHhcCC---CceeeEeee
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEF------INEIVILSQINH---RNVVKLLGC 232 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~------~~Ei~~l~~l~h---~niv~l~g~ 232 (468)
..++|...+.+-......|.+... +|+.+.+|......... ......| .+++..+..+.. .....++-+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~-er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRP-ERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhH-HHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 456788888888877777777766 47889999765533221 1222222 233333333322 222222222
Q ss_pred e-----ccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC
Q 012214 233 C-----LETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ 307 (468)
Q Consensus 233 ~-----~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~ 307 (468)
. .-....+++|||++|..|.+... ++. .++..+.+++.-||+.| +.|+|..|.|+++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEEC
Confidence 2 22334568999999988765542 222 24567788899999999 999999999999986
Q ss_pred CCcEEEEecCCcc
Q 012214 308 RYRAKVADFGTSK 320 (468)
Q Consensus 308 ~~~~kl~DfGla~ 320 (468)
++ +++.||+..+
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 54 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=6.2e-05 Score=77.97 Aligned_cols=166 Identities=16% Similarity=0.163 Sum_probs=100.6
Q ss_pred ccccccCHHHHHHH------------hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHH----------
Q 012214 149 DRFKLFSSKELDKA------------TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELL---------- 206 (468)
Q Consensus 149 ~~~~~~~~~ei~~~------------~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~---------- 206 (468)
++.+.++.+|+... -..|. .+.||.-+.|.||++++++|+.||||+.+......-..
T Consensus 135 D~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~ 213 (538)
T KOG1235|consen 135 DQAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAK 213 (538)
T ss_pred ccCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHH
Confidence 34455666666443 23343 24699999999999999999999999876543221000
Q ss_pred -----------------------HHHHHHHHHHHHHhc----CCCc---eeeEeeeecc-CCcceeEeeecCCCChhhHh
Q 012214 207 -----------------------KLEEFINEIVILSQI----NHRN---VVKLLGCCLE-TEVPLLVYEFIPNGTLYQHL 255 (468)
Q Consensus 207 -----------------------~~~~~~~Ei~~l~~l----~h~n---iv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l 255 (468)
..=+|.+|++-..++ .|-+ -|.+=.++.+ .....|+||||+|..+.+.-
T Consensus 214 ~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~ 293 (538)
T KOG1235|consen 214 VLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLD 293 (538)
T ss_pred HHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHH
Confidence 001345555443333 3444 1112222222 34678999999999887653
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC----CCcEEEEecCCcccccC
Q 012214 256 HDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ----RYRAKVADFGTSKFIAM 324 (468)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~----~~~~kl~DfGla~~~~~ 324 (468)
.-... .++...+..-+.+...-+-+ ..| ++|.|=.|.||++++ ++.+.+-|||+...+..
T Consensus 294 ~i~~~----gi~~~~i~~~l~~~~~~qIf--~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 294 AIDKR----GISPHDILNKLVEAYLEQIF--KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHc----CCCHHHHHHHHHHHHHHHHH--hcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 32111 25555443333333222222 335 999999999999984 67899999999876543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.04 E-value=3e-05 Score=70.12 Aligned_cols=104 Identities=25% Similarity=0.368 Sum_probs=82.0
Q ss_pred HHHHHHHhcCC-CceeeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 012214 213 NEIVILSQINH-RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSS 291 (468)
Q Consensus 213 ~Ei~~l~~l~h-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ 291 (468)
+|..+++.+++ +++.+++|+|- .++|.||...+++...... -..-...+|..+.+|+.++++.+.+|++....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~--l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP--LSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc--cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 57788888865 69999999994 3689999987766432100 00112368999999999999999999986555
Q ss_pred CEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 292 PIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 292 ~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
.+.-.|++|+|+-+++++++|+.|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5999999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.04 E-value=0.0001 Score=67.10 Aligned_cols=135 Identities=22% Similarity=0.311 Sum_probs=91.1
Q ss_pred CceeeecCcEEEEEEEecCCcEEEEEecccccchH------------HHHHHHHHHHHHHHHHhcC------CCceeeEe
Q 012214 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDE------------ELLKLEEFINEIVILSQIN------HRNVVKLL 230 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~------------~~~~~~~~~~Ei~~l~~l~------h~niv~l~ 230 (468)
...||+|+.-.||. ++++...+||+........ .....++..+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45699999999886 5566678899887644000 0012345666665555554 88999999
Q ss_pred eeeccCCcceeEeeecCC--C----ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEE
Q 012214 231 GCCLETEVPLLVYEFIPN--G----TLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNIL 304 (468)
Q Consensus 231 g~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NIL 304 (468)
|+..++....+|+|.+.+ | +|.+++... .++. . +...+-+-..||-++. |+.+|++|+||+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~------~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG------GLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC------CccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEE
Confidence 999999999999998743 2 566666431 2444 3 3333444556777777 999999999999
Q ss_pred EcCCC----cEEEEe-cCC
Q 012214 305 LDQRY----RAKVAD-FGT 318 (468)
Q Consensus 305 l~~~~----~~kl~D-fGl 318 (468)
+..+. .+.|+| ||.
T Consensus 151 ~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EEecCCCceEEEEEeCCCC
Confidence 96432 567776 454
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00011 Score=68.49 Aligned_cols=144 Identities=24% Similarity=0.272 Sum_probs=80.9
Q ss_pred ceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCC--ceeeEeeeecc---CCcceeEee
Q 012214 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR--NVVKLLGCCLE---TEVPLLVYE 244 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~g~~~~---~~~~~lV~E 244 (468)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++..... ....+++|+
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 568999999999999876 58899986542 2234566788888777422 34566654422 234689999
Q ss_pred ecCCCChhh----------------HhhhcccC--CCCCCCHHH---------HHHH------------HHHHHH-HHHH
Q 012214 245 FIPNGTLYQ----------------HLHDRHQN--EEFPLTWEM---------RLRI------------ATEVAG-ALAY 284 (468)
Q Consensus 245 ~~~~gsL~~----------------~l~~~~~~--~~~~l~~~~---------~~~i------------~~qia~-gL~y 284 (468)
++++.++.. .+..-... ...+..... .... ...+.+ .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 999988777 11110000 111111110 0000 111222 3333
Q ss_pred HHh----CCCCCEEecCCCCCCEEEc-CCCcEEEEecCCcc
Q 012214 285 LHS----ATSSPIYHRDIKSTNILLD-QRYRAKVADFGTSK 320 (468)
Q Consensus 285 LH~----~~~~~iiH~DLkp~NILl~-~~~~~kl~DfGla~ 320 (468)
+++ .....++|+|+.|.||+++ +++.+-|.||+.+.
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 332 1334599999999999999 66666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.00 E-value=9e-05 Score=70.05 Aligned_cols=141 Identities=18% Similarity=0.138 Sum_probs=83.2
Q ss_pred eeecCc-EEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccCCcceeEeeecCCC
Q 012214 172 LGQGGQ-GTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNG 249 (468)
Q Consensus 172 LG~G~f-G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~g 249 (468)
|..|.+ ..||+...+ +..+.+|...... .....+|+.+++.+. +--+.+++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 445555 788998764 4678888765431 124557888887773 444557777776666789999999988
Q ss_pred ChhhHhh----------------hcccC--CCCCCCH--HHHHHHHH--------------------HHHHHHHHHHh--
Q 012214 250 TLYQHLH----------------DRHQN--EEFPLTW--EMRLRIAT--------------------EVAGALAYLHS-- 287 (468)
Q Consensus 250 sL~~~l~----------------~~~~~--~~~~l~~--~~~~~i~~--------------------qia~gL~yLH~-- 287 (468)
+|..... .-... ...++.. ........ .+...+..|-.
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 7764321 00000 0111110 00000000 01111222211
Q ss_pred --CCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 288 --ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 288 --~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
...+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 123459999999999999998888999999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00012 Score=81.46 Aligned_cols=80 Identities=14% Similarity=0.250 Sum_probs=55.9
Q ss_pred CceeeecCcEEEEEEEecCC---cEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCce--eeEeeeeccC---Ccc
Q 012214 169 NRILGQGGQGTVYKGMLEDG---RIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNV--VKLLGCCLET---EVP 239 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g---~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~ni--v~l~g~~~~~---~~~ 239 (468)
.+.++.|.+..+|+....++ ..+++|+....... .....+.+|+.+++.+. |.++ .+++.+|.+. ...
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~---~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL---QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC---ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 45688999999999876543 46777765432211 11235778999999985 6654 7788888664 467
Q ss_pred eeEeeecCCCCh
Q 012214 240 LLVYEFIPNGTL 251 (468)
Q Consensus 240 ~lV~E~~~~gsL 251 (468)
++||||+++..+
T Consensus 120 flVME~v~G~~~ 131 (822)
T PLN02876 120 FYIMEYLEGRIF 131 (822)
T ss_pred eEEEEecCCccc
Confidence 899999987653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=8.4e-07 Score=91.09 Aligned_cols=182 Identities=21% Similarity=0.158 Sum_probs=129.8
Q ss_pred CceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCc-eeeEeeeeccCCcceeEeeecC
Q 012214 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN-VVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~~~~lV~E~~~ 247 (468)
.+-+++|+++++++.+-.-.+....+.+... ....-++++|.+++||| .++.++-+..++..+++++++.
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc---------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 3447899999999887433333334443322 22345788999999999 7788888888888999999997
Q ss_pred CC-ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 012214 248 NG-TLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQ 326 (468)
Q Consensus 248 ~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 326 (468)
.+ +....... ..-.+..-+...+.+.-+++++++|+.. =+|+| ||+..+ +..+..||+....+....
T Consensus 318 ~~rs~~~~~~~----se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 318 TGRSSALEMTV----SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred CCccccccCCh----hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 76 22111111 0111333344566777788999999865 48998 777655 688999999987665433
Q ss_pred ceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCC
Q 012214 327 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 373 (468)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~ 373 (468)
......+|+.|+|||....+.+..+.|+||+|+--.++.-|..|-
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 234456899999999999999999999999998877777777664
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00054 Score=66.85 Aligned_cols=76 Identities=9% Similarity=0.017 Sum_probs=54.2
Q ss_pred CceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCC---CceeeEeeeecc---CCcceeE
Q 012214 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH---RNVVKLLGCCLE---TEVPLLV 242 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h---~niv~l~g~~~~---~~~~~lV 242 (468)
.+.||.|..+.||.....+++ +.+|..+.... ...|..|+..++.+.. ..+.+++++|.. .+..++|
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~~------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARSFST------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEeccccc------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 456999999999998765554 56676432111 1357789999888843 467788887754 3568999
Q ss_pred eeecCCCCh
Q 012214 243 YEFIPNGTL 251 (468)
Q Consensus 243 ~E~~~~gsL 251 (468)
||+++++++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00036 Score=65.61 Aligned_cols=73 Identities=18% Similarity=0.202 Sum_probs=44.3
Q ss_pred ceeeecCcE-EEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCC---ceeeEeeeeccC---CcceeE
Q 012214 170 RILGQGGQG-TVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR---NVVKLLGCCLET---EVPLLV 242 (468)
Q Consensus 170 ~~LG~G~fG-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~g~~~~~---~~~~lV 242 (468)
+.|+.|+.. .||+. +..+++|..... .....+.+|+.++..+... -+.++++..... ...+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~------~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA------GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc------chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457877776 48875 234677764431 1224577888888877431 334444444332 245889
Q ss_pred eeecCCCChh
Q 012214 243 YEFIPNGTLY 252 (468)
Q Consensus 243 ~E~~~~gsL~ 252 (468)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999987774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00011 Score=80.79 Aligned_cols=197 Identities=19% Similarity=0.178 Sum_probs=137.6
Q ss_pred HHHHHHHHHHhcCCCceeeEeeeeccCCcce----eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 012214 210 EFINEIVILSQINHRNVVKLLGCCLETEVPL----LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285 (468)
Q Consensus 210 ~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 285 (468)
.-.-|...+..+.|+|++.++++..+....- +..+++..-++...+.... .++..+.+.+..+...||.|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-----~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-----SIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-----ccCHHHHHHHHHHHhhhHHHH
Confidence 3445677888889999999999886654333 3457777777777775532 478889999999999999999
Q ss_pred HhCCCCCEEecCCCCC---CEEEcCCCcEEEE--ecCCcccccCCCceeeecccccCCccCccccccCCCCC--cccHHH
Q 012214 286 HSATSSPIYHRDIKST---NILLDQRYRAKVA--DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD--KSDVYS 358 (468)
Q Consensus 286 H~~~~~~iiH~DLkp~---NILl~~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDVwS 358 (468)
|+.. ..|.-|..+ +...+..+.+.++ ||+.++..+...... ....+..|.+||.......+. ..|+|.
T Consensus 303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHH
Confidence 9986 666666665 5556677778777 998887665433222 122455677888777655554 479999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHH
Q 012214 359 FGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTME 438 (468)
Q Consensus 359 lGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 438 (468)
+|.+...+..|..+-.... ....+++.. ....+.+...+|+..++++|+++.
T Consensus 378 lgll~~~~~~~~~i~~~~~--------------------~~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~ 429 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSA--------------------VPVSLLDVL--------STSELLDALPKCLDEDSEERLSAL 429 (1351)
T ss_pred HHHHHhhhhhcCccccccc--------------------chhhhhccc--------cchhhhhhhhhhcchhhhhccchh
Confidence 9999999999876632100 001111110 001467788899999999999999
Q ss_pred HHHHHH
Q 012214 439 EVSMEL 444 (468)
Q Consensus 439 evl~~L 444 (468)
+++...
T Consensus 430 ~ll~~~ 435 (1351)
T KOG1035|consen 430 ELLTHP 435 (1351)
T ss_pred hhhhch
Confidence 998643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00048 Score=62.39 Aligned_cols=129 Identities=29% Similarity=0.442 Sum_probs=89.2
Q ss_pred cCCCCCceeeecCc-EEEEEEEecCCcEEEEEeccc---ccc--------hHHH------HHHHHHHHHHHHHHhc---C
Q 012214 164 NHFNANRILGQGGQ-GTVYKGMLEDGRIIAVKKSKL---TVD--------DEEL------LKLEEFINEIVILSQI---N 222 (468)
Q Consensus 164 ~~f~~~~~LG~G~f-G~Vy~~~~~~g~~vavK~l~~---~~~--------~~~~------~~~~~~~~Ei~~l~~l---~ 222 (468)
..++..+.||.|.- |.||++.+. |+.+|+|.... ... ..+. ...+-|..|.+...++ .
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 77888999999999 999999985 78999998221 110 1111 2234578888777766 4
Q ss_pred CCce--eeEeeeeccC------------------CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHH
Q 012214 223 HRNV--VKLLGCCLET------------------EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282 (468)
Q Consensus 223 h~ni--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL 282 (468)
+.++ |+.+|+..-. ....+|.||.+... .++. .-+.+|.+-|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~----~~~~~~~~dl 177 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQI----RDIPQMLRDL 177 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccch----hHHHHHHHHH
Confidence 5566 8999887321 01246777765432 1222 2356777788
Q ss_pred HHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 283 ~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 178 ~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 8999999 999999999976 4588999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00034 Score=61.52 Aligned_cols=127 Identities=18% Similarity=0.204 Sum_probs=86.4
Q ss_pred CCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceee-EeeeeccCCcceeEeee
Q 012214 167 NANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK-LLGCCLETEVPLLVYEF 245 (468)
Q Consensus 167 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~-l~g~~~~~~~~~lV~E~ 245 (468)
...+.|++|.+|.||+|.+. |..+|+|+-..++.. ..+..|++++..+.-.++.. ++.+- ..++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r------~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPR------RNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCcch------hhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhh
Confidence 34566999999999999986 558899987665433 45778999998887665543 33332 22455999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCC-CC-CEEEcCCCcEEEEecCCcc
Q 012214 246 IPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIK-ST-NILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 246 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLk-p~-NILl~~~~~~kl~DfGla~ 320 (468)
+.|-+|.+.-.. .+-+. ...++..-.-|...+ |-|+.|. |. ||++.+ ..+.|+||..|+
T Consensus 94 i~G~~L~~~~~~--------~~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~-~~~~iIDFd~At 154 (201)
T COG2112 94 IDGRPLGKLEIG--------GDRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVND-RDVYIIDFDSAT 154 (201)
T ss_pred hcCcchhhhhhc--------ccHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecC-CcEEEEEccchh
Confidence 988788766542 11122 334455544566667 9999987 44 555554 499999999886
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0012 Score=61.96 Aligned_cols=74 Identities=20% Similarity=0.215 Sum_probs=46.1
Q ss_pred ceeeecCcEEEEEEEecC--CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCc-eeeEeeeeccCCcceeEeeec
Q 012214 170 RILGQGGQGTVYKGMLED--GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN-VVKLLGCCLETEVPLLVYEFI 246 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~~~~lV~E~~ 246 (468)
+.|..|-...+|+....+ +..+++|+.... .. ..-...+|+.++..+...+ ..++++.+. ..++|||+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~-~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i 74 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK-TE----LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFI 74 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCC-cc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEee
Confidence 457778788999988664 678888875432 11 1112236888888874333 334444332 24899999
Q ss_pred CCCChh
Q 012214 247 PNGTLY 252 (468)
Q Consensus 247 ~~gsL~ 252 (468)
++.++.
T Consensus 75 ~G~~l~ 80 (235)
T cd05157 75 PGRTLE 80 (235)
T ss_pred CCCcCC
Confidence 987763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.004 Score=62.87 Aligned_cols=79 Identities=23% Similarity=0.224 Sum_probs=52.7
Q ss_pred ceeeecCcEEEEEEEecCC-cEEEEEecccccc--hHH-HHHHHHHHHHHHHHHhcC---CCceeeEeeeeccCCcceeE
Q 012214 170 RILGQGGQGTVYKGMLEDG-RIIAVKKSKLTVD--DEE-LLKLEEFINEIVILSQIN---HRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~g-~~vavK~l~~~~~--~~~-~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~lV 242 (468)
+.||.|.+..||++...+| +.++||.-..... ... ....+.+..|.+.|..+. ..++.+++.+. .+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 4689999999999998776 5899997431110 000 123455667777777762 34567777663 3557899
Q ss_pred eeecCCCC
Q 012214 243 YEFIPNGT 250 (468)
Q Consensus 243 ~E~~~~gs 250 (468)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.002 Score=61.32 Aligned_cols=139 Identities=17% Similarity=0.172 Sum_probs=75.4
Q ss_pred eeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCce-eeEeeeeccCCcceeEeeecCCCC
Q 012214 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNV-VKLLGCCLETEVPLLVYEFIPNGT 250 (468)
Q Consensus 172 LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~~~gs 250 (468)
+..|-...+|+... ++..+++|........ .. -...+|..+++.+....+ .+++.... .++|+||++|.+
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~---~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKA---LG-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCccccc---cc-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 55677778998874 4667888865432111 00 124568888888754333 33444332 368999999876
Q ss_pred hhhH--------------hhhcc--cCCCCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCEEecCCC
Q 012214 251 LYQH--------------LHDRH--QNEEFPLTWEMR-LRIATE---------VAGALAYLHSA-----TSSPIYHRDIK 299 (468)
Q Consensus 251 L~~~--------------l~~~~--~~~~~~l~~~~~-~~i~~q---------ia~gL~yLH~~-----~~~~iiH~DLk 299 (468)
+... +.+-. .....+++.... .....+ +...+..+-.. ....++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 5421 11100 011112222211 111111 11112222211 12348999999
Q ss_pred CCCEEEcCCCcEEEEecCCcc
Q 012214 300 STNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 300 p~NILl~~~~~~kl~DfGla~ 320 (468)
|.||++++++ +.|.||..+.
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred cCcEEEeCCC-CEEEeccccC
Confidence 9999999877 7899999774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.012 Score=58.03 Aligned_cols=30 Identities=20% Similarity=0.262 Sum_probs=25.9
Q ss_pred CCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 291 ~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
..+||+|+.|.||+++.+...-|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 349999999999999977666899999874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.017 Score=56.65 Aligned_cols=145 Identities=19% Similarity=0.216 Sum_probs=78.4
Q ss_pred CceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCC--ceeeEeeee------ccCCcce
Q 012214 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR--NVVKLLGCC------LETEVPL 240 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~g~~------~~~~~~~ 240 (468)
.+.++.|....+|+....+| .+++|+....... ++...|+.++..+... .+.+++... ...+..+
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~~------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVKA------EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCCH------HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 34466777778998876555 5677875442111 2233455666665322 234444322 1234568
Q ss_pred eEeeecCCCChhh-----------H---hhhcccC--CC--C---CCCHHHHH------------HHHHHHHHHHHHHHh
Q 012214 241 LVYEFIPNGTLYQ-----------H---LHDRHQN--EE--F---PLTWEMRL------------RIATEVAGALAYLHS 287 (468)
Q Consensus 241 lV~E~~~~gsL~~-----------~---l~~~~~~--~~--~---~l~~~~~~------------~i~~qia~gL~yLH~ 287 (468)
+++||++|.++.. . ++..... .. . .-.|.... .....+.+.++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 9999998865421 0 1110000 00 0 01111110 111223345555543
Q ss_pred ----CCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 288 ----ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 288 ----~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
.....++|+|+.+.||++++++.+.|.||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123459999999999999998877899999863
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0074 Score=58.68 Aligned_cols=144 Identities=21% Similarity=0.182 Sum_probs=81.3
Q ss_pred CceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCC--ceeeEeeee------ccCCcce
Q 012214 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR--NVVKLLGCC------LETEVPL 240 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~g~~------~~~~~~~ 240 (468)
.+.|..|....+|+....+ ..+++|+... ... .....|+.++..+.+. .+.+++... ...+..+
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~-~~~------~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK-VSA------EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC-CCh------HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 3457778778899987654 4688887654 111 2345567777766432 244444321 1234567
Q ss_pred eEeeecCCCChhh----Hh----------hhcccC-C-----CCCCCHHHHH----------HHHHHHHHHHHHHHhC--
Q 012214 241 LVYEFIPNGTLYQ----HL----------HDRHQN-E-----EFPLTWEMRL----------RIATEVAGALAYLHSA-- 288 (468)
Q Consensus 241 lV~E~~~~gsL~~----~l----------~~~~~~-~-----~~~l~~~~~~----------~i~~qia~gL~yLH~~-- 288 (468)
+++++++|.++.. .+ +..... . .....|.... .....+..++.++...
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999876532 01 110000 0 0011221110 1112233445555431
Q ss_pred --CCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 289 --TSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 289 --~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
-...++|+|+.|.||+++++..+.|.||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 12349999999999999998778899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0012 Score=63.52 Aligned_cols=139 Identities=18% Similarity=0.181 Sum_probs=93.4
Q ss_pred CCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchH----------------HHH--HHHHHHHHHHHHHhcCC--C
Q 012214 165 HFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDE----------------ELL--KLEEFINEIVILSQINH--R 224 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~----------------~~~--~~~~~~~Ei~~l~~l~h--~ 224 (468)
-+.+.++||-|--+.||.+...+|+..++|.-......- ... ..-...+|...|+.+.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 367788999999999999999999999998543221100 000 11134567777777742 2
Q ss_pred ceeeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEE
Q 012214 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNIL 304 (468)
Q Consensus 225 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NIL 304 (468)
-|.+.+++ ...++|||++.+-+|...-.- ... ..+...+..-+.-|..++ +||+|..-=||+
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v--------~d~---~~ly~~lm~~Iv~la~~G---lIHgDFNEFNim 234 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV--------EDP---PTLYDDLMGLIVRLANHG---LIHGDFNEFNIM 234 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec--------CCh---HHHHHHHHHHHHHHHHcC---ceecccchheeE
Confidence 33444443 456789999988776543321 111 233444555556677788 999999999999
Q ss_pred EcCCCcEEEEecCCccc
Q 012214 305 LDQRYRAKVADFGTSKF 321 (468)
Q Consensus 305 l~~~~~~kl~DfGla~~ 321 (468)
+++++.++++||--...
T Consensus 235 v~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 235 VKDDDKIVVIDFPQMVS 251 (465)
T ss_pred EecCCCEEEeechHhhc
Confidence 99999999999976543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0092 Score=57.51 Aligned_cols=30 Identities=27% Similarity=0.515 Sum_probs=25.1
Q ss_pred CCEEecCCCCCCEEEcCCCc-EEEEecCCcc
Q 012214 291 SPIYHRDIKSTNILLDQRYR-AKVADFGTSK 320 (468)
Q Consensus 291 ~~iiH~DLkp~NILl~~~~~-~kl~DfGla~ 320 (468)
+.++|+|+.|.||++++++. .-|.||+.+.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 44899999999999997555 4699999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0053 Score=59.95 Aligned_cols=141 Identities=26% Similarity=0.362 Sum_probs=79.4
Q ss_pred eeeecCcEEEEEEEecC-------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCce-eeEeeeeccCCcceeE
Q 012214 171 ILGQGGQGTVYKGMLED-------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNV-VKLLGCCLETEVPLLV 242 (468)
Q Consensus 171 ~LG~G~fG~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV 242 (468)
.|..|-...+|+....+ ++.+++|+...... ......+|..++..+...++ .++++++.. .+|
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-----LLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 45566667889887654 47888998654221 11234567777777743333 345555432 368
Q ss_pred eeecCCCChhhH-h----------------hhcccC--C----CCCCCHHHHHH--------------------------
Q 012214 243 YEFIPNGTLYQH-L----------------HDRHQN--E----EFPLTWEMRLR-------------------------- 273 (468)
Q Consensus 243 ~E~~~~gsL~~~-l----------------~~~~~~--~----~~~l~~~~~~~-------------------------- 273 (468)
+||++|.++... + +..... . ..+.-+..+..
T Consensus 76 ~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (302)
T cd05156 76 EEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSL 155 (302)
T ss_pred hheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHH
Confidence 999988776431 1 110000 0 00111111111
Q ss_pred HHHHHHHHHHHHHh------CCCCCEEecCCCCCCEEEcCC----CcEEEEecCCcc
Q 012214 274 IATEVAGALAYLHS------ATSSPIYHRDIKSTNILLDQR----YRAKVADFGTSK 320 (468)
Q Consensus 274 i~~qia~gL~yLH~------~~~~~iiH~DLkp~NILl~~~----~~~kl~DfGla~ 320 (468)
+...+..-+..|.. .....++|+|+.|.||+++++ +.+.++||..|.
T Consensus 156 ~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 156 FLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 11222233334432 234559999999999999985 889999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.016 Score=57.03 Aligned_cols=144 Identities=19% Similarity=0.212 Sum_probs=95.6
Q ss_pred CCCceeeecCcEEEEEEEecCCcEEEEEeccccc---chH------------------HHHHH-HHHHHHHHHHHhcCCC
Q 012214 167 NANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTV---DDE------------------ELLKL-EEFINEIVILSQINHR 224 (468)
Q Consensus 167 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~---~~~------------------~~~~~-~~~~~Ei~~l~~l~h~ 224 (468)
.+...|..|--+.||.+.-.+|..+|||+.+... .+. ....+ .-...|+.-|.+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3456688999999999998899999999765321 000 00111 1234677777777655
Q ss_pred ceeeEeeeeccCCcceeEeeecCCCCh-hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCE
Q 012214 225 NVVKLLGCCLETEVPLLVYEFIPNGTL-YQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNI 303 (468)
Q Consensus 225 niv~l~g~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NI 303 (468)
.|...--... ....|||+|+....- ...|+ ...++...+...-.|++.-|.-|-+.++ +||.||+--|+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK------d~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~ 296 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK------DASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNL 296 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccc------cccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhh
Confidence 5432111111 234699999853211 11222 2357777888888999999998888775 99999999999
Q ss_pred EEcCCCcEEEEecCCccc
Q 012214 304 LLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 304 Ll~~~~~~kl~DfGla~~ 321 (468)
|+. +|.+.|+|-+-+..
T Consensus 297 Lyh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 297 LYH-DGKLYIIDVSQSVE 313 (520)
T ss_pred eEE-CCEEEEEEcccccc
Confidence 985 46899999887643
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.037 Score=54.04 Aligned_cols=128 Identities=16% Similarity=0.280 Sum_probs=77.0
Q ss_pred EEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCC--CceeeEeeeeccCC--cceeEeeecCCCChhhHh
Q 012214 180 VYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH--RNVVKLLGCCLETE--VPLLVYEFIPNGTLYQHL 255 (468)
Q Consensus 180 Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l 255 (468)
+|..... ++.+++. ... ............+|..+++.+.- .-+.+.+++|.++. ..+.||+++++..+.+.+
T Consensus 41 t~~~~~~-~~~~vlR-~P~--~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~ 116 (321)
T COG3173 41 TFRLGDT-GQKYVLR-KPP--RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSAL 116 (321)
T ss_pred eEEEecC-CceEEEe-cCC--ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcC
Confidence 4444333 6777877 331 11111334455678888877743 34456678887766 779999999885443322
Q ss_pred hhcccCCCCCCCHHHHHHHHH-HHHHHHH--------------------------------------------------H
Q 012214 256 HDRHQNEEFPLTWEMRLRIAT-EVAGALA--------------------------------------------------Y 284 (468)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~i~~-qia~gL~--------------------------------------------------y 284 (468)
... +.. .+++. .+++.|+ +
T Consensus 117 ~~~--------~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 117 PPE--------SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred Ccc--------cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 110 000 01111 3333333 3
Q ss_pred HHhCC-----CCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 285 LHSAT-----SSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 285 LH~~~-----~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
|+.+. .+.++|+|+.+.|++++++.-+=|.||+++..
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 33322 25599999999999999998899999999864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.021 Score=55.29 Aligned_cols=73 Identities=22% Similarity=0.216 Sum_probs=44.6
Q ss_pred CceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc---CCCceeeEeeeeccCCcceeEeee
Q 012214 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI---NHRNVVKLLGCCLETEVPLLVYEF 245 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~~~~~~lV~E~ 245 (468)
.+.++.|.-..+|+.. .+++.+.||.-... ....|..|+.-|+.| .--.+.+++++....+..+||+||
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~-------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSES-------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEGG-------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecChh-------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 3458888889999877 56788999976521 123466777777777 345577888887777778999999
Q ss_pred cCCC
Q 012214 246 IPNG 249 (468)
Q Consensus 246 ~~~g 249 (468)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 9876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.017 Score=59.03 Aligned_cols=50 Identities=18% Similarity=0.250 Sum_probs=39.0
Q ss_pred HHHHHHHHHHHhcCCCceeeEeeeeccC-CcceeEeeecCCCChhhHhhhcc
Q 012214 209 EEFINEIVILSQINHRNVVKLLGCCLET-EVPLLVYEFIPNGTLYQHLHDRH 259 (468)
Q Consensus 209 ~~~~~Ei~~l~~l~h~niv~l~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~ 259 (468)
...+-...+++.+.|+|+..++++.... ....+|+|++ +.||.+.+..+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 3456678899999999999999887543 3467889998 669999887643
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.061 Score=53.62 Aligned_cols=141 Identities=21% Similarity=0.252 Sum_probs=76.9
Q ss_pred eeeecCcEEEEEEEecC-----CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCcee-eEeeeeccCCcceeEee
Q 012214 171 ILGQGGQGTVYKGMLED-----GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVV-KLLGCCLETEVPLLVYE 244 (468)
Q Consensus 171 ~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~g~~~~~~~~~lV~E 244 (468)
.|-.|-.-.+|+....+ ++.+++|+..... . ..+ ...+|..+++.+...++. ++++++... .|++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~---~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e 113 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-E---LFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE 113 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-C---eee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence 35456667788876432 3678888764421 1 111 124688888877543333 455655332 5899
Q ss_pred ecCCCChhhH-----------------hhhcc-cCCCCCCCHHHHHHHHHHH-----------------HHHHHHH----
Q 012214 245 FIPNGTLYQH-----------------LHDRH-QNEEFPLTWEMRLRIATEV-----------------AGALAYL---- 285 (468)
Q Consensus 245 ~~~~gsL~~~-----------------l~~~~-~~~~~~l~~~~~~~i~~qi-----------------a~gL~yL---- 285 (468)
|+++.+|... ++... .....+..+.++..+..++ ...+..|
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9987776421 11100 0001112233333333221 1112222
Q ss_pred Hh-CCCCCEEecCCCCCCEEEcC-CCcEEEEecCCcc
Q 012214 286 HS-ATSSPIYHRDIKSTNILLDQ-RYRAKVADFGTSK 320 (468)
Q Consensus 286 H~-~~~~~iiH~DLkp~NILl~~-~~~~kl~DfGla~ 320 (468)
.. .....++|+|+++.||++++ ++.+.++||..+.
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 21 12334899999999999986 5789999998874
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.0012 Score=74.69 Aligned_cols=160 Identities=13% Similarity=-0.007 Sum_probs=110.4
Q ss_pred HHHHHHHHhcCCCceeeEeeeecc--CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 012214 212 INEIVILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289 (468)
Q Consensus 212 ~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 289 (468)
..|....+...|+++.....-... ....+.+++++..|.+.+.+-...... +.+...-+.-...+......-+|+..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~-~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEES-PDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccC-CcchhchHHHHHHHHHhccchhhhcc
Confidence 344445556688888776554432 345678899999999999887643222 22332222222233244445555432
Q ss_pred --CCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHH
Q 012214 290 --SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELL 367 (468)
Q Consensus 290 --~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~ 367 (468)
...-+|++||+.|.+|..+.++|++++|+.++....... .....+++-|+.|+....-.++.++|+|+.|+.+|+..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf-~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF-FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHhh-hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 344799999999999999999999999999844333222 23345677889999888888888899999999999998
Q ss_pred hCCCCC
Q 012214 368 TGKKPI 373 (468)
Q Consensus 368 tG~~p~ 373 (468)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887775
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.12 Score=50.48 Aligned_cols=29 Identities=31% Similarity=0.398 Sum_probs=25.0
Q ss_pred CCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 291 ~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
..++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 44999999999999988 578999999753
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.18 Score=51.11 Aligned_cols=77 Identities=14% Similarity=0.132 Sum_probs=48.1
Q ss_pred CceeeecCcEEEEEEEecCCcEEEEEecccccc--hH-HHHHHHHHHHHHHHHHhcC---CCceeeEeeeeccCCcceeE
Q 012214 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVD--DE-ELLKLEEFINEIVILSQIN---HRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~--~~-~~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~lV 242 (468)
.+.||.|....||+.... +..++||.-..... .. .......-..|+..|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 356899999999998864 55688997541111 00 0011223334566665553 357788888887 446789
Q ss_pred eeecCC
Q 012214 243 YEFIPN 248 (468)
Q Consensus 243 ~E~~~~ 248 (468)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.18 Score=50.08 Aligned_cols=76 Identities=22% Similarity=0.235 Sum_probs=45.4
Q ss_pred eeeecCcEEEEEEEecCC-cEEEEEecccccc---hHHHHHHHHHHHHHHHHHhcC--CC-ceeeEeeeeccCCcceeEe
Q 012214 171 ILGQGGQGTVYKGMLEDG-RIIAVKKSKLTVD---DEELLKLEEFINEIVILSQIN--HR-NVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 171 ~LG~G~fG~Vy~~~~~~g-~~vavK~l~~~~~---~~~~~~~~~~~~Ei~~l~~l~--h~-niv~l~g~~~~~~~~~lV~ 243 (468)
.||.|....||++..++| +.|+||.-..-.. .......++..-|...|+... -| .+.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999997654 6899995321110 000122334456667776652 34 44455544 345556899
Q ss_pred eecCC
Q 012214 244 EFIPN 248 (468)
Q Consensus 244 E~~~~ 248 (468)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.43 Score=46.25 Aligned_cols=30 Identities=23% Similarity=0.348 Sum_probs=24.8
Q ss_pred CCEEecCCCCCCEEEcCC--C---cEEEEecCCcc
Q 012214 291 SPIYHRDIKSTNILLDQR--Y---RAKVADFGTSK 320 (468)
Q Consensus 291 ~~iiH~DLkp~NILl~~~--~---~~kl~DfGla~ 320 (468)
..++|+|++++|||+..+ + .+++.||-+++
T Consensus 215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred eEEEcCccCHHhEeEccccccccccceeecccccc
Confidence 449999999999999665 3 58999998764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.31 Score=48.27 Aligned_cols=30 Identities=23% Similarity=0.343 Sum_probs=25.7
Q ss_pred CCEEecCCCCCCEEEcC-CCcEEEEecCCcc
Q 012214 291 SPIYHRDIKSTNILLDQ-RYRAKVADFGTSK 320 (468)
Q Consensus 291 ~~iiH~DLkp~NILl~~-~~~~kl~DfGla~ 320 (468)
..++|+|+.+.|||+++ ++.++++||..|.
T Consensus 182 ~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 182 VVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred eEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 34899999999999975 5789999999874
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.39 E-value=0.15 Score=50.26 Aligned_cols=54 Identities=26% Similarity=0.301 Sum_probs=47.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 266 LTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 266 l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
..+.+...|+++.+..+.-+..+- ++-|||+.-.||||+ +|++-|+||-+++..
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeecc
Confidence 567889999999998888887754 489999999999999 999999999999854
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.37 E-value=0.73 Score=52.72 Aligned_cols=30 Identities=33% Similarity=0.563 Sum_probs=25.4
Q ss_pred CCEEecCCCCCCEEEcCCC--cEE-EEecCCcc
Q 012214 291 SPIYHRDIKSTNILLDQRY--RAK-VADFGTSK 320 (468)
Q Consensus 291 ~~iiH~DLkp~NILl~~~~--~~k-l~DfGla~ 320 (468)
..+||+|+.+.|||++.+. .+. |.|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4499999999999999875 555 99999875
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.96 E-value=1.8 Score=42.81 Aligned_cols=141 Identities=23% Similarity=0.346 Sum_probs=77.8
Q ss_pred eeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCc------eeeEeee----eccCCccee
Q 012214 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN------VVKLLGC----CLETEVPLL 241 (468)
Q Consensus 172 LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~g~----~~~~~~~~l 241 (468)
|.+ .--.+|+....+|+. ++|+....... .+...|+..+..+.-.. +.++-|- .......+-
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~~~~------~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPGWTR------AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCCCCH------HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 444 445789988877776 88887664222 23445666666662111 2222221 111136678
Q ss_pred EeeecCCCChhh-H-----------h---hh----cc---cCCCCCCCHHH-------------HHHHHHHHHHHHHHHH
Q 012214 242 VYEFIPNGTLYQ-H-----------L---HD----RH---QNEEFPLTWEM-------------RLRIATEVAGALAYLH 286 (468)
Q Consensus 242 V~E~~~~gsL~~-~-----------l---~~----~~---~~~~~~l~~~~-------------~~~i~~qia~gL~yLH 286 (468)
+++|++|..+.. . + +. .. ........|.. -.....++...+..+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 899999888772 1 0 00 00 00011123331 0112234444444444
Q ss_pred hC----CC---CCEEecCCCCCCEEEcCCCc-EEEEecCCcc
Q 012214 287 SA----TS---SPIYHRDIKSTNILLDQRYR-AKVADFGTSK 320 (468)
Q Consensus 287 ~~----~~---~~iiH~DLkp~NILl~~~~~-~kl~DfGla~ 320 (468)
+. -. ..+||+|+.|.||+++.+.. +-+.||+-+.
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 32 11 22899999999999999875 8999999874
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.73 E-value=0.36 Score=44.43 Aligned_cols=153 Identities=18% Similarity=0.174 Sum_probs=85.8
Q ss_pred CcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecCCCChhhHh
Q 012214 176 GQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHL 255 (468)
Q Consensus 176 ~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l 255 (468)
+.++.-.+..+-|.. .+|++...... ....-|.++.+++.+++ .|+++..= +.-..-++.|+|.....
T Consensus 74 gNsTl~~~kt~iG~L-~lKKi~slp~~---~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---- 141 (308)
T PF07387_consen 74 GNSTLLIGKTKIGPL-FLKKIRSLPCC---INDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---- 141 (308)
T ss_pred CceEEEEeccccchh-hhhhccCCCcc---cchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----
Confidence 444544444333433 44444322111 12345678888887764 45666521 22344588888842110
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCceeeecccc
Q 012214 256 HDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQG 335 (468)
Q Consensus 256 ~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 335 (468)
.. .-.|..+ ..+|.-.|+.. ...+|+|-.|+||+-|.+|.+||.|-+..- . .
T Consensus 142 ----------~~---~N~i~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~-----------~ 193 (308)
T PF07387_consen 142 ----------NF---SNFITAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--E-----------N 193 (308)
T ss_pred ----------ch---hHHHHHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhh--h-----------h
Confidence 11 1112222 35677788543 349999999999999999999999987532 1 0
Q ss_pred cCCccCccccccCCCCCcccHHHHHHHHHHHHhCCC
Q 012214 336 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKK 371 (468)
Q Consensus 336 t~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~ 371 (468)
+..|.--|+ ...|.++.+=+|=.-++++....+
T Consensus 194 ~V~~vN~~Y---~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 194 QVNMVNIEY---ESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred eeeEEeeec---cccChHHHHHHHHHHHHHHHHHHh
Confidence 111222111 234667777777777777766443
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.68 E-value=0.23 Score=50.15 Aligned_cols=73 Identities=21% Similarity=0.281 Sum_probs=42.1
Q ss_pred eeeecCcEEEEEEEecCC--cE-----EEEEecccccchHHHHHHHHHHHHHHHHHhcCCCce-eeEeeeeccCCcceeE
Q 012214 171 ILGQGGQGTVYKGMLEDG--RI-----IAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNV-VKLLGCCLETEVPLLV 242 (468)
Q Consensus 171 ~LG~G~fG~Vy~~~~~~g--~~-----vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV 242 (468)
.|..|-...+|++...++ .. |.++.... .. ...-+-.+|+.+++.+...++ .++++.+.. .++
T Consensus 57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~----~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l 127 (383)
T PTZ00384 57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YN----SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTI 127 (383)
T ss_pred EeCCcccceEEEEEecCCCCCccccceEEEEeccC-CC----ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEE
Confidence 455577788898875432 12 44443211 11 111123468888888865444 445565542 599
Q ss_pred eeecCCCChh
Q 012214 243 YEFIPNGTLY 252 (468)
Q Consensus 243 ~E~~~~gsL~ 252 (468)
+||++|.+|.
T Consensus 128 ~efIeGr~l~ 137 (383)
T PTZ00384 128 QEWVEGNTMG 137 (383)
T ss_pred EEEeccccCC
Confidence 9999987764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.53 E-value=4.5 Score=39.86 Aligned_cols=28 Identities=21% Similarity=0.274 Sum_probs=23.5
Q ss_pred CCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 291 ~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
..+||+|+.+.|||++ + .+.|.||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3489999999999995 4 57899999874
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.38 E-value=1.1 Score=41.71 Aligned_cols=59 Identities=25% Similarity=0.289 Sum_probs=42.7
Q ss_pred CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc---CCCceeeEeeeeccCCcceeEeeecCCCChh
Q 012214 187 DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI---NHRNVVKLLGCCLETEVPLLVYEFIPNGTLY 252 (468)
Q Consensus 187 ~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 252 (468)
+...+-||+-.. .....|..|+.-|..+ +--.+.+++.+-.+..+.++|+||++-+++.
T Consensus 38 g~~~~FvK~n~~-------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 38 GTDPFFVKCNQR-------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CCcceEEEecch-------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 456788885322 3345677787666666 3456778888888889999999999987775
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.53 E-value=0.32 Score=49.02 Aligned_cols=78 Identities=21% Similarity=0.164 Sum_probs=46.9
Q ss_pred CceeeecCcEEEEEEEecC-CcEEEEEecccc--cchHHHHHHHHHHHHHHHHHhcC--CC-ceeeEeeeeccCCcceeE
Q 012214 169 NRILGQGGQGTVYKGMLED-GRIIAVKKSKLT--VDDEELLKLEEFINEIVILSQIN--HR-NVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~~~~~Ei~~l~~l~--h~-niv~l~g~~~~~~~~~lV 242 (468)
.+.||.|.-..||++...+ ++.|+||.-..- .........++..-|.+.|+... .| .+.+++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3468999999999999743 567999953211 11111133445566777777652 34 45556544 34455678
Q ss_pred eeecCC
Q 012214 243 YEFIPN 248 (468)
Q Consensus 243 ~E~~~~ 248 (468)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888754
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.06 E-value=0.55 Score=47.15 Aligned_cols=60 Identities=15% Similarity=0.169 Sum_probs=41.9
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEecCCCCCCEEEcCC
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS-ATSSPIYHRDIKSTNILLDQR 308 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLkp~NILl~~~ 308 (468)
.++=+|+.+.++..++.... .++....+++.-.++|+--+-- .+ ++|.|+.|.||++.-+
T Consensus 321 vl~E~~~~Gl~v~~~v~~~~------~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWKS------QPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIRFN 381 (565)
T ss_pred eeeeeccccccHHhhhhccc------ChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEEec
Confidence 45667888889988887632 3444556666666666655443 34 9999999999999543
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=91.22 E-value=0.22 Score=48.69 Aligned_cols=53 Identities=23% Similarity=0.226 Sum_probs=33.3
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCCCEEecCCCCCCEEEcCC------------------CcEEEEecCCcccc
Q 012214 270 MRLRIATEVAGALAYLHS-ATSSPIYHRDIKSTNILLDQR------------------YRAKVADFGTSKFI 322 (468)
Q Consensus 270 ~~~~i~~qia~gL~yLH~-~~~~~iiH~DLkp~NILl~~~------------------~~~kl~DfGla~~~ 322 (468)
-+..+..|||--.--+-. .++..++|.||||+|||+-+. -.++|.||.+++..
T Consensus 276 YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 276 YVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 345567777543321322 234459999999999999432 23577788777643
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 468 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-47 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-46 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-31 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-30 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-29 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-27 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-24 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-22 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-22 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-22 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-21 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-21 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-20 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-19 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 6e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-06 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 356 bits (916), Expect = e-121
Identities = 114/295 (38%), Positives = 167/295 (56%), Gaps = 11/295 (3%)
Query: 154 FSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFIN 213
+L++ATN+F+ ++G G G VYKG+L DG +A+K+ E +EEF
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRR----TPESSQGIEEFET 84
Query: 214 EIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLR 273
EI LS H ++V L+G C E +L+Y+++ NG L +HL+ ++WE RL
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM-SMSWEQRLE 143
Query: 274 IATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK-FIAMDQTHVTTK 332
I A L YLH+ I HRD+KS NILLD+ + K+ DFG SK +DQTH++T
Sbjct: 144 ICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200
Query: 333 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVH 392
++GT GY+DPEY +LT+KSDVYSFGVVL E+L + I + +E V+LA + V
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI--VQSLPREMVNLAEWAVE 258
Query: 393 SMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
S +L I+D L + F + A +CL L+ + RP+M +V +L
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 337 bits (866), Expect = e-114
Identities = 105/289 (36%), Positives = 170/289 (58%), Gaps = 4/289 (1%)
Query: 152 KLFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEF 211
K FS +EL A+++F+ ILG+GG G VYKG L DG ++AVK+ L + + +L+ F
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR--LKEERTQGGELQ-F 74
Query: 212 INEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMR 271
E+ ++S HRN+++L G C+ LLVY ++ NG++ L +R +++ PL W R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP-PLDWPKR 133
Query: 272 LRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTT 331
RIA A LAYLH I HRD+K+ NILLD+ + A V DFG +K + THVTT
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193
Query: 332 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391
++GT G++ PEY + + ++K+DV+ +GV+L+EL+TG++ A + ++V L +
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+++ +L ++D L ++ +A C + +RP M EV
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 322 bits (828), Expect = e-108
Identities = 102/308 (33%), Positives = 157/308 (50%), Gaps = 18/308 (5%)
Query: 150 RFKLFSSKELDKATNHFN------ANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDE 203
RF FS EL TN+F+ +G+GG G VYKG + + +AVKK VD
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 204 ELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEE 263
++F EI ++++ H N+V+LLG + + LVY ++PNG+L L
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP- 128
Query: 264 FPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK-FI 322
PL+W MR +IA A + +LH HRDIKS NILLD+ + AK++DFG ++
Sbjct: 129 -PLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE 382
QT +T++I GT Y+ PE ++T KSD+YSFGVVL+E++TG + + +E
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV----DEHRE 239
Query: 383 NVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442
L + + + D+ M + ++A +CL KRP +++V
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
Query: 443 ELNGIRGS 450
L + S
Sbjct: 300 LLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 9e-76
Identities = 68/317 (21%), Positives = 115/317 (36%), Gaps = 37/317 (11%)
Query: 154 FSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFIN 213
++ L + + +G G V+K L +AVK + D+ + +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKI--FPIQDK---QSWQNEY 67
Query: 214 EIVILSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGTLYQHLHDRHQNEEFPLTWE 269
E+ L + H N+++ +G L+ F G+L L ++W
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWN 121
Query: 270 MRLRIATEVAGALAYLHSATSS-------PIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322
IA +A LAYLH I HRDIKS N+LL A +ADFG +
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 323 AMDQTHVTTKIQ-GTFGYLDPEY-----HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWA 376
++ T Q GT Y+ PE + + D+Y+ G+VL EL +
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA--AD 239
Query: 377 GNTSQENVSLAAYF-----VHSMRKNRLHDILDDQLMKLGVKNQIM-TFANLAKRCLDLN 430
G + + + M++ +H L K+ M + C D +
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD 299
Query: 431 GKKRPTMEEVSMELNGI 447
+ R + V + +
Sbjct: 300 AEARLSAGCVGERITQM 316
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 6e-71
Identities = 84/289 (29%), Positives = 139/289 (48%), Gaps = 37/289 (12%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKK---SKLTVDDEELLKLEEFINEIVILSQINHRN 225
+ +G+GG G V+KG ++D ++A+K + E + K +EF E+ I+S +NH N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
+VKL G P +V EF+P G LY L D+ P+ W ++LR+ ++A + Y+
Sbjct: 85 IVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIALGIEYM 138
Query: 286 HSATSSPIYHRDIKSTNILLDQR-----YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 340
+ PI HRD++S NI L AKVADFG S+ H + + G F ++
Sbjct: 139 QNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWM 193
Query: 341 DPE--YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398
PE + T+K+D YSF ++L +LTG+ P + + + + +
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGP--FDEYSYGK----IKFINMIREEGL 247
Query: 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
I +D +L N+ + C + KKRP + EL+ +
Sbjct: 248 RPTIPEDCPPRL---------RNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 7e-71
Identities = 80/286 (27%), Positives = 130/286 (45%), Gaps = 35/286 (12%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
I+G GG G VY+ G +AVK ++ D++ +E E + + + H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
G CL+ LV EF G L + L + + ++ + A ++A + YLH
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIARGMNYLHDEA 125
Query: 290 SSPIYHRDIKSTNILLDQRYR--------AKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 341
PI HRD+KS+NIL+ Q+ K+ DFG ++ +T + G + ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSAA-GAYAWMA 182
Query: 342 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401
PE ++S + SDV+S+GV+L ELLTG+ P + G AY V +M K L
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVP--FRGIDGLA----VAYGV-AMNKLAL-P 234
Query: 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
I A L + C + + RP+ + +L I
Sbjct: 235 IPSTCPEPF---------AKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 2e-70
Identities = 82/282 (29%), Positives = 132/282 (46%), Gaps = 24/282 (8%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+G G GTV++ G +AVK L D ++ EF+ E+ I+ ++ H N+V
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKI--LMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
+G + +V E++ G+LY+ LH L RL +A +VA + YLH+
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 349
PI HR++KS N+L+D++Y KV DFG S+ A + GT ++ PE +
Sbjct: 158 -PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDEP 215
Query: 350 LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMK 409
+KSDVYSFGV+L EL T ++P W + V + RL +I + +
Sbjct: 216 SNEKSDVYSFGVILWELATLQQP--WGNLNPAQ----VVAAV-GFKCKRL-EIPRNLNPQ 267
Query: 410 LGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451
+ A + + C KRP+ + L + S+
Sbjct: 268 V---------AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-69
Identities = 79/283 (27%), Positives = 130/283 (45%), Gaps = 34/283 (12%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
++G+G G V K + +A+K+ + + E + FI E+ LS++NH N+VKL
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQ--IESESER----KAFIVELRQLSRVNHPNIVKL 66
Query: 230 LGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
G CL P+ LV E+ G+LY LH T + + + +AYLHS
Sbjct: 67 YGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPY--YTAAHAMSWCLQCSQGVAYLHSM 121
Query: 289 TSSPIYHRDIKSTNILLDQRYR-AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 347
+ HRD+K N+LL K+ DFGT+ D T +G+ ++ PE +
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 348 SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQL 407
S ++K DV+S+G++L E++T +KP F + + A+ + N L L
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKP-F-------DEIGGPAFRIMWAVHNGTRPPLIKNL 229
Query: 408 MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450
K +L RC + +RP+MEE+ + +
Sbjct: 230 PK--------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 2e-65
Identities = 59/284 (20%), Positives = 109/284 (38%), Gaps = 35/284 (12%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
L + G ++KG G I VK K+ K +F E L +H NV+ +
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTR--KSRDFNEECPRLRIFSHPNVLPV 72
Query: 230 LGCCLETEVPLL--VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS 287
LG C P + ++P G+LY LH+ F + ++ A ++A +A+LH+
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE---Y 344
I + S ++++D+ A+++ ++ PE
Sbjct: 130 LEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQK 182
Query: 345 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404
+D++SF V+L EL+T + P +A ++ E A R I
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVP--FADLSNMEIGMKVAL-----EGLRP-TIPP 234
Query: 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448
+ + L K C++ + KRP + + L ++
Sbjct: 235 GISPHV---------SKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 6e-63
Identities = 58/291 (19%), Positives = 108/291 (37%), Gaps = 42/291 (14%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
++G+G G VY G G + A++ + D+E+ L + F E++ Q H NVV
Sbjct: 39 ELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQL--KAFKREVMAYRQTRHENVVLF 94
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
+G C+ ++ TLY + D L +IA E+ + YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKI----VLDVNKTRQIAQEIVKGMGYLH--- 147
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA----MDQTHVTTKIQGTFGYLDPEYH 345
+ I H+D+KS N+ D + + DFG + G +L PE
Sbjct: 148 AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 346 QSSQL---------TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396
+ + SDV++ G + EL + P + ++ + +
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--FKTQPAEA----IIWQMG---T 257
Query: 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
++ + K +++ C ++RPT ++ L +
Sbjct: 258 GMKPNLSQIGMGK--------EISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 9e-63
Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 31/283 (10%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+ +G G GTVYKG +AVK +T + L+ F NE+ +L + H N++
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQ--AFKNEVGVLRKTRHVNILLF 85
Query: 230 LGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
+G T L +V ++ +LY HLH E + + IA + A + YLH+
Sbjct: 86 MGYS--TAPQLAIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHA- 138
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA-MDQTHVTTKIQGTFGYLDPE---Y 344
I HRD+KS NI L + K+ DFG + + +H ++ G+ ++ PE
Sbjct: 139 --KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 345 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404
S+ + +SDVY+FG+VL EL+TG+ P ++ +++ + L +
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIEMV--GRGSLSPDLSKVRS 252
Query: 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
+ ++ L CL +RP+ + E+ +
Sbjct: 253 NCPKRM---------KRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-59
Identities = 66/342 (19%), Positives = 127/342 (37%), Gaps = 48/342 (14%)
Query: 154 FSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFIN 213
++ E ++ ++G+G G VYKG L D R +AVK + + + FIN
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKV--FSFANRQ-----NFIN 54
Query: 214 E--IVILSQINHRNVVKLLGCCLETEVP-----LLVYEFIPNGTLYQHLHDRHQNEEFPL 266
E I + + H N+ + + LLV E+ PNG+L ++L
Sbjct: 55 EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TS 108
Query: 267 TWEMRLRIATEVAGALAYLHSATSS------PIYHRDIKSTNILLDQRYRAKVADFGTSK 320
W R+A V LAYLH+ I HRD+ S N+L+ ++DFG S
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168
Query: 321 FIA-------MDQTHVTTKIQGTFGYLDPEY-------HQSSQLTDKSDVYSFGVVLVEL 366
+ ++ + GT Y+ PE + D+Y+ G++ E+
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228
Query: 367 LTGKKPIFWAGNTSQENVSLAAYF-----VHSMRKNRLHDILDDQLMKLGVKNQIM--TF 419
+F + + ++ M+ + + + +N + +
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288
Query: 420 ANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKRAMFSKI 461
+ C D + + R T + + + ++ +++
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 5e-58
Identities = 66/293 (22%), Positives = 114/293 (38%), Gaps = 41/293 (13%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+LG+G G K + + V K + D+E F+ E+ ++ + H NV+K
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCLEHPNVLKF 72
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
+G + + + E+I GTL + W R+ A ++A +AYLH
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIASGMAYLH--- 125
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ-------------GT 336
S I HRD+ S N L+ + VADFG ++ + ++T G
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 337 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAG-NTSQENVSLAAYFVHSMR 395
++ PE +K DV+SFG+VL E++ + L +
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--DPDYLPRTMDFGLN--VRGFLD 241
Query: 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448
+ + F + RC DL+ +KRP+ ++ L +R
Sbjct: 242 RYCPPNCPPS-------------FFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-53
Identities = 65/306 (21%), Positives = 107/306 (34%), Gaps = 33/306 (10%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+ +G+G G V+ G G +AVK +E E EI + H N++
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKV--FFTTEEASWFRE---TEIYQTVLMRHENILGF 96
Query: 230 LGCCLETEVP----LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
+ ++ L+ ++ NG+LY +L L + L++A L +L
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHL 150
Query: 286 HSATSS-----PIYHRDIKSTNILLDQRYRAKVADFGTSKFIA---MDQTHVTTKIQGTF 337
H+ S I HRD+KS NIL+ + +AD G + + GT
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 338 GYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENVSLAAY 389
Y+ PE Q +D+YSFG++L E+ ++ +
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270
Query: 390 FVHSMRKNRLHDILDDQLMKLGVKNQIM-TFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448
MR+ L ++ + L C N R T V L +
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330
Query: 449 GSSKKK 454
S K
Sbjct: 331 ESQDIK 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-52
Identities = 67/304 (22%), Positives = 109/304 (35%), Gaps = 43/304 (14%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+G+G G V++G G +AVK + DE+ E E+ + H N++
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKI--FSSRDEKSWFRE---TELYNTVMLRHENILGF 67
Query: 230 LGCCLETEVP----LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
+ + + L+ + G+LY +L L LRI +A LA+L
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHL 121
Query: 286 HSATSS-----PIYHRDIKSTNILLDQRYRAKVADFGTSKFIA----MDQTHVTTKIQGT 336
H I HRD+KS NIL+ + + +AD G + + ++ GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GT 180
Query: 337 FGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENVSLAA 388
Y+ PE + D+++FG+VL E+ + +V
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 389 YFVHSMRKNRLHD-----ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443
MRK D I + + + A L K C N R T +
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLT----SLAKLMKECWYQNPSARLTALRIKKT 296
Query: 444 LNGI 447
L I
Sbjct: 297 LTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-50
Identities = 62/317 (19%), Positives = 113/317 (35%), Gaps = 57/317 (17%)
Query: 171 ILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINE--IVILSQINHRNVVK 228
+G+G G V++G G +AVK + +E + E I + H N++
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKI--FSSREER-----SWFREAEIYQTVMLRHENILG 100
Query: 229 LLGCCLETEVP----LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
+ + LV ++ +G+L+ +L+ +T E +++A A LA+
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAH 154
Query: 285 LHSATSS-----PIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI---QGT 336
LH I HRD+KS NIL+ + +AD G + + GT
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 337 FGYLDPE--------YHQSSQLTDKSDVYSFGVVLVELLTGKKP--------IFWAGNTS 380
Y+ PE H S ++D+Y+ G+V E+ + +
Sbjct: 215 KRYMAPEVLDDSINMKHFES--FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272
Query: 381 QENVSLAAYFVHSMRKNRLH---DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTM 437
+ V +K R + + ++ A + + C NG R T
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR--------VMAKIMRECWYANGAARLTA 324
Query: 438 EEVSMELNGIRGSSKKK 454
+ L+ + K
Sbjct: 325 LRIKKTLSQLSQQEGIK 341
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 68/276 (24%), Positives = 118/276 (42%), Gaps = 30/276 (10%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLT--VDDEELLKLEEFINEIVILSQINHRNV 226
+ +G+G VY+ L DG +A+KK ++ +D + + I EI +L Q+NH NV
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQLNHPNV 94
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHL-HDRHQNEEFPLTWEMR-LRIATEVAGALAY 284
+K +E +V E G L + + H + Q P E + ++ AL +
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP---ERTVWKYFVQLCSALEH 151
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 344
+HS + HRDIK N+ + K+ D G +F + T + + GT Y+ PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 345 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404
+ KSD++S G +L E+ + P F+ + ++ +K I
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP-FYGDKMNLYSL---------CKK-----IEQ 252
Query: 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
L + L C++ + +KRP + V
Sbjct: 253 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-42
Identities = 68/277 (24%), Positives = 118/277 (42%), Gaps = 29/277 (10%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKK-SKLTVDDEELLKLEEFINEIVILSQINHRNVV 227
+G G G K DG+I+ K+ ++ + E + ++E+ +L ++ H N+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK---QMLVSEVNLLRELKHPNIV 68
Query: 228 KLLGCCLETEVPLL--VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
+ ++ L V E+ G L + + E L E LR+ T++ AL
Sbjct: 69 RYYDRIIDRTNTTLYIVMEYCEGGDLASVI-TKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 286 HS--ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
H + HRD+K N+ LD + K+ DFG ++ + D + T + GT Y+ PE
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPE 186
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403
+KSD++S G +L EL P F A + + A + + R+
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPP-FTAFSQKE-----LAGKIREGKFRRIPYRY 240
Query: 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
D+L + R L+L RP++EE+
Sbjct: 241 SDEL------------NEIITRMLNLKDYHRPSVEEI 265
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-41
Identities = 65/274 (23%), Positives = 114/274 (41%), Gaps = 32/274 (11%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLT-VDDEELLKLEEFINEIVILSQINHRNVV 227
+ +G+G G EDGR +K+ ++ + +E EE E+ +L+ + H N+V
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER---EESRREVAVLANMKHPNIV 86
Query: 228 KLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMR-LRIATEVAGALAYLH 286
+ E +V ++ G L++ ++ + F E + L ++ AL ++H
Sbjct: 87 QYRESFEENGSLYIVMDYCEGGDLFKRIN-AQKGVLFQ---EDQILDWFVQICLALKHVH 142
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 346
I HRDIKS NI L + ++ DFG ++ + I GT YL PE +
Sbjct: 143 DRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICE 198
Query: 347 SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQ 406
+ +KSD+++ G VL EL T K F AG+ + S +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA-FEAGSMKN-----LVLKIISGSFPPVSLHYSYD 252
Query: 407 LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
L +L + N + RP++ +
Sbjct: 253 L------------RSLVSQLFKRNPRDRPSVNSI 274
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-41
Identities = 65/288 (22%), Positives = 110/288 (38%), Gaps = 56/288 (19%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
++G GG G V+K DG+ +K+ K E+ E+ L++++H N+V
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKY--------NNEKAEREVKALAKLDHVNIVH 68
Query: 229 LLGCCLETEVPL----------------LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRL 272
GC + + EF GTL Q + R L + L
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE---KLDKVLAL 125
Query: 273 RIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK 332
+ ++ + Y+HS + +RD+K +NI L + K+ DFG ++ T+
Sbjct: 126 ELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT--SLKNDGKRTR 180
Query: 333 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVH 392
+GT Y+ PE S + D+Y+ G++L ELL F F
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----------FFT 229
Query: 393 SMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+R + DI D + L ++ L + RP E+
Sbjct: 230 DLRDGIISDIFDKKE------------KTLLQKLLSKKPEDRPNTSEI 265
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 63/280 (22%), Positives = 120/280 (42%), Gaps = 40/280 (14%)
Query: 169 NRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLK--LEEFINEIVILSQINHRN 225
+ +G+G TVYKG+ E +A + + D +L K + F E +L + H N
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCE----LQDRKLTKSERQRFKEEAEMLKGLQHPN 86
Query: 226 VVKLLGCCLETEVP----LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGA 281
+V+ T +LV E + +GTL +L R + + ++ ++
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFK----VMKIKVLRSWCRQILKG 141
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRY-RAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 340
L +LH+ + PI HRD+K NI + K+ D G + + + GT ++
Sbjct: 142 LQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKA-VIGTPEFM 197
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF-VHSMRKNRL 399
PE ++ + + DVY+FG+ ++E+ T + P + S+ + Y V S K
Sbjct: 198 APEMYE-EKYDESVDVYAFGMCMLEMATSEYP--Y----SECQNAAQIYRRVTSGVKPAS 250
Query: 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
D + +K + + C+ N +R ++++
Sbjct: 251 FDKVAIPEVK-----------EIIEGCIRQNKDERYSIKD 279
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 170 RILGQGGQGTVYKGMLED---GRIIAVK--KSKLTVDDEELLKLEEFINEIVILSQINHR 224
LG GG TVY ED +A+K + EE L + F E+ SQ++H+
Sbjct: 17 DKLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPR-EKEETL--KRFEREVHNSSQLSHQ 71
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
N+V ++ E + LV E+I TL +++ PL+ + + ++ + +
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKH 126
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTT--KIQGTFGYLDP 342
H I HRDIK NIL+D K+ DFG +K A+ +T +T + GT Y P
Sbjct: 127 AHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSP 181
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
E + + +D+YS G+VL E+L G+ P
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-40
Identities = 64/317 (20%), Positives = 117/317 (36%), Gaps = 40/317 (12%)
Query: 154 FSSKELDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFI 212
F + H+ + LG+GG V L DG A+K+ + +++ EE
Sbjct: 19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR--ILCHEQQ--DREEAQ 74
Query: 213 NEIVILSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGTLYQHLHDRHQNEEFPLTW 268
E + NH N+++L+ CL L+ F GTL+ + F LT
Sbjct: 75 READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTE 133
Query: 269 EMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH 328
+ L + + L +H+ HRD+K TNILL + + D G+ +
Sbjct: 134 DQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 329 VTTKIQ--------GTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAG 377
+ T Y PE + +++DV+S G VL ++ G+ P +
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP-YDMV 249
Query: 378 NTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTM 437
++V+LA V + L L + ++ +RP +
Sbjct: 250 FQKGDSVALA---VQNQLSIPQSPRHSSAL------------WQLLNSMMTVDPHQRPHI 294
Query: 438 EEVSMELNGIRGSSKKK 454
+ +L ++ + +
Sbjct: 295 PLLLSQLEALQPPAPGQ 311
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 62/274 (22%), Positives = 97/274 (35%), Gaps = 37/274 (13%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVV 227
LG G G V+K EDGR+ AVK+S + + E+ ++ H V
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK--DRARKLAEVGSHEKVGQHPCCV 120
Query: 228 KLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLR-IATEVAGALAYLH 286
+L E + L E +L QH P E ++ + ALA+LH
Sbjct: 121 RLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLP---EAQVWGYLRDTLLALAHLH 174
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 346
S + H D+K NI L R R K+ DFG + +G Y+ PE Q
Sbjct: 175 S---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV--ELGTAGAGEVQEGDPRYMAPELLQ 229
Query: 347 SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQ 406
+DV+S G+ ++E+ + +R+ L
Sbjct: 230 -GSYGTAADVFSLGLTILEVACNMELPHGGEG------------WQQLRQGYLPPEFTAG 276
Query: 407 LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
L ++ L+ + K R T E +
Sbjct: 277 LSS--------ELRSVLVMMLEPDPKLRATAEAL 302
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-39
Identities = 62/295 (21%), Positives = 111/295 (37%), Gaps = 52/295 (17%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+ LG+GG G V++ D A+K+ +L + E+ + E+ L+++ H +V+
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR---EKVMREVKALAKLEHPGIVR 67
Query: 229 LLGCCLE---------TEVPLLVY---EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT 276
LE + + +Y + L ++ R EE + L I
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE--RSVCLHIFL 125
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ-- 334
++A A+ +LHS + HRD+K +NI KV DFG + D+ T
Sbjct: 126 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 335 ---------GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVS 385
GT Y+ PE + + K D++S G++L ELL
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY----------------- 225
Query: 386 LAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ R L D+ + + L + + + L + +RP +
Sbjct: 226 --PFSTQMERVRTLTDVRNLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-38
Identities = 68/275 (24%), Positives = 114/275 (41%), Gaps = 32/275 (11%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+LG+G G VY G L + IA+K+ + + + + EI + + H+N+V+
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKE----IPERDSRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT-EVAGALAYLHS 287
LG E + E +P G+L L R + E + T ++ L YLH
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALL--RSKWGPLKDN-EQTIGFYTKQILEGLKYLH- 139
Query: 288 ATSSPIYHRDIKSTNILLDQRY-RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE--Y 344
+ I HRDIK N+L++ K++DFGTSK +A T GT Y+ PE
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIID 196
Query: 345 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404
+D++S G ++E+ TGK P + AA F + ++H +
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPP--FYELGEP----QAAMF--KVGMFKVHPEIP 248
Query: 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
+ + +C + + KR +
Sbjct: 249 ESMSAEA--------KAFILKCFEPDPDKRACAND 275
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-38
Identities = 44/211 (20%), Positives = 81/211 (38%), Gaps = 29/211 (13%)
Query: 170 RILGQGGQGTVYKG--MLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVV 227
+ GG G +Y +GR + +K + D E + E L+++ H ++V
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQ---AMAMAERQFLAEVVHPSIV 142
Query: 228 KLL-----GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
++ V +V E++ +L + L + E+ AL
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPAL 195
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 342
+YLHS + + D+K NI+L + + K+ D G ++ + GT G+ P
Sbjct: 196 SYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINSFGY---LYGTPGFQAP 246
Query: 343 EYHQ-SSQLTDKSDVYSFGVVLVELLTGKKP 372
E + T +D+Y+ G L L
Sbjct: 247 E--IVRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 57/210 (27%), Positives = 84/210 (40%), Gaps = 22/210 (10%)
Query: 170 RILGQGGQGTVYKGMLED---GRIIAVK--KSKLTVDDEELLKLEEFINEIVILSQINHR 224
R++G+GG G VY+ ED RI+A+K L+ D E ++
Sbjct: 40 RLVGRGGMGDVYEA--EDTVRERIVALKLMSETLS-SDPVFR--TRMQREARTAGRLQEP 94
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
+VV + + I L L + PL + I ++ AL
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDA 149
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTT--KIQGTFGYLDP 342
H+A HRD+K NIL+ A + DFG + A +T GT Y+ P
Sbjct: 150 AHAAG---ATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAP 204
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
E S T ++D+Y+ VL E LTG P
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-38
Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 49/295 (16%)
Query: 170 RILGQGGQGTVYKGMLEDGRI-IAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+G+G G V+ G L +AVK + T+ + +F+ E IL Q +H N+V+
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK---AKFLQEARILKQYSHPNIVR 176
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
L+G C + + +V E + G L + E L + L++ + A + YL
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLE-- 230
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY--LDPEYHQ 346
S HRD+ + N L+ ++ K++DFG S+ A D + + PE
Sbjct: 231 -SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALN 288
Query: 347 SSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHS---MRK-----N 397
+ + +SDV+SFG++L E + G P + ++Q+ FV + +
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASP--YPNLSNQQ----TREFVEKGGRLPCPELCPD 342
Query: 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452
+ ++M +C +RP+ + EL IR +
Sbjct: 343 AVF--------------RLME------QCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-38
Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 170 RILGQGGQGTVYKGMLED---GRIIAVK--KSKLTVDDEELLKLEEFINEIVILSQINHR 224
ILG GG V+ D R +AVK ++ L D F E + +NH
Sbjct: 18 EILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLA-RDPSFY--LRFRREAQNAAALNHP 72
Query: 225 NVVKLL--GC--CLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
+V + G +P +V E++ TL +H P+T + + + +
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQ 127
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTT--KIQGTFG 338
AL + H I HRD+K NI++ KV DFG ++ IA VT + GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 339 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
YL PE + + +SDVYS G VL E+LTG+ P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-37
Identities = 71/309 (22%), Positives = 122/309 (39%), Gaps = 63/309 (20%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
+ F +LGQG G V K D R A+KK + T + + +E+++L+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL-----SEVMLLASL 59
Query: 222 NHRNVVKLLGCCLETEVPL-------------LVYEFIPNGTLYQHLHDRHQNEEFPLTW 268
NH+ VV+ LE + + E+ NGTLY +H + N++ W
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 269 EMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI------ 322
R+ ++ AL+Y+HS I HRD+K NI +D+ K+ DFG +K +
Sbjct: 120 ----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 323 --------AMDQTHVTTKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPI 373
++T+ I GT Y+ E + +K D+YS G++ E++ P
Sbjct: 173 LKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF 228
Query: 374 FWAGNTSQ--ENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNG 431
+ + + DD MK + + +D +
Sbjct: 229 STGMERVNILKKLRSVSI--------EFPPDFDDNKMK--------VEKKIIRLLIDHDP 272
Query: 432 KKRPTMEEV 440
KRP +
Sbjct: 273 NKRPGARTL 281
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-37
Identities = 63/288 (21%), Positives = 116/288 (40%), Gaps = 48/288 (16%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKK-SKLTVDDEELLKLEEFINEIVILSQINHRN--V 226
+ +G GG V++ + E +I A+K + D++ L+ + NEI L+++ + +
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT---LDSYRNEIAYLNKLQQHSDKI 90
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH 286
++L + + +V E N L L + + R + A+ +H
Sbjct: 91 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIH 144
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ-GTFGYLDPE-- 343
I H D+K N L+ K+ DFG + + D T V Q GT Y+ PE
Sbjct: 145 QHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 344 ---------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF--VH 392
S+++ KSDV+S G +L + GK P + +Q ++ +
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQ----ISKLHAIID 254
Query: 393 SMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ DI + L ++ K CL + K+R ++ E+
Sbjct: 255 PNHEIEFPDIPEKDLQ------------DVLKCCLKRDPKQRISIPEL 290
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-37
Identities = 68/317 (21%), Positives = 110/317 (34%), Gaps = 53/317 (16%)
Query: 130 QNGGLLLQQMLNSYDGSVIDRFKLFSSKELDKATNHFNANRILGQGGQGTVYKGM-LEDG 188
N G+LL + L D + + + +G+G G V++ + G
Sbjct: 36 DNEGVLLTEKLKPVDYEYREEVHWMTHQPR------------VGRGSFGEVHRMKDKQTG 83
Query: 189 RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 248
AVKK +L V E E+V + ++ +V L G E + E +
Sbjct: 84 FQCAVKKVRLEVFRVE---------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134
Query: 249 GTLYQHLHDRHQNEEFPLTWEMRLRIAT-EVAGALAYLHSATSSPIYHRDIKSTNILLDQ 307
G+L Q + Q P E R + L YLH + I H D+K+ N+LL
Sbjct: 135 GSLGQLI---KQMGCLP---EDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSS 185
Query: 308 R-YRAKVADFGTSKFIAMDQTHVTTK----IQGTFGYLDPEYHQSSQLTDKSDVYSFGVV 362
RA + DFG + + D + I GT ++ PE K D++S +
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245
Query: 363 LVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANL 422
++ +L G P W +Q + S + L A
Sbjct: 246 MLHMLNGCHP--W----TQYFRGPLCLKIASEPPPIRE--IPPSCAPL--------TAQA 289
Query: 423 AKRCLDLNGKKRPTMEE 439
+ L R + E
Sbjct: 290 IQEGLRKEPVHRASAME 306
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 63/287 (21%), Positives = 116/287 (40%), Gaps = 46/287 (16%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH--RNVV 227
+ +G GG V++ + E +I A+K L D + L+ + NEI L+++ ++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ--TLDSYRNEIAYLNKLQQHSDKII 72
Query: 228 KLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS 287
+L + + +V E N L L + + R + A+ +H
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ 126
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ-GTFGYLDPE--- 343
I H D+K N L+ K+ DFG + + D T V Q GT Y+ PE
Sbjct: 127 HG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 344 --------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395
S+++ KSDV+S G +L + GK P + +Q + +
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQ---------ISKLH 231
Query: 396 K--NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ H+I + + +++ + K CL + K+R ++ E+
Sbjct: 232 AIIDPNHEIEFPDIPEKDLQDVL-------KCCLKRDPKQRISIPEL 271
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 15/217 (6%)
Query: 158 ELDKATNHFNANRILGQGGQGTVYKGMLEDGRI-IAVKKSKLTVDDEELLKLEEFINEIV 216
E+++ LG G G VY+G+ + + +AVK K E+ +++EEF+ E
Sbjct: 216 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAA 268
Query: 217 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT 276
++ +I H N+V+LLG C ++ EF+ G L +L + ++ + L +AT
Sbjct: 269 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMAT 325
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGT 336
+++ A+ YL HR++ + N L+ + + KVADFG S+ + D +
Sbjct: 326 QISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 382
Query: 337 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
+ PE ++ + KSDV++FGV+L E+ T G P
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 64/285 (22%), Positives = 113/285 (39%), Gaps = 42/285 (14%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH--RNVV 227
+ +G GG V++ + E +I A+K L D + L+ + NEI L+++ ++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ--TLDSYRNEIAYLNKLQQHSDKII 119
Query: 228 KLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS 287
+L + + +V E N L L + + R + A+ +H
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ 173
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ-GTFGYLDPE--- 343
I H D+K N L+ K+ DFG + + D T V Q G Y+ PE
Sbjct: 174 HG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 344 --------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395
S+++ KSDV+S G +L + GK P + +Q +S +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQ--ISKLHAIIDPNH 285
Query: 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ DI + L ++ K CL + K+R ++ E+
Sbjct: 286 EIEFPDIPEKDLQ------------DVLKCCLKRDPKQRISIPEL 318
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-36
Identities = 58/222 (26%), Positives = 110/222 (49%), Gaps = 24/222 (10%)
Query: 170 RILGQGGQGTVYKGML----EDGRI-IAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
++LG G GTVYKG+ E +I +A+K+ + + +E ++E +++ +++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN---KEILDEAYVMASVDNP 77
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
+V +LLG CL + V L+ + +P G L ++ + N + + L ++A + Y
Sbjct: 78 HVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNY 132
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGT---FGYLD 341
L + HRD+ + N+L+ K+ DFG +K + ++ +G ++
Sbjct: 133 LEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMA 187
Query: 342 PEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
E T +SDV+S+GV + EL+T G KP + G + E
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASE 227
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 61/308 (19%), Positives = 121/308 (39%), Gaps = 59/308 (19%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVV 227
+G G G+V+K + DG I A+K+SK + + + E+ + + H +VV
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV--DEQNALREVYAHAVLGQHSHVV 74
Query: 228 KLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEE-FPLTWEMRLR-IATEVAGALAYL 285
+ E + L+ E+ G+L + + ++ F E L+ + +V L Y+
Sbjct: 75 RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK---EAELKDLLLQVGRGLRYI 131
Query: 286 HSATSSPIYHRDIKSTNILLDQ-------------------RYRAKVADFGTSKFIAMDQ 326
HS + H DIK +NI + + + K+ D G I+ Q
Sbjct: 132 HS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 327 THVTTKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVS 385
G +L E ++ K+D+++ + +V +P+ G+
Sbjct: 189 VEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA-EPLPRNGDQ------ 236
Query: 386 LAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445
H +R+ RL I L + F L K + + ++RP+ + ++ +
Sbjct: 237 -----WHEIRQGRLPRI-PQVLSQ--------EFTELLKVMIHPDPERRPSAMAL-VKHS 281
Query: 446 GIRGSSKK 453
+ +S+K
Sbjct: 282 VLLSASRK 289
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 60/286 (20%), Positives = 117/286 (40%), Gaps = 41/286 (14%)
Query: 166 FNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HR 224
F +LG G +GT+ + D R +AVK+ + + E+ +L + + H
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKR--ILPECFSFAD-----REVQLLRESDEHP 78
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
NV++ + + + E TL + + ++F + + + LA+
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCA-ATL----QEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 285 LHSATSSPIYHRDIKSTNILL-----DQRYRAKVADFGTSKFIAMDQ--THVTTKIQGTF 337
LHS I HRD+K NIL+ + +A ++DFG K +A+ + + + GT
Sbjct: 134 LHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 338 GYLDPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394
G++ PE T D++S G V +++ F Q N+ L A
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC----- 245
Query: 395 RKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
L + ++ + + L ++ + ++ +KRP+ + V
Sbjct: 246 ---SLDCLHPEKHEDVIAR-------ELIEKMIAMDPQKRPSAKHV 281
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-35
Identities = 72/303 (23%), Positives = 125/303 (41%), Gaps = 52/303 (17%)
Query: 170 RILGQGGQGTVYKGMLE-----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
+ LG+G G+V + G ++AVKK + + ++ L +F EI IL + H
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILKSLQHD 71
Query: 225 NVVKLLGCCLET-EVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
N+VK G C L L+ E++P G+L +L + + L+ +++ +
Sbjct: 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGM 127
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYL 340
YL + HRD+ + NIL++ R K+ DFG +K + D+ K G +
Sbjct: 128 EYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400
PE S+ + SDV+SFGVVL EL T + + M L
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG--QMIVFHLI 242
Query: 401 DILDD---------------QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445
++L + +M C + N +RP+ ++++ ++
Sbjct: 243 ELLKNNGRLPRPDGCPDEIYMIM---------------TECWNNNVNQRPSFRDLALRVD 287
Query: 446 GIR 448
IR
Sbjct: 288 QIR 290
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 170 RILGQGGQGTVYKGMLEDGR----IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
++G+G G VY G L D AVK D E+ +F+ E +I+ +H N
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKDFSHPN 151
Query: 226 VVKLLGCCLETEVPLL-VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
V+ LLG CL +E L V ++ +G L + +NE T + + +VA + +
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKF 207
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL---- 340
L S HRD+ + N +LD+++ KVADFG ++ + + T L
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKW 262
Query: 341 -DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
E Q+ + T KSDV+SFGV+L EL+T G P
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 170 RILGQGGQGTVYKGMLEDGR----IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
++G+G G VY G L D AVK D E+ +F+ E +I+ +H N
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKDFSHPN 87
Query: 226 VVKLLGCCLETEVPLL-VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
V+ LLG CL +E L V ++ +G L + +NE T + + +VA + Y
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKY 143
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL---- 340
L S HRD+ + N +LD+++ KVADFG ++ + + T L
Sbjct: 144 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEYYSVHNKTGAKLPVKW 198
Query: 341 -DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
E Q+ + T KSDV+SFGV+L EL+T G P
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 75/308 (24%), Positives = 116/308 (37%), Gaps = 56/308 (18%)
Query: 170 RILGQGGQGTVYKGMLED-----GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
R LG+G G V + G ++AVK K + + EI IL + H
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR---SGWKQEIDILRTLYHE 93
Query: 225 NVVKLLGCCLETEVP--LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
+++K GCC + LV E++P G+L +L + L A ++ +
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGM 147
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYL 340
AYLH+ HRD+ + N+LLD K+ DFG +K + + + G +
Sbjct: 148 AYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399
PE + + SDV+SFGV L ELLT + T + A M RL
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSS--QSPPTKFLELIGIAQ--GQMTVLRL 260
Query: 400 HDILDD---------------QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444
++L+ LM K C + RPT E + L
Sbjct: 261 TELLERGERLPRPDKCPAEVYHLM---------------KNCWETEASFRPTFENLIPIL 305
Query: 445 NGIRGSSK 452
+ +
Sbjct: 306 KTVHEKYQ 313
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 72/307 (23%), Positives = 126/307 (41%), Gaps = 52/307 (16%)
Query: 170 RILGQGGQGTVYKGMLE-----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
+ LG+G G+V + G ++AVKK + + ++ L +F EI IL + H
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILKSLQHD 102
Query: 225 NVVKLLGCCLET-EVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
N+VK G C L L+ E++P G+L +L + + L+ +++ +
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGM 158
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYL 340
YL + HRD+ + NIL++ R K+ DFG +K + D+ + K G +
Sbjct: 159 EYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 215
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400
PE S+ + SDV+SFGVVL EL T + + M L
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG--QMIVFHLI 273
Query: 401 DILDD---------------QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445
++L + +M C + N +RP+ ++++ ++
Sbjct: 274 ELLKNNGRLPRPDGCPDEIYMIM---------------TECWNNNVNQRPSFRDLALRVD 318
Query: 446 GIRGSSK 452
IR
Sbjct: 319 QIRDQMA 325
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 76/298 (25%), Positives = 131/298 (43%), Gaps = 48/298 (16%)
Query: 169 NRILGQGGQGTVYKGMLEDG----RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
R+LG+G G+V + L+ +AVK K + +EEF+ E + + +H
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS--DIEEFLREAACMKEFDHP 85
Query: 225 NVVKLLGCCLETE------VPLLVYEFIPNGTLYQHL-HDRHQNEEFPLTWEMRLRIATE 277
+V KL+G L + +P+++ F+ +G L+ L R F L + +R +
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF 337
+A + YL +S HRD+ + N +L + VADFG S+ I + QG
Sbjct: 146 IACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----QGCA 198
Query: 338 GYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFV 391
L E + T SDV++FGV + E++T G+ P +AG + E + Y +
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--YAGIENAE---IYNYLI 253
Query: 392 HSMRKNRLHDILDD--QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
R + + +++ LM +C + K+RP+ + MEL I
Sbjct: 254 GGNRLKQPPECMEEVYDLM---------------YQCWSADPKQRPSFTCLRMELENI 296
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 29/222 (13%)
Query: 169 NRILGQGGQGTVYKGMLEDGR----IIAVK--KSKLTVDDEELLKLEEFINEIVILSQIN 222
+ILG+G G+V +G L+ +AVK K + E +EEF++E + +
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE----IEEFLSEAACMKDFS 94
Query: 223 HRNVVKLLGCCLETE-----VPLLVYEFIPNGTLYQHL-HDRHQNEEFPLTWEMRLRIAT 276
H NV++LLG C+E P+++ F+ G L+ +L + R + + + L+
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGT 336
++A + YL ++ HRD+ + N +L VADFG SK I + QG
Sbjct: 155 DIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----QGR 207
Query: 337 FGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
+ E T KSDV++FGV + E+ T G P
Sbjct: 208 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 62/231 (26%), Positives = 111/231 (48%), Gaps = 29/231 (12%)
Query: 169 NRILGQGGQGTVYKGMLEDGR------IIAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
+R LGQG G VY+G+ + +A+K E EF+NE ++ + N
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER---IEFLNEASVMKEFN 86
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDR-----HQNEEFPLTWEMRLRIATE 277
+VV+LLG + + L++ E + G L +L + P + +++A E
Sbjct: 87 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF 337
+A +AYL+ ++ HRD+ + N ++ + + K+ DFG ++ I + +G
Sbjct: 147 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGK 199
Query: 338 GYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
G L PE + T SDV+SFGVVL E+ T ++P + G ++++
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQ 248
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 70/304 (23%), Positives = 126/304 (41%), Gaps = 52/304 (17%)
Query: 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-N 222
N + +ILG G GTV GR +AVK ++ +D ++ EI +L++ +
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVK--RMLIDFCDIAL-----MEIKLLTESDD 67
Query: 223 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMR--LRIATEVA 279
H NV++ C T+ L + E N L + ++ ++E + + + ++A
Sbjct: 68 HPNVIRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLD-------------QRYRAKVADFGTSKFIAMDQ 326
+A+LH S I HRD+K NIL+ + R ++DFG K + Q
Sbjct: 126 SGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 327 THVTTKIQ---GTFGYLDPE-------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWA 376
+ T + GT G+ PE +LT D++S G V +L+ K F
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 377 GNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT 436
+ + N+ + + M+ ++ + +L + +D + KRPT
Sbjct: 243 KYSRESNIIRGIFSLDEMKCLHDRSLIAE-------------ATDLISQMIDHDPLKRPT 289
Query: 437 MEEV 440
+V
Sbjct: 290 AMKV 293
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 57/222 (25%), Positives = 108/222 (48%), Gaps = 24/222 (10%)
Query: 170 RILGQGGQGTVYKGML----EDGRI-IAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
++LG G GTVYKG+ E +I +A+K+ + + +E ++E +++ +++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN---KEILDEAYVMASVDNP 77
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
+V +LLG CL L+ + +P G L ++ + N + + L ++A + Y
Sbjct: 78 HVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNY 132
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGT---FGYLD 341
L + HRD+ + N+L+ K+ DFG +K + ++ +G ++
Sbjct: 133 LEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMA 187
Query: 342 PEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
E T +SDV+S+GV + EL+T G KP + G + E
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASE 227
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 65/209 (31%), Positives = 110/209 (52%), Gaps = 21/209 (10%)
Query: 170 RILGQGGQGTVYKGMLEDGRI-IAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
LG G G VY+G+ + + +AVK K E+ +++EEF+ E ++ +I H N+V+
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
LLG C ++ EF+ G L +L + ++ E ++ + L +AT+++ A+ YL
Sbjct: 74 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYL--- 127
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK----IQGTFGYLDPEY 344
HRD+ + N L+ + + KVADFG S+ + D I+ T PE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APES 183
Query: 345 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
++ + KSDV++FGV+L E+ T G P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 72/303 (23%), Positives = 119/303 (39%), Gaps = 54/303 (17%)
Query: 170 RILGQGGQGTVYKGMLE-----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
R LG+G G V + G +AVK K + + EI IL + H
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI---ADLKKEIEILRNLYHE 83
Query: 225 NVVKLLGCCLETEVP--LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
N+VK G C E L+ EF+P+G+L ++L + + + +L+ A ++ +
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGM 139
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYL 340
YL S HRD+ + N+L++ ++ K+ DFG +K I D+ + T K +
Sbjct: 140 DYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY 196
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399
PE S+ SDV+SFGV L ELLT + + + M RL
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSD----SSPMALFLKMIGPTHGQMTVTRL 252
Query: 400 HDILDD---------------QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444
+ L + QLM ++C + R + + +
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVYQLM---------------RKCWEFQPSNRTSFQNLIEGF 297
Query: 445 NGI 447
+
Sbjct: 298 EAL 300
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-34
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 23/214 (10%)
Query: 170 RILGQGGQGTVYKGMLEDGR----IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
R++G+G G VY G D A+K + +++ E F+ E +++ +NH N
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV---EAFLREGLLMRGLNHPN 83
Query: 226 VVKLLGCCLETE-VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
V+ L+G L E +P ++ ++ +G L Q + ++ + T + + +VA + Y
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQVARGMEY 139
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL---- 340
L HRD+ + N +LD+ + KVADFG ++ I + Q L
Sbjct: 140 L---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI--LDREYYSVQQHRHARLPVKW 194
Query: 341 -DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
E Q+ + T KSDV+SFGV+L ELLT G P
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-34
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 170 RILGQGGQGTVYKGML----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
+I+G G G V G L + +A+K K + + +F++E I+ Q +H N
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR---RDFLSEASIMGQFDHPN 111
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
+++L G + ++V E++ NG+L L + + T + + V + YL
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 286 HSATSSPIY-HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL--DP 342
S Y HRD+ + N+L+D KV+DFG S+ + D T G P
Sbjct: 168 ----SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
E + SDV+SFGVV+ E+L G++P
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-34
Identities = 73/312 (23%), Positives = 127/312 (40%), Gaps = 55/312 (17%)
Query: 170 RILGQGGQGTVYKGML-----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
LG+G G+V G ++AVK+ + + D++ +F EI IL ++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ----RDFQREIQILKALHSD 84
Query: 225 NVVKLLGCCLET-EVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
+VK G L LV E++P+G L L L L ++++ +
Sbjct: 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGM 140
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYL 340
YL S HRD+ + NIL++ K+ADFG +K + +D+ + + G +
Sbjct: 141 EYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399
PE + + +SDV+SFGVVL EL T K + S E + + +RL
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSP--SAEFLRMMGCERDVPALSRL 253
Query: 400 HDILDD---------------QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444
++L++ +LM K C + + RP+ + +L
Sbjct: 254 LELLEEGQRLPAPPACPAEVHELM---------------KLCWAPSPQDRPSFSALGPQL 298
Query: 445 NGIRGSSKKKRA 456
+ + S+
Sbjct: 299 DMLWSGSRGCET 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 33/314 (10%), Positives = 71/314 (22%), Gaps = 50/314 (15%)
Query: 158 ELDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIV 216
L + L G + V+ +E A+K + ++ +LE
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS-ELERLHEATF 114
Query: 217 ILSQINHRNVVKLLGCCLETEVP--------------------------LLVYEFIPNGT 250
+++ + + LL+ +
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVD 173
Query: 251 LYQ--HLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR 308
L D + ++ A L S + H N+ +
Sbjct: 174 LELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPD 230
Query: 309 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY--HQSSQLTDKSDVYSFGVVLVEL 366
R + D Y E+ ++ T + + G+ + +
Sbjct: 231 GRLMLGDVSALW----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286
Query: 367 LTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRC 426
P F + + + VK L R
Sbjct: 287 WCLFLP-FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTP--LPDFVK-------TLIGRF 336
Query: 427 LDLNGKKRPTMEEV 440
L+ + ++R E
Sbjct: 337 LNFDRRRRLLPLEA 350
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 170 RILGQGGQGTVYKGML----EDGRI-IAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
++LG G GTV+KG+ E +I + +K + + + + ++ + ++H
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF---QAVTDHMLAIGSLDHA 75
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
++V+LLG C LV +++P G+L H+ L ++ L ++A + Y
Sbjct: 76 HIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGA----LGPQLLLNWGVQIAKGMYY 130
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGT---FGYLD 341
L + HR++ + N+LL + +VADFG + + D + ++
Sbjct: 131 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMA 185
Query: 342 PEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
E + T +SDV+S+GV + EL+T G +P +AG E
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEP--YAGLRLAE 225
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 29/230 (12%)
Query: 170 RILGQGGQGTVYKGMLEDGR------IIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
R LG G G VY+G + +AVK +++ +F+ E +I+S+ NH
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALIISKFNH 92
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHL--HDRHQNEEFPLTWEMRLRIATEVAGA 281
+N+V+ +G L++ ++ E + G L L ++ L L +A ++A
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQR---YRAKVADFGTSKFIAMDQTHVTTKIQGTFG 338
YL + HRDI + N LL AK+ DFG ++ I + +G
Sbjct: 153 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR----KGGCA 205
Query: 339 YL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
L PE T K+D +SFGV+L E+ + G P + ++QE
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQE 253
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 17/215 (7%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
LGQG G V+ G +A+K K + E F+ E ++ ++ H +V+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLVQL 327
Query: 230 LGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
+E P+ +V E++ G+L L L + +A ++A +AY+
Sbjct: 328 YAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVERM 382
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 348
HRD+++ NIL+ + KVADFG ++ I ++ + + PE
Sbjct: 383 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 349 QLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
+ T KSDV+SFG++L EL T G+ P + G ++E
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVP--YPGMVNRE 472
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
LGQG G V+ G +A+K K + E F+ E ++ ++ H +V+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLVQL 244
Query: 230 LGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
+E P+ +V E++ G+L L L + +A ++A +AY+
Sbjct: 245 YAVV--SEEPIYIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 348
HRD+++ NIL+ + KVADFG ++ I ++ + + PE
Sbjct: 300 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 349 QLTDKSDVYSFGVVLVELLT-GKKP 372
+ T KSDV+SFG++L EL T G+ P
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVP 381
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 60/221 (27%), Positives = 110/221 (49%), Gaps = 21/221 (9%)
Query: 169 NRILGQGGQGTVYKGMLEDGRI---IAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
++ LG G GTV KG + ++ +AVK K +D +E + E ++ Q+++
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA--LKDELLAEANVMQQLDNPY 79
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
+V+++G C E +LV E G L ++L + + + + +V+ + YL
Sbjct: 80 IVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYL 133
Query: 286 HSATSSPIY-HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDP 342
+ HRD+ + N+LL ++ AK++DFG SK + D+ + + G + + P
Sbjct: 134 ----EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
E + + KSDV+SFGV++ E + G+KP + G E
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSE 228
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+ LG G G V G + +AVK K E + +EF E + +++H +VK
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIK-----EGSMSEDEFFQEAQTMMKLSHPKLVKF 68
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
G C + +V E+I NG L +L ++ L L + +V +A+L S
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLNYL----RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQ--THVTTK--IQGTFGYLDPEYH 345
HRD+ + N L+D+ KV+DFG ++++ DQ + V TK ++ + PE
Sbjct: 125 ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVF 177
Query: 346 QSSQLTDKSDVYSFGVVLVELLT-GKKP 372
+ + KSDV++FG+++ E+ + GK P
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
LG G G V+ G +AVK K + + + F+ E ++ Q+ H+ +V+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 230 LGCCLETEVPLL-VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
T+ P+ + E++ NG+L L LT L +A ++A +A++
Sbjct: 74 YAVV--TQEPIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFI--- 125
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY--LDPEYHQ 346
HRD+++ NIL+ K+ADFG ++ I ++ T + F PE
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAIN 183
Query: 347 SSQLTDKSDVYSFGVVLVELLT-GKKP 372
T KSDV+SFG++L E++T G+ P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 20/221 (9%)
Query: 170 RILGQGGQGTVYKGML--EDGRII--AVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
LG G G V +G G+ + AVK K V + ++FI E+ + ++HRN
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-DDFIREVNAMHSLDHRN 82
Query: 226 VVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
+++L G L P+ +V E P G+L L + R A +VA + Y
Sbjct: 83 LIRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGY 136
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY--LDP 342
L S HRD+ + N+LL R K+ DFG + + + H + + P
Sbjct: 137 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
E ++ + SD + FGV L E+ T G++P W G +
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQ 232
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 59/225 (26%), Positives = 110/225 (48%), Gaps = 22/225 (9%)
Query: 157 KELDKATNHFNANRILGQGGQGTVYKGMLEDGRI-----IAVKKSKLTVDDEELLKLEEF 211
E+ + +++G G G VYKGML+ +A+K K +++ +F
Sbjct: 39 TEIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR---VDF 93
Query: 212 INEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMR 271
+ E I+ Q +H N+++L G + + +++ E++ NG L + L + ++ +
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL----REKDGEFSVLQL 149
Query: 272 LRIATEVAGALAYLHSATSSPIY-HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT 330
+ + +A + YL ++ Y HRD+ + NIL++ KV+DFG S+ + D
Sbjct: 150 VGMLRGIAAGMKYL----ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205
Query: 331 TKIQGTFGY--LDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
T G PE + T SDV+SFG+V+ E++T G++P
Sbjct: 206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 25/219 (11%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+ LG G G V G +A+K K E + +EFI E ++ ++H +V+L
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSHEKLVQL 84
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
G C + ++ E++ NG L +L + + L + +V A+ YL
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYL---- 136
Query: 290 SSPIY-HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQ--THVTTK--IQGTFGYLDPEY 344
S + HRD+ + N L++ + KV+DFG S+++ D+ + V +K ++ + PE
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEV 192
Query: 345 HQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
S+ + KSD+++FGV++ E+ + GK P + T+ E
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMP--YERFTNSE 229
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 61/234 (26%), Positives = 115/234 (49%), Gaps = 23/234 (9%)
Query: 157 KELDKATNHFNANRILGQGGQGTVYKGML----EDGRIIAVKKSKLTVDDEELLKLEEFI 212
KELD + + ++++G G G V G L + +A+K K+ +++ +F+
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFL 94
Query: 213 NEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRL 272
E I+ Q +H N+++L G +++ ++V E++ NG+L L + + T +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLV 150
Query: 273 RIATEVAGALAYLHSATSSPIY-HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTT 331
+ +A + YL S Y HRD+ + NIL++ KV+DFG + + D T
Sbjct: 151 GMLRGIASGMKYL----SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 332 KIQGTFGYL--DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
G PE + T SDV+S+G+VL E+++ G++P + ++Q+
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWEMSNQD 258
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 29/230 (12%)
Query: 170 RILGQGGQGTVYKGMLEDGR------IIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
R LG G G VY+G + +AVK +++ +F+ E +I+S+ NH
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALIISKFNH 133
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDR--HQNEEFPLTWEMRLRIATEVAGA 281
+N+V+ +G L++ ++ E + G L L + ++ L L +A ++A
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQR---YRAKVADFGTSKFIAMDQTHVTTKIQGTFG 338
YL + HRDI + N LL AK+ DFG ++ I + +G
Sbjct: 194 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR----KGGCA 246
Query: 339 YL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
L PE T K+D +SFGV+L E+ + G P + ++QE
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQE 294
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-33
Identities = 63/218 (28%), Positives = 110/218 (50%), Gaps = 23/218 (10%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+ +G G G V+ G + +A+K + E + E+FI E ++ +++H +V+L
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQL 68
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
G CLE LV EF+ +G L +L + + E L + +V +AYL
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQ--THVTTK--IQGTFGYLDPEYH 345
+ + HRD+ + N L+ + KV+DFG ++F+ DQ + TK ++ PE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVF 177
Query: 346 QSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
S+ + KSDV+SFGV++ E+ + GK P + ++ E
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSNSE 213
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+ LG G G V+ +AVK K + +E F+ E ++ + H +VKL
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-----PGSMSVEAFLAEANVMKTLQHDKLVKL 248
Query: 230 LGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
T+ P+ ++ EF+ G+L L E + + ++A +A++
Sbjct: 249 HAVV--TKEPIYIITEFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFI--- 300
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 348
HRD+++ NIL+ K+ADFG ++ I ++ + + PE
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 360
Query: 349 QLTDKSDVYSFGVVLVELLT-GKKP 372
T KSDV+SFG++L+E++T G+ P
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-33
Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 21/218 (9%)
Query: 172 LGQGGQGTVYKGML--EDGRI-IAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
LG G G+V +G+ +I +A+K K + + EE + E I+ Q+++ +V+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT---EEMMREAQIMHQLDNPYIVR 74
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
L+G C + +LV E G L++ L + + + +V+ + YL
Sbjct: 75 LIGVCQAEAL-MLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYL--- 126
Query: 289 TSSPIY-HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPEYH 345
+ HRD+ + N+LL R+ AK++DFG SK + D ++ T + G + + PE
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 346 QSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
+ + +SDV+S+GV + E L+ G+KP + E
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGPE 221
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+ +G+G G V G G +AVK K + F+ E +++Q+ H N+V+L
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA------FLAEASVMTQLRHSNLVQL 251
Query: 230 LGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
LG +E + L +V E++ G+L +L R ++ L + L+ + +V A+ YL
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDVCEAMEYLE-- 306
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQ 346
+ HRD+ + N+L+ + AKV+DFG +K T T K ++ T PE +
Sbjct: 307 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWT----APEALR 359
Query: 347 SSQLTDKSDVYSFGVVLVELLT-GKKP 372
+ + KSDV+SFG++L E+ + G+ P
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 63/310 (20%), Positives = 116/310 (37%), Gaps = 51/310 (16%)
Query: 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVILS 219
+ + + ILGQG V++G + G + A+K + + E +L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM------REFEVLK 62
Query: 220 QINHRNVVKLLGC--CLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLR-IAT 276
++NH+N+VKL T +L+ EF P G+LY L + P E +
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP---ESEFLIVLR 119
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILL----DQRYRAKVADFGTSKFIAMDQTHVTTK 332
+V G + +L I HR+IK NI+ D + K+ DFG ++ ++
Sbjct: 120 DVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVS 174
Query: 333 IQGTFGYLDPEYHQSSQLTD--------KSDVYSFGVVLVELLTGKKPIFWAGNTSQENV 384
+ GT YL P+ ++ + L D++S GV TG P F + N
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP-FRPFEGPRRNK 233
Query: 385 SL--------------AAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLN 430
+ + + D+ + G++ + + L+ +
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLL---TPVLANILEAD 290
Query: 431 GKKRPTMEEV 440
+K ++
Sbjct: 291 QEKCWGFDQF 300
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 170 RILGQGGQGTVYKGML--EDGRII--AVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
R +G+G G V++G+ + + A+K K D E+F+ E + + Q +H +
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR---EKFLQEALTMRQFDHPH 77
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
+VKL+G E ++ E G L L Q ++ L + A +++ ALAYL
Sbjct: 78 IVKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTALAYL 132
Query: 286 HSATSSPIY-HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 344
S + HRDI + N+L+ K+ DFG S+++ + +K + ++ PE
Sbjct: 133 ----ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 188
Query: 345 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
+ T SDV+ FGV + E+L G KP
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 172 LGQGGQGTVYKGML--EDGRI-IAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
LG G G+V +G+ +I +A+K K + + EE + E I+ Q+++ +V+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT---EEMMREAQIMHQLDNPYIVR 400
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
L+G C + +LV E G L++ L + + + +V+ + YL
Sbjct: 401 LIGVCQAEAL-MLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYL--- 452
Query: 289 TSSPIY-HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY--LDPEYH 345
+ HR++ + N+LL R+ AK++DFG SK + D ++ T + G + PE
Sbjct: 453 -EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 346 QSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
+ + +SDV+S+GV + E L+ G+KP + E
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGPE 547
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 65/309 (21%), Positives = 128/309 (41%), Gaps = 33/309 (10%)
Query: 155 SSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVK---KSKLTVDDEELLKLEEF 211
KE DK N + R L QG + +D + A+K KS L + +
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 212 I----------NEIVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDR-- 258
I NE+ I++ I + + G + + ++YE++ N ++ +
Sbjct: 81 ISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 259 -HQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG 317
+N + ++ I V + +Y+H+ + I HRD+K +NIL+D+ R K++DFG
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFG 197
Query: 318 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD--KSDVYSFGVVLVELLTGKKPIFW 375
S+++ + ++ GT+ ++ PE+ + + K D++S G+ L + P F
Sbjct: 198 ESEYMVDKKIK-GSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP-FS 253
Query: 376 AGNTSQ---ENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFA-NLAKRCLDLNG 431
+ N+ R + L+ + + + N + + K L N
Sbjct: 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSN--NFLSNEDIDFLKLFLRKNP 311
Query: 432 KKRPTMEEV 440
+R T E+
Sbjct: 312 AERITSEDA 320
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 80/282 (28%), Positives = 117/282 (41%), Gaps = 52/282 (18%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVILSQINHRN 225
R LG+G G VY + I+A+K K++L E + E+ I S + H N
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE----HQLRREVEIQSHLRHPN 70
Query: 226 VVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
+++L G + L+ E+ P GT+Y+ L + +E TE+A AL+Y
Sbjct: 71 ILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTA-TYITELANALSY 124
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 344
HS + HRDIK N+LL K+ADFG S A GT YL PE
Sbjct: 125 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDL--CGTLDYLPPEM 178
Query: 345 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENVSLAAY----FVHSMRKNR 398
+ +K D++S GV+ E L GK P F A + + +S + FV +
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRVEFTFPDFVTEGAR-- 235
Query: 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+L R L N +RP + EV
Sbjct: 236 ----------------------DLISRLLKHNPSQRPMLREV 255
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 23/207 (11%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+ +G+G G V G G +AVK K + F+ E +++Q+ H N+V+L
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA------FLAEASVMTQLRHSNLVQL 79
Query: 230 LGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
LG +E + L +V E++ G+L +L R ++ L + L+ + +V A+ YL
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYL--- 133
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQ 346
+ HRD+ + N+L+ + AKV+DFG +K + T T K ++ T PE +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWT----APEALR 187
Query: 347 SSQLTDKSDVYSFGVVLVELLT-GKKP 372
+ + KSDV+SFG++L E+ + G+ P
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 38/304 (12%), Positives = 75/304 (24%), Gaps = 59/304 (19%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK----KSKLTVDDEELLKLEEFI------------ 212
+LGQ + E G V + + + +K E
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 213 -----NEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHD------RHQN 261
I + K++ L+ ++ F + +L H +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 262 EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321
L RL++ +V LA LH + H ++ +I+LDQR + F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 322 IAMDQTHVTTKIQGTFGYLDPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWA 376
+ H + +T D ++ G+ + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP-NTD 319
Query: 377 GNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT 436
L + + L + L + R
Sbjct: 320 DAA------LGGSEWIFRSCKNIPQPVRA----------------LLEGFLRYPKEDRLL 357
Query: 437 MEEV 440
+
Sbjct: 358 PLQA 361
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-32
Identities = 73/334 (21%), Positives = 124/334 (37%), Gaps = 99/334 (29%)
Query: 170 RILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
+ LG+G G V K +AVK K EL + ++E +L Q+NH
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL---RDLLSEFNVLKQVNH 85
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHL-------------------HDRHQNEEF 264
+V+KL G C + LL+ E+ G+L L +E
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 265 PLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324
LT + A +++ + YL + HRD+ + NIL+ + + K++DFG S+ +
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV-- 200
Query: 325 DQTHVTTKIQGTFGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELL 367
Y + Y + SQ L D +SDV+SFGV+L E++
Sbjct: 201 --------------YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 368 T-GKKPIFWAGNTSQENVSLAAYFV---HSMRK-----NRLHDILDDQLMKLGVKNQIMT 418
T G P + G + + + H M + ++ + M
Sbjct: 247 TLGGNP--YPGIPPERLFN----LLKTGHRMERPDNCSEEMYRL-----M---------- 285
Query: 419 FANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452
+C KRP ++S +L + +
Sbjct: 286 -----LQCWKQEPDKRPVFADISKDLEKMMVKRR 314
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 20/219 (9%)
Query: 170 RILGQGGQGTVYKGML--EDGRII--AVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
RILG+G G VY+G+ G I AVK K + E+F++E VI+ ++H +
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK---EKFMSEAVIMKNLDHPH 74
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
+VKL+G E E ++ E P G L +L + + L + + ++ A+AYL
Sbjct: 75 IVKLIGIIEE-EPTWIIMELYPYGELGHYL----ERNKNSLKVLTLVLYSLQICKAMAYL 129
Query: 286 HSATSSPIY-HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 344
S HRDI NIL+ K+ DFG S++I + + + + ++ PE
Sbjct: 130 ----ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 185
Query: 345 HQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
+ T SDV+ F V + E+L+ GK+P + +++
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQP--FFWLENKD 222
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-32
Identities = 63/309 (20%), Positives = 119/309 (38%), Gaps = 57/309 (18%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVV 227
R+L +GG VY+ + GR A+K+ L ++EE K I E+ + ++ H N+V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKR--LLSNEEE--KNRAIIQEVCFMKKLSGHPNIV 89
Query: 228 KLLGCCLETEVP-------LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMR-LRIATEVA 279
+ + L+ + G L + L L+I +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLS---CDTVLKIFYQTC 146
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ----- 334
A+ ++H PI HRD+K N+LL + K+ DFG++ I+ + + +
Sbjct: 147 RAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 335 ------GTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVS 385
T Y PE + + + +K D+++ G +L L + P F G + +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP-FEDGA--KLRIV 262
Query: 386 LAAYFV--HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443
Y + H + H ++ + L +N ++R ++ EV +
Sbjct: 263 NGKYSIPPHDTQYTVFHSLI--------------------RAMLQVNPEERLSIAEVVHQ 302
Query: 444 LNGIRGSSK 452
L I +
Sbjct: 303 LQEIAAARN 311
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 33/225 (14%)
Query: 170 RILGQGGQGTVYKGMLEDGR------IIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
LG+G G V+ + ++AVK K + ++F E +L+ + H
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR----QDFQREAELLTMLQH 102
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHL----------HDRHQNEEFPLTWEMRLR 273
+++V+ G C E L+V+E++ +G L + L PL L
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 274 IATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
+A++VA + YL HRD+ + N L+ Q K+ DFG S+ I + ++
Sbjct: 163 VASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYYRV 216
Query: 334 QGTFGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
G L PE + T +SDV+SFGVVL E+ T GK+P
Sbjct: 217 GGR-TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 41/310 (13%), Positives = 82/310 (26%), Gaps = 70/310 (22%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK----KSKLTVDDEELLKLEE-------------- 210
+LGQ + E G V + + + +K E
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 211 ------FINEIVILSQINHRNVVKLLGCCLETEVPLLVYEF-IPNGTLYQHLHD--RHQN 261
FI ++ + ++++ + V + + L H +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 262 EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321
L RL++ +V LA LH + H ++ +I+LDQR + F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQL-----------TDKSDVYSFGVVLVELLTGK 370
+ G+ PE T D ++ G+V+ +
Sbjct: 256 DGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 371 KPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLN 430
P + + ++ KN + L + L
Sbjct: 311 LP-ITK-----DAALGGSEWIFRSCKNIPQPVRA-----------------LLEGFLRYP 347
Query: 431 GKKRPTMEEV 440
+ R +
Sbjct: 348 KEDRLLPLQA 357
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-32
Identities = 77/329 (23%), Positives = 121/329 (36%), Gaps = 92/329 (27%)
Query: 170 RILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-N 222
+ LG+G G V + R +AVK K E ++E+ IL I +
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH---RALMSELKILIHIGH 89
Query: 223 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHL-HDRHQNEEF----------PLTWEM 270
H NVV LLG C + PL ++ EF G L +L R++ + LT E
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 271 RLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT 330
+ + +VA + +L S HRD+ + NILL ++ K+ DFG ++ I
Sbjct: 150 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI-------- 198
Query: 331 TKIQGTFGYLDPEYHQSSQ-----------------LTDKSDVYSFGVVLVELLT-GKKP 372
Y DP+Y + T +SDV+SFGV+L E+ + G P
Sbjct: 199 --------YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
Query: 373 IFWAGNTSQENVSLAAYFV---HSMRK-----NRLHDILDDQLMKLGVKNQIMTFANLAK 424
+ G E + MR ++ M
Sbjct: 251 --YPGVKIDEEF---CRRLKEGTRMRAPDYTTPEMYQT-----M---------------L 285
Query: 425 RCLDLNGKKRPTMEEVSMELNGIRGSSKK 453
C +RPT E+ L + ++ +
Sbjct: 286 DCWHGEPSQRPTFSELVEHLGNLLQANAQ 314
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 65/314 (20%), Positives = 117/314 (37%), Gaps = 45/314 (14%)
Query: 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVILS 219
+ + + ILGQG V++G + G + A+K + ++ E +L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR------EFEVLK 62
Query: 220 QINHRNVVKLLGC--CLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLR-IAT 276
++NH+N+VKL T +L+ EF P G+LY L + P E +
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP---ESEFLIVLR 119
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILL----DQRYRAKVADFGTSKFIAMDQTHVTTK 332
+V G + +L I HR+IK NI+ D + K+ DFG ++ ++
Sbjct: 120 DVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVS 174
Query: 333 IQGTFGYLDPEYHQSSQLTD--------KSDVYSFGVVLVELLTGKKPIFWAGNTSQENV 384
+ GT YL P+ ++ + L D++S GV TG P F + N
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP-FRPFEGPRRNK 233
Query: 385 SL------AAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFA-----NLAKRCLDLNGKK 433
+ + + D + V + + L+ + +K
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
Query: 434 RPTMEEVSMELNGI 447
++ E + I
Sbjct: 294 CWGFDQFFAETSDI 307
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 60/241 (24%)
Query: 170 RILGQGGQGTVYKGML--------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
+ LG+G G V ++ +AVK K +++L + ++E+ ++ I
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL---SDLVSEMEMMKMI 97
Query: 222 -NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHL-----------HDRHQNEEFPLTWE 269
H+N++ LLG C + ++ E+ G L ++L +D ++ E +T++
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 270 MRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHV 329
+ ++A + YL S HRD+ + N+L+ + K+ADFG ++ I
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI------- 207
Query: 330 TTKIQGTFGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELLT-GKK 371
Y +++ L D +SDV+SFGV++ E+ T G
Sbjct: 208 ---------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 372 P 372
P
Sbjct: 259 P 259
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 73/274 (26%), Positives = 128/274 (46%), Gaps = 41/274 (14%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+GQG GTVY M + G+ +A+++ L ++ E INEI+++ + + N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK----ELIINEILVMRENKNPNIVNYL 83
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT---EVAGALAYLHS 287
L + +V E++ G+L + + +E +IA E AL +LHS
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG---------QIAAVCRECLQALEFLHS 134
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 347
+ + HRDIKS NILL K+ DFG I +Q+ +T + GT ++ PE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
Query: 348 SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF-VHSMRKNRLHDILDDQ 406
K D++S G++ +E++ G+ P Y + +R L I +
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPP----------------YLNENPLRALYL--IATNG 232
Query: 407 LMKLGVKNQI-MTFANLAKRCLDLNGKKRPTMEE 439
+L ++ F + RCL+++ +KR + +E
Sbjct: 233 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 266
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 63/284 (22%), Positives = 104/284 (36%), Gaps = 54/284 (19%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVILSQINHRN 225
R LG+GG ++ + + A K KS L + E+ EI I + H++
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR----EKMSMEISIHRSLAHQH 102
Query: 226 VVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
VV G E + +V E +L + R E E R ++ Y
Sbjct: 103 VVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEAR-YYLRQIVLGCQY 156
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 344
LH + + HRD+K N+ L++ K+ DFG + + D + GT Y+ PE
Sbjct: 157 LHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEV 212
Query: 345 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404
+ + DV+S G ++ LL GK P F +
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGKPP-FETSC------------LKETYLR------- 252
Query: 405 DQLMKLGVKNQIMTF--------ANLAKRCLDLNGKKRPTMEEV 440
+K + A+L ++ L + RPT+ E+
Sbjct: 253 -------IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINEL 289
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 73/280 (26%), Positives = 118/280 (42%), Gaps = 54/280 (19%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G V+KG+ +++A+K L ++E+ E+ EI +LSQ + V K
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI---EDIQQEITVLSQCDSPYVTKYY 86
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT---EVAGALAYLHS 287
G L+ ++ E++ G+ L +E IAT E+ L YLHS
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ---------IATILREILKGLDYLHS 137
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 347
HRDIK+ N+LL + K+ADFG + + Q T + GT ++ PE +
Sbjct: 138 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 193
Query: 348 SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF-VHSMRKNRLHDI---- 402
S K+D++S G+ +EL G+ P + +H M+ L I
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP----------------HSELHPMKV--LFLIPKNN 235
Query: 403 ---LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
L+ K + CL+ RPT +E
Sbjct: 236 PPTLEGNYSK--------PLKEFVEACLNKEPSFRPTAKE 267
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 73/288 (25%), Positives = 119/288 (41%), Gaps = 52/288 (18%)
Query: 164 NHFNANRILGQGGQGTVYKG-MLEDGRIIAVK---KSKLTVDDEELLKLEEFIN-EIVIL 218
+ F+ R LG+G G VY ++ I+A+K KS+L E +E + EI I
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-----EKEGVEHQLRREIEIQ 68
Query: 219 SQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATE 277
S + H N++++ + L+ EF P G LY+ L + +E E
Sbjct: 69 SHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDE----QRSA-TFMEE 122
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF 337
+A AL Y H + HRDIK N+L+ + K+ADFG S + GT
Sbjct: 123 LADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTL 176
Query: 338 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397
YL PE + +K D++ GV+ E L G P F + + ++ +
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP-FDSPSHTE------------THRR 223
Query: 398 RLHDILDDQL-----MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
I++ L + G K +L + L + +R ++ V
Sbjct: 224 ----IVNVDLKFPPFLSDGSK-------DLISKLLRYHPPQRLPLKGV 260
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 68/285 (23%), Positives = 113/285 (39%), Gaps = 55/285 (19%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLK---LEEFINEIVILSQINHRN 225
+LG+G VY+ + G +A+K +D + + K ++ NE+ I Q+ H +
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIK----MIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 226 VVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLT-WEMRLRIATEVAGALA 283
+++L E + LV E NG + ++L +R + P + E R ++ +
Sbjct: 73 ILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEAR-HFMHQIITGML 126
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
YLHS I HRD+ +N+LL + K+ADFG + + M T + GT Y+ PE
Sbjct: 127 YLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE 182
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403
S +SDV+S G + LL G+ P F V +
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPP-FDTDT------------VKNTLNK------ 223
Query: 404 DDQLMKLGVKNQIMTF--------ANLAKRCLDLNGKKRPTMEEV 440
V +L + L N R ++ V
Sbjct: 224 --------VVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSV 260
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 62/236 (26%), Positives = 106/236 (44%), Gaps = 36/236 (15%)
Query: 170 RILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
R LG+G G V+ +D ++AVK K ++F E +L+ + H
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR----KDFQREAELLTNLQH 76
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDR-----------HQNEEFPLTWEMRL 272
++VK G C + + ++V+E++ +G L + L + + L L
Sbjct: 77 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 273 RIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK 332
IA+++A + YL S HRD+ + N L+ K+ DFG S+ + + +
Sbjct: 137 HIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---R 190
Query: 333 IQGTFGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
+ G L PE + T +SDV+SFGV+L E+ T GK+P W ++ E
Sbjct: 191 VGGH-TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--WFQLSNTE 243
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 68/337 (20%), Positives = 124/337 (36%), Gaps = 46/337 (13%)
Query: 142 SYDGSVIDRFKLFSSKELDKATNHFNANRILGQGGQGTVYKG-MLEDGRIIAVK---KSK 197
+ G + +F + + + + + LG G G V A+K K+
Sbjct: 15 YFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS 74
Query: 198 LTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHD 257
++ L E+ +L ++H N++KL + LV E G L+ +
Sbjct: 75 VSTSSNSKLL-----EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH 129
Query: 258 RHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL---DQRYRAKVA 314
R + E I +V + YLH I HRD+K N+LL ++ K+
Sbjct: 130 RMKFNE-----VDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIV 181
Query: 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
DFG S + + GT Y+ PE + +K DV+S GV+L LL G P F
Sbjct: 182 DFGLSAVF--ENQKKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPP-F 237
Query: 375 WAGNTSQ--ENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGK 432
+ V Y + ++ + K +L K+ L + +
Sbjct: 238 GGQTDQEILRKVEKGKY---TFDSPEWKNVSEG------AK-------DLIKQMLQFDSQ 281
Query: 433 KRPTMEEVS----MELNGIRGSSKKKRAMFSKIIKRL 465
+R + ++ ++ + S + + I+ +
Sbjct: 282 RRISAQQALEHPWIKEMCSKKESGIELPSLANAIENM 318
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 60/241 (24%)
Query: 170 RILGQGGQGTVYKGML--------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
+ LG+G G V ++ +AVK K +++L + ++E+ ++ I
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL---SDLVSEMEMMKMI 143
Query: 222 -NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHL-----------HDRHQNEEFPLTWE 269
H+N++ LLG C + ++ E+ G L ++L +D ++ E +T++
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 270 MRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHV 329
+ ++A + YL S HRD+ + N+L+ + K+ADFG ++ I
Sbjct: 204 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI------- 253
Query: 330 TTKIQGTFGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELLT-GKK 371
Y +++ L D +SDV+SFGV++ E+ T G
Sbjct: 254 ---------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 304
Query: 372 P 372
P
Sbjct: 305 P 305
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-31
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 170 RILGQGGQGTVYKGML--EDGRII--AVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
R +G+G G V++G+ + + A+K K D E+F+ E + + Q +H +
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR---EKFLQEALTMRQFDHPH 452
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
+VKL+G E V ++ E G L L Q +F L + A +++ ALAYL
Sbjct: 453 IVKLIGVITENPV-WIIMELCTLGELRSFL----QVRKFSLDLASLILYAYQLSTALAYL 507
Query: 286 HSATSSPIY-HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 344
S + HRDI + N+L+ K+ DFG S+++ + +K + ++ PE
Sbjct: 508 ----ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 563
Query: 345 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
+ T SDV+ FGV + E+L G KP
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 63/284 (22%), Positives = 104/284 (36%), Gaps = 54/284 (19%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVILSQINHRN 225
R LG+GG ++ + + A K KS L + E+ EI I + H++
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR----EKMSMEISIHRSLAHQH 76
Query: 226 VVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
VV G E + +V E +L + R E E R ++ Y
Sbjct: 77 VVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEAR-YYLRQIVLGCQY 130
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 344
LH + + HRD+K N+ L++ K+ DFG + + D + GT Y+ PE
Sbjct: 131 LHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEV 186
Query: 345 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404
+ + DV+S G ++ LL GK P F +
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGKPP-FETSC------------LKETYLR------- 226
Query: 405 DQLMKLGVKNQIMTF--------ANLAKRCLDLNGKKRPTMEEV 440
+K + A+L ++ L + RPT+ E+
Sbjct: 227 -------IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINEL 263
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-31
Identities = 75/274 (27%), Positives = 120/274 (43%), Gaps = 41/274 (14%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G V GR +AVK L E NE+VI+ H NVV++
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR----ELLFNEVVIMRDYQHFNVVEMY 108
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT---EVAGALAYLHS 287
L E ++ EF+ G L + NEE +IAT V ALAYLH+
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE---------QIATVCEAVLQALAYLHA 159
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 347
+ HRDIKS +ILL R K++DFG I+ D + + GT ++ PE
Sbjct: 160 ---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISR 215
Query: 348 SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF-VHSMRKNRLHDILDDQ 406
S + D++S G++++E++ G+ P YF ++ + + D
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPP----------------YFSDSPVQAMKR--LRDSP 257
Query: 407 LMKLGVKNQI-MTFANLAKRCLDLNGKKRPTMEE 439
KL +++ + +R L + ++R T +E
Sbjct: 258 PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQE 291
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 56/237 (23%), Positives = 105/237 (44%), Gaps = 37/237 (15%)
Query: 170 RILGQGGQGTVYKGMLEDGR------IIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
LG+ G VYKG L +A+K K + EEF +E ++ +++ H
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR---EEFRHEAMLRARLQH 71
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDR-----------HQNEEFPLTWEMRL 272
NVV LLG + + +++ + +G L++ L R + + L +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 273 RIATEVAGALAYLHSATSSPIY-HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTT 331
+ ++A + YL SS H+D+ + N+L+ + K++D G + +
Sbjct: 132 HLVAQIAAGMEYL----SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV---YAADYY 184
Query: 332 KIQGTFGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
K+ G L PE + + SD++S+GVVL E+ + G +P + G ++Q+
Sbjct: 185 KLLGN-SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYSNQD 238
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-31
Identities = 74/286 (25%), Positives = 119/286 (41%), Gaps = 42/286 (14%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G G V +A+K+ L + +E + EI +SQ +H N+V
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM---DELLKEIQAMSQCHHPNIVSYY 79
Query: 231 GCCLETEVPLLVYEFIPNG---TLYQHLHDRHQNEEFPLTWEMRLRIAT---EVAGALAY 284
+ + LV + + G + +H+ + +++ L E IAT EV L Y
Sbjct: 80 TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-E--STIATILREVLEGLEY 136
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF-G---YL 340
LH + HRD+K+ NILL + ++ADFG S F+A K++ TF G ++
Sbjct: 137 LHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 341 DPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR---- 395
PE Q K+D++SFG+ +EL TG P Y M+
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAP-------------YHKY--PPMKVLML 238
Query: 396 --KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
+N + K +K +F + CL + +KRPT E
Sbjct: 239 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-31
Identities = 72/309 (23%), Positives = 121/309 (39%), Gaps = 45/309 (14%)
Query: 145 GSVIDRFKLFSSKELDKATNHFNAN----RILGQGGQGTVYKG-MLEDGRIIAVK---KS 196
GS++D + +T F+ R+LG+G G V G+ AVK K
Sbjct: 3 GSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62
Query: 197 KLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLH 256
++ ++ E + E+ +L Q++H N++KL + LV E G L+ +
Sbjct: 63 QVKQKTDK----ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 118
Query: 257 DRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL---DQRYRAKV 313
R + E RI +V + Y+H I HRD+K N+LL + ++
Sbjct: 119 SRKRFSE-----VDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRI 170
Query: 314 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 373
DFG S + + GT Y+ PE + +K DV+S GV+L LL+G P
Sbjct: 171 IDFGLSTHF--EASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP- 226
Query: 374 FWAGNTSQ--ENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNG 431
F N + V Y + + + + K +L ++ L
Sbjct: 227 FNGANEYDILKKVEKGKY---TFELPQWKKVSES------AK-------DLIRKMLTYVP 270
Query: 432 KKRPTMEEV 440
R + +
Sbjct: 271 SMRISARDA 279
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 72/298 (24%), Positives = 121/298 (40%), Gaps = 31/298 (10%)
Query: 161 KATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVK--KSKLTVDDEELLKLEEFINEIVI 217
+ + LG GG G V + + + G +A+K + +L+ + E EI I
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC-----LEIQI 65
Query: 218 LSQINHRNVVKLLGCCLETE-------VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEM 270
+ ++NH NVV + +PLL E+ G L ++L+ L
Sbjct: 66 MKKLNHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC--CGLKEGP 122
Query: 271 RLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD---QRYRAKVADFGTSKFIAMDQT 327
+ ++++ AL YLH + I HRD+K NI+L QR K+ D G +K +DQ
Sbjct: 123 IRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQG 177
Query: 328 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ-ENVSL 386
+ T+ GT YL PE + + T D +SFG + E +TG +P Q
Sbjct: 178 ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 387 AAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKR----CLDLNGKKRPTMEEV 440
H + + L + + + A +R L + ++R T +
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 60/244 (24%), Positives = 105/244 (43%), Gaps = 43/244 (17%)
Query: 170 RILGQGGQGTVYKGMLEDGR------IIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
R +G+G G V++ ++AVK K + +F E ++++ ++
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ---ADFQREAALMAEFDN 109
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDR-------------------HQNEEF 264
N+VKLLG C + L++E++ G L + L
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 265 PLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324
PL+ +L IA +VA +AYL + HRD+ + N L+ + K+ADFG S+ I
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 325 DQTHVTTKIQGTFGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGN 378
+ + PE ++ T +SDV+++GVVL E+ + G +P + G
Sbjct: 227 ADYYK----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP--YYGM 280
Query: 379 TSQE 382
+E
Sbjct: 281 AHEE 284
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 51/239 (21%), Positives = 93/239 (38%), Gaps = 52/239 (21%)
Query: 170 RILGQGGQGTVYKGMLEDGRI--------IAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
LGQG ++KG+ + + +K +D E F ++S++
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLK----VLDKAHRNYSESFFEAASMMSKL 69
Query: 222 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGA 281
+H+++V G C+ + +LV EF+ G+L +L + + + +L +A ++A A
Sbjct: 70 SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL----KKNKNCINILWKLEVAKQLAAA 125
Query: 282 LAYLHSATSSPIY-HRDIKSTNILLDQRYR--------AKVADFGTSKFIAMDQTHVTTK 332
+ +L H ++ + NILL + K++D G S +
Sbjct: 126 MHFL----EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ 175
Query: 333 IQGTFGYLD-------PE-YHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQE 382
L PE L +D +SFG L E+ + G KP + SQ
Sbjct: 176 ------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--LSALDSQR 226
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 34/224 (15%)
Query: 170 RILGQGGQGTVYKGMLEDG---RIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRN 225
++G+G G V K ++ A+K+ K ++ +F E+ +L ++ +H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCKLGHHPN 87
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFP-----------LTWEMRLRI 274
++ LLG C L E+ P+G L L E P L+ + L
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 275 ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ 334
A +VA + YL + HRD+ + NIL+ + Y AK+ADFG S+ + T
Sbjct: 148 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--EVYVKKTM-- 200
Query: 335 GTFGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
G L E S T SDV+S+GV+L E+++ G P
Sbjct: 201 ---GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 2e-30
Identities = 44/268 (16%), Positives = 83/268 (30%), Gaps = 31/268 (11%)
Query: 135 LLQQM---LNSYDGSVIDRFKLFSSK---ELDKATNHFNANRILGQGGQGTVYKGM---- 184
LL + ++SY + + KL + K E + + +LG+G VY+
Sbjct: 30 LLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDL 89
Query: 185 --LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242
++ + +K K + + L +K L +LV
Sbjct: 90 NDAKNKQKFVLKVQK----PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145
Query: 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTN 302
E GTL ++ E + + + A + + +H I H DIK N
Sbjct: 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDN 202
Query: 303 ILLDQRYRA-----------KVADFGTSKFI-AMDQTHVTTKIQGTFGYLDPEYHQSSQL 350
+L + + D G S + + + T T G+ E +
Sbjct: 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW 262
Query: 351 TDKSDVYSFGVVLVELLTGKKPIFWAGN 378
+ D + + +L G
Sbjct: 263 NYQIDYFGVAATVYCMLFGTYMKVKNEG 290
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 59/249 (23%), Positives = 97/249 (38%), Gaps = 58/249 (23%)
Query: 170 RILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-N 222
+ LG G G V + + +AVK K T +E E ++E+ I+S +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK---EALMSELKIMSHLGQ 108
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEF---------PLTWEMRLR 273
H N+V LLG C L++ E+ G L L + + E + L
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 274 IATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
+++VA +A+L S HRD+ + N+LL + AK+ DFG ++ I
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI----------- 214
Query: 334 QGTFGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELLT-GKKPIFW 375
D Y + D +SDV+S+G++L E+ + G P +
Sbjct: 215 -----MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--Y 267
Query: 376 AGNTSQENV 384
G
Sbjct: 268 PGILVNSKF 276
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 66/294 (22%), Positives = 111/294 (37%), Gaps = 39/294 (13%)
Query: 172 LGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
LG G G V+K G ++A K L + + I E+ +L + N +V
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR---NQIIRELQVLHECNSPYIVGFY 97
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
G + E + G+L Q L + E L +++ V L YL
Sbjct: 98 GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHK 152
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 350
I HRD+K +NIL++ R K+ DFG S + + + + GT Y+ PE Q +
Sbjct: 153 --IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFV-GTRSYMSPERLQGTHY 207
Query: 351 TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKL 410
+ +SD++S G+ LVE+ G+ PI E + + L K
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 411 GVKNQIM-------------------------TFANLAKRCLDLNGKKRPTMEE 439
G+ ++ F + +CL N +R +++
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 58/242 (23%), Positives = 101/242 (41%), Gaps = 60/242 (24%)
Query: 169 NRILGQGGQGTVYKGML--------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQ 220
+ LG+G G V +AVK K +++L + I+E+ ++
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL---SDLISEMEMMKM 130
Query: 221 I-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHL-----------HDRHQNEEFPLTW 268
I H+N++ LLG C + ++ E+ G L ++L ++ N E L+
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 269 EMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH 328
+ + A +VA + YL S HRD+ + N+L+ + K+ADFG ++ I
Sbjct: 191 KDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI------ 241
Query: 329 VTTKIQGTFGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELLT-GK 370
+ Y +++ L D +SDV+SFGV+L E+ T G
Sbjct: 242 ----------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291
Query: 371 KP 372
P
Sbjct: 292 SP 293
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-30
Identities = 64/229 (27%), Positives = 98/229 (42%), Gaps = 36/229 (15%)
Query: 170 RILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-N 222
+ LG G G V + + +AVK K + E E ++E+ +LS + N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER---EALMSELKVLSYLGN 85
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDR-------------HQNEEFPLTWE 269
H N+V LLG C L++ E+ G L L + +++E L E
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 270 MRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHV 329
L + +VA +A+L S HRD+ + NILL K+ DFG ++ I D +V
Sbjct: 146 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 330 TTKIQGTFGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372
L PE + T +SDV+S+G+ L EL + G P
Sbjct: 203 ----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 82/304 (26%), Positives = 118/304 (38%), Gaps = 45/304 (14%)
Query: 153 LFSSKELDKATNHFNANRILGQGGQGTVYKG-MLEDGRIIAVK---KSKLTVDDEELL-- 206
++ K+ K + R LG G G V A+K KS+
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 207 ----KLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNE 262
EE NEI +L ++H N++KL + + LV EF G L++ + +RH+ +
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD 144
Query: 263 EFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL---DQRYRAKVADFGTS 319
E I ++ + YLH I HRDIK NILL + K+ DFG S
Sbjct: 145 E-----CDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 320 KFIAMDQTHVTTKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGN 378
F + + GT Y+ PE + +K DV+S GV++ LL G P F N
Sbjct: 197 SFF--SKDYKLRDRLGTAYYIAPEVLKKKY--NEKCDVWSCGVIMYILLCGYPP-FGGQN 251
Query: 379 TSQ--ENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT 436
+ V Y N +I D+ K L K L + KR T
Sbjct: 252 DQDIIKKVEKGKY---YFDFNDWKNISDE------AK-------ELIKLMLTYDYNKRCT 295
Query: 437 MEEV 440
EE
Sbjct: 296 AEEA 299
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 76/308 (24%), Positives = 115/308 (37%), Gaps = 59/308 (19%)
Query: 149 DRFKLFSSKELDKATNHFNANRILGQGGQGTVYKG-MLEDGRIIAVK---KSKLTVDDEE 204
R L+ +N +LG+G G V K + AVK K+ D
Sbjct: 10 GRENLYFQGTF---AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66
Query: 205 LLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDR-HQNE 262
+ E+ +L +++H N++KL E +V E G L+ + R +E
Sbjct: 67 TIL-----REVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSE 120
Query: 263 EFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL---DQRYRAKVADFGTS 319
RI +V + Y+H I HRD+K NILL ++ K+ DFG S
Sbjct: 121 ------HDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 320 KFIAMDQTHVTTKIQGTFGYLDPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
Q GT Y+ PE Y +K DV+S GV+L LL+G P F
Sbjct: 172 TCF--QQNTKMKDRIGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPP-F 222
Query: 375 WAGNTSQ--ENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGK 432
+ N + V Y + + I DD K +L ++ L +
Sbjct: 223 YGKNEYDILKRVETGKY---AFDLPQWRTISDD------AK-------DLIRKMLTFHPS 266
Query: 433 KRPTMEEV 440
R T +
Sbjct: 267 LRITATQC 274
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-29
Identities = 75/279 (26%), Positives = 115/279 (41%), Gaps = 51/279 (18%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
LG+G G+VYK + E G+I+A+K+ + D L+E I EI I+ Q + +VVK
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESD------LQEIIKEISIMQQCDSPHVVKYY 90
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
G + +V E+ G++ D + LT + I L YLH
Sbjct: 91 GSYFKNTDLWIVMEYCGAGSVS----DIIRLRNKTLTEDEIATILQSTLKGLEYLHF--- 143
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 350
HRDIK+ NILL+ AK+ADFG + + T I GT ++ PE Q
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGY 202
Query: 351 TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF-VHSMR------KN---RLH 400
+D++S G+ +E+ GK P Y +H MR N
Sbjct: 203 NCVADIWSLGITAIEMAEGKPP----------------YADIHPMRAIFMIPTNPPPTFR 246
Query: 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
+ F + K+CL + ++R T +
Sbjct: 247 K--PELWSD--------NFTDFVKQCLVKSPEQRATATQ 275
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 57/246 (23%), Positives = 95/246 (38%), Gaps = 65/246 (26%)
Query: 170 RILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-N 222
++LG G G V +AVK K D E E ++E+ +++Q+ +
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER---EALMSELKMMTQLGS 107
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDR------------------HQNEEF 264
H N+V LLG C + L++E+ G L +L + + +
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 265 PLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324
LT+E L A +VA + +L HRD+ + N+L+ K+ DFG ++ I
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI-- 222
Query: 325 DQTHVTTKIQGTFGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELL 367
D Y L + KSDV+S+G++L E+
Sbjct: 223 --------------MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
Query: 368 T-GKKP 372
+ G P
Sbjct: 269 SLGVNP 274
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-29
Identities = 72/282 (25%), Positives = 113/282 (40%), Gaps = 37/282 (13%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
F+ R +G G G VY + + ++A+KK + K ++ I E+ L ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKL 111
Query: 222 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGA 281
H N ++ GC L LV E+ D + + PL +
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSAS-----DLLEVHKKPLQEVEIAAVTHGALQG 166
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 341
LAYLHS + HRD+K+ NILL + K+ DFG++ +A + V GT ++
Sbjct: 167 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMA 218
Query: 342 PE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF-VHSMRKN 397
PE Q K DV+S G+ +EL K P F +++M
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----------------LFNMNAMSA- 261
Query: 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
L+ I ++ L + F N CL + RPT E
Sbjct: 262 -LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 302
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-29
Identities = 72/285 (25%), Positives = 118/285 (41%), Gaps = 38/285 (13%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
+ LG G G VYK E G + A K + ++E LE++I EI IL+
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE----LEDYIVEIEILATC 73
Query: 222 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGA 281
+H +VKLLG ++ EF P G + + LT + ++ A
Sbjct: 74 DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 341
L +LHS I HRD+K+ N+L+ ++ADFG S + I GT ++
Sbjct: 130 LNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMA 185
Query: 342 PE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF-VHSMR 395
PE + + K+D++S G+ L+E+ + P + ++ MR
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP----------------HHELNPMR 229
Query: 396 KNRLHDILDDQLMKLGVKNQI-MTFANLAKRCLDLNGKKRPTMEE 439
L I L ++ + F + K LD N + RP+ +
Sbjct: 230 V--LLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQ 272
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 44/293 (15%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTV-DDEELLKLEEFINEIVI 217
+ + ++ LG G G V + + +A++ K K + E EI I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 218 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDR-HQNEEFPLTWEMRLRIAT 276
L ++NH ++K+ + E +V E + G L+ + E +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-LYFY 246
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILL---DQRYRAKVADFGTSKFIAMDQTHVTTKI 333
++ A+ YLH I HRD+K N+LL ++ K+ DFG SK + +T + +
Sbjct: 247 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTL 301
Query: 334 QGTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ---ENVSLA 387
GT YL PE ++ D +S GV+L L+G P F T + ++
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-FSEHRTQVSLKDQITSG 360
Query: 388 AYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
Y + ++ + L +L K+ L ++ K R T EE
Sbjct: 361 KY---NFIPEVWAEVSEKAL-------------DLVKKLLVVDPKARFTTEEA 397
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 53/318 (16%), Positives = 95/318 (29%), Gaps = 52/318 (16%)
Query: 163 TNHFNANRILGQGGQ--GTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILS 219
+ ++G+G + TV G + V++ L E + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE--MVTFLQGELHVSK 81
Query: 220 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT--- 276
NH N+V + +V F+ G+ + L H + IA
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMNELA-----IAYILQ 135
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ-- 334
V AL Y+H HR +K+++IL+ + ++ ++ +
Sbjct: 136 GVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 335 ----GTFGYLDPEYHQSSQL--TDKSDVYSFGVVLVELLTGKKPIF-------------- 374
+L PE Q + KSD+YS G+ EL G P
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252
Query: 375 -------------WAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFAN 421
S + S+ + D + F +
Sbjct: 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH 312
Query: 422 LAKRCLDLNGKKRPTMEE 439
++CL N RP+
Sbjct: 313 FVEQCLQRNPDARPSAST 330
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 80/297 (26%), Positives = 122/297 (41%), Gaps = 56/297 (18%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
F ++G G G VYKG ++ G++ A+K +T D+EE E EI +L +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-----EIKQEINMLKKY 77
Query: 222 -NHRNVVKLLGCCLETEVPL------LVYEFIPNGT---LYQHLHDRHQNEEFPLTWEMR 271
+HRN+ G ++ P LV EF G+ L ++ EE+
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW------- 130
Query: 272 LRIAT---EVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH 328
IA E+ L++LH + HRDIK N+LL + K+ DFG S +
Sbjct: 131 --IAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185
Query: 329 VTTKIQGTFGYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFWAGNTSQEN 383
T I GT ++ PE + D KSD++S G+ +E+ G P
Sbjct: 186 RNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP----------- 233
Query: 384 VSLAAYF-VHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
+H MR L I + +L K F + + CL N +RP E+
Sbjct: 234 -----LCDMHPMRA--LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQ 283
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 37/279 (13%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEI-VILSQINHRNVVKL 229
+G+G G+V K + G+I+AVK+ + TVD++E ++ + ++ V++ + +V+
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ---KQLLMDLDVVMRSSDCPYIVQF 86
Query: 230 LGCCL-ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRL-RIATEVAGALAYLHS 287
G E + + E + + + + + + + E L +I AL +L
Sbjct: 87 YGALFREGDC-WICMELM-STSFDKFYKYVYSVLDDVIP-EEILGKITLATVKALNHLKE 143
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 347
I HRDIK +NILLD+ K+ DFG S + + T+ G Y+ PE
Sbjct: 144 NLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQ--LVDSIAKTRDAGCRPYMAPERIDP 199
Query: 348 SQLTD----KSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403
S +SDV+S G+ L EL TG+ P + +S+ +L ++
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFP-------------YPKW--NSVFD-QLTQVV 243
Query: 404 DDQLMKLGVKNQI---MTFANLAKRCLDLNGKKRPTMEE 439
+L + +F N CL + KRP +E
Sbjct: 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 32/268 (11%), Positives = 74/268 (27%), Gaps = 56/268 (20%)
Query: 172 LGQGGQGTVYKGMLED---GRIIAVK--KSKLTVDDEELLKLEEFINEIVILSQINHRNV 226
G ++ D R +A+ + + D+ L +E ++ + LS+I+ V
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVL---QETLSRTLRLSRIDKPGV 93
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH 286
++L L+V E+I G+L + + +R +A A H
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAH 146
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 346
A + + + + +A +
Sbjct: 147 RA---GVALSIDHPSRVRVSIDGDVVLAYPA---------------------TMPDA--- 179
Query: 347 SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVH------SMRKNRLH 400
+ D+ G L LL + P + ++ A + +
Sbjct: 180 ----NPQDDIRGIGASLYALLVNRWP--LPEAGVRSGLAPAERDTAGQPIEPADIDRDIP 233
Query: 401 DILDDQLMKLGVKNQIMTFANLAKRCLD 428
+ + + + A+ +
Sbjct: 234 FQISAVAARSVQGDGGIRSASTLLNLMQ 261
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 66/278 (23%), Positives = 120/278 (43%), Gaps = 39/278 (14%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEI-VILSQINHRNVVKL 229
LG+G G V K + G+I+AVK+ + TV+ +E + + ++ + + ++ V
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ---KRLLMDLDISMRTVDCPFTVTF 71
Query: 230 LGCCL-ETEVPLLVYEFIPNGT--LYQHLHDRHQN-EEFPLTWEMRLRIATEVAGALAYL 285
G E +V + E + Y+ + D+ Q E L +IA + AL +L
Sbjct: 72 YGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDILG-----KIAVSIVKALEHL 125
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-- 343
HS S + HRD+K +N+L++ + K+ DFG S + + G Y+ PE
Sbjct: 126 HSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGY--LVDDVAKDIDAGCKPYMAPERI 181
Query: 344 --YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401
+ KSD++S G+ ++EL + P + ++ L
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPY--------------DSWGTPFQQ--LKQ 225
Query: 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
++++ +L F + +CL N K+RPT E
Sbjct: 226 VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 62/338 (18%), Positives = 113/338 (33%), Gaps = 93/338 (27%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+ +G+GG G V++ D A+K+ +L + E+ + E+ L+++ H +V+
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA---REKVMREVKALAKLEHPGIVR 68
Query: 229 LLGCCLETEVPLL---------------------------------------------VY 243
LET +
Sbjct: 69 YFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQ 128
Query: 244 EFIPNGTLY--------QHLHD--RHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPI 293
P LY ++L D + + L I ++A A+ +LHS +
Sbjct: 129 PSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---L 185
Query: 294 YHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ-----------GTFGYLDP 342
HRD+K +NI KV DFG + D+ T GT Y+ P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402
E + + K D++S G++L ELL T E V + + +R + +
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFS-------TQMERVRI----ITDVRNLKFPLL 294
Query: 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ + + + L + +RP ++
Sbjct: 295 FTQKYPQE---------HMMVQDMLSPSPTERPEATDI 323
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 57/264 (21%), Positives = 110/264 (41%), Gaps = 27/264 (10%)
Query: 137 QQMLNSYDGSVIDRFKLFSSKELDKATNHFNAN----RILGQGGQGTVYKGM-LEDGRII 191
+N YD D +K + + ++ LG G G V++ + GR+
Sbjct: 20 GPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVF 79
Query: 192 AVKK-SKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNG 249
K + D+ +K NEI I++Q++H ++ L E + + L+ EF+ G
Sbjct: 80 VAKFINTPYPLDKYTVK-----NEISIMNQLHHPKLINLHDAF-EDKYEMVLILEFLSGG 133
Query: 250 TLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY 309
L+ DR E++ ++ + + L ++H I H DIK NI+ + +
Sbjct: 134 ELF----DRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKK 186
Query: 310 RA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELL 367
+ K+ DFG + + + + T + PE + +D+++ GV+ LL
Sbjct: 187 ASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244
Query: 368 TGKKPIFWAGNTSQ--ENVSLAAY 389
+G P F + + +NV +
Sbjct: 245 SGLSP-FAGEDDLETLQNVKRCDW 267
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 67/350 (19%), Positives = 116/350 (33%), Gaps = 70/350 (20%)
Query: 139 MLNSYDGSVIDRFKLFSSKELDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVK--- 194
M + + S F L + ++ +GQG G V + + I A+K
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 195 KSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQH 254
K+K+ + + +E E+ ++ +++H N+ +L + + LV E G L
Sbjct: 61 KNKIRQINPK--DVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDK 118
Query: 255 LHDRHQNEEFPLTWEMRL-----------------------------------RIATEVA 279
L+ + ++ I ++
Sbjct: 119 LNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178
Query: 280 GALAYLHSATSSPIYHRDIKSTNILL--DQRYRAKVADFGTSKFIA---MDQTHVTTKIQ 334
AL YLH+ I HRDIK N L ++ + K+ DFG SK + + T
Sbjct: 179 SALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235
Query: 335 GTFGYLDPE--YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENVSLAAYF 390
GT ++ PE + K D +S GV+L LL G P F N + V
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP-FPGVNDADTISQVLNKKL- 293
Query: 391 VHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ + + +L L+ N +R
Sbjct: 294 --CFENPNYNVLSPL------AR-------DLLSNLLNRNVDERFDAMRA 328
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 74/306 (24%), Positives = 116/306 (37%), Gaps = 55/306 (17%)
Query: 149 DRFKLFSSKELDKATNHFNANRILGQGGQGTVYKG-MLEDGRIIAVK---KSKLTVDDEE 204
R L+ + +N +LG+G G V K + AVK K+ D
Sbjct: 10 GRENLYFQGTFAE---RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66
Query: 205 LLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEF 264
+ E+ +L +++H N++KL ++ +V E G L+ D +
Sbjct: 67 TIL-----REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF----DEIIKRKR 117
Query: 265 PLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL---DQRYRAKVADFGTSKF 321
+ RI +V + Y+H I HRD+K NILL ++ K+ DFG S
Sbjct: 118 -FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 322 IAMDQTHVTTKIQGTFGYLDPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWA 376
Q GT Y+ PE Y +K DV+S GV+L LL+G P F+
Sbjct: 174 F--QQNTKMKDRIGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPP-FYG 224
Query: 377 GNTSQ--ENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKR 434
N + V Y + + I DD K+ I ++ L + R
Sbjct: 225 KNEYDILKRVETGKY---AFDLPQWRTISDD------AKDLI-------RKMLTFHPSLR 268
Query: 435 PTMEEV 440
T +
Sbjct: 269 ITATQC 274
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 68/301 (22%), Positives = 116/301 (38%), Gaps = 45/301 (14%)
Query: 150 RFKLFSSKELDKATNHFNANRILGQGGQGTVYKG-MLEDGRIIAVK---KSKLTVDDEEL 205
R L+ +D F R LG G G V+ G +K K + V E++
Sbjct: 11 RENLYFQGTIDD---LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI 67
Query: 206 LKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEF 264
EI +L ++H N++K+ E + +V E G L + + +
Sbjct: 68 E------AEIEVLKSLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKA 120
Query: 265 PLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA---KVADFGTSKF 321
L+ + ++ ALAY HS + H+D+K NIL K+ DFG ++
Sbjct: 121 -LSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
Query: 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381
+T GT Y+ PE + +T K D++S GVV+ LLTG P F + +
Sbjct: 177 --FKSDEHSTNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLP-FTGTSLEE 232
Query: 382 --ENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
+ + + + +L K+ L + ++RP+ +
Sbjct: 233 VQQKATYKEPNYAVECRP----LTPQ------AV-------DLLKQMLTKDPERRPSAAQ 275
Query: 440 V 440
V
Sbjct: 276 V 276
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 53/234 (22%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKK-SKLTVDDEELLKLEEFINEIVILSQ 220
+H++ + LG G G V++ G A K D+E ++ EI +S
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR-----KEIQTMSV 210
Query: 221 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVA 279
+ H +V L E + + ++YEF+ G L+ ++ +E ++ + + +V
Sbjct: 211 LRHPTLVNLHDAF-EDDNEMVMIYEFMSGGELF----EKVADEHNKMSEDEAVEYMRQVC 265
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQR--YRAKVADFGTSKFIAMDQTHVTTKIQGTF 337
L ++H + H D+K NI+ + K+ DFG + + D GT
Sbjct: 266 KGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTA 320
Query: 338 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENVSLAAY 389
+ PE + + +D++S GV+ LL+G P F N + NV +
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP-FGGENDDETLRNVKSCDW 373
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 72/247 (29%), Positives = 107/247 (43%), Gaps = 22/247 (8%)
Query: 144 DGSVIDRFKLFSSKELDKAT-NHFNANRILGQGGQGTVYKGMLED-GRIIAVK---KSKL 198
D +RF + E T N F R+LG+GG G V + G++ A K K ++
Sbjct: 163 DSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI 222
Query: 199 TVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHD 257
E +NE IL ++N R VV L ET+ L LV + G L H++
Sbjct: 223 KKRKGE----AMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY- 276
Query: 258 RHQNEEFPLTWEMRLRI-ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316
FP E R A E+ L LH I +RD+K NILLD +++D
Sbjct: 277 HMGQAGFP---EARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDL 330
Query: 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWA 376
G + + QT GT GY+ PE ++ + T D ++ G +L E++ G+ P F
Sbjct: 331 GLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP-FQQ 387
Query: 377 GNTSQEN 383
+
Sbjct: 388 RKKKIKR 394
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 57/218 (26%), Positives = 93/218 (42%), Gaps = 39/218 (17%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEI-VILSQINHRNVVKL 229
+G G G V+K + G +IAVK+ + + + EE + + ++ V+L + +V+
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN---KRILMDLDVVLKSHDCPYIVQC 89
Query: 230 LGCCLETEVPLLVYEFIPNGTLY---------QHLHDRHQNEEFPLTWEMRL-RIATEVA 279
G FI N ++ + P E L ++ +
Sbjct: 90 FGT------------FITNTDVFIAMELMGTCAEKLKKRMQGPIP---ERILGKMTVAIV 134
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 339
AL YL + HRD+K +NILLD+R + K+ DFG S + + G Y
Sbjct: 135 KALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR--LVDDKAKDRSAGCAAY 190
Query: 340 LDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKP 372
+ PE T ++DV+S G+ LVEL TG+ P
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 66/293 (22%), Positives = 113/293 (38%), Gaps = 44/293 (15%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTV-DDEELLKLEEFINEIVI 217
+ + ++ LG G G V + + +A+K K K + E EI I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 218 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDR-HQNEEFPLTWEMRLRIAT 276
L ++NH ++K+ + E +V E + G L+ + E +
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-LYFY 121
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILL---DQRYRAKVADFGTSKFIAMDQTHVTTKI 333
++ A+ YLH I HRD+K N+LL ++ K+ DFG SK + +T + +
Sbjct: 122 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTL 176
Query: 334 QGTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ---ENVSLA 387
GT YL PE ++ D +S GV+L L+G P F T + ++
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-FSEHRTQVSLKDQITSG 235
Query: 388 AYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
Y + + + + K+ L ++ K R T EE
Sbjct: 236 KYNFIPEVWAEVSE---------KALDLV-------KKLLVVDPKARFTTEEA 272
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 61/233 (26%), Positives = 101/233 (43%), Gaps = 22/233 (9%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
+ LG+G G V++ + + K K+ D+ L+K EI IL+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK-----KEISILNIA 58
Query: 222 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
HRN++ L E+ L +++EFI ++ +R F L + +V
Sbjct: 59 RHRNILHLHESF-ESMEELVMIFEFISGLDIF----ERINTSAFELNEREIVSYVHQVCE 113
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRA--KVADFGTSKFIAMDQTHVTTKIQGTFG 338
AL +LH S I H DI+ NI+ R + K+ +FG ++ + +
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPE 168
Query: 339 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENVSLAAY 389
Y PE HQ ++ +D++S G ++ LL+G P F A Q EN+ A Y
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP-FLAETNQQIIENIMNAEY 220
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 166 FNANRILGQGGQGTVYKG-MLEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVILSQI 221
F +ILG+G TV L R A+K K + ++ K+ E ++S++
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN----KVPYVTRERDVMSRL 87
Query: 222 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATEVA 279
+H VKL + + L + NG L +++ + F E R E+
Sbjct: 88 DHPFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYIR---KIGSFD---ETCTRFYTAEIV 140
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK-IQGTFG 338
AL YLH I HRD+K NILL++ ++ DFGT+K ++ + GT
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 339 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381
Y+ PE SD+++ G ++ +L+ G P F AGN
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYL 239
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 23/231 (9%)
Query: 166 FNANRILGQGGQGTVYKGM-LEDGRIIAVKK-SKLTVDDEELLKLEEFINEIVILSQINH 223
+ ILG G G V+K G +A K + D+E +K NEI +++Q++H
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK-----NEISVMNQLDH 145
Query: 224 RNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
N+++L E++ + LV E++ G L+ DR +E + LT + ++ +
Sbjct: 146 ANLIQLYD-AFESKNDIVLVMEYVDGGELF----DRIIDESYNLTELDTILFMKQICEGI 200
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYL 340
++H I H D+K NIL R K+ DFG ++ GT +L
Sbjct: 201 RHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFL 255
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENVSLAAY 389
PE ++ +D++S GV+ LL+G P F N ++ N+ +
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP-FLGDNDAETLNNILACRW 305
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-26
Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 20/232 (8%)
Query: 149 DRFKLFSSKELDKAT-NHFNANRILGQGGQGTVYKGMLED-GRIIAVK---KSKLTVDDE 203
RF + E + F R+LG+GG G V+ ++ G++ A K K +L
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG 228
Query: 204 ELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNE 262
+ + E IL++++ R +V L ET+ L LV + G + H+++ ++
Sbjct: 229 Y----QGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 263 E-FPLTWEMRLRI-ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320
F E R ++ L +LH I +RD+K N+LLD +++D G +
Sbjct: 284 PGFQ---EPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
+ QT GT G++ PE + D ++ GV L E++ + P
Sbjct: 338 ELKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVIL 218
+++++ LG+G V + + G A K KL+ D + L+ E I
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE-----REARIC 59
Query: 219 SQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDR-HQNEEFPLTWEMRLRIAT 276
++ H N+V+L + E LV++ + G L++ + R +E +
Sbjct: 60 RKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFYSEA-----DAS-HCIQ 112
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA---KVADFGTSKFIAMDQTHVTTKI 333
++ ++AY H S+ I HR++K N+LL + + K+ADFG + + + +
Sbjct: 113 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGF 167
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGN 378
GT GYL PE + + D+++ GV+L LL G P FW +
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP-FWDED 211
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 65/287 (22%), Positives = 115/287 (40%), Gaps = 34/287 (11%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVIL 218
+ + ++G+G V + + E G+ AVK +K T L E+ E I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT--SSPGLSTEDLKREASIC 80
Query: 219 SQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATE 277
+ H ++V+LL ++ L +V+EF+ L + R + F + + +
Sbjct: 81 HMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKR-ADAGFVYSEAVASHYMRQ 138
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA---KVADFGTSKFIAMDQTHVTTKIQ 334
+ AL Y H + I HRD+K +LL + + K+ FG + + ++
Sbjct: 139 ILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV- 194
Query: 335 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTS-QENVSLAAYFVHS 393
GT ++ PE + DV+ GV+L LL+G P F+ E + Y
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP-FYGTKERLFEGIIKGKY---K 250
Query: 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
M + I + K +L +R L L+ +R T+ E
Sbjct: 251 MNPRQWSHISES------AK-------DLVRRMLMLDPAERITVYEA 284
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 77/284 (27%), Positives = 118/284 (41%), Gaps = 55/284 (19%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVILSQINHRN 225
+ +G+G V + GR +A+K K++L + L E+ I+ +NH N
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-----REVRIMKILNHPN 75
Query: 226 VVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
+VKL +ETE L L+ E+ G ++ +L + +E E R ++ A+ Y
Sbjct: 76 IVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EAR-SKFRQIVSAVQY 129
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE- 343
H I HRD+K+ N+LLD K+ADFG S + G Y PE
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPEL 184
Query: 344 -----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENVSLAAYFVHSMRK 396
Y + DV+S GV+L L++G P F N + E V Y +
Sbjct: 185 FQGKKYDGP-----EVDVWSLGVILYTLVSGSLP-FDGQNLKELRERVLRGKYRIPFY-- 236
Query: 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
M +N + KR L LN KR T+E++
Sbjct: 237 -----------MSTDCENLL-------KRFLVLNPIKRGTLEQI 262
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 27/231 (11%)
Query: 164 NHFNANRILGQGGQGTVYKG-MLEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVILS 219
+ F +++G+G V M + G++ A+K K + E + F E +L
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE----VSCFREERDVLV 116
Query: 220 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATE 277
+ R + +L + E L LV E+ G L L E P R E
Sbjct: 117 NGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIP---AEMARFYLAE 170
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF 337
+ A+ +H HRDIK NILLD+ ++ADFG+ + D T + GT
Sbjct: 171 IVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227
Query: 338 GYLDPEYHQSSQLTDKSDVY-------SFGVVLVELLTGKKPIFWAGNTSQ 381
YL PE Q+ + Y + GV E+ G+ P F+A +T++
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP-FYADSTAE 277
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 72/310 (23%), Positives = 125/310 (40%), Gaps = 51/310 (16%)
Query: 145 GSVIDRFKLFSSKELDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTV 200
G + R F K +++++ LG+G V + + G A K KL+
Sbjct: 10 GQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA 69
Query: 201 DDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRH 259
D + L+ E I ++ H N+V+L + E LV++ + G L++ + R
Sbjct: 70 RDFQKLE-----REARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVARE 123
Query: 260 QNEEFPLTWEMRLRIATE----VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA---K 312
E A+ + ++AY H S+ I HR++K N+LL + + K
Sbjct: 124 FYSE---------ADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVK 171
Query: 313 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
+ADFG + + + + GT GYL PE + + D+++ GV+L LL G P
Sbjct: 172 LADFGLAIEV--NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
Query: 373 IFWAGNTSQ--ENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLN 430
FW + + + AY + + K +L L +N
Sbjct: 230 -FWDEDQHRLYAQIKAGAY---DYPSPEWDTVTPE------AK-------SLIDSMLTVN 272
Query: 431 GKKRPTMEEV 440
KKR T ++
Sbjct: 273 PKKRITADQA 282
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 59/238 (24%), Positives = 96/238 (40%), Gaps = 24/238 (10%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVIL 218
+ ++ LG G V K G A K K + + + EE E+ IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSR-EEIEREVSIL 69
Query: 219 SQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATE 277
Q+ H NV+ L E + L+ E + G L+ L + E T ++ +
Sbjct: 70 RQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-----Q 123
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILL----DQRYRAKVADFGTSKFIAMDQTHVTTKI 333
+ + YLH + I H D+K NI+L K+ DFG + I + I
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNI 178
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENVSLAAY 389
GT ++ PE L ++D++S GV+ LL+G P F + N++ +Y
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-FLGDTKQETLANITSVSY 235
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 63/291 (21%), Positives = 106/291 (36%), Gaps = 52/291 (17%)
Query: 163 TNHFNANRILGQGGQGTVYKG-MLEDGRIIAVKK-SKLTVDDEELLKLEEFINEIVILSQ 220
++ +G+G G V A KK K V+D + K EI I+
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK-----QEIEIMKS 62
Query: 221 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVA 279
++H N+++L E + LV E G L++ + + E RI +V
Sbjct: 63 LDHPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRE-----SDAARIMKDVL 116
Query: 280 GALAYLHSATSSPIYHRDIKSTNILL---DQRYRAKVADFGTSKFIAMDQTHVTTKIQGT 336
A+AY H + HRD+K N L K+ DFG + + GT
Sbjct: 117 SAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKVGT 171
Query: 337 FGYLDPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENVSLAAY 389
Y+ P+ Y + D +S GV++ LL G P F A S+ + +
Sbjct: 172 PYYVSPQVLEGLY------GPECDEWSAGVMMYVLLCGYPP-FSAPTDSEVMLKIREGTF 224
Query: 390 FVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ + ++ + +L +R L + K+R T +
Sbjct: 225 ---TFPEKDWLNVSPQ------AE-------SLIRRLLTKSPKQRITSLQA 259
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 62/238 (26%), Positives = 102/238 (42%), Gaps = 24/238 (10%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVIL 218
+H+ LG G V K G+ A K K +L+ + + EE E+ IL
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSR-EEIEREVNIL 62
Query: 219 SQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATE 277
+I H N++ L E + + L+ E + G L+ L ++ E T ++ +
Sbjct: 63 REIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-----Q 116
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA----KVADFGTSKFIAMDQTHVTTKI 333
+ + YLH S I H D+K NI+L + K+ DFG + I + + I
Sbjct: 117 ILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNI 171
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENVSLAAY 389
GT ++ PE L ++D++S GV+ LL+G P F + N+S Y
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-FLGETKQETLTNISAVNY 228
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 64/229 (27%), Positives = 99/229 (43%), Gaps = 28/229 (12%)
Query: 164 NHFNANRILGQGGQGTVYK-GMLEDGRIIAVKK-SKLTVDDEELLKLEE---FINEIVIL 218
+ +++G+G G V ++ A+K SK E++K + F E I+
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK-----FEMIKRSDSAFFWEERDIM 123
Query: 219 SQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-AT 276
+ N VV+L + + L +V E++P G L + N + P E R
Sbjct: 124 AFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVP---EKWARFYTA 175
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGT 336
EV AL +HS HRD+K N+LLD+ K+ADFGT + + GT
Sbjct: 176 EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 232
Query: 337 FGYLDPEYHQSSQLT---DKS-DVYSFGVVLVELLTGKKPIFWAGNTSQ 381
Y+ PE +S + D +S GV L E+L G P F+A +
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP-FYADSLVG 280
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 58/238 (24%), Positives = 97/238 (40%), Gaps = 24/238 (10%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVIL 218
+ ++ LG G V K G A K K + + + EE E+ IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR-EEIEREVSIL 69
Query: 219 SQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATE 277
Q+ H N++ L E + L+ E + G L+ L + E T ++ +
Sbjct: 70 RQVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-----Q 123
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQR----YRAKVADFGTSKFIAMDQTHVTTKI 333
+ + YLH + I H D+K NI+L + K+ DFG + I + I
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNI 178
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENVSLAAY 389
GT ++ PE L ++D++S GV+ LL+G P F + N++ +Y
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-FLGDTKQETLANITAVSY 235
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 65/238 (27%), Positives = 99/238 (41%), Gaps = 24/238 (10%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVIL 218
++++ LG G V K G A K K + + + E+ E+ IL
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR-EDIEREVSIL 68
Query: 219 SQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATE 277
+I H NV+ L E + + L+ E + G L+ D +E LT E +
Sbjct: 69 KEIQHPNVITLHEVY-ENKTDVILILELVAGGELF----DFLAEKES-LTEEEATEFLKQ 122
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA----KVADFGTSKFIAMDQTHVTTKI 333
+ + YLH S I H D+K NI+L R K+ DFG + I D + I
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNI 177
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENVSLAAY 389
GT ++ PE L ++D++S GV+ LL+G P F + NVS Y
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-FLGDTKQETLANVSAVNY 234
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 63/282 (22%), Positives = 112/282 (39%), Gaps = 44/282 (15%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVILSQINHRN 225
LG+G V + + + G+ A KL+ D + L+ E I + H N
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE-----REARICRLLKHPN 71
Query: 226 VVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDR-HQNEEFPLTWEMRLRIATEVAGALA 283
+V+L E L+++ + G L++ + R + +E + ++ A+
Sbjct: 72 IVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVAREYYSEA-----DAS-HCIQQILEAVL 124
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRA---KVADFGTSKFIAMDQTHVTTKIQGTFGYL 340
+ H + HR++K N+LL + + K+ADFG + + +Q GT GYL
Sbjct: 125 HCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYL 180
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENVSLAAYFVHSMRKNR 398
PE + D+++ GV+L LL G P FW + + + + AY
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPP-FWDEDQHRLYQQIKAGAY---DFPSPE 236
Query: 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ + K +L + L +N KR T E
Sbjct: 237 WDTVTPE------AK-------DLINKMLTINPSKRITAAEA 265
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 67/230 (29%), Positives = 110/230 (47%), Gaps = 28/230 (12%)
Query: 164 NHFNANRILGQGGQGTVYKGMLED-GRIIAVK---KSKLTVDDEELLKLEEFINEIVILS 219
N F+ +RI+G+GG G VY D G++ A+K K ++ + E L L NE ++LS
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL----NERIMLS 244
Query: 220 QIN---HRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI- 274
++ +V + T L + + + G L+ HL Q+ F E +R
Sbjct: 245 LVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFS---EADMRFY 297
Query: 275 ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ 334
A E+ L ++H+ + +RD+K NILLD+ +++D G + + + H +
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 335 GTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFWAGNTSQEN 383
GT GY+ PE Q D S D +S G +L +LL G P F T ++
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKH 400
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 71/227 (31%), Positives = 106/227 (46%), Gaps = 26/227 (11%)
Query: 164 NHFNANRILGQGGQGTVY----KGMLEDGRIIAVK---KSKLTVDDEELLKLEEFINEIV 216
+ F ++LGQG G V+ + ++ A+K K+ L V D E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-----RTKMERD 78
Query: 217 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI- 274
IL ++NH +VKL +TE L L+ +F+ G L+ L F E ++
Sbjct: 79 ILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVM---FT---EEDVKFY 131
Query: 275 ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ 334
E+A AL +LHS I +RD+K NILLD+ K+ DFG SK ++D
Sbjct: 132 LAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFC 187
Query: 335 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381
GT Y+ PE T +D +SFGV++ E+LTG P F + +
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKE 233
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 57/232 (24%), Positives = 93/232 (40%), Gaps = 28/232 (12%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVILSQINHR- 224
+ LG+G V + + G+ A K K + D + +EI +L
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL-----HEIAVLELAKSCP 89
Query: 225 NVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
V+ L E + L+ E+ G ++ ++ +R+ ++ +
Sbjct: 90 RVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAE---MVSENDVIRLIKQILEGVY 145
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRY---RAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 340
YLH + I H D+K NILL Y K+ DFG S+ I +I GT YL
Sbjct: 146 YLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEYL 200
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE---NVSLAAY 389
PE +T +D+++ G++ LLT P F G +QE N+S
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTHTSP-FV-GEDNQETYLNISQVNV 250
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 26/216 (12%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKK-SKLTVDDEELLKLEEFINEIVILSQINHRNVV 227
+LG G V+ G++ A+K K + L+ NEI +L +I H N+V
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE-----NEIAVLKKIKHENIV 69
Query: 228 KLLGCCLETEVPL-LVYEFIPNGTLYQHLHDR-HQNEEFPLTWEMRLRIATEVAGALAYL 285
L E+ LV + + G L+ + +R E + + +V A+ YL
Sbjct: 70 TLEDIY-ESTTHYYLVMQLVSGGELFDRILERGVYTE------KDASLVIQQVLSAVKYL 122
Query: 286 HSATSSPIYHRDIKSTNILL---DQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 342
H I HRD+K N+L ++ + + DFG SK Q + + GT GY+ P
Sbjct: 123 HENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGTPGYVAP 176
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGN 378
E + D +S GV+ LL G P F+
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCGYPP-FYEET 211
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 26/229 (11%)
Query: 164 NHFNANRILGQGGQGTVYKGMLED-GRIIAVK---KSKLTVDDEELLKLEEFINEIVILS 219
+HF R +G+G G V D ++ A+K K K +E + E+ I+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE----VRNVFKELQIMQ 70
Query: 220 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATE 277
+ H +V L + E + +V + + G L HL QN F E +++ E
Sbjct: 71 GLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQ---QNVHFK---EETVKLFICE 123
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF 337
+ AL YL + I HRD+K NILLD+ + DF + + + T + GT
Sbjct: 124 LVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTK 178
Query: 338 GYLDPEYHQSSQLT--DKS-DVYSFGVVLVELLTGKKPIFWAGNTSQEN 383
Y+ PE S + + D +S GV ELL G++P + +++
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP-YHIRSSTSSK 226
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 33/233 (14%)
Query: 164 NHFNANRILGQGGQGTVYKGML----EDGRIIAVKK-SKLTVDDEELLKLEE---FINEI 215
F +++G+G G V + ++ A+K +K E+LK E F E
Sbjct: 74 EDFEILKVIGRGAFGEV---AVVKLKNADKVFAMKILNK-----WEMLKRAETACFREER 125
Query: 216 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI 274
+L + + + L + + L LV ++ G L L + P E R
Sbjct: 126 DVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLP---EEMARF 179
Query: 275 -ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
E+ A+ +H HRDIK NIL+D ++ADFG+ + D T ++
Sbjct: 180 YLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 334 QGTFGYLDPEYHQSSQLTDKS-----DVYSFGVVLVELLTGKKPIFWAGNTSQ 381
GT Y+ PE Q+ + D +S GV + E+L G+ P F+A + +
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP-FYAESLVE 288
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 71/305 (23%), Positives = 121/305 (39%), Gaps = 66/305 (21%)
Query: 155 SSKELDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVK---KSKLT----VDDEELL 206
KE + + + +LG GG G+VY G+ + D +A+K K +++ + + +
Sbjct: 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93
Query: 207 KLEEFINEIVILSQINHR--NVVKLLGCCLETEVPL-LVYEFI-PNGTLYQHLHDRHQNE 262
+E +V+L +++ V++LL E L+ E P L+ + +R +
Sbjct: 94 PME-----VVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQ 147
Query: 263 EFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ-RYRAKVADFGTSKF 321
E R +V A+ + H+ + HRDIK NIL+D R K+ DFG+
Sbjct: 148 EE----LAR-SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL 199
Query: 322 IAMDQTHVTTKIQGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFW 375
+ T T GT Y PE YH + V+S G++L +++ G P F
Sbjct: 200 --LKDTVYTD-FDGTRVYSPPEWIRYHRYHGR-----SAAVWSLGILLYDMVCGDIP-F- 249
Query: 376 AGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP 435
E + + + +L + CL L RP
Sbjct: 250 ---EHDEEIIRGQV--------FFRQRVSSECQ------------HLIRWCLALRPSDRP 286
Query: 436 TMEEV 440
T EE+
Sbjct: 287 TFEEI 291
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVK-----KSKLTVDDEELLKLEEFINEIV 216
++ ILG+G V + + + AVK +E E + E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 217 ILSQIN-HRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDR-HQNEEFPLTWEMRLR 273
IL +++ H N+++L ET LV++ + G L+ +L ++ +E+ E R +
Sbjct: 76 ILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSEK-----ETR-K 128
Query: 274 IATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
I + + LH I HRD+K NILLD K+ DFG S + D ++
Sbjct: 129 IMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREV 183
Query: 334 QGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGN 378
GT YL PE + D++S GV++ LL G P FW
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-FWHRK 233
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 65/239 (27%), Positives = 110/239 (46%), Gaps = 46/239 (19%)
Query: 155 SSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFIN- 213
K ++ + +++G G G V++ L + +A+KK +L+ + F N
Sbjct: 31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKK---------VLQDKRFKNR 81
Query: 214 EIVILSQINHRNVVKLLGCCLET-----EVPL-LVYEFIPNGTLYQHL-HDRHQNEEFPL 266
E+ I+ + H NVV L EV L LV E++P T+Y+ H + P+
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPM 140
Query: 267 ------TWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR-YRAKVADFGTS 319
+++ LR +LAY+HS I HRDIK N+LLD K+ DFG++
Sbjct: 141 LLIKLYMYQL-LR-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189
Query: 320 KFIAMDQ--TH-VTTKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
K + + + ++ Y PE ++ T D++S G V+ EL+ G +P+F
Sbjct: 190 KILIAGEPNVSYICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPLF 242
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 68/260 (26%), Positives = 110/260 (42%), Gaps = 22/260 (8%)
Query: 129 KQNGGLLLQQMLNSYDGSVIDRFKLFSSKELDKAT-NHFNANRILGQGGQGTVYKGMLED 187
KQ + + + D S + ++ +K + T N F ++LG+G G V +
Sbjct: 112 KQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKA 171
Query: 188 -GRIIAVK---KSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL-LV 242
GR A+K K + DE + + E +L H + L +T L V
Sbjct: 172 TGRYYAMKILKKEVIVAKDE----VAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFV 226
Query: 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATEVAGALAYLHSATSSPIYHRDIKST 301
E+ G L+ HL + F E R R E+ AL YLHS + + +RD+K
Sbjct: 227 MEYANGGELFFHLS---RERVFS---EDRARFYGAEIVSALDYLHSEKN--VVYRDLKLE 278
Query: 302 NILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGV 361
N++LD+ K+ DFG K + GT YL PE + + D + GV
Sbjct: 279 NLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 337
Query: 362 VLVELLTGKKPIFWAGNTSQ 381
V+ E++ G+ P F+ + +
Sbjct: 338 VMYEMMCGRLP-FYNQDHEK 356
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 48/258 (18%)
Query: 138 QMLNSYDGSVIDRFKLFSSKELDKA-TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKK 195
++ DGS + + D+ + +++G G G VY+ L + G ++A+KK
Sbjct: 27 KVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK 86
Query: 196 SKLTVDDEELLKLEEFIN-EIVILSQINHRNVVKLLGCCLET-----EVPL-LVYEFIPN 248
+L+ + F N E+ I+ +++H N+V+L + EV L LV +++P
Sbjct: 87 ---------VLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 137
Query: 249 GTLYQHL-HDRHQNEEFPL------TWEMRLRIATEVAGALAYLHSATSSPIYHRDIKST 301
T+Y+ H + P+ +++ R +LAY+HS I HRDIK
Sbjct: 138 -TVYRVARHYSRAKQTLPVIYVKLYMYQL-FR-------SLAYIHSFG---ICHRDIKPQ 185
Query: 302 NILLDQR-YRAKVADFGTSKFIAMDQ--TH-VTTKIQGTFGYLDPEY-HQSSQLTDKSDV 356
N+LLD K+ DFG++K + + + ++ Y PE ++ T DV
Sbjct: 186 NLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSSIDV 240
Query: 357 YSFGVVLVELLTGKKPIF 374
+S G VL ELL G +PIF
Sbjct: 241 WSAGCVLAELLLG-QPIF 257
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 7e-23
Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 27/223 (12%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFI-NEIVILSQI-NH 223
++G+G V + + G AVK + + E+L ++ E E IL Q+ H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 224 RNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDR-HQNEEFPLTWEMRLRIATEVAGA 281
+++ L+ E+ + LV++ + G L+ +L ++ +E+ E R I + A
Sbjct: 160 PHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSEK-----ETR-SIMRSLLEA 212
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 341
+++LH+ + I HRD+K NILLD + +++DFG S ++ ++ GT GYL
Sbjct: 213 VSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLRELCGTPGYLA 267
Query: 342 PE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGN 378
PE + D+++ GV+L LL G P FW
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP-FWHRR 309
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 70/290 (24%), Positives = 116/290 (40%), Gaps = 64/290 (22%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK---KSKLT--VDDEELLKLEEFINEIVILSQIN- 222
+LG+GG GTV+ G L D +A+K ++++ + + E+ +L ++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP---LEVALLWKVGA 93
Query: 223 ---HRNVVKLLGCCLETEVPL-LVYEF-IPNGTLYQHLHDRHQNEEFPLTWEMRLRIATE 277
H V++LL ET+ LV E +P L+ ++ ++ E R +
Sbjct: 94 GGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEG----PSR-CFFGQ 147
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRY-RAKVADFGTSKFIAMDQTHVTTKIQGT 336
V A+ + HS + HRDIK NIL+D R AK+ DFG+ + T GT
Sbjct: 148 VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGAL--LHDEPYTD-FDGT 201
Query: 337 FGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF 390
Y PE YH + V+S G++L +++ G P F + + A
Sbjct: 202 RVYSPPEWISRHQYHAL-----PATVWSLGILLYDMVCGDIP-F----ERDQEILEAEL- 250
Query: 391 VHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ L +RCL RP++EE+
Sbjct: 251 -------HFPAHVSPDC------------CALIRRCLAPKPSSRPSLEEI 281
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 2e-22
Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 24/227 (10%)
Query: 164 NHFNANRILGQGGQGTVY----KGMLEDGRIIAVK---KSKLTVDDEELLKLEEFINEIV 216
F R+LG+GG G V+ G+I A+K K+ + + ++ E
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT---AHTKAERN 73
Query: 217 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI- 274
IL ++ H +V L+ +T L L+ E++ G L+ L + F E
Sbjct: 74 ILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE---REGIFM---EDTACFY 126
Query: 275 ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ 334
E++ AL +LH I +RD+K NI+L+ + K+ DFG K ++ VT
Sbjct: 127 LAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFC 182
Query: 335 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381
GT Y+ PE S D +S G ++ ++LTG P F N +
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP-FTGENRKK 228
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 66/286 (23%), Positives = 112/286 (39%), Gaps = 50/286 (17%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVILSQINHRN 225
+LG+G G V + + E AVK K KL ++ EI +L ++ H+N
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK---KEIQLLRRLRHKN 67
Query: 226 VVKLLG-CCLETEVPL-LVYEFIPNGT--LYQHLHDRHQNEEFPLTWEMRLRIATEVAGA 281
V++L+ E + + +V E+ G + + ++ + ++
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV-----CQAH-GYFCQLIDG 121
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS---KFIAMDQTHVTTKIQGTFG 338
L YLHS I H+DIK N+LL K++ G + A D T T+ QG+
Sbjct: 122 LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS--QGSPA 176
Query: 339 YLDPEYHQSSQLTD--KSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENVSLAAYFVHSM 394
+ PE K D++S GV L + TG P F N + EN+ +Y
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP-FEGDNIYKLFENIGKGSY----- 230
Query: 395 RKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ L ++L K L+ KR ++ ++
Sbjct: 231 ---AIPGDCGPPL------------SDLLKGMLEYEPAKRFSIRQI 261
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 60/258 (23%), Positives = 114/258 (44%), Gaps = 54/258 (20%)
Query: 144 DGSVIDRFKLFSSKELD-KATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVD 201
GS++ ++ E K + F R+ GQG GTV G G +A+KK V
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK----VI 57
Query: 202 DEELLKLEEFINEIVILSQINHRNVVKLL------GCCLETEVPL-LVYEFIPNGTLYQH 254
+ + E + + L+ ++H N+V+L G ++ L +V E++P+ TL++
Sbjct: 58 QDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRC 115
Query: 255 L-HDRHQNEEFPL------TWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ 307
+ + P +++ +R ++ LH S + HRDIK N+L+++
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQL-IR-------SIGCLHL-PSVNVCHRDIKPHNVLVNE 166
Query: 308 R-YRAKVADFGTSKFIAMDQTH---VTTK-------IQGTFGYLDPEYHQSSQLTDKSDV 356
K+ DFG++K ++ + + + ++ I G Y T D+
Sbjct: 167 ADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHY-----------TTAVDI 215
Query: 357 YSFGVVLVELLTGKKPIF 374
+S G + E++ G +PIF
Sbjct: 216 WSVGCIFAEMMLG-EPIF 232
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 75/333 (22%), Positives = 125/333 (37%), Gaps = 76/333 (22%)
Query: 141 NSYDGSVIDRFKLFSSKELDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLT 199
+S+ G D ++L ++ +LG+G V + L + AVK
Sbjct: 4 DSFSGRFEDVYQL--QED------------VLGEGAHARVQTCINLITSQEYAVK----I 45
Query: 200 VDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDR 258
++ + E+ +L Q HRNV++L+ E + LV+E + G++ H+H R
Sbjct: 46 IEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR 105
Query: 259 -HQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL---DQRYRAKVA 314
H NE E + +VA AL +LH+ I HRD+K NIL +Q K+
Sbjct: 106 RHFNEL-----EAS-VVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKIC 156
Query: 315 DFGTSKFIAMDQTHVTTKIQ------GTFGYLDPE----YHQSSQLTDKS-DVYSFGVVL 363
DF I ++ G+ Y+ PE + + + + DK D++S GV+L
Sbjct: 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
Query: 364 VELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIM----TF 419
LL+G P F S + I F
Sbjct: 217 YILLSGYPP-FVGRCGSDCGWDRGEACPACQN---------------MLFESIQEGKYEF 260
Query: 420 A------------NLAKRCLDLNGKKRPTMEEV 440
+L + L + K+R + +V
Sbjct: 261 PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV 293
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 54/284 (19%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVD-DEELLKLEEFINEIVILSQINHR 224
LG G G V+ + E + + VK K K+ D E KL + EI ILS++ H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 225 NVVKLLGCCLETEVPL-LVYEFIPNGT-LYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
N++K+L E + LV E +G L+ + + +E I ++ A+
Sbjct: 90 NIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP----LAS-YIFRQLVSAV 143
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 342
YL I HRDIK NI++ + + K+ DFG++ ++ + T GT Y P
Sbjct: 144 GYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYCAP 198
Query: 343 E------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396
E Y + +++S GV L L+ + P F E AA
Sbjct: 199 EVLMGNPYRGP-----ELEMWSLGVTLYTLVFEENP-F----CELEETVEAAI------- 241
Query: 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
++ +LM +L L ++R T+E++
Sbjct: 242 -HPPYLVSKELM------------SLVSGLLQPVPERRTTLEKL 272
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-22
Identities = 71/281 (25%), Positives = 111/281 (39%), Gaps = 44/281 (15%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFIN-EIVILSQINHRNVV 227
+ LG+G G V + +AVK VD + + E I EI I +NH NVV
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 228 KLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH 286
K G L E+ G L+ + E + + R ++ + YLH
Sbjct: 69 KFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQ-RFFHQLMAGVVYLH 122
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM-DQTHVTTKIQGTFGYLDPE-- 343
I HRDIK N+LLD+R K++DFG + ++ + K+ GT Y+ PE
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 344 ----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399
+H DV+S G+VL +L G+ P + Q + S Y K +
Sbjct: 180 KRREFHAE-----PVDVWSCGIVLTAMLAGELP-W-----DQPSDSCQEYS---DWKEKK 225
Query: 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ + + L + L N R T+ ++
Sbjct: 226 TYLNPWKKIDSAPL-------ALLHKILVENPSARITIPDI 259
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 62/239 (25%), Positives = 106/239 (44%), Gaps = 39/239 (16%)
Query: 157 KELDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFI 212
D ++ F LG+G VY+ + A+K K+ D+++++
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVR----- 96
Query: 213 NEIVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDR-HQNEEFPLTWEM 270
EI +L +++H N++KL ET + LV E + G L+ + ++ + +E
Sbjct: 97 TEIGVLLRLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGYYSE-------- 147
Query: 271 RLRIATE----VAGALAYLHSATSSPIYHRDIKSTNILL---DQRYRAKVADFGTSKFIA 323
R A + + A+AYLH I HRD+K N+L K+ADFG SK +
Sbjct: 148 --RDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV- 201
Query: 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE 382
+ + + GT GY PE + + D++S G++ LL G +P F+ Q
Sbjct: 202 -EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP-FYDERGDQF 258
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 67/242 (27%), Positives = 109/242 (45%), Gaps = 30/242 (12%)
Query: 149 DRFKLFSSKELDKAT-NHFNANRILGQGGQGTVYKGML----EDGRIIAVKKSKLTVDDE 203
D K + + + A + F+ + LG G G V ML E G A+K +D +
Sbjct: 25 DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMK----ILDKQ 77
Query: 204 ELLKLEEF---INEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQ 260
+++KL++ +NE IL +N +VKL + +V E++ G ++ HL +
Sbjct: 78 KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 261 NEEFPLTWEMRLRI-ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319
F E R A ++ YLHS + +RD+K N+L+DQ+ +V DFG +
Sbjct: 138 ---FS---EPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNT 379
K + T + GT L PE S D ++ GV++ E+ G P F+A
Sbjct: 189 KRV----KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP-FFADQP 243
Query: 380 SQ 381
Q
Sbjct: 244 IQ 245
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 68/241 (28%), Positives = 101/241 (41%), Gaps = 27/241 (11%)
Query: 154 FSSKELDKAT-NHFNANRILGQGGQGTVY----KGMLEDGRIIAVK---KSKLTVDDEEL 205
+ +K +F ++LG G G V+ + G++ A+K K+ + +
Sbjct: 43 NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 102
Query: 206 LKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEE- 263
E E +L I + L +TE L L+ ++I G L+ HL E
Sbjct: 103 ---EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL----SQRER 155
Query: 264 FPLTWEMRLRI-ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322
F E ++I E+ AL +LH I +RDIK NILLD + DFG SK
Sbjct: 156 FT---EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 209
Query: 323 AMDQTHVTTKIQGTFGYLDPE-YHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFWAGNTS 380
D+T GT Y+ P+ DK+ D +S GV++ ELLTG P F
Sbjct: 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP-FTVDGEK 268
Query: 381 Q 381
Sbjct: 269 N 269
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 71/281 (25%), Positives = 111/281 (39%), Gaps = 44/281 (15%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFIN-EIVILSQINHRNVV 227
+ LG+G G V + +AVK VD + + E I EI I +NH NVV
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVK----IVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 228 KLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH 286
K G L E+ G L+ + E + + R ++ + YLH
Sbjct: 69 KFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQ-RFFHQLMAGVVYLH 122
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM-DQTHVTTKIQGTFGYLDPE-- 343
I HRDIK N+LLD+R K++DFG + ++ + K+ GT Y+ PE
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 344 ----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399
+H DV+S G+VL +L G+ P ++ QE Y K +
Sbjct: 180 KRREFHAE-----PVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YS---DWKEKK 225
Query: 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ + + L + L N R T+ ++
Sbjct: 226 TYLNPWKKIDSAPL-------ALLHKILVENPSARITIPDI 259
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 58/293 (19%), Positives = 104/293 (35%), Gaps = 61/293 (20%)
Query: 169 NRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNV 226
++ LG+G K + + + AVK + EI L H N+
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVK----IISKR---MEANTQKEITALKLCEGHPNI 68
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH 286
VKL + LV E + G L++ + + E I ++ A++++H
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSE-----TEASYIMRKLVSAVSHMH 123
Query: 287 SATSSPIYHRDIKSTNILL---DQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
+ HRD+K N+L + K+ DFG ++ D + T T Y PE
Sbjct: 124 DVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPE 179
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403
+ + D++S GV+L +L+G+ P F + + S S
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVP-FQSHDRSLTCTSAV---------------- 222
Query: 404 DDQLMKLGVKNQIM----TFA------------NLAKRCLDLNGKKRPTMEEV 440
+ +I +F +L + L ++ KR M +
Sbjct: 223 -------EIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 22/224 (9%)
Query: 164 NHFNANRILGQGGQGTVYKGMLED-GRIIAVK---KSKLTVDDEELLKLEEFINEIVILS 219
N F+ ++LG+G G V + GR A+K K + DE + + E +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE----VAHTVTESRVLQ 60
Query: 220 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATE 277
H + L +T L V E+ G L+ HL + F E R R E
Sbjct: 61 NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS---RERVFT---EERARFYGAE 113
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF 337
+ AL YLHS + +RDIK N++LD+ K+ DFG K + GT
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTP 169
Query: 338 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381
YL PE + + D + GVV+ E++ G+ P F+ + +
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHER 212
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 37/217 (17%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK---KSKL-TVDDEELLKLEEFINEIVILSQINHR 224
LG G G V G G +AVK + K+ ++D +K EI L H
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-----REIQNLKLFRHP 71
Query: 225 NVVKLLGCCLETEVPL-LVYEFIPNGTLYQHL--HDRHQNEEFPLTWEMRLRIATEVAGA 281
+++KL + T +V E++ G L+ ++ H R + E R+ ++ A
Sbjct: 72 HIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEME-------ARRLFQQILSA 123
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 341
+ Y H + HRD+K N+LLD AK+ADFG S ++ + T+ G+ Y
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAA 178
Query: 342 PE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
PE Y + D++S GV+L LL G P
Sbjct: 179 PEVISGRLYAGP-----EVDIWSCGVILYALLCGTLP 210
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 56/313 (17%), Positives = 104/313 (33%), Gaps = 77/313 (24%)
Query: 157 KELDKATNHFNAN----RILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKL 208
++L + + F +G G + + AVK KSK +E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEI---- 66
Query: 209 EEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDR-HQNEEFPLT 267
++L H N++ L + + +V E + G L + + +E
Sbjct: 67 ------EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER---- 116
Query: 268 WEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL----DQRYRAKVADFGTSKFIA 323
E + + + YLH+ + HRD+K +NIL ++ DFG +K +
Sbjct: 117 -EAS-AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171
Query: 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQEN 383
+ + T T ++ PE + D++S GV+L +LTG P F G
Sbjct: 172 AENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP-FANGPDDTPE 229
Query: 384 VSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIM----TFA------------NLAKRCL 427
+ +I + + +L + L
Sbjct: 230 ---------------------------EILARIGSGKFSLSGGYWNSVSDTAKDLVSKML 262
Query: 428 DLNGKKRPTMEEV 440
++ +R T V
Sbjct: 263 HVDPHQRLTAALV 275
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 33/226 (14%)
Query: 166 FNANRILGQGGQGTVYKGML----EDGRIIAVK---KSKLTVDDEELLKLEEFINEIVIL 218
F R LG G G V L +GR A+K K + + +E +E ++L
Sbjct: 8 FQILRTLGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQ----VEHTNDERLML 60
Query: 219 SQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEE-FPLTWEMRLRI-A 275
S + H ++++ G + + ++ ++I G L+ L + + FP + A
Sbjct: 61 SIVTHPFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLL----RKSQRFP---NPVAKFYA 112
Query: 276 TEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQG 335
EV AL YLHS I +RD+K NILLD+ K+ DFG +K++ VT + G
Sbjct: 113 AEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCG 165
Query: 336 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381
T Y+ PE + D +SFG+++ E+L G P F+ NT +
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP-FYDSNTMK 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 2e-19
Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 21/224 (9%)
Query: 164 NHFNANRILGQGGQGTVYKGMLED-GRIIAVK---KSKLTVDDEELLKLEEFINEIVILS 219
FN +LG+G G V + + AVK K + DD+ +E + E +L+
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD----VECTMVEKRVLA 396
Query: 220 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI-ATE 277
+ L C +T L V E++ G L H+ Q F E A E
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFK---EPHAVFYAAE 450
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF 337
+A L +L S I +RD+K N++LD K+ADFG K + T GT
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTP 506
Query: 338 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381
Y+ PE D ++FGV+L E+L G+ P F + +
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP-FEGEDEDE 549
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 68/228 (29%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 164 NHFNANRILGQGGQGTVYKGML----EDGRIIAVK---KSKLTVDDEELLKLEEFINEIV 216
+ F+ +++G+G G V +L + AVK K + E + ++E
Sbjct: 38 SDFHFLKVIGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKE----EKHIMSERN 90
Query: 217 ILSQ-INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI 274
+L + + H +V L +T L V ++I G L+ HL F E R R
Sbjct: 91 VLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERC---FL---EPRARF 143
Query: 275 -ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
A E+A AL YLHS I +RD+K NILLD + + DFG K ++ T+
Sbjct: 144 YAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTF 199
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381
GT YL PE D + G VL E+L G P F++ NT++
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP-FYSRNTAE 246
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 69/300 (23%), Positives = 116/300 (38%), Gaps = 57/300 (19%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK---KSKL-------------------TVDDEELL 206
+G+G G V D A+K K KL +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 207 KLEEFINEIVILSQINHRNVVKL---LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEE 263
+E+ EI IL +++H NVVKL L E + +V+E + G + + + +E+
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSED 137
Query: 264 FPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323
+ R ++ + YLH I HRDIK +N+L+ + K+ADFG S
Sbjct: 138 -----QAR-FYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF- 187
Query: 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLT---DKSDVYSFGVVLVELLTGKKPIFWAGNTS 380
+ + GT ++ PE ++ DV++ GV L + G+ P F
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP-FMDERIM 246
Query: 381 QENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+HS K++ + D + +K +L R LD N + R + E+
Sbjct: 247 C---------LHSKIKSQALEFPDQPDIAEDLK-------DLITRMLDKNPESRIVVPEI 290
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 77/228 (33%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 164 NHFNANRILGQGGQGTVYKGML----EDGRIIAVK---KSKLTVDDEELLKLEEFINEIV 216
++F R+LG+G G V ML E G + AVK K + DD+ +E + E
Sbjct: 23 DNFEFIRVLGKGSFGKV---MLARVKETGDLYAVKVLKKDVILQDDD----VECTMTEKR 75
Query: 217 ILSQI-NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI 274
ILS NH + +L CC +T L V EF+ G L H+ ++ F E R R
Sbjct: 76 ILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFD---EARARF 128
Query: 275 -ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
A E+ AL +LH I +RD+K N+LLD K+ADFG K + T
Sbjct: 129 YAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATF 184
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381
GT Y+ PE Q D ++ GV+L E+L G P F A N
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP-FEAENEDD 231
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 28/219 (12%)
Query: 164 NHFNANRILGQGGQGTVYKGML----EDGRIIAVK---KSKLTVDDEELLKLEEFINEIV 216
F+ R++G+G V +L + RI A+K K + D++ ++ E
Sbjct: 9 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDED----IDWVQTEKH 61
Query: 217 ILSQI-NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI 274
+ Q NH +V L C +TE L V E++ G L H+ + + P E R
Sbjct: 62 VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP---EEHARF 114
Query: 275 -ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
+ E++ AL YLH I +RD+K N+LLD K+ D+G K + T+
Sbjct: 115 YSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTF 170
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
GT Y+ PE + D ++ GV++ E++ G+ P
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 40/218 (18%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVV 227
R LG+G V++ + + + + VK K V +++ + EI IL + N++
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKR------EIKILENLRGGPNII 94
Query: 228 KLLGCCL--ETEVPLLVYEFIPNG---TLYQHLHDRH-QNEEFPLTWEMRLRIATEVAGA 281
L + P LV+E + N LYQ L D + +E+ L+ A
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF----YMYEI-LK-------A 142
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRA-KVADFGTSKFIAMDQT---HVTTKIQGTF 337
L Y HS I HRD+K N+++D +R ++ D+G ++F Q V ++
Sbjct: 143 LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY---- 195
Query: 338 GYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 374
+ PE Q+ D S D++S G +L ++ K+P F
Sbjct: 196 -FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 28/219 (12%)
Query: 164 NHFNANRILGQGGQGTVYKGML----EDGRIIAVK---KSKLTVDDEELLKLEEFINEIV 216
F+ R++G+G V +L + RI A++ K + D++ ++ E
Sbjct: 52 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMRVVKKELVNDDED----IDWVQTEKH 104
Query: 217 ILSQI-NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI 274
+ Q NH +V L C +TE L V E++ G L H+ + + P E R
Sbjct: 105 VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP---EEHARF 157
Query: 275 -ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
+ E++ AL YLH I +RD+K N+LLD K+ D+G K + T+
Sbjct: 158 YSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTF 213
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
GT Y+ PE + D ++ GV++ E++ G+ P
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 29/228 (12%)
Query: 164 NHFNANRILGQGGQGTVYKGML----EDGRIIAVK---KSKLTVDDE-ELLKLEEFINEI 215
FN +LG+G G V ML + AVK K + DD+ E +E+ + +
Sbjct: 20 TDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 216 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI 274
+ +L C +T L V E++ G L H+ Q F E
Sbjct: 77 PG----KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFK---EPHAVF 125
Query: 275 -ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
A E+A L +L S I +RD+K N++LD K+ADFG K + T
Sbjct: 126 YAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTF 181
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381
GT Y+ PE D ++FGV+L E+L G+ P F + +
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP-FEGEDEDE 228
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 64/228 (28%), Positives = 100/228 (43%), Gaps = 29/228 (12%)
Query: 164 NHFNANRILGQGGQGTVYKGML----EDGRIIAVK---KSKLTVDDE-ELLKLEEFINEI 215
F +++LG+G G V L + + A+K K + +DD+ E +E+ + +
Sbjct: 17 EDFILHKMLGKGSFGKV---FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 216 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI 274
H + + C +T+ L V E++ G L H+ +F R
Sbjct: 74 AW----EHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFD---LSRATF 122
Query: 275 -ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
A E+ L +LHS I +RD+K NILLD+ K+ADFG K M T
Sbjct: 123 YAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTF 178
Query: 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ 381
GT Y+ PE + D +SFGV+L E+L G+ P F + +
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEE 225
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-19
Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G V K + GRI+A+KK + DD+ + K+ + EI +L Q+ H N+V LL
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA--MREIKLLKQLRHENLVNLL 90
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
C + + LV+EF+ + T+ L L +++ + ++ + + HS
Sbjct: 91 EVCKKKKRWYLVFEFVDH-TILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSHN- 144
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 350
I HRDIK NIL+ Q K+ DFG ++ +A ++ T Y PE
Sbjct: 145 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVK 201
Query: 351 TDKS-DVYSFGVVLVELLTGKKPIF 374
K+ DV++ G ++ E+ G +P+F
Sbjct: 202 YGKAVDVWAIGCLVTEMFMG-EPLF 225
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 66/287 (22%), Positives = 116/287 (40%), Gaps = 60/287 (20%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK---KSKL-TVDDEELLKLEEFINEIVILSQINHR 224
LG G G V G G +AVK + K+ ++D ++ EI L H
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR-----REIQNLKLFRHP 76
Query: 225 NVVKLLGCCLETEVPL-LVYEFIPNGTLYQHL--HDRHQNEEFPLTWEMRLRIATEVAGA 281
+++KL + T + +V E++ G L+ ++ + R +E R+ ++
Sbjct: 77 HIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE-------SRRLFQQILSG 128
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 341
+ Y H + HRD+K N+LLD AK+ADFG S ++ + T+ G+ Y
Sbjct: 129 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAA 183
Query: 342 PE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--ENVSLAAYFVHS 393
PE Y + D++S GV+L LL G P F + + + ++
Sbjct: 184 PEVISGRLYAGP-----EVDIWSSGVILYALLCGTLP-FDDDHVPTLFKKICDGIFYTPQ 237
Query: 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ V +L K L ++ KR T++++
Sbjct: 238 Y-------------LNPSVI-------SLLKHMLQVDPMKRATIKDI 264
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLL 230
+G+G G V+K + G+I+A+KK + DD + K+ + EI +L Q+ H N+V LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA--LREIRMLKQLKHPNLVNLL 68
Query: 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATS 290
LV+E+ + T+ L + + + I + A+ + H
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKHN- 122
Query: 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 350
HRD+K NIL+ + K+ DFG ++ + + ++ T Y PE
Sbjct: 123 --CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQ 179
Query: 351 TDKS-DVYSFGVVLVELLTGKKPIF 374
DV++ G V ELL+G P++
Sbjct: 180 YGPPVDVWAIGCVFAELLSG-VPLW 203
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 2e-18
Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEF----INEIVILSQINHRNV 226
+G+G GTV+K E I+A+K+ +L DD++ E + EI +L ++ H+N+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRL--DDDD----EGVPSSALREICLLKELKHKNI 63
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH 286
V+L + LV+EF L ++ + L E+ ++ L + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCH 118
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY-- 344
S + HRD+K N+L+++ K+A+FG ++ + + ++ T Y P+
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 174
Query: 345 ---HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
S+ + D++S G + EL +P+F
Sbjct: 175 GAKLYSTSI----DMWSAGCIFAELANAGRPLF 203
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEF----INEIVILSQINHRNVV 227
+G+G G VYK GRI+A+K+ +L D E+ E I EI +L +++H N+V
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRL--DAED----EGIPSTAIREISLLKELHHPNIV 82
Query: 228 KLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS 287
L+ LV+EF+ L + L + L ++ +A+ H
Sbjct: 83 SLIDVIHSERCLTLVFEFMEKD-LKKVLDENKT----GLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY--- 344
I HRD+K N+L++ K+ADFG ++ + T ++ T Y P+
Sbjct: 138 ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMG 193
Query: 345 --HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
S+ + D++S G + E++TG KP+F
Sbjct: 194 SKKYSTSV----DIWSIGCIFAEMITG-KPLF 220
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 28/217 (12%)
Query: 171 ILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVK 228
+LG G G V + G+ A+K + D + E+ Q ++V
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALK----LLYDSPKAR-----QEVDHHWQASGGPHIVC 86
Query: 229 LLGCCLETEVP----LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
+L L++ E + G L+ + +R T I ++ A+ +
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ---AFTEREAAEIMRDIGTAIQF 143
Query: 285 LHSATSSPIYHRDIKSTNILL---DQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 341
LHS I HRD+K N+L ++ K+ DFG +K Q + T T Y+
Sbjct: 144 LHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPC-YTPYYVA 197
Query: 342 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGN 378
PE + D++S GV++ LL G P F++
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIMYILLCGFPP-FYSNT 233
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 8e-18
Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 29/212 (13%)
Query: 172 LGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEF----INEIVILSQINHRNVV 227
+G+G G VYK G A+KK +L + E+ E I EI IL ++ H N+V
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRL--EKED----EGIPSTTIREISILKELKHSNIV 63
Query: 228 KLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS 287
KL + +LV+E + L + L L ++ +AY H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHD 118
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE---- 343
+ HRD+K N+L+++ K+ADFG ++ + T +I T Y P+
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMG 174
Query: 344 -YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
S+ + D++S G + E++ G P+F
Sbjct: 175 SKKYSTTI----DIWSVGCIFAEMVNG-TPLF 201
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 57/268 (21%), Positives = 110/268 (41%), Gaps = 79/268 (29%)
Query: 159 LDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFIN-EIV 216
L+ ++ ++ + LG G G V + +E G+ A+KK +L+ + N E+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK---------VLQDPRYKNRELD 52
Query: 217 ILSQINHRNVVKLLGC-------------------------------------CLETEVP 239
I+ ++H N++KL+
Sbjct: 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112
Query: 240 L-LVYEFIPNGTLYQHL-HDRHQNEEFPL------TWEMRLRIATEVAGALAYLHSATSS 291
L ++ E++P+ TL++ L P+ +++ R A+ ++HS
Sbjct: 113 LNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQL-FR-------AVGFIHSLG-- 161
Query: 292 PIYHRDIKSTNILLDQR-YRAKVADFGTSKFIAMDQTH---VTTKIQGTFGYLDPE-YHQ 346
I HRDIK N+L++ + K+ DFG++K + + + ++ Y PE
Sbjct: 162 -ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLG 215
Query: 347 SSQLTDKSDVYSFGVVLVELLTGKKPIF 374
+++ T D++S G V EL+ G KP+F
Sbjct: 216 ATEYTPSIDLWSIGCVFGELILG-KPLF 242
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 55/226 (24%), Positives = 88/226 (38%), Gaps = 43/226 (19%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVV 227
++LG G G V + A+K + D + E+ + + ++V
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALK----MLQDCPKAR-----REVELHWRASQCPHIV 118
Query: 228 KLLGCCLETEVP-----LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
+++ E L+V E + G L+ + DR T I + A+
Sbjct: 119 RIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAI 174
Query: 283 AYLHSATSSPIYHRDIKSTNILL---DQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 339
YLHS I HRD+K N+L K+ DFG +K + T T Y
Sbjct: 175 QYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYY 229
Query: 340 LDPE------YHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFWAGN 378
+ PE Y DKS D++S GV++ LL G P F++ +
Sbjct: 230 VAPEVLGPEKY-------DKSCDMWSLGVIMYILLCGYPP-FYSNH 267
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEF----INEIVILSQINHRNV 226
LG G TVYKG+ G +A+K+ KL D E E I EI ++ ++ H N+
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKL---DSE----EGTPSTAIREISLMKELKHENI 65
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRH-QNEEFPLTWEMRLRIATEVAGALAYL 285
V+L LV+EF+ N L +++ R N L + ++ LA+
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY- 344
H + I HRD+K N+L+++R + K+ DFG ++ + ++++ T Y P+
Sbjct: 125 HE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVL 180
Query: 345 ----HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
S+ + D++S G +L E++TG KP+F
Sbjct: 181 MGSRTYSTSI----DIWSCGCILAEMITG-KPLF 209
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 39/231 (16%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEF----INEIVILSQINHRNV 226
+GQG G V+K + G+ +A+KK + ++E+ E F + EI IL + H NV
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLM--ENEK----EGFPITALREIKILQLLKHENV 78
Query: 227 VKLLGCCLETEVPL--------LVYEFIPNGTLYQHLHDR---HQNEEFPLTWEMRLRIA 275
V L+ C P LV++F HD N T R+
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDLAGLLSNVLVKFTLSEIKRVM 130
Query: 276 TEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQG 335
+ L Y+H + I HRD+K+ N+L+ + K+ADFG ++ ++ + +
Sbjct: 131 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187
Query: 336 ---TFGYLDPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE 382
T Y PE D++ G ++ E+ T + PI GNT Q
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIM-QGNTEQH 236
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 38/217 (17%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK---KSKL-TVDDEELLKLEEFINEIVILSQINHR 224
LG+G G V + + +A+K + L D ++ EI L + H
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-----REISYLKLLRHP 69
Query: 225 NVVKLLGCCLETEVPL-LVYEFIPNGTLYQHL--HDRHQNEEFPLTWEMRLRIATEVAGA 281
+++KL + T + +V E+ G L+ ++ R +E R ++ A
Sbjct: 70 HIIKLYDV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDE-------GRRFFQQIICA 120
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 341
+ Y H I HRD+K N+LLD K+ADFG S + T+ G+ Y
Sbjct: 121 IEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAA 175
Query: 342 PE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
PE Y + DV+S G+VL +L G+ P
Sbjct: 176 PEVINGKLYAGP-----EVDVWSCGIVLYVMLVGRLP 207
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 31/213 (14%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEF----INEIVILSQINHRNV 226
LG+G TVYKG ++A+K+ +L + EE I E+ +L + H N+
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRL--EHEE-----GAPCTAIREVSLLKDLKHANI 62
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH 286
V L + LV+E++ L Q+L D + ++ LAY H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN----IINMHNVKLFLFQLLRGLAYCH 117
Query: 287 SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY-- 344
+ HRD+K N+L+++R K+ADFG ++ ++ ++ T Y P+
Sbjct: 118 RQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILL 173
Query: 345 ---HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
S+Q+ D++ G + E+ TG +P+F
Sbjct: 174 GSTDYSTQI----DMWGVGCIFYEMATG-RPLF 201
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 64/293 (21%), Positives = 104/293 (35%), Gaps = 68/293 (23%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVILSQINHRN 225
+ +G G G ++AVK + +E ++ EI+ + H N
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQ-----REIINHRSLRHPN 77
Query: 226 VVKLLGCCLETEVPL-LVYEFIPNGTLYQHL--HDRHQNEEFPLTWEMRLRIATEVAGAL 282
+V+ + T L ++ E+ G LY+ + R +E ++ +
Sbjct: 78 IVRFKEV-ILTPTHLAIIMEYASGGELYERICNAGRFSEDE-------ARFFFQQLLSGV 129
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRY--RAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 340
+Y HS I HRD+K N LLD R K+ DFG SK + +T GT Y+
Sbjct: 130 SYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYI 184
Query: 341 DPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394
PE Y +DV+S GV L +L G P F +
Sbjct: 185 APEVLLRQEYDGK-----IADVWSCGVTLYVMLVGAYP-FEDPEEPR------------D 226
Query: 395 RKNRLHDIL-------DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ + IL DD + +L R + R ++ E+
Sbjct: 227 YRKTIQRILSVKYSIPDDIRISPECC-------HLISRIFVADPATRISIPEI 272
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 59/311 (18%), Positives = 115/311 (36%), Gaps = 53/311 (17%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
+ + +G G QG V R +A+KK ++ K E+V++ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK--RAYRELVLMKCV 81
Query: 222 NHRNVVKLLGCCLETEVPL------LVYEFIP---NGTLYQHLHDRHQNEEFPLTWEMRL 272
NH+N++ LL + +V E + + L + L ++M L
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---YLLYQM-L 137
Query: 273 RIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK 332
+ +LHSA I HRD+K +NI++ K+ DFG ++ + + T
Sbjct: 138 C-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTP 185
Query: 333 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNT------------- 379
T Y PE + D++S G ++ E++ G +F +
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWNKVIEQLGT 244
Query: 380 -SQENV----SLAAYFVHSMRKNR---LHDILDDQLMKLGVKNQIMTFA---NLAKRCLD 428
E + +V + K + D L ++ + + +L + L
Sbjct: 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 304
Query: 429 LNGKKRPTMEE 439
++ KR +++E
Sbjct: 305 IDASKRISVDE 315
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 65/306 (21%), Positives = 119/306 (38%), Gaps = 70/306 (22%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEF----INEIVILSQINHRNV 226
LG+G G VYK + +A+K+ +L + EE E I E+ +L ++ HRN+
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRL--EHEE----EGVPGTAIREVSLLKELQHRNI 95
Query: 227 VKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH 286
++L L++E+ N L +++ D++ ++ + ++ + + H
Sbjct: 96 IELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNP----DVSMRVIKSFLYQLINGVNFCH 149
Query: 287 SATSSPIYHRDIKSTNILLDQRYRA-----KVADFGTSKFIAMDQTHVTTKIQGTFGYLD 341
S HRD+K N+LL + K+ DFG ++ + T +I T Y
Sbjct: 150 SRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRP 205
Query: 342 PEY-----HQSSQLTDKSDVYSFGVVLVELLTGKKPIF---------------------- 374
PE H S+ + D++S + E+L P+F
Sbjct: 206 PEILLGSRHYSTSV----DIWSIACIWAEMLMK-TPLFPGDSEIDQLFKIFEVLGLPDDT 260
Query: 375 -WAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKK 433
W G T+ + F R L +L L G+ +L L+++ K
Sbjct: 261 TWPGVTALPDWK--QSF-PKFRGKTLKRVLGALLDDEGL--------DLLTAMLEMDPVK 309
Query: 434 RPTMEE 439
R + +
Sbjct: 310 RISAKN 315
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 50/223 (22%), Positives = 93/223 (41%), Gaps = 35/223 (15%)
Query: 172 LGQGGQGTVYKGM---LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+G+G G VYK +D + A+K+ ++ + EI +L ++ H NV+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQ----IEGTGIS--MSACREIALLRELKHPNVIS 82
Query: 229 LLGCCLE-TEVPL-LVYEFIPN---GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
L L + + L++++ + + H + + L M + ++ +
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRA----KVADFGTSKFIAM---DQTHVTTKIQGT 336
YLH+ + HRD+K NIL+ K+AD G ++ + + T
Sbjct: 143 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-T 198
Query: 337 FGYLDPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
F Y PE H + + D+++ G + ELLT +PIF
Sbjct: 199 FWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT-SEPIF 236
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 42/224 (18%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEF----INEIVILSQIN---H 223
+G G GTVYK G +A+K ++ + E+ +L ++ H
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGG---GGLPISTVREVALLRRLEAFEH 73
Query: 224 RNVVKLLGCCLETEVPL-----LVYEFIPNGTLYQHLHDRHQNEEFP------LTWEMRL 272
NVV+L+ C + LV+E + L +L D+ P L + L
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKDLMRQF-L 130
Query: 273 RIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF--IAMDQTHVT 330
R L +LH+ + I HRD+K NIL+ K+ADFG ++ M T V
Sbjct: 131 R-------GLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180
Query: 331 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
T Y PE S D++S G + E+ +KP+F
Sbjct: 181 V----TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLF 219
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 64/226 (28%), Positives = 95/226 (42%), Gaps = 44/226 (19%)
Query: 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFIN-----EIVILSQINHRN 225
LG+G TVYK +I+A+KK KL E ++ IN EI +L +++H N
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA----KDGINRTALREIKLLQELSHPN 73
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWE-------MRLRIATEV 278
++ LL LV++F+ L + D LT M L+
Sbjct: 74 IIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSL----VLTPSHIKAYMLMTLQ----- 123
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 338
L YLH I HRD+K N+LLD+ K+ADFG +K T ++ T
Sbjct: 124 --GLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRW 177
Query: 339 YLDPEY-----HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNT 379
Y PE + D+++ G +L ELL P G++
Sbjct: 178 YRAPELLFGARMYGVGV----DMWAVGCILAELLLR-VPFL-PGDS 217
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 50/230 (21%), Positives = 88/230 (38%), Gaps = 34/230 (14%)
Query: 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFIN--------- 213
+ + R + G G V G+ +G +A+K+ + + + +
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKR--VFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 214 EIVILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGTLYQHLHDRHQNEEFPLTW 268
EI +L+ +H N++ L + E P LV E + L Q +HD+ ++
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI----VISP 133
Query: 269 EMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT- 327
+ + L LH A + HRD+ NILL + DF ++ D
Sbjct: 134 QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 328 --HVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 374
+VT + Y PE + K D++S G V+ E+ K +F
Sbjct: 191 THYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALF 234
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 59/304 (19%), Positives = 114/304 (37%), Gaps = 39/304 (12%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
+ + +G G QG V R +A+KK ++ K E+V++ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK--RAYRELVLMKCV 118
Query: 222 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHL--HDRHQNEEFPLTWEMRLRIATEVA 279
NH+N++ LL P E + L L + Q + L E + ++
Sbjct: 119 NHKNIISLL----NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 174
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 339
+ +LHSA I HRD+K +NI++ K+ DFG ++ + + T T Y
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 229
Query: 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNT--------------SQENV- 384
PE + D++S G ++ E++ K +F + E +
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDYIDQWNKVIEQLGTPCPEFMK 288
Query: 385 ---SLAAYFVHSMRKNR---LHDILDDQLMKLGVKNQIMT---FANLAKRCLDLNGKKRP 435
+V + K + D L ++ + +L + L ++ KR
Sbjct: 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348
Query: 436 TMEE 439
++++
Sbjct: 349 SVDD 352
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 53/224 (23%), Positives = 92/224 (41%), Gaps = 34/224 (15%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
+ + +G G G+V + G +A+KK E K E+++L +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK--RAYRELLLLKHM 80
Query: 222 NHRNVVKLLGCCLETEVPL------LVYEFIP---NGTLYQHLHDRHQNEEFPLTWEMRL 272
H NV+ LL LV F+ + + L ++M L
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQ---YLVYQM-L 136
Query: 273 RIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH-VTT 331
+ L Y+HSA + HRD+K N+ +++ K+ DFG ++ + T V T
Sbjct: 137 K-------GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT 186
Query: 332 KIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 374
+ Y PE S +++ D++S G ++ E+LTG K +F
Sbjct: 187 RW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLF 224
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 58/336 (17%), Positives = 109/336 (32%), Gaps = 96/336 (28%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK--KSKLTVDDEELLKLEEFINEIVILSQIN---- 222
R LG G TV+ + + +A+K + + EI +L ++N
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED-------EIKLLQRVNDADN 77
Query: 223 -------HRNVVKLLGC-----------CLETEVPLL---VYEFIPNGTLYQHLHDRHQN 261
+++KLL + E +L + I +
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALI------------KKY 123
Query: 262 EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA------KVAD 315
E + +I+ ++ L Y+H I H DIK N+L++ K+AD
Sbjct: 124 EHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIAD 181
Query: 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF- 374
G + + H T IQ Y PE + +D++S ++ EL+TG +F
Sbjct: 182 LGNACW---YDEHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD-FLFE 236
Query: 375 ------WAGNTSQ----------------ENVSLAAYF---------VHSMRKNRLHDIL 403
+ + N F + ++ L D+L
Sbjct: 237 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL 296
Query: 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
++ K++ ++ L L+ +KR
Sbjct: 297 TEKYK--FSKDEAKEISDFLSPMLQLDPRKRADAGG 330
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 70/354 (19%), Positives = 124/354 (35%), Gaps = 108/354 (30%)
Query: 160 DKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVK--KSKLTVDDEELLKLEEFINEIV 216
+K + + + ++G+G G V K + +A+K K+K ++ + E+
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-------EVR 102
Query: 217 ILSQINHR------NVVKLLGC-------CLETEVPLL---VYEFIPNGTLYQHLHDRHQ 260
+L +N +V L CL E +L +Y+ +
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLL------------RN 148
Query: 261 NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA--KVADFGT 318
++ + + A ++ AL +L + S I H D+K NILL R+ K+ DFG+
Sbjct: 149 TNFRGVSLNLTRKFAQQMCTALLFLATPELSII-HCDLKPENILLCNPKRSAIKIVDFGS 207
Query: 319 SKFIAMDQTHVTTKIQGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
S + IQ F Y PE Y + D++S G +LVE+ TG +P
Sbjct: 208 SCQ---LGQRIYQYIQSRF-YRSPEVLLGMPYDLAI------DMWSLGCILVEMHTG-EP 256
Query: 373 IFWAGNTSQENVSL-------------------AAYF-------------------VHSM 394
+F +G + ++ +F
Sbjct: 257 LF-SGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP 315
Query: 395 RKNRLHDILDDQLMKLGVKNQIMT---------FANLAKRCLDLNGKKRPTMEE 439
+LH+IL + G + + F +L R LD + K R
Sbjct: 316 GTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYY 369
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 5e-15
Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 46/225 (20%)
Query: 172 LGQGGQGTVYKG--MLEDGRIIAVKKSKLTVDDEELLKLEEF----INEIVILSQIN--- 222
+G+G G V+K + GR +A+K+ ++ E E I E+ +L +
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGE----EGMPLSTIREVAVLRHLETFE 72
Query: 223 HRNVVKLLGCCLETEVPL-----LVYEFIPNGTLYQHLHDRHQNEEFP------LTWEMR 271
H NVV+L C + LV+E + L +L D+ P + +++
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIKDMMFQL- 129
Query: 272 LRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF--IAMDQTHV 329
LR L +LHS + HRD+K NIL+ + K+ADFG ++ M T V
Sbjct: 130 LR-------GLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179
Query: 330 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
T Y PE S D++S G + E+ +KP+F
Sbjct: 180 VV----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLF 219
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 73/339 (21%), Positives = 114/339 (33%), Gaps = 105/339 (30%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK--KSKLTVDDEELLKLEEFINEIVILSQINHR-- 224
+++G+G G V K + + +A+K +++ + EI IL + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-------EIRILEHLRKQDK 155
Query: 225 ----NVVKLLGC-------CLETEVPLL---VYEFIPNGTLYQHLHDRHQNEEFPLTWEM 270
NV+ +L C+ E LL +YE I +N+ + +
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELI------------KKNKFQGFSLPL 201
Query: 271 RLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA--KVADFGTSKFIAMDQTH 328
+ A + L LH I H D+K NILL Q+ R+ KV DFG+S + +
Sbjct: 202 VRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQR 255
Query: 329 VTTKIQGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE 382
V T IQ F Y PE Y D++S G +L ELLTG P+ G +
Sbjct: 256 VYTYIQSRF-YRAPEVILGARYGMPI------DMWSLGCILAELLTG-YPLL-PGEDEGD 306
Query: 383 ------------------NVSLAAYFVHSM------------------------RKNRLH 400
A FV S R
Sbjct: 307 QLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRG 366
Query: 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
+ F + K+CL+ + R T +
Sbjct: 367 PPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 69/272 (25%), Positives = 98/272 (36%), Gaps = 73/272 (26%)
Query: 170 RILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-N 222
+ LG+G G V + R +AVK K E ++E+ IL I +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH---RALMSELKILIHIGH 84
Query: 223 HRNVVKLLGCCLETEVPLLV-YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGA 281
H NVV LLG C + PL+V EF G L +L + T R R + GA
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144
Query: 282 L-----AYLHSATSSPI-----------------------YHRDIKSTNILLDQRYR-AK 312
+ L S TSS ++D + L+ ++ AK
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204
Query: 313 VADFGTSK-FIAMD--------QTHVTTKIQGTFG-----YLDPEYHQSSQ--------- 349
+F S+ I D KI FG Y DP+Y +
Sbjct: 205 GMEFLASRKCIHRDLAARNILLSEKNVVKI-CDFGLARDIYKDPDYVRKGDARLPLKWMA 263
Query: 350 --------LTDKSDVYSFGVVLVELLT-GKKP 372
T +SDV+SFGV+L E+ + G P
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 27/221 (12%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
+ + +G G G V + G +A+KK E K E+ +L +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK--RAYRELRLLKHM 81
Query: 222 NHRNVVKLLGCCLETEVPL------LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIA 275
H NV+ LL E LV F+ L + + +H+ L + +
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM--KHE----KLGEDRIQFLV 134
Query: 276 TEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT-HVTTKIQ 334
++ L Y+H+A I HRD+K N+ +++ K+ DFG ++ + T +V T+
Sbjct: 135 YQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW- 190
Query: 335 GTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 374
Y PE + ++ D++S G ++ E++TG K +F
Sbjct: 191 ----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLF 226
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 31/223 (13%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
+ +G G G+V + G +AVKK K E+ +L +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK--RTYRELRLLKHM 85
Query: 222 NHRNVVKLLGCCLETEVPL------LVYEFIPNGTLYQHLHDRHQNEEF--PLTWEMRLR 273
H NV+ LL LV + L + + ++ L +++ LR
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQI-LR 143
Query: 274 IATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT-HVTTK 332
L Y+HSA I HRD+K +N+ +++ K+ DFG ++ A + T +V T+
Sbjct: 144 -------GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193
Query: 333 IQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 374
Y PE + +++ D++S G ++ ELLTG + +F
Sbjct: 194 W-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLF 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 9e-14
Identities = 65/332 (19%), Positives = 127/332 (38%), Gaps = 94/332 (28%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
+ + + LG GG G V+ + + + +A+KK + + D + +K + EI I+ ++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK--IVLTDPQSVK--HALREIKIIRRL 65
Query: 222 NHRNVVKLL------GCCLETEVPL--------LVYEF--------IPNGTLYQHLHDRH 259
+H N+VK+ G L +V +V E+ + G L L +
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL---LEEHA 122
Query: 260 QNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR-YRAKVADFGT 318
+ +++ LR L Y+HSA + HRD+K N+ ++ K+ DFG
Sbjct: 123 RL----FMYQL-LR-------GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGL 167
Query: 319 SKFIAMDQTH-------VTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGK 370
++ + +H + TK Y P S K+ D+++ G + E+LTG
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG- 221
Query: 371 KPIFWAGNT--------------SQENV----SLAAYFVHSMRKNRLHDILDDQLMKLGV 412
K +F + +E+ S+ ++ + +
Sbjct: 222 KTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPL---------- 271
Query: 413 KNQIMTFAN-----LAKRCLDLNGKKRPTMEE 439
Q++ + ++ L + R T EE
Sbjct: 272 -TQLLPGISREAVDFLEQILTFSPMDRLTAEE 302
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 63/354 (17%), Positives = 123/354 (34%), Gaps = 97/354 (27%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
+++ ++G+G G VY + +A+KK +D K + EI IL+++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK--RILREITILNRL 82
Query: 222 NHRNVVKLLGCCLETEVPL-----LVYEFIPNGT-LY------QHLHDRH-QNEEFPLTW 268
+++L + ++ +V E + L L + H + + +
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEEHIKT----ILY 136
Query: 269 EMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQ-T 327
+ L ++H + I HRD+K N LL+Q KV DFG ++ I ++ T
Sbjct: 137 NL-LL-------GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 328 HVTTKIQGTFGYLDPEYHQSSQLTD--------------------KS-DVYSFGVVLVEL 366
++ ++ + QLT KS D++S G + EL
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 367 LTG----------KKPIFWAGNTSQENVSLAAYFVHSMR--KNRLHDILD-------DQL 407
L + P+F G++ + +++L+ I + D L
Sbjct: 246 LNMLQSHINDPTNRFPLF-PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDL 304
Query: 408 MKLGVKN-----------------QIMTFAN-----LAKRCLDLNGKKRPTMEE 439
+ Q + L + L N KR T+++
Sbjct: 305 KNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQ 358
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFIN-------- 213
+ +G+G G V + +A+KK + F +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK------------ISPFEHQTYCQRTL 73
Query: 214 -EIVILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGT-LYQHLHDRHQNEEFP- 265
EI IL + H N++ + + +V + + T LY+ L +H + +
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHIC 131
Query: 266 -LTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324
+++ LR L Y+HSA + HRD+K +N+LL+ K+ DFG ++
Sbjct: 132 YFLYQI-LR-------GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 325 DQTHVT--TKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 374
D H T+ T Y PE +S+ KS D++S G +L E+L+ +PIF
Sbjct: 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIF 232
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 72/361 (19%), Positives = 122/361 (33%), Gaps = 103/361 (28%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
+ + ++G G G V + + R++A+KK +D K + EI IL+++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK--RILREIAILNRL 109
Query: 222 NHRNVVKLLGCCLETEVPL-----LVYEFIPNGT-LY------QHLHDRH-QNEEFPLTW 268
NH +VVK+L + +V +V E + +L + H + L +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKT----LLY 163
Query: 269 EMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG------TSKFI 322
+ L + Y+HSA I HRD+K N L++Q KV DFG +
Sbjct: 164 NL-LV-------GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212
Query: 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTD--------------------KS-DVYSFGV 361
+ + QLT ++ DV+S G
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272
Query: 362 VLVELLT----------GKKPIF----WAGNTSQENVSLAAYFVHSMRKNRLHDIL---- 403
+ ELL + P+F + + F +++L+ I
Sbjct: 273 IFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILG 332
Query: 404 ---DDQLMKLG---VKNQIMTFA-------------------NLAKRCLDLNGKKRPTME 438
++ + L K I F +L KR L N KR T+
Sbjct: 333 TPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITIN 392
Query: 439 E 439
E
Sbjct: 393 E 393
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 76/344 (22%), Positives = 126/344 (36%), Gaps = 93/344 (27%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
+ + LG+G G V+K + G ++AVKK + + EI+IL+++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ--RTFREIMILTEL 65
Query: 222 N-HRNVVKLLGCCLETEVPL--------LVYEFIPNGT-LY-----QHLHDRH-QNEEFP 265
+ H N+V LL V LV++++ T L+ L H Q
Sbjct: 66 SGHENIVNLL------NVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQY---- 113
Query: 266 LTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMD 325
+ +++ ++ + YLHS + HRD+K +NILL+ KVADFG S+
Sbjct: 114 VVYQL-IK-------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162
Query: 326 QTHVTTKIQGTFGYLDPEYHQSSQLTD---------------------KSDVYSFGVVLV 364
+ + LTD D++S G +L
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222
Query: 365 ELLTGKKPIFWAGNT--------------SQENVS-----LAAYFVHSM---RKNRLHDI 402
E+L G KPIF +T S E+V A + S+ + R +
Sbjct: 223 EILCG-KPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNK 281
Query: 403 LDDQLMKLGVKNQIMTFAN-------LAKRCLDLNGKKRPTMEE 439
D + +I A+ L + L N KR + +
Sbjct: 282 RDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 63/330 (19%), Positives = 106/330 (32%), Gaps = 98/330 (29%)
Query: 133 GLLLQQMLNSYDGSVIDRFKLFSSKELDKATNHFNANRILGQGGQGTVYKGM-LEDGRII 191
G ++ L ++ID +K+ S ++LG G G V +
Sbjct: 1 GPHVKSGLQIKKNAIIDDYKVTS--------------QVLGLGINGKVLQIFNKRTQEKF 46
Query: 192 AVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP-----LLVYEF 245
A+K + D + E+ + + ++V+++ E L+V E
Sbjct: 47 ALK----MLQDCPKAR-----REVELHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMEC 96
Query: 246 IPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL 305
+ G L+ + DR T I + A+ YLHS I HRD+K N+L
Sbjct: 97 LDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLY 150
Query: 306 ---DQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVV 362
K+ DFG +K T + Y D D++S GV+
Sbjct: 151 TSKRPNAILKLTDFGFAK-------ETTGE-----KY-DKS----------CDMWSLGVI 187
Query: 363 LVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFA-- 420
+ LL G P F++ + MK ++ F
Sbjct: 188 MYILLCGYPP-FYSNHGLA----------------------ISPGMKTRIRMGQYEFPNP 224
Query: 421 ----------NLAKRCLDLNGKKRPTMEEV 440
L + L +R T+ E
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 58/243 (23%), Positives = 91/243 (37%), Gaps = 60/243 (24%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFIN-------- 213
++ F +LG+G G V G I+A+KK +E F
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK------------IEPFDKPLFALRTL 57
Query: 214 -EIVILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGT-LY-----QHLHDRHQN 261
EI IL H N++ + ++ E + T L+ Q L D H
Sbjct: 58 REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQ 115
Query: 262 EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321
++ LR A+ LH + + HRD+K +N+L++ KV DFG ++
Sbjct: 116 ---YFIYQT-LR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161
Query: 322 IAMDQTHVTTKIQGTFG---------YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKK 371
I + G Y PE +S ++ DV+S G +L EL +
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-R 220
Query: 372 PIF 374
PIF
Sbjct: 221 PIF 223
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 71/358 (19%), Positives = 105/358 (29%), Gaps = 134/358 (37%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVK--KSKLTVDDEELLKLEEFINEIVILSQINHR-- 224
R +G G G V +++ + AVK ++ + E IL +I +
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI-------EADILKKIQNDDI 93
Query: 225 ---NVVKLLGC-------CLETEVPLL---VYEFIPNGTLYQHLHDRHQNEEFPLTWEMR 271
N+VK G CL E L +YE I +N E
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEII------------TRNNYNGFHIEDI 139
Query: 272 LRIATEVAGALAYLHSATSSPIYHRDIKSTNILL-------------------------D 306
E+ AL YL + + H D+K NILL
Sbjct: 140 KLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 307 QRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE------YHQSSQLTDKSDVYSFG 360
+ K+ DFG + F + + I Y PE + SS D++SFG
Sbjct: 197 KSTGIKLIDFGCATF---KSDYHGSIINTRQ-YRAPEVILNLGWDVSS------DMWSFG 246
Query: 361 VVLVELLTGKKPIF---------------------------------------WAGNTSQ 381
VL EL TG +F
Sbjct: 247 CVLAELYTG-SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWP 305
Query: 382 ENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
EN S H + L+ I+ +L F + L ++ RP+ E
Sbjct: 306 ENASSINSIKHVKKCLPLYKIIKHEL-----------FCDFLYSILQIDPTLRPSPAE 352
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 29/226 (12%)
Query: 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
N F R +G G G +Y G ++ +A+K + +LL E I +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY------ESKIYRILQ 60
Query: 223 -HRNVVKLLGCCLETEVPLLVYEFI-PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
+ + +E + +LV + + P+ L + + L + L +A ++
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPS--LEDLF--NFCSRKLSL--KTVLMLADQMIN 114
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAK---VADFGTSKFIAMDQTHV------TT 331
+ ++HS + HRDIK N L+ RA + DFG +K TH
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
Query: 332 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAG 377
+ GT Y H + + + D+ S G VL+ L G P W G
Sbjct: 172 NLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP--WQG 215
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 66/343 (19%), Positives = 110/343 (32%), Gaps = 110/343 (32%)
Query: 170 RILGQGGQGTVYKGM--LEDGRIIAVK--KSKLTVDDEELLKLEEFINEIVILSQINHR- 224
LG+G G V + + +A+K ++ + L EI +L +I +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-------EINVLKKIKEKD 77
Query: 225 -----NVVKLLGC-------CLETEVPLL---VYEFIPNGTLYQHLHDRHQNEEFPLTWE 269
V + C+ E LL +EF+ +N P
Sbjct: 78 KENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFL------------KENNFQPYPLP 123
Query: 270 MRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA------------------ 311
+A ++ AL +LH + H D+K NIL
Sbjct: 124 HVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 312 -KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLV 364
+VADFG++ F D H TT + Y PE + Q DV+S G +L
Sbjct: 181 IRVADFGSATF---DHEHHTTIVATRH-YRPPEVILELGWAQPC------DVWSIGCILF 230
Query: 365 ELLTGKKPIFWAGNTSQE------------------NVSLAAYFVHSMRKNRLHDILDDQ 406
E G +F + ++E YF + D +
Sbjct: 231 EYYRG-FTLF-QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG-GLVWDENSSDGR 287
Query: 407 LMKLGVKN----------QIMTFANLAKRCLDLNGKKRPTMEE 439
+K K + + +L +R L+ + +R T+ E
Sbjct: 288 YVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 51/226 (22%), Positives = 87/226 (38%), Gaps = 29/226 (12%)
Query: 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
N + R +G G G +Y G + G +A+K + +L E I +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI------ESKIYKMMQ 62
Query: 223 H-RNVVKLLGCCLETEVPLLVYEFI-PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
+ + C E + ++V E + P+ L + +F L + L +A ++
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELLGPS--LEDLF--NFCSRKFSL--KTVLLLADQMIS 116
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAK---VADFGTSKFIAMDQTHV------TT 331
+ Y+HS HRD+K N L+ + + DFG +K +TH
Sbjct: 117 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173
Query: 332 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAG 377
+ GT Y H + + + D+ S G VL+ G P W G
Sbjct: 174 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP--WQG 217
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 46/228 (20%), Positives = 85/228 (37%), Gaps = 31/228 (13%)
Query: 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI- 221
H+ R +G+G G +++G L + + +A+K D +L +E +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLR------DEYRTYKLLA 63
Query: 222 NHRNVVKLLGCCLETEVPLLVYEFI-PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
+ + E +LV + + P+ L L +F + + A ++
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLLGPS--LEDLL--DLCGRKFSV--KTVAMAAKQMLA 117
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAK-----VADFGTSKFIAMDQTHV------ 329
+ +H + + +RDIK N L+ + V DFG KF T
Sbjct: 118 RVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174
Query: 330 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAG 377
+ GT Y+ H + + + D+ + G V + L G P W G
Sbjct: 175 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP--WQG 220
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 70/342 (20%), Positives = 113/342 (33%), Gaps = 108/342 (31%)
Query: 170 RILGQGGQGTVYKG--MLEDGRIIAVK--KSKLTVDDEELLKLEEFINEIVILSQINHR- 224
LG+G G V + GR +AVK K+ + EI +L +N
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-------EIQVLEHLNTTD 72
Query: 225 -----NVVKLLGC-------CLETEVPLL---VYEFIPNGTLYQHLHDRHQNEEFPLTWE 269
V++L C+ E LL Y+FI +N P +
Sbjct: 73 PNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFI------------KENGFLPFRLD 118
Query: 270 MRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL-DQRYRA----------------- 311
++A ++ ++ +LHS + H D+K NIL Y
Sbjct: 119 HIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 312 -KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLV 364
KV DFG++ + D H +T + Y PE + Q DV+S G +L+
Sbjct: 176 IKVVDFGSATY---DDEHHSTLVSTRH-YRAPEVILALGWSQPC------DVWSIGCILI 225
Query: 365 ELLTGKKPIFWAGNTSQE------------------NVSLAAYFVH---------SMRKN 397
E G +F + S+E YF H S +
Sbjct: 226 EYYLG-FTVF-PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRY 283
Query: 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
+ L + +L ++ L+ + KR T+ E
Sbjct: 284 VSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 50/247 (20%), Positives = 80/247 (32%), Gaps = 34/247 (13%)
Query: 160 DKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVIL 218
D N + + +G GG G +Y A K+ + L E + +
Sbjct: 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSE--LKFYQRV 90
Query: 219 SQINHRNVVKLLGCCLETEVPLLVY--EFIPNGTLY------------QHLHDRHQNEEF 264
++ + +PL G Y Q + QN F
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG--QNGTF 148
Query: 265 PLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKV--ADFGTSKFI 322
L++ + L Y+H H DIK+ N+LL + +V AD+G S
Sbjct: 149 KK--STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 323 AMDQTHV------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWA 376
+ H GT + + H+ L+ +SDV G ++ L GK P W
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP--WE 261
Query: 377 GNTSQEN 383
N
Sbjct: 262 QNLKDPV 268
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 1e-09
Identities = 32/215 (14%), Positives = 62/215 (28%), Gaps = 52/215 (24%)
Query: 162 ATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDD----EELLKLEEFINEIVI 217
T +G+G G V++ + D +A+K + D EE + EI+I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 218 LSQI---------NHRNVVKLLGCCL----------------------ETEVPL------ 240
++ + L + P
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 241 --LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDI 298
+V EF G + + + + I ++ +LA ++ HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL------SSLATAKSILHQLTASLAVAEASLR--FEHRDL 188
Query: 299 KSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKI 333
N+LL + K+ K + + I
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 45/247 (18%), Positives = 81/247 (32%), Gaps = 35/247 (14%)
Query: 160 DKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKS---KLTVDDEELLKLEEFINEIV 216
D A + +GQGG G +Y + + K+ D L E +
Sbjct: 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTE--LKFYQ 88
Query: 217 ILSQINHRNVVKLLGCCLETEVPLLVY--EFIPNGTLY------------QHLHDRHQNE 262
++ VP NG Y Q +++ +
Sbjct: 89 RAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA-NAK 147
Query: 263 EFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKV--ADFGTSK 320
F + L+++ + L Y+H H DIK++N+LL+ + +V D+G +
Sbjct: 148 RFSR--KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
Query: 321 FIAMDQTHV------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
+ H GT + + H + + D+ G +++ LTG P
Sbjct: 203 RYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP-- 260
Query: 375 WAGNTSQ 381
W N
Sbjct: 261 WEDNLKD 267
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 42/257 (16%), Positives = 80/257 (31%), Gaps = 51/257 (19%)
Query: 160 DKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLE---------- 209
DK+ + + QG +Y+ + + LKL+
Sbjct: 38 DKSGRQWKLKSFQTRDNQGILYEAA----PTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQ 93
Query: 210 ---------EFINEIVILSQINHRNVVKLLGC-CLETEVPLLVYEFIPNGTLYQHLHDRH 259
+N+ L + +G + + LV + G Q D
Sbjct: 94 NFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVS 151
Query: 260 QNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKV--ADFG 317
L++A + AL +LH H ++ + NI +D +++V A +G
Sbjct: 152 PKHVLSE--RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYG 206
Query: 318 TSKFIAMDQTHV------TTKIQGTFGYLDPEY-----HQSSQLTDKSDVYSFGVVLVEL 366
+ HV + +G E+ H+ + +SD+ S G +++
Sbjct: 207 FAFRYCPSGKHVAYVEGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKW 261
Query: 367 LTGKKPIFWAGNTSQEN 383
L G P W
Sbjct: 262 LYGFLP--WTNCLPNTE 276
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 60/285 (21%), Positives = 90/285 (31%), Gaps = 94/285 (32%)
Query: 160 DKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVIL 218
D ++ R LG G TV+ ++ + +A+K K E +EI +L
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL-----DEIRLL 87
Query: 219 SQI--------NHRNVVKLLGC-----------CLETEVPLLVYEFIPNGTLYQHLHD-R 258
+ N VV+LL C+ V+E L HL
Sbjct: 88 KSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICM-------VFEV-----LGHHLLKWI 135
Query: 259 HQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL------------- 305
++ L +I +V L YLH+ I H DIK NILL
Sbjct: 136 IKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAE 193
Query: 306 ------------------------------------DQRYRAKVADFGTSKFIAMDQTHV 329
++ + K+AD G + + H
Sbjct: 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHF 250
Query: 330 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 374
T IQ T Y E S +D++S + EL TG +F
Sbjct: 251 TEDIQ-TRQYRSLEVLIGSGYNTPADIWSTACMAFELATG-DYLF 293
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 7e-08
Identities = 61/374 (16%), Positives = 114/374 (30%), Gaps = 88/374 (23%)
Query: 113 IIRKKRMDIKLTEKFF--KQNGGLLLQQMLNSYDG-SVIDRFKLFSSKELDKATNHFNAN 169
+ R + KL + + +L+ +L S G + + L
Sbjct: 131 VSRLQPYL-KLRQALLELRPAKNVLIDGVLGS--GKTW-----VALDVCLSYKVQCKMDF 182
Query: 170 RI----LGQGGQGTVYKGMLED----------GRIIAVKKSKLTVDDEE-----LLKLEE 210
+I L ML+ R KL + + LLK +
Sbjct: 183 KIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP 242
Query: 211 FINEIVILSQINHRNVVKL--LGC-CLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLT 267
+ N +++L + + L C L T V +F+ + H+ H + LT
Sbjct: 243 YENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFL-SAATTTHISLDHHSM--TLT 299
Query: 268 WEMRLRIATEVAGALA-YLH-SATSSPIYHRDIKSTNILL----DQRYRAKVADFGTSKF 321
EV L YL P R++ +TN + R +A + K
Sbjct: 300 -------PDEVKSLLLKYLDCRPQDLP---REVLTTNPRRLSIIAESIRDGLATWDNWKH 349
Query: 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY-SFGV----VLV--ELLTGKKPIF 374
+ D+ +TT I+ + L+P ++ ++ V + LL+ +
Sbjct: 350 VNCDK--LTTIIESSLNVLEPAEYR--------KMFDRLSVFPPSAHIPTILLS----LI 395
Query: 375 WAGNTSQE---------NVSLAAYFVHSMRKNRLHDILDDQLMKL----GVKNQIMTFAN 421
W + SL + I + +KL + I+ N
Sbjct: 396 WFDVIKSDVMVVVNKLHKYSLVEKQPKESTI-SIPSIYLELKVKLENEYALHRSIVDHYN 454
Query: 422 LAKRCLDLNGKKRP 435
+ + D + P
Sbjct: 455 I-PKTFDSDDLIPP 467
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 43/228 (18%), Positives = 83/228 (36%), Gaps = 31/228 (13%)
Query: 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI- 221
+F + +G G G + G L +A+K + +L E Q+
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQL------HLEYRFYKQLG 62
Query: 222 NHRNVVKLLGCCLETEVPLLVYEFI-PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
+ + ++ + +V E + P+ L + F L + L IA ++
Sbjct: 63 SGDGIPQVYYFGPCGKYNAMVLELLGPS--LEDLF--DLCDRTFSL--KTVLMIAIQLIS 116
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAK-----VADFGTSKFIAMDQTHV------ 329
+ Y+HS + +RD+K N L+ + + DF +K +T
Sbjct: 117 RMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173
Query: 330 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAG 377
+ GT Y+ H + + + D+ + G + + L G P W G
Sbjct: 174 HKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP--WQG 219
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.99 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.7 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.44 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.09 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.81 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.79 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.65 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.51 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.39 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.37 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.19 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.14 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.94 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.92 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.91 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.52 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.52 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.18 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.18 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.43 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 92.85 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.62 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.4 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 90.65 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 90.44 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.28 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.47 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.41 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-57 Score=439.66 Aligned_cols=262 Identities=22% Similarity=0.338 Sum_probs=213.1
Q ss_pred cCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 237 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 237 (468)
+.+++.++||+|+||+||+|.+. +++.||||+++..... ...++|.+|+.++++++|||||+++|+|.+.+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~---~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG---PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh---HHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 34566788999999999999862 4688999998764433 34578999999999999999999999999999
Q ss_pred cceeEeeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQN-----------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD 306 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~ 306 (468)
..++|||||++|+|.++|..+... ....++|..++.|+.|||+||+|||+++ ||||||||+||||+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEEC
Confidence 999999999999999999764321 1246999999999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCCcccccCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchh
Q 012214 307 QRYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENV 384 (468)
Q Consensus 307 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~ 384 (468)
+++++||+|||+|+....... .......||+.|||||++.++.++.++|||||||++|||+| |+.||... ...
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~-----~~~ 254 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-----SNQ 254 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC-----CHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC-----CHH
Confidence 999999999999987654332 23445679999999999999999999999999999999998 89998431 111
Q ss_pred chHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 385 SLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
.+...+...... +.+..++..+.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus 255 ----~~~~~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 255 ----DVVEMIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp ----HHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred ----HHHHHHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 112222222211 1233456689999999999999999999999999997653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=434.36 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=212.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 237 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 237 (468)
++|.+.+.||+|+||+||+|.+. +++.||||+++... . ...++|.+|+.++++++|||||+++|+|.+.+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~---~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-D---NARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-H---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-h---HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 56788899999999999999853 47889999987532 2 34578999999999999999999999999999
Q ss_pred cceeEeeecCCCChhhHhhhcc--------cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRH--------QNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY 309 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~ 309 (468)
..++|||||++|+|.++|.... ......++|..++.|+.|||.||+|||+++ ||||||||+||||++++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCC
Confidence 9999999999999999997642 122346999999999999999999999999 99999999999999999
Q ss_pred cEEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchH
Q 012214 310 RAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLA 387 (468)
Q Consensus 310 ~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~ 387 (468)
.+||+|||+|+......... .....||+.|||||++.+..++.++|||||||++|||+| |+.||... ...
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~-----~~~--- 237 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-----SNN--- 237 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHH---
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----CHH---
Confidence 99999999998765443332 333569999999999999999999999999999999999 89998531 111
Q ss_pred HHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 388 AYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
+ +...+..+... ..+..+++.+.+|+.+||+.||++|||++||++.|+.+..
T Consensus 238 ~-~~~~i~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 238 E-VIECITQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp H-HHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-HHHHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1 11122221111 1133455689999999999999999999999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-56 Score=430.80 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=206.7
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.+++.+.++||+|+||+||+|++.+ .||||+++...... ...+.|.+|+.++++++|||||+++|+|.+ +..++|
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTP--EQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 3678888999999999999998753 58999987543332 456789999999999999999999999865 568999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
||||++|+|.++|.... .+++|..+..|+.|||.||+|||+++ ||||||||+||||++++.+||+|||+|+..
T Consensus 110 mEy~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EECCSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEcCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 99999999999997532 35999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCC-ceeeecccccCCccCcccccc---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 323 AMDQ-THVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 323 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
.... ........||+.|||||++.+ ++++.++|||||||++|||+||+.||.... . ..............+.
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~--~--~~~~~~~~~~~~~~p~ 258 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN--N--RDQIIFMVGRGYASPD 258 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC--C--HHHHHHHHHTTCCCCC
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC--h--HHHHHHHHhcCCCCCC
Confidence 5432 223445679999999999864 468999999999999999999999985311 1 1111111111111111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
+.. .+.++++.+.+|+.+||+.||++|||+.||++.|+.|+.+.
T Consensus 259 ~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 259 LSK---------LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp STT---------SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred ccc---------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 111 12345568999999999999999999999999999887654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-56 Score=435.89 Aligned_cols=263 Identities=26% Similarity=0.428 Sum_probs=207.9
Q ss_pred cCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 237 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 237 (468)
++|.+.++||+|+||+||+|++. +++.||||+++.. .. ...++|.+|+.++++++|||||+++|+|.+..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~---~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SE---SARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 46777889999999999999864 4788999998753 22 34578999999999999999999999999999
Q ss_pred cceeEeeecCCCChhhHhhhcccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQN----------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ 307 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~ 307 (468)
..++|||||++|+|.+++...... ...+++|.+++.|+.|||.||+|||+.+ ||||||||+||||++
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECC
Confidence 999999999999999999764321 2246999999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCCcccccCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhc
Q 012214 308 RYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVS 385 (468)
Q Consensus 308 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~ 385 (468)
++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||... ....
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~-----~~~~ 268 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL-----SNTE 268 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS-----CHHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC-----CHHH
Confidence 99999999999987654332 23345679999999999999999999999999999999999 89998531 1111
Q ss_pred hHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 386 LAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.. ..+..+.. ...+..+++.+.+|+.+||+.||++|||+.||++.|+.|.+..
T Consensus 269 ~~----~~i~~g~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 269 AI----DCITQGRE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp HH----HHHHHTCC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred HH----HHHHcCCC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 11 11111111 1113345568999999999999999999999999999987653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=429.96 Aligned_cols=275 Identities=25% Similarity=0.342 Sum_probs=221.0
Q ss_pred cCHHHHHHHhcCCCCCceeeecCcEEEEEEEecC------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCce
Q 012214 154 FSSKELDKATNHFNANRILGQGGQGTVYKGMLED------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNV 226 (468)
Q Consensus 154 ~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~ni 226 (468)
++..+.+...++|++.+.||+|+||+||+|.... ++.||||++...... ...++|.+|+.++.++. ||||
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~---~~~~~~~~E~~il~~l~hhpnI 130 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNV 130 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh---HHHHHHHHHHHHHHHcCCCCcE
Confidence 4455666677899999999999999999998542 368999999765444 34578999999999995 5999
Q ss_pred eeEeeeeccC-CcceeEeeecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEE
Q 012214 227 VKLLGCCLET-EVPLLVYEFIPNGTLYQHLHDRHQ-----------NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIY 294 (468)
Q Consensus 227 v~l~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ii 294 (468)
|+++|+|.+. ...++|||||++|+|.++|+.... .....+++..+..++.|||.||+|||+++ ||
T Consensus 131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---ii 207 (353)
T 4ase_A 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI 207 (353)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---ee
Confidence 9999999764 568999999999999999976432 11245899999999999999999999999 99
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCC
Q 012214 295 HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372 (468)
Q Consensus 295 H~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p 372 (468)
||||||+|||+++++.+||+|||+|+....+... ......||+.|||||++.+..++.++|||||||++|||+| |+.|
T Consensus 208 HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P 287 (353)
T 4ase_A 208 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287 (353)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence 9999999999999999999999999976544333 3445679999999999999999999999999999999998 8999
Q ss_pred CCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 373 IFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
|...... ..+...+..+.. ...+..+++++.+++.+||+.||++|||+.||++.|+.+.++.
T Consensus 288 f~~~~~~--------~~~~~~i~~g~~---------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 288 YPGVKID--------EEFCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp STTCCCS--------HHHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCHH--------HHHHHHHHcCCC---------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 8532111 111122221111 1112334558899999999999999999999999999887543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-54 Score=424.17 Aligned_cols=252 Identities=22% Similarity=0.340 Sum_probs=202.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||+||+|+.. +|+.||||++....... ...+.+.+|+.++++++|||||++++++.+.+..|+|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS--KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH--HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 67999999999999999999964 69999999987543332 3457899999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
||||++|+|.++|.... ...+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+..
T Consensus 102 mEy~~gg~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp EECCTTCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceee
Confidence 99999999999997632 235899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
.... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||... . ....+..... .....
T Consensus 176 ~~~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-----~---~~~~~~~i~~-~~~~~- 244 (350)
T 4b9d_A 176 NSTV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-----S---MKNLVLKIIS-GSFPP- 244 (350)
T ss_dssp CHHH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----S---HHHHHHHHHH-TCCCC-
T ss_pred cCCc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----C---HHHHHHHHHc-CCCCC-
Confidence 4321 1233467999999999999999999999999999999999999998531 1 1111111111 11111
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 245 --------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 --------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12234457899999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-53 Score=406.02 Aligned_cols=248 Identities=22% Similarity=0.341 Sum_probs=197.3
Q ss_pred CCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc----CCccee
Q 012214 167 NANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE----TEVPLL 241 (468)
Q Consensus 167 ~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~~~l 241 (468)
...++||+|+||+||+|.+. ++..||+|++....... ...+.|.+|+.++++++|||||++++++.+ ....++
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK--SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 55677999999999999965 68899999986543322 345779999999999999999999999864 346799
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc-CCCcEEEEecCCcc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD-QRYRAKVADFGTSK 320 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~-~~~~~kl~DfGla~ 320 (468)
|||||++|+|.+++.... ++++..+..++.||+.||+|||+++ ++|+||||||+||||+ .++.+||+|||+|+
T Consensus 107 vmEy~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 999999999999997643 5899999999999999999999976 4599999999999998 48999999999998
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
..... .....+||+.|||||++.+ .++.++|||||||++|||+||+.||.... .... ..........+
T Consensus 181 ~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-------~~~~-~~~~i~~~~~~ 248 (290)
T 3fpq_A 181 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQ-IYRRVTSGVKP 248 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHH-HHHHHTTTCCC
T ss_pred eCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------cHHH-HHHHHHcCCCC
Confidence 64332 2344679999999998865 69999999999999999999999984311 1111 11222221111
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
... +...++++.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~--------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 ASF--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGG--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC--------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 1223347889999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-53 Score=415.35 Aligned_cols=249 Identities=25% Similarity=0.400 Sum_probs=205.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
..|+..++||+|+||+||+|... +|+.||||++...... ..+.+.+|+.++++++|||||++++++.+.+..|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS----SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 56888899999999999999975 6999999998653222 234578999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
||||++|+|.+++... .+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+
T Consensus 150 mEy~~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 150 MEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220 (346)
T ss_dssp ECCCTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceec
Confidence 9999999999998652 4899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||... ... ..+ ..+.......+
T Consensus 221 ~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~---~~~-~~i~~~~~~~~ 290 (346)
T 4fih_A 221 SKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPL---KAM-KMIRDNLPPRL 290 (346)
T ss_dssp CSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHH---HHH-HHHHHSSCCCC
T ss_pred CCCCC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHH---HHH-HHHHcCCCCCC
Confidence 54332 234568999999999999999999999999999999999999998531 111 111 11111111110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
......++.+.+|+.+||+.||++|||+.|+++
T Consensus 291 -------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 -------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 012234557899999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=412.01 Aligned_cols=272 Identities=21% Similarity=0.278 Sum_probs=201.8
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC----cc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE----VP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----~~ 239 (468)
.+|.+.++||+|+||+||+|++ +|+.||||++..... ....+..|+..+.+++|||||+++|+|.+.+ ..
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4567788999999999999998 589999999865321 1122335666667889999999999998654 56
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT-----SSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
+||||||++|+|.++|... +++|..+..++.|++.||+|||++. .++||||||||+||||+.++++||+
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~ 150 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEecCCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence 8999999999999999762 4899999999999999999999871 2349999999999999999999999
Q ss_pred ecCCcccccCCCcee---eecccccCCccCccccccC------CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCcc--c-
Q 012214 315 DFGTSKFIAMDQTHV---TTKIQGTFGYLDPEYHQSS------QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--E- 382 (468)
Q Consensus 315 DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~--~- 382 (468)
|||+|+......... .....||+.|||||++.+. .++.++|||||||++|||+||..|+........ .
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 999998775543322 2345799999999998764 467899999999999999999887643211100 0
Q ss_pred ---hhchHHHHHHHhhcccc-chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 383 ---NVSLAAYFVHSMRKNRL-HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 383 ---~~~~~~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
................+ +.+.+ .....+.+..+.+|+.+||+.||++|||+.||++.|++|.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCG----GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cccccchHHHHHHHHhcccCCCCCCc----cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 00111112222211111 11111 0112345668899999999999999999999999999987654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-53 Score=413.23 Aligned_cols=252 Identities=22% Similarity=0.239 Sum_probs=204.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
+.|...++||+|+||.||+|++. +|+.||||+++.... +.+|+.+++.++|||||++++++.+.+..+||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 56788889999999999999965 689999999875322 24699999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC-cEEEEecCCccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY-RAKVADFGTSKF 321 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~-~~kl~DfGla~~ 321 (468)
||||++|+|.+++.... ++++..+..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.
T Consensus 129 mEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMG-----CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALC 200 (336)
T ss_dssp ECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred EeccCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence 99999999999997643 5999999999999999999999999 99999999999999987 699999999987
Q ss_pred ccCCCce----eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 322 IAMDQTH----VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 322 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
+..+... .....+||+.|||||++.+..++.++|||||||++|||+||+.||..... . ........ ...
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--~---~~~~~i~~--~~~ 273 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR--G---PLCLKIAS--EPP 273 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC--S---CCHHHHHH--SCC
T ss_pred ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--H---HHHHHHHc--CCC
Confidence 7543221 12335799999999999999999999999999999999999999853211 1 11111111 011
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
... ..+...++.+.+++.+||+.||++|||+.|+++.|....
T Consensus 274 ~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 274 PIR---------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp GGG---------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Cch---------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 111 113345568899999999999999999999998887543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=409.59 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=207.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||+||+++.. +|+.||||++...... .....+.+.+|+.++++++|||||++++++.+.+..|+|
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 56999999999999999999964 6899999998653211 113356789999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 111 mEy~~gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp ECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 99999999999997643 4999999999999999999999999 999999999999999999999999999977
Q ss_pred cCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
..... ......+||+.|||||++.+..++.++||||+||++|||++|+.||... .. ...+..... ..+
T Consensus 183 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~---~~~~~~i~~-~~~-- 251 (311)
T 4aw0_A 183 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NE---GLIFAKIIK-LEY-- 251 (311)
T ss_dssp CTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SH---HHHHHHHHH-TCC--
T ss_pred CCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CH---HHHHHHHHc-CCC--
Confidence 54332 3345578999999999999999999999999999999999999999531 11 111111111 111
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVS 441 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 441 (468)
..+...++++.+|+.+||+.||++|||+.|++
T Consensus 252 --------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 --------DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --------CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 01122345788999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=397.01 Aligned_cols=248 Identities=24% Similarity=0.336 Sum_probs=190.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||+||+|... +|+.||||++....... ....+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 68999999999999999999964 69999999986543221 13346789999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+ +|+|.+++..+. ++++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+..
T Consensus 92 mEy~-~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp EECC-CEEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred EeCC-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeec
Confidence 9999 689999997632 5999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCceeeecccccCCccCccccccCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.... .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||... . ....+.. .......
T Consensus 163 ~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-----~---~~~~~~~-i~~~~~~- 230 (275)
T 3hyh_A 163 TDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-----S---IPVLFKN-ISNGVYT- 230 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----S---HHHHHHH-HHHTCCC-
T ss_pred CCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-----C---HHHHHHH-HHcCCCC-
Confidence 4332 2334679999999999998876 57999999999999999999998431 1 1111111 1111110
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+...++.+.+|+.+||+.||++|||+.|+++
T Consensus 231 ---------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 ---------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11223457889999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-52 Score=417.03 Aligned_cols=249 Identities=25% Similarity=0.402 Sum_probs=205.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
+.|+..++||+|+||.||+|... +|+.||||++...... ..+.+.+|+.+++.++|||||++++++.+.+..|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS----SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh----HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 56899999999999999999965 6999999998654322 234688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
||||++|+|.+++... .+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+
T Consensus 227 mEy~~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 227 MEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297 (423)
T ss_dssp EECCTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred EeCCCCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceEC
Confidence 9999999999999652 4899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||... ..... + ..+.......+
T Consensus 298 ~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~---~-~~i~~~~~~~~ 367 (423)
T 4fie_A 298 SKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPLKA---M-KMIRDNLPPRL 367 (423)
T ss_dssp CSSCC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHH---H-HHHHHSCCCCC
T ss_pred CCCCc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHH---H-HHHHcCCCCCC
Confidence 54332 234567999999999999999999999999999999999999998531 11111 1 11111111110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
......++.+.+|+.+||+.||++|||+.|+++
T Consensus 368 -------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 -------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011234457899999999999999999999986
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=397.57 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=190.1
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC-----
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE----- 237 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----- 237 (468)
++|++.+.||+|+||+||+|+.. +|+.||||++...... ...+.+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE---LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 45888999999999999999965 6899999998764433 34567899999999999999999999987544
Q ss_pred -------cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc
Q 012214 238 -------VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR 310 (468)
Q Consensus 238 -------~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~ 310 (468)
..++||||+++|+|.+++..+... ...++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~ 156 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTI--EERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDV 156 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSG--GGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCC--ChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCc
Confidence 368999999999999999864322 23567788999999999999999999 999999999999999999
Q ss_pred EEEEecCCcccccCCCce-----------eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 012214 311 AKVADFGTSKFIAMDQTH-----------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNT 379 (468)
Q Consensus 311 ~kl~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~ 379 (468)
+||+|||+|+........ ..+..+||+.|||||++.+..++.++|||||||++|||++ ||..
T Consensus 157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~---- 229 (299)
T 4g31_A 157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST---- 229 (299)
T ss_dssp EEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS----
T ss_pred EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC----
Confidence 999999999876543221 1234579999999999999999999999999999999996 6631
Q ss_pred ccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 380 SQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ..... ..........+.. .....+.+.+|+.+||+.||++|||+.|+++
T Consensus 230 -~--~~~~~-~~~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 230 -Q--MERVR-TLTDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -H--HHHHH-HHHHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -c--cHHHH-HHHHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 11111 1111122222111 1223345678999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=403.75 Aligned_cols=244 Identities=27% Similarity=0.292 Sum_probs=192.7
Q ss_pred cCCCCCceeeecCcEEEEEEEec----CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
++|++.+.||+|+||+||+|+.. .++.||||+++...... .....+.+|+.++++++|||||++++++.+.+..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV--RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE--EECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 67999999999999999999852 47889999986532211 1123578899999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred EEEEEcCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccc
Confidence 99999999999999997643 5999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
+....... .....+||+.|||||++.+..++.++|||||||++|||+||+.||... .. .+....... ...
T Consensus 174 ~~~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-----~~---~~~~~~i~~-~~~ 243 (304)
T 3ubd_A 174 KESIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-----DR---KETMTMILK-AKL 243 (304)
T ss_dssp EC-----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SH---HHHHHHHHH-CCC
T ss_pred eeccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-----CH---HHHHHHHHc-CCC
Confidence 86543322 233467999999999999999999999999999999999999998531 11 111111111 111
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTM 437 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 437 (468)
..+...++++.+|+.+||+.||++|||+
T Consensus 244 ----------~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 ----------GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ----------CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 0122344578999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=391.54 Aligned_cols=304 Identities=35% Similarity=0.590 Sum_probs=251.0
Q ss_pred ccccccCHHHHHHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceee
Q 012214 149 DRFKLFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228 (468)
Q Consensus 149 ~~~~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~ 228 (468)
.....|+..++...+++|.+.+.||+|+||.||+|...+++.||||++...... .....+.+|+.+++.++||||++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~ 91 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLR 91 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc---hHHHHHHHHHHHHHhccCCCccc
Confidence 445789999999999999999999999999999999888999999998764322 22236889999999999999999
Q ss_pred EeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC
Q 012214 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR 308 (468)
Q Consensus 229 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~ 308 (468)
+++++.+....++||||+++|+|.+++..... ...++++..+..++.|++.||+|||+...++|+||||||+|||++.+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~ 170 (326)
T 3uim_A 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170 (326)
T ss_dssp CCEEECCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT
T ss_pred eEEEEecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC
Confidence 99999999999999999999999999987542 33469999999999999999999999921229999999999999999
Q ss_pred CcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH
Q 012214 309 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 309 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~ 388 (468)
+.+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|+|++|+.||...............
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 171 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp CCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred CCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 99999999999877655555555667999999999999989999999999999999999999998532222223333444
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCchhhh
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKRA 456 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~ 456 (468)
..........+..+.+.......+...+..+.+++.+||+.||.+|||+.||+++|++....+...+-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 318 (326)
T 3uim_A 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEW 318 (326)
T ss_dssp HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC--
T ss_pred HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhhh
Confidence 44444555566666666666667778889999999999999999999999999999987666554443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=390.20 Aligned_cols=264 Identities=21% Similarity=0.279 Sum_probs=201.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc------
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE------ 235 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------ 235 (468)
.++|.+.+.||+|+||+||+|... +|+.||||+++...... ...+.+.+|+.+|+.++|||||++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV--TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch--HHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 367999999999999999999964 69999999987643332 345678899999999999999999998754
Q ss_pred CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
....|+|||||+ |+|.+++... .++++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~D 201 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGD 201 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECC
T ss_pred CCEEEEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEee
Confidence 357899999995 6899999653 35999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCC---ceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHH
Q 012214 316 FGTSKFIAMDQ---THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391 (468)
Q Consensus 316 fGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (468)
||+|+.+.... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||... ..........
T Consensus 202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~-----~~~~~l~~I~ 276 (398)
T 4b99_A 202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK-----NYVHQLQLIM 276 (398)
T ss_dssp CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS-----SHHHHHHHHH
T ss_pred cceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC-----CHHHHHHHHH
Confidence 99998764322 2223456899999999998875 5689999999999999999999998531 1111111111
Q ss_pred HHhhccccchhc---ch----HHh----------hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 392 HSMRKNRLHDIL---DD----QLM----------KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 392 ~~~~~~~~~~~~---d~----~l~----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
............ .. ... .......++.+.+|+.+||+.||++|||+.|+++
T Consensus 277 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 277 MVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111111100000 00 000 0001123457889999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=385.83 Aligned_cols=197 Identities=23% Similarity=0.361 Sum_probs=169.3
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec----CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccC
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLET 236 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~ 236 (468)
..++|++.+.||+|+||+||+|+.+ .++.||+|++..... ...+.+|+.+++.+ +||||+++++++.+.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~------~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH------PIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC------HHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC------HHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 4578999999999999999999853 467899998865432 24577899999998 699999999999999
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC-CcEEEEe
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR-YRAKVAD 315 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~-~~~kl~D 315 (468)
+..++||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred CEEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECc
Confidence 99999999999999999984 3899999999999999999999999 9999999999999877 7999999
Q ss_pred cCCcccccCCCc---------------------------eeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHH
Q 012214 316 FGTSKFIAMDQT---------------------------HVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELL 367 (468)
Q Consensus 316 fGla~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~ 367 (468)
||+|+....... ...+..+||+.|+|||++.+. .++.++||||+||++|||+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 999986543211 112335799999999999875 5899999999999999999
Q ss_pred hCCCCCCC
Q 012214 368 TGKKPIFW 375 (468)
Q Consensus 368 tG~~p~~~ 375 (468)
+|+.||..
T Consensus 242 ~G~~Pf~~ 249 (361)
T 4f9c_A 242 SGRYPFYK 249 (361)
T ss_dssp HTCSSSSC
T ss_pred HCCCCCCC
Confidence 99999954
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=375.22 Aligned_cols=289 Identities=38% Similarity=0.621 Sum_probs=236.6
Q ss_pred ccCHHHHHHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeee
Q 012214 153 LFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGC 232 (468)
Q Consensus 153 ~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~ 232 (468)
.++..++...+++|...+.||+|+||.||+|...+++.||||++..... ...+.+.+|+.+++.++||||++++++
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~ 103 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS----QGIEEFETEIETLSFCRHPHLVSLIGF 103 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS----SHHHHHHHHHHGGGSCCCTTBCCEEEE
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh----HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3445556667899999999999999999999988899999998865432 234678999999999999999999999
Q ss_pred eccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEE
Q 012214 233 CLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAK 312 (468)
Q Consensus 233 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~k 312 (468)
+.+.+..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~k 179 (321)
T 2qkw_B 104 CDERNEMILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179 (321)
T ss_dssp CCCTTCCEEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEE
T ss_pred EcCCCeEEEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999997643 22336899999999999999999999999 99999999999999999999
Q ss_pred EEecCCcccccCCC-ceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHH
Q 012214 313 VADFGTSKFIAMDQ-THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391 (468)
Q Consensus 313 l~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (468)
|+|||+++...... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ..+......+..
T Consensus 180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~--~~~~~~~~~~~~ 257 (321)
T 2qkw_B 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL--PREMVNLAEWAV 257 (321)
T ss_dssp ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS--SSSCCCHHHHTH
T ss_pred EeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC--cHHHHHHHHHhh
Confidence 99999998654322 222334568999999999999999999999999999999999999986422 222223333333
Q ss_pred HHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.......+...+++.+........+..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp HHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred hccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 334444555556655555566778889999999999999999999999999999887544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=391.79 Aligned_cols=252 Identities=21% Similarity=0.255 Sum_probs=199.2
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchH--HHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDE--ELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
.++|.+.+.||+|+||.||+++.. +|+.||||++....... ..........++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999965 69999999986432111 011122233446777788999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
|+||||++||+|.++|.... .+++..+..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|
T Consensus 268 ylVmEy~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEeccccee
Confidence 99999999999999997643 4999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh-cc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR-KN 397 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 397 (468)
+...... ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||...... ........... ..
T Consensus 340 ~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~-----~~~~i~~~i~~~~~ 411 (689)
T 3v5w_A 340 CDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTLTMAV 411 (689)
T ss_dssp EECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-----CHHHHHHHHHHCCC
T ss_pred eecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHhhcCCCC
Confidence 8765433 234679999999999975 57999999999999999999999999532111 11111111111 11
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT-----MEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 442 (468)
.+ +...++.+.+|+.+||+.||++|++ +.||++
T Consensus 412 ~~------------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 EL------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CC------------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CC------------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11 2233457899999999999999998 566654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=355.68 Aligned_cols=289 Identities=34% Similarity=0.550 Sum_probs=228.1
Q ss_pred cccccCHHHHHHHhcCCCCC------ceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCC
Q 012214 150 RFKLFSSKELDKATNHFNAN------RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223 (468)
Q Consensus 150 ~~~~~~~~ei~~~~~~f~~~------~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h 223 (468)
....|++.++..++++|... +.||+|+||.||+|.. +++.||+|++............+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34689999999999999888 8999999999999987 5789999988653221111345678999999999999
Q ss_pred CceeeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCE
Q 012214 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNI 303 (468)
Q Consensus 224 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NI 303 (468)
|||+++++++.+.+..++||||+++++|.+++..... ..++++..++.++.||+.||.|||+.+ |+|+||||+||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Ni 164 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANI 164 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHE
Confidence 9999999999999999999999999999999976332 236999999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEecCCcccccCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 012214 304 LLDQRYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE 382 (468)
Q Consensus 304 Ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~ 382 (468)
+++.++.+||+|||+++....... .......||+.|+|||.+.+ .++.++||||||+++|+|++|..||.......
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-- 241 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-- 241 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--
Confidence 999999999999999986654322 22334568999999998765 58899999999999999999999985422111
Q ss_pred hhchHHHHHHHh-hccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 383 NVSLAAYFVHSM-RKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 383 ~~~~~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
.......... ....+.+.++..+ ...+...++.+.+++.+||+.||.+|||+.++++.|+++..+
T Consensus 242 --~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 242 --LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp --BTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred --HHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 1111111111 1112222222221 223456777899999999999999999999999999998753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=391.90 Aligned_cols=251 Identities=21% Similarity=0.311 Sum_probs=206.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||+|..+ +|+.||+|++..... ...+.+.+|+.+|+.++|||||++++++.+....++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE----SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH----HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch----hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 368999999999999999999965 699999999865322 234678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC--CcEEEEecCCc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR--YRAKVADFGTS 319 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~--~~~kl~DfGla 319 (468)
|||||++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 232 v~E~~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a 304 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 304 (573)
T ss_dssp EEECCCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSC
T ss_pred EEeecCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccce
Confidence 999999999999986422 35899999999999999999999999 9999999999999854 89999999999
Q ss_pred ccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc-cc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK-NR 398 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 398 (468)
+.+..... ....+||+.|||||++.+..++.++|||||||++|||++|+.||... .. ...+...... ..
T Consensus 305 ~~~~~~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~-----~~---~~~~~~i~~~~~~ 374 (573)
T 3uto_A 305 AHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-----ND---DETLRNVKSCDWN 374 (573)
T ss_dssp EECCTTSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SH---HHHHHHHHTTCCC
T ss_pred eEccCCCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CH---HHHHHHHHhCCCC
Confidence 87754433 33457999999999999999999999999999999999999998531 11 1111111111 11
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
... ......++.+.+|+.+||+.||++|||+.|+++
T Consensus 375 ~~~--------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 375 MDD--------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCS--------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCc--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 110 111233457889999999999999999999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=355.14 Aligned_cols=261 Identities=25% Similarity=0.390 Sum_probs=211.6
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||+||++... +++.||+|++... .. ...+.+.+|+.++++++||||+++++++.+....++|
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DE---ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CH---HHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 67888999999999999999965 6899999987543 22 4457899999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLM 158 (310)
T ss_dssp EECCTTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceec
Confidence 99999999999997632 25899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCcee-------------eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHH
Q 012214 323 AMDQTHV-------------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAY 389 (468)
Q Consensus 323 ~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~ 389 (468)
....... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 238 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence 4332221 114569999999999999999999999999999999999999975322111111111110
Q ss_pred HHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 390 FVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
......+..+++.+.+++.+||+.||++|||+.++++.|+.++...
T Consensus 239 ----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 239 ----------------FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp ----------------HHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----------------cccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111112334457899999999999999999999999999887543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=371.18 Aligned_cols=265 Identities=24% Similarity=0.366 Sum_probs=214.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEec--------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE--------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCC 233 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~ 233 (468)
.++|.+.+.||+|+||.||+|... ++..||||+++..... ...+.+.+|+.+++.+ +||||+++++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH---HHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH---HHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 367899999999999999999852 3567999998765433 4567899999999999 899999999999
Q ss_pred ccCCcceeEeeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCC
Q 012214 234 LETEVPLLVYEFIPNGTLYQHLHDRHQN-----------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTN 302 (468)
Q Consensus 234 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~N 302 (468)
.+.+..++||||+++|+|.+++...... ....+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhh
Confidence 9999999999999999999999874321 1235899999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 012214 303 ILLDQRYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTS 380 (468)
Q Consensus 303 ILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~ 380 (468)
||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ..
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~--~~ 311 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PV 311 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CG
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC--CH
Confidence 99999999999999999866543322 2233457889999999999999999999999999999999 99998531 11
Q ss_pred cchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 381 QENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.... ........ ...+..++..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 312 ---~~~~----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 312 ---EELF----KLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp ---GGHH----HHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---HHHH----HHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 11111111 1112334557899999999999999999999999999987544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=348.51 Aligned_cols=260 Identities=26% Similarity=0.374 Sum_probs=213.6
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.++|.+.+.||+|+||.||++...++..||+|++...... .+++.+|+.++++++||||+++++++.+....++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 4678899999999999999999888889999998764332 25688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 82 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154 (268)
T ss_dssp EECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred EEccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceec
Confidence 99999999999997643 24899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
............+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.... .. ............
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~---~~~~~~~~~~~~-- 224 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-----NS---EVVLKVSQGHRL-- 224 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC-----HH---HHHHHHHTTCCC--
T ss_pred chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC-----hH---HHHHHHHcCCCC--
Confidence 6554444444557788999999999899999999999999999999 999984311 11 111111111110
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCc
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 452 (468)
..+...+..+.+++.+||+.||++|||+.++++.|+.++...+
T Consensus 225 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~k 267 (268)
T 3sxs_A 225 --------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267 (268)
T ss_dssp --------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC---
T ss_pred --------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhccC
Confidence 0112233478999999999999999999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=356.99 Aligned_cols=270 Identities=29% Similarity=0.425 Sum_probs=206.4
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
+...++|++.+.||+|+||+||++.. .++.||||++....... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA--ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 33457899999999999999999987 58899999987644332 4457899999999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999976321 124899999999999999999999986 45999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||... ..................
T Consensus 187 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~-----~~~~~~~~~~~~~~~~~~ 260 (309)
T 3p86_A 187 RLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-----NPAQVVAAVGFKCKRLEI 260 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS-----CHHHHHHHHHHSCCCCCC
T ss_pred ccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCCCCCC
Confidence 7544322 1233456999999999999999999999999999999999999998531 111111111101111111
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCch
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKK 453 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 453 (468)
+...+..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 261 ------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 261 ------------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp ------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred ------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 223445789999999999999999999999999998866543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=363.28 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=211.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEec----CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
.++|.+.+.||+|+||.||+|... .+..||||++...... ...+.|.+|+.+++.++||||+++++++.+...
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE---RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 467888999999999999999974 3556999998765443 345679999999999999999999999999999
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSS
T ss_pred cEEEeeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCc
Confidence 999999999999999996532 25899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCce--eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 319 SKFIAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 319 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||... ... ........
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-----~~~---~~~~~~~~ 269 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM-----TNR---DVISSVEE 269 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS-----CHH---HHHHHHHT
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC-----CHH---HHHHHHHc
Confidence 9876543222 2233456788999999999999999999999999999999 99998431 111 11111111
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCchh
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKK 454 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~ 454 (468)
.... ..+...+..+.+++.+||+.||++|||+.++++.|+.+.......
T Consensus 270 ~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 270 GYRL----------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred CCCC----------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 1111 112234557999999999999999999999999999988766543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=373.15 Aligned_cols=260 Identities=25% Similarity=0.379 Sum_probs=211.3
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
..++|.+.+.||+|+||.||+|... +++.||||+++..... ...+.|.+|+.++++++||||+++++++.+....+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP---DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCH---HHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3567889999999999999999976 7899999998754333 34467899999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 189 lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 9999999999999997643 24899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceee-ecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 321 FIAMDQTHVT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 321 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
.......... ....++..|+|||.+.++.++.++|||||||++|||++ |..||.... .. ..........
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~-----~~----~~~~~~~~~~ 332 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS-----NQ----QTREFVEKGG 332 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC-----HH----HHHHHHHTTC
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HH----HHHHHHHcCC
Confidence 6543222111 12235778999999999999999999999999999998 999974311 11 1111111111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
....+..++..+.+++.+||+.||++|||+.++++.|+.++.
T Consensus 333 ---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 333 ---------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 011123345578999999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=348.05 Aligned_cols=257 Identities=27% Similarity=0.398 Sum_probs=211.8
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
++|.+.+.||+|+||.||++...+++.||+|++...... .+.+.+|+.++++++||||+++++++.+....++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 678889999999999999999888899999998764332 246889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 85 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp ECCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred EeCCCCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccc
Confidence 9999999999996532 35899999999999999999999999 9999999999999999999999999998665
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||... ... ...........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~-----~~~---~~~~~~~~~~~---- 225 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNS---EVVEDISTGFR---- 225 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHH---HHHHHHHTTCC----
T ss_pred ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC-----CHH---HHHHHHhcCcc----
Confidence 433333334457788999999999999999999999999999999 89998431 111 11111111100
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
...+...+..+.+++.+||+.||++|||+.++++.|+++..+
T Consensus 226 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 226 ------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 011222345789999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=367.64 Aligned_cols=261 Identities=23% Similarity=0.409 Sum_probs=200.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEec----CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
.++|.+.+.||+|+||.||+|... ++..||||+++..... ...+.|.+|+.++++++||||+++++++.+...
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE---KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 368999999999999999999864 5778999998765433 445789999999999999999999999999999
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred eEEEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcc
Confidence 999999999999999997532 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCcee--eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 319 SKFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 319 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
++......... .....+|..|+|||++.+..++.++||||||+++|||++ |+.||... ... . ......
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~-----~~~---~-~~~~i~ 264 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-----SNQ---D-VIKAVD 264 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC-----CHH---H-HHHHHH
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC-----CHH---H-HHHHHH
Confidence 98765432221 222345778999999999999999999999999999998 99998431 111 1 111111
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
... ....+..++..+.+++.+||+.||++|||+.+++++|+.+....
T Consensus 265 ~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 265 EGY---------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp TTE---------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred cCC---------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 110 01112234557899999999999999999999999999887654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=380.79 Aligned_cols=270 Identities=25% Similarity=0.396 Sum_probs=220.2
Q ss_pred HhcCCCCCceeeecCcEEEEEEEecC-CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
..++|.+.+.||+|+||.||+|.+.. +..||||+++.... ..++|.+|+.++++++||||++++++|.+....+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 35678889999999999999999764 88999999876432 2467999999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 293 lv~E~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp EEEECCTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEEccCCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccce
Confidence 9999999999999997632 235899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
..............+|..|+|||.+.+..++.++|||||||++|||++ |..||.... ....... +...
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-----~~~~~~~----~~~~-- 435 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYEL----LEKD-- 435 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHHH----HHTT--
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHHH----HHcC--
Confidence 765444333344457789999999999999999999999999999999 888874311 1111111 1111
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCchhhhHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKRAMFSK 460 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~ 460 (468)
.....+..++..+.+|+.+||+.||++|||+.++++.|+.+.......++....
T Consensus 436 -------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~~~~~~~~~~ 489 (495)
T 1opk_A 436 -------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 489 (495)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSSCHHHHHHHH
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhccccchHHHHH
Confidence 011123344568999999999999999999999999999998776655544433
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=350.37 Aligned_cols=270 Identities=24% Similarity=0.379 Sum_probs=212.1
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|++.+.||+|+||.||++... +++.||+|++....... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREK-EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCC-HHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcccc-HHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 367899999999999999999964 68899999885533222 2455789999999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++++|.+++.... ++++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 v~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred EEeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 999999999999997643 4899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.............||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... ........... ....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~-~~~~ 231 (294)
T 4eqm_A 161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET--------AVSIAIKHIQD-SVPN 231 (294)
T ss_dssp C-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC--------HHHHHHHHHSS-CCCC
T ss_pred cccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhhc-cCCC
Confidence 65444334445679999999999999999999999999999999999999985311 01111111111 1111
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhcccCCchhh
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-TMEEVSMELNGIRGSSKKKR 455 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~i~~~~~~~~ 455 (468)
.........+..+.+++.+||+.||++|| +++++.+.|+.+.......+
T Consensus 232 -----~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 232 -----VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281 (294)
T ss_dssp -----HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred -----cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence 11111233456799999999999999999 99999999999876654433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=346.12 Aligned_cols=250 Identities=26% Similarity=0.434 Sum_probs=205.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||+||++.. .+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc----HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 36799999999999999999995 46899999988653322 23568899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 95 v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (297)
T ss_dssp EEECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEECCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCcee
Confidence 99999999999999762 4899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||... ... ........... ..
T Consensus 166 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~---~~~~~~~~~~~-~~ 235 (297)
T 3fxz_A 166 ITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-----NPL---RALYLIATNGT-PE 235 (297)
T ss_dssp CCSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHH---HHHHHHHHHCS-CC
T ss_pred cCCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHH---HHHHHHHhCCC-CC
Confidence 654333 233457999999999999999999999999999999999999998431 111 11111111110 00
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 L-------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp C-------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-------CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 012234457899999999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=355.67 Aligned_cols=270 Identities=23% Similarity=0.296 Sum_probs=208.2
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV---- 238 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~---- 238 (468)
.++|++.+.||+|+||+||+|... ++.||||++.... .....+..|+.++++++||||+++++++.+...
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 478999999999999999999875 7999999986532 223445669999999999999999999987543
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCEEecCCCCCCEEEcCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA----------TSSPIYHRDIKSTNILLDQR 308 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~----------~~~~iiH~DLkp~NILl~~~ 308 (468)
.++||||+++|+|.+++... .+++..++.++.|++.||+|||+. + |+||||||+|||++.+
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNN 167 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTT
T ss_pred EEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCC
Confidence 59999999999999999762 489999999999999999999998 7 9999999999999999
Q ss_pred CcEEEEecCCcccccCCCce-eeecccccCCccCcccccc-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 012214 309 YRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE 382 (468)
Q Consensus 309 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~ 382 (468)
+.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 99999999999876543332 2333579999999999887 35567889999999999999999998642221111
Q ss_pred hh-------chHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 383 NV-------SLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 383 ~~-------~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
.. ..................+... ......++.+.+|+.+||+.||++|||+.|+++.|+.|...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00 0111111111111111111110 11234556799999999999999999999999999998753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=348.25 Aligned_cols=260 Identities=23% Similarity=0.354 Sum_probs=201.7
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHh--cCCCceeeEeeeecc----C
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQ--INHRNVVKLLGCCLE----T 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~g~~~~----~ 236 (468)
.++|.+.+.||+|+||+||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++.+ .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 46899999999999999999988 5899999998652 12345567777666 799999999998654 3
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCEEecCCCCCCEEEcCC
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH--------SATSSPIYHRDIKSTNILLDQR 308 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~iiH~DLkp~NILl~~~ 308 (468)
...++||||+++|+|.+++.. ..+++..++.++.||+.||+||| +.+ |+||||||+|||++.+
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~ 149 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKN 149 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTT
T ss_pred ceeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCC
Confidence 457899999999999999954 24899999999999999999999 777 9999999999999999
Q ss_pred CcEEEEecCCcccccCCCcee---eecccccCCccCccccccC------CCCCcccHHHHHHHHHHHHhC----------
Q 012214 309 YRAKVADFGTSKFIAMDQTHV---TTKIQGTFGYLDPEYHQSS------QLTDKSDVYSFGVVLVELLTG---------- 369 (468)
Q Consensus 309 ~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvll~el~tG---------- 369 (468)
+.+||+|||+++......... .....||+.|+|||.+.+. .++.++|||||||++|||++|
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 999999999998765443332 2234699999999999876 455799999999999999999
Q ss_pred CCCCCCCCCCccchhchHHHHHHHh-hccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 370 KKPIFWAGNTSQENVSLAAYFVHSM-RKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 370 ~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
+.||......... ........ .......+.. ...+...+..+.+++.+||+.||++|||+.++++.|++|
T Consensus 230 ~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 230 KPPFYDVVPNDPS----FEDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCTTTTTSCSSCC----HHHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccCCCCcc----hhhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 7777432211111 11111111 1111111111 112334667899999999999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=352.57 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=205.6
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||+|.. .+|+.||||++....... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP--TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 46799999999999999999996 579999999986543322 345678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 92 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp EECCCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred EEECCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 999999999999997643 4899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCceeeecccccCCccCccccccCCCC-CcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
...... .....||+.|+|||.+.+..++ .++|||||||++|+|++|+.||... . ..... ........
T Consensus 164 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~---~~~~~-~~i~~~~~- 231 (328)
T 3fe3_A 164 FTVGGK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-----N---LKELR-ERVLRGKY- 231 (328)
T ss_dssp GSSSCG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS-----S---HHHHH-HHHHHCCC-
T ss_pred cCCCCc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC-----C---HHHHH-HHHHhCCC-
Confidence 644322 3445799999999999988775 7899999999999999999998531 1 11111 11111111
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
..+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 232 ---------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ---------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0112234478899999999999999999999863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=355.90 Aligned_cols=265 Identities=26% Similarity=0.381 Sum_probs=214.3
Q ss_pred HhcCCCCCceeeecCcEEEEEEEe------cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc
Q 012214 162 ATNHFNANRILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE 235 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~ 235 (468)
..++|.+.+.||+|+||.||++.. .+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP---SELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH---HHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 457899999999999999999985 24578999998764433 445778999999999999999999999999
Q ss_pred CCcceeEeeecCCCChhhHhhhcccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEec
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQN-------------------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHR 296 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~ 296 (468)
....++||||+++++|.+++...... ....+++..++.++.||+.||.|||+.+ |+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccc
Confidence 99999999999999999999874321 1134899999999999999999999999 9999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 012214 297 DIKSTNILLDQRYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIF 374 (468)
Q Consensus 297 DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~ 374 (468)
||||+|||++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998765443322 233457889999999999999999999999999999999 999984
Q ss_pred CCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 375 WAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
... . .... ......... ..+...++.+.+++.+||+.||++|||+.++++.|+++...
T Consensus 255 ~~~--~---~~~~----~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 255 GIP--P---ERLF----NLLKTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TCC--G---GGHH----HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCC--H---HHHH----HHhhcCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 311 1 1111 111111110 11223445789999999999999999999999999988654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=349.31 Aligned_cols=267 Identities=26% Similarity=0.429 Sum_probs=206.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-----cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC-
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET- 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~- 236 (468)
.++|++.+.||+|+||+||++.+ .+++.||||++.... . ...+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-E---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-H---HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-H---HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 36789999999999999999984 358899999987532 2 3456789999999999999999999998653
Q ss_pred -CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 237 -EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 237 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
...++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC
T ss_pred CCceEEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEcc
Confidence 45899999999999999997643 24899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCce--eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH
Q 012214 316 FGTSKFIAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 316 fGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
||+++........ ......+|..|+|||.+.+..++.++||||||+++|||++|..|+... . ..+...
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~----~------~~~~~~ 227 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP----P------AEFMRM 227 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH----H------HHHHHH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC----h------HHHHhh
Confidence 9999876543322 223345777899999999999999999999999999999999987421 0 000000
Q ss_pred hhcccc--------chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 394 MRKNRL--------HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 394 ~~~~~~--------~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
...... .+.+........+..+++.+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 228 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 000000 000000001112334556899999999999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=376.62 Aligned_cols=265 Identities=24% Similarity=0.380 Sum_probs=215.3
Q ss_pred HHHHHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC
Q 012214 157 KELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 236 (468)
Q Consensus 157 ~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~ 236 (468)
...+...++|.+.+.||+|+||.||+|..+++..||||+++.... ..+.|.+|+.++++++||||+++++++. .
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-----SVEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 344455678999999999999999999998889999999876432 2467999999999999999999999986 5
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DF 328 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADF 328 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECST
T ss_pred CccEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeC
Confidence 678999999999999999975321 24889999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
|+++..............+|..|+|||.+....++.++|||||||++|||++ |+.||... .......... .
T Consensus 329 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~-----~~~~~~~~i~---~ 400 (454)
T 1qcf_A 329 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-----SNPEVIRALE---R 400 (454)
T ss_dssp TGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHHHHHHHH---H
T ss_pred CCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHH---c
Confidence 9998765432222333456788999999999999999999999999999999 99998431 1111111111 1
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.... ..+..+++.+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 401 ~~~~----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 401 GYRM----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp TCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CCCC----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 1111 112344568999999999999999999999999999987654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=359.26 Aligned_cols=274 Identities=25% Similarity=0.349 Sum_probs=217.0
Q ss_pred ccCHHHHHHHhcCCCCCceeeecCcEEEEEEEe------cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCc
Q 012214 153 LFSSKELDKATNHFNANRILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRN 225 (468)
Q Consensus 153 ~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~n 225 (468)
.+...+.+...++|.+.+.||+|+||.||+|.+ .+++.||||++...... ...+.+.+|+.++.++ +|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLN 87 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTT
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH---HHHHHHHHHHHHHHhhcCCcc
Confidence 445566667789999999999999999999973 24678999999765443 3456799999999999 8999
Q ss_pred eeeEeeeeccCC-cceeEeeecCCCChhhHhhhcccCC------------------------------------------
Q 012214 226 VVKLLGCCLETE-VPLLVYEFIPNGTLYQHLHDRHQNE------------------------------------------ 262 (468)
Q Consensus 226 iv~l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~------------------------------------------ 262 (468)
|+++++++.+.+ ..++||||+++|+|.+++.......
T Consensus 88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 999999988755 4899999999999999997643210
Q ss_pred -------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 263 -------------------EFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 263 -------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 123899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 324 MDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 324 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.... .......||+.|+|||++.+..++.++|||||||++|||++ |..||...... .. ...........
T Consensus 245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~----~~~~~~~~~~~- 315 (359)
T 3vhe_A 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EE----FCRRLKEGTRM- 315 (359)
T ss_dssp SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----HH----HHHHHHHTCCC-
T ss_pred ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh----HH----HHHHHHcCCCC-
Confidence 4332 23344568999999999999999999999999999999998 99998532111 11 11111111110
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
..+...++.+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 316 --------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 316 --------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1122234478999999999999999999999999998874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=350.82 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=209.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.++|.+.+.||+|+||.||++...++..||+|++...... .+++.+|+.++++++||||+++++++.+....++|
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 4688999999999999999999988889999998764332 25688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 98 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 98 TEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp ECCCTTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred EeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccc
Confidence 99999999999997632 25899999999999999999999999 999999999999999999999999999866
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
............+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||... ....... .......
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~-----~~~~~~~---~~~~~~~--- 239 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-----TNSETAE---HIAQGLR--- 239 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHHH---HHHTTCC---
T ss_pred cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-----ChhHHHH---HHhcccC---
Confidence 5433333334457788999999999999999999999999999998 99998431 1111111 1111100
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
...+...++.+.+++.+||+.||++|||+.++++.|+++...
T Consensus 240 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 240 -------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 011122334789999999999999999999999999988754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=363.43 Aligned_cols=269 Identities=25% Similarity=0.355 Sum_probs=216.7
Q ss_pred HHhcCCCCCceeeecCcEEEEEEEec--------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEee
Q 012214 161 KATNHFNANRILGQGGQGTVYKGMLE--------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLG 231 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g 231 (468)
...++|.+.+.||+|+||.||+|... .+..||||++...... ...+.+.+|+.+++.+ +||||+++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE---KDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH---HHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 34578999999999999999999852 2467999998765443 4457789999999999 9999999999
Q ss_pred eeccCCcceeEeeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCC
Q 012214 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQN-----------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKS 300 (468)
Q Consensus 232 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp 300 (468)
++.+.+..++||||+++|+|.+++...... ....+++..++.++.||+.||.|||+.+ |+||||||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp 219 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAA 219 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCc
Confidence 999999999999999999999999875421 1235999999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 012214 301 TNILLDQRYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGN 378 (468)
Q Consensus 301 ~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~ 378 (468)
+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~-- 297 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-- 297 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--
Confidence 999999999999999999986654322 22334557889999999999999999999999999999999 99998431
Q ss_pred CccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCch
Q 012214 379 TSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKK 453 (468)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 453 (468)
.. ............. ..+...+..+.+++.+||+.||++|||+.|+++.|+.+......
T Consensus 298 ---~~----~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 298 ---PV----EELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp ---CH----HHHHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred ---CH----HHHHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 11 1111112111111 11223445789999999999999999999999999988765433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=348.80 Aligned_cols=260 Identities=26% Similarity=0.398 Sum_probs=198.6
Q ss_pred hcCCCCCceeeecCcEEEEEEEecC----CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLED----GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
.++|.+.+.||+|+||.||+|.... +..||+|+....... ...+.+.+|+.++++++||||+++++++. .+.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD---SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 4688999999999999999998642 557999998764333 44567899999999999999999999985 467
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccc
Confidence 899999999999999997632 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
++..............+|+.|+|||.+.+..++.++||||||+++|||++ |..||.... . ..... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~--~---~~~~~----~i~~~ 233 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--N---NDVIG----RIENG 233 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC--G---GGHHH----HHHTT
T ss_pred ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC--H---HHHHH----HHHcC
Confidence 98765444333344557889999999999999999999999999999997 899985311 1 11111 11111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
... ..+...++.+.+++.+||+.||++|||+.|+++.|+.+...+
T Consensus 234 ~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 234 ERL---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 100 112234557899999999999999999999999999987543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=356.88 Aligned_cols=268 Identities=25% Similarity=0.390 Sum_probs=214.6
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeee
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC 233 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~ 233 (468)
....++|.+.+.||+|+||.||++... +++.||||+++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---DMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH---HHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 334688999999999999999999974 3488999998764433 3456799999999999999999999999
Q ss_pred ccCCcceeEeeecCCCChhhHhhhcccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEE
Q 012214 234 LETEVPLLVYEFIPNGTLYQHLHDRHQN-------------------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIY 294 (468)
Q Consensus 234 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ii 294 (468)
.+....++||||+++|+|.+++...... ....+++..++.++.||+.||.|||+++ |+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 9999999999999999999999864211 1146999999999999999999999999 99
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCcccccCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCC
Q 012214 295 HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372 (468)
Q Consensus 295 H~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p 372 (468)
||||||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999986643322 22334568899999999999999999999999999999999 9999
Q ss_pred CCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 373 IFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
|... .. .............. .+...+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 277 ~~~~-----~~----~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 277 YYGM-----AH----EEVIYYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTTS-----CH----HHHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCC-----Ch----HHHHHHHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 8431 11 11111122221111 12234457899999999999999999999999999987654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=340.04 Aligned_cols=257 Identities=29% Similarity=0.451 Sum_probs=196.2
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
++|++.+.||+|+||.||++... ++.||||++............+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 67888999999999999999975 88999999876443332244567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC--------CCcEEEEe
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ--------RYRAKVAD 315 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~--------~~~~kl~D 315 (468)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+..+|+||||||+|||++. ++.+||+|
T Consensus 86 e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 86 EFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp ECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999853 25899999999999999999999988556899999999999986 77899999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
||+++....... ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... . .........
T Consensus 160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~---~~~~~~~~~ 228 (271)
T 3dtc_A 160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-----G---LAVAYGVAM 228 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC-----H---HHHHHHHHT
T ss_pred CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHhhhc
Confidence 999976543322 23468999999999999999999999999999999999999985311 0 011111111
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
.. .. ...+...++.+.+++.+||+.||++|||+.|+++.|+.|
T Consensus 229 ~~-~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 NK-LA--------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp SC-CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CC-CC--------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11 10 011223445789999999999999999999999999865
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=367.78 Aligned_cols=255 Identities=26% Similarity=0.408 Sum_probs=208.0
Q ss_pred HhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC-cce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE-VPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-~~~ 240 (468)
..++|.+.+.||+|+||.||+|... ++.||||+++... ..+.|.+|+.++++++||||+++++++.+.. ..+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 3467888999999999999999885 7899999987643 2357899999999999999999999987655 789
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 264 iv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 337 (450)
T ss_dssp EEEECCTTCBHHHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence 9999999999999998743 234799999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
..... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..... ....+.
T Consensus 338 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~~~~~----~i~~~~- 403 (450)
T 1k9a_A 338 EASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVP----RVEKGY- 403 (450)
T ss_dssp ECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-----TTHHH----HHHTTC-
T ss_pred ccccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH----HHHcCC-
Confidence 54321 122357889999999999999999999999999999998 9999853211 11111 111110
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
....+..++..+.+++.+||+.||++|||+.++++.|+.++...
T Consensus 404 --------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 404 --------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred --------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 11123345568999999999999999999999999999988654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=349.11 Aligned_cols=266 Identities=26% Similarity=0.392 Sum_probs=218.6
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
..++|.+.+.||+|+||.||+|... ++..||+|++..... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 4578899999999999999999976 488999999875432 3467889999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.
T Consensus 86 ~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEECCTTEEHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEcCCCCcHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccce
Confidence 999999999999999763 2245899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
..............+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.... ............
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~-----~~~~~~~~~~~~----- 229 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEKDY----- 229 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHHHHHTTC-----
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHhccC-----
Confidence 776555444555567889999999999999999999999999999999 888874311 111111111110
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCchhhh
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKRA 456 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~ 456 (468)
....+...++.+.+++.+||+.||.+|||+.++++.|+.+.......++
T Consensus 230 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~~~~ 278 (288)
T 3kfa_A 230 --------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 278 (288)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccccch
Confidence 0111223445789999999999999999999999999998876544433
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=362.88 Aligned_cols=265 Identities=24% Similarity=0.333 Sum_probs=211.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~ 236 (468)
.++|.+.+.||+|+||.||+|... +++.||||+++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE---QDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccCh---hhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 367889999999999999999843 4678999998754433 3445788999999999999999999999999
Q ss_pred CcceeEeeecCCCChhhHhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC---cE
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQN--EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY---RA 311 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~---~~ 311 (468)
...++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999999875422 2235899999999999999999999999 99999999999999554 59
Q ss_pred EEEecCCcccccCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHH
Q 012214 312 KVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAY 389 (468)
Q Consensus 312 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~ 389 (468)
||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||... ... .
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~-----~~~---~- 294 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-----SNQ---E- 294 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHH---H-
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----CHH---H-
Confidence 9999999986533221 22334567899999999999999999999999999999998 99998431 111 1
Q ss_pred HHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 390 FVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.......... ...+...+..+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus 295 ~~~~i~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 295 VLEFVTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHHHHcCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 1111111110 0112234457899999999999999999999999999887654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=345.28 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=211.3
Q ss_pred cccCHHHHHHHhcC----------CCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHh
Q 012214 152 KLFSSKELDKATNH----------FNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQ 220 (468)
Q Consensus 152 ~~~~~~ei~~~~~~----------f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~ 220 (468)
..++.+++..+++. |...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++.
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~ 98 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRD 98 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CSHHHHHHHHHHHTT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch----hHHHHHHHHHHHHHh
Confidence 45777888777654 666778999999999999976 799999999865432 234568899999999
Q ss_pred cCCCceeeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCC
Q 012214 221 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKS 300 (468)
Q Consensus 221 l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp 300 (468)
++||||+++++++......++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||
T Consensus 99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp 169 (321)
T 2c30_A 99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKS 169 (321)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCH
Confidence 9999999999999999999999999999999999864 24899999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCc
Q 012214 301 TNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTS 380 (468)
Q Consensus 301 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~ 380 (468)
+|||++.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~---- 244 (321)
T 2c30_A 170 DSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD---- 244 (321)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----
T ss_pred HHEEECCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----
Confidence 9999999999999999999876543222 23457999999999999999999999999999999999999998531
Q ss_pred cchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 381 QENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
... ... ............ .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 245 -~~~---~~~-~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 245 -SPV---QAM-KRLRDSPPPKLK-------NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp -CHH---HHH-HHHHHSSCCCCT-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -CHH---HHH-HHHhcCCCCCcC-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 111 111111111110 012334578999999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=355.53 Aligned_cols=258 Identities=23% Similarity=0.425 Sum_probs=200.7
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCc----EEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGR----IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
++|++.+.||+|+||+||+|.+. +++ .||+|.+...... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP---KANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 67889999999999999999954 344 3688877543222 34567999999999999999999999998754
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++|+||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred eEEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcc
Confidence 789999999999999997632 25899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 319 SKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 319 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
++........ ......+|..|+|||.+.+..++.++|||||||++|||++ |+.||.... . ..... ....
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~---~~~~~----~~~~ 234 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--A---SEISS----ILEK 234 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--G---GGHHH----HHHT
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC--H---HHHHH----HHHc
Confidence 9876544332 2333457889999999999999999999999999999999 999985311 1 11111 1111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
.. ....+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 235 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 235 GE---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TC---------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CC---------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 10 0111223445789999999999999999999999999887643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=370.90 Aligned_cols=262 Identities=26% Similarity=0.373 Sum_probs=207.5
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
+...++|.+.+.||+|+||.||+|...++..||||+++..... .++|.+|+.++++++||||+++++++.+ ...
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC-----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 3445778899999999999999999988888999998764322 3578999999999999999999999976 678
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred EEEehhhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccc
Confidence 999999999999999975321 24899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
+..............+|..|+|||.+.++.++.++||||||+++|||++ |+.||... .. ............
T Consensus 328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-----~~---~~~~~~i~~~~~ 399 (452)
T 1fmk_A 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VN---REVLDQVERGYR 399 (452)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CH---HHHHHHHHTTCC
T ss_pred eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC-----CH---HHHHHHHHcCCC
Confidence 8765443333334457889999999999999999999999999999999 89998431 11 111111111111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
...+..+++.+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 400 ----------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 400 ----------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 1112345568999999999999999999999999999987654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=338.70 Aligned_cols=257 Identities=27% Similarity=0.391 Sum_probs=210.9
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
++|.+.+.||+|+||.||++...+++.||+|++...... .+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 678889999999999999999888899999998764332 256889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 83 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp CCCTTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred eCCCCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccc
Confidence 9999999999997632 25899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...........+|..|+|||.+.+..++.++||||||+++|+|++ |+.||... .. ............
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~---~~~~~~i~~~~~---- 223 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SN---SEVVEDISTGFR---- 223 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CH---HHHHHHHHTTCC----
T ss_pred cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC-----CH---HHHHHHHhcCCc----
Confidence 332222333457788999999998899999999999999999999 89887431 11 111111111100
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
...+...+..+.+++.+||+.||++|||+.++++.|+++..+
T Consensus 224 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 224 ------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 011222345789999999999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=344.74 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=202.2
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.++|++.+.||+|+||+||++...+|+.||+|++....... .....+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE--GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccc--hhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 47899999999999999999999889999999987543221 2346788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||++ ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 ~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 98 FEFME-KDLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp EECCS-EEHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred EcCCC-CCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceec
Confidence 99997 48888886532 35899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc---
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR--- 398 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 398 (468)
..... ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ..............
T Consensus 170 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~ 243 (311)
T 3niz_A 170 GIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD-----DQLPKIFSILGTPNPRE 243 (311)
T ss_dssp TSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT-----THHHHHHHHHCCCCTTT
T ss_pred CCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHHCCCChHH
Confidence 43322 2333568999999999876 56899999999999999999999998542211 11111111111111
Q ss_pred cchhcc-------------hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHDILD-------------DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~~~d-------------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+....+ ...........+.++.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 00000111223457889999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=336.24 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=206.3
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC--Cccee
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EVPLL 241 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~l 241 (468)
++|.+.+.||+|+||.||+|... ++.||+|++....... ...+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWST--RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCH--HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCH--HHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 67889999999999999999985 8899999987643332 3456799999999999999999999999876 77899
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ ++++||||||+||+++.++.++|+|||++..
T Consensus 87 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EEECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred eecccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999999999999763 2235899999999999999999999876 4599999999999999999999999998754
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCC---cccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD---KSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
... ....+|+.|+|||.+.+...+. ++||||||+++|||++|+.||... .. ............
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~---~~~~~~~~~~~~ 228 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL-----SN---MEIGMKVALEGL 228 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS-----CH---HHHHHHHHHSCC
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc-----Ch---HHHHHHHHhcCC
Confidence 322 2345899999999998765554 799999999999999999998431 11 111111111111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
.. ..+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 229 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 229 RP---------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11 1122344578999999999999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=343.97 Aligned_cols=268 Identities=27% Similarity=0.400 Sum_probs=214.8
Q ss_pred HHhcCCCCCceeeecCcEEEEEEEe------cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeee
Q 012214 161 KATNHFNANRILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCC 233 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~ 233 (468)
...++|.+.+.||+|+||.||++.. .+++.||+|++...... ...+.+.+|+.+++++ +||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL---TEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH---HHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 3457899999999999999999984 34678999998765433 3456789999999999 999999999999
Q ss_pred ccCCcceeEeeecCCCChhhHhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCC
Q 012214 234 LETEVPLLVYEFIPNGTLYQHLHDRHQN-------------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKS 300 (468)
Q Consensus 234 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp 300 (468)
.+.+..++||||+++|+|.+++...... ...++++..++.++.||+.||.|||+.+ |+||||||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp 173 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCcc
Confidence 9999999999999999999999874321 1235899999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 012214 301 TNILLDQRYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGN 378 (468)
Q Consensus 301 ~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~ 378 (468)
+||+++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 99999999999999999998765443322 334457889999999999999999999999999999999 9999853211
Q ss_pred CccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 379 TSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
. ............ ...+...+..+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 254 ~----~~~~~~~~~~~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 254 D----SKFYKMIKEGFR-------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp S----HHHHHHHHHTCC-------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred h----hHHHHHhccCCC-------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1 111111111100 1112234457899999999999999999999999999876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=355.53 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=200.6
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 240 (468)
.++|.+.+.||+|+||.||+++.+ +++.||+|+++...... ....+.+.+|..++.++ +||||+++++++.+....+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~-~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC-HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 467999999999999999999965 58899999987543221 13345678899999887 8999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||+++|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 130 lV~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEcCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceee
Confidence 9999999999999997643 4899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........................+
T Consensus 202 ~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~- 279 (396)
T 4dc2_A 202 EGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 279 (396)
T ss_dssp CCCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-
T ss_pred ecccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-
Confidence 533222 223456799999999999999999999999999999999999999964322221111111111121111111
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTM 437 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 437 (468)
..+...+..+.+|+.+||+.||++||++
T Consensus 280 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 ---------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ---------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1122344578999999999999999996
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=348.56 Aligned_cols=269 Identities=24% Similarity=0.361 Sum_probs=211.1
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEe------cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeee
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGC 232 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~ 232 (468)
+...++|.+.+.||+|+||.||+|.. .++..||+|++...... ...+.+.+|+.+++++ +||||++++++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS---SEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH---HHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34567899999999999999999996 24568999998754322 3446789999999999 89999999999
Q ss_pred eccCCcceeEeeecCCCChhhHhhhcccC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEE
Q 012214 233 CLETEVPLLVYEFIPNGTLYQHLHDRHQN------------------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIY 294 (468)
Q Consensus 233 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ii 294 (468)
+.+.+..++||||+++|+|.+++...... ....+++..++.++.||+.||.|||+.+ |+
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv 194 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CV 194 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 99999999999999999999999764321 0124899999999999999999999999 99
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCC
Q 012214 295 HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372 (468)
Q Consensus 295 H~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p 372 (468)
||||||+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999999876544332 2334557889999999999999999999999999999998 9999
Q ss_pred CCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 373 IFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
|...... . .+......... ...+...++.+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 275 ~~~~~~~----~----~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 275 YPGIPVD----A----NFYKLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp STTCCCS----H----HHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cccCCcH----H----HHHHHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 8532111 1 11111111110 0112233457899999999999999999999999999987654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=347.45 Aligned_cols=275 Identities=26% Similarity=0.395 Sum_probs=197.2
Q ss_pred HhcCCCCCceeeecCcEEEEEEEecC-C---cEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLED-G---RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 237 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 237 (468)
..++|.+.+.||+|+||.||+|.... + ..||||++....... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS--SDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C--HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH--HHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 34789999999999999999999653 3 279999987542221 34578999999999999999999999998766
Q ss_pred cc------eeEeeecCCCChhhHhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc
Q 012214 238 VP------LLVYEFIPNGTLYQHLHDRHQN-EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR 310 (468)
Q Consensus 238 ~~------~lV~E~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~ 310 (468)
.. ++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 55 8999999999999999764322 2235899999999999999999999999 999999999999999999
Q ss_pred EEEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHH
Q 012214 311 AKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 311 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~ 388 (468)
+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.... ......
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-----~~~~~~ 250 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-----NAEIYN 250 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHH
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC-----hHHHHH
Confidence 999999999866443322 2233457789999999999999999999999999999999 899885311 111111
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCchhhhHHH
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKRAMFS 459 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~ 459 (468)
........ ..+...+..+.+++.+||+.||++|||+.++++.|+++...........+
T Consensus 251 ---~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 251 ---YLIGGNRL----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp ---HHHTTCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred ---HHhcCCCC----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 11111111 11223445789999999999999999999999999999887765554433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=342.15 Aligned_cols=275 Identities=23% Similarity=0.324 Sum_probs=211.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC--cce
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE--VPL 240 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--~~~ 240 (468)
++|.+.+.||+|+||.||+|... +++.||||++...... ...+.+.+|+.++++++||||+++++++.+.. ..+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 67899999999999999999975 5899999998753322 23466789999999999999999999987655 679
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE----cCCCcEEEEec
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL----DQRYRAKVADF 316 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl----~~~~~~kl~Df 316 (468)
+||||+++++|.+++...... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+||
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred EEEeCCCCCCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccC
Confidence 999999999999999874322 24899999999999999999999999 9999999999999 88889999999
Q ss_pred CCcccccCCCceeeecccccCCccCccccc--------cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ--------SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~ 388 (468)
|+++....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||......... .....
T Consensus 161 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~ 237 (319)
T 4euu_A 161 GAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-KEVMY 237 (319)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC-HHHHH
T ss_pred CCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh-HHHHH
Confidence 99987654332 23356899999999886 578899999999999999999999998542221111 11111
Q ss_pred HHHHHhhccccchhcc-----------hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 389 YFVHSMRKNRLHDILD-----------DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d-----------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
..........+..+.. ...........+..+.+++.+||+.||++|||+.|+++.......
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 1111111110000000 001112345677789999999999999999999999998876543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=347.10 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=201.9
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||.||++... +++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc---chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 67899999999999999999965 7899999998654322 2335688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 84 LEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp EECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeecccee
Confidence 9999999999999653 24899999999999999999999999 999999999999999999999999999866
Q ss_pred cCCCc-eeeecccccCCccCccccccCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 323 AMDQT-HVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 323 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ .+..........
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~~~ 228 (323)
T 3tki_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EYSDWKEKKTYL 228 (323)
T ss_dssp EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-------HHHHHHTTCTTS
T ss_pred ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-------HHHHHhcccccC
Confidence 43322 22334579999999999988765 7789999999999999999999854221111 111111111100
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 229 ---------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 ---------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0012334578899999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=347.16 Aligned_cols=278 Identities=26% Similarity=0.384 Sum_probs=221.0
Q ss_pred cccCHHHHHHHhcCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCc
Q 012214 152 KLFSSKELDKATNHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225 (468)
Q Consensus 152 ~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n 225 (468)
..+..++.+...++|.+.+.||+|+||.||+|... .++.||+|.+...... .....+.+|+.+++.++|||
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~ 89 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM---RERIEFLNEASVMKEFNCHH 89 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH---HHHHHHHHHHHHGGGCCCTT
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH---HHHHHHHHHHHHHHhcCCCC
Confidence 34555566677789999999999999999999854 3678999998764433 34467899999999999999
Q ss_pred eeeEeeeeccCCcceeEeeecCCCChhhHhhhccc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCC
Q 012214 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQ-----NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKS 300 (468)
Q Consensus 226 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp 300 (468)
|+++++++.+....++||||+++|+|.+++..... ....++++..++.++.||+.||.|||+.+ |+||||||
T Consensus 90 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp 166 (322)
T 1p4o_A 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAA 166 (322)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSG
T ss_pred EeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCcc
Confidence 99999999999999999999999999999976321 11235799999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 012214 301 TNILLDQRYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGN 378 (468)
Q Consensus 301 ~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~ 378 (468)
+||+++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 167 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-- 244 (322)
T 1p4o_A 167 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-- 244 (322)
T ss_dssp GGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--
T ss_pred ceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC--
Confidence 99999999999999999998664433222 223456889999999999999999999999999999999 88887431
Q ss_pred CccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCch
Q 012214 379 TSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKK 453 (468)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 453 (468)
.. .. ............ .+...+..+.+++.+||+.||++|||+.|+++.|+.+.....+
T Consensus 245 ---~~---~~-~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~ 303 (322)
T 1p4o_A 245 ---SN---EQ-VLRFVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 303 (322)
T ss_dssp ---CH---HH-HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred ---CH---HH-HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCc
Confidence 11 11 111111111111 1223445789999999999999999999999999998765443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=346.08 Aligned_cols=251 Identities=25% Similarity=0.317 Sum_probs=204.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||++... +|+.||+|++...... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 367889999999999999999965 6899999998653211 11235678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++|+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 v~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp EEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhh
Confidence 999999999999997632 4899999999999999999999999 99999999999999999999999999985
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... .. ......... ...
T Consensus 155 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~---~~~~~~i~~-~~~-- 222 (337)
T 1o6l_A 155 GISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DH---ERLFELILM-EEI-- 222 (337)
T ss_dssp SCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SH---HHHHHHHHH-CCC--
T ss_pred cccCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC-----CH---HHHHHHHHc-CCC--
Confidence 432222 233457999999999999999999999999999999999999998531 11 111111111 111
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
..+...+..+.+++.+||+.||++|| ++.|+++
T Consensus 223 --------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 --------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 01223345789999999999999999 8988875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=345.75 Aligned_cols=260 Identities=24% Similarity=0.396 Sum_probs=211.0
Q ss_pred HhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
..++|.+.+.||+|+||.||+|...++..||+|++...... .+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc-----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 44788999999999999999999888889999998754322 3568899999999999999999999864 56899
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++..
T Consensus 85 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EEECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 9999999999999975321 25899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||... ... ... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~---~~~-~~~~~~~~- 228 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNP---EVI-QNLERGYR- 228 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHH---HHH-HHHHTTCC-
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc-----CHH---HHH-HHHhcccC-
Confidence 65544333344557889999999998899999999999999999999 89887431 111 111 11111100
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
...+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 229 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 229 --------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 0112234457899999999999999999999999999886543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=344.66 Aligned_cols=272 Identities=23% Similarity=0.324 Sum_probs=205.8
Q ss_pred HHHHHHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc--CCCceeeEeeee
Q 012214 156 SKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI--NHRNVVKLLGCC 233 (468)
Q Consensus 156 ~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l--~h~niv~l~g~~ 233 (468)
...-....++|++.+.||+|+||.||+|... ++.||||++.... ...+..|.+++... +||||+++++++
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~ 100 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-------EASWFRETEIYQTVLMRHENILGFIAAD 100 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc-------cchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence 3444455688999999999999999999885 8999999986421 12344555555554 899999999999
Q ss_pred ccC----CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCEEecCCCCC
Q 012214 234 LET----EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA--------TSSPIYHRDIKST 301 (468)
Q Consensus 234 ~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~--------~~~~iiH~DLkp~ 301 (468)
.+. ...++||||+++|+|.+++... .+++..++.++.|++.||.|||+. + |+||||||+
T Consensus 101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~ 171 (337)
T 3mdy_A 101 IKGTGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSK 171 (337)
T ss_dssp EESCGGGCEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGG
T ss_pred ccCCCCCCceEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchH
Confidence 876 6789999999999999999652 489999999999999999999998 7 999999999
Q ss_pred CEEEcCCCcEEEEecCCcccccCCCcee---eecccccCCccCccccccCCCCCc------ccHHHHHHHHHHHHhC---
Q 012214 302 NILLDQRYRAKVADFGTSKFIAMDQTHV---TTKIQGTFGYLDPEYHQSSQLTDK------SDVYSFGVVLVELLTG--- 369 (468)
Q Consensus 302 NILl~~~~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~k------sDVwSlGvll~el~tG--- 369 (468)
|||++.++.+||+|||+++......... .....||+.|+|||.+.+...+.+ +|||||||++|||++|
T Consensus 172 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~ 251 (337)
T 3mdy_A 172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251 (337)
T ss_dssp GEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred HEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCc
Confidence 9999999999999999997664433221 124569999999999988766665 9999999999999999
Q ss_pred -------CCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 370 -------KKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 370 -------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+.||........ .................... ......++..+.+++.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (337)
T 3mdy_A 252 GGIVEEYQLPYHDLVPSDP----SYEDMREIVCIKKLRPSFPN---RWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324 (337)
T ss_dssp TTBCCCCCCTTTTTSCSSC----CHHHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccccccccHhhhcCCCC----chhhhHHHHhhhccCccccc---cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence 555532111111 11111121211111111111 1112366778999999999999999999999999
Q ss_pred HHHhcccCC
Q 012214 443 ELNGIRGSS 451 (468)
Q Consensus 443 ~L~~i~~~~ 451 (468)
.|+.+..+.
T Consensus 325 ~L~~l~~~~ 333 (337)
T 3mdy_A 325 TLAKMSESQ 333 (337)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHhhc
Confidence 999988765
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=342.14 Aligned_cols=260 Identities=28% Similarity=0.434 Sum_probs=206.2
Q ss_pred hcCCCCCceeeecCcEEEEEEEecC----CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLED----GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
.++|.+.+.||+|+||.||+|...+ +..||+|.+...... ...+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL---DNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH---HHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc---hHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 4778999999999999999998543 346999998765333 345779999999999999999999999865 45
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred CEEEEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCC
Confidence 689999999999999997632 25899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
+...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ........... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~-----~~~~~~~~~~~-~~~ 233 (281)
T 3cc6_A 160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-----NKDVIGVLEKG-DRL 233 (281)
T ss_dssp GGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----GGGHHHHHHHT-CCC
T ss_pred CcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC-----hHHHHHHHhcC-CCC
Confidence 98765544333444567889999999998999999999999999999998 999985321 11111111111 001
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
. .+...++.+.+++.+||+.||++|||+.|+++.|+.+.+.+
T Consensus 234 ~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 234 P------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp C------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 1 11223457899999999999999999999999999987644
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=343.55 Aligned_cols=266 Identities=25% Similarity=0.366 Sum_probs=207.0
Q ss_pred cCCCCCceeeecCcEEEEEEEe-----cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC--
Q 012214 164 NHFNANRILGQGGQGTVYKGML-----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET-- 236 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-- 236 (468)
++|++.+.||+|+||.||++.+ .+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG---NHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc---hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 5688899999999999999983 36899999998754322 3346788999999999999999999999876
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Df 170 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDF 170 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred ceEEEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcc
Confidence 66799999999999999996532 25899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCce--eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC------CccchhchHH
Q 012214 317 GTSKFIAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGN------TSQENVSLAA 388 (468)
Q Consensus 317 Gla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~------~~~~~~~~~~ 388 (468)
|++......... ......+|..|+|||.+.+..++.++||||||+++|+|++|..|+..... ..........
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 999876554332 23345688889999999999999999999999999999999998632000 0000000001
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
.......... ....+...++.+.+++.+||+.||++|||+.+++++|+.+.
T Consensus 251 ~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 251 RLVNTLKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111111100 11122344568999999999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=339.50 Aligned_cols=264 Identities=17% Similarity=0.208 Sum_probs=210.7
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 240 (468)
.++|.+.+.||+|+||.||+|.. .+++.||+|++...... +.+.+|+.++..+ +|+|++++++++.+....+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc------HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 46799999999999999999995 57899999988653222 3577899999999 8999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc-----EEEEe
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR-----AKVAD 315 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~-----~kl~D 315 (468)
+||||+ +++|.+++.... .++++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 83 lv~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~D 154 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVD 154 (298)
T ss_dssp EEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred EEEEec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence 999999 999999997632 25899999999999999999999999 999999999999987776 99999
Q ss_pred cCCcccccCCCce------eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHH
Q 012214 316 FGTSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAY 389 (468)
Q Consensus 316 fGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~ 389 (468)
||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~ 232 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--KQKYER 232 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--HHHHHH
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc--HHHHHH
Confidence 9999876543321 23345699999999999999999999999999999999999999864221111 111111
Q ss_pred HHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 390 FVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
............ .....++.+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 233 ~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 233 IGEKKQSTPLRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHHHHHHSCHHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHhhccCccHHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 111111111110 01234558999999999999999999999999999886543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=347.19 Aligned_cols=252 Identities=24% Similarity=0.371 Sum_probs=199.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 237 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~---- 237 (468)
.++|++.+.||+|+||.||+|... +|+.||||++...... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE---LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT---THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 467889999999999999999976 7899999998754332 34467899999999999999999999986543
Q ss_pred -----------------------------------------------------cceeEeeecCCCChhhHhhhcccCCCC
Q 012214 238 -----------------------------------------------------VPLLVYEFIPNGTLYQHLHDRHQNEEF 264 (468)
Q Consensus 238 -----------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~ 264 (468)
..++||||+++++|.+++..... ..
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~ 159 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LE 159 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GG
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--cc
Confidence 27899999999999999987432 23
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc-----------eeeecc
Q 012214 265 PLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT-----------HVTTKI 333 (468)
Q Consensus 265 ~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~ 333 (468)
..++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ......
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred chhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence 4677789999999999999999999 99999999999999999999999999987654321 112335
Q ss_pred cccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchH
Q 012214 334 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVK 413 (468)
Q Consensus 334 ~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 413 (468)
.||+.|+|||.+.+..++.++|||||||++|||++|..|+. ... ............. ...
T Consensus 237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-------~~~----~~~~~~~~~~~~~---------~~~ 296 (332)
T 3qd2_B 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-------ERV----RIITDVRNLKFPL---------LFT 296 (332)
T ss_dssp C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-------HHH----HHHHHHHTTCCCH---------HHH
T ss_pred CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-------HHH----HHHHHhhccCCCc---------ccc
Confidence 69999999999999999999999999999999999877641 110 1111111111111 122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 414 NQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 414 ~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...+.+.+++.+||+.||++|||+.|+++
T Consensus 297 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 297 QKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred cCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 34456789999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=360.67 Aligned_cols=265 Identities=22% Similarity=0.270 Sum_probs=209.2
Q ss_pred HHHHHHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeec
Q 012214 156 SKELDKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL 234 (468)
Q Consensus 156 ~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~ 234 (468)
..++....++|.+.++||+|+||+||+++.. +++.||+|++...... .......+.+|..++..++||||+++++++.
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-HTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh-hHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 3445556789999999999999999999976 4789999998642111 1112234889999999999999999999999
Q ss_pred cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 235 ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 235 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
+....++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEc
Confidence 9999999999999999999997521 35999999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeecccccCCccCccccc-----cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHH
Q 012214 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAY 389 (468)
Q Consensus 315 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~ 389 (468)
|||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||... ........
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~-----~~~~~~~~ 292 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETYGK 292 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHH
T ss_pred chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC-----ChhHHHHh
Confidence 99999877655555555568999999999987 567899999999999999999999998531 11111111
Q ss_pred HHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 012214 390 FVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKK--RPTMEEVSM 442 (468)
Q Consensus 390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~ 442 (468)
..........+.. ....++.+.+|+.+||+.+|++ ||++.|+++
T Consensus 293 i~~~~~~~~~p~~---------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 293 IMNHKERFQFPTQ---------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHTHHHHCCCCSS---------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhhccccccCCcc---------cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1111011111110 0123457889999999888887 999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=349.92 Aligned_cols=266 Identities=24% Similarity=0.369 Sum_probs=213.2
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec--------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeee
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE--------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGC 232 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~ 232 (468)
..++|.+.+.||+|+||.||+|... +++.||+|++...... ...+.+.+|+.+++.+ +||||++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH---HHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 3578999999999999999999863 4678999998765433 4457789999999999 89999999999
Q ss_pred eccCCcceeEeeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCC
Q 012214 233 CLETEVPLLVYEFIPNGTLYQHLHDRHQN-----------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKST 301 (468)
Q Consensus 233 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~ 301 (468)
+.+.+..++||||+++|+|.+++...... ....+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 186 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccc
Confidence 99999999999999999999999864321 1234899999999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC
Q 012214 302 NILLDQRYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNT 379 (468)
Q Consensus 302 NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~ 379 (468)
|||++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--- 263 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--- 263 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC---
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC---
Confidence 9999999999999999998765433322 333457889999999999899999999999999999999 99998431
Q ss_pred ccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 380 SQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.. .. ........... ..+...+..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 264 --~~---~~-~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 264 --PV---EE-LFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp --CH---HH-HHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CH---HH-HHHHHhcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11 11 11111111110 112234457899999999999999999999999999987543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=347.73 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=201.2
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCccee
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 241 (468)
++|.+.+.||+|+||.||+++.. +++.||+|++....... ....+.+.+|..++.++ +||||+++++++.+....++
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc-hHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 67889999999999999999975 58999999987543221 13456788999999988 89999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 v~e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccc
Confidence 999999999999997632 4899999999999999999999999 99999999999999999999999999975
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+......................
T Consensus 160 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 236 (345)
T 3a8x_A 160 GLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 236 (345)
T ss_dssp SCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--
T ss_pred ccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--
Confidence 43222 223445799999999999999999999999999999999999999964322211111111111111111111
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTM 437 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 437 (468)
..+...+..+.+|+.+||+.||.+||++
T Consensus 237 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 --------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 0122344578999999999999999996
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=343.87 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=204.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+....++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 467899999999999999999965 58899999887532 223568899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC--CCcEEEEecCCc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ--RYRAKVADFGTS 319 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~--~~~~kl~DfGla 319 (468)
||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 79 v~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a 151 (321)
T 1tki_A 79 IFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EECCCCCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEeCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence 99999999999999652 235899999999999999999999999 999999999999987 789999999999
Q ss_pred ccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
+....... .....||+.|+|||.+.+..++.++|||||||++|+|++|..||... ... ........ ...
T Consensus 152 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~---~~~~~i~~-~~~ 220 (321)
T 1tki_A 152 RQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-----TNQ---QIIENIMN-AEY 220 (321)
T ss_dssp EECCTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS-----SHH---HHHHHHHH-TCC
T ss_pred eECCCCCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC-----CHH---HHHHHHHc-CCC
Confidence 87654332 33456899999999999988999999999999999999999998531 111 11111111 111
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. .+.. .....+..+.+++.+||+.||.+|||+.|+++
T Consensus 221 ~--~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 221 T--FDEE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp C--CCHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--CChh----hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0000 01233457899999999999999999999987
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=349.15 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=205.6
Q ss_pred HHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 161 KATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
...++|.+.+.||+|+||.||++... +++.||+|++....... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 103 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 103 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 34578999999999999999999965 68999999986543322 3456789999999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC---CcEEEEec
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR---YRAKVADF 316 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~---~~~kl~Df 316 (468)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+||
T Consensus 104 ~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Df 175 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADF 175 (362)
T ss_dssp EEEECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeec
Confidence 9999999999999998653 25899999999999999999999999 9999999999999865 45999999
Q ss_pred CCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||... ...... .....
T Consensus 176 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~-----~~~~~~----~~i~~ 244 (362)
T 2bdw_A 176 GLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-----DQHRLY----AQIKA 244 (362)
T ss_dssp TTCBCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHH----HHHHH
T ss_pred CcceEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC-----CHHHHH----HHHHh
Confidence 99986653322 23457999999999999999999999999999999999999998531 111111 11111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
.... ... ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 245 ~~~~-~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 245 GAYD-YPS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TCCC-CCT-----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCC-CCc-----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1110 000 0012334578999999999999999999999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=353.38 Aligned_cols=272 Identities=17% Similarity=0.206 Sum_probs=206.3
Q ss_pred HhcCCCCCceeeecCcEEEEEEEecC------CcEEEEEecccccchHH--HH-----HHHHHHHHHHHHHhcCCCceee
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLED------GRIIAVKKSKLTVDDEE--LL-----KLEEFINEIVILSQINHRNVVK 228 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~~~--~~-----~~~~~~~Ei~~l~~l~h~niv~ 228 (468)
..++|.+.+.||+|+||.||+|.+.. ++.||||++........ .. ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998754 47899999865432110 00 1123455667778889999999
Q ss_pred EeeeeccC----CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEE
Q 012214 229 LLGCCLET----EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNIL 304 (468)
Q Consensus 229 l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NIL 304 (468)
+++++... ...++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nil 184 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLL 184 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEE
Confidence 99998764 4579999999 999999997632 35999999999999999999999999 999999999999
Q ss_pred Ec--CCCcEEEEecCCcccccCCCcee------eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 012214 305 LD--QRYRAKVADFGTSKFIAMDQTHV------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWA 376 (468)
Q Consensus 305 l~--~~~~~kl~DfGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~ 376 (468)
++ .++.+||+|||+++.+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99 88999999999998765432211 13345999999999999999999999999999999999999998531
Q ss_pred CCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 377 GNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
.... ........ .....+..+++..+. ....+..+.+++..||+.||++|||+.++++.|+.+..
T Consensus 265 ~~~~----~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 265 LKDP----KYVRDSKI-RYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp TTCH----HHHHHHHH-HHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCH----HHHHHHHH-HhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 1111 11111111 111222333332211 12345689999999999999999999999999988764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=356.20 Aligned_cols=255 Identities=22% Similarity=0.289 Sum_probs=204.6
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
..++|.+.+.||+|+||.||++... +|+.+|+|++....... ...+.+.+|+.+++.++||||+++++++.+....+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA--RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH--HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 4577999999999999999999864 68999999987644332 34567899999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc---CCCcEEEEecC
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD---QRYRAKVADFG 317 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~---~~~~~kl~DfG 317 (468)
+||||+++|+|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||
T Consensus 87 lv~E~~~gg~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp EEECCCBCCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEEEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 9999999999999997632 4899999999999999999999999 99999999999998 56889999999
Q ss_pred CcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 318 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 318 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||... ...... ......
T Consensus 159 ~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~-----~~~~~~----~~i~~~ 228 (444)
T 3soa_A 159 LAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE-----DQHRLY----QQIKAG 228 (444)
T ss_dssp SCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHH----HHHHHT
T ss_pred eeEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc-----cHHHHH----HHHHhC
Confidence 9986654332 223457999999999999999999999999999999999999998431 111111 111111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
... ... ......++.+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~-~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 229 AYD-FPS-----PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCC-CCT-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC-CCc-----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 110 000 001223457899999999999999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=338.87 Aligned_cols=262 Identities=27% Similarity=0.448 Sum_probs=197.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.++|.+.+.||+|+||.||+|... ..||+|+++...... ...+.+.+|+.++++++||||+++++++ .....++|
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP--QQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCH--HHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 478999999999999999999864 359999987654332 4567899999999999999999999976 45568999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccc
Confidence 99999999999996532 35899999999999999999999999 999999999999999999999999999765
Q ss_pred cCCC-ceeeecccccCCccCccccc---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 323 AMDQ-THVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 323 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
.... ........||+.|+|||.+. +..++.++||||||+++|+|++|+.||.... ... ..........
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~----~~~~~~~~~~ 242 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----NRD----QIIEMVGRGS 242 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC----CHH----HHHHHHHHTS
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc----hHH----HHHHHhcccc
Confidence 4322 22233456899999999986 5678889999999999999999999985321 111 1111111111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
..... ......++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 243 ~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 243 LSPDL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCCT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCcch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11100 00112344579999999999999999999999999998864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=348.25 Aligned_cols=270 Identities=27% Similarity=0.377 Sum_probs=207.8
Q ss_pred CCCCceeeecCcEEEEEEEec-----CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC--Cc
Q 012214 166 FNANRILGQGGQGTVYKGMLE-----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET--EV 238 (468)
Q Consensus 166 f~~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~ 238 (468)
|++.+.||+|+||+||++.+. +++.||||++...... ...+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP---QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh---HHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 488999999999999988642 5889999998765433 4456789999999999999999999999874 56
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++||||+++++|.+++... .+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EEEEEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccc
Confidence 78999999999999999652 3899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCce--eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 319 SKFIAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 319 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
+......... ......+|..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...............
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~ 257 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT---KFLELIGIAQGQMTV 257 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH---HHHHHHCSCCHHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccch---hhhhhhcccccchhH
Confidence 9877544332 23345578889999999999999999999999999999999999843100 000000000000000
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
..+.+.+........+...+..+.+|+.+||+.||++|||+.|+++.|+.+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 000111111111122334556899999999999999999999999999988643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=342.96 Aligned_cols=247 Identities=25% Similarity=0.270 Sum_probs=195.2
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 240 (468)
.++|++.++||+|+||+||+|... +++.||||++....... .....+..|+..+..+ +||||+++++++.+....+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP--KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh--HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 367999999999999999999976 79999999876543332 2334555666665555 9999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||+ +++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 134 lv~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLV 205 (311)
T ss_dssp EEEECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred EEEecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeee
Confidence 999999 679999887643 25999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
...... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.. .. ...........
T Consensus 206 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~-----~~-------~~~~~~~~~~~ 270 (311)
T 3p1a_A 206 ELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG-----GE-------GWQQLRQGYLP 270 (311)
T ss_dssp ECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS-----HH-------HHHHHTTTCCC
T ss_pred ecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC-----cc-------HHHHHhccCCC
Confidence 654332 2334569999999998876 789999999999999999999777532 10 01111111111
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.. .+...++.+.+++.+||+.||++|||+.|+++
T Consensus 271 ----~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 ----PE----FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ----HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----cc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11 12234557999999999999999999999985
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=348.71 Aligned_cols=255 Identities=24% Similarity=0.320 Sum_probs=204.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHH--HHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEE--LLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
.++|.+.+.||+|+||.||++... +|+.||+|++........ ....+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999965 689999998865432210 01235788999999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC----cEEEEe
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY----RAKVAD 315 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~----~~kl~D 315 (468)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999652 25999999999999999999999999 99999999999998877 799999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||... .. ...+.....
T Consensus 163 FG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~-----~~---~~~~~~i~~ 232 (361)
T 2yab_A 163 FGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TK---QETLANITA 232 (361)
T ss_dssp CSSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-----SH---HHHHHHHHT
T ss_pred cCCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-----CH---HHHHHHHHh
Confidence 999987654322 23456999999999999999999999999999999999999998531 11 111111111
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.... .+... ....++.+.+|+.+||+.||++|||+.|+++
T Consensus 233 -~~~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 233 -VSYD--FDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -TCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -cCCC--CCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1100 01111 1233457899999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=344.24 Aligned_cols=261 Identities=16% Similarity=0.212 Sum_probs=207.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 240 (468)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... +.+.+|+.+++.+ +||||+++++++.+....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 46789999999999999999995 57899999988654322 3577899999999 9999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc-----EEEEe
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR-----AKVAD 315 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~-----~kl~D 315 (468)
+||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 82 lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~D 153 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIID 153 (330)
T ss_dssp EEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECC
T ss_pred EEEEeC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEE
Confidence 999999 99999999763 236999999999999999999999999 999999999999999887 99999
Q ss_pred cCCcccccCCCcee------eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHH
Q 012214 316 FGTSKFIAMDQTHV------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAY 389 (468)
Q Consensus 316 fGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~ 389 (468)
||+++......... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .......
T Consensus 154 Fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~~~~ 231 (330)
T 2izr_A 154 FALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKERYQK 231 (330)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHHHHH
T ss_pred cccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHHHHH
Confidence 99998765433221 234679999999999999999999999999999999999999986421111 1111111
Q ss_pred HHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 390 FVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
.......... ..+ ....+ .+.+++.+||+.||.+||++.+|.+.|+.+..
T Consensus 232 i~~~~~~~~~-----~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 232 IGDTKRATPI-----EVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HHHHHHHSCH-----HHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHhhhccCCH-----HHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 1110000000 000 11123 79999999999999999999999999987654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=350.54 Aligned_cols=278 Identities=19% Similarity=0.240 Sum_probs=206.7
Q ss_pred hcCCCCCceeeec--CcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 163 TNHFNANRILGQG--GQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G--~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
.++|++.+.||+| +||.||++... +++.||||++....... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN--EMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh--HHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 4789999999999 99999999976 68999999987643332 4456788999999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEEEEccCCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccc
Confidence 99999999999999997632 235899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCce------eeecccccCCccCcccccc--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHH
Q 012214 320 KFIAMDQTH------VTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391 (468)
Q Consensus 320 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (468)
......... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..................
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 654322111 1122468899999999987 67999999999999999999999998542221111000000000
Q ss_pred HHhhcc------------------ccchhc---------chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH-
Q 012214 392 HSMRKN------------------RLHDIL---------DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME- 443 (468)
Q Consensus 392 ~~~~~~------------------~~~~~~---------d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~- 443 (468)
...... ...+.. ........+...++.+.+|+.+||+.||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 000000 000000 0000011223345678999999999999999999999863
Q ss_pred -HHhcc
Q 012214 444 -LNGIR 448 (468)
Q Consensus 444 -L~~i~ 448 (468)
++.+.
T Consensus 336 ~f~~~~ 341 (389)
T 3gni_B 336 FFKQIK 341 (389)
T ss_dssp GGGGC-
T ss_pred HHHHHh
Confidence 44444
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=338.70 Aligned_cols=263 Identities=22% Similarity=0.312 Sum_probs=199.2
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
++|.+.+.||+|+||.||++...+++.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE--GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG--CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc--ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 5688899999999999999998889999999986543221 22356789999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++ +|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 80 e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG 151 (288)
T ss_dssp ECCSE-EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred EecCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence 99975 9998886532 35899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc---c
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR---L 399 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 399 (468)
.... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||... ................. +
T Consensus 152 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T 1ob3_A 152 IPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV-----SEADQLMRIFRILGTPNSKNW 225 (288)
T ss_dssp C----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHHHCCCCTTTS
T ss_pred cccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHHCCCChhhc
Confidence 3222 2233468999999999876 45899999999999999999999998531 11111111111111110 0
Q ss_pred chh-----cchHH-------hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 400 HDI-----LDDQL-------MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 400 ~~~-----~d~~l-------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
... .++.. ........++.+.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 00000 00011234557889999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=334.33 Aligned_cols=259 Identities=32% Similarity=0.549 Sum_probs=203.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHH---HHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLK---LEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~---~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
.++|.+.+.||+|+||.||++... +++.||+|++........... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 377899999999999999999964 789999999865433221121 267899999999999999999999997654
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc-----EEE
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR-----AKV 313 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~-----~kl 313 (468)
++||||+++++|.+++.... .++++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEe
Confidence 79999999999999886532 36999999999999999999999986 45999999999999988776 999
Q ss_pred EecCCcccccCCCceeeecccccCCccCccccc--cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHH
Q 012214 314 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ--SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391 (468)
Q Consensus 314 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (468)
+|||+++.... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||...... .....
T Consensus 171 ~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~---- 239 (287)
T 4f0f_A 171 ADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG---KIKFI---- 239 (287)
T ss_dssp CCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC---HHHHH----
T ss_pred CCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc---HHHHH----
Confidence 99999974432 233456899999999984 456788999999999999999999998532111 11111
Q ss_pred HHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
.......... ..+...++.+.+++.+||+.||++|||+.|+++.|++|
T Consensus 240 ~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 240 NMIREEGLRP--------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHSCCCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHhccCCCC--------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111111110 11223445789999999999999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=342.96 Aligned_cols=255 Identities=26% Similarity=0.354 Sum_probs=204.1
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHH--HHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEE--LLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
.++|.+.+.||+|+||.||++... +|+.||+|++........ ....+.+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 366889999999999999999975 689999998865432210 01246788999999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC----cEEEEe
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY----RAKVAD 315 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~----~~kl~D 315 (468)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 9999999999999999652 35899999999999999999999999 99999999999999887 899999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||... . .. ........
T Consensus 162 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~---~~---~~~~~~~~ 231 (326)
T 2y0a_A 162 FGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--T---KQ---ETLANVSA 231 (326)
T ss_dssp CTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--S---HH---HHHHHHHH
T ss_pred CCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC--C---HH---HHHHHHHh
Confidence 999987653322 23456999999999999999999999999999999999999998431 1 11 11111111
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
... .. ... .....+..+.+++.+||+.||++|||+.|+++
T Consensus 232 -~~~-~~-~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 232 -VNY-EF-EDE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -TCC-CC-CHH----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -cCC-Cc-Ccc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 00 000 11233457889999999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=346.14 Aligned_cols=270 Identities=24% Similarity=0.345 Sum_probs=214.3
Q ss_pred HHHHhcCCCCCceeeecCcEEEEEEEecC------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEee
Q 012214 159 LDKATNHFNANRILGQGGQGTVYKGMLED------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLG 231 (468)
Q Consensus 159 i~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g 231 (468)
.+...++|.+.+.||+|+||.||+|.... ...||+|.+...... ...+.+.+|+.+++.+ +||||+++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA---DEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh---HHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34456889999999999999999999642 247999998765433 3456789999999999 8999999999
Q ss_pred eeccCCcceeEeeecCCCChhhHhhhcccC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCC
Q 012214 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQN---------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTN 302 (468)
Q Consensus 232 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~N 302 (468)
++.+....++||||+++|+|.+++...... ....+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 194 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARN 194 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccce
Confidence 999999999999999999999999764310 1235899999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 012214 303 ILLDQRYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTS 380 (468)
Q Consensus 303 ILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~ 380 (468)
||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~- 273 (333)
T 2i1m_A 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN- 273 (333)
T ss_dssp CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-
T ss_pred EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-
Confidence 99999999999999999866443322 2334457889999999999999999999999999999998 88887431111
Q ss_pred cchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 381 QENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.. +......... ...+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 274 ---~~----~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 274 ---SK----FYKLVKDGYQ---------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp ---HH----HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---HH----HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 11 1111111100 0011223457899999999999999999999999999887544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=339.16 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=208.4
Q ss_pred cCCCCCc-eeeecCcEEEEEEEec---CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 164 NHFNANR-ILGQGGQGTVYKGMLE---DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 164 ~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
++|.+.+ .||+|+||.||+|.+. ++..||+|++...... ...+.+.+|+.++++++||||+++++++ +.+..
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK---ADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 4555555 8999999999999853 5788999998765333 4557799999999999999999999999 55678
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp EEEEECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccce
Confidence 9999999999999999642 235899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCcee--eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 320 KFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 320 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~~----~~~~i~~ 228 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GPE----VMAFIEQ 228 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----THH----HHHHHHT
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----HHH----HHHHHhc
Confidence 8765443322 223456889999999998889999999999999999998 999985311 111 1111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.... ..+...+..+.+++.+||+.||++|||+.++++.|+.+..+.
T Consensus 229 ~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 229 GKRM---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp TCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCcC---------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111 112334558999999999999999999999999999886543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=348.11 Aligned_cols=246 Identities=27% Similarity=0.337 Sum_probs=196.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 240 (468)
.++|.+.+.||+|+||.||+++.. +++.||+|++...... .....+.+.+|..++..+ +||||+++++++.+....+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 478999999999999999999965 5899999998653211 113456688999999988 7999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 101 lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccccee
Confidence 9999999999999997643 4899999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||... .. ...+..... ...
T Consensus 173 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-----~~---~~~~~~i~~-~~~- 241 (353)
T 3txo_A 173 EGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE-----NE---DDLFEAILN-DEV- 241 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS-----SH---HHHHHHHHH-CCC-
T ss_pred ecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC-----CH---HHHHHHHHc-CCC-
Confidence 543222 2234467999999999999999999999999999999999999998531 11 111111111 111
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTM 437 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 437 (468)
..+...+..+.+++.+||+.||++||++
T Consensus 242 ---------~~p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 242 ---------VYPTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred ---------CCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 0112234478899999999999999998
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=342.25 Aligned_cols=274 Identities=25% Similarity=0.352 Sum_probs=216.4
Q ss_pred cCHHHHHHHhcCCCCCceeeecCcEEEEEEEe------cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCce
Q 012214 154 FSSKELDKATNHFNANRILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNV 226 (468)
Q Consensus 154 ~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~ni 226 (468)
+...+.....++|.+.+.||+|+||.||++.. .+++.||||++...... ...+.+.+|+.++.++ +||||
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~i 93 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNV 93 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTB
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc---HHHHHHHHHHHHHHhcccCCCe
Confidence 34455555678999999999999999999984 34688999998765443 3456789999999999 79999
Q ss_pred eeEeeeeccCC-cceeEeeecCCCChhhHhhhcccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEE
Q 012214 227 VKLLGCCLETE-VPLLVYEFIPNGTLYQHLHDRHQNE-----------EFPLTWEMRLRIATEVAGALAYLHSATSSPIY 294 (468)
Q Consensus 227 v~l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ii 294 (468)
+++++++.+.+ ..++||||+++++|.+++....... ...+++..++.++.||+.||.|||+.+ |+
T Consensus 94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~ 170 (316)
T 2xir_A 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI 170 (316)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 99999987654 5899999999999999998643210 123889999999999999999999999 99
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCcccccCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCC
Q 012214 295 HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 372 (468)
Q Consensus 295 H~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p 372 (468)
||||||+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p 250 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986644332 22334567889999999999999999999999999999998 9999
Q ss_pred CCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 373 IFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
|...... . .+........... .+...++.+.+++.+||+.||.+|||+.|+++.|+.+.+.
T Consensus 251 ~~~~~~~----~----~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 251 YPGVKID----E----EFCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp STTCCCS----H----HHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Ccccchh----H----HHHHHhccCccCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 8532111 1 1111111111000 1122344789999999999999999999999999988754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=358.48 Aligned_cols=257 Identities=24% Similarity=0.294 Sum_probs=206.2
Q ss_pred HHHHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC
Q 012214 158 ELDKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 236 (468)
Q Consensus 158 ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~ 236 (468)
++....++|.+.+.||+|+||.||+++.. +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 34445688999999999999999999975 5889999998642111 001223478899999999999999999999999
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...++||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecc
Confidence 9999999999999999998652 4899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCceeeecccccCCccCccccccCC----CCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHH
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ----LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVH 392 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 392 (468)
|+++..............||+.|+|||++.+.. ++.++|||||||++|||++|+.||... .. ...+..
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~---~~~~~~ 284 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-----SL---VGTYSK 284 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS-----SH---HHHHHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC-----Ch---hhHHHH
Confidence 999876655444445678999999999998755 789999999999999999999998531 11 111111
Q ss_pred Hhhc---cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 012214 393 SMRK---NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKK--RPTMEEVSM 442 (468)
Q Consensus 393 ~~~~---~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~ 442 (468)
.... ...+. ....+..+.+|+.+||+.+|.+ ||++.||++
T Consensus 285 i~~~~~~~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 285 IMNHKNSLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHTHHHHCCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHhccccccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 1111 01110 1123457899999999998888 999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=346.28 Aligned_cols=261 Identities=25% Similarity=0.409 Sum_probs=203.5
Q ss_pred cCCCCCceeeecCcEEEEEEEecC-----CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED-----GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
++|...+.||+|+||.||+|.... +..||+|++...... .....+.+|+.++++++||||+++++++.+...
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE---KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 567778999999999999998643 245999998764433 345678999999999999999999999999999
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred cEEEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCc
Confidence 999999999999999997632 25899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCce--eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 319 SKFIAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 319 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||... ... ........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~-----~~~---~~~~~~~~ 265 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-----SNH---EVMKAIND 265 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHH---HHHHHHHT
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC-----CHH---HHHHHHHC
Confidence 9876543221 1223346788999999999999999999999999999999 99998431 111 11111111
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCc
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 452 (468)
..... .+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 266 ~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 266 GFRLP----------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp TCCCC----------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CCcCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 11111 122344578999999999999999999999999998875543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=339.59 Aligned_cols=247 Identities=27% Similarity=0.386 Sum_probs=202.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||+++.. +|+.||+|++...... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 67889999999999999999965 6899999998653211 112346788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp ECCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceec
Confidence 99999999999997632 4899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... .. ...+...... .+
T Consensus 157 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~---~~~~~~i~~~-~~--- 220 (318)
T 1fot_A 157 PDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-----NT---MKTYEKILNA-EL--- 220 (318)
T ss_dssp SSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SH---HHHHHHHHHC-CC---
T ss_pred CCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC-----CH---HHHHHHHHhC-CC---
Confidence 432 23457999999999999999999999999999999999999998531 11 1111111111 11
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
..+...+..+.+++.+||+.||++|| ++.|+++
T Consensus 221 -------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 -------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 01122344789999999999999999 8888874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=337.49 Aligned_cols=264 Identities=22% Similarity=0.264 Sum_probs=201.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||++... +++.||+|++...... +....+.+.+|+.++++++||||+++++++.+....++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS-DPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGG-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccccc-CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 478999999999999999999965 6889999998754322 12345778999999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
|+||+++++|.+++.... ++++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 112 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEECCCCEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 999999999999997642 4899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
.............+|+.|+|||.+.+..++.++||||||+++|||++|+.||... ... .......... ..
T Consensus 184 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~----~~~~~~~~~~-~~ 253 (309)
T 2h34_A 184 TTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD-----QLS----VMGAHINQAI-PR 253 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC-----HHH----HHHHHHHSCC-CC
T ss_pred ccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc-----hHH----HHHHHhccCC-CC
Confidence 6544333334456899999999999999999999999999999999999998431 111 1111111110 00
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhcccCC
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-TMEEVSMELNGIRGSS 451 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~i~~~~ 451 (468)
....+...+..+.+++.+||+.||++|| |+.++++.|+.+....
T Consensus 254 ------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 254 ------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp ------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 0011223445789999999999999999 9999999999887655
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=341.75 Aligned_cols=276 Identities=21% Similarity=0.321 Sum_probs=214.0
Q ss_pred ccCHHHHHHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHh--cCCCceeeEe
Q 012214 153 LFSSKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQ--INHRNVVKLL 230 (468)
Q Consensus 153 ~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~ 230 (468)
..+...-....++|.+.+.||+|+||.||++.. +++.||||++... ....+.+|++++.. ++||||++++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~ni~~~~ 102 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFI 102 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-------GHHHHHHHHHHHHHSCCCCTTBCCEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-------hHHHHHHHHHHHHHhhcCCCcEEEEE
Confidence 344455566778999999999999999999998 4899999998642 12457788888887 7899999999
Q ss_pred eeeccCC----cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCEEecCC
Q 012214 231 GCCLETE----VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH--------SATSSPIYHRDI 298 (468)
Q Consensus 231 g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~iiH~DL 298 (468)
+++.... ..++||||+++|+|.+++... .+++..++.++.|++.||.||| +.+ |+||||
T Consensus 103 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dl 173 (342)
T 1b6c_B 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDL 173 (342)
T ss_dssp EEEECCCSSCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCC
T ss_pred eeecccCCccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCC
Confidence 9998765 789999999999999999752 4899999999999999999999 777 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCcccccCCCcee---eecccccCCccCccccccC------CCCCcccHHHHHHHHHHHHhC
Q 012214 299 KSTNILLDQRYRAKVADFGTSKFIAMDQTHV---TTKIQGTFGYLDPEYHQSS------QLTDKSDVYSFGVVLVELLTG 369 (468)
Q Consensus 299 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvll~el~tG 369 (468)
||+|||++.++.+||+|||++.......... .....||+.|+|||.+.+. .++.++|||||||++|||++|
T Consensus 174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 9999999999999999999998765544321 2345699999999998875 334689999999999999999
Q ss_pred ----------CCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 012214 370 ----------KKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439 (468)
Q Consensus 370 ----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e 439 (468)
..||........ . ................+.. .......+..+.+|+.+||+.||++|||+.+
T Consensus 254 ~~~~~~~~~~~~p~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ 326 (342)
T 1b6c_B 254 CSIGGIHEDYQLPYYDLVPSDP---S-VEEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALR 326 (342)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSC---C-HHHHHHHHTTSCCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred cCcCCcccccccCccccCcCcc---c-HHHHHHHHHHHHhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence 677643211111 1 1111122211111111111 0112356678999999999999999999999
Q ss_pred HHHHHHhcccCCc
Q 012214 440 VSMELNGIRGSSK 452 (468)
Q Consensus 440 vl~~L~~i~~~~~ 452 (468)
|++.|+.+.....
T Consensus 327 i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 327 IKKTLSQLSQQEG 339 (342)
T ss_dssp HHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhc
Confidence 9999999986653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=340.70 Aligned_cols=267 Identities=23% Similarity=0.331 Sum_probs=191.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|++.+.||+|+||.||+|... +++.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE---GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT---CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc---ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 467899999999999999999964 6899999998654322 223567899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 242 VYEFIPNGTLYQHLHDRHQ-NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
||||++ ++|.+++..... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccce
Confidence 999997 699999876432 22235899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc--
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN-- 397 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 397 (468)
....... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... ...............
T Consensus 157 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~ 230 (317)
T 2pmi_A 157 AFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN-----DEEQLKLIFDIMGTPNE 230 (317)
T ss_dssp ETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCSCCT
T ss_pred ecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCCh
Confidence 6643322 2233468999999999876 468999999999999999999999985311 111111111111100
Q ss_pred -ccch-----------------hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 -RLHD-----------------ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 -~~~~-----------------~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+.. -+...+........+..+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000 00001111112234557999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=333.13 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=206.2
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc-----
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE----- 235 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----- 235 (468)
..++|++.+.||+|+||.||++... +++.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 3467899999999999999999975 78999999987532 235689999999999999999998854
Q ss_pred -----------CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEE
Q 012214 236 -----------TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNIL 304 (468)
Q Consensus 236 -----------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NIL 304 (468)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil 154 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIF 154 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEE
Confidence 445789999999999999997643 235899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchh
Q 012214 305 LDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENV 384 (468)
Q Consensus 305 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~ 384 (468)
+++++.+||+|||++........ .....+|+.|+|||.+.+..++.++||||||+++|+|++|..|+.. .
T Consensus 155 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-------~- 224 (284)
T 2a19_B 155 LVDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-------T- 224 (284)
T ss_dssp EEETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-------H-
T ss_pred EcCCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-------H-
Confidence 99999999999999987654322 2334689999999999999999999999999999999999988631 0
Q ss_pred chHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCchhhh
Q 012214 385 SLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKRA 456 (468)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~ 456 (468)
...........+.. ..+..+.+++.+||+.||++|||+.|+++.|+.++.+..+.+.
T Consensus 225 ---~~~~~~~~~~~~~~------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~~ 281 (284)
T 2a19_B 225 ---SKFFTDLRDGIISD------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281 (284)
T ss_dssp ---HHHHHHHHTTCCCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-------
T ss_pred ---HHHHHHhhcccccc------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcccc
Confidence 01111112222222 2234688999999999999999999999999999887765443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=336.76 Aligned_cols=256 Identities=29% Similarity=0.455 Sum_probs=197.8
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
++|.+.+.||+|+||.||++... ++.||+|++... ...+.|.+|+.++++++||||+++++++.+ ..++||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE------SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 56888899999999999999875 788999998643 223678999999999999999999999874 479999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc-EEEEecCCcccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR-AKVADFGTSKFI 322 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~-~kl~DfGla~~~ 322 (468)
||+++++|.+++.... ....+++..++.++.|+++||+|||+.+...|+||||||+|||++.++. +||+|||++...
T Consensus 79 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp ECCTTCBHHHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EcCCCCCHHHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 9999999999997632 1224789999999999999999999932222999999999999998886 799999999755
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....... .......
T Consensus 157 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~-~~~~~~~- 224 (307)
T 2eva_A 157 QTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA------FRIMWAV-HNGTRPP- 224 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH------HHHHHHH-HTTCCCC-
T ss_pred ccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH------HHHHHHH-hcCCCCC-
Confidence 322 223458999999999999999999999999999999999999985321111 1111111 1111111
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
.....+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 225 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 225 --------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp --------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred --------cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1123345788999999999999999999999999988654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=374.58 Aligned_cols=263 Identities=25% Similarity=0.373 Sum_probs=213.1
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
+...++|.+.+.||+|+||.||+|.+.++..||||+++..... .++|.+|+.++++++|+||+++++++.+ ...
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC-----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 3445778899999999999999999988888999998764322 3578999999999999999999999976 678
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++|+|.+++..... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred eEeeehhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 999999999999999975321 24899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
+..............++..|+|||.+.+..++.++|||||||++|||++ |+.||... ... . ....+....
T Consensus 411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~-----~~~---~-~~~~i~~~~ 481 (535)
T 2h8h_A 411 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNR---E-VLDQVERGY 481 (535)
T ss_dssp TTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC-----CHH---H-HHHHHHTTC
T ss_pred eecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CHH---H-HHHHHHcCC
Confidence 8665332222233457789999999999999999999999999999999 89998431 111 1 111111110
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCc
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 452 (468)
....+..++..+.+|+.+||+.||++|||+.+|++.|+.+.....
T Consensus 482 ---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 482 ---------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 011123445578999999999999999999999999999876543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=346.82 Aligned_cols=259 Identities=22% Similarity=0.330 Sum_probs=204.2
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchH-HHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDE-ELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
.++|.+.+.||+|+||.||++... +++.||||++....... .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467899999999999999999964 68999999875421100 0012467889999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc---EEEEecC
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR---AKVADFG 317 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~---~kl~DfG 317 (468)
+||||+++++|.+.+..... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999988876432 2235899999999999999999999999 999999999999987655 9999999
Q ss_pred CcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 318 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 318 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||... . . ..+..... .
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~--~---~~~~~i~~-~ 247 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----K--E---RLFEGIIK-G 247 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----H--H---HHHHHHHH-T
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----H--H---HHHHHHHc-C
Confidence 9987654322 233456999999999999999999999999999999999999998531 1 1 11111111 1
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
... ..+.. ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 248 KYK--MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCC--CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 110 00100 1123457899999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=340.23 Aligned_cols=252 Identities=26% Similarity=0.336 Sum_probs=193.4
Q ss_pred hcCCCCCceeeecCcEEEEEEEe----cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 163 TNHFNANRILGQGGQGTVYKGML----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
.++|.+.+.||+|+||.||++.. .+++.||+|+++.............+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36799999999999999999986 47899999998764322222344568899999999999999999999999999
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCc
Confidence 999999999999999997632 4889999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||... ... ........ ..
T Consensus 168 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~---~~~~~i~~-~~ 237 (327)
T 3a62_A 168 CKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE-----NRK---KTIDKILK-CK 237 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHH---HHHHHHHH-TC
T ss_pred ccccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC-----CHH---HHHHHHHh-CC
Confidence 875433222 233457999999999999999999999999999999999999998531 111 11111111 11
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
. ..+...+..+.+++.+||+.||++|| ++.|+++
T Consensus 238 ~----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 L----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp C----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred C----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 01122345789999999999999999 6777765
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=338.31 Aligned_cols=264 Identities=22% Similarity=0.306 Sum_probs=201.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||+||+|... +++.||+|++....... ...+.+.+|+.++++++||||+++++++.+....++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST--THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC--CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 57888999999999999999975 68999999987543322 3346788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++ +|.+.+.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~e~~~~-~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF 151 (292)
T ss_dssp EECCSE-EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999975 6666665422 35999999999999999999999999 999999999999999999999999999866
Q ss_pred cCCCceeeecccccCCccCccccccCC-CCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc---
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR--- 398 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 398 (468)
..... ......||+.|+|||.+.+.. ++.++|||||||++|||++|..|+..... ................
T Consensus 152 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~----~~~~~~~i~~~~~~~~~~~ 226 (292)
T 3o0g_A 152 GIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND----VDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp CSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS----HHHHHHHHHHHHCCCCTTT
T ss_pred CCccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC----HHHHHHHHHHHhCCCChhh
Confidence 43322 233456899999999998765 79999999999999999999999743211 1111111111111110
Q ss_pred cchhcc------------hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHDILD------------DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~~~d------------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+..... ...........+..+.+|+.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000000 00000111234557889999999999999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=351.07 Aligned_cols=258 Identities=22% Similarity=0.405 Sum_probs=201.6
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcE----EEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRI----IAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~----vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
++|.+.+.||+|+||.||+|... +++. ||+|.+...... .....+.+|+.++++++||||+++++++. ...
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR---QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC---SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH---HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 57888999999999999999964 4443 788876543222 22345778999999999999999999986 466
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~ 161 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGV 161 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred cEEEEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCc
Confidence 889999999999999997632 25888999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 319 SKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 319 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ......
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~----~~~~~~ 232 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-----AEV----PDLLEK 232 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-----THH----HHHHHT
T ss_pred ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-----HHH----HHHHHc
Confidence 9876544322 2344568889999999999999999999999999999999 9999853211 111 111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
.... ..+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 233 ~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 233 GERL---------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TCBC---------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CCCC---------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1100 01112233678899999999999999999999999987643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=335.15 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=195.2
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHH----------------------HHHHHHHHHHHHHHH
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEE----------------------LLKLEEFINEIVILS 219 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~----------------------~~~~~~~~~Ei~~l~ 219 (468)
.++|.+.+.||+|+||.||+|... +++.||||++........ ....+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367999999999999999999964 689999999865321110 112356889999999
Q ss_pred hcCCCceeeEeeeecc--CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecC
Q 012214 220 QINHRNVVKLLGCCLE--TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRD 297 (468)
Q Consensus 220 ~l~h~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~D 297 (468)
+++||||+++++++.+ ....++||||+++++|.+++.. .++++..+..++.||+.||+|||+.+ |+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 162 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRD 162 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 9999999999999976 5678999999999999876532 35999999999999999999999999 99999
Q ss_pred CCCCCEEEcCCCcEEEEecCCcccccCCCceeeecccccCCccCccccccCC---CCCcccHHHHHHHHHHHHhCCCCCC
Q 012214 298 IKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ---LTDKSDVYSFGVVLVELLTGKKPIF 374 (468)
Q Consensus 298 Lkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvll~el~tG~~p~~ 374 (468)
|||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. .+.++|||||||++|+|++|+.||.
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999987654332 233457999999999998755 3678999999999999999999985
Q ss_pred CCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 375 WAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.. .... ........... . ......++.+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~-----~~~~----~~~~~~~~~~~-~-------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DE-----RIMC----LHSKIKSQALE-F-------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CS-----SHHH----HHHHHHHCCCC-C-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred Cc-----cHHH----HHHHHhcccCC-C-------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 31 1111 11111111110 0 001223457899999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=347.74 Aligned_cols=269 Identities=25% Similarity=0.354 Sum_probs=208.9
Q ss_pred cCCCCCceeeecCcEEEEEEEe-----cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeec--cC
Q 012214 164 NHFNANRILGQGGQGTVYKGML-----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL--ET 236 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~--~~ 236 (468)
++|++.+.||+|+||.||++.+ .+++.||||++.... . ...+.+.+|+.++++++||||+++++++. +.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-P---DQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-H---HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-H---HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 6789999999999999999984 368899999987642 2 33467899999999999999999999886 45
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCG
T ss_pred ceEEEEEeecCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccc
Confidence 568899999999999999976432 4899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCcee--eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCc------cchhchHH
Q 012214 317 GTSKFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTS------QENVSLAA 388 (468)
Q Consensus 317 Gla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~------~~~~~~~~ 388 (468)
|+++......... .....+|..|+|||.+.+..++.++||||||+++|+|++|+.||....... ........
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH
Confidence 9998765443322 233458888999999999999999999999999999999999984310000 00000000
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCc
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 452 (468)
....... .......+...++.+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 252 ~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 252 RLLELLE---------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHHHhh---------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 0111111 111111233455689999999999999999999999999999876554
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=333.33 Aligned_cols=260 Identities=26% Similarity=0.386 Sum_probs=205.2
Q ss_pred CCCCCceeeecCcEEEEEEEecC----CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc-
Q 012214 165 HFNANRILGQGGQGTVYKGMLED----GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP- 239 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~- 239 (468)
.|...+.||+|+||.||+|...+ +..+|+|.+...... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM---QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH---HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 45566889999999999998532 237999998764433 4567899999999999999999999999876655
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++|+||+.+++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 171 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLA 171 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSS
T ss_pred EEEEecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCc
Confidence 99999999999999997522 35899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCc---eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 320 KFIAMDQT---HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 320 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
+....... .......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+..... ........... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~----~~~~~~~~~~~-~~ 246 (298)
T 3pls_A 172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID----PFDLTHFLAQG-RR 246 (298)
T ss_dssp CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----GGGHHHHHHTT-CC
T ss_pred ccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC----HHHHHHHhhcC-CC
Confidence 86543321 122345678999999999999999999999999999999997777543111 11111111111 10
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.. .+...+..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 247 ~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 247 LP------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp CC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CC------------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 11 12223457899999999999999999999999999886543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=354.90 Aligned_cols=264 Identities=23% Similarity=0.242 Sum_probs=207.5
Q ss_pred HHHHHHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeec
Q 012214 156 SKELDKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL 234 (468)
Q Consensus 156 ~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~ 234 (468)
.++.....++|.+.+.||+|+||.||+++.+ +|+.||+|++...... .....+.+.+|..++..++||||+++++++.
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3445556789999999999999999999975 6899999998642111 1122345889999999999999999999999
Q ss_pred cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 235 ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 235 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
+....++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEe
Confidence 9999999999999999999997632 25899999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeecccccCCccCccccc-------cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchH
Q 012214 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-------SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLA 387 (468)
Q Consensus 315 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~ 387 (468)
|||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||... ......
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~~~~ 279 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD-----STAETY 279 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHH
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC-----CHHHHH
Confidence 99999877655444444567999999999987 357899999999999999999999998531 111111
Q ss_pred HHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCC---CCHHHHHH
Q 012214 388 AYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKR---PTMEEVSM 442 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~R---Pt~~evl~ 442 (468)
............+. .+...+..+.+|+.+||+ +|.+| |++.|+++
T Consensus 280 ~~i~~~~~~~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 280 GKIVHYKEHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHTHHHHCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHhcccCcCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 11111000001110 012344578999999999 99998 58888875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=334.20 Aligned_cols=261 Identities=29% Similarity=0.458 Sum_probs=203.5
Q ss_pred cCCCCCceeeecCcEEEEEEEecC----CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeec-cCCc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED----GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL-ETEV 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~-~~~~ 238 (468)
.+|.+.+.||+|+||.||+|...+ ...+|+|.+...... ...+.+.+|+.++++++||||+++++++. ....
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI---GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH---HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH---HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 568888999999999999998542 236899988764433 44577999999999999999999999864 4567
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred eEEEEeCCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccc
Confidence 89999999999999999652 235899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCc---eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 319 SKFIAMDQT---HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 319 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
++....... .......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+...... ....... ..
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----~~~~~~~---~~ 247 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FDITVYL---LQ 247 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT----TTHHHHH---HT
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH----HHHHHHH---hc
Confidence 986643322 1233445788999999999999999999999999999999955554321111 1111111 11
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.... ..+...+..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 248 ~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 248 GRRL----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CCCC----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1100 011223447899999999999999999999999999987654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=346.76 Aligned_cols=270 Identities=23% Similarity=0.379 Sum_probs=198.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHH--HHhcCCCceeeEeeeec-----c
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVI--LSQINHRNVVKLLGCCL-----E 235 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~--l~~l~h~niv~l~g~~~-----~ 235 (468)
.++|.+.+.||+|+||.||+|+. +++.||||++..... ..+..|..+ +..++||||+++++.+. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR-------QNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH-------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch-------hhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 37889999999999999999987 589999999865321 233344444 45589999999997543 2
Q ss_pred CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCEEecCCCCCCEEEc
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA---------TSSPIYHRDIKSTNILLD 306 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~---------~~~~iiH~DLkp~NILl~ 306 (468)
....++||||+++|+|.+++... ..++..+..++.||+.||.|||+. + |+||||||+|||++
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~ 154 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVK 154 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEEC
T ss_pred CceEEEEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEc
Confidence 33568999999999999999763 258899999999999999999998 7 99999999999999
Q ss_pred CCCcEEEEecCCcccccCCCc-------eeeecccccCCccCcccccc-------CCCCCcccHHHHHHHHHHHHhCCCC
Q 012214 307 QRYRAKVADFGTSKFIAMDQT-------HVTTKIQGTFGYLDPEYHQS-------SQLTDKSDVYSFGVVLVELLTGKKP 372 (468)
Q Consensus 307 ~~~~~kl~DfGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvll~el~tG~~p 372 (468)
.++.+||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 234 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence 999999999999987653321 11224569999999999887 4566789999999999999999888
Q ss_pred CCCCCCCccchhchH---------HHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 373 IFWAGNTSQENVSLA---------AYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
+.............. ...............+... .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 754333222111110 0111111111000000000 01123456689999999999999999999999999
Q ss_pred HHhcccCC
Q 012214 444 LNGIRGSS 451 (468)
Q Consensus 444 L~~i~~~~ 451 (468)
|+.+...-
T Consensus 313 L~~ll~~~ 320 (336)
T 3g2f_A 313 MAELMMIW 320 (336)
T ss_dssp HHHHHHCC
T ss_pred HHHHHHHH
Confidence 99887543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=341.22 Aligned_cols=260 Identities=25% Similarity=0.366 Sum_probs=206.2
Q ss_pred hcCCCCCc-eeeecCcEEEEEEEec---CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 163 TNHFNANR-ILGQGGQGTVYKGMLE---DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 163 ~~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
.++|.+.+ .||+|+||.||+|... +++.||||++...... ....+.+.+|+.+++.++||||+++++++ +.+.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 46777777 8999999999999642 4688999998764322 13457799999999999999999999999 5677
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++||||+++++|.+++.... .+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred cEEEEEeCCCCCHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCc
Confidence 899999999999999997632 4899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCcee--eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 319 SKFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 319 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
+.......... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||... ... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~----~~~~~~~ 234 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-----KGS----EVTAMLE 234 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHH----HHHHHHH
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC-----CHH----HHHHHHH
Confidence 98765444332 223346788999999998889999999999999999999 99998531 111 1111111
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
..... ..+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 235 ~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 235 KGERM---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp TTCCC---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred cCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 11111 112234557999999999999999999999999999887554
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=329.88 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=204.1
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|++.+.||+|+||.||++... +++.||+|++....... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH--HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 478999999999999999999965 58899999986543322 345678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc---EEEEecCC
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR---AKVADFGT 318 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~---~kl~DfGl 318 (468)
||||+++++|.+.+.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 83 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp EECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 999999999999887642 4899999999999999999999999 999999999999987655 99999999
Q ss_pred cccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
+........ .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||... ....... ......
T Consensus 155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-----~~~~~~~----~~~~~~ 223 (284)
T 3kk8_A 155 AIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-----DQHRLYA----QIKAGA 223 (284)
T ss_dssp CEECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHH----HHHHTC
T ss_pred eEEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC-----chhHHHH----HHHhcc
Confidence 976543322 23456899999999999999999999999999999999999998431 1111111 111111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
... .. ......++.+.+++.+||+.||++|||+.|+++
T Consensus 224 ~~~-~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 224 YDY-PS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCC-CT-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccC-Cc-----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 100 00 001223457899999999999999999999987
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=343.82 Aligned_cols=253 Identities=24% Similarity=0.326 Sum_probs=196.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCC--CceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH--RNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~~~~~ 240 (468)
.++|.+.+.||+|+||.||++...+++.||||++....... ...+.+.+|+.++..++| +||+++++++.+....+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN--QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccch--HHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 46789999999999999999998889999999987543332 455788999999999976 99999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||| +.+++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++
T Consensus 86 lv~e-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIAN 155 (343)
T ss_dssp EEEC-CCSEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred EEEe-CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccc
Confidence 9999 55889999997632 5899999999999999999999999 99999999999997 6789999999998
Q ss_pred cccCCCce-eeecccccCCccCcccccc-----------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH
Q 012214 321 FIAMDQTH-VTTKIQGTFGYLDPEYHQS-----------SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 321 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~ 388 (468)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... . ...
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~---~~~ 228 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII----N---QIS 228 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC----S---HHH
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh----h---HHH
Confidence 76543322 2334579999999999865 678899999999999999999999984311 1 111
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
.......... ....+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 229 ~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 229 KLHAIIDPNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHHHCTTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhcCCc---------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111111111 111112223468899999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=334.77 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=201.9
Q ss_pred cCCCCCceeeecCcEEEEEEEecC-C-------cEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED-G-------RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE 235 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~-g-------~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~ 235 (468)
++|.+.+.||+|+||.||+|.... + ..||+|++..... ...+.+.+|+.++++++||||+++++++.+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR----NYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG----GGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH----HHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 678889999999999999998542 3 4799998865322 334678999999999999999999999999
Q ss_pred CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc-----
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR----- 310 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~----- 310 (468)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 156 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGN 156 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTB
T ss_pred CCCCEEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccc
Confidence 999999999999999999997632 24899999999999999999999999 999999999999998887
Q ss_pred ---EEEEecCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhch
Q 012214 311 ---AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSL 386 (468)
Q Consensus 311 ---~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~ 386 (468)
+||+|||++...... ....+|+.|+|||.+.+ ..++.++||||||+++|||++|..|+.... ..
T Consensus 157 ~~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~----~~--- 224 (289)
T 4fvq_A 157 PPFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL----DS--- 224 (289)
T ss_dssp CCEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS----CH---
T ss_pred cceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc----ch---
Confidence 999999998654321 23457889999999987 778999999999999999999766653211 10
Q ss_pred HHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCch
Q 012214 387 AAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKK 453 (468)
Q Consensus 387 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 453 (468)
............... ..+..+.+++.+||+.||++|||+.++++.|+.+..+.-.
T Consensus 225 ~~~~~~~~~~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 225 QRKLQFYEDRHQLPA------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp HHHHHHHHTTCCCCC------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred HHHHHHhhccCCCCC------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 111111111111111 1233688999999999999999999999999999876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=348.25 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=202.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||++... +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV-ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc-cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 67899999999999999999965 5889999988643211 113356788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp ECCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999753 25899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCcccccc---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..... ........
T Consensus 166 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-----~~~~~-~~~~~~~~ 237 (384)
T 4fr4_A 166 PRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-----SKEIV-HTFETTVV 237 (384)
T ss_dssp CTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-----HHHHH-HHHHHCCC
T ss_pred cCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-----HHHHH-HHHhhccc
Confidence 4332 2344679999999999874 458999999999999999999999985422211 11111 11111110
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT-MEEVSM 442 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~ 442 (468)
..+...+..+.+|+.+||+.||.+||+ +.++.+
T Consensus 238 ----------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ----------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 112233457899999999999999998 666653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=346.24 Aligned_cols=259 Identities=15% Similarity=0.209 Sum_probs=208.5
Q ss_pred HHHHhcCCCCCceeeecCcEEEEEEE------ecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC---CCceeeE
Q 012214 159 LDKATNHFNANRILGQGGQGTVYKGM------LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN---HRNVVKL 229 (468)
Q Consensus 159 i~~~~~~f~~~~~LG~G~fG~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l 229 (468)
++...++|.+.+.||+|+||+||+|. ..+++.||+|++.... ..++..|+.++..++ |+||+++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-------PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-------HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-------hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 33456789999999999999999994 4468899999987532 235777888888886 9999999
Q ss_pred eeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC--
Q 012214 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ-- 307 (468)
Q Consensus 230 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~-- 307 (468)
++++...+..++||||+++|+|.+++..........+++..++.|+.||+.||+|||+.+ |+||||||+|||++.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGF 209 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGG
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccc
Confidence 999999999999999999999999998654444457999999999999999999999999 999999999999998
Q ss_pred ---------CCcEEEEecCCcccccC-CCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 012214 308 ---------RYRAKVADFGTSKFIAM-DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAG 377 (468)
Q Consensus 308 ---------~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~ 377 (468)
++.+||+|||+++.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence 89999999999976542 22333455679999999999999999999999999999999999999985321
Q ss_pred CCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHhcccC
Q 012214 378 NTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKR-PTMEEVSMELNGIRGS 450 (468)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~R-Pt~~evl~~L~~i~~~ 450 (468)
..... ........ ...+.+.+++..|++.+|.+| |++.++.+.|+.+...
T Consensus 290 ~~~~~------------~~~~~~~~-----------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 290 GGECK------------PEGLFRRL-----------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp TTEEE------------ECSCCTTC-----------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCcee------------echhcccc-----------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 11000 00000000 123467789999999999998 5888888888876654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=345.16 Aligned_cols=252 Identities=25% Similarity=0.324 Sum_probs=201.8
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCC
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETE 237 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~ 237 (468)
....++|.+.+.||+|+||.||+++.+ +++.||+|+++..... .....+.+..|..++..+ +||||+++++++.+..
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh-hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 344578999999999999999999975 6899999998653211 112345678899999877 9999999999999999
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG 317 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfG 317 (468)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG 163 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG 163 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeECh
Confidence 9999999999999999997632 4899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh-c
Q 012214 318 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR-K 396 (468)
Q Consensus 318 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 396 (468)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ... ..+..... .
T Consensus 164 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~---~~~~~i~~~~ 234 (345)
T 1xjd_A 164 MCKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-----DEE---ELFHSIRMDN 234 (345)
T ss_dssp TCBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHH---HHHHHHHHCC
T ss_pred hhhhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC-----CHH---HHHHHHHhCC
Confidence 9975432222 234467999999999999999999999999999999999999998531 111 11111111 1
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTME-EVS 441 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-evl 441 (468)
... +...+..+.+|+.+||+.||++||++. +++
T Consensus 235 ~~~------------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 PFY------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCC------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCC------------CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111 122344788999999999999999997 554
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=347.03 Aligned_cols=258 Identities=23% Similarity=0.429 Sum_probs=198.7
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcE----EEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRI----IAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~----vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
++|++.+.||+|+||.||+|... +++. ||+|.+...... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP---KANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC---CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH---HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 67899999999999999999954 4443 577776543322 23467889999999999999999999998754
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++|+|++.+|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~ 163 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred ceEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcc
Confidence 789999999999999997632 25899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 319 SKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 319 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.... ...... ....
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-----~~~~~~----~~~~ 234 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISS----ILEK 234 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHH----HHHT
T ss_pred eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHH----HHHc
Confidence 9876433222 2233457889999999999999999999999999999999 999985311 111111 1111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
.. ....+...+..+.+++.+||+.||.+|||+.|+++.|+.+...
T Consensus 235 ~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 235 GE---------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11 0011223444789999999999999999999999999988754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=341.75 Aligned_cols=247 Identities=24% Similarity=0.322 Sum_probs=202.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||++... +|+.||+|++..... ......+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh-ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 67899999999999999999965 689999999864321 1113356788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 120 ~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceec
Confidence 99999999999997643 4899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... .. ...+.... .....
T Consensus 192 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~---~~~~~~i~-~~~~~-- 256 (350)
T 1rdq_E 192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-----QP---IQIYEKIV-SGKVR-- 256 (350)
T ss_dssp SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SH---HHHHHHHH-HCCCC--
T ss_pred cCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC-----CH---HHHHHHHH-cCCCC--
Confidence 432 23356899999999999999999999999999999999999998531 11 11111111 11110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT-----MEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 442 (468)
.+...+..+.+++.+||+.||++||+ +.|+++
T Consensus 257 --------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 --------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 12233457899999999999999998 777654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=340.15 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=202.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.+.|...+.||+|+||.||+|.. .+++.||||++....... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 35588889999999999999996 578999999986543222 2445779999999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+. |+|.+++.... .++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 132 v~e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp EEECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 999997 68888886532 35899999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCCceeeecccccCCccCccccc---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
.... ....||+.|+|||++. ++.++.++|||||||++|||++|+.||.... .. ......... .
T Consensus 204 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-----~~---~~~~~~~~~-~ 269 (348)
T 1u5q_A 204 MAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AM---SALYHIAQN-E 269 (348)
T ss_dssp SSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HH---HHHHHHHHS-C
T ss_pred cCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hH---HHHHHHHhc-C
Confidence 5432 2346899999999884 5678999999999999999999999985311 11 111111111 1
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
..... ....++.+.+++.+||+.||++|||+.++++...
T Consensus 270 ~~~~~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 270 SPALQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp CCCCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CCCCC--------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 11111 1223457889999999999999999999987543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=330.71 Aligned_cols=265 Identities=19% Similarity=0.277 Sum_probs=203.3
Q ss_pred HhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeee-ccCCcc
Q 012214 162 ATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC-LETEVP 239 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~-~~~~~~ 239 (468)
..++|.+.+.||+|+||.||+|.. .+++.||||+....... ..+.+|+.+++.++|++++..++.+ .+....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C------CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc------hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 457899999999999999999996 57899999986543221 3577899999999888777666655 566778
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE---cCCCcEEEEec
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL---DQRYRAKVADF 316 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl---~~~~~~kl~Df 316 (468)
++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+||
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Df 152 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCC
T ss_pred EEEEEcc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecC
Confidence 9999999 999999997532 25899999999999999999999999 9999999999999 78999999999
Q ss_pred CCcccccCCCce------eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHH
Q 012214 317 GTSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF 390 (468)
Q Consensus 317 Gla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~ 390 (468)
|+++........ ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||......... ......
T Consensus 153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~ 230 (296)
T 4hgt_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYERI 230 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SHHHHH
T ss_pred ccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh--hhhhhh
Confidence 999876544331 123456899999999999999999999999999999999999998642221111 111111
Q ss_pred HHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 391 VHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.......... ......+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 231 ~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 231 SEKKMSTPIE---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHHHSCHH---------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hcccccchhh---------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 1110000000 001223457999999999999999999999999999877543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=338.85 Aligned_cols=267 Identities=22% Similarity=0.310 Sum_probs=206.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeec----cCC
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL----ETE 237 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~----~~~ 237 (468)
.++|.+.+.||+|+||.||++.. .+++.||+|++.... . ...+.+.+|+.+++.++||||+++++++. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-Q---QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-H---HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-H---HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 47899999999999999999996 578999999886532 2 34567889999999999999999999986 345
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG 317 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfG 317 (468)
..++|+||+++|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred eeEEEEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecC
Confidence 77899999999999999976432 2346999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCce--------eeecccccCCccCccccccCC---CCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhch
Q 012214 318 TSKFIAMDQTH--------VTTKIQGTFGYLDPEYHQSSQ---LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSL 386 (468)
Q Consensus 318 la~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~ 386 (468)
++......... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..... .....
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~ 256 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ---KGDSV 256 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHH---TTSCH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhc---ccchh
Confidence 98754321110 012234799999999987643 68899999999999999999999842100 00000
Q ss_pred HHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCch
Q 012214 387 AAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKK 453 (468)
Q Consensus 387 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 453 (468)
... ... . .........+..+.+++.+||+.||.+|||+.++++.|+.+......
T Consensus 257 ~~~----~~~-~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 257 ALA----VQN-Q--------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp HHH----HHC-C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred hHH----hhc-c--------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 000 000 0 00111223445799999999999999999999999999999876643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=330.55 Aligned_cols=265 Identities=19% Similarity=0.274 Sum_probs=206.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeee-ccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC-LETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~-~~~~~~~ 240 (468)
.++|.+.+.||+|+||.||+|.. .+++.||+|++...... +.+.+|+.+++.++|++++..+..+ .+....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch------hHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 47899999999999999999996 57999999987654332 3578899999999888766666555 5667789
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE---cCCCcEEEEecC
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL---DQRYRAKVADFG 317 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl---~~~~~~kl~DfG 317 (468)
+||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 82 lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 153 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence 999999 899999997532 25999999999999999999999999 9999999999999 488999999999
Q ss_pred CcccccCCCce------eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHH
Q 012214 318 TSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391 (468)
Q Consensus 318 la~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (468)
+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~ 231 (296)
T 3uzp_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYERIS 231 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SHHHHHH
T ss_pred CcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh--hhhhhhc
Confidence 99876544331 123456999999999999999999999999999999999999998642221111 1111111
Q ss_pred HHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCc
Q 012214 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452 (468)
Q Consensus 392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 452 (468)
........ +. .....++.+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 232 ~~~~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 232 EKKMSTPI-----EV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHHHSCH-----HH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccccCCch-----HH----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 11100000 00 012334579999999999999999999999999998765443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=342.79 Aligned_cols=267 Identities=23% Similarity=0.258 Sum_probs=202.9
Q ss_pred HHHHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccch-HHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc
Q 012214 158 ELDKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDD-EELLKLEEFINEIVILSQINHRNVVKLLGCCLE 235 (468)
Q Consensus 158 ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~ 235 (468)
.+....++|.+.+.||+|+||.||++... +++.||+|++...... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34566788999999999999999999964 6889999987643111 011345678999999999999999999999999
Q ss_pred CCcceeEeeecCCCChhhHhhhcccC-----------------------------------CCCCCCHHHHHHHHHHHHH
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQN-----------------------------------EEFPLTWEMRLRIATEVAG 280 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~qia~ 280 (468)
....++||||+++|+|.+++...... ....+++..+..++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998632111 0112467788899999999
Q ss_pred HHHHHHhCCCCCEEecCCCCCCEEEcCCC--cEEEEecCCcccccCCCc---eeeecccccCCccCcccccc--CCCCCc
Q 012214 281 ALAYLHSATSSPIYHRDIKSTNILLDQRY--RAKVADFGTSKFIAMDQT---HVTTKIQGTFGYLDPEYHQS--SQLTDK 353 (468)
Q Consensus 281 gL~yLH~~~~~~iiH~DLkp~NILl~~~~--~~kl~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~s~k 353 (468)
||+|||+.+ |+||||||+|||++.++ .+||+|||+++.+..... .......||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999999 99999999999998776 899999999986543221 12344569999999999875 678999
Q ss_pred ccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCC
Q 012214 354 SDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKK 433 (468)
Q Consensus 354 sDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~ 433 (468)
+|||||||++|||++|+.||.... . .............. . .......++.+.+|+.+||+.||.+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~-----~---~~~~~~~~~~~~~~--~-----~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVN-----D---ADTISQVLNKKLCF--E-----NPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHHHCCCCT--T-----SGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCC-----h---HHHHHHHHhccccc--C-----CcccccCCHHHHHHHHHHcCCChhH
Confidence 999999999999999999984311 1 11111111111100 0 0011223457899999999999999
Q ss_pred CCCHHHHHH
Q 012214 434 RPTMEEVSM 442 (468)
Q Consensus 434 RPt~~evl~ 442 (468)
|||+.++++
T Consensus 322 Rps~~~~l~ 330 (345)
T 3hko_A 322 RFDAMRALQ 330 (345)
T ss_dssp SCCHHHHHH
T ss_pred CCCHHHHhc
Confidence 999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=345.59 Aligned_cols=270 Identities=19% Similarity=0.214 Sum_probs=201.7
Q ss_pred hcCCCCCceeeecCcEEEEEEEec----CCcEEEEEecccccchHH--H-----HHHHHHHHHHHHHHhcCCCceeeEee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE----DGRIIAVKKSKLTVDDEE--L-----LKLEEFINEIVILSQINHRNVVKLLG 231 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~--~-----~~~~~~~~Ei~~l~~l~h~niv~l~g 231 (468)
.++|.+.+.||+|+||.||+|... ++..+|+|+......... . .....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999975 578899998865432210 0 11234678889999999999999999
Q ss_pred eecc----CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC
Q 012214 232 CCLE----TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ 307 (468)
Q Consensus 232 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~ 307 (468)
++.+ ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEES
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEcc
Confidence 9987 67889999999 999999997643 5899999999999999999999999 999999999999998
Q ss_pred CC--cEEEEecCCcccccCCCcee------eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 012214 308 RY--RAKVADFGTSKFIAMDQTHV------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNT 379 (468)
Q Consensus 308 ~~--~~kl~DfGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~ 379 (468)
++ .+||+|||+++.+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 87 99999999998764332111 13456999999999999999999999999999999999999998431111
Q ss_pred ccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 380 SQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
.. .......... ..+...+.. .......+..+.+++.+||+.||++|||+.+|++.|+.+.-
T Consensus 267 ~~----~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 267 PV----AVQTAKTNLL-DELPQSVLK---WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HH----HHHHHHHHHH-HTTTHHHHH---HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cH----HHHHHHHhhc-ccccHHHHh---hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11 1111111111 111111100 00111345589999999999999999999999999998654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=351.98 Aligned_cols=259 Identities=29% Similarity=0.463 Sum_probs=194.9
Q ss_pred CCCCCceeeecCcEEEEEEEec--CC--cEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc-CCcc
Q 012214 165 HFNANRILGQGGQGTVYKGMLE--DG--RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE-TEVP 239 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~--~g--~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~ 239 (468)
.|.+.+.||+|+||.||+|... ++ ..||+|.+...... ...+.|.+|+.++++++||||+++++++.+ ....
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI---GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS---HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 4667788999999999999853 22 36899988654333 455789999999999999999999998754 5578
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a 239 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA 239 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred EEEEECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccc
Confidence 99999999999999996532 35889999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCce---eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 320 KFIAMDQTH---VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 320 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
+........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||..... ....... ..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~-----~~~~~~~---~~ 311 (373)
T 3c1x_A 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITVYL---LQ 311 (373)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS-----SCHHHHH---HT
T ss_pred ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH-----HHHHHHH---Hc
Confidence 866433221 1233457889999999999999999999999999999999 5666532111 1111111 11
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.... ..+..++..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 312 ~~~~----------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 312 GRRL----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1110 012234457899999999999999999999999999887554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=339.75 Aligned_cols=262 Identities=25% Similarity=0.360 Sum_probs=198.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc--
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP-- 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~-- 239 (468)
.++|.+.+.||+|+||.||++.. .+++.||||++....... ......+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD-PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTS-HHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCC-HHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 46799999999999999999996 578999999987643222 24456789999999999999999999998766544
Q ss_pred --eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 012214 240 --LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG 317 (468)
Q Consensus 240 --~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfG 317 (468)
++||||+++++|.+++.... ++++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCS
T ss_pred ccEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeecc
Confidence 99999999999999997632 4899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCce--eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 318 TSKFIAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 318 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ..........
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~ 233 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVR 233 (311)
T ss_dssp CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHH
T ss_pred CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhc
Confidence 99866443221 2334568999999999999999999999999999999999999984311 1111111111
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHH-HHHHHHhcc
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE-VSMELNGIR 448 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e-vl~~L~~i~ 448 (468)
...... .......+..+.+++.+||+.||++||++.+ +...|..+.
T Consensus 234 ~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 234 EDPIPP-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CCCCCH-------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCCc-------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 111110 0001224457899999999999999996554 445565543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=345.30 Aligned_cols=253 Identities=21% Similarity=0.318 Sum_probs=204.1
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP----LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH----HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch----hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 467999999999999999999965 688999998865432 233568899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC--CCcEEEEecCCc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ--RYRAKVADFGTS 319 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~--~~~~kl~DfGla 319 (468)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 126 v~E~~~gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a 198 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 198 (387)
T ss_dssp EEECCCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEcCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccc
Confidence 99999999999998652 235899999999999999999999999 999999999999974 578999999999
Q ss_pred ccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|..||... ... ........ ..+
T Consensus 199 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-----~~~---~~~~~i~~-~~~ 267 (387)
T 1kob_A 199 TKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-----DDL---ETLQNVKR-CDW 267 (387)
T ss_dssp EECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHH---HHHHHHHH-CCC
T ss_pred eecCCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC-----CHH---HHHHHHHh-CCC
Confidence 87654433 23346999999999999999999999999999999999999998531 111 11111111 110
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
. .+ .......+..+.+++.+||+.||++|||+.|+++.
T Consensus 268 ~--~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 268 E--FD----EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp C--CC----SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred C--CC----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 00 00112334578999999999999999999999873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=335.95 Aligned_cols=266 Identities=27% Similarity=0.411 Sum_probs=200.4
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec----CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 237 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 237 (468)
..++|.+.+.||+|+||.||+|... .++.||+|++....... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ--REIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch--hHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 4578999999999999999999854 34589999987543332 44577999999999999999999999997655
Q ss_pred -----cceeEeeecCCCChhhHhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcE
Q 012214 238 -----VPLLVYEFIPNGTLYQHLHDRHQ-NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA 311 (468)
Q Consensus 238 -----~~~lV~E~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~ 311 (468)
..++||||+++++|.+++..... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 34999999999999999865322 23346999999999999999999999999 9999999999999999999
Q ss_pred EEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHH
Q 012214 312 KVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAY 389 (468)
Q Consensus 312 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~ 389 (468)
||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... .......
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~~~~ 261 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-----NHEMYDY 261 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHHH
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC-----HHHHHHH
Confidence 99999999866443322 2233457889999999999999999999999999999999 888874311 1111111
Q ss_pred HHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 390 FVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
....... ..+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 262 ---~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 262 ---LLHGHRL----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp ---HHTTCCC----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHcCCCC----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111110 11223445789999999999999999999999999988653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=335.55 Aligned_cols=268 Identities=22% Similarity=0.351 Sum_probs=202.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||++.. .+|+.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 46799999999999999999996 47899999998753221 11445678999999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 110 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred EEecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 9999999999999976332 2235899999999999999999999999 99999999999999999999999999876
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
...... ......+|..|+|||.+.+..++.++||||||+++|+|++|+.||..... .... ............
T Consensus 186 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~-~~~~~~~~~~~~ 257 (310)
T 2wqm_A 186 FSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYS-LCKKIEQCDYPP 257 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C------CHHH-HHHHHHTTCSCC
T ss_pred ecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------hHHH-HHHHhhcccCCC
Confidence 543322 22334689999999999999999999999999999999999999853111 1111 111111111111
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.. ....+..+.+++.+||+.||++|||+.++++.|+.|....
T Consensus 258 ~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 258 LP--------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp CC--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred Cc--------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 11 1233457899999999999999999999999999987544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=338.22 Aligned_cols=266 Identities=26% Similarity=0.407 Sum_probs=208.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-----cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 237 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 237 (468)
.++|.+.+.||+|+||.||++.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE----EHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS----HHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH----HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 36788999999999999999983 3688999999876422 34567899999999999999999999987644
Q ss_pred --cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 238 --VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 238 --~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~D 188 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD 188 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred CCceEEEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEec
Confidence 7899999999999999997632 25899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCcee--eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCC--------CCccchhc
Q 012214 316 FGTSKFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAG--------NTSQENVS 385 (468)
Q Consensus 316 fGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~--------~~~~~~~~ 385 (468)
||++.......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+.... ..... ..
T Consensus 189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~-~~ 267 (326)
T 2w1i_A 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-QM 267 (326)
T ss_dssp CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCT-HH
T ss_pred CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccch-hh
Confidence 99998765443322 223457778999999999889999999999999999999999874210 00000 00
Q ss_pred hHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 386 LAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
............ .....+...+..+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 268 ~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 268 IVFHLIELLKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHHHHHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHhhcC---------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000011111110 0011123445689999999999999999999999999998864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=345.03 Aligned_cols=248 Identities=22% Similarity=0.287 Sum_probs=200.4
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||+|.. .+++.||+|++...... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 6789999999999999999996 57899999988642211 112234688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+ +|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 88 ~E~~-~g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp ECCC-CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EECC-CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999 789999887643 4899999999999999999999999 999999999999999999999999999866
Q ss_pred cCCCceeeecccccCCccCccccccCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
..... .....||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||.......... .....
T Consensus 159 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---------~i~~~---- 223 (336)
T 3h4j_B 159 TDGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK---------KVNSC---- 223 (336)
T ss_dssp TTSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---------CCCSS----
T ss_pred cCCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---------HHHcC----
Confidence 44322 234569999999999988776 679999999999999999999985321111000 00000
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
....+...++.+.+|+.+||+.||.+|||+.|+++
T Consensus 224 ------~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 224 ------VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ------CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ------CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00112223457889999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=347.08 Aligned_cols=265 Identities=25% Similarity=0.336 Sum_probs=192.4
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccCC--
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETE-- 237 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~-- 237 (468)
..++|.+.+.||+|+||.||+|... +|+.||||++....... .....+.+|+.++..+. ||||+++++++...+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS--TDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCH--HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccCh--HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 4578999999999999999999964 68999999886543222 34567889999999997 999999999986543
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG 317 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfG 317 (468)
..++||||++ ++|..++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCc
Confidence 6899999997 6899988752 4899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCC--------------------CceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 012214 318 TSKFIAMD--------------------QTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWA 376 (468)
Q Consensus 318 la~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~ 376 (468)
+++..... .....+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99865321 1112334579999999999887 67899999999999999999999998531
Q ss_pred CCCccchhchHHHHHHHhhccccc-----------------------------hhcc----hHHhhhchHHHHHHHHHHH
Q 012214 377 GNTSQENVSLAAYFVHSMRKNRLH-----------------------------DILD----DQLMKLGVKNQIMTFANLA 423 (468)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~d----~~l~~~~~~~~~~~l~~li 423 (468)
. ..............+... .... ...........++.+.+|+
T Consensus 235 ~-----~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 309 (388)
T 3oz6_A 235 S-----TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL 309 (388)
T ss_dssp S-----HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHH
T ss_pred C-----HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHH
Confidence 1 111111111111111000 0000 0000001113356789999
Q ss_pred HHhhccCCCCCCCHHHHHHH
Q 012214 424 KRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 424 ~~cl~~dp~~RPt~~evl~~ 443 (468)
.+||+.||++|||+.|+++.
T Consensus 310 ~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 310 DKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHCCSSGGGSCCHHHHTTS
T ss_pred HHhhccCcccCCCHHHHhCC
Confidence 99999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=343.31 Aligned_cols=264 Identities=27% Similarity=0.403 Sum_probs=206.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcE--EEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRI--IAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~--vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~ 239 (468)
++|.+.+.||+|+||.||++... ++.. +|+|.+...... ...+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch---HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 67899999999999999999964 5664 499988653222 3446788999999999 999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQ-----------NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR 308 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~ 308 (468)
++||||+++++|.+++..... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCC
Confidence 999999999999999976431 12246899999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchH
Q 012214 309 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLA 387 (468)
Q Consensus 309 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~ 387 (468)
+.+||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..
T Consensus 179 ~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~ 248 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CA 248 (327)
T ss_dssp GCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HH
T ss_pred CeEEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc--------HH
Confidence 99999999998743221 11233457889999999998889999999999999999998 999984311 11
Q ss_pred HHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCch
Q 012214 388 AYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKK 453 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 453 (468)
. ......... ....+...+..+.+++.+||+.||++|||+.++++.|+.+....+.
T Consensus 249 ~-~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 249 E-LYEKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp H-HHHHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred H-HHHHhhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 1 111111110 0011223445789999999999999999999999999988766543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=370.98 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=198.6
Q ss_pred eeeecCcEEEEEEEec---CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecC
Q 012214 171 ILGQGGQGTVYKGMLE---DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 171 ~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
.||+|+||.||+|.+. ++..||||+++..... ...++|.+|+.++++++||||+++++++.+ +..++||||++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~ 418 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK---ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG 418 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS---TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCC
Confidence 7999999999999864 4667999998764332 345679999999999999999999999976 56899999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCc
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT 327 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 327 (468)
+|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 419 ~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 419 GGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp TCBHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred CCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 99999999653 235899999999999999999999999 99999999999999999999999999987654332
Q ss_pred ee--eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchhcc
Q 012214 328 HV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404 (468)
Q Consensus 328 ~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 404 (468)
.. .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... . .. ....+.....
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~--~---~~----~~~~i~~~~~----- 557 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--G---PE----VMAFIEQGKR----- 557 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--S---HH----HHHHHHTTCC-----
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC--H---HH----HHHHHHcCCC-----
Confidence 22 223346789999999999999999999999999999998 999985311 1 11 1111111111
Q ss_pred hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 405 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
...+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 558 ----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 558 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp ----CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 11123455689999999999999999999999999988653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=339.43 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=179.6
Q ss_pred CceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccCCcceeEeeec
Q 012214 169 NRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLLVYEFI 246 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~ 246 (468)
.+.||+|+||.||++... +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 88 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL 88 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence 477999999999999975 6899999998642 2245678999999996 999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC---cEEEEecCCccccc
Q 012214 247 PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY---RAKVADFGTSKFIA 323 (468)
Q Consensus 247 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~---~~kl~DfGla~~~~ 323 (468)
++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 89 ~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 89 NGGELFERIKKK-----KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp CSCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999999763 25899999999999999999999999 99999999999997765 89999999998654
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
.... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||....... ................... .
T Consensus 161 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~i~~~~~~~-~ 236 (325)
T 3kn6_A 161 PDNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL--TCTSAVEIMKKIKKGDFSF-E 236 (325)
T ss_dssp C-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCCHHHHHHHHTTTCCCC-C
T ss_pred CCCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc--ccccHHHHHHHHHcCCCCC-C
Confidence 4322 2234568999999999999999999999999999999999999985422110 0011111122222221110 0
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.......++.+.+|+.+||+.||++|||+.|+++
T Consensus 237 -----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 237 -----GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp -----SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred -----cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0111234557899999999999999999999885
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=333.61 Aligned_cols=263 Identities=24% Similarity=0.317 Sum_probs=198.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||++... +|+.||+|++....... ...+.+.+|+.++++++||||+++++++.+....++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP--VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-H--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 67889999999999999999975 58999999886644332 3456788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLL 152 (311)
T ss_dssp EECCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence 9999999998887652 24899999999999999999999999 999999999999999999999999999866
Q ss_pred cCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc-----
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK----- 396 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 396 (468)
..... ......||..|+|||.+.+ ..++.++||||||+++|+|++|+.||.... ..+ ...........
T Consensus 153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~---~~~~~~~~~~~~~~~~ 226 (311)
T 4agu_A 153 TGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS--DVD---QLYLIRKTLGDLIPRH 226 (311)
T ss_dssp C-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHH---HHHHHHHHHCSCCHHH
T ss_pred cCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHH---HHHHHHHHhccccccc
Confidence 43322 2234568999999999876 678999999999999999999999985311 111 11111111000
Q ss_pred ------c------ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 397 ------N------RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 397 ------~------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ......+...........+..+.+|+.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 000000000000001234557899999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=348.83 Aligned_cols=274 Identities=23% Similarity=0.327 Sum_probs=212.7
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC--cc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE--VP 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--~~ 239 (468)
.++|.+.+.||+|+||.||+|... +++.||||++...... ...+.+.+|+.++++++||||+++++++.+.. ..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 367899999999999999999975 5899999998753322 23466789999999999999999999987655 67
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE----cCCCcEEEEe
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL----DQRYRAKVAD 315 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl----~~~~~~kl~D 315 (468)
++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred EEEEecCCCCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEec
Confidence 9999999999999999764322 24899999999999999999999999 9999999999999 7888899999
Q ss_pred cCCcccccCCCceeeecccccCCccCcccccc--------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchH
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS--------SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLA 387 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~ 387 (468)
||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .
T Consensus 160 FG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~----~ 233 (396)
T 4eut_A 160 FGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN----K 233 (396)
T ss_dssp GGGCEECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC----H
T ss_pred CCCceEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch----H
Confidence 999987654332 233569999999998865 56788999999999999999999998642221111 1
Q ss_pred HHHHHHhhccc---cchhcc-----------hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 388 AYFVHSMRKNR---LHDILD-----------DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 388 ~~~~~~~~~~~---~~~~~d-----------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
........... +..+.. ..............+.+++.+||+.||++|||+.++++.++.+...
T Consensus 234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11111111110 000000 0001122356777899999999999999999999999999987654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=341.69 Aligned_cols=209 Identities=29% Similarity=0.306 Sum_probs=180.9
Q ss_pred ccccCHHHHHHHhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-----CC
Q 012214 151 FKLFSSKELDKATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-----HR 224 (468)
Q Consensus 151 ~~~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-----h~ 224 (468)
...++..+.....++|.+.+.||+|+||.||+|.. .+++.||||++... . .....+..|+.+++.+. ||
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~---~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--K---KYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--H---HHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--h---hhhhhhHHHHHHHHHhcccCCCCC
Confidence 34566666667789999999999999999999996 46889999998642 1 33456778999999986 99
Q ss_pred ceeeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEE
Q 012214 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNIL 304 (468)
Q Consensus 225 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NIL 304 (468)
||+++++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 169 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENIL 169 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEE
Confidence 9999999999999999999999 899999998633 235899999999999999999999999 999999999999
Q ss_pred EcC-------------------------CCcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHH
Q 012214 305 LDQ-------------------------RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSF 359 (468)
Q Consensus 305 l~~-------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSl 359 (468)
++. ++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||
T Consensus 170 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 245 (360)
T 3llt_A 170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSF 245 (360)
T ss_dssp ESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred EccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHH
Confidence 975 789999999999864432 234568999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCC
Q 012214 360 GVVLVELLTGKKPIFW 375 (468)
Q Consensus 360 Gvll~el~tG~~p~~~ 375 (468)
||++|+|++|+.||..
T Consensus 246 G~il~ell~g~~pf~~ 261 (360)
T 3llt_A 246 GCVLAELYTGSLLFRT 261 (360)
T ss_dssp HHHHHHHHHSSCSCCC
T ss_pred HHHHHHHHHCCCCCCC
Confidence 9999999999999853
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=343.86 Aligned_cols=252 Identities=22% Similarity=0.295 Sum_probs=193.4
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||++... +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+....++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 468999999999999999999975 7899999998653322 2457799999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc--EEEEecCCc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR--AKVADFGTS 319 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~--~kl~DfGla 319 (468)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 94 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 94 IMEYASGGELYERICNAG-----RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred EEEeCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 999999999999997633 4899999999999999999999999 999999999999987765 999999998
Q ss_pred ccccCCCceeeecccccCCccCccccccCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc-
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDK-SDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN- 397 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 397 (468)
+...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... .............
T Consensus 166 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~~~~~~~~ 239 (361)
T 3uc3_A 166 KSSVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR----DYRKTIQRILSVKY 239 (361)
T ss_dssp -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC----CHHHHHHHHHTTCC
T ss_pred ccccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH----HHHHHHHHHhcCCC
Confidence 7433221 2233569999999999988887766 899999999999999999985422111 1111111111110
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
.... ....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 240 ~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 SIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCT----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCC----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1110 11234578899999999999999999999873
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=345.72 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=197.2
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC--CCceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN--HRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~~~~~~ 240 (468)
..+|.+.+.||+|+||.||++...+++.||||++....... ...+.+.+|+.++..++ ||||+++++++...+..+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN--QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccH--HHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 35699999999999999999998889999999986543322 45678999999999996 599999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||| +.+++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++
T Consensus 133 lv~E-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIAN 202 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred EEEe-cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccc
Confidence 9999 56889999997632 5889999999999999999999999 99999999999995 5899999999998
Q ss_pred cccCCCce-eeecccccCCccCcccccc-----------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH
Q 012214 321 FIAMDQTH-VTTKIQGTFGYLDPEYHQS-----------SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 321 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~ 388 (468)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... . ...
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~----~---~~~ 275 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII----N---QIS 275 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC----C---HHH
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh----H---HHH
Confidence 76543322 2344579999999999865 468889999999999999999999984311 1 111
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
.+........ ....+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 276 ~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 276 KLHAIIDPNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHHCTTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhCccc---------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111111111 001111223478899999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=328.42 Aligned_cols=250 Identities=29% Similarity=0.392 Sum_probs=199.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||++... +++.||+|++...... .......+.+|+.+++.++||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc-hhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 467899999999999999999865 5778999987543211 11224568899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 87 v~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp EECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecccccc
Confidence 999999999999997642 4899999999999999999999999 99999999999999999999999999865
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
..... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||... . ....... .....
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~---~~~~~~~-~~~~~--- 223 (279)
T 3fdn_A 159 APSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----T---YQETYKR-ISRVE--- 223 (279)
T ss_dssp C-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----S---HHHHHHH-HHHTC---
T ss_pred CCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC-----c---HHHHHHH-HHhCC---
Confidence 43222 23456899999999999999999999999999999999999998431 1 0111111 11100
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
...+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 224 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 -------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01122234478899999999999999999999973
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=336.66 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=200.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC-Cccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET-EVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-~~~~l 241 (468)
.++|.+.+.||+|+||.||++... |+.||+|++.... ..+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 477899999999999999999875 8899999987542 235688999999999999999999997654 47899
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 93 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 166 (278)
T ss_dssp EECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred EEecCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccc
Confidence 9999999999999976421 23789999999999999999999999 99999999999999999999999999875
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
.... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.... ..... ........
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-----~~~~~----~~~~~~~~- 232 (278)
T 1byg_A 167 ASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVV----PRVEKGYK- 232 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----GGGHH----HHHTTTCC-
T ss_pred cccc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC-----HHHHH----HHHhcCCC-
Confidence 4332 122357889999999999999999999999999999998 999984311 11111 11111100
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
...+...++.+.+++.+||+.||++|||+.++++.|+.++...
T Consensus 233 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 233 --------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 1112234557899999999999999999999999999987654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=354.58 Aligned_cols=250 Identities=25% Similarity=0.318 Sum_probs=194.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||++... +|+.||||++...... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 467999999999999999999964 6899999998643111 11334567899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS-ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++
T Consensus 226 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EECCCSSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEeeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCce
Confidence 999999999999997632 58999999999999999999998 88 9999999999999999999999999997
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh-cccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR-KNRL 399 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 399 (468)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ... ........ ....
T Consensus 298 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~---~~~~~i~~~~~~~ 368 (446)
T 4ejn_A 298 EGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHE---KLFELILMEEIRF 368 (446)
T ss_dssp TTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHH---HHHHHHHHCCCCC
T ss_pred eccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC-----CHH---HHHHHHHhCCCCC
Confidence 5433222 234467999999999999999999999999999999999999998531 111 11111111 1111
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
+...++.+.+|+.+||+.||.+|| |+.|+++
T Consensus 369 ------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 ------------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 222345789999999999999999 9999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=341.78 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=189.0
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
..++|.+.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 4577999999999999999999976 57899999987532 2256788999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC---CCcEEEEecC
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ---RYRAKVADFG 317 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~---~~~~kl~DfG 317 (468)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 125 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg 196 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFG 196 (349)
T ss_dssp EEECCCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred EEEEeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCc
Confidence 999999999999999653 24899999999999999999999999 999999999999975 8999999999
Q ss_pred CcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 318 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 318 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||..... . ...+..... .
T Consensus 197 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~---~~~~~~i~~-~ 266 (349)
T 2w4o_A 197 LSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG----D---QFMFRRILN-C 266 (349)
T ss_dssp ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC----H---HHHHHHHHT-T
T ss_pred cccccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc----c---HHHHHHHHh-C
Confidence 998654322 22345689999999999999999999999999999999999999853111 0 011111111 1
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
... ... ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 267 ~~~-~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 267 EYY-FIS-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CCC-CCT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCc-cCC-----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 110 000 011233457899999999999999999999987
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=339.30 Aligned_cols=251 Identities=25% Similarity=0.298 Sum_probs=202.1
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 240 (468)
.++|.+.+.||+|+||.||++... +++.||+|++...... .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 478999999999999999999976 4789999998653211 112346688999999888 8999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 98 lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 9999999999999997643 4899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... .. ...+..... ...
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-----~~---~~~~~~i~~-~~~- 238 (353)
T 2i0e_A 170 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-----DE---DELFQSIME-HNV- 238 (353)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-----SH---HHHHHHHHH-CCC-
T ss_pred ccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC-----CH---HHHHHHHHh-CCC-
Confidence 543222 2234467999999999999999999999999999999999999998531 11 111111111 111
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT-----MEEVSM 442 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 442 (468)
..+...+..+.+|+.+||+.||++||+ +.++++
T Consensus 239 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 ---------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 012234457899999999999999996 466654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=341.41 Aligned_cols=265 Identities=24% Similarity=0.329 Sum_probs=207.6
Q ss_pred hcCCCCCceeeecCcEEEEEEEe------cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC
Q 012214 163 TNHFNANRILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~ 236 (468)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... .....+.+|+.++++++||||+++++++.+.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE---QDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch---hhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 47899999999999999999983 24778999998754333 3446788999999999999999999999999
Q ss_pred CcceeEeeecCCCChhhHhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC---CCcE
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQN--EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ---RYRA 311 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~---~~~~ 311 (468)
...++||||+++++|.+++...... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999999875322 1235899999999999999999999999 999999999999984 4569
Q ss_pred EEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHH
Q 012214 312 KVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAY 389 (468)
Q Consensus 312 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~ 389 (468)
||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||... ... .
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-----~~~----~ 253 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-----SNQ----E 253 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHH----H
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc-----CHH----H
Confidence 99999999765433222 2234567899999999999999999999999999999998 88887431 111 1
Q ss_pred HHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 390 FVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
........... ..+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 254 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 254 VLEFVTSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 11111111110 112234457899999999999999999999999999887654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=336.15 Aligned_cols=267 Identities=23% Similarity=0.281 Sum_probs=197.1
Q ss_pred HhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHH-HHHHHHHHHHHHHHHhc---CCCceeeEeeeeccC
Q 012214 162 ATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEE-LLKLEEFINEIVILSQI---NHRNVVKLLGCCLET 236 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~-~~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~~ 236 (468)
..++|++.+.||+|+||+||+|.. .+++.||+|++........ ......+.+|+.+++.+ +||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999995 4689999998864321100 01112455666666665 599999999999765
Q ss_pred C-----cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcE
Q 012214 237 E-----VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA 311 (468)
Q Consensus 237 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~ 311 (468)
. ..++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCE
Confidence 4 4789999996 69999997632 234899999999999999999999999 9999999999999999999
Q ss_pred EEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHH
Q 012214 312 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391 (468)
Q Consensus 312 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (468)
||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||... ..........
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-----~~~~~~~~i~ 232 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN-----SEADQLGKIF 232 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS-----SHHHHHHHHH
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHH
Confidence 999999998654322 234457899999999999999999999999999999999999998531 1111111111
Q ss_pred HHhhccc---cchhc---chH-------HhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 392 HSMRKNR---LHDIL---DDQ-------LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 392 ~~~~~~~---~~~~~---d~~-------l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
....... +.... ... .........++.+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1111110 00000 000 000111234457899999999999999999999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=325.39 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=203.4
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|++.+.||+|+||.||++... +++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT---THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch---hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 367889999999999999999975 6899999998654332 234678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV 154 (276)
T ss_dssp EEECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccc
Confidence 99999999999998642 24899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCce-eeecccccCCccCccccccCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 322 IAMDQTH-VTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 322 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
....... ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||........ ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~ 227 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EYSDWKEKKTY 227 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-------HHHHHHTTCTT
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-------HHHHhhhcccc
Confidence 5433221 2334568999999999988665 7789999999999999999999854221111 11111111110
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 228 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 L---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp S---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c---------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0 001233457889999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=347.00 Aligned_cols=259 Identities=27% Similarity=0.336 Sum_probs=203.1
Q ss_pred hcCCCCCceeeecCcEEEEEEEe----cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCC
Q 012214 163 TNHFNANRILGQGGQGTVYKGML----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETE 237 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~ 237 (468)
.++|.+.+.||+|+||.||++.. .+++.||||+++...........+.+.+|+.++..+ +||||+++++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999996 368999999986432111111224567899999999 7999999999999999
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG 317 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfG 317 (468)
..++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred eEEEEeecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCC
Confidence 9999999999999999997642 4899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCceeeecccccCCccCcccccc--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 318 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 318 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
+++..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~ 280 (355)
T 1vzo_A 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRRILK 280 (355)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHHHHH
T ss_pred CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch----HHHHHHHHhc
Confidence 998765444444445679999999999986 3578899999999999999999999864221111 1111111111
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSMEL 444 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~L 444 (468)
.. ...+...+..+.+|+.+||+.||++|| |+.|+++..
T Consensus 281 ~~-----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 281 SE-----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred cC-----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 10 011223345788999999999999999 899988643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=329.99 Aligned_cols=263 Identities=25% Similarity=0.392 Sum_probs=198.1
Q ss_pred hcCCCCCceeeecCcEEEEEEEec--CCc--EEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE--DGR--IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~--~g~--~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
.++|.+.+.||+|+||.||+|.+. +++ .||+|++...... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 367899999999999999999853 233 6899988653221 1144578999999999999999999999998755
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ceeeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccc
Confidence 889999999999999997642 24899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCcee--eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 319 SKFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 319 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
+.......... .....+|..|+|||.+.+..++.++||||||+++|+|++ |+.||... .. .........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~---~~~~~~~~~ 239 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NG---SQILHKIDK 239 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CH---HHHHHHHHT
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC-----CH---HHHHHHHHc
Confidence 98765443322 233457888999999998889999999999999999999 99998431 11 111111111
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
..... ..+...+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 240 ~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 240 EGERL---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp SCCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cCCCC---------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 11100 012234457999999999999999999999999999987654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=350.33 Aligned_cols=249 Identities=25% Similarity=0.339 Sum_probs=203.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||+|... +|+.||||++...... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 67899999999999999999975 7999999998653211 112346788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 95 MEYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 9999999999999652 25899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
..... .....||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||.... . ...+.... ....
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~---~~~~~~i~-~~~~-- 233 (476)
T 2y94_A 167 SDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-----V---PTLFKKIC-DGIF-- 233 (476)
T ss_dssp CTTCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----S---HHHHHHHH-TTCC--
T ss_pred ccccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-----H---HHHHHHHh-cCCc--
Confidence 54322 234579999999999988765 679999999999999999999985311 0 11111111 1110
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 234 --------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 --------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 011223347889999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=369.00 Aligned_cols=251 Identities=26% Similarity=0.377 Sum_probs=198.4
Q ss_pred ceeeecCcEEEEEEEec---CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeec
Q 012214 170 RILGQGGQGTVYKGMLE---DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFI 246 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 246 (468)
+.||+|+||.||+|.+. .++.||||+++...... ...+++.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP--ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG--GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence 47999999999999753 46789999987643221 335679999999999999999999999964 5578999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 012214 247 PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQ 326 (468)
Q Consensus 247 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 326 (468)
++|+|.+++.... .+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 452 ~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 452 ELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp TTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCCCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 9999999997532 4899999999999999999999999 9999999999999999999999999998765443
Q ss_pred ce--eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 327 TH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 327 ~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
.. ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ... .....+.....
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-----~~~----~~~~~i~~~~~---- 590 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-----KGS----EVTAMLEKGER---- 590 (635)
T ss_dssp -----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHH----HHHHHHHTTCC----
T ss_pred cccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----CHH----HHHHHHHcCCC----
Confidence 22 2333457889999999999999999999999999999998 99998431 111 11111111111
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
...+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 591 -----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 591 -----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11123445689999999999999999999999999997653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=328.60 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=182.3
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||++.. .+++.||+|++...... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 5788999999999999999996 47899999998642211 112246788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.... .++++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 99999999999997532 36899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ ..... ....
T Consensus 163 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~-~~~~--- 229 (278)
T 3cok_A 163 KMPHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--------LNKVV-LADY--- 229 (278)
T ss_dssp C-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CC-SSCC---
T ss_pred cCCCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------HHHHh-hccc---
Confidence 432221 2235689999999999999999999999999999999999999854211100 00000 0000
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+...+..+.+++.+||+.||++|||+.++++
T Consensus 230 -------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 -------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 011223447889999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=330.16 Aligned_cols=248 Identities=22% Similarity=0.320 Sum_probs=199.1
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 240 (468)
.++|.+.+.||+|+||.||++... +++.||+|++....... .....+.+|+..+..+ +||||+++++++.+.+..+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS--VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS--HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 467899999999999999999975 78999999987543322 3456788999999999 9999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC------------
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR------------ 308 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~------------ 308 (468)
+||||+++++|.+++...... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------
T ss_pred EEEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccc
Confidence 999999999999999764321 135899999999999999999999999 9999999999999844
Q ss_pred -------CcEEEEecCCcccccCCCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCc
Q 012214 309 -------YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTS 380 (468)
Q Consensus 309 -------~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~ 380 (468)
..+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||++|+|++|..++..
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~----- 233 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----- 233 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS-----
T ss_pred ccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc-----
Confidence 479999999998664332 23489999999998875 667899999999999999999877532
Q ss_pred cchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 381 QENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.. . ........... .+...+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~--~-----~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 234 GD--Q-----WHEIRQGRLPR---------IPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp SH--H-----HHHHHTTCCCC---------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hh--H-----HHHHHcCCCCC---------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 00 0 11111111111 11233457899999999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=324.55 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=201.4
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
..++|.+.+.||+|+||.||++... ++..+|+|++...... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE----DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 3467899999999999999999965 4778999988653322 2457889999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE---cCCCcEEEEecC
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL---DQRYRAKVADFG 317 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl---~~~~~~kl~DfG 317 (468)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||||+||++ +.++.+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKR-----VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp EEEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEeccCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 9999999999999987632 4899999999999999999999999 9999999999999 788999999999
Q ss_pred CcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 318 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 318 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
++........ .....||+.|+|||.+.+. ++.++||||||+++|+|++|+.||.... .. ..... ....
T Consensus 155 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~---~~~~~-~~~~ 222 (277)
T 3f3z_A 155 LAARFKPGKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT-----DS---EVMLK-IREG 222 (277)
T ss_dssp TCEECCTTSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HH---HHHHH-HHHC
T ss_pred cceeccCccc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC-----HH---HHHHH-HHhC
Confidence 9986654332 2334689999999988664 8999999999999999999999985311 11 11111 1111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.... ... .....++.+.+++.+||+.||++|||+.++++
T Consensus 223 ~~~~-~~~-----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 223 TFTF-PEK-----DWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CCCC-CHH-----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCC-Cch-----hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1100 000 01123457899999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=329.63 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=196.6
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||++... ++..+|+|++...... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ---VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc---hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 367899999999999999999964 6889999988654332 234678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE---cCCCcEEEEecCC
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL---DQRYRAKVADFGT 318 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl---~~~~~~kl~DfGl 318 (468)
||||+++|+|.+++...... ...+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+
T Consensus 98 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 99999999999998654211 235999999999999999999999999 9999999999999 5568899999999
Q ss_pred cccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
+........ .....||+.|+|||.+. +.++.++||||||+++|||++|+.||.... ....... .......
T Consensus 174 a~~~~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~-----~~~~~~~--~~~~~~~ 243 (285)
T 3is5_A 174 AELFKSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-----LEEVQQK--ATYKEPN 243 (285)
T ss_dssp CCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH--HHHCCCC
T ss_pred ceecCCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC-----HHHHHhh--hccCCcc
Confidence 976543322 33456899999999876 568899999999999999999999985311 0000000 0001111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.... ....++.+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 YAVE---------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCC-----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccc---------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0112347889999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=349.01 Aligned_cols=260 Identities=21% Similarity=0.288 Sum_probs=195.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 237 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~---- 237 (468)
.++|++.+.||+|+||.||++... +++.||||++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh--HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 478999999999999999999864 68999999987543222 44567889999999999999999999996543
Q ss_pred --cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 238 --VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 238 --~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
..++||||+++ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~D 207 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 207 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred CCeEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEE
Confidence 46999999975 56666643 3889999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............
T Consensus 208 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~-----~~~~~~~i~~~lg 280 (464)
T 3ttj_A 208 FGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-----YIDQWNKVIEQLG 280 (464)
T ss_dssp CCCC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHC
T ss_pred EEeeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcC
Confidence 9999865432 22344679999999999999999999999999999999999999985311 1111111111110
Q ss_pred cc--------------------c-----cchhcchHH---hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 396 KN--------------------R-----LHDILDDQL---MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 396 ~~--------------------~-----~~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+ . +.......+ ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp SCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0 000000000 00011223567899999999999999999999987
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=357.42 Aligned_cols=256 Identities=25% Similarity=0.301 Sum_probs=205.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||++... +|+.||+|++...... .......+.+|+.+++.++||||+++++++.+....++
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh-hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 467999999999999999999975 6899999998653211 11234568899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 262 VmEy~~gg~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EECCCCSCBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEcCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccccee
Confidence 999999999999997632 235899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ...........
T Consensus 336 ~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~----~~-~~i~~~i~~~~--- 405 (576)
T 2acx_A 336 VPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KR-EEVERLVKEVP--- 405 (576)
T ss_dssp CCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC----CH-HHHHHHHHHCC---
T ss_pred cccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch----hH-HHHHHHhhccc---
Confidence 654332 233579999999999999999999999999999999999999986422111 01 11111111110
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
...+...+..+.+|+.+||+.||++|| ++.|+++
T Consensus 406 -------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 -------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 011223345789999999999999999 7788875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=334.37 Aligned_cols=255 Identities=25% Similarity=0.336 Sum_probs=204.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHH--HHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEE--LLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
.++|.+.+.||+|+||.||++... +|+.||+|++........ ....+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467899999999999999999965 689999998865432210 01246788999999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC----cEEEEe
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY----RAKVAD 315 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~----~~kl~D 315 (468)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999999752 25899999999999999999999999 99999999999999888 799999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
||++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|..||... . . ........
T Consensus 163 fg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~---~---~~~~~~i~- 231 (321)
T 2a2a_A 163 FGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--T---K---QETLANIT- 231 (321)
T ss_dssp CTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--S---H---HHHHHHHH-
T ss_pred CccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC--C---H---HHHHHHHH-
Confidence 999986654322 23456899999999999999999999999999999999999998431 1 1 11111111
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.... . .+... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~-~-~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 232 SVSY-D-FDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TTCC-C-CCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hccc-c-cChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1100 0 01111 1233457899999999999999999999987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=326.18 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=204.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||++... +++.+|+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC-HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 367889999999999999999975 57889999876532211 1345678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 93 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp EEECCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 999999999999887632 4899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... ......... ....
T Consensus 165 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~-- 232 (294)
T 2rku_A 165 VEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIK-KNEY-- 232 (294)
T ss_dssp CCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH-TTCC--
T ss_pred cccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHh-hccC--
Confidence 643322 2233568999999999999999999999999999999999999984311 011111111 1110
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 233 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 --------SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --------CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 011223347889999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=338.29 Aligned_cols=262 Identities=22% Similarity=0.312 Sum_probs=195.3
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||+||+|... +++.||+|++...... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 57888999999999999999975 6899999998653322 2222456799999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||++ |+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 150 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAK 150 (324)
T ss_dssp EECCS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred ecccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence 99997 59999887632 25899999999999999999999999 999999999999999999999999999765
Q ss_pred cCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc---cc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK---NR 398 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 398 (468)
..... ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||... ............... ..
T Consensus 151 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~ 224 (324)
T 3mtl_A 151 SIPTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS-----TVEEQLHFIFRILGTPTEET 224 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHHHCCCCTTT
T ss_pred cCCcc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHhCCCChHh
Confidence 43222 2233468999999999876 56899999999999999999999998531 111111111111111 11
Q ss_pred cchhcchHHh-------------hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHDILDDQLM-------------KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~~~d~~l~-------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+......... .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 1111111000 0011233457899999999999999999999987
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=341.66 Aligned_cols=246 Identities=23% Similarity=0.294 Sum_probs=193.8
Q ss_pred CceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeecC
Q 012214 169 NRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM----KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 567999999999999964 689999999876422 334678999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE--cCCCcEEEEecCCcccccCC
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL--DQRYRAKVADFGTSKFIAMD 325 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl--~~~~~~kl~DfGla~~~~~~ 325 (468)
+++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 170 ~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 170 GGELFDRIIDES----YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp TCEEHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 999999887532 25899999999999999999999999 9999999999999 67789999999999876543
Q ss_pred CceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcch
Q 012214 326 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDD 405 (468)
Q Consensus 326 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 405 (468)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .. .......... +. ...
T Consensus 243 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~~---~~~~~i~~~~-~~-~~~- 309 (373)
T 2x4f_A 243 EK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN-----DA---ETLNNILACR-WD-LED- 309 (373)
T ss_dssp CB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS-----HH---HHHHHHHHTC-CC-SCS-
T ss_pred cc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----HH---HHHHHHHhcc-CC-CCh-
Confidence 32 233469999999999999999999999999999999999999985311 11 1111111110 00 000
Q ss_pred HHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 406 QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 406 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
......++.+.+|+.+||+.||.+|||+.|+++
T Consensus 310 ----~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 ----EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011233457899999999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=343.00 Aligned_cols=265 Identities=15% Similarity=0.207 Sum_probs=204.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEecC---------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceee-----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLED---------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK----- 228 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~----- 228 (468)
.++|.+.+.||+|+||.||+|.... ++.||+|++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhhh
Confidence 3689999999999999999999753 789999998653 24778999999999999988
Q ss_pred ----------Eeeeecc-CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecC
Q 012214 229 ----------LLGCCLE-TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRD 297 (468)
Q Consensus 229 ----------l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~D 297 (468)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+.+ |+|||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~D 184 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENE---YVHGN 184 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSC
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCC
Confidence 5666654 67889999999 999999998642 235999999999999999999999999 99999
Q ss_pred CCCCCEEEcCCC--cEEEEecCCcccccCCCce------eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhC
Q 012214 298 IKSTNILLDQRY--RAKVADFGTSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTG 369 (468)
Q Consensus 298 Lkp~NILl~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG 369 (468)
|||+|||++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|
T Consensus 185 ikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 264 (352)
T 2jii_A 185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG 264 (352)
T ss_dssp CCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999998 9999999999876533221 12334799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 370 KKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 370 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
+.||....... ............ ....+.+... .....+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 265 ~~pf~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 265 FLPWTNCLPNT---EDIMKQKQKFVD--KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp CCTTGGGTTCH---HHHHHHHHHHHH--SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCcccCCcCH---HHHHHHHHhccC--Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 99985422111 111111111111 1111111000 011234579999999999999999999999999998765
Q ss_pred CC
Q 012214 450 SS 451 (468)
Q Consensus 450 ~~ 451 (468)
..
T Consensus 337 ~~ 338 (352)
T 2jii_A 337 DL 338 (352)
T ss_dssp HT
T ss_pred hc
Confidence 43
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=349.28 Aligned_cols=196 Identities=27% Similarity=0.411 Sum_probs=155.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc-----C
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE-----T 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-----~ 236 (468)
.++|.+.+.||+|+||.||+|... +++.||||++....... ...+.+.+|+.+++.++||||+++++++.. .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDL--IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCH--HHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 378999999999999999999865 68999999886543322 445778999999999999999999999844 3
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...++||||+ +++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DF 200 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDF 200 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecc-ccchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeeccc
Confidence 5689999998 57999988652 25999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCc--------------------------eeeecccccCCccCcccc-ccCCCCCcccHHHHHHHHHHHHhC
Q 012214 317 GTSKFIAMDQT--------------------------HVTTKIQGTFGYLDPEYH-QSSQLTDKSDVYSFGVVLVELLTG 369 (468)
Q Consensus 317 Gla~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlGvll~el~tG 369 (468)
|+++....... ...+..+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 99987643211 122345689999999976 456799999999999999999994
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=326.68 Aligned_cols=274 Identities=22% Similarity=0.318 Sum_probs=197.7
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|++.+.||+|+||.||++.. .+++.||+|++....... ...+.+..+...++.++||||+++++++.+....++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ--EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH--HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 47789999999999999999996 478999999987643332 223344555566888899999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA-TSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
||||++ |+|.+++..... ....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++
T Consensus 84 v~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEECCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEehhc-cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999997 588888765322 223699999999999999999999998 8 9999999999999999999999999997
Q ss_pred cccCCCceeeecccccCCccCcccc----ccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYH----QSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
....... .....||+.|+|||.+ .+..++.++||||||+++|+|++|+.||..... ...........
T Consensus 159 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~ 229 (290)
T 3fme_A 159 YLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-------PFQQLKQVVEE 229 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-------HHHHHHHHHHS
T ss_pred ccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-------hHHHHHHHhcc
Confidence 6644322 2334689999999996 556788999999999999999999999853111 11111111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhcccCCchhhhHHHHH
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGIRGSSKKKRAMFSKI 461 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i~~~~~~~~~~~~~~ 461 (468)
... .. .....+..+.+++.+||+.||++|||+.|+++ .+...............++
T Consensus 230 ~~~-~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~ 287 (290)
T 3fme_A 230 PSP-QL--------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVASFVKLI 287 (290)
T ss_dssp CCC-CC--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCCCHHHHHHHH
T ss_pred CCC-Cc--------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcccccCHHHHHHHh
Confidence 111 10 11223457899999999999999999999987 5555554444444444443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=337.65 Aligned_cols=265 Identities=18% Similarity=0.260 Sum_probs=194.5
Q ss_pred HHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 161 KATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
...++|.+.+.||+|+||+||++... +++.||||++....... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE--GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc--ccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 34578999999999999999999854 78999999987643322 3345678999999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE-----cCCCcEEEE
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL-----DQRYRAKVA 314 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl-----~~~~~~kl~ 314 (468)
++||||++ |+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 109 ~lv~e~~~-~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp EEEEECCS-EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred EEEEecCC-CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEEC
Confidence 99999997 59999997632 4899999999999999999999999 9999999999999 455669999
Q ss_pred ecCCcccccCCCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH
Q 012214 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 315 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
|||+++....... ......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||... ............
T Consensus 180 Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~~~~~ 253 (329)
T 3gbz_A 180 DFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD-----SEIDQLFKIFEV 253 (329)
T ss_dssp CTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHH
T ss_pred cCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC-----CHHHHHHHHHHH
Confidence 9999986643322 22334689999999999874 5899999999999999999999998531 111111111111
Q ss_pred hhccc----------------cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 394 MRKNR----------------LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 394 ~~~~~----------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..... ........+....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 11000 00011111111112224467899999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=341.78 Aligned_cols=249 Identities=26% Similarity=0.330 Sum_probs=192.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHH-HHhcCCCceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVI-LSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~-l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
.++|.+.+.||+|+||.||+++.+ +++.||+|++........ .....+.+|..+ ++.++||||+++++++.+.+..+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~-~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh-HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 467999999999999999999975 588999999865432211 234556677766 56789999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 116 lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~ 187 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK 187 (373)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred EEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccc
Confidence 9999999999999997633 4889999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
...... .......||+.|+|||++.+..++.++|||||||++|||++|..||... .. ...+...... .+.
T Consensus 188 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-----~~---~~~~~~i~~~-~~~ 257 (373)
T 2r5t_A 188 ENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----NT---AEMYDNILNK-PLQ 257 (373)
T ss_dssp GGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS-----BH---HHHHHHHHHS-CCC
T ss_pred ccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CH---HHHHHHHHhc-ccC
Confidence 643222 2234467999999999999999999999999999999999999998531 11 1111111111 110
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ev 440 (468)
.+...+..+.+|+.+||+.||.+||++.+.
T Consensus 258 ----------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 258 ----------LKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp ----------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred ----------CCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 112234478899999999999999998643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=325.64 Aligned_cols=264 Identities=25% Similarity=0.354 Sum_probs=205.6
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHH--HHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEE--LLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
.++|.+.+.||+|+||.||++... +++.||+|++........ ....+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356889999999999999999976 689999998765432210 01246788999999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC----cEEEEe
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY----RAKVAD 315 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~----~~kl~D 315 (468)
++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++ .+||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEeecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEe
Confidence 99999999999999997632 4899999999999999999999999 99999999999998877 899999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
||++........ .....+|+.|+|||.+.+..++.++||||||+++|+|++|..||.... . ...... ..
T Consensus 156 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~---~~~~~~-~~ 224 (283)
T 3bhy_A 156 FGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET-----K---QETLTN-IS 224 (283)
T ss_dssp CTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS-----H---HHHHHH-HH
T ss_pred cccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc-----h---HHHHHH-hH
Confidence 999986543322 233468999999999999999999999999999999999999985311 1 111111 11
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhcccCC
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGIRGSS 451 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i~~~~ 451 (468)
..... .... .....+..+.+++.+||+.||++|||+.++++ .++.++...
T Consensus 225 ~~~~~--~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 225 AVNYD--FDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp TTCCC--CCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred hcccC--Ccch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 11000 0011 11233457899999999999999999999997 455555443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=342.20 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=189.2
Q ss_pred cCCCCC-ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHH-hcCCCceeeEeeeecc----C
Q 012214 164 NHFNAN-RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILS-QINHRNVVKLLGCCLE----T 236 (468)
Q Consensus 164 ~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~-~l~h~niv~l~g~~~~----~ 236 (468)
++|.+. +.||+|+||+||++... +++.||||++... ..+.+|+.++. ..+||||+++++++.. .
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 456555 68999999999999965 6889999998642 23557887764 4589999999998865 5
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC---CCcEEE
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ---RYRAKV 313 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~---~~~~kl 313 (468)
...++||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl 205 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKL 205 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEE
T ss_pred cEEEEEEEeCCCCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEE
Confidence 67899999999999999997632 235999999999999999999999999 999999999999998 789999
Q ss_pred EecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH
Q 012214 314 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 314 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ........
T Consensus 206 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~i~~- 281 (400)
T 1nxk_A 206 TDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKTRIRM- 281 (400)
T ss_dssp CCCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-SHHHHHHH-
T ss_pred EecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-HHHHHHHc-
Confidence 9999998654322 2334568999999999999999999999999999999999999986422111110 01111110
Q ss_pred hhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 394 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
....... ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 282 -~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 282 -GQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -TCCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CcccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000000 0012334578999999999999999999999873
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=332.34 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=204.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||++... +++.+|+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 467899999999999999999975 57899999876532211 1345678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 119 v~e~~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp EECCCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 999999999999987632 4899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh-ccccc
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR-KNRLH 400 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 400 (468)
...... ......||..|+|||.+.+..++.++||||||+++|+|++|+.||.... .......... ...+
T Consensus 191 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~- 260 (335)
T 2owb_A 191 VEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKKNEYSI- 260 (335)
T ss_dssp CCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCCC-
T ss_pred cccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHhcCCCCC-
Confidence 643322 2234568999999999999999999999999999999999999985311 0111111111 1111
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+...+..+.+++.+||+.||++|||+.|+++
T Consensus 261 -----------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 261 -----------PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -----------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223347889999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=334.02 Aligned_cols=261 Identities=23% Similarity=0.410 Sum_probs=206.1
Q ss_pred HHHHHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccc----hHHHHHHHHHHHHHHHHHhc-CCCceeeEe
Q 012214 157 KELDKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVD----DEELLKLEEFINEIVILSQI-NHRNVVKLL 230 (468)
Q Consensus 157 ~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~ 230 (468)
.......++|.+.+.||+|+||.||+|... +|+.||||++..... .......+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334555678999999999999999999975 699999998865431 11112345688999999999 899999999
Q ss_pred eeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc
Q 012214 231 GCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR 310 (468)
Q Consensus 231 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~ 310 (468)
+++......++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 99999999999999999999999997632 4899999999999999999999999 999999999999999999
Q ss_pred EEEEecCCcccccCCCceeeecccccCCccCcccccc------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchh
Q 012214 311 AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS------SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENV 384 (468)
Q Consensus 311 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~ 384 (468)
+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ...
T Consensus 239 ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~-----~~~ 311 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR-----RQI 311 (365)
T ss_dssp EEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHH
T ss_pred EEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC-----CHH
Confidence 99999999987654322 234579999999998863 35888999999999999999999998531 111
Q ss_pred chHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 385 SLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.... ........ ...+. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 312 ~~~~----~i~~~~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 312 LMLR----MIMEGQYQ-FSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHH----HHHHTCCC-CCHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHH----HHHhCCCC-CCCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 11111110 00000 1123457899999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=345.17 Aligned_cols=200 Identities=25% Similarity=0.361 Sum_probs=167.4
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC-----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----- 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~----- 236 (468)
.++|.+.+.||+|+||.||+|... +++.||||++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL--IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcCh--HHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 478999999999999999999965 68899999987543322 4456789999999999999999999999766
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...++||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DF 173 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDF 173 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred CeEEEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccC
Confidence 56899999986 6999999652 25899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCce---------------------eeecccccCCccCcccc-ccCCCCCcccHHHHHHHHHHHHhCCCCC
Q 012214 317 GTSKFIAMDQTH---------------------VTTKIQGTFGYLDPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPI 373 (468)
Q Consensus 317 Gla~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlGvll~el~tG~~p~ 373 (468)
|+++........ ..+...||+.|+|||++ .+..++.++|||||||++|||++|..||
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 999876543211 12456799999999986 5567999999999999999999865554
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=337.41 Aligned_cols=252 Identities=19% Similarity=0.261 Sum_probs=199.1
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcc
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~ 239 (468)
..++|.+.+.||+|+||.||++..+ +++.||+|++..... ...+|+.++.++ +||||+++++++.+....
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 3567999999999999999999975 689999999865432 234688888887 799999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC----CcEEEEe
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR----YRAKVAD 315 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~----~~~kl~D 315 (468)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+.++ +.+||+|
T Consensus 92 ~lv~E~~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~D 163 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICD 163 (342)
T ss_dssp EEEECCCCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEE
Confidence 9999999999999999753 24899999999999999999999999 9999999999998543 3599999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|..||....... ... ....+.
T Consensus 164 fg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~-~~~~i~ 236 (342)
T 2qr7_A 164 FGFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-----PEE-ILARIG 236 (342)
T ss_dssp CTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-----HHH-HHHHHH
T ss_pred CCCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-----HHH-HHHHHc
Confidence 999987654332 2234568999999999998889999999999999999999999985421111 111 111111
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...... ........+..+.+|+.+||+.||++|||+.++++
T Consensus 237 ~~~~~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 237 SGKFSL------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HCCCCC------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCccc------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111110 00011234457899999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=324.74 Aligned_cols=250 Identities=27% Similarity=0.401 Sum_probs=204.7
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
+.|.+.+.||+|+||.||+|... +++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS---TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 56888999999999999999864 6889999998654333 3356788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.. .++++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++...
T Consensus 99 ~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL 169 (303)
T ss_dssp EECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceec
Confidence 999999999999864 25899999999999999999999999 999999999999999999999999999766
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||... ...... ..........
T Consensus 170 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~----~~~~~~~~~~- 238 (303)
T 3a7i_A 170 TDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-----HPMKVL----FLIPKNNPPT- 238 (303)
T ss_dssp BTTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHH----HHHHHSCCCC-
T ss_pred Ccccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc-----CHHHHH----HHhhcCCCCC-
Confidence 54322 223456899999999999999999999999999999999999998431 111111 1111111110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 444 (468)
.+...+..+.+++.+||+.||++|||+.++++..
T Consensus 239 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 239 --------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp --------CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred --------CccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 1122344789999999999999999999998743
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=337.37 Aligned_cols=260 Identities=26% Similarity=0.405 Sum_probs=203.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||++... +++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH---HHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH---HHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 67899999999999999999975 6899999998765333 4456789999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA-TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
|||+++++|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++..
T Consensus 110 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp ECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EECCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999997643 489999999999999999999995 8 99999999999999999999999999875
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH--------
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS-------- 393 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~-------- 393 (468)
.... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... .. ........
T Consensus 182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~--~~~~~~~~~~~~~~~~ 253 (360)
T 3eqc_A 182 LIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA---KE--LELMFGCQVEGDAAET 253 (360)
T ss_dssp HHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH---HH--HHHHHC----------
T ss_pred cccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HH--HHHHhcccccccCCCC
Confidence 5322 12335689999999999999999999999999999999999999853211 00 00000000
Q ss_pred ------------------hhccccchhcchHHh----hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 394 ------------------MRKNRLHDILDDQLM----KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 394 ------------------~~~~~~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.......+..+.... .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp --------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000000110000 0011223557899999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=336.01 Aligned_cols=264 Identities=22% Similarity=0.294 Sum_probs=197.2
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 237 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~---- 237 (468)
.++|.+.+.||+|+||.||+|... +|+.||||++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE--LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH--HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCH--HHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 467999999999999999999964 68999999986543332 34567899999999999999999999997653
Q ss_pred --cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 238 --VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 238 --~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~D 171 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILD 171 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred CceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEe
Confidence 459999999 7899999875 24899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
||+++..... .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... ............
T Consensus 172 fg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~l~~i~~~~ 242 (367)
T 1cm8_A 172 FGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD-----HLDQLKEIMKVT 242 (367)
T ss_dssp CTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHH
T ss_pred eecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhc
Confidence 9999865432 234568999999999887 789999999999999999999999985311 111111111111
Q ss_pred hccc---cchhcchHH--------------hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhc
Q 012214 395 RKNR---LHDILDDQL--------------MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGI 447 (468)
Q Consensus 395 ~~~~---~~~~~d~~l--------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i 447 (468)
.... +..+..... ........++.+.+|+.+||+.||++|||+.|+++ .++.+
T Consensus 243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 0000 000000000 00011234567899999999999999999999987 34444
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=324.06 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=197.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc----CCc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE----TEV 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~ 238 (468)
..|.+.+.||+|+||.||+|... ++..||+|++....... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK--SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH--HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 45778888999999999999864 67889999886543322 445778999999999999999999998764 456
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc-CCCcEEEEecC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD-QRYRAKVADFG 317 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~-~~~~~kl~DfG 317 (468)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ ++|+|+||||+|||++ +++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEEEecCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 899999999999999997642 4899999999999999999999976 4599999999999998 78999999999
Q ss_pred CcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 318 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 318 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
++....... .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.... ...... ......
T Consensus 178 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------~~~~~~-~~~~~~ 245 (290)
T 1t4h_A 178 LATLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIY-RRVTSG 245 (290)
T ss_dssp GGGGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHH-HHHTTT
T ss_pred Ccccccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC-------cHHHHH-HHHhcc
Confidence 997544332 233568999999998764 58999999999999999999999984311 111111 111111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..... .+...++.+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 VKPAS--------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCCGG--------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCccc--------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11111 11222347899999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=332.55 Aligned_cols=255 Identities=21% Similarity=0.296 Sum_probs=198.6
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeecc--CCcc
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLE--TEVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~--~~~~ 239 (468)
++|++.+.||+|+||.||+|.. .+++.||+|++.... .+.+.+|+.++++++ ||||+++++++.+ ....
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 6799999999999999999985 478999999987532 246889999999996 9999999999987 5678
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC-cEEEEecCC
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY-RAKVADFGT 318 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~-~~kl~DfGl 318 (468)
++||||+++++|.+++.. +++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 109 ~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp EEEEECCCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEeccCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 999999999999998853 888999999999999999999999 99999999999999776 899999999
Q ss_pred cccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
++....... .....+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ............
T Consensus 178 a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~----~l~~~~~~~~~~ 251 (330)
T 3nsz_A 178 AEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD----QLVRIAKVLGTE 251 (330)
T ss_dssp CEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH----HHHHHHHHHCHH
T ss_pred ceEcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH----HHHHHHHhcCCc
Confidence 986654332 233468999999999887 6789999999999999999999999854221111 111111111000
Q ss_pred ccchhc-----------------------chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RLHDIL-----------------------DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~-----------------------d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...+.+ ............+..+.+|+.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 000001112224568999999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=324.07 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=202.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||++... +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc-hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 67899999999999999999965 5788999987642211 112245688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++...
T Consensus 93 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG-----RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp ECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 99999999999997642 4899999999999999999999999 999999999999999999999999998755
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
.... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.... . ......... ...
T Consensus 165 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~---~~~~~~~~~-~~~--- 229 (284)
T 2vgo_A 165 PSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS-----H---TETHRRIVN-VDL--- 229 (284)
T ss_dssp SSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----H---HHHHHHHHT-TCC---
T ss_pred cccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC-----H---hHHHHHHhc-ccc---
Confidence 4322 233568999999999999999999999999999999999999985311 1 011111111 110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+...+..+.+++.+||+.||.+|||+.++++
T Consensus 230 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 -------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 011223447889999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=326.33 Aligned_cols=262 Identities=23% Similarity=0.361 Sum_probs=204.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeec--cCCcc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL--ETEVP 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~--~~~~~ 239 (468)
.++|++.+.||+|+||.||++... +++.||+|++....... ...+.+.+|+.++++++||||+++++++. .....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH--HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 367889999999999999999965 68999999987543322 34567899999999999999999999874 45678
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCEEecCCCCCCEEEcCCCcEEEEecC
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT--SSPIYHRDIKSTNILLDQRYRAKVADFG 317 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~iiH~DLkp~NILl~~~~~~kl~DfG 317 (468)
++||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ..+|+|+||||+||+++.++.+||+|||
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999999976432 2235899999999999999999999976 2349999999999999999999999999
Q ss_pred CcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 318 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 318 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
+++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||... ... .........
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~----~~~~~i~~~ 231 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-----SQK----ELAGKIREG 231 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHH----HHHHHHHHT
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc-----CHH----HHHHHHhhc
Confidence 9976543322 122346899999999999999999999999999999999999998531 111 111111111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNG 446 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 446 (468)
.... .+...+..+.+++.+||+.||++|||+.|+++.+..
T Consensus 232 ~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 232 KFRR---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccc---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1111 112344578999999999999999999999986643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=353.13 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=203.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|...+.||+|+||.||+++.. +|+.||+|++...... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh-hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 67888899999999999999975 6899999998653211 112346788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++..... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 264 mE~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999999976432 2336999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........... ...
T Consensus 340 ~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~----~~~~~~~~i~~-~~~--- 410 (543)
T 3c4z_A 340 KAGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRVLE-QAV--- 410 (543)
T ss_dssp CTTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC----CHHHHHHHHHH-CCC---
T ss_pred cCCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch----hHHHHHHHHhh-ccc---
Confidence 543322 234579999999999999999999999999999999999999996422111 11111111111 110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTM 437 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 437 (468)
..+...+..+.+|+.+||+.||++||++
T Consensus 411 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 -------TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred -------CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 0122344578999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=348.26 Aligned_cols=247 Identities=17% Similarity=0.176 Sum_probs=190.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHH---HHHHhcCCCceeeEe-------e
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEI---VILSQINHRNVVKLL-------G 231 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei---~~l~~l~h~niv~l~-------g 231 (468)
.++|.+.+.||+|+||.||+|.. .+|+.||||++....... ....+.+.+|+ .++++++||||++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC-TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc-hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 46788899999999999999995 469999999986432111 13446788999 555666899999998 4
Q ss_pred eeccCC-----------------cceeEeeecCCCChhhHhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 012214 232 CCLETE-----------------VPLLVYEFIPNGTLYQHLHDRHQNE--EFPLTWEMRLRIATEVAGALAYLHSATSSP 292 (468)
Q Consensus 232 ~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 292 (468)
++.+.+ ..++||||+ +|+|.+++....... ...+++..++.|+.||+.||+|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 444332 378999999 689999998643211 123556888999999999999999999
Q ss_pred EEecCCCCCCEEEcCCCcEEEEecCCcccccCCCceeeecccccCCccCccccccC-----------CCCCcccHHHHHH
Q 012214 293 IYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-----------QLTDKSDVYSFGV 361 (468)
Q Consensus 293 iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwSlGv 361 (468)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999985322 2334567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 012214 362 VLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVS 441 (468)
Q Consensus 362 ll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 441 (468)
++|||++|+.||....... ....+.. .....++.+.+|+.+||+.||++|||+.|++
T Consensus 302 il~elltg~~Pf~~~~~~~-----------------~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 358 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALG-----------------GSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 358 (377)
T ss_dssp HHHHHHHSSCCC------C-----------------CSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred HHHHHHHCCCCCccccccc-----------------chhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence 9999999999984311100 0000000 0122345789999999999999999999998
Q ss_pred H
Q 012214 442 M 442 (468)
Q Consensus 442 ~ 442 (468)
+
T Consensus 359 ~ 359 (377)
T 3byv_A 359 E 359 (377)
T ss_dssp T
T ss_pred h
Confidence 6
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=333.42 Aligned_cols=264 Identities=22% Similarity=0.279 Sum_probs=204.7
Q ss_pred CHHHHHHHhcCCCCC-ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEee
Q 012214 155 SSKELDKATNHFNAN-RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLG 231 (468)
Q Consensus 155 ~~~ei~~~~~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g 231 (468)
.+...+...++|.+. +.||+|+||.||++... +++.||+|++....... .....+.+|+.++..+ +||||+++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ--DCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE--ECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 344455666778877 88999999999999965 68999999887543221 2346788999999999 5799999999
Q ss_pred eeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC---C
Q 012214 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ---R 308 (468)
Q Consensus 232 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~---~ 308 (468)
++.+....++||||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. +
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~ 170 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPL 170 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTB
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCC
Confidence 999999999999999999999998652 2246899999999999999999999999 999999999999998 7
Q ss_pred CcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH
Q 012214 309 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 309 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~ 388 (468)
+.+||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||... .......
T Consensus 171 ~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~ 243 (327)
T 3lm5_A 171 GDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE-----DNQETYL 243 (327)
T ss_dssp CCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHH
T ss_pred CcEEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CchHHHH
Confidence 8999999999986643322 23456999999999999999999999999999999999999998431 1111111
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
..... . .... .......+..+.+++.+||+.||++|||+.++++.
T Consensus 244 ~i~~~-~-~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 244 NISQV-N-VDYS--------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHT-C-CCCC--------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHhc-c-cccC--------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11110 0 0000 01112344578999999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=343.94 Aligned_cols=257 Identities=25% Similarity=0.304 Sum_probs=191.7
Q ss_pred HHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccch----HHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc
Q 012214 161 KATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDD----EELLKLEEFINEIVILSQINHRNVVKLLGCCLE 235 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~ 235 (468)
...++|.+.+.||+|+||.||+|... +++.||||++...... ........+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45688999999999999999999865 5889999988643211 111223357899999999999999999999854
Q ss_pred CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC---CcEE
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR---YRAK 312 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~---~~~k 312 (468)
...++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.+ +.+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEE
T ss_pred -CceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEE
Confidence 4579999999999999988652 25899999999999999999999999 9999999999999754 4599
Q ss_pred EEecCCcccccCCCceeeecccccCCccCcccccc---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHH
Q 012214 313 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAY 389 (468)
Q Consensus 313 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~ 389 (468)
|+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....
T Consensus 283 l~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~----~~~~~- 355 (419)
T 3i6u_A 283 ITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSLKD- 355 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS----CCHHH-
T ss_pred EeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch----HHHHH-
Confidence 9999999876432 22344579999999999864 67888999999999999999999998532111 11111
Q ss_pred HHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 390 FVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
......... . +. .....++.+.+|+.+||+.||++|||+.|+++
T Consensus 356 ---~i~~~~~~~-~-~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 356 ---QITSGKYNF-I-PE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp ---HHHTTCCCC-C-HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHhcCCCCC-C-ch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111111100 0 00 01223457899999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=334.46 Aligned_cols=268 Identities=24% Similarity=0.251 Sum_probs=196.6
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHH-HHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEEL-LKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
..++|.+.+.||+|+||.||++... +|+.||||++......... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999965 5899999998753322111 1124678999999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred EEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 999999975 8888886532 35888899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
+....... ......+|+.|+|||.+.+. .++.++|||||||++|||++|..||... .................
T Consensus 160 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~-----~~~~~~~~i~~~~~~~~ 233 (346)
T 1ua2_A 160 KSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD-----SDLDQLTRIFETLGTPT 233 (346)
T ss_dssp STTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHHHCCCC
T ss_pred eeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHHHcCCCC
Confidence 87643322 23345689999999998764 5888999999999999999999887431 11111111111111111
Q ss_pred ---cchhcch------H-----HhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 399 ---LHDILDD------Q-----LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 399 ---~~~~~d~------~-----l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
+.+.... . .........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 1100000 0 0000012334679999999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=332.25 Aligned_cols=261 Identities=24% Similarity=0.344 Sum_probs=195.9
Q ss_pred cCCCCC-ceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcce
Q 012214 164 NHFNAN-RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 164 ~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 240 (468)
+.|.+. +.||+|+||.||++... +++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+.+..+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG----HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 567774 77999999999999954 689999999865422 2235688999999985 7999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc---EEEEecC
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR---AKVADFG 317 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~---~kl~DfG 317 (468)
+||||+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 88 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRR-----HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred EEEEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 9999999999999997642 4899999999999999999999999 999999999999998776 9999999
Q ss_pred CcccccCCCc------eeeecccccCCccCcccccc-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccc----
Q 012214 318 TSKFIAMDQT------HVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE---- 382 (468)
Q Consensus 318 la~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~---- 382 (468)
++........ .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 9876542211 11223458999999999875 56889999999999999999999998642211100
Q ss_pred --hhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 383 --NVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 383 --~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
................. .+.... ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~i~~~~~-~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGKY-EFPDKD-----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp -CCHHHHHHHHHHHHHCCC-CCCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccchhHHHHHHHHHhccCc-ccCchh-----cccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00001111111111111 000000 1123457899999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=335.78 Aligned_cols=263 Identities=26% Similarity=0.380 Sum_probs=198.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||++... +++.||+|++....... ...+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK--MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch--HHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 67899999999999999999975 58999999886543332 3446688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 103 FEFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp EECCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EecCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 9999998888876542 24899999999999999999999999 999999999999999999999999999765
Q ss_pred cCCCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh------
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR------ 395 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~------ 395 (468)
..... ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.... .............
T Consensus 175 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~ 248 (331)
T 4aaa_A 175 AAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS-----DIDQLYHIMMCLGNLIPRH 248 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCSCCHHH
T ss_pred cCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHHHHHhCCCChhh
Confidence 43322 22335689999999998875 78999999999999999999999985311 1111111110000
Q ss_pred ------c-----cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 396 ------K-----NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 396 ------~-----~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ..+..+.............++.+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0011111000001111234568999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=362.03 Aligned_cols=262 Identities=27% Similarity=0.410 Sum_probs=206.8
Q ss_pred HHHHhcCCCCCceeeecCcEEEEEEEec----CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeec
Q 012214 159 LDKATNHFNANRILGQGGQGTVYKGMLE----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL 234 (468)
Q Consensus 159 i~~~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~ 234 (468)
.+...++|.+.+.||+|+||.||+|.+. .+..||+|++...... ...+.+.+|+.++++++||||+++++++.
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD---SVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3344577888999999999999999864 2567999988764333 44567999999999999999999999985
Q ss_pred cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 235 ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 235 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
+ +..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~ 533 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLG 533 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEEC
T ss_pred c-CceEEEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEE
Confidence 4 56899999999999999997632 35899999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHH
Q 012214 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 315 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
|||+++..............+|+.|+|||.+.+..++.++|||||||++|||++ |..||... ..... ...
T Consensus 534 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~-----~~~~~----~~~ 604 (656)
T 2j0j_A 534 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-----KNNDV----IGR 604 (656)
T ss_dssp CCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHH----HHH
T ss_pred ecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC-----CHHHH----HHH
Confidence 999998765544433444567889999999999999999999999999999997 89898431 11111 111
Q ss_pred hhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 394 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
....... ..+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 605 i~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 605 IENGERL---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp HHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCC---------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1111100 1122345578999999999999999999999999998864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=338.52 Aligned_cols=247 Identities=24% Similarity=0.336 Sum_probs=201.3
Q ss_pred HhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHH----HHHHHHHHHHHHHHHhcCCCceeeEeeeeccC
Q 012214 162 ATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEE----LLKLEEFINEIVILSQINHRNVVKLLGCCLET 236 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~ 236 (468)
..++|.+.+.||+|+||.||++.. .+++.||||++........ ....+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 357899999999999999999995 4689999998865432110 01223567899999999999999999999999
Q ss_pred CcceeEeeecCCC-ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 237 EVPLLVYEFIPNG-TLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 237 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
...++||||+.+| +|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEee
Confidence 9999999999777 9999987532 4899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
||+++....... .....||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||..... ..
T Consensus 174 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------~~ 237 (335)
T 3dls_A 174 FGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------TV 237 (335)
T ss_dssp CTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------GT
T ss_pred cccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------HH
Confidence 999987654332 233569999999999988776 7899999999999999999999843100 00
Q ss_pred hccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 395 RKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 395 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
. ... ..+...+..+.+|+.+||+.||++|||+.++++.
T Consensus 238 ~-~~~----------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 E-AAI----------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp T-TCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred h-hcc----------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 0111234478999999999999999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=337.69 Aligned_cols=264 Identities=23% Similarity=0.258 Sum_probs=201.1
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC--------CCceeeEeeee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN--------HRNVVKLLGCC 233 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~--------h~niv~l~g~~ 233 (468)
.++|.+.+.||+|+||+||++... +++.||||++... . ...+.+.+|+.+++.++ |+||+++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--E---HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--H---HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--C---cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 478999999999999999999854 6889999998753 2 33467889999999985 78899999998
Q ss_pred c----cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEecCCCCCCEEEcCC
Q 012214 234 L----ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA-TSSPIYHRDIKSTNILLDQR 308 (468)
Q Consensus 234 ~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLkp~NILl~~~ 308 (468)
. +....++||||+ +++|.+.+.... ...+++..+..++.||+.||.|||++ + |+||||||+|||++.+
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~ 183 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVN 183 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCC
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEecc
Confidence 7 566889999999 667777776532 23589999999999999999999998 8 9999999999999977
Q ss_pred C-------------------------------------------------cEEEEecCCcccccCCCceeeecccccCCc
Q 012214 309 Y-------------------------------------------------RAKVADFGTSKFIAMDQTHVTTKIQGTFGY 339 (468)
Q Consensus 309 ~-------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y 339 (468)
+ .+||+|||+++..... .....||+.|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y 259 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGG
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcc
Confidence 5 7999999999865432 2334689999
Q ss_pred cCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccc-hhchHHHHHHHhhccc---------cchhcc-----
Q 012214 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE-NVSLAAYFVHSMRKNR---------LHDILD----- 404 (468)
Q Consensus 340 ~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~---------~~~~~d----- 404 (468)
+|||++.+..++.++|||||||++|||++|+.||......... ................ ......
T Consensus 260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 339 (397)
T 1wak_A 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 339 (397)
T ss_dssp CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence 9999999999999999999999999999999998642221111 1111111111111000 000000
Q ss_pred ------------hHH--hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 405 ------------DQL--MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 405 ------------~~l--~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+ ....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 01224566778999999999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=349.28 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=201.2
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
..++|.+.+.||+|+||+||++... +++.||||++....... .....+.+|+.++++++||||+++++++.+....+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 3467999999999999999999965 68999999975421111 23467889999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc---CCCcEEEEecC
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD---QRYRAKVADFG 317 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~---~~~~~kl~DfG 317 (468)
+||||+++|+|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||
T Consensus 98 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 169 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG 169 (486)
T ss_dssp EEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred EEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECC
Confidence 9999999999999987643 4899999999999999999999999 99999999999995 45689999999
Q ss_pred CcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 318 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 318 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||... ... ... ..+...
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~---~~~-~~i~~~ 237 (486)
T 3mwu_A 170 LSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK-----NEY---DIL-KRVETG 237 (486)
T ss_dssp CTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHH---HHH-HHHHHT
T ss_pred cCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHH---HHH-HHHHhC
Confidence 998664332 2334569999999999876 5899999999999999999999998531 111 111 111111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
....- .......+..+.+|+.+||+.||++|||+.++++.
T Consensus 238 ~~~~~------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 238 KYAFD------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CCCSC------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCC------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11100 00112344578999999999999999999999973
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=340.03 Aligned_cols=263 Identities=21% Similarity=0.293 Sum_probs=197.4
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc---
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE--- 235 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--- 235 (468)
+...++|.+.+.||+|+||.||+|.. .+|+.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGD 74 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCc
Confidence 45567899999999999999999986 47899999988653221 2369999999999999999999843
Q ss_pred -----------------------------------CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHH
Q 012214 236 -----------------------------------TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280 (468)
Q Consensus 236 -----------------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~ 280 (468)
....++||||++ ++|.+.+...... ...+++..+..++.||+.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFR 152 (383)
T ss_dssp -----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHH
Confidence 334789999997 5888888653322 236999999999999999
Q ss_pred HHHHHHhCCCCCEEecCCCCCCEEEc-CCCcEEEEecCCcccccCCCceeeecccccCCccCccccccC-CCCCcccHHH
Q 012214 281 ALAYLHSATSSPIYHRDIKSTNILLD-QRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYS 358 (468)
Q Consensus 281 gL~yLH~~~~~~iiH~DLkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwS 358 (468)
||+|||+.+ |+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||
T Consensus 153 aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 153 AVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 999999999 99999999999998 689999999999986644332 2334689999999998874 5899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc---------------ccchhcchHHhhhchHHHHHHHHHHH
Q 012214 359 FGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN---------------RLHDILDDQLMKLGVKNQIMTFANLA 423 (468)
Q Consensus 359 lGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~d~~l~~~~~~~~~~~l~~li 423 (468)
|||++|||++|+.||... ...............+ ....+.........+...+..+.+|+
T Consensus 228 lG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 302 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGE-----TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLL 302 (383)
T ss_dssp HHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHH
Confidence 999999999999998531 1111111111111111 01111111112222334556799999
Q ss_pred HHhhccCCCCCCCHHHHHH
Q 012214 424 KRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 424 ~~cl~~dp~~RPt~~evl~ 442 (468)
.+||+.||++|||+.|+++
T Consensus 303 ~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 303 EQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHCCSSGGGSCCHHHHHT
T ss_pred HHHccCChhhCCCHHHHhc
Confidence 9999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=335.05 Aligned_cols=272 Identities=22% Similarity=0.285 Sum_probs=200.4
Q ss_pred HHHHHHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccch-------HHHHHHHHHHHHHHHHHhcCCCceee
Q 012214 156 SKELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDD-------EELLKLEEFINEIVILSQINHRNVVK 228 (468)
Q Consensus 156 ~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~-------~~~~~~~~~~~Ei~~l~~l~h~niv~ 228 (468)
..++....++|.+.+.||+|+||.||+|...+|+.||||++...... ......+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45677788999999999999999999999888999999988543221 11133467999999999999999999
Q ss_pred Eeeeecc-----CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCE
Q 012214 229 LLGCCLE-----TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNI 303 (468)
Q Consensus 229 l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NI 303 (468)
+++++.. ....++||||++ |+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 9999843 346799999997 6888888642 236899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEecCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccc
Q 012214 304 LLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE 382 (468)
Q Consensus 304 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~ 382 (468)
|++.++.+||+|||+++...... ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||... .
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-----~ 238 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS-----T 238 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS-----S
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC-----C
Confidence 99999999999999997543322 2334568999999999887 77899999999999999999999998531 1
Q ss_pred hhchHHHHHHHhhccccchhc---chH---------------HhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 383 NVSLAAYFVHSMRKNRLHDIL---DDQ---------------LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~---d~~---------------l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..................... ... .........++.+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 111111111111111110000 000 000111233457899999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=332.94 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=200.7
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC-----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----- 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~----- 236 (468)
.++|.+.+.||+|+||.||++... +++.||||++...... ...+.+.+|+.++++++||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ---TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH---HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc---HHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 468999999999999999999965 6889999998754333 3456789999999999999999999998654
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...++|+||+. ++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Df 172 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDF 172 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeC
Confidence 36799999997 5999988652 4899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCcee--eecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH
Q 012214 317 GTSKFIAMDQTHV--TTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 317 Gla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
|+++......... .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ...........
T Consensus 173 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~ 247 (364)
T 3qyz_A 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH-----YLDQLNHILGI 247 (364)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS-----GGGHHHHHHHH
T ss_pred cceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC-----hHHHHHHHHHH
Confidence 9998765432221 234579999999998765 558999999999999999999999985321 11111111111
Q ss_pred hhcccc---chhcchHH--------------hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 394 MRKNRL---HDILDDQL--------------MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 394 ~~~~~~---~~~~d~~l--------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...... ..+.+... ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111100 00000000 00011223457899999999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=320.37 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=194.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||++... +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+....++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc-cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 367899999999999999999975 689999998864311 111234678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 89 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred EEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccc
Confidence 999999999999997642 4899999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCCceeeecccccCCccCccccccCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
...... .....+|+.|+|||.+.+..+ +.++||||||+++|+|++|+.||... ... . ..........
T Consensus 161 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~---~-~~~~~~~~~~- 228 (276)
T 2h6d_A 161 MSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE-----HVP---T-LFKKIRGGVF- 228 (276)
T ss_dssp CCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS-----SHH---H-HHHHHHHCCC-
T ss_pred cCCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC-----cHH---H-HHHHhhcCcc-
Confidence 543322 233468999999999988765 68999999999999999999998431 111 1 1111111110
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 229 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 ---------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 011223347889999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=334.67 Aligned_cols=261 Identities=24% Similarity=0.336 Sum_probs=189.7
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeec---
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCL--- 234 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~--- 234 (468)
+....+|.+.+.||+|+||.||++... +++.||+|++.... . ...+.+.+|+.++.++. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-E---EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-H---HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-h---HHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 334568999999999999999999964 68999999885432 2 34467889999999995 999999999983
Q ss_pred -----cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC
Q 012214 235 -----ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY 309 (468)
Q Consensus 235 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~ 309 (468)
.....++|+||+. |+|.+++..... ..++++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTS
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCC
Confidence 3445789999995 799999876332 235999999999999999999999876 4599999999999999999
Q ss_pred cEEEEecCCcccccCCCcee-----------eecccccCCccCcccc---ccCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 012214 310 RAKVADFGTSKFIAMDQTHV-----------TTKIQGTFGYLDPEYH---QSSQLTDKSDVYSFGVVLVELLTGKKPIFW 375 (468)
Q Consensus 310 ~~kl~DfGla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~s~ksDVwSlGvll~el~tG~~p~~~ 375 (468)
.+||+|||+++......... .....||+.|+|||.+ .+..++.++|||||||++|+|++|+.||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999998765432211 1134589999999998 567788999999999999999999999843
Q ss_pred CCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 376 AGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
.... ........ .......+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 256 ~~~~--------~~~~~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 256 GAKL--------RIVNGKYS-------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ------------------CC-------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHH--------HhhcCccc-------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1100 00000000 00011122357889999999999999999999999998764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=347.90 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=197.2
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
..++|.+.+.||+|+||+||++... ++..||+|++....... .....+.+|+.+++.++||||+++++++.+....+
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST--SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc--hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3467999999999999999999975 68899999986543221 22456889999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC---CcEEEEecC
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR---YRAKVADFG 317 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~---~~~kl~DfG 317 (468)
+||||+++|+|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 113 lv~e~~~~g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 9999999999999887642 4899999999999999999999999 9999999999999764 559999999
Q ss_pred CcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 318 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 318 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
+++....... .....||+.|+|||++. +.++.++|||||||++|+|++|..||... ... . ........
T Consensus 185 ~a~~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~---~-~~~~i~~~ 252 (494)
T 3lij_A 185 LSAVFENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ-----TDQ---E-ILRKVEKG 252 (494)
T ss_dssp TCEECBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHH---H-HHHHHHHT
T ss_pred CCeECCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHH---H-HHHHHHhC
Confidence 9987654322 33456999999999876 56899999999999999999999998531 111 1 11111111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.... ..+ .....++.+.+|+.+||+.||.+|||+.|+++
T Consensus 253 ~~~~-~~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 253 KYTF-DSP-----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCCC-CSG-----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCC-Cch-----hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1100 000 01233457889999999999999999999885
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=347.37 Aligned_cols=255 Identities=30% Similarity=0.381 Sum_probs=200.1
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHH---------HHHHHHHHHHHHHHHhcCCCceeeEee
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEE---------LLKLEEFINEIVILSQINHRNVVKLLG 231 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~---------~~~~~~~~~Ei~~l~~l~h~niv~l~g 231 (468)
..++|.+.+.||+|+||+||+|... +++.||+|++........ ....+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4678999999999999999999965 578999999865322110 012457889999999999999999999
Q ss_pred eeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC--
Q 012214 232 CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY-- 309 (468)
Q Consensus 232 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~-- 309 (468)
++.+....++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCC
Confidence 9999999999999999999999997642 4899999999999999999999999 99999999999998776
Q ss_pred -cEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH
Q 012214 310 -RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 310 -~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~ 388 (468)
.+||+|||+++....... .....||+.|+|||.+. +.++.++|||||||++|+|++|..||... ... .
T Consensus 186 ~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~---~ 254 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ-----NDQ---D 254 (504)
T ss_dssp SSEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHH---H
T ss_pred ccEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC-----CHH---H
Confidence 699999999987654322 33456999999999887 46899999999999999999999998531 111 1
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
....+....... +.. .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 255 -~~~~i~~~~~~~--~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 255 -IIKKVEKGKYYF--DFN----DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -HHHHHHHCCCCC--CHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHHHcCCCCC--Ccc----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111111111100 000 01223457899999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=321.35 Aligned_cols=255 Identities=22% Similarity=0.251 Sum_probs=197.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeee--ccCCcc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC--LETEVP 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~--~~~~~~ 239 (468)
.++|.+.+.||+|+||.||++... +++.||+|++............+.+.+|+.+++.++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999964 68899999986532221113346789999999999999999999998 445678
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||++++ |.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEehhccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence 9999999876 777776532 235899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC-ceeeecccccCCccCccccccCC--CCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 320 KFIAMDQ-THVTTKIQGTFGYLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 320 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
....... ........||+.|+|||.+.+.. .+.++||||||+++|||++|+.||... . ..... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~---~~~~~-~~i~~ 227 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD-----N---IYKLF-ENIGK 227 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS-----S---HHHHH-HHHHH
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc-----h---HHHHH-HHHhc
Confidence 8664322 22233456899999999988644 377999999999999999999998531 1 11111 11111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
... ..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 228 GSY----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CCC----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCC----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 0122334578899999999999999999999963
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=325.60 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=202.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||++... +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA----FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc----cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 467889999999999999999965 689999999875322 223568899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE---cCCCcEEEEecCC
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL---DQRYRAKVADFGT 318 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl---~~~~~~kl~DfGl 318 (468)
||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||||+||++ +.++.+||+|||+
T Consensus 84 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~ 155 (304)
T 2jam_A 84 VMQLVSGGELFDRILERG-----VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGL 155 (304)
T ss_dssp EECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred EEEcCCCccHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence 999999999999987632 4899999999999999999999999 9999999999999 7889999999999
Q ss_pred cccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
+...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||... ..... . .......
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~---~-~~i~~~~ 223 (304)
T 2jam_A 156 SKMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE-----TESKL---F-EKIKEGY 223 (304)
T ss_dssp TCCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHH---H-HHHHHCC
T ss_pred ceecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC-----CHHHH---H-HHHHcCC
Confidence 8754322 122345899999999999999999999999999999999999998431 11111 1 1111111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhc
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGI 447 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i 447 (468)
.. . ........+..+.+++.+||+.||++|||+.|+++ .+++.
T Consensus 224 ~~-~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 224 YE-F-----ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp CC-C-----CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred CC-C-----CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 00 0 00111233457899999999999999999999987 44443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=350.41 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=202.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||++... +++.||||++....... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 467999999999999999999975 78999999985432111 1234678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE---cCCCcEEEEecCC
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL---DQRYRAKVADFGT 318 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl---~~~~~~kl~DfGl 318 (468)
||||+.+|+|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 104 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EECCCCSCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 999999999999987532 4899999999999999999999999 9999999999999 5678999999999
Q ss_pred cccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||... ..... . ..+....
T Consensus 176 a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~---~-~~i~~~~ 243 (484)
T 3nyv_A 176 STHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA-----NEYDI---L-KKVEKGK 243 (484)
T ss_dssp HHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHH---H-HHHHHCC
T ss_pred eEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC-----CHHHH---H-HHHHcCC
Confidence 986644322 234569999999999876 6899999999999999999999998531 11111 1 1111111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...- .......++.+.+|+.+||+.||.+|||+.|+++
T Consensus 244 ~~~~------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 244 YTFE------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCCC------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 1100 0011234557899999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=324.65 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=198.6
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
..++|.+.+.||+|+||.||+|... +|+.||+|.+..... .+.+.+|+.+++.++||||+++++++.+....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD------LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC------CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH------HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 4577999999999999999999975 589999999875432 256889999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 101 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAG 173 (314)
T ss_dssp EEEECCTTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEeecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccch
Confidence 9999999999999997432 25899999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... .. ........ ....
T Consensus 174 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~---~~~~~~~~-~~~~ 243 (314)
T 3com_A 174 QLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH-----PM---RAIFMIPT-NPPP 243 (314)
T ss_dssp ECBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC-----HH---HHHHHHHH-SCCC
T ss_pred hhhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----hH---HHHHHHhc-CCCc
Confidence 6643322 2233568999999999999999999999999999999999999985311 10 11111111 1100
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
... .+...+..+.+++.+||+.||.+|||+.++++
T Consensus 244 ~~~-------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 244 TFR-------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CCS-------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccC-------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 100 12223457899999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=320.04 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=197.2
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
+.|.....||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS----RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch----HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence 3455566899999999999996 4688999998865432 3346788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC-CCcEEEEecCCccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ-RYRAKVADFGTSKF 321 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~-~~~~kl~DfGla~~ 321 (468)
|||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+|+||||+||+++. ++.+||+|||++..
T Consensus 98 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp EECCSEEEHHHHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred EEeCCCCCHHHHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccc
Confidence 99999999999997642 2235788999999999999999999999 999999999999987 89999999999986
Q ss_pred ccCCCceeeecccccCCccCccccccCC--CCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
...... ......||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .......... ...
T Consensus 173 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~-~~~ 244 (295)
T 2clq_A 173 LAGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP------QAAMFKVGMF-KVH 244 (295)
T ss_dssp SCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH------HHHHHHHHHH-CCC
T ss_pred cCCCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch------hHHHHhhccc-ccc
Confidence 543222 123456899999999987754 788999999999999999999998531110 0011110000 000
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...+...+..+.+++.+||+.||++|||+.++++
T Consensus 245 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 245 ---------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ---------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ---------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0112234457899999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=332.19 Aligned_cols=260 Identities=21% Similarity=0.294 Sum_probs=192.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 237 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~---- 237 (468)
.++|.+.+.||+|+||.||+|... +++.||||++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCCh--HHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 367999999999999999999864 68999999987543322 44567889999999999999999999987654
Q ss_pred --cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 238 --VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 238 --~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
..++||||++ ++|.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D 170 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 170 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred ccceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEE
Confidence 6799999997 578888753 4889999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHH---
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVH--- 392 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~--- 392 (468)
||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..........
T Consensus 171 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~ 243 (371)
T 2xrw_A 171 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-----HIDQWNKVIEQLG 243 (371)
T ss_dssp CCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHC-CC
T ss_pred eeccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhC
Confidence 99998654321 2334568999999999999999999999999999999999999985311 1000000000
Q ss_pred ----------------Hhhc-ccc-----chhcchHH---hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 393 ----------------SMRK-NRL-----HDILDDQL---MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 393 ----------------~~~~-~~~-----~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.... ... ........ ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000 000 00000000 00012234668999999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=333.12 Aligned_cols=264 Identities=22% Similarity=0.288 Sum_probs=198.6
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC------
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET------ 236 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------ 236 (468)
++|.+.+.||+|+||.||++.. .+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+.
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS--SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc--cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 6799999999999999999997 478999999886543221 2234678999999999999999999998763
Q ss_pred --CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 237 --EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 237 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
...++||||+++ +|.+.+.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred CCceEEEEEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEc
Confidence 467899999975 7877776532 25899999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCC---ceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHH
Q 012214 315 DFGTSKFIAMDQ---THVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF 390 (468)
Q Consensus 315 DfGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~ 390 (468)
|||+++...... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||... .........
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~i 241 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-----TEQHQLALI 241 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHH
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHH
Confidence 999998764322 122344568999999998876 56899999999999999999999998531 111111111
Q ss_pred HHHhhc---cccchhcchH--------------Hh-hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 391 VHSMRK---NRLHDILDDQ--------------LM-KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 391 ~~~~~~---~~~~~~~d~~--------------l~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...... ..+....... .. .......++.+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111111 0011100000 00 0000011346889999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=342.04 Aligned_cols=262 Identities=19% Similarity=0.285 Sum_probs=206.2
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCC-CceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH-RNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~ 240 (468)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ..+.+|+.+++.++| +++..+..++.+....+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 47899999999999999999996 46899999987654332 347789999999976 56666667777788889
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE---cCCCcEEEEecC
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL---DQRYRAKVADFG 317 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl---~~~~~~kl~DfG 317 (468)
+||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||
T Consensus 80 lvme~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFG 151 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (483)
T ss_dssp EEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred EEEECC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCC
Confidence 999999 999999997532 25999999999999999999999999 9999999999999 688999999999
Q ss_pred CcccccCCCcee------eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHH
Q 012214 318 TSKFIAMDQTHV------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391 (468)
Q Consensus 318 la~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (468)
+++......... .....||..|+|||.+.+..++.++|||||||++|||++|+.||......... .......
T Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~i~ 229 (483)
T 3sv0_A 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK--QKYEKIS 229 (483)
T ss_dssp TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH--HHHHHHH
T ss_pred cceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH--HHHHHHh
Confidence 998765443321 22467999999999999999999999999999999999999998642221111 1111111
Q ss_pred HHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
.......+. ......+..+.+++.+||+.+|++||++.+|++.|+.+..
T Consensus 230 ~~~~~~~~~---------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 230 EKKVATSIE---------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHHHSCHH---------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred hccccccHH---------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 110001100 1112335589999999999999999999999999998754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=330.81 Aligned_cols=267 Identities=24% Similarity=0.367 Sum_probs=187.1
Q ss_pred HHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 161 KATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 161 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
...++|.+.+.||+|+||.||++... +++.||||++...... ...+++.+|+.++++++||||+++++++...+..
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ---TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc---hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 34578999999999999999999854 6889999988653322 3456788999999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQ---NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
++||||+++++|.+++..... .....+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCC
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEec
Confidence 999999999999999875221 12345899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCc----eeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHH
Q 012214 317 GTSKFIAMDQT----HVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391 (468)
Q Consensus 317 Gla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (468)
|++........ .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.... .. ... .
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~---~~~---~ 237 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP--PM---KVL---M 237 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC--GG---GHH---H
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc--hh---hHH---H
Confidence 99876543221 11233568999999999876 568999999999999999999999985321 11 100 1
Q ss_pred HHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..... ..................+..+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 238 LTLQN-DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHHTS-SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhcc-CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11111 111100000011112233457899999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=319.83 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=203.6
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccc-----hHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeec
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVD-----DEELLKLEEFINEIVILSQIN-HRNVVKLLGCCL 234 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~ 234 (468)
..++|.+.+.||+|+||.||++... +++.||||++..... .......+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3478999999999999999999975 689999999865421 111233567889999999995 999999999999
Q ss_pred cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 235 ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 235 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
+....++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence 9999999999999999999997632 4899999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCCceeeecccccCCccCccccc------cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH
Q 012214 315 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ------SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 315 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~ 388 (468)
|||++........ .....+|+.|+|||.+. ...++.++||||||+++|+|++|+.||... ......
T Consensus 167 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~- 238 (298)
T 1phk_A 167 DFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-----KQMLML- 238 (298)
T ss_dssp CCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHH-
T ss_pred cccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc-----cHHHHH-
Confidence 9999986644322 23356899999999885 456889999999999999999999998431 111111
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.......... . .......+..+.+++.+||+.||++|||+.|+++
T Consensus 239 ---~~~~~~~~~~-~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 ---RMIMSGNYQF-G-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ---HHHHHTCCCC-C-----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---HHHhcCCccc-C-----cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111111100 0 0011234557899999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=338.70 Aligned_cols=197 Identities=25% Similarity=0.322 Sum_probs=169.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc------CCCceeeEeeeecc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI------NHRNVVKLLGCCLE 235 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l------~h~niv~l~g~~~~ 235 (468)
..+|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+.++..+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 467999999999999999999865 58999999987531 2335677788888776 57799999999999
Q ss_pred CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc--EEE
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR--AKV 313 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~--~kl 313 (468)
....++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL 243 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKV 243 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEE
T ss_pred CCeEEEEEeccC-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEE
Confidence 999999999995 69999997633 235899999999999999999999999 999999999999999987 999
Q ss_pred EecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 012214 314 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFW 375 (468)
Q Consensus 314 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~ 375 (468)
+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 244 ~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 244 IDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp CCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 999999754332 2235689999999999999999999999999999999999999853
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=326.67 Aligned_cols=256 Identities=25% Similarity=0.303 Sum_probs=195.7
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccch----HHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDD----EELLKLEEFINEIVILSQINHRNVVKLLGCCLET 236 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~ 236 (468)
..++|.+.+.||+|+||.||++... +++.||||++...... ........+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999965 5889999988653211 1112234588999999999999999999998765
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc---EEE
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR---AKV 313 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~---~kl 313 (468)
. .++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEE
T ss_pred c-eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEE
Confidence 4 89999999999999988652 25899999999999999999999999 999999999999987664 999
Q ss_pred EecCCcccccCCCceeeecccccCCccCccccc---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHH
Q 012214 314 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF 390 (468)
Q Consensus 314 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~ 390 (468)
+|||+++...... ......||+.|+|||++. ...++.++|||||||++|+|++|..||...... .......
T Consensus 159 ~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~ 232 (322)
T 2ycf_A 159 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSLKDQI 232 (322)
T ss_dssp CCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS----SCHHHHH
T ss_pred ccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH----HHHHHHH
Confidence 9999998654322 123356899999999874 467889999999999999999999998532211 1111111
Q ss_pred HHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 391 VHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ...... .+.. ....+..+.+++.+||+.||++|||+.++++
T Consensus 233 ~----~~~~~~--~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 T----SGKYNF--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp H----HTCCCC--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H----hCcccc--Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1 111100 0000 1223457899999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=340.32 Aligned_cols=269 Identities=23% Similarity=0.312 Sum_probs=183.1
Q ss_pred cCCCC-CceeeecCcEEEEEEEec---CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeec--cCC
Q 012214 164 NHFNA-NRILGQGGQGTVYKGMLE---DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL--ETE 237 (468)
Q Consensus 164 ~~f~~-~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~--~~~ 237 (468)
+.|.+ .++||+|+||.||+|... +++.||||++...... ..+.+|+.+++.++||||+++++++. ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS------MSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC------HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC------HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 34555 457999999999999965 5788999998764332 35778999999999999999999994 467
Q ss_pred cceeEeeecCCCChhhHhhhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE----cCCC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQ----NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL----DQRY 309 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl----~~~~ 309 (468)
..++||||+. ++|.+++..... .....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCC
Confidence 8899999996 588888764321 12235899999999999999999999999 9999999999999 7789
Q ss_pred cEEEEecCCcccccCCCc--eeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccch---
Q 012214 310 RAKVADFGTSKFIAMDQT--HVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQEN--- 383 (468)
Q Consensus 310 ~~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~--- 383 (468)
.+||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 999999999987653221 22334578999999999987 458999999999999999999999995422211000
Q ss_pred -hchHHHHHHHhhcc---ccchhc---ch------------------HHhhhchHHHHHHHHHHHHHhhccCCCCCCCHH
Q 012214 384 -VSLAAYFVHSMRKN---RLHDIL---DD------------------QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTME 438 (468)
Q Consensus 384 -~~~~~~~~~~~~~~---~~~~~~---d~------------------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 438 (468)
.............+ .+..+. .. ..........+..+.+|+.+||+.||.+|||+.
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 01111111111110 000000 00 000000001144688999999999999999999
Q ss_pred HHHH
Q 012214 439 EVSM 442 (468)
Q Consensus 439 evl~ 442 (468)
|+++
T Consensus 330 e~L~ 333 (405)
T 3rgf_A 330 QAMQ 333 (405)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=329.10 Aligned_cols=265 Identities=22% Similarity=0.349 Sum_probs=202.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHH-------------HHHHHHHHHHHHHHhcCCCceeeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEEL-------------LKLEEFINEIVILSQINHRNVVKL 229 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~-------------~~~~~~~~Ei~~l~~l~h~niv~l 229 (468)
.++|.+.+.||+|+||.||++.. +++.||+|++......... ...+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999999 8999999987643111000 011678999999999999999999
Q ss_pred eeeeccCCcceeEeeecCCCChhhHhhhcc---cCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEecCCCCCCEEE
Q 012214 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRH---QNEEFPLTWEMRLRIATEVAGALAYLHS-ATSSPIYHRDIKSTNILL 305 (468)
Q Consensus 230 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLkp~NILl 305 (468)
++++.+.+..++||||+++++|.+++.... ......+++..++.++.||+.||.|||+ .+ |+|+||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 999999999999999999999999832110 1113469999999999999999999999 88 9999999999999
Q ss_pred cCCCcEEEEecCCcccccCCCceeeecccccCCccCccccccC-CCCC-cccHHHHHHHHHHHHhCCCCCCCCCCCccch
Q 012214 306 DQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTD-KSDVYSFGVVLVELLTGKKPIFWAGNTSQEN 383 (468)
Q Consensus 306 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDVwSlGvll~el~tG~~p~~~~~~~~~~~ 383 (468)
+.++.+||+|||++...... ......||..|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---- 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence 99999999999999865433 23445689999999999887 6666 999999999999999999998532110
Q ss_pred hchHHHHHHHhhccccchh---------cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 384 VSLAAYFVHSMRKNRLHDI---------LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~---------~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.... ........... .............+..+.+++.+||+.||++|||+.|+++
T Consensus 259 ---~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 ---VELF-NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ---HHHH-HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---HHHH-HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111 11111111000 0000000011334557899999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=338.97 Aligned_cols=257 Identities=12% Similarity=0.062 Sum_probs=181.7
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc--CCCceeeEe-------ee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI--NHRNVVKLL-------GC 232 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l--~h~niv~l~-------g~ 232 (468)
...|.+.+.||+|+||.||+|... +++.||||++...... .....+.+.+|+.++..+ +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN-SRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT-HHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc-cccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 345889999999999999999965 7899999998775432 224456677885544444 699988855 33
Q ss_pred eccC-----------------CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHH------HHHHHHHHHHHHHHHhCC
Q 012214 233 CLET-----------------EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMR------LRIATEVAGALAYLHSAT 289 (468)
Q Consensus 233 ~~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~qia~gL~yLH~~~ 289 (468)
+... ...++||||++ |+|.+++..... .+++..+ ..++.||+.||+|||+++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSKG 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC
Confidence 3222 33799999998 899999987432 2444555 788899999999999999
Q ss_pred CCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCceeeecccccCCccCcccccc--CCCCCcccHHHHHHHHHHHH
Q 012214 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELL 367 (468)
Q Consensus 290 ~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvll~el~ 367 (468)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 215 ---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 215 ---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp ---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred ---CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 999999999999999999999999999865321 224457799999999987 78999999999999999999
Q ss_pred hCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 368 TGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 368 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+|+.||.......... ......................++.+.+|+.+||+.||++|||+.++++
T Consensus 288 tg~~Pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 288 CLFLPFGLVTPGIKGS----------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HSSCSTTBCCTTCTTC----------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hCCCCCCCcCcccccc----------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999986432111100 0000000000000011111234558899999999999999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=329.78 Aligned_cols=261 Identities=27% Similarity=0.399 Sum_probs=198.0
Q ss_pred ccCHHHHHHHhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEe
Q 012214 153 LFSSKELDKATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLL 230 (468)
Q Consensus 153 ~~~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~ 230 (468)
.++..++....++|.+.+.||+|+||.||+|.. .+++.||+|++...... .+.+.+|+.+++++ +||||++++
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~e~~~l~~l~~h~~i~~~~ 87 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-----EEEIKQEINMLKKYSHHRNIATYY 87 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST-----THHHHHHHHHHHHHCCSTTBCCEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc-----HHHHHHHHHHHHhccCCCCeeeee
Confidence 334444455678899999999999999999996 46899999998654322 25688999999999 899999999
Q ss_pred eeecc------CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEE
Q 012214 231 GCCLE------TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNIL 304 (468)
Q Consensus 231 g~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NIL 304 (468)
+++.. ....++||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||
T Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl 161 (326)
T 2x7f_A 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVL 161 (326)
T ss_dssp EEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEE
T ss_pred eEEeeccCccccceEEEEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEE
Confidence 99976 457899999999999999998632 235899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEecCCcccccCCCceeeecccccCCccCccccc-----cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 012214 305 LDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNT 379 (468)
Q Consensus 305 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~ 379 (468)
++.++.+||+|||++........ ......||+.|+|||.+. +..++.++|||||||++|+|++|..||....
T Consensus 162 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-- 238 (326)
T 2x7f_A 162 LTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-- 238 (326)
T ss_dssp ECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC--
T ss_pred EcCCCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc--
Confidence 99999999999999876543221 223346899999999987 5678999999999999999999999984311
Q ss_pred ccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 380 SQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.. ........ ....... ....+..+.+++.+||+.||++|||+.++++
T Consensus 239 ---~~---~~~~~~~~-~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 239 ---PM---RALFLIPR-NPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ---HH---HHHHHHHH-SCCCCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---HH---HHHHHhhc-CccccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11 11111111 1111111 1223457899999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=327.97 Aligned_cols=281 Identities=23% Similarity=0.317 Sum_probs=192.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHH-HHHhcCCCceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIV-ILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
.++|.+.+.||+|+||.||++... +|+.||||++...... .....+..|+. +++.++||||+++++++.+.+..+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE---KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH---HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc---hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 478899999999999999999975 6899999998765433 23345666665 677789999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA-TSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
+||||+++ +|.+++..........+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 99999975 888887653323334689999999999999999999998 8 999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCcccc----ccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYH----QSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
+....... .....||+.|+|||.+ .+..++.++||||||+++|+|++|+.||........ .... ..
T Consensus 174 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~-~~ 243 (327)
T 3aln_A 174 GQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------QLTQ-VV 243 (327)
T ss_dssp CC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CC-CC
T ss_pred eecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-------HHHH-Hh
Confidence 76643322 2234689999999998 456789999999999999999999999853211000 0000 00
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhcccCCchhhhHHHHHHhhh
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGIRGSSKKKRAMFSKIIKRL 465 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i~~~~~~~~~~~~~~~~~~ 465 (468)
......+ ........+..+.+|+.+||+.||++|||+.++++ .+...............+++++.
T Consensus 244 ~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~ 310 (327)
T 3aln_A 244 KGDPPQL-----SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQM 310 (327)
T ss_dssp CSCCCCC-----CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCCCHHHHHHHHHHHC
T ss_pred cCCCCCC-----CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhHHHHHHHHHHHHhcC
Confidence 0111110 01111234457899999999999999999999987 34444444444445555555443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=325.35 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=198.7
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC-----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----- 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~----- 236 (468)
.++|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP---LFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH---HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc---hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 478999999999999999999965 6899999998653332 3456788999999999999999999988654
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...++||||+. ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Df 156 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDF 156 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEec
Confidence 67899999996 699998875 24899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCce---------eeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhch
Q 012214 317 GTSKFIAMDQTH---------VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSL 386 (468)
Q Consensus 317 Gla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~ 386 (468)
|+++........ ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ....
T Consensus 157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~ 231 (353)
T 2b9h_A 157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD-----YRHQ 231 (353)
T ss_dssp TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHH
T ss_pred ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC-----cHHH
Confidence 999876432211 1123468999999998765 778999999999999999999999985311 1111
Q ss_pred HHHHHHHhhccc----cchhcchHH--------------hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 387 AAYFVHSMRKNR----LHDILDDQL--------------MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 387 ~~~~~~~~~~~~----~~~~~d~~l--------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
............ ......... ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111111111000 000000000 00011234567899999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=326.81 Aligned_cols=273 Identities=23% Similarity=0.327 Sum_probs=203.4
Q ss_pred HhcCCCCCceeeecCcEEEEEEEe--cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc---CCCceeeEeeeec--
Q 012214 162 ATNHFNANRILGQGGQGTVYKGML--EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI---NHRNVVKLLGCCL-- 234 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~-- 234 (468)
..++|.+.+.||+|+||.||++.. .+++.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc--cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 457899999999999999999997 468899999886533221 1112455677776666 8999999999987
Q ss_pred ---cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcE
Q 012214 235 ---ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA 311 (468)
Q Consensus 235 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~ 311 (468)
.....++||||++ |+|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~ 159 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQI 159 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCE
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCE
Confidence 5667899999997 69999997632 235899999999999999999999999 9999999999999999999
Q ss_pred EEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHH
Q 012214 312 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391 (468)
Q Consensus 312 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (468)
||+|||+++...... ......||..|+|||.+.+..++.++||||||+++|+|++|+.||... ..........
T Consensus 160 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~i~ 232 (326)
T 1blx_A 160 KLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS-----SDVDQLGKIL 232 (326)
T ss_dssp EECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHH
T ss_pred EEecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHH
Confidence 999999997654322 223456899999999999999999999999999999999999998531 1111111111
Q ss_pred HHhhccccchhc---c----------hHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhcccC
Q 012214 392 HSMRKNRLHDIL---D----------DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGIRGS 450 (468)
Q Consensus 392 ~~~~~~~~~~~~---d----------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i~~~ 450 (468)
..........+. . ...........+..+.+|+.+||+.||++|||+.|+++ .++.+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 233 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred HHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 111110000000 0 00001112234567899999999999999999999985 35554433
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=335.41 Aligned_cols=259 Identities=22% Similarity=0.304 Sum_probs=183.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccC-----
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLET----- 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~----- 236 (468)
.++|.+.+.||+|+||.||+|.. .+|+.||||++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI--IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 47899999999999999999985 468999999986543322 4456788999999999999999999998654
Q ss_pred -CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 237 -EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 237 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
...++|+|++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~D 175 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILD 175 (367)
T ss_dssp CCCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEee
Confidence 5679999999 6899888864 25899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
||+++..... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||... .............
T Consensus 176 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~l~~i~~~~ 246 (367)
T 2fst_X 176 FGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-----DHIDQLKLILRLV 246 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHHH
T ss_pred cccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHh
Confidence 9999765432 234568999999999887 67899999999999999999999998531 1111111111111
Q ss_pred hccc---cchhcchHHh--------------hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 395 RKNR---LHDILDDQLM--------------KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 395 ~~~~---~~~~~d~~l~--------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+. +..+...... .......++.+.+|+.+||+.||++|||+.|+++
T Consensus 247 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 1100 0000000000 0001123457899999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=331.53 Aligned_cols=267 Identities=23% Similarity=0.377 Sum_probs=200.2
Q ss_pred HHHHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC
Q 012214 158 ELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE 237 (468)
Q Consensus 158 ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 237 (468)
+.+...++|.+.+.||+|+||.||+|...+ .+|+|++....... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE--DQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC--CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH--HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 334445789999999999999999998753 48999886543221 22345778999999999999999999999999
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG 317 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfG 317 (468)
..++|+||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCS
T ss_pred ceEEEeecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecC
Confidence 9999999999999999996532 35899999999999999999999999 99999999999998 6799999999
Q ss_pred CcccccCCCc----eeeecccccCCccCcccccc---------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchh
Q 012214 318 TSKFIAMDQT----HVTTKIQGTFGYLDPEYHQS---------SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENV 384 (468)
Q Consensus 318 la~~~~~~~~----~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~ 384 (468)
+++....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||... ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~~ 249 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ-----PAE 249 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC-----CHH
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHH
Confidence 9876532111 11233458999999998874 45788999999999999999999998531 111
Q ss_pred chHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCch
Q 012214 385 SLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKK 453 (468)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 453 (468)
... ............ ....+..+.+++.+||+.||++|||+.+++++|+.+......
T Consensus 250 ---~~~-~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 250 ---AII-WQMGTGMKPNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp ---HHH-HHHHTTCCCCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred ---HHH-HHhccCCCCCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111 111111111111 112234688999999999999999999999999999876543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=329.38 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=196.4
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc--
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP-- 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~-- 239 (468)
.++|.+.+.||+|+||.||+|... +|+.||||++....... ...+.+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE--IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccch--hHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 478999999999999999999965 68999999987643332 3456788999999999999999999999877655
Q ss_pred ----eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 240 ----LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 240 ----~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
++||||+. ++|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~D 187 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILD 187 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECS
T ss_pred ceeEEEEEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEe
Confidence 99999997 688877743 4899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
||+++..... .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ............
T Consensus 188 fg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~ 258 (371)
T 4exu_A 188 FGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-----YLDQLTQILKVT 258 (371)
T ss_dssp TTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHH
T ss_pred cCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHh
Confidence 9999755332 234568999999999887 788999999999999999999999985311 111111111111
Q ss_pred hccc--c-chhcchHH--------------hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 395 RKNR--L-HDILDDQL--------------MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 395 ~~~~--~-~~~~d~~l--------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.... . ..+.+... ........++.+.+|+.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000 0 00000000 00001233567899999999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=355.61 Aligned_cols=247 Identities=26% Similarity=0.300 Sum_probs=201.0
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcc
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~ 239 (468)
..++|.+.+.||+|+||.||++... +++.||||+++..... .....+.+..|..++..+ +||+|+++++++.+.+..
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH-HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4578999999999999999999965 5888999998653211 112345678899999887 799999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EEEEeCcCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeeccee
Confidence 99999999999999997643 4899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... .. ...+...... .+
T Consensus 490 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-----~~---~~~~~~i~~~-~~ 559 (674)
T 3pfq_A 490 KENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-----DE---DELFQSIMEH-NV 559 (674)
T ss_dssp EECCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-----SH---HHHHHHHHSS-CC
T ss_pred eccccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC-----CH---HHHHHHHHhC-CC
Confidence 86433222 234567999999999999999999999999999999999999998531 11 1111122111 11
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTM 437 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 437 (468)
..+...+..+.+|+.+||+.||++||++
T Consensus 560 ----------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 560 ----------AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ----------CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ----------CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 1122344578999999999999999997
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=335.87 Aligned_cols=267 Identities=22% Similarity=0.307 Sum_probs=196.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC-----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE----- 237 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----- 237 (468)
..+|.+.+.||+|+||.||++....+..+|+|++...... ..+|+.+++.++||||+++++++....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 3578999999999999999999877777999987543221 236999999999999999999985433
Q ss_pred -cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc-CCCcEEEEe
Q 012214 238 -VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD-QRYRAKVAD 315 (468)
Q Consensus 238 -~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~-~~~~~kl~D 315 (468)
..++||||++++ +...+..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|
T Consensus 111 ~~~~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 111 VFLNLVLEYVPET-VYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp EEEEEEEECCSEE-HHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEeeccCcc-HHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEee
Confidence 378999999764 4444432211 1236899999999999999999999999 99999999999999 799999999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
||+++....... .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||... .............
T Consensus 186 FG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-----~~~~~l~~i~~~~ 258 (394)
T 4e7w_A 186 FGSAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE-----SGIDQLVEIIKVL 258 (394)
T ss_dssp CTTCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHHH
T ss_pred CCCcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHh
Confidence 999987644332 2335689999999998764 5899999999999999999999998531 1111111111111
Q ss_pred hcc---------------ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhccc
Q 012214 395 RKN---------------RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME--LNGIRG 449 (468)
Q Consensus 395 ~~~---------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~~ 449 (468)
..+ ..................++.+.+|+.+||+.||++|||+.|+++. +++++.
T Consensus 259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 110 0111111111111222345689999999999999999999999873 555443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=322.14 Aligned_cols=265 Identities=22% Similarity=0.310 Sum_probs=202.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEe--cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCC------ceeeEeeeec
Q 012214 163 TNHFNANRILGQGGQGTVYKGML--EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR------NVVKLLGCCL 234 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~------niv~l~g~~~ 234 (468)
.++|.+.+.||+|+||.||++.. .+++.||||++... . ...+.+.+|+.+++.++|+ +++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--D---RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--H---HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--C---chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 46899999999999999999986 36889999998653 2 3345678899999888665 4999999999
Q ss_pred cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC-------
Q 012214 235 ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ------- 307 (468)
Q Consensus 235 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~------- 307 (468)
+.+..++||||+ +++|.+++.... ..++++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEE
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEecccccccc
Confidence 999999999999 889999997632 235899999999999999999999999 999999999999987
Q ss_pred ------------CCcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 012214 308 ------------RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFW 375 (468)
Q Consensus 308 ------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~ 375 (468)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|..||..
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 678999999999764332 2335689999999999999999999999999999999999999853
Q ss_pred CCCCccchhchHHHHHHHhhccc-------------------cchhcc------h-----HHhhhchHHHHHHHHHHHHH
Q 012214 376 AGNTSQENVSLAAYFVHSMRKNR-------------------LHDILD------D-----QLMKLGVKNQIMTFANLAKR 425 (468)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~d------~-----~l~~~~~~~~~~~l~~li~~ 425 (468)
.. ................ +..... . ..........++.+.+|+.+
T Consensus 237 ~~-----~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 311 (339)
T 1z57_A 237 HD-----SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQK 311 (339)
T ss_dssp SC-----HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred CC-----hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHH
Confidence 11 1111111111110000 000000 0 00001123456789999999
Q ss_pred hhccCCCCCCCHHHHHHH--HHhcc
Q 012214 426 CLDLNGKKRPTMEEVSME--LNGIR 448 (468)
Q Consensus 426 cl~~dp~~RPt~~evl~~--L~~i~ 448 (468)
||+.||++|||+.|+++. ++.++
T Consensus 312 ~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 312 MLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp HTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred HhCcCcccccCHHHHhcCHHHHHHh
Confidence 999999999999999853 44443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=322.47 Aligned_cols=258 Identities=24% Similarity=0.324 Sum_probs=198.1
Q ss_pred HHHHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC--CCceeeEeeeecc
Q 012214 158 ELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN--HRNVVKLLGCCLE 235 (468)
Q Consensus 158 ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~ 235 (468)
.+....++|.+.+.||+|+||.||++...+++.||||++....... ...+.+.+|+.++.+++ |+||+++++++.+
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN--QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccc--cchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 3444567899999999999999999998889999999986543322 45577899999999996 5999999999999
Q ss_pred CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
....++||| +.+++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+++ +.+||+|
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred CCEEEEEEe-cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 999999999 56889999997632 5899999999999999999999999 999999999999965 8999999
Q ss_pred cCCcccccCCCce-eeecccccCCccCcccccc-----------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccch
Q 012214 316 FGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQS-----------SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQEN 383 (468)
Q Consensus 316 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~ 383 (468)
||+++........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----- 244 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----- 244 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----
Confidence 9999876543322 2234568999999999875 4688899999999999999999999843110
Q ss_pred hchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 384 VSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
.............. ...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 245 --~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 245 --QISKLHAIIDPNHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp --HHHHHHHHHCTTSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHHHHHHHHhcccc---------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11111111111110 01111223478899999999999999999999863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=322.92 Aligned_cols=252 Identities=26% Similarity=0.372 Sum_probs=197.4
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE----EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH----HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 477999999999999999999975 588999998865321 234678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 94 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp EEECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred EEEeCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 999999999999987532 25899999999999999999999999 99999999999999999999999998754
Q ss_pred ccCCCceeeecccccCCccCcccc-----ccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYH-----QSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
..... .......||+.|+|||.+ .+..++.++||||||+++|+|++|+.||.... . ..........
T Consensus 167 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~---~~~~~~~~~~ 237 (302)
T 2j7t_A 167 NLKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-----P---MRVLLKIAKS 237 (302)
T ss_dssp HHHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC-----H---HHHHHHHHHS
T ss_pred ccccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC-----H---HHHHHHHhcc
Confidence 32111 112234689999999988 36778999999999999999999999984311 1 1111111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ..... .+...+..+.+++.+||+.||++|||+.++++
T Consensus 238 ~-~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 238 D-PPTLL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp C-CCCCS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred C-CcccC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1 11110 12234457899999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=318.09 Aligned_cols=253 Identities=24% Similarity=0.364 Sum_probs=200.9
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
..++|.+.+.||+|+||.||++... +++.||+|++....... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch--HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 4578999999999999999999975 68999999986533221 23467889999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC---CcEEEEecC
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR---YRAKVADFG 317 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~---~~~kl~DfG 317 (468)
+|+||+++++|.+++.... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+ +.+||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEccCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccC
Confidence 9999999999999887632 4899999999999999999999999 9999999999999764 479999999
Q ss_pred CcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 318 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 318 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
++........ .....+|+.|+|||.+.+ .++.++||||||+++|+|++|..||... .... ........
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~----~~~~~~~~ 237 (287)
T 2wei_A 170 LSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK-----NEYD----ILKRVETG 237 (287)
T ss_dssp GGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHH----HHHHHHHC
T ss_pred cceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC-----CHHH----HHHHHHcC
Confidence 9986543322 223458899999998876 4899999999999999999999998531 1111 11111111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 238 KYAFDL------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCCCS------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCc------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 111000 001223457899999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=336.76 Aligned_cols=265 Identities=25% Similarity=0.317 Sum_probs=195.2
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc------C
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE------T 236 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------~ 236 (468)
.+|.+.+.||+|+||.||+|.+. +|+.||||++..... .+.+|+.+++.++||||+++++++.. .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 46888999999999999999975 589999998865321 23469999999999999999998843 2
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC-CcEEEEe
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR-YRAKVAD 315 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~-~~~kl~D 315 (468)
...++||||+++ +|.+.+..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred eeEEeehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEecc
Confidence 246799999975 67666654221 2236999999999999999999999999 9999999999999965 6789999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
||+++....... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||... .............
T Consensus 201 FG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~-----~~~~~l~~i~~~l 273 (420)
T 1j1b_A 201 FGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD-----SGVDQLVEIIKVL 273 (420)
T ss_dssp CTTCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHHH
T ss_pred chhhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHh
Confidence 999987644332 2335689999999998764 7899999999999999999999998531 1111111111111
Q ss_pred hccc---------------cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhcc
Q 012214 395 RKNR---------------LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGIR 448 (468)
Q Consensus 395 ~~~~---------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i~ 448 (468)
..+. +..+.............+..+.+|+.+||+.||.+|||+.|+++ .+++++
T Consensus 274 g~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 274 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred CCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 1100 00000000111112234567899999999999999999999986 344544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=320.32 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=191.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc------
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE------ 235 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------ 235 (468)
.++|++.+.||+|+||.||+|... +++.||||++... . ...+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--E---EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--H---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--H---HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 467899999999999999999964 7899999998642 2 345678999999999999999999998754
Q ss_pred -------CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC
Q 012214 236 -------TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR 308 (468)
Q Consensus 236 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~ 308 (468)
....++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+|+||||+|||++.+
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~ 152 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDES 152 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCC
Confidence 456789999999999999997632 24788999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCcccccCCC-------------ceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCC
Q 012214 309 YRAKVADFGTSKFIAMDQ-------------THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIF 374 (468)
Q Consensus 309 ~~~kl~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~ 374 (468)
+.+||+|||++....... ........||+.|+|||.+.+. .++.++|||||||++|||++ ||.
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~ 229 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS 229 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence 999999999997654221 1112345689999999998864 78999999999999999998 442
Q ss_pred CCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 375 WAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
. .... .. .......... . .....+...+..+.+++.+||+.||++|||+.++++.
T Consensus 230 ~----~~~~---~~-~~~~~~~~~~-~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 230 T----GMER---VN-ILKKLRSVSI-E-----FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp S----HHHH---HH-HHHHHHSTTC-C-----CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred C----chhH---HH-HHHhcccccc-c-----cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1 0111 11 1111111100 0 0111123344578999999999999999999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=323.31 Aligned_cols=258 Identities=22% Similarity=0.309 Sum_probs=195.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc---
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV--- 238 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~--- 238 (468)
.++|.+.+.||+|+||.||+|... +|+.||||++....... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE--IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccch--HHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 367889999999999999999964 68999999987643332 345678899999999999999999999987654
Q ss_pred ---ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 239 ---PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 239 ---~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
.++||||+. ++|.+++.. .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~D 169 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILD 169 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECS
T ss_pred ceeEEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEee
Confidence 499999997 688877742 4899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
||+++..... .....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ............
T Consensus 170 fg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~ 240 (353)
T 3coi_A 170 FGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-----YLDQLTQILKVT 240 (353)
T ss_dssp TTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC-----HHHHHHHHHHHH
T ss_pred cccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHh
Confidence 9999765322 233568999999999887 678999999999999999999999985311 111111111111
Q ss_pred hccc---cchhcchHH--------------hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 395 RKNR---LHDILDDQL--------------MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 395 ~~~~---~~~~~d~~l--------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.... ...+.+... ........+..+.+|+.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 000000000 00011234568999999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=325.57 Aligned_cols=270 Identities=20% Similarity=0.230 Sum_probs=190.2
Q ss_pred HHHHHHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeec
Q 012214 156 SKELDKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL 234 (468)
Q Consensus 156 ~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~ 234 (468)
........++|.+.+.||+|+||.||+|... +++.||||++...... ...+.+++..+..++||||+++++++.
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~l~~l~h~niv~~~~~~~ 89 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-----RNRELQIMQDLAVLHHPNIVQLQSYFY 89 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-----CCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-----cHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence 3456677789999999999999999999975 6899999987543221 234567888889999999999999986
Q ss_pred cCCc-------ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCEEecCCCCCCEEE
Q 012214 235 ETEV-------PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH--SATSSPIYHRDIKSTNILL 305 (468)
Q Consensus 235 ~~~~-------~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--~~~~~~iiH~DLkp~NILl 305 (468)
.... .++||||+++ +|...+.... .....+++..+..++.|++.||.||| +.+ |+||||||+|||+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll 164 (360)
T 3e3p_A 90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLV 164 (360)
T ss_dssp EECSSCTTCEEEEEEEECCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEE
T ss_pred ccccccccceeEEEEeecccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEE
Confidence 5333 7899999975 6655554322 22235899999999999999999999 888 9999999999999
Q ss_pred cC-CCcEEEEecCCcccccCCCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccch
Q 012214 306 DQ-RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQEN 383 (468)
Q Consensus 306 ~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~ 383 (468)
+. ++.+||+|||+++....... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||... ..
T Consensus 165 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~-----~~ 237 (360)
T 3e3p_A 165 NEADGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD-----NS 237 (360)
T ss_dssp ETTTTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SH
T ss_pred eCCCCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC-----Ch
Confidence 97 89999999999987654332 2345689999999998764 4899999999999999999999998531 11
Q ss_pred hchHHHHHHHhhccc------------cchh------cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 384 VSLAAYFVHSMRKNR------------LHDI------LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 384 ~~~~~~~~~~~~~~~------------~~~~------~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
............... .... .............+..+.+|+.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 238 AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111111111110000 0000 0001111112234668999999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=327.18 Aligned_cols=263 Identities=21% Similarity=0.261 Sum_probs=198.6
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-----------CCceeeEee
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-----------HRNVVKLLG 231 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~g 231 (468)
++|.+.+.||+|+||.||+|.. .+++.||||++... . ...+.+.+|+.++++++ |+||+++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--K---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--H---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--c---cchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 6799999999999999999996 46899999998742 1 23456788999988876 899999999
Q ss_pred eeccCC----cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEecCCCCCCEEEc
Q 012214 232 CCLETE----VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA-TSSPIYHRDIKSTNILLD 306 (468)
Q Consensus 232 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLkp~NILl~ 306 (468)
++.... ..++|||++ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLME 166 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEE
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEe
Confidence 987644 789999999 889999997632 23589999999999999999999998 8 99999999999994
Q ss_pred ------CCCcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCc
Q 012214 307 ------QRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTS 380 (468)
Q Consensus 307 ------~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~ 380 (468)
.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 242 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred ccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 4458999999999865432 233468999999999999999999999999999999999999986422111
Q ss_pred c-chhchHHHHHHHhhccc-------------------cchh-------cch--HHhhhchHHHHHHHHHHHHHhhccCC
Q 012214 381 Q-ENVSLAAYFVHSMRKNR-------------------LHDI-------LDD--QLMKLGVKNQIMTFANLAKRCLDLNG 431 (468)
Q Consensus 381 ~-~~~~~~~~~~~~~~~~~-------------------~~~~-------~d~--~l~~~~~~~~~~~l~~li~~cl~~dp 431 (468)
. ................. +..+ +.. ......+...+..+.+|+.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 0 01111111111110000 0000 000 00112345677889999999999999
Q ss_pred CCCCCHHHHHH
Q 012214 432 KKRPTMEEVSM 442 (468)
Q Consensus 432 ~~RPt~~evl~ 442 (468)
++|||+.|+++
T Consensus 323 ~~Rpt~~ell~ 333 (373)
T 1q8y_A 323 RKRADAGGLVN 333 (373)
T ss_dssp TTCBCHHHHHT
T ss_pred cccCCHHHHhh
Confidence 99999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.46 Aligned_cols=261 Identities=23% Similarity=0.320 Sum_probs=191.1
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeec-------
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL------- 234 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~------- 234 (468)
.++|.+.+.||+|+||.||+|... +++.||+|++.... . ...+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-P---QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-H---HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-h---HHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 467899999999999999999976 48999999886532 2 44577899999999999999999998873
Q ss_pred -------cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc-
Q 012214 235 -------ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD- 306 (468)
Q Consensus 235 -------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~- 306 (468)
+....++||||++ |+|.+++.. .++++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 155 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINT 155 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEET
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcC
Confidence 3467799999997 699998854 25899999999999999999999999 99999999999997
Q ss_pred CCCcEEEEecCCcccccCCCce--eeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccch
Q 012214 307 QRYRAKVADFGTSKFIAMDQTH--VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQEN 383 (468)
Q Consensus 307 ~~~~~kl~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~ 383 (468)
+++.+||+|||+++........ ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||.... .
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~ 230 (320)
T 2i6l_A 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH-----E 230 (320)
T ss_dssp TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----H
T ss_pred CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC-----H
Confidence 5679999999999866432211 1233457899999998866 678999999999999999999999985311 1
Q ss_pred hchHHHHHHHhhcc----------ccchhcchHHh------hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 384 VSLAAYFVHSMRKN----------RLHDILDDQLM------KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 384 ~~~~~~~~~~~~~~----------~~~~~~d~~l~------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.............. .+......... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 231 LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 11111111110000 00000000000 0011234567999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=334.35 Aligned_cols=254 Identities=26% Similarity=0.332 Sum_probs=186.0
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV 242 (468)
+.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.+++++ +||||+++++++.+....++|
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 4455678899999999987666679999999886521 23567899999876 899999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC------------
Q 012214 243 YEFIPNGTLYQHLHDRHQNEE--FPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR------------ 308 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~------------ 308 (468)
|||+. |+|.+++........ ...++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCC
Confidence 99995 699999976432211 11233456789999999999999999 9999999999999754
Q ss_pred -CcEEEEecCCcccccCCCce---eeecccccCCccCcccccc-------CCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q 012214 309 -YRAKVADFGTSKFIAMDQTH---VTTKIQGTFGYLDPEYHQS-------SQLTDKSDVYSFGVVLVELLT-GKKPIFWA 376 (468)
Q Consensus 309 -~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvll~el~t-G~~p~~~~ 376 (468)
+.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||...
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 48999999999876543322 1234579999999999875 678999999999999999999 89998431
Q ss_pred CCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 377 GNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. .. .............. ........+..+.+++.+||+.||++|||+.++++
T Consensus 244 ~--~~----~~~i~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 244 Y--SR----ESNIIRGIFSLDEM--------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp T--TH----HHHHHHTCCCCCCC--------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred h--hh----HHHHhcCCCCcccc--------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 00 01111111111111 11113355678999999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=325.66 Aligned_cols=200 Identities=26% Similarity=0.349 Sum_probs=169.5
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CC-----ceeeEeee
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HR-----NVVKLLGC 232 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~-----niv~l~g~ 232 (468)
+...++|.+.+.||+|+||+||+|... +++.||||++... . ....++..|+.++..++ |+ ++++++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--K---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--H---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--H---HHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 344678999999999999999999965 6889999998753 1 23456778888888874 54 49999999
Q ss_pred eccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCEEecCCCCCCEEEc--CC
Q 012214 233 CLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS--ATSSPIYHRDIKSTNILLD--QR 308 (468)
Q Consensus 233 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~--~~~~~iiH~DLkp~NILl~--~~ 308 (468)
+......++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+ .+ |+||||||+|||++ .+
T Consensus 125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~ 197 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLS-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKR 197 (382)
T ss_dssp EEETTEEEEEEECCC-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTS
T ss_pred eccCCceEEEEecCC-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCC
Confidence 999999999999996 59999998632 2358999999999999999999995 45 99999999999994 57
Q ss_pred CcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 012214 309 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFW 375 (468)
Q Consensus 309 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~ 375 (468)
+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 198 ~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 88999999999866432 2335689999999999999999999999999999999999999853
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=317.70 Aligned_cols=259 Identities=22% Similarity=0.272 Sum_probs=197.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CC-cEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCc------eeeEeeeec
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DG-RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN------VVKLLGCCL 234 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~g~~~ 234 (468)
.++|.+.+.||+|+||.||++... ++ +.||+|++... . ...+.+.+|+.+++.++|++ ++.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--G---KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--H---HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--c---cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 478999999999999999999964 34 78999998653 2 23456788999999887665 999999999
Q ss_pred cCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEE---------
Q 012214 235 ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILL--------- 305 (468)
Q Consensus 235 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl--------- 305 (468)
.....++||||+ +++|.+++.... ..++++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEE
T ss_pred eCCeEEEEEecc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccc
Confidence 999999999999 678888776632 235899999999999999999999999 9999999999999
Q ss_pred ----------cCCCcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 012214 306 ----------DQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFW 375 (468)
Q Consensus 306 ----------~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~ 375 (468)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 66889999999999764332 2335689999999999999999999999999999999999999853
Q ss_pred CCCCccchhchHHHHHHHhhccc-------------------cchhcch-H----------HhhhchHHHHHHHHHHHHH
Q 012214 376 AGNTSQENVSLAAYFVHSMRKNR-------------------LHDILDD-Q----------LMKLGVKNQIMTFANLAKR 425 (468)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~d~-~----------l~~~~~~~~~~~l~~li~~ 425 (468)
.. ................ +...... . .........+..+.+|+.+
T Consensus 242 ~~-----~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 316 (355)
T 2eu9_A 242 HE-----NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR 316 (355)
T ss_dssp SS-----HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred CC-----HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHH
Confidence 11 1111111111110000 0000000 0 0001122345689999999
Q ss_pred hhccCCCCCCCHHHHHH
Q 012214 426 CLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 426 cl~~dp~~RPt~~evl~ 442 (468)
||+.||++|||+.|+++
T Consensus 317 ~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 317 MLEFDPAQRITLAEALL 333 (355)
T ss_dssp HTCSSTTTSCCHHHHTT
T ss_pred HhcCChhhCcCHHHHhc
Confidence 99999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=318.77 Aligned_cols=249 Identities=27% Similarity=0.383 Sum_probs=190.9
Q ss_pred HHHHHhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHH--HHHHHHHHHHHHHHHhc----CCCceeeEe
Q 012214 158 ELDKATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEE--LLKLEEFINEIVILSQI----NHRNVVKLL 230 (468)
Q Consensus 158 ei~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~--~~~~~~~~~Ei~~l~~l----~h~niv~l~ 230 (468)
+.+...++|.+.+.||+|+||.||+|.. .+++.||||++........ ......+.+|+.++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3455568899999999999999999986 4688999999865432211 11223466799999998 899999999
Q ss_pred eeeccCCcceeEeee-cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc-CC
Q 012214 231 GCCLETEVPLLVYEF-IPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD-QR 308 (468)
Q Consensus 231 g~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~-~~ 308 (468)
+++.+.+..++|+|+ +.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++ .+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCC
Confidence 999999999999999 78999999997632 4899999999999999999999999 99999999999999 88
Q ss_pred CcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCC-CcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchH
Q 012214 309 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLA 387 (468)
Q Consensus 309 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~ 387 (468)
+.+||+|||++....... .....||..|+|||++.+..+. .++||||||+++|||++|+.||... .
T Consensus 177 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~----- 243 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----Q----- 243 (312)
T ss_dssp TEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----H-----
T ss_pred CeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----H-----
Confidence 999999999998765432 2335689999999998876664 4899999999999999999998420 0
Q ss_pred HHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 388 AYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ... .... .+...+..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~-~~~--~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 E-ILE--AELH------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp H-HHH--TCCC------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred H-Hhh--hccC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000 0011 11233447889999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=313.44 Aligned_cols=270 Identities=23% Similarity=0.341 Sum_probs=186.2
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||++... +|+.||||++....... ...+.+..+..+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE--ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH--HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch--HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 467888999999999999999975 68999999987654332 223344455567888899999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA-TSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
||||+ ++.+..+.... ...+++..+..++.||+.||.|||+. + |+|+||||+||+++.++.+||+|||++.
T Consensus 102 v~e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISG 173 (318)
T ss_dssp EECCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred EEecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCch
Confidence 99999 44555554432 13589999999999999999999995 8 9999999999999999999999999997
Q ss_pred cccCCCceeeecccccCCccCccccc-----cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
....... .....+|+.|+|||.+. ...++.++||||||+++|||++|+.||.... .. .........
T Consensus 174 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~---~~~~~~~~~ 244 (318)
T 2dyl_A 174 RLVDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK----TD---FEVLTKVLQ 244 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC----SH---HHHHHHHHH
T ss_pred hccCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC----cc---HHHHHHHhc
Confidence 6543322 23346899999999984 4678899999999999999999999985311 11 111111111
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhcccCCchhhhHHH
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGIRGSSKKKRAMFS 459 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i~~~~~~~~~~~~ 459 (468)
.. ...+.. ....+..+.+++.+||+.||.+|||+.++++ .++..............
T Consensus 245 ~~-~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~ 302 (318)
T 2dyl_A 245 EE-PPLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFK 302 (318)
T ss_dssp SC-CCCCCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHSCCCHHHHHH
T ss_pred cC-CCCCCc-------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcccccchhHHHhh
Confidence 11 110000 1123447899999999999999999999986 34444433333333333
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=321.29 Aligned_cols=252 Identities=20% Similarity=0.277 Sum_probs=172.3
Q ss_pred hcCCCCCc-eeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc----C
Q 012214 163 TNHFNANR-ILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE----T 236 (468)
Q Consensus 163 ~~~f~~~~-~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~ 236 (468)
.++|.+.+ .||+|+||.||++... +++.||||++... . .... .....++.+.||||+++++++.. .
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~---~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--P---KARQ---EVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--H---HHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--H---HHHH---HHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 47788854 6999999999999976 6899999998652 1 1111 22234566799999999999875 4
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC---CCcEEE
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ---RYRAKV 313 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~---~~~~kl 313 (468)
...++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEE
T ss_pred ceEEEEEeccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEE
Confidence 45899999999999999998632 236999999999999999999999999 999999999999976 456999
Q ss_pred EecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH
Q 012214 314 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 314 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
+|||+++...... .....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......... ......
T Consensus 173 ~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~ 244 (336)
T 3fhr_A 173 TDFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS-----PGMKRR 244 (336)
T ss_dssp CCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred eccccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh-----hhHHHh
Confidence 9999997654322 23346899999999998889999999999999999999999998532111100 000000
Q ss_pred hhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 394 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...... . .........+..+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~-~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 245 IRLGQY-G-----FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -------C-----CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhcccc-c-----cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 0 000011234557899999999999999999999997
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=322.71 Aligned_cols=252 Identities=27% Similarity=0.425 Sum_probs=198.4
Q ss_pred CHHHHHHHhcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchH--HHHHHHHHHHHHHHHHhcC--CCceeeE
Q 012214 155 SSKELDKATNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDE--ELLKLEEFINEIVILSQIN--HRNVVKL 229 (468)
Q Consensus 155 ~~~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~--~~~~~~~~~~Ei~~l~~l~--h~niv~l 229 (468)
+..+.+...++|.+.+.||+|+||.||+|.. .+++.||||++....... .....+.+.+|+.+++.++ |+||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 3444555678899999999999999999985 468999999886532210 0011234667999999996 5999999
Q ss_pred eeeeccCCcceeEeeecCC-CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc-C
Q 012214 230 LGCCLETEVPLLVYEFIPN-GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD-Q 307 (468)
Q Consensus 230 ~g~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~-~ 307 (468)
++++.+.+..++|+|++.+ ++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++ +
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN 185 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCC
Confidence 9999999999999999976 89999997632 4899999999999999999999999 99999999999999 7
Q ss_pred CCcEEEEecCCcccccCCCceeeecccccCCccCccccccCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhch
Q 012214 308 RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSL 386 (468)
Q Consensus 308 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~ 386 (468)
++.+||+|||+++...... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||... .
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-----~---- 253 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----E---- 253 (320)
T ss_dssp TTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----H----
T ss_pred CCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh-----h----
Confidence 8999999999998765332 233468999999999887665 67889999999999999999998431 0
Q ss_pred HHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 387 AAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 387 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...... . ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 254 -----~~~~~~-~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 -----EIIRGQ-V----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -----HHHHCC-C----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----hhhccc-c----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000100 0 011223447889999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=329.64 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=185.1
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 241 (468)
..+|...+.||+|+||+|+.....+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+....++
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 356888899999999997655556789999999865322 2345799999999 79999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC-----CCcEEEEec
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ-----RYRAKVADF 316 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~-----~~~~kl~Df 316 (468)
||||+. |+|.+++..... ..++..+..++.||+.||.|||+.+ |+||||||+|||++. ...+||+||
T Consensus 96 v~E~~~-g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp EEECCS-EEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred EEECCC-CCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 999996 699999976432 2444456789999999999999999 999999999999953 346889999
Q ss_pred CCcccccCCCc--eeeecccccCCccCccccc---cCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHH
Q 012214 317 GTSKFIAMDQT--HVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYF 390 (468)
Q Consensus 317 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~ 390 (468)
|+++....... .......||+.|+|||++. ...++.++|||||||++|||++ |..||... . . ...
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~--~-~------~~~ 238 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS--L-Q------RQA 238 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST--T-T------HHH
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh--h-H------HHH
Confidence 99987654322 2234467999999999987 4567889999999999999999 88887321 0 0 001
Q ss_pred HHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 391 VHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
........... .. ........+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~-~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 239 NILLGACSLDC-LH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHTTCCCCTT-SC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhccCCccc-cC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11111111111 10 12234456889999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=339.82 Aligned_cols=278 Identities=24% Similarity=0.311 Sum_probs=203.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc------
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE------ 235 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------ 235 (468)
.++|.+.+.||+|+||.||++... +|+.||||++...... ...+.+.+|+.+++.++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP---KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH---HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH---HHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 378999999999999999999864 6899999998764433 445678999999999999999999999765
Q ss_pred CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCc---EE
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYR---AK 312 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~---~k 312 (468)
....++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +|
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEE
T ss_pred CCeEEEEEEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEE
Confidence 6678999999999999999986432 235888999999999999999999999 999999999999997765 99
Q ss_pred EEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhch-HHHHH
Q 012214 313 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSL-AAYFV 391 (468)
Q Consensus 313 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~-~~~~~ 391 (468)
|+|||++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|..||........-.... .....
T Consensus 165 L~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 165 IIDLGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp ECSCCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred Ecccccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 999999987654332 234579999999999999999999999999999999999999985321000000000 00000
Q ss_pred HHhhccccchh--cch--HHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHH-----HHHHHHhcccC
Q 012214 392 HSMRKNRLHDI--LDD--QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE-----VSMELNGIRGS 450 (468)
Q Consensus 392 ~~~~~~~~~~~--~d~--~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e-----vl~~L~~i~~~ 450 (468)
........... ... ..........+..+.+++.+||+.||++|||+.+ +.+.++.+...
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00000000000 000 0011123446678999999999999999999988 55666655543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.57 Aligned_cols=240 Identities=23% Similarity=0.336 Sum_probs=193.2
Q ss_pred cCCCCCceeeecCcEEEEEEEec--CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc---
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE--DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV--- 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~--- 238 (468)
++|.+.+.||+|+||.||++.+. +++.||||++...... .....+.+|+.++++++||||+++++++.+.+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA---EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH---HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH---HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 67999999999999999999975 5899999988654332 345678899999999999999999999987665
Q ss_pred --ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 239 --PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 239 --~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
.++||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+||
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp EEEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCC
T ss_pred ceeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEec
Confidence 6999999999999887643 5899999999999999999999999 9999999999999986 9999999
Q ss_pred CCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
|+++..... ....||+.|+|||++.++. +.++|||||||++|+|++|..|+.....
T Consensus 226 G~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~------------------ 281 (681)
T 2pzi_A 226 GAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV------------------ 281 (681)
T ss_dssp TTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC------------------
T ss_pred ccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc------------------
Confidence 999865432 3356999999999987754 8899999999999999999888642100
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhcc
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-TMEEVSMELNGIR 448 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~i~ 448 (468)
..+.. .......+..+.+++.+||+.||++|| ++.++.+.|.++.
T Consensus 282 ~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 282 DGLPE-------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp SSCCT-------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccccc-------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00000 000112335788999999999999999 5667777776543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=304.24 Aligned_cols=237 Identities=15% Similarity=0.094 Sum_probs=184.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||.||+|... +++.||||++....... ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP-DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC-HHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 367999999999999999999975 48999999987653321 1445779999999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++++|.+++... .....+..++.|++.||+|||+.+ |+||||||+|||++.++.+||++++
T Consensus 109 v~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~---- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA---- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred EEEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc----
Confidence 99999999999998541 345578899999999999999999 9999999999999999999997443
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
|++ +++.++|||||||++|||++|+.||............ . ... .....
T Consensus 175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-~----~~~-~~~~~- 223 (286)
T 3uqc_A 175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-E----RDT-AGQPI- 223 (286)
T ss_dssp -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-C----BCT-TSCBC-
T ss_pred -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-H----HHh-ccCCC-
Confidence 333 3688999999999999999999998642211100000 0 000 00000
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
.. .......+..+.+++.+||+.||++| |+.|+++.|+.+....
T Consensus 224 --~~---~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 224 --EP---ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp --CH---HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred --Ch---hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 00 01112344578999999999999999 9999999999987654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=297.66 Aligned_cols=230 Identities=21% Similarity=0.320 Sum_probs=176.5
Q ss_pred cCCCCC-ceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHH-HhcCCCceeeEeeeecc----C
Q 012214 164 NHFNAN-RILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVIL-SQINHRNVVKLLGCCLE----T 236 (468)
Q Consensus 164 ~~f~~~-~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l-~~l~h~niv~l~g~~~~----~ 236 (468)
++|.+. +.||+|+||.||++.. .+++.||+|++... ..+.+|+.++ +..+||||+++++++.. .
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 556666 7799999999999996 46899999998642 2356788877 55699999999999876 6
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC---CCcEEE
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ---RYRAKV 313 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~---~~~~kl 313 (468)
...++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl 161 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKL 161 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEE
T ss_pred ceEEEEEeecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEE
Confidence 77899999999999999998732 235999999999999999999999999 999999999999998 789999
Q ss_pred EecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHH
Q 012214 314 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHS 393 (468)
Q Consensus 314 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 393 (468)
+|||++.... +..++.++|||||||++|||++|+.||........... ....
T Consensus 162 ~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-----~~~~ 213 (299)
T 3m2w_A 162 TDFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----MKTR 213 (299)
T ss_dssp CCCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-----SCCS
T ss_pred eccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-----HHHH
Confidence 9999985432 23567899999999999999999999853211100000 0000
Q ss_pred hhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 394 MRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 394 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...... ... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 214 ~~~~~~-~~~-----~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 214 IRMGQY-EFP-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCTTCC-SSC-----HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Hhhccc-cCC-----chhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000 000 0001234557999999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=316.21 Aligned_cols=247 Identities=17% Similarity=0.162 Sum_probs=179.4
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCC-Cceee------------
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH-RNVVK------------ 228 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~------------ 228 (468)
+.+|...+.||+|+||.||+|.+ .+|+.||||++...... .....+.+.+|+.++..++| +|...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc-cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34577788999999999999995 46899999998743322 11345678899999999977 22111
Q ss_pred ---E------eeeecc-----CCcceeEeeecCCCChhhHhhhcc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 012214 229 ---L------LGCCLE-----TEVPLLVYEFIPNGTLYQHLHDRH--QNEEFPLTWEMRLRIATEVAGALAYLHSATSSP 292 (468)
Q Consensus 229 ---l------~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 292 (468)
+ ..++.. ....+++|+++ +++|.+++.... .....++++..++.++.||+.||+|||+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1 111111 12345666655 689999885321 122335888999999999999999999999
Q ss_pred EEecCCCCCCEEEcCCCcEEEEecCCcccccCCCceeeecccccCCccCcccc----------ccCCCCCcccHHHHHHH
Q 012214 293 IYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH----------QSSQLTDKSDVYSFGVV 362 (468)
Q Consensus 293 iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDVwSlGvl 362 (468)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999998764332 334567 999999998 55668889999999999
Q ss_pred HHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 363 LVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 363 l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+|||++|+.||..... .. ....++.. ....++.+.+|+.+||+.||++|||+.++++
T Consensus 307 l~elltg~~Pf~~~~~--~~---------------~~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAA--LG---------------GSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGG--GS---------------CSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcch--hh---------------hHHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999853110 00 00011100 1123357899999999999999999888764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=306.02 Aligned_cols=246 Identities=15% Similarity=0.179 Sum_probs=182.4
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccch----HHHHHHHHHHHHHHHHHhcC---------CCceeeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDD----EELLKLEEFINEIVILSQIN---------HRNVVKL 229 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~----~~~~~~~~~~~Ei~~l~~l~---------h~niv~l 229 (468)
.++|.+.+.||+|+||.||+|+. +|+.||||++...... ......+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999998 6899999998754321 01122356788998888885 6666666
Q ss_pred eee-----------------ecc-------------CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHH
Q 012214 230 LGC-----------------CLE-------------TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVA 279 (468)
Q Consensus 230 ~g~-----------------~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia 279 (468)
.++ +.+ ....++||||+++|++.+.+.. ..+++..+..++.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 554 332 6788999999999987777743 2489999999999999
Q ss_pred HHHHHHH-hCCCCCEEecCCCCCCEEEcCCC--------------------cEEEEecCCcccccCCCceeeecccccCC
Q 012214 280 GALAYLH-SATSSPIYHRDIKSTNILLDQRY--------------------RAKVADFGTSKFIAMDQTHVTTKIQGTFG 338 (468)
Q Consensus 280 ~gL~yLH-~~~~~~iiH~DLkp~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~ 338 (468)
.||+||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 899 99999999999999887 9999999999866432 2369999
Q ss_pred ccCccccccCCCCCcccHHHHHHH-HHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHH
Q 012214 339 YLDPEYHQSSQLTDKSDVYSFGVV-LVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIM 417 (468)
Q Consensus 339 y~aPE~~~~~~~s~ksDVwSlGvl-l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 417 (468)
|+|||++.+.. +.++||||++++ .+++++|..||.. ..................... ........++
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-------~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~ 310 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-------VLWLHYLTDKMLKQMTFKTKC----NTPAMKQIKR 310 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-------HHHHHHHHHHHHHTCCCSSCC----CSHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-------hhhhhHHHHhhhhhhccCccc----chhhhhhcCH
Confidence 99999998766 889999998777 7778889988621 000000011111110111000 0112345677
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHH
Q 012214 418 TFANLAKRCLDLNGKKRPTMEEVS 441 (468)
Q Consensus 418 ~l~~li~~cl~~dp~~RPt~~evl 441 (468)
.+.+|+.+||+.| |+.|++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHH
Confidence 8999999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-31 Score=277.78 Aligned_cols=189 Identities=20% Similarity=0.142 Sum_probs=132.1
Q ss_pred eeecCcEEEEEEE-ecCCcEEEEEeccccc------chHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcceeEe
Q 012214 172 LGQGGQGTVYKGM-LEDGRIIAVKKSKLTV------DDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 172 LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~------~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 243 (468)
.+.|++|.+..++ .-.|+.+++|.+.... ........++|.+|+++|+++ +|+||+++++++.++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5566666665544 3358889999886432 122234567899999999999 7999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||++|++|.+.|.... +++.. +|+.||+.||+|+|+++ ||||||||+||||++++.+||+|||+|+...
T Consensus 322 Eyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp ECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred ecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999997632 46553 58999999999999999 9999999999999999999999999998765
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCC
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 373 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~ 373 (468)
.+.. .....+||+.|+|||++.+ .+..++|+||+|++++++.++..++
T Consensus 391 ~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 4333 2344679999999999876 4677899999999988876665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=248.73 Aligned_cols=188 Identities=14% Similarity=0.202 Sum_probs=146.1
Q ss_pred CCCceeeecCcEEEEEEEecCCcEEEEEecccccch----HHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 167 NANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDD----EELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 167 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~----~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
...+.||+|+||.||++.. .++.+++|+....... ......+.+.+|+.++++++||||+++..++.+.+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 4778888875432211 1112345689999999999999999665556577788999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++++|.+++.. +..++.|+++||.|||+++ |+||||||+|||++. .+||+|||+++..
T Consensus 418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999999964 3578999999999999999 999999999999999 9999999999877
Q ss_pred cCCCcee------eecccccCCccCcccccc--CCCCCcccHHHHHHHHHHHHhCCCCC
Q 012214 323 AMDQTHV------TTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPI 373 (468)
Q Consensus 323 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvll~el~tG~~p~ 373 (468)
....... .....||+.|+|||++.. ..|+..+|+||..+-..+.+.++.+|
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 5432211 234679999999999987 67888999999999999888877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6e-24 Score=204.58 Aligned_cols=155 Identities=18% Similarity=0.158 Sum_probs=120.9
Q ss_pred HHHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHH--------------HHHHHHHHHHHHHHHhcCCC
Q 012214 159 LDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEE--------------LLKLEEFINEIVILSQINHR 224 (468)
Q Consensus 159 i~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~--------------~~~~~~~~~Ei~~l~~l~h~ 224 (468)
+......|.+.+.||+|+||.||+|...+|+.||+|.++....... ......+.+|+.+++.++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3344556777799999999999999997799999999864321100 013467899999999999
Q ss_pred ceeeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEE
Q 012214 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNIL 304 (468)
Q Consensus 225 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NIL 304 (468)
| +++.+++. .+..++||||+++++|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||
T Consensus 163 ~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 4 56666543 366799999999999988 421 123469999999999999999 999999999999
Q ss_pred EcCCCcEEEEecCCcccccCCCceeeecccccCCccCcccccc
Q 012214 305 LDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 347 (468)
Q Consensus 305 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 347 (468)
++ ++.+||+|||+|+ .+..+.|||++..
T Consensus 226 l~-~~~vkl~DFG~a~--------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSV--------------EVGEEGWREILER 253 (282)
T ss_dssp EE-TTEEEECCCTTCE--------------ETTSTTHHHHHHH
T ss_pred EE-CCcEEEEECCCCe--------------ECCCCCHHHHHHH
Confidence 99 9999999999985 2345788998754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.5e-19 Score=171.49 Aligned_cols=141 Identities=19% Similarity=0.170 Sum_probs=106.4
Q ss_pred CCCCCceeeecCcEEEEEEEe-cCCcE--EEEEecccccchH--------------------HHHHHHHHHHHHHHHHhc
Q 012214 165 HFNANRILGQGGQGTVYKGML-EDGRI--IAVKKSKLTVDDE--------------------ELLKLEEFINEIVILSQI 221 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~--vavK~l~~~~~~~--------------------~~~~~~~~~~Ei~~l~~l 221 (468)
-|.+.+.||+|+||.||+|.. .+|+. ||||+++...... .......+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999997 68989 9999865431110 001224678999999999
Q ss_pred CCCce--eeEeeeeccCCcceeEeeecCC-C----ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCE
Q 012214 222 NHRNV--VKLLGCCLETEVPLLVYEFIPN-G----TLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH-SATSSPI 293 (468)
Q Consensus 222 ~h~ni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~i 293 (468)
+|+++ ..++++ ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| +.+ |
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g---i 192 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE---L 192 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC---E
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 87754 334432 467899999942 4 56555432 223456789999999999999 888 9
Q ss_pred EecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 294 YHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 294 iH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||||||.|||+++ .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999999998 9999999999643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.2e-17 Score=165.57 Aligned_cols=140 Identities=12% Similarity=0.132 Sum_probs=99.8
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccc----------------hHHHHH--HHHHHHHHHHHHhcCCCc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVD----------------DEELLK--LEEFINEIVILSQINHRN 225 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~----------------~~~~~~--~~~~~~Ei~~l~~l~h~n 225 (468)
.-|.+.+.||+|++|.||+|...+|+.||||+++.... ...... ......|...+.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34889999999999999999998999999998653211 000000 011234566666665443
Q ss_pred ee--eEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCE
Q 012214 226 VV--KLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNI 303 (468)
Q Consensus 226 iv--~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NI 303 (468)
+. ..+++ ...+|||||+++++|..+... .....++.|++.+|.+||+.+ ||||||||.||
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NI 236 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNI 236 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHE
Confidence 32 22222 234799999998888654321 123567899999999999999 99999999999
Q ss_pred EEcCCC----------cEEEEecCCccc
Q 012214 304 LLDQRY----------RAKVADFGTSKF 321 (468)
Q Consensus 304 Ll~~~~----------~~kl~DfGla~~ 321 (468)
|+++++ .+.|+||+-+..
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EEeCCCCcccccccccceEEEEeCCccc
Confidence 998876 389999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=2.7e-11 Score=114.46 Aligned_cols=144 Identities=15% Similarity=0.098 Sum_probs=109.8
Q ss_pred HhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~ 240 (468)
....|.....++.|+.+.||+.... ++.+++|+....... ....+.+|+.+++.+. +..+.++++++.+....+
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~----~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC----CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 3456777777888888999999764 678999987642111 1134778999999884 677888999988888899
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT------------------------------- 289 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------- 289 (468)
+|||+++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 87 lv~e~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEEEecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 99999999998776421 1123467899999999999811
Q ss_pred -------------------------CCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 290 -------------------------SSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 290 -------------------------~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1349999999999999876666799999763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.08 E-value=2e-10 Score=107.86 Aligned_cols=128 Identities=19% Similarity=0.196 Sum_probs=94.9
Q ss_pred eecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCc--eeeEeeeeccCCcceeEeeecCCCC
Q 012214 173 GQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN--VVKLLGCCLETEVPLLVYEFIPNGT 250 (468)
Q Consensus 173 G~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~~~~~~~~~lV~E~~~~gs 250 (468)
+.|..+.||++...+|..+++|...... ...+.+|+.+++.+.+.+ +.+++++..+.+..++||||++|.+
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~-------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~ 101 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 101 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc-------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcc
Confidence 3555699999987778889999865431 134667888888885444 5568888877778899999999988
Q ss_pred hhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 012214 251 LYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT----------------------------------------- 289 (468)
Q Consensus 251 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~----------------------------------------- 289 (468)
|. ... .+ ...++.++++.|..||+..
T Consensus 102 l~--~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 102 LL--SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp TT--TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cC--cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 84 211 11 1256778888888888743
Q ss_pred --------------CCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 290 --------------SSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 290 --------------~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1229999999999999887667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=5.2e-10 Score=110.74 Aligned_cols=142 Identities=15% Similarity=0.212 Sum_probs=104.9
Q ss_pred CceeeecCcEEEEEEEecCCcEEEEEecc--cccchHHHHHHHHHHHHHHHHHhcC--CCceeeEeeeeccC---Cccee
Q 012214 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSK--LTVDDEELLKLEEFINEIVILSQIN--HRNVVKLLGCCLET---EVPLL 241 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~--~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~~---~~~~l 241 (468)
.+.|+.|.++.||+....+ ..+++|+.. ..... .....+.+|+.+++.+. +..+.+++.++.+. +..++
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~---~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLL---PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCC---CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 4568999999999988754 578888765 32111 12345778999999986 45678888888766 45789
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT-------------------------------- 289 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------------------------------- 289 (468)
||||++|.++.+... ..++...+..++.++++.|+.||+..
T Consensus 119 vme~v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 119 IMEFVSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp EEECCCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred EEEecCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 999999877743211 13678888899999999999999831
Q ss_pred -----------------------CCCEEecCCCCCCEEEcCCCc--EEEEecCCccc
Q 012214 290 -----------------------SSPIYHRDIKSTNILLDQRYR--AKVADFGTSKF 321 (468)
Q Consensus 290 -----------------------~~~iiH~DLkp~NILl~~~~~--~kl~DfGla~~ 321 (468)
...++|+|++|.||++++++. +.|.||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.99 E-value=6.6e-10 Score=107.37 Aligned_cols=183 Identities=21% Similarity=0.232 Sum_probs=121.6
Q ss_pred CceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCc--eeeEeeeeccCC---cceeE
Q 012214 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRN--VVKLLGCCLETE---VPLLV 242 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~n--iv~l~g~~~~~~---~~~lV 242 (468)
.+.++.|....||+.. ..+++|+.... .....+.+|+.+++.+ .+.. +.+++....... ..++|
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3568999999999853 45888875432 2345678899999887 3332 344555543333 45889
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT--------------------------------- 289 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--------------------------------- 289 (468)
|++++|.+|...... .++..++..++.++++.++.||+..
T Consensus 95 m~~i~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp EECCCCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred EcccCCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 999999888654322 3677778888889999998888621
Q ss_pred ----------------------CCCEEecCCCCCCEEEcC--CCcEEEEecCCcccccCCCceeeecccccCCc---cCc
Q 012214 290 ----------------------SSPIYHRDIKSTNILLDQ--RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY---LDP 342 (468)
Q Consensus 290 ----------------------~~~iiH~DLkp~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y---~aP 342 (468)
.+.++|+|++|.||++++ +..+.|.||+.+..-..... . .....+ ..|
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l----~~~~~~~~~~~~ 242 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-F----ISLMEDDEEYGM 242 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-H----HTTCCTTTSCCH
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-H----HHHHhhccccCH
Confidence 134899999999999998 56688999998864322100 0 000111 223
Q ss_pred ccccc-----CCC---------CCcccHHHHHHHHHHHHhCCCCC
Q 012214 343 EYHQS-----SQL---------TDKSDVYSFGVVLVELLTGKKPI 373 (468)
Q Consensus 343 E~~~~-----~~~---------s~ksDVwSlGvll~el~tG~~p~ 373 (468)
+.... +.. ....+.|+++.++|.+.+|..++
T Consensus 243 ~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 243 EFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 22111 111 12358999999999999998875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=2.3e-06 Score=82.44 Aligned_cols=135 Identities=17% Similarity=0.172 Sum_probs=91.7
Q ss_pred CceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCC---ceeeEeeeec-cCCcceeEee
Q 012214 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR---NVVKLLGCCL-ETEVPLLVYE 244 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~g~~~-~~~~~~lV~E 244 (468)
.+.++.|....||+. |..+++|+-.. . .....+.+|+.+++.+.+. .+.+.+.++. ..+..++|||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~---~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS---Q---QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS---H---HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC---c---hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 345888888899987 56688887432 1 2345688999999998642 3556666653 4456789999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 012214 245 FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA------------------------------------ 288 (468)
Q Consensus 245 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------------------------------------ 288 (468)
+++|.++...... .++......++.++++.|+.||+.
T Consensus 94 ~i~G~~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~ 166 (306)
T 3tdw_A 94 KVQGQILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE 166 (306)
T ss_dssp CCCSEECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred ccCCeECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence 9999888663211 134444455555555555555542
Q ss_pred ---------------------CCCCEEecCCCCCCEEEcC---CCc-EEEEecCCcc
Q 012214 289 ---------------------TSSPIYHRDIKSTNILLDQ---RYR-AKVADFGTSK 320 (468)
Q Consensus 289 ---------------------~~~~iiH~DLkp~NILl~~---~~~-~kl~DfGla~ 320 (468)
..+.++|+|++|.||++++ ++. +.|.||+.+.
T Consensus 167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 2234799999999999987 455 4899999875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.7e-06 Score=81.52 Aligned_cols=134 Identities=21% Similarity=0.224 Sum_probs=95.0
Q ss_pred eeeecCcE-EEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccCCcceeEeeecC
Q 012214 171 ILGQGGQG-TVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 171 ~LG~G~fG-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~ 247 (468)
.+..|..| .||+.... ++..+++|+-.. .....+.+|...++.+. +--+.++++++.+.+..++|||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 35556554 68987754 467789997553 22345778998888874 4446678888888889999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 012214 248 NGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT-------------------------------------- 289 (468)
Q Consensus 248 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------------------------------------- 289 (468)
+.++.+...... .....+..+++..|.-||+..
T Consensus 104 G~~~~~~~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 104 GKTAFQVLEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp SEEHHHHHHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred CccccccccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 988876654311 122345666666677776431
Q ss_pred -----------------CCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 290 -----------------SSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 290 -----------------~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
.+.++|+|+.+.||++++++.+-|.||+.+.
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1238999999999999988777899999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=1.2e-05 Score=78.89 Aligned_cols=83 Identities=5% Similarity=0.009 Sum_probs=52.7
Q ss_pred cee-eecCcEEEEEEEec-------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-C--CceeeEeeeeccC--
Q 012214 170 RIL-GQGGQGTVYKGMLE-------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-H--RNVVKLLGCCLET-- 236 (468)
Q Consensus 170 ~~L-G~G~fG~Vy~~~~~-------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h--~niv~l~g~~~~~-- 236 (468)
+.| +.|....+|+.... ++..+++|......... ......+.+|+.+++.+. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~-~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVP-VFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCC-SSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccc-cCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 457 78888999988754 26678888764321000 000123557777777773 2 3566777777654
Q ss_pred -CcceeEeeecCCCChhh
Q 012214 237 -EVPLLVYEFIPNGTLYQ 253 (468)
Q Consensus 237 -~~~~lV~E~~~~gsL~~ 253 (468)
...++|||+++|.++.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=5.7e-05 Score=75.34 Aligned_cols=79 Identities=18% Similarity=0.145 Sum_probs=47.9
Q ss_pred CceeeecCcEEEEEEEec-CCcEEEEEecccccc-hHH--HHHHHHHHHHHHHHHhcCC--C-ceeeEeeeeccCCccee
Q 012214 169 NRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVD-DEE--LLKLEEFINEIVILSQINH--R-NVVKLLGCCLETEVPLL 241 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~--~~~~~~~~~Ei~~l~~l~h--~-niv~l~g~~~~~~~~~l 241 (468)
.+.||.|..+.||++... +++.+++|....... ... ....+.+..|..+++.+.. + .+.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 356899999999999754 467899997543211 000 0112345678888887732 3 344555543 445689
Q ss_pred EeeecCCC
Q 012214 242 VYEFIPNG 249 (468)
Q Consensus 242 V~E~~~~g 249 (468)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00021 Score=69.21 Aligned_cols=30 Identities=27% Similarity=0.350 Sum_probs=26.8
Q ss_pred CCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 291 ~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 459999999999999888899999999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.0002 Score=68.93 Aligned_cols=140 Identities=16% Similarity=0.155 Sum_probs=89.2
Q ss_pred CceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC---CCceeeEeeeeccCCcceeEeee
Q 012214 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN---HRNVVKLLGCCLETEVPLLVYEF 245 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~lV~E~ 245 (468)
.+.|+.|....+|+... ++..+++|+.... ....+..|+..++.+. ...+.++++++...+..++|||+
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 35689999999999886 4667888876532 1345778888888773 35678888888777889999999
Q ss_pred cCCCChhh-----------HhhhcccCC-----------------CCCCCHHHHH---HHH----------------HHH
Q 012214 246 IPNGTLYQ-----------HLHDRHQNE-----------------EFPLTWEMRL---RIA----------------TEV 278 (468)
Q Consensus 246 ~~~gsL~~-----------~l~~~~~~~-----------------~~~l~~~~~~---~i~----------------~qi 278 (468)
+++.++.. .|+...... ...-+|.... ++. ..+
T Consensus 113 l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l 192 (312)
T 3jr1_A 113 LNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLI 192 (312)
T ss_dssp CCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHH
T ss_pred ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHH
Confidence 99876521 122211100 0112454322 111 111
Q ss_pred HHH-HHHHHh-CCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 012214 279 AGA-LAYLHS-ATSSPIYHRDIKSTNILLDQRYRAKVADFG 317 (468)
Q Consensus 279 a~g-L~yLH~-~~~~~iiH~DLkp~NILl~~~~~~kl~DfG 317 (468)
+.. ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 193 ~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 193 VQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 123432 2246699999999999999887 8888874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00028 Score=67.00 Aligned_cols=79 Identities=19% Similarity=0.124 Sum_probs=54.5
Q ss_pred CCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCC---CceeeEeeeeccCCccee
Q 012214 165 HFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH---RNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h---~niv~l~g~~~~~~~~~l 241 (468)
.....+.+|.|..+.||+....+|+.+.+|+....... ....|..|+..|+.+.. --+.+++++. ..++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~----~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA----LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC----CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc----hhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 34445679999999999999999999999986543211 11246678888888742 2344455442 3578
Q ss_pred EeeecCCCCh
Q 012214 242 VYEFIPNGTL 251 (468)
Q Consensus 242 V~E~~~~gsL 251 (468)
|||+++++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0015 Score=58.72 Aligned_cols=103 Identities=16% Similarity=0.112 Sum_probs=67.1
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCce
Q 012214 249 GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH 328 (468)
Q Consensus 249 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 328 (468)
-||.+.|.... .+++++++|.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc--------
Confidence 47889997754 3799999999999999998876321111 1333457899999999988763 1110
Q ss_pred eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCC
Q 012214 329 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372 (468)
Q Consensus 329 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p 372 (468)
.....+.|||... ...+.+.=|||||+++|.-+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122466888763 3446788899999999998874444
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0012 Score=66.25 Aligned_cols=78 Identities=13% Similarity=0.075 Sum_probs=46.7
Q ss_pred CCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCCceeeecccccCCccCccccccCC---CCCcccHHHHHHHHHHHH
Q 012214 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ---LTDKSDVYSFGVVLVELL 367 (468)
Q Consensus 291 ~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvll~el~ 367 (468)
+.++|+|++|.|||+++++ +.|.||+.+..-+........-..-...|++|+...... .....++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4499999999999999876 999999988643211000000000123456666543211 112345567888888877
Q ss_pred hC
Q 012214 368 TG 369 (468)
Q Consensus 368 tG 369 (468)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.003 Score=60.62 Aligned_cols=161 Identities=12% Similarity=0.177 Sum_probs=85.0
Q ss_pred ccCHHHHHHHhcCCCCC-----ceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCc--
Q 012214 153 LFSSKELDKATNHFNAN-----RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN-- 225 (468)
Q Consensus 153 ~~~~~ei~~~~~~f~~~-----~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-- 225 (468)
.++.+++.....+|... +.|+.|....+|+....+| .+++|........ +.+..|+.++..+...+
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~------~~l~~e~~~l~~L~~~g~~ 78 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK------NDLPFFLGLMQHLAAKGLS 78 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C------CHHHHHHHHHHHHHHTTCC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH------HHHHHHHHHHHHHHHCCCC
Confidence 34556666665666542 3456687789999887655 5788877642111 23445666666653212
Q ss_pred eeeEeeee------ccCCcceeEeeecCCCChhh--------------HhhhcccCCCC----CC---CHHHHHH-----
Q 012214 226 VVKLLGCC------LETEVPLLVYEFIPNGTLYQ--------------HLHDRHQNEEF----PL---TWEMRLR----- 273 (468)
Q Consensus 226 iv~l~g~~------~~~~~~~lV~E~~~~gsL~~--------------~l~~~~~~~~~----~l---~~~~~~~----- 273 (468)
+.+++... ...+..++++++++|.++.. .++.....-.. .. .|.....
T Consensus 79 vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~ 158 (322)
T 2ppq_A 79 CPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEER 158 (322)
T ss_dssp CCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGG
T ss_pred CCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHH
Confidence 23333211 11245689999998865421 01111000000 01 1222110
Q ss_pred -------HHHHHHHHHHHHHhC----CCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 274 -------IATEVAGALAYLHSA----TSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 274 -------i~~qia~gL~yLH~~----~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+...+...+..++.. ....++|+|+.+.|||++++..+.|.||+.+.
T Consensus 159 ~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 159 ADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455555532 12449999999999999987666899999764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0024 Score=61.68 Aligned_cols=32 Identities=31% Similarity=0.444 Sum_probs=27.3
Q ss_pred CCCEEecCCCCCCEEEcCC----CcEEEEecCCccc
Q 012214 290 SSPIYHRDIKSTNILLDQR----YRAKVADFGTSKF 321 (468)
Q Consensus 290 ~~~iiH~DLkp~NILl~~~----~~~kl~DfGla~~ 321 (468)
...++|+|+.+.||+++.+ ..+.|.||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3459999999999999875 6899999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0085 Score=57.54 Aligned_cols=160 Identities=13% Similarity=0.089 Sum_probs=83.9
Q ss_pred ccCHHHHHHHhcCCCC-----CceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCC--Cc
Q 012214 153 LFSSKELDKATNHFNA-----NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH--RN 225 (468)
Q Consensus 153 ~~~~~ei~~~~~~f~~-----~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~n 225 (468)
..+.+.+......|.+ ...++ |....||+....+|+.+++|........ ...+..|..++..+.. -.
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~-----~~~~~~E~~~~~~L~~~g~~ 83 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT-----ADQILEEHQFALQLVNDEVP 83 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC-----HHHHHHHHHHHHHHHHTTCS
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCC-----HHHHHHHHHHHHHHHHcCCe
Confidence 3444555444444432 23466 7778999887777778999987532111 1234456666666632 12
Q ss_pred eeeEeee-----eccCCcceeEeeecCCCChhh-----------H---hhhcccC----CCCCCCHHHH----HHH----
Q 012214 226 VVKLLGC-----CLETEVPLLVYEFIPNGTLYQ-----------H---LHDRHQN----EEFPLTWEMR----LRI---- 274 (468)
Q Consensus 226 iv~l~g~-----~~~~~~~~lV~E~~~~gsL~~-----------~---l~~~~~~----~~~~l~~~~~----~~i---- 274 (468)
+.+++.. ....+..++++++++|.++.. . ++..... .....++... ..+
T Consensus 84 vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 163 (328)
T 1zyl_A 84 VAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDA 163 (328)
T ss_dssp BCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTC
T ss_pred ecceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhc
Confidence 3444443 111334578999998755421 0 1110000 0111222211 000
Q ss_pred -----------HHHHHHHHHHHHhC----CCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 275 -----------ATEVAGALAYLHSA----TSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 275 -----------~~qia~gL~yLH~~----~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
...+...+..+.+. ....++|+|+++.||+++ + .+.|.||+.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 164 TLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp SSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred CcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 11111222333221 234489999999999999 4 89999998775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0029 Score=60.23 Aligned_cols=71 Identities=14% Similarity=0.115 Sum_probs=42.4
Q ss_pred CceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCce-eeEeeeeccCCcceeEeeec-
Q 012214 169 NRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNV-VKLLGCCLETEVPLLVYEFI- 246 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~- 246 (468)
.+.|+.|....+|+. ..+++|+..... . ......+|+.+++.+...++ .+++++. .+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~-~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGT-E----EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC---------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCc-c----ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 567999999999998 457888765321 1 01112357766666632222 3555544 33457899999
Q ss_pred CCCCh
Q 012214 247 PNGTL 251 (468)
Q Consensus 247 ~~gsL 251 (468)
++.++
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 65554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0021 Score=64.75 Aligned_cols=72 Identities=18% Similarity=0.210 Sum_probs=47.3
Q ss_pred ceeeecCcEEEEEEEecC--------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCc-eeeEeeeeccCCcce
Q 012214 170 RILGQGGQGTVYKGMLED--------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN-VVKLLGCCLETEVPL 240 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~~~~ 240 (468)
+.|+.|-...||+....+ +..+++|+...... .+.+.+|..+++.+...+ ..++++.+.+ .
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~------~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET------ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC------HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc------HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 457888889999998653 47888998743111 123457888888774333 3566776543 3
Q ss_pred eEeeecCCCCh
Q 012214 241 LVYEFIPNGTL 251 (468)
Q Consensus 241 lV~E~~~~gsL 251 (468)
+|+||+++.+|
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0097 Score=58.71 Aligned_cols=142 Identities=19% Similarity=0.245 Sum_probs=80.8
Q ss_pred ceeeecCcEEEEEEEec--------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccCCcce
Q 012214 170 RILGQGGQGTVYKGMLE--------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~ 240 (468)
+.|..|-...+|+.... +++.+++|+.-... .....+.+|..+++.+. +.-..++++++.+ .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 45666777788998864 24688888752211 12344568888888774 2223566776654 2
Q ss_pred eEeeecCCCChhhH-h----------------hhcc-cCCCCCC-CHHHHHHHHHHHHH-------------------HH
Q 012214 241 LVYEFIPNGTLYQH-L----------------HDRH-QNEEFPL-TWEMRLRIATEVAG-------------------AL 282 (468)
Q Consensus 241 lV~E~~~~gsL~~~-l----------------~~~~-~~~~~~l-~~~~~~~i~~qia~-------------------gL 282 (468)
+|+||++|.+|..- + +... .....+. -+.++.++..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 89999988665321 1 1100 0011111 24555555544322 22
Q ss_pred HHH----HhC-CCCCEEecCCCCCCEEEcCC----CcEEEEecCCcc
Q 012214 283 AYL----HSA-TSSPIYHRDIKSTNILLDQR----YRAKVADFGTSK 320 (468)
Q Consensus 283 ~yL----H~~-~~~~iiH~DLkp~NILl~~~----~~~kl~DfGla~ 320 (468)
..| ... ....++|+|+.+.||+++++ +.+.++||..+.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 333 222 23459999999999999876 789999999874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0085 Score=60.70 Aligned_cols=73 Identities=15% Similarity=0.083 Sum_probs=45.9
Q ss_pred ceeeecCcEEEEEEEecC-CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCce-eeEeeeeccCCcceeEeeecC
Q 012214 170 RILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNV-VKLLGCCLETEVPLLVYEFIP 247 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~~ 247 (468)
+.|+.|-...+|+....+ +..+++|+....... .-...+|..++..+...++ .++++++.. .+|+||++
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-----~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~ 184 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-----IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMD 184 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-----CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-----hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeC
Confidence 458888888999998764 477888876332110 0012478888888864444 467777632 35999998
Q ss_pred CCCh
Q 012214 248 NGTL 251 (468)
Q Consensus 248 ~gsL 251 (468)
+.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7555
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.18 E-value=0.018 Score=55.87 Aligned_cols=31 Identities=19% Similarity=0.360 Sum_probs=27.2
Q ss_pred CCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 291 ~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
..++|+|+.+.||++++++.+.|.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999987653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.18 E-value=0.0052 Score=60.31 Aligned_cols=73 Identities=15% Similarity=0.168 Sum_probs=41.2
Q ss_pred ceeeecCcEEEEEEEecC---------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCc-eeeEeeeeccCCcc
Q 012214 170 RILGQGGQGTVYKGMLED---------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN-VVKLLGCCLETEVP 239 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~~~ 239 (468)
+.|+.|..-.+|+....+ +..+++|+...... .......|..+++.+...+ +.++++.. .-
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~ 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-----ELYNTISEFEVYKTMSKYKIAPQLLNTF----NG 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-----GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TT
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-----ceecHHHHHHHHHHHHhcCCCCceEEec----CC
Confidence 457777778899988653 26788887543211 1112346777777764333 34566544 23
Q ss_pred eeEeeecCCCCh
Q 012214 240 LLVYEFIPNGTL 251 (468)
Q Consensus 240 ~lV~E~~~~gsL 251 (468)
++||||++|.++
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999987544
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=92.85 E-value=0.071 Score=34.37 Aligned_cols=12 Identities=17% Similarity=0.191 Sum_probs=7.2
Q ss_pred CCccccchhhhH
Q 012214 85 GSQDSLACSGYG 96 (468)
Q Consensus 85 ~~~~~~~~~~~~ 96 (468)
+...+++++++|
T Consensus 9 ~~~~~Ia~~vVG 20 (44)
T 2jwa_A 9 SPLTSIISAVVG 20 (44)
T ss_dssp CSHHHHHHHHHH
T ss_pred CcccchHHHHHH
Confidence 334456777777
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.62 E-value=0.11 Score=33.55 Aligned_cols=19 Identities=26% Similarity=0.382 Sum_probs=9.3
Q ss_pred CccccchhhhHHHHHHHHH
Q 012214 86 SQDSLACSGYGRLILIATI 104 (468)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~i 104 (468)
....+++.+++.+++++++
T Consensus 9 ~~~~IA~gVVgGv~~~~ii 27 (44)
T 2ks1_B 9 KIPSIATGMVGALLLLLVV 27 (44)
T ss_dssp CSSSSTHHHHHHHHHHHHH
T ss_pred CcceEEeehhHHHHHHHHH
Confidence 3445565555544444333
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.40 E-value=0.49 Score=47.17 Aligned_cols=141 Identities=16% Similarity=0.168 Sum_probs=80.7
Q ss_pred ceeeecCcEEEEEEEecC--------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccCCcce
Q 012214 170 RILGQGGQGTVYKGMLED--------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~ 240 (468)
+.+..|-...+|+....+ ++.+++++..... . ..-+..+|..+++.+. +.-..++++.+. -+
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~----~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-G----KFYDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC------CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-c----hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 456677778899988653 5778888754321 1 1112246777777764 222345555432 37
Q ss_pred eEeeecCCCChhh-Hh----------------hhcc------cC--CCCCCCHHHHHHHHHHHH----------------
Q 012214 241 LVYEFIPNGTLYQ-HL----------------HDRH------QN--EEFPLTWEMRLRIATEVA---------------- 279 (468)
Q Consensus 241 lV~E~~~~gsL~~-~l----------------~~~~------~~--~~~~l~~~~~~~i~~qia---------------- 279 (468)
+|+||++|.+|.. .+ +... .. ...+..|.++..+..++-
T Consensus 147 ~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 226 (424)
T 3mes_A 147 RIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYS 226 (424)
T ss_dssp EEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHH
T ss_pred EEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHH
Confidence 8999999866421 00 0000 00 111223444444443321
Q ss_pred ---HHHHHHHh---------------------CCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 280 ---GALAYLHS---------------------ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 280 ---~gL~yLH~---------------------~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
..+..|.+ .....++|+|+.+.||+ ++++.+.++||..+.
T Consensus 227 ~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 227 KILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 22333321 11344899999999999 888899999999875
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=90.65 E-value=0.11 Score=32.55 Aligned_cols=26 Identities=19% Similarity=0.201 Sum_probs=15.3
Q ss_pred CCCccccchhhhHHHHHHHHHHHHHH
Q 012214 84 TGSQDSLACSGYGRLILIATIITSLV 109 (468)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~~~i~~~~~ 109 (468)
..+...++.++++.++.+++++.+++
T Consensus 7 ~ls~GaIAGiVvG~v~gv~li~~l~~ 32 (38)
T 2k1k_A 7 GLTGGEIVAVIFGLLLGAALLLGILV 32 (38)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCceeeeehHHHHHHHHHHHHHH
Confidence 34455677777777766654444333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.44 E-value=0.12 Score=33.41 Aligned_cols=14 Identities=21% Similarity=0.370 Sum_probs=6.7
Q ss_pred cccchhhhHHHHHH
Q 012214 88 DSLACSGYGRLILI 101 (468)
Q Consensus 88 ~~~~~~~~~~~~~~ 101 (468)
..+++.+++.++++
T Consensus 10 ~aIA~gVVgGv~~v 23 (44)
T 2l2t_A 10 PLIAAGVIGGLFIL 23 (44)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred ceEEEeehHHHHHH
Confidence 34555555544444
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.28 E-value=1.1 Score=40.10 Aligned_cols=114 Identities=11% Similarity=0.089 Sum_probs=75.0
Q ss_pred CCCceeeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCEEecCCCC
Q 012214 222 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA-YLHSATSSPIYHRDIKS 300 (468)
Q Consensus 222 ~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~-yLH~~~~~~iiH~DLkp 300 (468)
.||+. -...-.+++...+.|+.-+++.-...+. .++...++.++.+|+.... +++. -+|--|.|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 67777 3334456667667776654443333443 2778889999998887766 5543 57889999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCC
Q 012214 301 TNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 373 (468)
Q Consensus 301 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~ 373 (468)
+||+++.++.+++.-.|+-. -++|.-+ +..-=.-.+=+++..++.++..|
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~------------------~lpP~e~-----~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKE------------------SLPPDEW-----DDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp GGEEECTTCCEEESCCEETT------------------TBSSCSC-----CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred ceEEEeCCCcEEEEEcCCcc------------------cCCCCCC-----CHHHHHHHHHHHHHHHHcCCCCH
Confidence 99999999999998777532 2233211 11111335678888888888776
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.47 E-value=0.77 Score=40.95 Aligned_cols=116 Identities=9% Similarity=0.139 Sum_probs=76.7
Q ss_pred cCCCceeeEeeeeccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCC
Q 012214 221 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKS 300 (468)
Q Consensus 221 l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp 300 (468)
..||+.+.. .+-.+.+...+.|+.-+.+--...+. .++...++.++.+|+....++++ =+|--|.|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik--------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P 107 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK--------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP 107 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG--------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH--------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence 368888765 45555666666666543222222232 27788999999999988855543 37889999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCC
Q 012214 301 TNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 373 (468)
Q Consensus 301 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~ 373 (468)
+||+++.++.+++.-.|+-.. ++|. ..+...=.-.+=+++..+++++..|
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp GGEEECTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred ceEEEcCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 999999999999987665322 1222 1111222345778899999998887
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.41 E-value=0.16 Score=51.42 Aligned_cols=61 Identities=7% Similarity=-0.033 Sum_probs=16.5
Q ss_pred CceeeecCcEEEEEEEecC-CcEEEE------EecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeec
Q 012214 169 NRILGQGGQGTVYKGMLED-GRIIAV------KKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCL 234 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~-g~~vav------K~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~ 234 (468)
.+.|| ||.||+|.+.. ...||| |..+..... ......|.+|..+++..+|||+++.+++..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~--~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS--EKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCcccccccccc--ccccccccccccccccccccccCCCcceEE
Confidence 44566 99999999753 357888 655432111 133457889999999999999999887753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 468 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-70 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-67 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-66 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-63 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-59 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-53 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-51 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-48 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-46 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-43 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-39 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 3e-70
Identities = 72/291 (24%), Positives = 125/291 (42%), Gaps = 29/291 (9%)
Query: 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
+ +G G GTVYKG +AVK +T + +L+ F NE+ +L + H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQ--QLQAFKNEVGVLRKTRH 63
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
N++ +G ++ +V ++ +LY HLH + IA + A +
Sbjct: 64 VNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMD 118
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA-MDQTHVTTKIQGTFGYLDP 342
YLH+ I HRD+KS NI L + K+ DFG + + +H ++ G+ ++ P
Sbjct: 119 YLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 343 EY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399
E + + +SDVY+FG+VL EL+TG+ P ++ +++ +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRD----------QIIFMVG 223
Query: 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450
L L K+ N L CL +RP ++ + + S
Sbjct: 224 RGYLSPDLSKV-RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 2e-68
Identities = 60/289 (20%), Positives = 115/289 (39%), Gaps = 29/289 (10%)
Query: 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
LG G G V+ G +AVK K + + + F+ E ++ Q+ H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQH 67
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
+ +V+L + + ++ E++ NG+L L LT L +A ++A +A
Sbjct: 68 QRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMA 123
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
++ HRD+++ NIL+ K+ADFG ++ I ++ + + PE
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403
T KSDV+SFG++L E++T + + + + R R +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----VIQNLERGYRMVRPDNCP 236
Query: 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452
++ L + C + RPT + + L +++
Sbjct: 237 EE-------------LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 8e-67
Identities = 66/287 (22%), Positives = 122/287 (42%), Gaps = 29/287 (10%)
Query: 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
+ + +G G G V+ G + +A+K + EE +FI E ++ +++H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSH 59
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
+V+L G CLE LV+EF+ +G L +L + E L + +V +A
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMA 115
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
YL + + HRD+ + N L+ + KV+DFG ++F+ DQ +T + + PE
Sbjct: 116 YLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403
S+ + KSDV+SFGV++ E+ + K + + S+ + + + +
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVEDISTGFRLYKPRLA 227
Query: 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450
+ + C + RP + +L I S
Sbjct: 228 STHV------------YQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 6e-66
Identities = 68/308 (22%), Positives = 118/308 (38%), Gaps = 39/308 (12%)
Query: 159 LDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVI 217
++ + F LG G G V+K G ++A K L + + I E+ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR---NQIIRELQV 57
Query: 218 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATE 277
L + N +V G + E + G+L Q L + ++ +++
Sbjct: 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIA 112
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF 337
V L YL I HRD+K +NIL++ R K+ DFG S + + GT
Sbjct: 113 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTR 167
Query: 338 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF-----------------WAGNTS 380
Y+ PE Q + + +SD++S G+ LVE+ G+ PI A T
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 381 QENVSLAAYFVHSMRKNR--------LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGK 432
+ +R L I+++ KL + F + +CL N
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 433 KRPTMEEV 440
+R ++++
Sbjct: 288 ERADLKQL 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 2e-64
Identities = 68/286 (23%), Positives = 124/286 (43%), Gaps = 35/286 (12%)
Query: 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
+ +G+G G V G G +AVK K + F+ E +++Q+ H
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT------AQAFLAEASVMTQLRH 59
Query: 224 RNVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
N+V+LLG +E + L +V E++ G+L +L R ++ L + L+ + +V A+
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAM 116
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 342
YL + HRD+ + N+L+ + AKV+DFG +K + Q + + P
Sbjct: 117 EYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAP 169
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402
E + + + KSDV+SFG++L E+ + + + V + K D
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDA 221
Query: 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448
D + + K C L+ RP+ ++ +L I+
Sbjct: 222 PDGCPPAV---------YEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 3e-64
Identities = 62/277 (22%), Positives = 114/277 (41%), Gaps = 29/277 (10%)
Query: 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
+ LG G G V G +A+K K E+ EFI E ++ ++H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKVMMNLSH 58
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
+V+L G C + ++ E++ NG L +L + + L + +V A+
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAME 114
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
YL S HRD+ + N L++ + KV+DFG S+++ D+ + + + PE
Sbjct: 115 YLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403
S+ + KSD+++FGV++ E+ + K + S+ A + +R R H
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TAEHIAQGLRLYRPHLAS 227
Query: 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ + C +RPT + +
Sbjct: 228 EK-------------VYTIMYSCWHEKADERPTFKIL 251
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (521), Expect = 2e-63
Identities = 70/291 (24%), Positives = 130/291 (44%), Gaps = 31/291 (10%)
Query: 158 ELDKATNHFNANRILGQGGQGTVYKGMLED-GRIIAVKKSKLTVDDEELLKLEEFINEIV 216
E+++ LG G G VY+G+ + +AVK K E+ +++EEF+ E
Sbjct: 13 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAA 65
Query: 217 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT 276
++ +I H N+V+LLG C ++ EF+ G L +L + ++ ++ + L +AT
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMAT 122
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGT 336
+++ A+ YL HRD+ + N L+ + + KVADFG S+ + D +
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 337 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396
+ PE ++ + KSDV++FGV+L E+ T + + SQ
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------- 224
Query: 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
++++L+ + L + C N RP+ E+ +
Sbjct: 225 --VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-63
Identities = 64/281 (22%), Positives = 112/281 (39%), Gaps = 29/281 (10%)
Query: 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH 223
LGQG G V+ G +A+K K E F+ E ++ ++ H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-----AFLQEAQVMKKLRH 71
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
+V+L E + +V E++ G+L L L + +A ++A +A
Sbjct: 72 EKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMA 127
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 343
Y+ HRD+++ NIL+ + KVADFG ++ I ++ + + PE
Sbjct: 128 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403
+ T KSDV+SFG++L EL T + + G ++E + R +
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNRE---VLDQVERGYRMPCPPECP 240
Query: 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444
+ +L +C ++RPT E + L
Sbjct: 241 ES-------------LHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 204 bits (519), Expect = 7e-63
Identities = 68/317 (21%), Positives = 125/317 (39%), Gaps = 49/317 (15%)
Query: 157 KELDKATNHFNANRILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEE 210
L+ N+ R +G+G G V++ E ++AVK K + +
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ---AD 62
Query: 211 FINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDR------------ 258
F E ++++ ++ N+VKLLG C + L++E++ G L + L
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 259 -------HQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRA 311
PL+ +L IA +VA +AYL HRD+ + N L+ +
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVV 179
Query: 312 KVADFGTSKFIAM-DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 370
K+ADFG S+ I D ++ PE ++ T +SDV+++GVVL E+ +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 371 KPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLN 430
++ + ++ + D ++ +N + NL + C
Sbjct: 240 LQPYYGMAHEE----------------VIYYVRDGNILAC-PENCPLELYNLMRLCWSKL 282
Query: 431 GKKRPTMEEVSMELNGI 447
RP+ + L +
Sbjct: 283 PADRPSFCSIHRILQRM 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (519), Expect = 7e-63
Identities = 65/311 (20%), Positives = 122/311 (39%), Gaps = 44/311 (14%)
Query: 154 FSSKELDKATNHFNAN---------RILGQGGQGTVYKGML----EDGRIIAVKKSKLTV 200
F+ ++ ++A F +++G G G V G L + +A+K K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 201 DDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQ 260
+++ +F++E I+ Q +H NV+ L G ++ +++ EF+ NG+L L
Sbjct: 67 TEKQR---RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123
Query: 261 NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320
T + + +A + YL HRD+ + NIL++ KV+DFG S+
Sbjct: 124 ----QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 321 FIAMDQTHVTTK----IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWA 376
F+ D + T + + PE Q + T SDV+S+G+V+ E+++ + +W
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236
Query: 377 GNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT 436
+ R D L C + RP
Sbjct: 237 MTNQD----VINAIEQDYRLPPPMDCPSA-------------LHQLMLDCWQKDRNHRPK 279
Query: 437 MEEVSMELNGI 447
++ L+ +
Sbjct: 280 FGQIVNTLDKM 290
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 5e-62
Identities = 66/282 (23%), Positives = 120/282 (42%), Gaps = 33/282 (11%)
Query: 169 NRILGQGGQGTVYKGMLED---GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN 225
++ LG G GTV KG + + +AVK K +D L +E + E ++ Q+++
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 69
Query: 226 VVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
+V+++G C E E +LV E G L ++L + + + + +V+ + YL
Sbjct: 70 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYL 123
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ--GTFGYLDPE 343
S HRD+ + N+LL ++ AK++DFG SK + D+ + + + PE
Sbjct: 124 EE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 344 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403
+ + KSDV+SFGV++ E + + + S+ + A R
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEKGERMGCPAGCP 236
Query: 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445
+ +L C + + RP V + L
Sbjct: 237 RE-------------MYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 6e-62
Identities = 66/276 (23%), Positives = 115/276 (41%), Gaps = 27/276 (9%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+G G G K DG+I+ K+ E + + ++E+ +L ++ H N+V+
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLVSEVNLLRELKHPNIVR 67
Query: 229 LLGCCLETE--VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLH 286
++ +V E+ G L + + E L E LR+ T++ AL H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 287 --SATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 344
S + HRD+K N+ LD + K+ DFG ++ + D + GT Y+ PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQ 185
Query: 345 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILD 404
+KSD++S G +L EL P + + +E A + + R+
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKE----LAGKIREGKFRRIPYRYS 239
Query: 405 DQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
D+L + R L+L RP++EE+
Sbjct: 240 DEL------------NEIITRMLNLKDYHRPSVEEI 263
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-61
Identities = 74/325 (22%), Positives = 130/325 (40%), Gaps = 43/325 (13%)
Query: 148 IDRFKLFSSKELDKATNHFNANRILGQGGQGTVYKGML------EDGRIIAVKKSKLTVD 201
ID +L + + N + + LG G G V + + +AVK K +
Sbjct: 7 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 202 DEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRH- 259
E E ++E+ +LS + NH N+V LLG C L++ E+ G L L +
Sbjct: 67 LTER---EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 260 ------------QNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ 307
+++E L E L + +VA +A+L S HRD+ + NILL
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH 180
Query: 308 RYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVEL 366
K+ DFG ++ I D + V + ++ PE + T +SDV+S+G+ L EL
Sbjct: 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
Query: 367 LTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRC 426
+ + + + ++ + L ++ ++ K C
Sbjct: 241 FSLGSSPYPGMPVDSK----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTC 284
Query: 427 LDLNGKKRPTMEEVSMELNGIRGSS 451
D + KRPT +++ + S
Sbjct: 285 WDADPLKRPTFKQIVQLIEKQISES 309
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 3e-61
Identities = 81/306 (26%), Positives = 133/306 (43%), Gaps = 37/306 (12%)
Query: 160 DKATNHFNANRILGQGGQGTVYKGMLED----GRIIAVKKSKLTVDDEELLKLEEFINEI 215
HFN ++G+G G VY G L D AVK D E+ +F+ E
Sbjct: 25 SSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEG 79
Query: 216 VILSQINHRNVVKLLGCCLETE-VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI 274
+I+ +H NV+ LLG CL +E PL+V ++ +G L +NE T + +
Sbjct: 80 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF----IRNETHNPTVKDLIGF 135
Query: 275 ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA---MDQTHVTT 331
+VA + +L S HRD+ + N +LD+++ KVADFG ++ + D H T
Sbjct: 136 GLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 192
Query: 332 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391
+ ++ E Q+ + T KSDV+SFGV+L EL+T P + NT + Y +
Sbjct: 193 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLL 248
Query: 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451
R + D + +C + RP+ E+ ++ I +
Sbjct: 249 QGRRLLQPEYCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
Query: 452 KKKRAM 457
+ +
Sbjct: 296 IGEHYV 301
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 8e-61
Identities = 63/299 (21%), Positives = 129/299 (43%), Gaps = 36/299 (12%)
Query: 156 SKELDKATNHFNANRILGQGGQGTVYKGMLEDG-----RIIAVKKSKLTVDDEELLKLEE 210
+ E+ + +++G G G VYKGML+ +A+K K +++ +
Sbjct: 1 TTEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR---VD 55
Query: 211 FINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEM 270
F+ E I+ Q +H N+++L G + + +++ E++ NG L + L ++ +
Sbjct: 56 FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQ 111
Query: 271 RLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQ--TH 328
+ + +A + YL + HRD+ + NIL++ KV+DFG S+ + D T+
Sbjct: 112 LVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 168
Query: 329 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388
T+ + + PE + T SDV+SFG+V+ E++T + +W + +
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------- 221
Query: 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
+ ++D + L +C +RP ++ L+ +
Sbjct: 222 ----------VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 9e-61
Identities = 78/278 (28%), Positives = 117/278 (42%), Gaps = 32/278 (11%)
Query: 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
F R LG+G G VY + I+A+K ++ ++ + E+ I S +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLR 64
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
H N+++L G + L+ E+ P GT+Y+ L + TE+A AL
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANAL 119
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 342
+Y HS + HRDIK N+LL K+ADFG S + + GT YL P
Sbjct: 120 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPP 173
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402
E + +K D++S GV+ E L GK P + NT QE Y S + D
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQE-----TYKRISRVEFTFPDF 226
Query: 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ + +L R L N +RP + EV
Sbjct: 227 VTEGA------------RDLISRLLKHNPSQRPMLREV 252
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-60
Identities = 66/304 (21%), Positives = 125/304 (41%), Gaps = 34/304 (11%)
Query: 157 KELDKATNHFN-ANRILGQGGQGTVYKGML---EDGRIIAVKKSKLTVDDEELLKLEEFI 212
K+L ++ A+ LG G G+V +G+ + +A+K K + + EE +
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD---TEEMM 57
Query: 213 NEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRL 272
E I+ Q+++ +V+L+G C + E +LV E G L++ L + + +
Sbjct: 58 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVA 112
Query: 273 RIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTK 332
+ +V+ + YL HRD+ + N+LL R+ AK++DFG SK + D ++ T +
Sbjct: 113 ELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169
Query: 333 --IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF 390
+ + PE + + +SDV+S+GV + E L+ + + + F
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMAF 224
Query: 391 VHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450
+ ++ +L L C + RP V + S
Sbjct: 225 IEQGKRMECPPECPPEL------------YALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
Query: 451 SKKK 454
K
Sbjct: 273 LASK 276
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 4e-60
Identities = 62/300 (20%), Positives = 110/300 (36%), Gaps = 33/300 (11%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+G+G G V++G G +AVK + EI + H N++
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-----REAEIYQTVMLRHENILGF 62
Query: 230 LGCCLETE----VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
+ + LV ++ +G+L+ +L+ +T E +++A A LA+L
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHL 116
Query: 286 HS-----ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHV---TTKIQGTF 337
H I HRD+KS NIL+ + +AD G + + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 338 GYLDPEYHQSS------QLTDKSDVYSFGVVLVELLTGKKP--IFWAGNTSQENVSLAAY 389
Y+ PE S + ++D+Y+ G+V E+ I ++ +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 390 FVHSMRKNRLHDILDDQLMKLGVKNQIM-TFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448
V MRK L + + + A + + C NG R T + L+ +
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (499), Expect = 8e-60
Identities = 73/293 (24%), Positives = 115/293 (39%), Gaps = 38/293 (12%)
Query: 152 KLFSSKELDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEE 210
+LF + +K F+ R +G G G VY + + ++A+KK + K ++
Sbjct: 6 ELFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQD 61
Query: 211 FINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEM 270
I E+ L ++ H N ++ GC L LV E+ + PL
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVE 116
Query: 271 RLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT 330
+ LAYLHS + HRD+K+ NILL + K+ DFG++ +A + V
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV- 172
Query: 331 TKIQGTFGYLDPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLA 387
GT ++ PE Q K DV+S G+ +EL K P + N
Sbjct: 173 ----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP-LFNMNAMSA----- 222
Query: 388 AYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
L+ I ++ L + F N CL + RPT E +
Sbjct: 223 -----------LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-59
Identities = 69/318 (21%), Positives = 131/318 (41%), Gaps = 42/318 (13%)
Query: 164 NHFNANRILGQGGQGTVYKGMLEDG---RIIAVKKSKLTVDDEELLKLEEFINEIVILSQ 220
N ++G+G G V K ++ A+K+ K ++ +F E+ +L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCK 66
Query: 221 I-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFP-----------LTW 268
+ +H N++ LLG C L E+ P+G L L E P L+
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 269 EMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH 328
+ L A +VA + YL HRD+ + NIL+ + Y AK+ADFG S+ +
Sbjct: 127 QQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYV 181
Query: 329 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388
T + ++ E S T SDV+S+GV+L E+++ + ++ L
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYE 237
Query: 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448
R + + D+ +L ++C +RP+ ++ + LN +
Sbjct: 238 KLPQGYRLEKPLNCDDE-------------VYDLMRQCWREKPYERPSFAQILVSLNRML 284
Query: 449 GSSKKKRAMFSKIIKRLS 466
++K + + + ++ +
Sbjct: 285 --EERKTYVNTTLYEKFT 300
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-59
Identities = 65/331 (19%), Positives = 122/331 (36%), Gaps = 50/331 (15%)
Query: 141 NSYDGSVIDRFKLFSSKELDKATNHFNANRILGQGGQGTVYKGMLED------GRIIAVK 194
N Y ++ E + + ++LG G G V +AVK
Sbjct: 16 NEYFYVDFREYEYDLKWEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK 73
Query: 195 KSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQ 253
K D E E ++E+ +++Q+ +H N+V LLG C + L++E+ G L
Sbjct: 74 MLKEKADSSER---EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 130
Query: 254 HLHDRHQN------------------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYH 295
+L + + + LT+E L A +VA + +L H
Sbjct: 131 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 187
Query: 296 RDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT-TKIQGTFGYLDPEYHQSSQLTDKS 354
RD+ + N+L+ K+ DFG ++ I D +V + ++ PE T KS
Sbjct: 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS 247
Query: 355 DVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKN 414
DV+S+G++L E+ + + + ++ +
Sbjct: 248 DVWSYGILLWEIFSLGVNPYPGIPVDAN----------------FYKLIQNGFKMDQPFY 291
Query: 415 QIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445
+ + C + +KRP+ ++ L
Sbjct: 292 ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 6e-59
Identities = 54/278 (19%), Positives = 115/278 (41%), Gaps = 34/278 (12%)
Query: 169 NRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVV 227
+ +G+G TVYKG+ E +A + + + + + F E +L + H N+V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEAEMLKGLQHPNIV 71
Query: 228 KLLGCCLET----EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
+ T + +LV E + +GTL +L + ++ ++ L
Sbjct: 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQ 126
Query: 284 YLHSATSSPIYHRDIKSTNILL-DQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 342
+LH+ + PI HRD+K NI + K+ D G + + + GT ++ P
Sbjct: 127 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAP 182
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402
E ++ + + DVY+FG+ ++E+ T + P N +Q + ++ +
Sbjct: 183 EMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYRRVTSGVKPASFDKV 237
Query: 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
++ + + C+ N +R +++++
Sbjct: 238 AIPEV------------KEIIEGCIRQNKDERYSIKDL 263
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 7e-59
Identities = 70/273 (25%), Positives = 124/273 (45%), Gaps = 33/273 (12%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+GQG GTVY M + G+ +A+++ L ++ E INEI+++ + + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK----ELIINEILVMRENKNPNIVN 81
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
L L + +V E++ G+L + + + E AL +LHS
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCM------DEGQIAAVCRECLQALEFLHSN 135
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 348
+ HRDIKS NILL K+ DFG I +Q+ +T + GT ++ PE
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191
Query: 349 QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLM 408
K D++S G++ +E++ G+ P + N + L+ I +
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP-YLNENPLRA----------------LYLIATNGTP 234
Query: 409 KLGVKNQI-MTFANLAKRCLDLNGKKRPTMEEV 440
+L ++ F + RCLD++ +KR + +E+
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 8e-59
Identities = 66/288 (22%), Positives = 116/288 (40%), Gaps = 32/288 (11%)
Query: 164 NHFNANRILGQGGQGTVYKGML----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILS 219
R +G+G G V++G+ +A+K K D E+F+ E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR---EKFLQEALTMR 63
Query: 220 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVA 279
Q +H ++VKL+G E V ++ E G L L R + L + A +++
Sbjct: 64 QFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLS 118
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 339
ALAYL S HRDI + N+L+ K+ DFG S+++ + +K + +
Sbjct: 119 TALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399
+ PE + T SDV+ FGV + E+L F + + + + +
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIENGERLPM 230
Query: 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
L +L +C + +RP E+ +L+ I
Sbjct: 231 PPNCPPTL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 193 bits (491), Expect = 4e-58
Identities = 63/305 (20%), Positives = 120/305 (39%), Gaps = 35/305 (11%)
Query: 143 YDGSVIDRFKLFSSKEL----DKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSK 197
YD V D +K + + + D +H++ + LG G G V++ G A K
Sbjct: 1 YDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 60
Query: 198 LTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHD 257
+ ++ E EI +S + H +V L + +++YEF+ G L++ + D
Sbjct: 61 TPHESDK----ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD 116
Query: 258 RHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY--RAKVAD 315
H ++ + + +V L ++H H D+K NI+ + K+ D
Sbjct: 117 EHN----KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLID 169
Query: 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFW 375
FG + + Q+ T GT + PE + + +D++S GV+ LL+G P +
Sbjct: 170 FGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP--F 225
Query: 376 AGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP 435
G E + +M + I +D + ++ L + R
Sbjct: 226 GGENDDETLRNVKSCDWNMDDSAFSGISED-------------GKDFIRKLLLADPNTRM 272
Query: 436 TMEEV 440
T+ +
Sbjct: 273 TIHQA 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 6e-58
Identities = 65/274 (23%), Positives = 105/274 (38%), Gaps = 30/274 (10%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+ LG+G G V + +AVK + + E EI I +NH NVVK
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLNHENVVK 67
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
G E + L E+ G L+ + + R ++ + YLH
Sbjct: 68 FYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGYLDPEYHQS 347
I HRDIK N+LLD+R K++DFG + ++ + K+ GT Y+ PE +
Sbjct: 123 ---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 348 SQLTD-KSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQ 406
+ DV+S G+VL +L G+ P ++ QE + ++
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 238
Query: 407 LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
L + L N R T+ ++
Sbjct: 239 ---------------LLHKILVENPSARITIPDI 257
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-57
Identities = 74/292 (25%), Positives = 118/292 (40%), Gaps = 37/292 (12%)
Query: 156 SKELDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINE 214
+++L+ + + LG G G VYK E + A K ++E LE+++ E
Sbjct: 5 TRDLN-PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE----LEDYMVE 59
Query: 215 IVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRI 274
I IL+ +H N+VKLL ++ EF G + + + + PLT +
Sbjct: 60 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVV 115
Query: 275 ATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQ 334
+ AL YLH I HRD+K+ NIL K+ADFG S + I
Sbjct: 116 CKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI- 171
Query: 335 GTFGYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAY 389
GT ++ PE D K+DV+S G+ L+E+ + P N +
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRV------- 223
Query: 390 FVHSMRKNRLHDILDDQLMKLGVKNQI-MTFANLAKRCLDLNGKKRPTMEEV 440
L I + L ++ F + K+CL+ N R T ++
Sbjct: 224 ---------LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-55
Identities = 72/296 (24%), Positives = 123/296 (41%), Gaps = 35/296 (11%)
Query: 164 NHFNANRILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVI 217
+R LGQG G VY+G+ E +A+K E EF+NE +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER---IEFLNEASV 76
Query: 218 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEE-----FPLTWEMRL 272
+ + N +VV+LLG + + L++ E + G L +L P + +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 273 RIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI-AMDQTHVTT 331
++A E+A +AYL+ ++ HRD+ + N ++ + + K+ DFG ++ I D
Sbjct: 137 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 332 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391
K ++ PE + T SDV+SFGVVL E+ T + + + Q +
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--------VL 245
Query: 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447
+ + L D D+ L L + C N K RP+ E+ +
Sbjct: 246 RFVMEGGLLDKPDNCPDML---------FELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 3e-55
Identities = 67/282 (23%), Positives = 110/282 (39%), Gaps = 33/282 (11%)
Query: 170 RILGQGGQGTVYKGMLE----DGRIIAVKK-SKLTVDDEELLKLEEFINEIVILSQINHR 224
LG G G V +G + +AVK + E +++FI E+ + ++HR
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE--AMDDFIREVNAMHSLDHR 71
Query: 225 NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAY 284
N+++L G L + +V E P G+L L R A +VA + Y
Sbjct: 72 NLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGY 126
Query: 285 LHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH--VTTKIQGTFGYLDP 342
L S HRD+ + N+LL R K+ DFG + + + H + + F + P
Sbjct: 127 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402
E ++ + SD + FGV L E+ T + + N SQ LH I
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----------------LHKI 227
Query: 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMEL 444
+ ++ N+ +C + RPT + L
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 4e-55
Identities = 58/298 (19%), Positives = 125/298 (41%), Gaps = 34/298 (11%)
Query: 166 FNANRILGQGGQGTVYKGML-----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQ 220
F ++LG G GTVYKG+ + +A+K+ + + +E ++E +++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN---KEILDEAYVMAS 67
Query: 221 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
+++ +V +LLG CL + V L+ + +P G L ++ + N + L ++A
Sbjct: 68 VDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAK 122
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGY 339
+ YL + HRD+ + N+L+ K+ DFG +K + ++ + + +
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399
+ E T +SDV+S+GV + EL+T + + + +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----------------DGIPASEI 222
Query: 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKRAM 457
IL+ + + +C ++ RP E+ +E + + ++ +
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 280
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 180 bits (457), Expect = 4e-53
Identities = 59/308 (19%), Positives = 119/308 (38%), Gaps = 35/308 (11%)
Query: 140 LNSYDGSVIDRFKLFSSKELDKAT----NHFNANRILGQGGQGTVYKGM-LEDGRIIAVK 194
+N YD D +K + + ++ ++++ LG G G V++ + GR+ K
Sbjct: 1 INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 60
Query: 195 KSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQH 254
++ L NEI I++Q++H ++ L + +L+ EF+ G L+
Sbjct: 61 F----INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR 116
Query: 255 LHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY--RAK 312
+ + ++ + + L ++H I H DIK NI+ + + K
Sbjct: 117 IAAED----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVK 169
Query: 313 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 372
+ DFG + + D+ T T + PE + +D+++ GV+ LL+G P
Sbjct: 170 IIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227
Query: 373 IFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGK 432
+AG E + ++ + + + K L +
Sbjct: 228 --FAGEDDLETLQNVKRCDWEFDEDAFSSVSPE-------------AKDFIKNLLQKEPR 272
Query: 433 KRPTMEEV 440
KR T+ +
Sbjct: 273 KRLTVHDA 280
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-53
Identities = 68/311 (21%), Positives = 126/311 (40%), Gaps = 46/311 (14%)
Query: 158 ELDKATNHFNANRILGQGGQGTVYKGML--------EDGRIIAVKKSKLTVDDEELLKLE 209
EL + + + LG+G G V +AVK K +++L
Sbjct: 9 ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL---S 63
Query: 210 EFINEIVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRH--------- 259
+ I+E+ ++ I H+N++ LLG C + ++ E+ G L ++L R
Sbjct: 64 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 123
Query: 260 --QNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG 317
N E L+ + + A +VA + YL S HRD+ + N+L+ + K+ADFG
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFG 180
Query: 318 TSKFIAMDQTHVTTK-IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWA 376
++ I + T + ++ PE T +SDV+SFGV+L E+ T +
Sbjct: 181 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240
Query: 377 GNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT 436
+ L R ++ + ++ + + C +RPT
Sbjct: 241 VPVEE----LFKLLKEGHRMDKPSNCTNE-------------LYMMMRDCWHAVPSQRPT 283
Query: 437 MEEVSMELNGI 447
+++ +L+ I
Sbjct: 284 FKQLVEDLDRI 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 7e-53
Identities = 67/283 (23%), Positives = 110/283 (38%), Gaps = 32/283 (11%)
Query: 161 KATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKK-SKLTVDDEELLKLEEFINEIVIL 218
K F +ILG+G TV L R A+K K + E K+ E ++
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVM 62
Query: 219 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEV 278
S+++H VKL + E + NG L +++ E+
Sbjct: 63 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEI 117
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMD-QTHVTTKIQGTF 337
AL YLH I HRD+K NILL++ ++ DFGT+K ++ + + GT
Sbjct: 118 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174
Query: 338 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397
Y+ PE SD+++ G ++ +L+ G P F AGN + +
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYL------IFQKIIKLEY 227
Query: 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ + +L ++ L L+ KR EE+
Sbjct: 228 DFPEKFFPKAR------------DLVEKLLVLDATKRLGCEEM 258
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 4e-52
Identities = 60/274 (21%), Positives = 107/274 (39%), Gaps = 32/274 (11%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
LG+G G V++ + + K K+ D+ L EI IL+ HRN++
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-----VKKEISILNIARHRNILH 65
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
L E ++++EFI +++ ++ F L + +V AL +LHS
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHS- 120
Query: 289 TSSPIYHRDIKSTNILLDQR--YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 346
I H DI+ NI+ R K+ +FG ++ + Y PE HQ
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQ 176
Query: 347 SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQ 406
++ +D++S G ++ LL+G P + T+Q+ + ++ + +I +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDEEAFKEISIE- 233
Query: 407 LMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ R L K R T E
Sbjct: 234 ------------AMDFVDRLLVKERKSRMTASEA 255
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 6e-52
Identities = 72/304 (23%), Positives = 116/304 (38%), Gaps = 42/304 (13%)
Query: 164 NHFNANRILGQGGQGTVYKGM------LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVI 217
+ + LG+G G V + R +AVK K E ++E+ I
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH---RALMSELKI 69
Query: 218 LSQINHR-NVVKLLGCCLETEVPL-LVYEFIPNGTLYQHLHDRHQN-----------EEF 264
L I H NVV LLG C + PL ++ EF G L +L + +
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 265 PLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAM 324
LT E + + +VA + +L S HRD+ + NILL ++ K+ DFG ++ I
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 325 DQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQEN 383
D +V + ++ PE T +SDV+SFGV+L E+ + + +E
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 245
Query: 384 VSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443
+ + R D ++ C +RPT E+
Sbjct: 246 ---FCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEH 290
Query: 444 LNGI 447
L +
Sbjct: 291 LGNL 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (445), Expect = 8e-52
Identities = 59/310 (19%), Positives = 112/310 (36%), Gaps = 27/310 (8%)
Query: 157 KELDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEI 215
K+ + + ++ +LG G V +++A+K + K NEI
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG---KEGSMENEI 58
Query: 216 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIA 275
+L +I H N+V L L+ + + G L+ + ++ T R+
Sbjct: 59 AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLI 113
Query: 276 TEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQG 335
+V A+ YLH + LD+ + ++DFG SK D V + G
Sbjct: 114 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACG 171
Query: 336 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395
T GY+ PE + D +S GV+ LL G P + + +
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYDENDAKLFEQILKAEYEFD 229
Query: 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKR 455
DI D + + ++ + +KR T E+ ++ I G + +
Sbjct: 230 SPYWDDISDS-------------AKDFIRHLMEKDPEKRFTCEQA-LQHPWIAGDTALDK 275
Query: 456 AMFSKIIKRL 465
+ + +++
Sbjct: 276 NIHQSVSEQI 285
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 174 bits (441), Expect = 1e-51
Identities = 71/294 (24%), Positives = 118/294 (40%), Gaps = 32/294 (10%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
++ + ILG GG V+ L R +AVK + + + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSF-YLRFRREAQNAAAL 64
Query: 222 NHRNVVKLLGCCLETE----VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATE 277
NH +V + +P +V E++ TL +H P+T + + + +
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIAD 119
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHV--TTKIQG 335
AL + H I HRD+K NI++ KV DFG ++ IA V T + G
Sbjct: 120 ACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 176
Query: 336 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395
T YL PE + + +SDVYS G VL E+LTG+ P + G++
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVS----------VAY 224
Query: 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-TMEEVSMELNGIR 448
++ D + G+ + + L N + R T E+ +L +
Sbjct: 225 QHVREDPIPPSARHEGLSAD---LDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 171 bits (435), Expect = 7e-51
Identities = 66/289 (22%), Positives = 112/289 (38%), Gaps = 38/289 (13%)
Query: 165 HFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLK-----LEEFINEIVIL 218
++ ILG+G V + + + AVK +T + E + E+ IL
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 219 SQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATE 277
+++ H N+++L LV++ + G L+ +L ++ L+ + +I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRA 118
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTF 337
+ + LH I HRD+K NILLD K+ DFG S + D ++ GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTP 173
Query: 338 GYLDPEYHQSSQL------TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391
YL PE + S + D++S GV++ LL G P + + +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHRKQMLMLRMIMSGN 231
Query: 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ D D +L R L + +KR T EE
Sbjct: 232 YQFGSPEWDDYSDT-------------VKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 6e-48
Identities = 56/294 (19%), Positives = 106/294 (36%), Gaps = 21/294 (7%)
Query: 161 KATNHFNANRILGQGGQGTVYKG--MLEDGRIIAVKKSKL-TVDDEELLKLEEFINEIVI 217
+A + +G+G G V+K + GR +A+K+ ++ T ++ L + +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 218 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQ-HLHDRHQNEEFPLTWEMRLRIAT 276
L H NVV+L C + + + Q + E + E +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGT 336
++ L +LHS + HRD+K NIL+ + K+ADFG ++ + + T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VT 178
Query: 337 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396
Y PE S D++S G + E+ K + G++ + + + +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL--FRGSSDVDQLGKILDVIGLPGE 236
Query: 397 NRLHDILDDQLMKLGVKNQIMT----------FANLAKRCLDLNGKKRPTMEEV 440
+ K+ +L +CL N KR +
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 3e-47
Identities = 72/295 (24%), Positives = 120/295 (40%), Gaps = 35/295 (11%)
Query: 153 LFSSKELDKATNHFNANRILGQGGQGTVYKGM-LEDGRIIAVK--KSKLTVDDEELLKLE 209
+F + +D ++++ LG G V K G A K K + T + E
Sbjct: 2 VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58
Query: 210 EFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWE 269
+ E+ IL +I H NV+ L +L+ E + G L+ L ++ LT E
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEE 113
Query: 270 MRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR----YRAKVADFGTSKFIAMD 325
++ + YLHS I H D+K NI+L R R K+ DFG + I D
Sbjct: 114 EATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 168
Query: 326 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVS 385
+ I GT ++ PE L ++D++S GV+ LL+G P + G+T QE ++
Sbjct: 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLA 226
Query: 386 LAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ + + + +R L + KKR T+++
Sbjct: 227 NVSAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 163 bits (414), Expect = 8e-47
Identities = 62/285 (21%), Positives = 113/285 (39%), Gaps = 33/285 (11%)
Query: 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVK---KSKLTVDDEELLKLEEFINEIVILS 219
N F+ +RI+G+GG G VY + G++ A+K K ++ + E L L E + ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVS 62
Query: 220 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVA 279
+ +V + + + + + G L+ HL E A E+
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-----ADMRFYAAEII 117
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 339
L ++H+ + +RD+K NILLD+ +++D G + + + H + GT GY
Sbjct: 118 LGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGY 171
Query: 340 LDPEYHQSSQLTD-KSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398
+ PE Q D +D +S G +L +LL G P + + +
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMAVE 227
Query: 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443
L D +L +L + L + +R +
Sbjct: 228 LPDSFSPEL------------RSLLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-46
Identities = 66/279 (23%), Positives = 106/279 (37%), Gaps = 33/279 (11%)
Query: 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVKK-SKLTVDDEELLKLEEFINEIVILS-Q 220
F +++LG+G G V+ + + A+K K V ++ +E + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD--DVECTMVEKRVLSLA 59
Query: 221 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAG 280
H + + E V E++ G L H+ H A E+
Sbjct: 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIIL 114
Query: 281 ALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 340
L +LHS I +RD+K NILLD+ K+ADFG K + T GT Y+
Sbjct: 115 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYI 170
Query: 341 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400
PE + D +SFGV+L E+L G+ P + G +E + M
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSP--FHGQDEEE-----LFHSIRMDNPFYP 223
Query: 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEE 439
L+ + +L + +KR +
Sbjct: 224 RWLEKEA------------KDLLVKLFVREPEKRLGVRG 250
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 160 bits (406), Expect = 1e-46
Identities = 56/283 (19%), Positives = 108/283 (38%), Gaps = 24/283 (8%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKL 229
+G+G G VYK G A+KK +L +DE + I EI IL ++ H N+VKL
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIP--STTIREISILKELKHSNIVKL 65
Query: 230 LGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT 289
+ +LV+E + L ++ +AY H
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 290 SSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 349
+ HRD+K N+L+++ K+ADFG ++ + T +I + S +
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 350 LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSL------------AAYFVHSMRKN 397
+ D++S G + E++ G + G + + + + +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPL--FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ + + +K + +L + L L+ +R T ++
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-46
Identities = 62/283 (21%), Positives = 100/283 (35%), Gaps = 21/283 (7%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEE-FINEIVILSQINHRNVV 227
LG+G TVYK +I+A+KK KL E + + EI +L +++H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 228 KLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS 287
LL LV++F+ + LT L YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 288 ATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 347
I HRD+K N+LLD+ K+ADFG +K T ++ T Y PE
Sbjct: 119 ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFG 174
Query: 348 SQLTD-KSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF---------VHSMRKN 397
+++ D+++ G +L ELL + + Q + S+
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ +L + N R T +
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 4e-46
Identities = 56/284 (19%), Positives = 110/284 (38%), Gaps = 24/284 (8%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+G+G GTV+K E I+A+K+ +L DDE + + EI +L ++ H+N+V+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP--SSALREICLLKELKHKNIVR 65
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
L + LV+EF E+ ++ L + HS
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGLGFCHSR 120
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 348
+ HRD+K N+L+++ K+A+FG ++ + + ++ + +
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 349 QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLM 408
+ D++S G + EL +P+F GN + + + + + + +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLF-PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 409 KLGVKNQIMT------------FANLAKRCLDLNGKKRPTMEEV 440
K T +L + L N +R + EE
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 6e-46
Identities = 59/294 (20%), Positives = 109/294 (37%), Gaps = 24/294 (8%)
Query: 163 TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI 221
+ +G+G G V + +A+KK + + EI IL +
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC---QRTLREIKILLRF 63
Query: 222 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGA 281
H N++ + + + ++ + L+ + + L+ + ++
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRG 121
Query: 282 LAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVT--TKIQGTFGY 339
L Y+HSA + HRD+K +N+LL+ K+ DFG ++ D H T+ T Y
Sbjct: 122 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 340 LDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398
PE +S+ KS D++S G +L E+L+ + Q N L S
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 399 LHDILDDQLMKLGVKNQIMT------------FANLAKRCLDLNGKKRPTMEEV 440
L + L + ++ +L + L N KR +E+
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (402), Expect = 1e-45
Identities = 67/281 (23%), Positives = 116/281 (41%), Gaps = 33/281 (11%)
Query: 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
F R LG G G V+ +GR A+K K + ++E +E ++LS +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK-QVEHTNDERLMLSIVT 62
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
H ++++ G + + ++ ++I G L+ L + + A EV AL
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-----VAKFYAAEVCLAL 117
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 342
YLHS I +RD+K NILLD+ K+ DFG +K++ + GT Y+ P
Sbjct: 118 EYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAP 170
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402
E + D +SFG+++ E+L G P F+ NT + Y + R
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYTP-FYDSNTMK------TYEKILNAELRFPPF 223
Query: 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443
++ + +L R + + +R + E
Sbjct: 224 FNEDV------------KDLLSRLITRDLSQRLGNLQNGTE 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-45
Identities = 60/284 (21%), Positives = 108/284 (38%), Gaps = 24/284 (8%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+G+G G VYK G ++A+KK +L + E + I EI +L ++NH N+VK
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP--STAIREISLLKELNHPNIVK 65
Query: 229 LLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA 288
LL LV+EF + L + + + + ++ LA+ HS
Sbjct: 66 LLDVIHTENKLYLVFEF-LHQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 289 TSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 348
+ HRD+K N+L++ K+ADFG ++ + T ++ +
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 349 QLTDKSDVYSFGVVLVELLTGKKP------------IFWAGNTSQENVSLAAYFVHSMRK 396
+ D++S G + E++T + IF T E V + +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ D V +L + L + KR + +
Sbjct: 239 SFPKWARQD--FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-45
Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 42/284 (14%)
Query: 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVK--KSKLTVDDEELLKLEEFINEIVILSQ 220
+ + +LG GG G+VY G+ + D +A+K + D EL E+V+L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 221 IN--HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEV 278
++ V++LL + +L+ E L E+ +V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQV 119
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQ-RYRAKVADFGTSKFIAMDQTHVTTKIQGTF 337
A+ + H + + HRDIK NIL+D R K+ DFG+ + + V T GT
Sbjct: 120 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTR 173
Query: 338 GYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396
Y PE+ + + +S V+S G++L +++ G P F H
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----------------FEHDEEI 216
Query: 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
R ++ +L + CL L RPT EE+
Sbjct: 217 IRGQVFFRQRVSS--------ECQHLIRWCLALRPSDRPTFEEI 252
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-44
Identities = 63/293 (21%), Positives = 107/293 (36%), Gaps = 32/293 (10%)
Query: 166 FNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHR 224
+ +++G G G VY+ L + G ++A+KK E+ I+ +++H
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDHC 73
Query: 225 NVVKLLGCCLETEVP------LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEV 278
N+V+L + LV +++P H + + L ++
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 131
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQR-YRAKVADFGTSKFIAMDQTHVTTKIQGTF 337
+LAY+HS I HRDIK N+LLD K+ DFG++K + + +V+ I +
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRY 187
Query: 338 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ----------ENVSLA 387
++ T DV+S G VL ELL G+ Q
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 388 AYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ + + I K+ L R L+ R T E
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 6e-44
Identities = 54/281 (19%), Positives = 100/281 (35%), Gaps = 37/281 (13%)
Query: 169 NRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNV 226
+++LG G G V + A+K + + E+ + + ++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRASQCPHI 67
Query: 227 VKLLGCC----LETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
V+++ + L+V E + G L+ + DR T I + A+
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAI 124
Query: 283 AYLHSATSSPIYHRDIKSTNILLD---QRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 339
YLHS I HRD+K N+L K+ DFG +K + T T Y
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYY 179
Query: 340 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399
+ PE + D++S GV++ LL G P F++ + + + +
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP-FYSNHGLAISPGMKTRIRMG--QYEF 236
Query: 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ ++ + L + L +R T+ E
Sbjct: 237 PNPEWSEVSE--------EVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 2e-43
Identities = 50/293 (17%), Positives = 93/293 (31%), Gaps = 36/293 (12%)
Query: 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
N + R +G G G +Y G + G +A+K + + E I +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ------LHIESKIYKMMQ 60
Query: 223 HRNVVKLLG-CCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGA 281
+ + C E + ++V E + + + L +A ++
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISR 115
Query: 282 LAYLHSATSSPIYHRDIKSTNIL---LDQRYRAKVADFGTSKFIAMDQTHV------TTK 332
+ Y+HS HRD+K N L + + DFG +K +TH
Sbjct: 116 IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 333 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVH 392
+ GT Y H + + + D+ S G VL+ G P ++
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK------RQKYE 226
Query: 393 SMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445
+ + ++ ++ K FA C L +P +
Sbjct: 227 RISEKKMSTPIEVL-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 9e-43
Identities = 60/304 (19%), Positives = 114/304 (37%), Gaps = 26/304 (8%)
Query: 154 FSSKELDKAT----NHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKL 208
F +E+ K + + +G G G V + G +A+KK E K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK- 62
Query: 209 EEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTW 268
E+ +L + H NV+ LL E +F + E L
Sbjct: 63 -RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-KLGE 120
Query: 269 EMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH 328
+ + ++ L Y+H+A I HRD+K N+ +++ K+ DFG ++ +
Sbjct: 121 DRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSE 174
Query: 329 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQEN----- 383
+T + + + T D++S G ++ E++TGK + + Q
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234
Query: 384 -VSLAAYFVHSMRKNRLHDI------LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT 436
+ A FV ++ + + L+ + + N NL ++ L L+ ++R T
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 294
Query: 437 MEEV 440
E
Sbjct: 295 AGEA 298
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 8e-42
Identities = 61/294 (20%), Positives = 113/294 (38%), Gaps = 30/294 (10%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
+GQG G V+K + G+ +A+KK + + E + EI IL + H NVV
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI--TALREIKILQLLKHENVVN 73
Query: 229 LLGCCLETEVPLLVYE---FIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYL 285
L+ C P + ++ L N T R+ + L L
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML---LNGL 130
Query: 286 HSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT---HVTTKIQGTFGYLDP 342
+ + I HRD+K+ N+L+ + K+ADFG ++ ++ + + T T Y P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 343 EYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401
E + D++ G ++ E+ T GNT Q ++L + S+ +
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPI--MQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 402 ILDDQLM---------------KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEV 440
+ + +L +L + +L + L L+ +R ++
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 4e-41
Identities = 65/281 (23%), Positives = 105/281 (37%), Gaps = 30/281 (10%)
Query: 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
N F+ ++LG+G G V GR A+K + V + ++ + E +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVTESRVLQNTR 63
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
H + L + V E+ G L+ HL T E E+ AL
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSAL 118
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 342
YLHS + +RDIK N++LD+ K+ DFG K D GT YL P
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAP 174
Query: 343 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402
E + + D + GVV+ E++ G+ P F+ + + + + M + R
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHER------LFELILMEEIRFPRT 227
Query: 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443
L + +L L + K+R +
Sbjct: 228 LSPEA------------KSLLAGLLKKDPKQRLGGGPSDAK 256
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (361), Expect = 6e-40
Identities = 49/317 (15%), Positives = 105/317 (33%), Gaps = 50/317 (15%)
Query: 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
H+ R +G+G G +++G L + + +A+K D + +E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ------LRDEYRTYKLLA 58
Query: 223 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGAL 282
+ + + + ++ + +L L + + + A ++ +
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR----KFSVKTVAMAAKQMLARV 114
Query: 283 AYLHSATSSPIYHRDIKSTNILLDQRYR-----AKVADFGTSKFIAMDQTHV------TT 331
+H + +RDIK N L+ + V DFG KF T
Sbjct: 115 QSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171
Query: 332 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391
+ GT Y+ H + + + D+ + G V + L G + W G + N
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS--LPWQGLKAATNK------- 222
Query: 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451
+ R+ + ++ F +L P + +
Sbjct: 223 --QKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL----------- 269
Query: 452 KKKRAMFSKIIKRLSLK 468
+ +FSK+++RL+
Sbjct: 270 ---QGLFSKVLERLNTT 283
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (361), Expect = 2e-39
Identities = 66/301 (21%), Positives = 113/301 (37%), Gaps = 36/301 (11%)
Query: 146 SVIDRFKLFSSKELDKAT-NHFNANRILGQGGQGTVYKGM-LEDGRIIAVKK-SKLTVDD 202
+ D K + + + A + F+ + LG G G V E G A+K K V
Sbjct: 22 AKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK 81
Query: 203 EELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNE 262
+ ++E +NE IL +N +VKL + +V E++ G ++ HL
Sbjct: 82 LK--QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--- 136
Query: 263 EFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322
+ A ++ YLHS + +RD+K N+L+DQ+ +V DFG +K +
Sbjct: 137 --RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE 382
+ GT L PE S D ++ GV++ E+ G P + + +
Sbjct: 192 KGRTWTL----CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP--FFADQPIQ 245
Query: 383 NVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442
Y K R L +L + L ++ KR + +
Sbjct: 246 -----IYEKIVSGKVRFPSHFSSDLK------------DLLRNLLQVDLTKRFGNLKNGV 288
Query: 443 E 443
Sbjct: 289 N 289
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 137 bits (346), Expect = 2e-37
Identities = 60/302 (19%), Positives = 114/302 (37%), Gaps = 45/302 (14%)
Query: 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
+ + R LG+G V++ + + + + VK K K ++ EI IL +
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLR 87
Query: 223 -HRNVVKLLGCCLE--TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVA 279
N++ L + + P LV+E + N Q LT E+
Sbjct: 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEIL 139
Query: 280 GALAYLHSATSSPIYHRDIKSTNILLDQR-YRAKVADFGTSKFIAMDQTHVTTKIQGTFG 338
AL Y HS I HRD+K N+++D + ++ D+G ++F Q + +
Sbjct: 140 KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRY 194
Query: 339 YLDPEYHQSSQLTD-KSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA------YFV 391
+ PE Q+ D D++S G +L ++ K+P F + + V +A +
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254
Query: 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFA-------------NLAKRCLDLNGKKRPTME 438
+ + N D + ++ + + F + + L + + R T
Sbjct: 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314
Query: 439 EV 440
E
Sbjct: 315 EA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-37
Identities = 66/287 (22%), Positives = 106/287 (36%), Gaps = 30/287 (10%)
Query: 164 NHFNANRILGQGGQGTVYKGML----EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILS 219
+F ++LG G G V+ + G++ A+K K ++ E E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 220 QINHR-NVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEV 278
I +V L L+ ++I G L+ HL R T E+
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEI 138
Query: 279 AGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 338
AL +LH I +RDIK NILLD + DFG SK D+T GT
Sbjct: 139 VLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 339 YLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396
Y+ P+ + D +S GV++ ELLTG P + + + + + + +
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSEP 253
Query: 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443
++ +L +R L + KKR +
Sbjct: 254 PYPQEMSAL-------------AKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 1e-35
Identities = 55/304 (18%), Positives = 101/304 (33%), Gaps = 26/304 (8%)
Query: 154 FSSKELDKA----TNHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKL 208
F +EL+K + +G G G+V + G +AVKK
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HA 61
Query: 209 EEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTW 268
+ E+ +L + H NV+ LL + L + + LT
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTD 120
Query: 269 EMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTH 328
+ + ++ L Y+HSA I HRD+K +N+ +++ K+ DFG ++
Sbjct: 121 DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---E 174
Query: 329 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP------------IFWA 376
+T + + D++S G ++ ELLTG+ I
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
Query: 377 GNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT 436
T + + + + +L ++ L L+ KR T
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294
Query: 437 MEEV 440
+
Sbjct: 295 AAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 7e-35
Identities = 54/307 (17%), Positives = 109/307 (35%), Gaps = 45/307 (14%)
Query: 164 NHFNANRILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN 222
+ + +G G QG V R +A+KK ++ + E+V++ +N
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT--HAKRAYRELVLMKCVN 74
Query: 223 HRNVVKLLGCCL------ETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIAT 276
H+N++ LL E + LV E + + E +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLY 126
Query: 277 EVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQTHVTTKIQGT 336
++ + +LHS + I HRD+K +NI++ K+ DFG ++ + + T T
Sbjct: 127 QMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 181
Query: 337 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ--------------- 381
Y PE + D++S G ++ E++ K Q
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 382 --ENVSLAAYFVHSMRK---NRLHDILDDQLMKLGVKNQIMT---FANLAKRCLDLNGKK 433
+ +V + K + D L ++ + +L + L ++ K
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 434 RPTMEEV 440
R ++++
Sbjct: 302 RISVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (295), Expect = 3e-30
Identities = 56/320 (17%), Positives = 110/320 (34%), Gaps = 62/320 (19%)
Query: 170 RILGQGGQGTVYKGM-LEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVK 228
R LG G TV+ + + +A+K + + + E +EI +L ++N + K
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 229 LLGCCLETEVPLLVY--EFIPNGTLYQ---------HLHDRHQNEEFPLTWEMRLRIATE 277
+ LL + PNG L + E + +I+ +
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 278 VAGALAYLHSATSSPIYHRDIKSTNILLDQR------YRAKVADFGTSKFIAMDQTHVTT 331
+ L Y+H I H DIK N+L++ + K+AD G + + T+
Sbjct: 134 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS-- 189
Query: 332 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP------------------- 372
T Y PE + +D++S ++ EL+TG
Sbjct: 190 --IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 373 ----------IFWAGNTSQENVSLAAYF--VHSMRKNRLHDILDDQLMKLGVKNQIMTFA 420
+ G ++ + + ++ L D+L ++ K++ +
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF--SKDEAKEIS 305
Query: 421 NLAKRCLDLNGKKRPTMEEV 440
+ L L+ +KR +
Sbjct: 306 DFLSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.0 bits (199), Expect = 2e-18
Identities = 29/185 (15%), Positives = 60/185 (32%), Gaps = 27/185 (14%)
Query: 170 RILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLK------LEEFINEIVILSQINH 223
+++G+G + V+ E VK K+ + +K F + ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 224 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALA 283
R + KL G + Y + N L + + + E + + +A
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVR---VENPDEVLDMILEEVA 117
Query: 284 YLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK---------FIAMDQTHVTTKIQ 334
+ I H D+ N+L+ + + DF S + D ++ T
Sbjct: 118 KFYHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173
Query: 335 GTFGY 339
T+
Sbjct: 174 RTYRT 178
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.36 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.96 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.29 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.29 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.01 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.78 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=413.12 Aligned_cols=257 Identities=26% Similarity=0.393 Sum_probs=201.3
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
++|++.+.||+|+||+||+|.+.+++.||||+++..... .++|.+|+.++++++|||||+++|+|.+.+..++||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc-----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 568888999999999999999988899999998764332 257999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++|+|.+++.... ..+++..++.++.|||.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 80 E~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp ECCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred EecCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheecc
Confidence 9999999999987532 35899999999999999999999999 9999999999999999999999999998776
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
...........||+.|+|||.+.+..++.++|||||||++|||+|+..|+... ............. ..
T Consensus 153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~----~~~~~~~~~i~~~---~~----- 220 (263)
T d1sm2a_ 153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN----RSNSEVVEDISTG---FR----- 220 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS----CCHHHHHHHHHHT---CC-----
T ss_pred CCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC----CCHHHHHHHHHhc---CC-----
Confidence 55444444567999999999999999999999999999999999965554321 1111111111111 11
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
...+..+++.+.+|+.+||+.||++|||++||++.|++|..
T Consensus 221 -----~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 221 -----LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 11122344578999999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.8e-55 Score=419.81 Aligned_cols=267 Identities=25% Similarity=0.388 Sum_probs=220.6
Q ss_pred HhcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcce
Q 012214 162 ATNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPL 240 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 240 (468)
..++|++.+.||+|+||+||+|.+. +++.||||+++.... ..++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 3467889999999999999999975 588999999875432 2357999999999999999999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
+||||+++|+|.+++... ....+++..++.|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+
T Consensus 90 iv~E~~~~g~l~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEECCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEeecccCcchHHHhhhc---cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999763 2346999999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
....+.........||+.|+|||++.++.++.++|||||||++|||++|..|+....+ ... .......+.
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-------~~~-~~~~i~~~~-- 233 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQ-VYELLEKDY-- 233 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHH-HHHHHHTTC--
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-------HHH-HHHHHhcCC--
Confidence 8766655555556789999999999999999999999999999999998877643111 111 111111111
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCchhhh
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSKKKRA 456 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~ 456 (468)
....+...++.+.+|+.+||+.||++|||+.||++.|+.+.+...-.++
T Consensus 234 -------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~~~~~ 282 (287)
T d1opja_ 234 -------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 282 (287)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSCHHHH
T ss_pred -------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCCCChH
Confidence 1112234456899999999999999999999999999998776544433
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-54 Score=409.79 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=211.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.++|++.+.||+|+||.||+|.+++++.||||+++..... .+.|.+|+.++++++|||||+++|++.+ +..++|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC-----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 4678899999999999999999988899999998764332 3579999999999999999999998865 567999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++..... .++++..++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+..
T Consensus 86 ~Ey~~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEc
Confidence 999999999998865322 35899999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
............||+.|+|||++.++.++.++|||||||++|||+||..|+..... . .. ....+.....
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----~---~~-~~~~i~~~~~--- 228 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----N---PE-VIQNLERGYR--- 228 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----H---HH-HHHHHHTTCC---
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----H---HH-HHHHHHhcCC---
Confidence 66555555566799999999999999999999999999999999997776532111 1 11 1111111110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
...+...++.+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 229 ------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 229 ------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 11123345578999999999999999999999999998654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=408.80 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=205.6
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.++|.+.+.||+|+||+||+|+.+ ..||||+++...... ...+.|.+|+.++++++|||||+++|++.+ ...++|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP--QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCT--THHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 467999999999999999999864 359999987543332 446789999999999999999999999865 567999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... ..+++..+..|+.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+..
T Consensus 82 ~Ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EECCCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EecCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeec
Confidence 99999999999997532 25999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCc-eeeecccccCCccCcccccc---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 323 AMDQT-HVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 323 ~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
..... .......||+.|+|||++.+ +.++.++|||||||++|||+||+.||.... . ..............+.
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~--~--~~~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--N--RDQIIFMVGRGYLSPD 230 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC--C--HHHHHHHHHHTSCCCC
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC--h--HHHHHHHHhcCCCCCc
Confidence 54332 23445679999999999864 458899999999999999999999985311 1 1111111111111111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
+. ..+.++++.+.+|+.+||+.||++|||+.||++.|+.|..+
T Consensus 231 ~~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 231 LS---------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp GG---------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ch---------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 11 11234456899999999999999999999999999988754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.7e-54 Score=414.48 Aligned_cols=261 Identities=24% Similarity=0.412 Sum_probs=201.9
Q ss_pred cCCCCCceeeecCcEEEEEEEecC-C---cEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED-G---RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
++|++.+.||+|+||+||+|.++. + ..||||++...... ...++|.+|+.++++++|||||+++|++.+.+..
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE---KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH---HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 456778899999999999999642 2 36899988765444 4457899999999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++|+|.+++.... ..+++.+++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred EEEEEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccc
Confidence 99999999999999887532 35899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCcee----eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHh
Q 012214 320 KFIAMDQTHV----TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 320 ~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
+......... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||... ... . ....+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~-----~~~---~-~~~~i 246 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-----TNQ---D-VINAI 246 (299)
T ss_dssp --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHH---H-HHHHH
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC-----CHH---H-HHHHH
Confidence 8765433221 223457899999999999999999999999999999998 89998431 111 1 11111
Q ss_pred hccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCc
Q 012214 395 RKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452 (468)
Q Consensus 395 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 452 (468)
..+. ....+..+++.+.+|+.+||+.||++|||+.||++.|+.+.++.+
T Consensus 247 ~~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~ 295 (299)
T d1jpaa_ 247 EQDY---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295 (299)
T ss_dssp HTTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred HcCC---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChh
Confidence 1111 111233455689999999999999999999999999999876654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=401.33 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=213.1
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
++|+..++||+|+||+||+|++++++.||||+++..... .++|.+|+.++++++||||++++|+|.+....++||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 678999999999999999999988889999998764332 257999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++|+|..++.... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 79 Ey~~~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp ECCTTEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred EccCCCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheecc
Confidence 9999999999976533 25899999999999999999999999 9999999999999999999999999998776
Q ss_pred CCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
...........+|+.|+|||.+.+..++.++|||||||++|||+| |+.||... . ..... ..+.....
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~--~---~~~~~----~~i~~~~~--- 219 (258)
T d1k2pa_ 152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--T---NSETA----EHIAQGLR--- 219 (258)
T ss_dssp SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--C---HHHHH----HHHHTTCC---
T ss_pred CCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC--C---HHHHH----HHHHhCCC---
Confidence 555544555679999999999999999999999999999999998 78887431 1 11111 11111110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
...+...++.+.+|+.+||+.||++|||++|+++.|.+|
T Consensus 220 ------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 220 ------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ------CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 111233445899999999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=400.17 Aligned_cols=252 Identities=26% Similarity=0.381 Sum_probs=202.6
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||+||+|... +|+.||||++...... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 57889999999999999999975 6899999998654322 2345689999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 82 mEy~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF 153 (271)
T ss_dssp EECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeccCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheee
Confidence 9999999999999652 25999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCc-eeeecccccCCccCccccccCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 323 AMDQT-HVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 323 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
..... ......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ............
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-------~~~~~~~~~~~~ 226 (271)
T d1nvra_ 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EYSDWKEKKTYL 226 (271)
T ss_dssp EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-------HHHHHHTTCTTS
T ss_pred ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-------HHHHHhcCCCCC
Confidence 54332 22445679999999999988776 5689999999999999999999854221111 111111111110
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
......++.+.+|+.+||+.||++|||+.|+++
T Consensus 227 ---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 ---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011233457889999999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=401.28 Aligned_cols=262 Identities=23% Similarity=0.391 Sum_probs=205.3
Q ss_pred cCCCCCceeeecCcEEEEEEEecCC-----cEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDG-----RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g-----~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
+.|+..+.||+|+||.||+|.++++ ..||||++...... ....+|.+|+.++++++|||||+++|++.+...
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE---KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh---HHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 5678889999999999999986532 46999998765444 344679999999999999999999999999999
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++||||+.++++.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eEEEEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccch
Confidence 999999999999999886532 35999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCc--eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 319 SKFIAMDQT--HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 319 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
++....... .......||+.|+|||++.++.++.++|||||||++|||++|..|+..... ... ....+..
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-------~~~-~~~~i~~ 228 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHE-VMKAIND 228 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHH-HHHHHHT
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-------HHH-HHHHHhc
Confidence 987654322 223345689999999999999999999999999999999997777643111 111 1111211
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCc
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 452 (468)
+. ....+...+..+.+|+.+||+.||++|||+.||+++|+.+.+...
T Consensus 229 ~~---------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 229 GF---------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp TC---------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred cC---------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence 11 111223345579999999999999999999999999998876543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=403.15 Aligned_cols=256 Identities=24% Similarity=0.357 Sum_probs=207.1
Q ss_pred cCCCCCc-eeeecCcEEEEEEEec---CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 164 NHFNANR-ILGQGGQGTVYKGMLE---DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 164 ~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
++|.+.+ +||+|+||+||+|.++ ++..||||+++..... ...++|.+|+.++++++|||||+++|++.+ +..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK---ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH---HHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 4455666 4999999999999853 3567999998765443 445789999999999999999999999865 567
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLS 156 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhh
Confidence 99999999999999986532 35999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCcee--eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 320 KFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 320 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
+......... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||.... ... +...+..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-----~~~----~~~~i~~ 227 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GPE----VMAFIEQ 227 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----THH----HHHHHHT
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC-----HHH----HHHHHHc
Confidence 8776544332 234568999999999999999999999999999999998 899985311 111 1111222
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
+... ..+...++++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 228 ~~~~---------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 228 GKRM---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp TCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC---------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111 123345568999999999999999999999999998654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-52 Score=394.25 Aligned_cols=248 Identities=30% Similarity=0.402 Sum_probs=204.9
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||+||+|+.+ +++.||+|++...... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc-ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 56899999999999999999975 6889999988643211 112346788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 85 mEy~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred EeecCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeec
Confidence 99999999999997643 4899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... . .......... ...
T Consensus 157 ~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~------~~~~~~~i~~-~~~--- 221 (263)
T d2j4za1 157 PSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--T------YQETYKRISR-VEF--- 221 (263)
T ss_dssp CCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--S------HHHHHHHHHT-TCC---
T ss_pred CCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC--C------HHHHHHHHHc-CCC---
Confidence 4332 23457999999999999999999999999999999999999998431 1 1111111111 111
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+...++.+.+|+.+||+.||++|||+.|+++
T Consensus 222 -------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 -------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 012233457899999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=400.35 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=199.1
Q ss_pred ceeeecCcEEEEEEEecC---CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeec
Q 012214 170 RILGQGGQGTVYKGMLED---GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFI 246 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 246 (468)
++||+|+||+||+|.+.+ ++.||||+++..... ....++|.+|+.++++++|||||+++|+|.+ +..++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC--HHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence 469999999999998643 568999998754322 2345789999999999999999999999965 4678999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 012214 247 PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQ 326 (468)
Q Consensus 247 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 326 (468)
++|+|.+++.... ++++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 90 ELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp TTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred CCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 9999999997632 4999999999999999999999999 9999999999999999999999999998765444
Q ss_pred cee--eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccchhc
Q 012214 327 THV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL 403 (468)
Q Consensus 327 ~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||... ... + ....+..+...
T Consensus 162 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~-----~~~---~-~~~~i~~~~~~--- 229 (277)
T d1xbba_ 162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-----KGS---E-VTAMLEKGERM--- 229 (277)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHH---H-HHHHHHTTCCC---
T ss_pred cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC-----CHH---H-HHHHHHcCCCC---
Confidence 333 234568999999999999999999999999999999998 89998431 111 1 11222221111
Q ss_pred chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 012214 404 DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGI 447 (468)
Q Consensus 404 d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i 447 (468)
..+..+++.+.+|+.+||+.||++|||+.+|+++|+..
T Consensus 230 ------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 ------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 11234456889999999999999999999999988765
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-52 Score=395.58 Aligned_cols=257 Identities=23% Similarity=0.381 Sum_probs=195.4
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc--CCcce
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE--TEVPL 240 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~ 240 (468)
++|++.+.||+|+||+||+|+.. +|+.||||++....... ...+.+.+|+.++++++|||||++++++.+ ....+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH--HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH--HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 57899999999999999999964 68999999987644332 345679999999999999999999999865 45679
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT--SSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
+||||+++|+|.+++...... ...+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999999764322 236999999999999999999999864 23499999999999999999999999999
Q ss_pred cccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
|+....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||... ... . ....+....
T Consensus 161 a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~-----~~~---~-~~~~i~~~~ 230 (269)
T d2java1 161 ARILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-----SQK---E-LAGKIREGK 230 (269)
T ss_dssp HHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHH---H-HHHHHHHTC
T ss_pred eeecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC-----CHH---H-HHHHHHcCC
Confidence 987654332 234467999999999999999999999999999999999999998431 111 1 111222222
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
... .+...++++.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~---------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 FRR---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 211 12234457899999999999999999999874
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=393.75 Aligned_cols=249 Identities=27% Similarity=0.438 Sum_probs=205.1
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh----HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 4799999999999999999996 46999999998653222 235689999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 96 mEy~~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp EECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheee
Confidence 9999999999987652 4899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... . .. ........... ..+
T Consensus 167 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--~---~~---~~~~~~~~~~~-~~~ 236 (293)
T d1yhwa1 167 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--N---PL---RALYLIATNGT-PEL 236 (293)
T ss_dssp CSTTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS--C---HH---HHHHHHHHHCS-CCC
T ss_pred ccccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC--C---HH---HHHHHHHhCCC-CCC
Confidence 54332 234457999999999999999999999999999999999999998431 1 11 11111111111 000
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+...++.+.+|+.+||+.||++|||+.|+++
T Consensus 237 -------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 -------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112334557899999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-52 Score=397.52 Aligned_cols=260 Identities=24% Similarity=0.351 Sum_probs=206.1
Q ss_pred hcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
.++|++.+.||+|+||.||+|++++++.||||+++..... .+.|.+|+.++++++|||||+++|+|.+ +..++|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~-----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC-----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 3679999999999999999999988889999998764332 3579999999999999999999999965 567999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|..++..... ..++|..++.++.||+.||+|||+.+ |+||||||+||||++++++||+|||+++..
T Consensus 90 ~Ey~~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp ECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEecCCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhc
Confidence 999999999998876322 35999999999999999999999999 999999999999999999999999999877
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
............||+.|+|||++.++.++.++|||||||++|||++|..|+.... ...+.. ..+....
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-------~~~~~~-~~i~~~~---- 231 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREVL-DQVERGY---- 231 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHH-HHHHTTC----
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-------CHHHHH-HHHHhcC----
Confidence 5554444455679999999999999999999999999999999999877764311 111111 1111111
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
..+.+...++++.+++.+||+.||++|||+++|+++|+....+.
T Consensus 232 -----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 232 -----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -----CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 01122344568999999999999999999999999999877554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-52 Score=406.82 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=206.7
Q ss_pred hcCCCCCceeeecCcEEEEEEEecC------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeecc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLED------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLE 235 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~ 235 (468)
.++|++.+.||+|+||+||+|+... ...||+|++...... .....+.+|+.++.++ +|||||++++++.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS---SEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH---HHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 4678999999999999999998643 236999988654332 3446789999999998 89999999999999
Q ss_pred CCcceeEeeecCCCChhhHhhhcccC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecC
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQN------------------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRD 297 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~D 297 (468)
.+..++||||+++|+|.+++...... ....+++..++.++.||++||+|||+++ |+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 99999999999999999999764321 1235899999999999999999999999 99999
Q ss_pred CCCCCEEEcCCCcEEEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCC
Q 012214 298 IKSTNILLDQRYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFW 375 (468)
Q Consensus 298 Lkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~ 375 (468)
|||+|||++.++.+||+|||+|+........ ......||+.|+|||++.++.++.++|||||||++|||+| |+.||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544333 3345568999999999999999999999999999999998 8999843
Q ss_pred CCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 012214 376 AGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELN 445 (468)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 445 (468)
... . ..+........ ....+...++.+.+|+.+||+.||++|||++||++.|.
T Consensus 270 ~~~--~------~~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPV--D------ANFYKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCC--S------HHHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCH--H------HHHHHHHhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 111 1 11111121111 11113344568999999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-52 Score=405.00 Aligned_cols=283 Identities=23% Similarity=0.338 Sum_probs=212.4
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|++.+.||+|+||+||+|... +|+.||+|+++..... ...+.+.+|+.++++++|||||++++++.+....++
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT---THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 478999999999999999999964 6899999998764333 334678999999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSA-TSSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+. + |+||||||+|||+++++.+||+|||+|+
T Consensus 82 VmEy~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG 153 (322)
T ss_dssp EEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred EEEcCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCcc
Confidence 999999999999997643 489999999999999999999974 7 9999999999999999999999999998
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh------
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM------ 394 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~------ 394 (468)
...... ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.....................
T Consensus 154 ~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 154 QLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp HHHHHT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred ccCCCc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence 664322 23457999999999999999999999999999999999999999642211110000000000000
Q ss_pred ------------h---ccccchhcchHHhh----hchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhcccCCch
Q 012214 395 ------------R---KNRLHDILDDQLMK----LGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGIRGSSKK 453 (468)
Q Consensus 395 ------------~---~~~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i~~~~~~ 453 (468)
. .....+..+..... ......+.++.+|+.+||+.||++|||+.|+++ .+++....+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~d 310 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 310 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCCC
T ss_pred ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCccccc
Confidence 0 00000000000000 001123457899999999999999999999987 46655544433
Q ss_pred hhhHHH
Q 012214 454 KRAMFS 459 (468)
Q Consensus 454 ~~~~~~ 459 (468)
.....+
T Consensus 311 ~~~~~~ 316 (322)
T d1s9ja_ 311 FAGWLC 316 (322)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 333333
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=386.74 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=196.3
Q ss_pred CCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc----CCccee
Q 012214 167 NANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE----TEVPLL 241 (468)
Q Consensus 167 ~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~~~l 241 (468)
+..++||+|+||+||+|.+. +++.||+|++....... ...+.|.+|++++++++|||||++++++.+ ....++
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK--SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 55667999999999999965 68899999886543222 345679999999999999999999999864 345789
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc-CCCcEEEEecCCcc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD-QRYRAKVADFGTSK 320 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~-~~~~~kl~DfGla~ 320 (468)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+
T Consensus 90 vmE~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEeCCCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 999999999999997643 4899999999999999999999876 4599999999999996 58999999999998
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
...... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.... .... .......+...
T Consensus 164 ~~~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-------~~~~-~~~~i~~~~~~ 231 (270)
T d1t4ha_ 164 LKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQ-IYRRVTSGVKP 231 (270)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHH-HHHHHTTTCCC
T ss_pred eccCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-------cHHH-HHHHHHcCCCC
Confidence 644322 234579999999998865 69999999999999999999999984211 1111 11111111111
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.. .+...++++.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~--------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 AS--------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GG--------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc--------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11 11223446889999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=393.88 Aligned_cols=251 Identities=26% Similarity=0.351 Sum_probs=203.1
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
+.|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS----GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH----HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 56888999999999999999965 689999999865432 2346788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... .++++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 88 mEy~~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp EECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhcc
Confidence 99999999999986532 25999999999999999999999999 999999999999999999999999999765
Q ss_pred cCCCceeeecccccCCccCccccc-----cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
..... ......||+.|+|||++. +..++.++|||||||++|||+||+.||.... .. .. +......
T Consensus 161 ~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~--~~---~~---~~~i~~~- 230 (288)
T d2jfla1 161 TRTIQ-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN--PM---RV---LLKIAKS- 230 (288)
T ss_dssp HHHHH-HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC--GG---GH---HHHHHHS-
T ss_pred CCCcc-cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC--HH---HH---HHHHHcC-
Confidence 33211 223457999999999884 4568899999999999999999999985311 11 11 1111111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
....+ ..+...++.+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 231 EPPTL-------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCCCC-------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCC-------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 112344568899999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-51 Score=395.79 Aligned_cols=265 Identities=25% Similarity=0.377 Sum_probs=212.7
Q ss_pred HHHhcCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeee
Q 012214 160 DKATNHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCC 233 (468)
Q Consensus 160 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~ 233 (468)
+...++|++.+.||+|+||+||+|+.+ +++.||||+++..... ...++|.+|+.++++++||||++++++|
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---DMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh---HHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 334578999999999999999999864 3578999998764433 3457899999999999999999999999
Q ss_pred ccCCcceeEeeecCCCChhhHhhhccc-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEE
Q 012214 234 LETEVPLLVYEFIPNGTLYQHLHDRHQ-------------------NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIY 294 (468)
Q Consensus 234 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ii 294 (468)
.+....+++|||+++|+|.+++..... .....+++..++.|+.|++.||+|||+.+ ||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 999999999999999999999975321 11235899999999999999999999999 99
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCcccccCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCC-C
Q 012214 295 HRDIKSTNILLDQRYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKK-P 372 (468)
Q Consensus 295 H~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~-p 372 (468)
||||||+|||++.++.+||+|||+|+....... ...+...||+.|+|||.+.+..++.++|||||||++|||++|.. |
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999999999999999999999999986644332 23344668999999999999999999999999999999999865 5
Q ss_pred CCCCCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 373 IFWAGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
|.. ... .+ ....+..+....+ +...++++.+|+.+||+.||++||||.||+++|++|.
T Consensus 243 ~~~--~~~------~e-~~~~v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYG--MAH------EE-VIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTT--SCH------HH-HHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCC--CCH------HH-HHHHHHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 432 111 11 1122222222211 2234457899999999999999999999999999886
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=393.49 Aligned_cols=259 Identities=26% Similarity=0.401 Sum_probs=198.7
Q ss_pred hcCCCCCceeeecCcEEEEEEEecC----CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLED----GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
.++|++.+.||+|+||.||+|.+.. +..||||+++..... ...+.|.+|+.++++++||||++++|++. .+.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD---SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence 3678899999999999999998642 456899988654433 44578999999999999999999999996 467
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++||||+++|+|.+++.... .++++..++.++.||++||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred EEEEEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchh
Confidence 899999999999999886532 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhcc
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKN 397 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (468)
|+..............||+.|+|||.+.+..++.++|||||||++|||++ |..||.... ....... ....
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~-----~~~~~~~----i~~~ 225 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-----NNDVIGR----IENG 225 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHH----HHTT
T ss_pred heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC-----HHHHHHH----HHcC
Confidence 98776555545556678999999999999999999999999999999998 788874311 1111111 1111
Q ss_pred ccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 398 RLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 398 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
... ..+.+.++.+.+|+.+||+.||++|||+.||++.|+.|.+.
T Consensus 226 ~~~---------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 226 ERL---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC---------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111 11234456899999999999999999999999999988644
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=395.31 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=203.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||+||+|... +|+.||||++...... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc-CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 56999999999999999999974 6899999998643211 113346789999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+
T Consensus 87 mEy~~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp ECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEccCCCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceec
Confidence 99999999999987643 4999999999999999999999999 999999999999999999999999999877
Q ss_pred cCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... .. ...+..... ..+
T Consensus 159 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~---~~~~~~i~~-~~~-- 227 (288)
T d1uu3a_ 159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NE---YLIFQKIIK-LEY-- 227 (288)
T ss_dssp C----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SH---HHHHHHHHT-TCC--
T ss_pred ccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc-----CH---HHHHHHHHc-CCC--
Confidence 54332 2334467999999999999999999999999999999999999998531 11 111111111 111
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..+...++.+.+|+.+||+.||++|||++|++.
T Consensus 228 --------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 --------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 011233457899999999999999999999754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.8e-51 Score=394.43 Aligned_cols=252 Identities=23% Similarity=0.312 Sum_probs=190.0
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.+.|++.+.||+|+||+||+|... +|+.||||++...... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 467899999999999999999975 6899999998754333 223568899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc---CCCcEEEEecCC
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD---QRYRAKVADFGT 318 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~---~~~~~kl~DfGl 318 (468)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+
T Consensus 85 vmE~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp EECCCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred EEeccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccce
Confidence 99999999999999753 25999999999999999999999999 99999999999994 578999999999
Q ss_pred cccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
|+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... ... ..........
T Consensus 157 a~~~~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~---~~~~~i~~~~- 225 (307)
T d1a06a_ 157 SKMEDPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE-----NDA---KLFEQILKAE- 225 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHH---HHHHHHHTTC-
T ss_pred eEEccCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC-----CHH---HHHHHHhccC-
Confidence 986643322 33457999999999999999999999999999999999999998431 111 1111111111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
... ........++.+.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 226 YEF------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCC------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCC------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 100 00112234557899999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-50 Score=391.96 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=201.8
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
..|+..+.||+|+||+||+|+.. +++.||||++....... ....+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 45888999999999999999964 68999999987543322 24557799999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|..++... .++++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 94 ~E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (309)
T ss_dssp EECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccccccc
Confidence 9999999987666542 25999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCceeeecccccCCccCcccccc---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
... ....||+.|+|||++.+ +.++.++|||||||++|||++|+.||... . ........... ..
T Consensus 166 ~~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-----~---~~~~~~~i~~~-~~ 231 (309)
T d1u5ra_ 166 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----N---AMSALYHIAQN-ES 231 (309)
T ss_dssp SSB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----C---HHHHHHHHHHS-CC
T ss_pred CCC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-----C---HHHHHHHHHhC-CC
Confidence 432 23569999999999864 46899999999999999999999998531 1 11111111111 11
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.... +...++.+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~--------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 PALQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCS--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC--------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1111 1233457899999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=389.35 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=199.0
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc-CCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE-TEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~lV 242 (468)
++|++.+.||+|+||.||+|.++ |+.||||+++... ..++|.+|+.++++++||||++++|+|.+ .+..++|
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 56788899999999999999985 7889999987542 23578999999999999999999999865 4567999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++..+.. .++++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~ey~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp ECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred EeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceec
Confidence 999999999999976432 24899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
... .....+|..|+|||++.++.++.++|||||||++|||+| |+.||... ...... ..+..+...
T Consensus 154 ~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-----~~~~~~----~~i~~~~~~- 219 (262)
T d1byga_ 154 SST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVV----PRVEKGYKM- 219 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-----CGGGHH----HHHTTTCCC-
T ss_pred CCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-----CHHHHH----HHHHcCCCC-
Confidence 432 223457899999999999999999999999999999998 56665321 111111 111111111
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCC
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSS 451 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 451 (468)
+.+...++.+.+|+.+||+.||++|||+.+++++|+.|+..+
T Consensus 220 --------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~ 261 (262)
T d1byga_ 220 --------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261 (262)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence 112334457899999999999999999999999999997653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=393.18 Aligned_cols=270 Identities=25% Similarity=0.333 Sum_probs=202.4
Q ss_pred HHHHHHhcCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeE
Q 012214 157 KELDKATNHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKL 229 (468)
Q Consensus 157 ~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l 229 (468)
.+.+...++|++.+.||+|+||.||+|... +++.||||+++..... ...+.+.+|...+.++ +|+||+.+
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH---HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc---HHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 333344578999999999999999999853 2468999998764443 3456788888888777 79999999
Q ss_pred eeeeccC-CcceeEeeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecC
Q 012214 230 LGCCLET-EVPLLVYEFIPNGTLYQHLHDRHQN-----------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRD 297 (468)
Q Consensus 230 ~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~D 297 (468)
++++.+. ...++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+++ |+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 9998654 4689999999999999999764321 1235899999999999999999999999 99999
Q ss_pred CCCCCEEEcCCCcEEEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCC-CCCC
Q 012214 298 IKSTNILLDQRYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKK-PIFW 375 (468)
Q Consensus 298 Lkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~-p~~~ 375 (468)
|||+||||++++.+||+|||+|+........ ......||+.|+|||.+.++.++.++|||||||++|||+||.. ||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876543332 2344679999999999999999999999999999999999755 5532
Q ss_pred CCCCccchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 376 AGNTSQENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
.... ..+......+.... .+...++.+.+++.+||+.||++|||+.|++++|+.|.+
T Consensus 240 -~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 240 -VKID-------EEFCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp -CCCS-------HHHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCHH-------HHHHHHHhcCCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111 11111222111111 122344578999999999999999999999999998864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=394.52 Aligned_cols=257 Identities=23% Similarity=0.440 Sum_probs=201.2
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCc----EEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGR----IIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEV 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 238 (468)
++|++.+.||+|+||+||+|.+. +|+ .||+|+++..... ...++|.+|+.++++++|||||+++|+|.+. .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP---KANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 45889999999999999999864 343 5899988653222 3456899999999999999999999999865 5
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++++|++.+|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGl 157 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGL 157 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred eeEEEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecccc
Confidence 678899999999999887632 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 319 SKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 319 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
|+......... .....||+.|+|||.+.++.++.++|||||||++|||+| |..||... .. ......+...
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~--~~---~~~~~~i~~~--- 229 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PA---SEISSILEKG--- 229 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--CG---GGHHHHHHHT---
T ss_pred ceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC--CH---HHHHHHHHcC---
Confidence 98775443332 334568999999999999999999999999999999999 77776431 11 1111111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
..+ ..+..+++.+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 230 ~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 230 ERL----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CCC----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC----------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 111 1123445578999999999999999999999999987753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-49 Score=390.43 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=205.9
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
-++|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+.+..++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE----SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH----HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch----hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 368999999999999999999964 689999999876432 234678899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc--CCCcEEEEecCCc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD--QRYRAKVADFGTS 319 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~--~~~~~kl~DfGla 319 (468)
||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|
T Consensus 101 vmE~~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a 173 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 173 (350)
T ss_dssp EECCCCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEcCCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchh
Confidence 999999999999986422 35999999999999999999999999 99999999999996 4688999999999
Q ss_pred ccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcc-c
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKN-R 398 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~ 398 (468)
+.+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... . . ...+....... .
T Consensus 174 ~~~~~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~---~---~~~~~~i~~~~~~ 243 (350)
T d1koaa2 174 AHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--N---D---DETLRNVKSCDWN 243 (350)
T ss_dssp EECCTTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--S---H---HHHHHHHHHTCCC
T ss_pred eecccccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC--C---H---HHHHHHHHhCCCC
Confidence 87654433 33457999999999999999999999999999999999999998431 1 1 11111111111 1
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
... ......++.+.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 MDD--------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp SCC--------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCc--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 110 1122344578999999999999999999999873
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=380.56 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=197.5
Q ss_pred cCCCCCceeeecCcEEEEEEEecC--C--cEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLED--G--RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~--g--~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
++|++.+.||+|+||.||+|++.. + ..||||++....... ....++|.+|+.++++++||||++++|++.+ ...
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 568889999999999999998542 2 368999886543222 2455789999999999999999999999976 467
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++|++.+++.... .++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred heeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhh
Confidence 89999999999999887643 25999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCcee--eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 320 KFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 320 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
+......... .....||..|+|||.+.+..++.++|||||||++|||+| |+.||... ..........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--------~~~~~~~~i~~~ 230 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--------NGSQILHKIDKE 230 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTS
T ss_pred hhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--------CHHHHHHHHHhC
Confidence 9775443322 334568889999999999999999999999999999998 89997421 111111222222
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcc
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIR 448 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~ 448 (468)
+... +.+...+..+.+|+.+||+.||++|||+.||.+.|++++
T Consensus 231 ~~~~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 231 GERL---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp CCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCC---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 1111 112234457899999999999999999999999998753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=382.93 Aligned_cols=255 Identities=26% Similarity=0.340 Sum_probs=205.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchH--HHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDE--ELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
.++|.+.+.||+|+||+||+|+.. +|+.||||++....... .....+.+.+|+.++++++|||||++++++.+....
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999974 68999999886432211 112346789999999999999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC----cEEEEe
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY----RAKVAD 315 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~----~~kl~D 315 (468)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecc
Confidence 99999999999999997643 5999999999999999999999999 99999999999998876 599999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
||+|+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... .. .........
T Consensus 161 fG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~~------~~~~~~i~~ 230 (293)
T d1jksa_ 161 FGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--TK------QETLANVSA 230 (293)
T ss_dssp CTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SH------HHHHHHHHT
T ss_pred hhhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC--CH------HHHHHHHHh
Confidence 999987654322 33456899999999999999999999999999999999999998531 11 111111111
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.... . ....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 231 -~~~~-~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 231 -VNYE-F-----EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -TCCC-C-----CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -cCCC-C-----CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1100 0 00112234457889999999999999999999975
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-50 Score=388.74 Aligned_cols=267 Identities=26% Similarity=0.388 Sum_probs=214.6
Q ss_pred HhcCCCCCceeeecCcEEEEEEEe------cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeec
Q 012214 162 ATNHFNANRILGQGGQGTVYKGML------EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCL 234 (468)
Q Consensus 162 ~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~ 234 (468)
..++|++.+.||+|+||.||+|++ .+++.||||+++..... ....+|.+|+.+++.+ +|||||+++|+|.
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL---TEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH---HHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 347888999999999999999985 24678999999765443 3456799999999999 7999999999999
Q ss_pred cCCcceeEeeecCCCChhhHhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCC
Q 012214 235 ETEVPLLVYEFIPNGTLYQHLHDRHQN-------------EEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKST 301 (468)
Q Consensus 235 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~ 301 (468)
+....++||||+++|+|.+++...... ....+++..+..++.||++||+|||+++ ++||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccc
Confidence 999999999999999999999764321 2236899999999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEecCCcccccCCCc-eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCc
Q 012214 302 NILLDQRYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTS 380 (468)
Q Consensus 302 NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~ 380 (468)
|||++.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+|+..|+.......
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987765433 33445679999999999999999999999999999999999655553322111
Q ss_pred cchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 381 QENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
. .+......+. ....+...+..+.+|+.+||+.||++|||+.||+++|+++...
T Consensus 255 ~-------~~~~~i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 S-------KFYKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp H-------HHHHHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-------HHHHHHhcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 1 1111111111 1111223445799999999999999999999999999876543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.7e-49 Score=378.07 Aligned_cols=263 Identities=25% Similarity=0.371 Sum_probs=204.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC----
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 237 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~---- 237 (468)
.++|++.+.||+|+||+||+|.. .+|+.||||+++...... ....+.|.+|+.+++.++||||+++++++...+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD-PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 46799999999999999999996 479999999987643322 244567999999999999999999999987644
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG 317 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfG 317 (468)
..++||||+++++|.+++.... ++++.++..++.||+.||+|||+.+ |+||||||+|||++.++..+|+|||
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCT
T ss_pred eEEEEEECCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhh
Confidence 3789999999999999887643 4899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCc--eeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 318 TSKFIAMDQT--HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 318 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
.+........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||... . ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--~------~~~~~~~~~~ 228 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--S------PVSVAYQHVR 228 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--S------HHHHHHHHHH
T ss_pred hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc--C------HHHHHHHHHh
Confidence 9876543222 2234567999999999999999999999999999999999999998431 1 1111222222
Q ss_pred ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhccc
Q 012214 396 KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-TMEEVSMELNGIRG 449 (468)
Q Consensus 396 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~i~~ 449 (468)
...... .......++.+.+++.+||+.||++|| |++++++.|.++++
T Consensus 229 ~~~~~~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 229 EDPIPP-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp CCCCCG-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred cCCCCC-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 221110 011223445789999999999999999 89999999988753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=385.34 Aligned_cols=270 Identities=26% Similarity=0.367 Sum_probs=216.5
Q ss_pred HHHHhcCCCCCceeeecCcEEEEEEEec------CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeee
Q 012214 159 LDKATNHFNANRILGQGGQGTVYKGMLE------DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGC 232 (468)
Q Consensus 159 i~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~ 232 (468)
++...++|.+.+.||+|+||+||+|.+. +++.||||+++..... .....|.+|+.++++++||||++++|+
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM---RERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH---HHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh---HHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 3344578899999999999999999863 3578999998764433 345679999999999999999999999
Q ss_pred eccCCcceeEeeecCCCChhhHhhhccc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC
Q 012214 233 CLETEVPLLVYEFIPNGTLYQHLHDRHQ-----NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ 307 (468)
Q Consensus 233 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~ 307 (468)
|......++||||+++|+|.+++..... .....+++..+..++.|+++||.|||+++ |+||||||+|||+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 168 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecC
Confidence 9999999999999999999999875321 12235799999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCCcccccCCCcee-eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCC-CCCCCCCCCccchhc
Q 012214 308 RYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK-KPIFWAGNTSQENVS 385 (468)
Q Consensus 308 ~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~-~p~~~~~~~~~~~~~ 385 (468)
++++||+|||+|+......... .....||+.|+|||.+.++.++.++||||||+++|||+||. .||.. ..
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~--------~~ 240 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--------LS 240 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--------SC
T ss_pred CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC--------CC
Confidence 9999999999998765443333 33346899999999999999999999999999999999986 44421 11
Q ss_pred hHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCc
Q 012214 386 LAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452 (468)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 452 (468)
..+.+.. +..+.... .+...++.+.+++.+||+.||++|||+.+|+++|++..+...
T Consensus 241 ~~~~~~~-i~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~ 297 (308)
T d1p4oa_ 241 NEQVLRF-VMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297 (308)
T ss_dssp HHHHHHH-HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred HHHHHHH-HHhCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 1111211 11111111 122344579999999999999999999999999998876553
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.2e-49 Score=388.79 Aligned_cols=250 Identities=20% Similarity=0.317 Sum_probs=205.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+....++|
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP----LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH----HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 57999999999999999999964 699999999876432 2235688999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEc--CCCcEEEEecCCcc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLD--QRYRAKVADFGTSK 320 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~--~~~~~kl~DfGla~ 320 (468)
|||+++|+|.+.+... ..++++..+..|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+
T Consensus 105 mE~~~gg~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~ 177 (352)
T d1koba_ 105 LEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLAT 177 (352)
T ss_dssp EECCCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEcCCCChHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccce
Confidence 9999999999887542 235999999999999999999999999 99999999999998 67899999999998
Q ss_pred cccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc-ccc
Q 012214 321 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK-NRL 399 (468)
Q Consensus 321 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 399 (468)
....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||... ... ..+...... ...
T Consensus 178 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~---~~~~~i~~~~~~~ 247 (352)
T d1koba_ 178 KLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-----DDL---ETLQNVKRCDWEF 247 (352)
T ss_dssp ECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHH---HHHHHHHHCCCCC
T ss_pred ecCCCCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-----CHH---HHHHHHHhCCCCC
Confidence 7765433 33456899999999999999999999999999999999999998431 111 111111111 111
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.. ......++.+.+|+.+||+.||.+|||+.|+++
T Consensus 248 ~~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 DE--------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CS--------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred Cc--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 111234457899999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=383.94 Aligned_cols=255 Identities=29% Similarity=0.458 Sum_probs=203.8
Q ss_pred CceeeecCcEEEEEEEecCC----cEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc-CCcceeEe
Q 012214 169 NRILGQGGQGTVYKGMLEDG----RIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE-TEVPLLVY 243 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~~g----~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~lV~ 243 (468)
.++||+|+||+||+|.+.++ ..||||+++..... ...++|.+|+.++++++||||++++|++.+ +...++||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI---GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCH---HHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCH---HHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 46799999999999996432 35899998754333 456789999999999999999999999875 45789999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 109 E~~~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 181 (311)
T ss_dssp ECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred EEeecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcc
Confidence 9999999999987532 35788999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCcee---eecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccc
Q 012214 324 MDQTHV---TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLH 400 (468)
Q Consensus 324 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (468)
...... .....||..|+|||.+.++.++.++||||||+++|||+||+.||....+. ...... ...+...
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~----~~~~~~----i~~g~~~ 253 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FDITVY----LLQGRRL 253 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHH----HHTTCCC
T ss_pred ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH----HHHHHH----HHcCCCC
Confidence 433222 23356899999999999999999999999999999999988887532111 111111 1111111
Q ss_pred hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 401 DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 401 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
..+...++.+.+|+.+||+.||++|||+.||++.|++++..
T Consensus 254 ---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 254 ---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11223445789999999999999999999999999999765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=386.20 Aligned_cols=264 Identities=26% Similarity=0.393 Sum_probs=206.3
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCc--EEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeeeccCCcc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGR--IIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~--~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~ 239 (468)
++|++.+.||+|+||.||+|.++ +|. .||||++...... ...++|.+|+.+++++ +|||||+++|+|.+.+..
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh---HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 67888999999999999999965 444 4778877543332 3456799999999999 799999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcc-----------cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC
Q 012214 240 LLVYEFIPNGTLYQHLHDRH-----------QNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR 308 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~ 308 (468)
++||||+++|+|.+++.... ......+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 163 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCC
Confidence 99999999999999997532 122346999999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHH
Q 012214 309 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAA 388 (468)
Q Consensus 309 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~ 388 (468)
+.+||+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|..|+... . ....
T Consensus 164 ~~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-~------~~~~ 234 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-M------TCAE 234 (309)
T ss_dssp GCEEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-C------CHHH
T ss_pred CceEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC-C------CHHH
Confidence 9999999999976543222 22345899999999999999999999999999999999976653221 1 1111
Q ss_pred HHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccCCc
Q 012214 389 YFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGSSK 452 (468)
Q Consensus 389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 452 (468)
+...+..+.. ...+...++.+.+|+.+||+.||++||||.||++.|+++....+
T Consensus 235 -~~~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 235 -LYEKLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp -HHHHGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred -HHHHHHhcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 1111211111 11123345689999999999999999999999999999875543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=385.79 Aligned_cols=263 Identities=26% Similarity=0.374 Sum_probs=207.7
Q ss_pred hcCCCCCceeeecCcEEEEEEEecC--------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhc-CCCceeeEeeee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLED--------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI-NHRNVVKLLGCC 233 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~ 233 (468)
.++|.+.+.||+|+||.||+|+... +..||||+++..... ....++.+|+..+.++ +|||||+++++|
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE---KDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh---HHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 3678889999999999999998532 347999999775544 4457789999999888 899999999999
Q ss_pred ccCCcceeEeeecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCC
Q 012214 234 LETEVPLLVYEFIPNGTLYQHLHDRHQ-----------NEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTN 302 (468)
Q Consensus 234 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~N 302 (468)
.+....++||||+++|+|.+++..+.. .....+++.+++.++.||+.||+|||+.+ ||||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccc
Confidence 999999999999999999999976432 12346899999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCCce-eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 012214 303 ILLDQRYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFWAGNTS 380 (468)
Q Consensus 303 ILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~t-G~~p~~~~~~~~ 380 (468)
||++.++.+||+|||+++........ ......+|+.|+|||.+.++.++.++|||||||++|||++ |..||.. ..
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~--~~- 242 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--VP- 242 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--CC-
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC--CC-
Confidence 99999999999999999877544332 2344568999999999999999999999999999999998 6777632 11
Q ss_pred cchhchHHHHHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 381 QENVSLAAYFVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
... ....+..+... ..+...++.+.+|+.+||+.||++|||+.||++.|++|..
T Consensus 243 -----~~~-~~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 243 -----VEE-LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -----HHH-HHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHH-HHHHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 111 11222222111 1123345579999999999999999999999999988753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=383.91 Aligned_cols=250 Identities=26% Similarity=0.313 Sum_probs=205.6
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|.+.+.||+|+||.||+|+.+ +|+.||||++...... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc-CHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 67999999999999999999964 7999999998653211 113456788999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+..
T Consensus 84 ~ey~~gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred eeccCCCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccc
Confidence 99999999999997743 4899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ...+.. .....+
T Consensus 156 ~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-----~---~~~~~~-i~~~~~--- 222 (337)
T d1o6la_ 156 ISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----H---ERLFEL-ILMEEI--- 222 (337)
T ss_dssp CCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHH-HHHCCC---
T ss_pred ccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-----H---HHHHHH-HhcCCC---
Confidence 43322 2344679999999999999999999999999999999999999985311 1 111111 111111
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT-----MEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 442 (468)
..+...++++.+|+.+||+.||++||+ ++|+++
T Consensus 223 -------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 -------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 112234457889999999999999995 777765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-48 Score=380.11 Aligned_cols=246 Identities=27% Similarity=0.394 Sum_probs=203.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||+||+|+.+ +|+.||||+++..... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 56899999999999999999964 6899999998643211 113456789999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 83 mE~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp ECCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred eeecCCccccccccccc-----cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEe
Confidence 99999999999887643 4788999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc-cccch
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK-NRLHD 401 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 401 (468)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... . ........... ...
T Consensus 155 ~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-----~---~~~~~~~i~~~~~~~-- 220 (316)
T d1fota_ 155 PDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-----N---TMKTYEKILNAELRF-- 220 (316)
T ss_dssp SSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----S---HHHHHHHHHHCCCCC--
T ss_pred ccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc-----C---HHHHHHHHHcCCCCC--
Confidence 533 23457999999999999999999999999999999999999998531 1 11111111111 111
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
+...++.+.+++.+||+.||.+|| |++++++
T Consensus 221 ----------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 221 ----------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 223345788999999999999996 8898875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.2e-48 Score=369.36 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=204.0
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccch-----HHHHHHHHHHHHHHHHHhcC-CCceeeEeeeeccC
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDD-----EELLKLEEFINEIVILSQIN-HRNVVKLLGCCLET 236 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~-----~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~ 236 (468)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ......+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6789999999999999999996 47899999998653321 11223456889999999997 99999999999999
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
+..++||||+++|+|.+++.... ++++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cceEEEEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence 99999999999999999997633 5999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCceeeecccccCCccCcccccc------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHH
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS------SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYF 390 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~ 390 (468)
|+++....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||... ..... .
T Consensus 155 G~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~-----~~~~~---~ 224 (277)
T d1phka_ 155 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-----KQMLM---L 224 (277)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHH---H
T ss_pred hheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC-----CHHHH---H
Confidence 99987654332 344579999999998863 35688999999999999999999998531 11111 1
Q ss_pred HHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 391 VHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
..... .... . ........++.+.+|+.+||+.||++|||+.|+++
T Consensus 225 ~~i~~-~~~~-~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 225 RMIMS-GNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHH-TCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHh-CCCC-C-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111 1110 0 01112245568999999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=375.58 Aligned_cols=271 Identities=21% Similarity=0.284 Sum_probs=200.9
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC----cc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE----VP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----~~ 239 (468)
.+|.+.+.||+|+||.||+|++ +|+.||||++..... ....+..|+..+.+++||||++++++|.+.+ ..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4567778899999999999997 589999999865321 1112234555666789999999999997654 57
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCEEecCCCCCCEEEcCCCcEEEE
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT-----SSPIYHRDIKSTNILLDQRYRAKVA 314 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~iiH~DLkp~NILl~~~~~~kl~ 314 (468)
++||||+++|+|.+++++. +++|..++.++.|+|.||+|||+.. .++|+||||||+||||+.++.+||+
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEEecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 8999999999999999762 4899999999999999999999741 2339999999999999999999999
Q ss_pred ecCCcccccCCCcee---eecccccCCccCccccccC------CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccc---
Q 012214 315 DFGTSKFIAMDQTHV---TTKIQGTFGYLDPEYHQSS------QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQE--- 382 (468)
Q Consensus 315 DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~--- 382 (468)
|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||+||..|+.........
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence 999998775543322 3346799999999998764 2677899999999999999998887432211110
Q ss_pred ---hhchHHHHHHHhhccccc-hhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhcccC
Q 012214 383 ---NVSLAAYFVHSMRKNRLH-DILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRGS 450 (468)
Q Consensus 383 ---~~~~~~~~~~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 450 (468)
..............+... .+.+ .....+....+.+|+.+||+.||++|||+.||++.|++|...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~p~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVCEQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCG----GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHhccccCCCCCc----ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 001111122222221111 1111 111234556799999999999999999999999999988754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-48 Score=379.58 Aligned_cols=247 Identities=24% Similarity=0.322 Sum_probs=204.0
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||.||+|.++ +|+.||||++..... ......+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc-cCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 57999999999999999999974 699999998864221 1113456789999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+||+.+|+|..++.... .+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+..
T Consensus 120 ~e~~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cccccccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 99999999999997643 4899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||... .. ......... ....
T Consensus 192 ~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-----~~---~~~~~~i~~-~~~~-- 256 (350)
T d1rdqe_ 192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-----QP---IQIYEKIVS-GKVR-- 256 (350)
T ss_dssp SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SH---HHHHHHHHH-CCCC--
T ss_pred ccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc-----CH---HHHHHHHhc-CCCC--
Confidence 432 22356999999999999999999999999999999999999998531 11 111111111 1110
Q ss_pred cchHHhhhchHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 012214 403 LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRP-----TMEEVSM 442 (468)
Q Consensus 403 ~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 442 (468)
.+...++.+.+|+.+||+.||.+|+ |++++++
T Consensus 257 --------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 --------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1223445789999999999999994 8888875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-47 Score=380.46 Aligned_cols=251 Identities=21% Similarity=0.255 Sum_probs=197.9
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHH---HHHHHHHhcCCCceeeEeeeeccCCcc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFI---NEIVILSQINHRNVVKLLGCCLETEVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~---~Ei~~l~~l~h~niv~l~g~~~~~~~~ 239 (468)
++|.+.+.||+|+||.||+|+.. +|+.||||++........ .....+. +++.+++.++|||||++++++.+.+..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~-~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH-TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchh-hHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 67999999999999999999965 689999998854221111 1112233 446777788999999999999999999
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCc
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTS 319 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla 319 (468)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred EEEEEecCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeecee
Confidence 99999999999999997643 4889999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR 398 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (468)
+...... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||....... ... .........
T Consensus 155 ~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~-~~~~~~~~~ 225 (364)
T d1omwa3 155 CDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHE-IDRMTLTMA 225 (364)
T ss_dssp EECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----HHH-HHHHSSSCC
T ss_pred eecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-----HHH-HHHhcccCC
Confidence 8765432 234579999999999875 568999999999999999999999985421111 111 111111111
Q ss_pred cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 012214 399 LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT-----MEEVSM 442 (468)
Q Consensus 399 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 442 (468)
. ..+...++.+.+|+.+||+.||++||| ++|+++
T Consensus 226 ~----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 V----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp C----------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred C----------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0 012234457899999999999999999 677764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=372.68 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=203.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCccee
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 241 (468)
.++|.+.+.||+|+||+||+|... +++.||||+++.... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-----DQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 367899999999999999999965 688999999876432 22457899999999999999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC--CcEEEEecCCc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR--YRAKVADFGTS 319 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~--~~~kl~DfGla 319 (468)
||||+++|+|.+++.... .++++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||++
T Consensus 79 vmE~~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EECCCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchh
Confidence 999999999999996532 35899999999999999999999999 9999999999999854 58999999999
Q ss_pred ccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhcccc
Q 012214 320 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRL 399 (468)
Q Consensus 320 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (468)
+....... .....+|+.|+|||.+.+..++.++|||||||++|+|++|..||... .. ...+..... ...
T Consensus 152 ~~~~~~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~-----~~---~~~~~~i~~-~~~ 220 (321)
T d1tkia_ 152 RQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-----TN---QQIIENIMN-AEY 220 (321)
T ss_dssp EECCTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS-----SH---HHHHHHHHH-TCC
T ss_pred hccccCCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC-----CH---HHHHHHHHh-CCC
Confidence 87644332 33356899999999999999999999999999999999999998531 11 111111111 111
Q ss_pred chhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 400 HDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 400 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
. ++.. .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 221 ~--~~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 221 T--FDEE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp C--CCHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--CChh----hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0010 11223457899999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-48 Score=375.27 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=201.5
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHH-hcCCCceeeEeeeeccCCccee
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILS-QINHRNVVKLLGCCLETEVPLL 241 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~-~l~h~niv~l~g~~~~~~~~~l 241 (468)
++|.+.+.||+|+||+||+|+.. +|+.||||+++..... .....+.+..|..++. .++||||+++++++.+.+..++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~-~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhcc-ChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 57889999999999999999965 6899999998643211 1123456777777665 6899999999999999999999
Q ss_pred EeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012214 242 VYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKF 321 (468)
Q Consensus 242 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~ 321 (468)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 81 vmEy~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeecCCCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhh
Confidence 999999999999997643 4899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccch
Q 012214 322 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHD 401 (468)
Q Consensus 322 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (468)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... . .. ... ........
T Consensus 153 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~--~---~~---~~~-~~i~~~~~-- 220 (320)
T d1xjda_ 153 NMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--D---EE---ELF-HSIRMDNP-- 220 (320)
T ss_dssp CCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--S---HH---HHH-HHHHHCCC--
T ss_pred cccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC--C---HH---HHH-HHHHcCCC--
Confidence 544332 234457999999999999999999999999999999999999998531 1 11 111 11111111
Q ss_pred hcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 012214 402 ILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTME-EVSM 442 (468)
Q Consensus 402 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-evl~ 442 (468)
..+...++.+.+|+.+||+.||++|||+. |+++
T Consensus 221 --------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 --------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 01223345789999999999999999995 6653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=376.26 Aligned_cols=252 Identities=21% Similarity=0.302 Sum_probs=196.5
Q ss_pred hcCCCCCc-eeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHh-cCCCceeeEeeeecc----
Q 012214 163 TNHFNANR-ILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQ-INHRNVVKLLGCCLE---- 235 (468)
Q Consensus 163 ~~~f~~~~-~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~-l~h~niv~l~g~~~~---- 235 (468)
.++|.+.+ .||+|+||+||+|.. .+++.||||+++.. ..+.+|+.++.+ .+|||||++++++.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 36787764 599999999999996 46899999998642 245679988655 489999999999865
Q ss_pred CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC---CCcEE
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ---RYRAK 312 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~---~~~~k 312 (468)
....++|||||++|+|.+++..+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+|
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~K 154 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK 154 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEE
T ss_pred CCEEEEEEECCCCCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccc
Confidence 467899999999999999997632 236999999999999999999999999 999999999999985 56799
Q ss_pred EEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHH
Q 012214 313 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVH 392 (468)
Q Consensus 313 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 392 (468)
|+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||....... .......
T Consensus 155 l~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-----~~~~~~~ 227 (335)
T d2ozaa1 155 LTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKT 227 (335)
T ss_dssp ECCCTTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------
T ss_pred ccccceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-----HHHHHHH
Confidence 999999987654333 334579999999999999999999999999999999999999995321111 0011111
Q ss_pred HhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 393 SMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 393 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
....... .+. .......++++.+|+.+||+.||++|||+.|+++
T Consensus 228 ~i~~~~~-~~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 228 RIRMGQY-EFP-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CCCSCSS-SCC-----TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCC-CCC-----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111110 000 0112234567999999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=370.05 Aligned_cols=259 Identities=24% Similarity=0.223 Sum_probs=192.6
Q ss_pred CceeeecCcEEEEEEEec-CCcEEEEEecccccchHHH-HHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEeeec
Q 012214 169 NRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEEL-LKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVYEFI 246 (468)
Q Consensus 169 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 246 (468)
.++||+|+||+||+|.+. +|+.||||+++........ ...+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 467999999999999964 6899999998654322111 12346889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccccCCC
Q 012214 247 PNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIAMDQ 326 (468)
Q Consensus 247 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 326 (468)
.++++..+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 88776665543 235888999999999999999999999 9999999999999999999999999998665433
Q ss_pred ceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchhc--
Q 012214 327 THVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDIL-- 403 (468)
Q Consensus 327 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 403 (468)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++|..||... . ...................+.
T Consensus 155 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~--~---~~~~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 155 RA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD--S---DLDQLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp CC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS--S---HHHHHHHHHHHHCCCCTTTSSST
T ss_pred cc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC--C---HHHHHHHHHHhcCCCChhhccch
Confidence 22 233569999999998875 46799999999999999999999998531 1 111111111111111000000
Q ss_pred -------------chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 404 -------------DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 404 -------------d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
...+ .......++.+.+|+.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 229 CSLPDYVTFKSFPGIPL-HHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TSSTTCCCCCCCCCCCH-HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccchhhhhccCCCCCh-HHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000 0001123457899999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.9e-47 Score=364.40 Aligned_cols=263 Identities=21% Similarity=0.265 Sum_probs=199.4
Q ss_pred cCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeEe
Q 012214 164 NHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLVY 243 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 243 (468)
++|.+.++||+|+||+||+|++++|+.||||++....... ...+.+.+|+.++++++||||+++++++.+.+..++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE--GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG--CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcCh--HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 5788999999999999999999899999999987643322 23467899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012214 244 EFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFIA 323 (468)
Q Consensus 244 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~~ 323 (468)
|++.++.+..+.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 80 e~~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG 151 (286)
T ss_dssp ECCSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred EeehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecc
Confidence 999876665555332 35999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccccchh
Q 012214 324 MDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNRLHDI 402 (468)
Q Consensus 324 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (468)
.... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.... ....................
T Consensus 152 ~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~ 225 (286)
T d1ob3a_ 152 IPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS-----EADQLMRIFRILGTPNSKNW 225 (286)
T ss_dssp C----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTS
T ss_pred cCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC-----HHHHHHHHHHhhCCCChhhc
Confidence 4322 2233458999999999876 456899999999999999999999985311 11111111111111100000
Q ss_pred cch---------------HHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 403 LDD---------------QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 403 ~d~---------------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
.+. ..........++.+.+|+.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0001112234567899999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-47 Score=365.60 Aligned_cols=270 Identities=23% Similarity=0.302 Sum_probs=201.1
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||+||+|.. .+|+.||||+++..... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC--hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 5789999999999999999996 47899999998654322 12346789999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
|||+.+ ++.+++... ....+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+..
T Consensus 80 ~e~~~~-~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF 152 (298)
T ss_dssp EECCSE-EHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred EeecCC-chhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceec
Confidence 999965 555555442 2235999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCC-CCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh--cccc
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR--KNRL 399 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 399 (468)
..... ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||... . .............. ....
T Consensus 153 ~~~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~--~--~~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 153 GVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD--S--EIDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp CCCSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS--S--HHHHHHHHHHHHCCCCTTTS
T ss_pred cCCcc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC--C--HHHHHHHHHHhcCCCchhhc
Confidence 54332 233356999999999877755 578999999999999999999998531 1 11111111111000 0000
Q ss_pred chh-------------cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhcc
Q 012214 400 HDI-------------LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME--LNGIR 448 (468)
Q Consensus 400 ~~~-------------~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~ 448 (468)
... ..... .......++.+.+|+.+||+.||++|||+.|+++. ++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCH-HHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccccccccccccccccch-hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 000 00000 00112334578999999999999999999999874 55543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=364.49 Aligned_cols=271 Identities=23% Similarity=0.311 Sum_probs=198.2
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-C-CcEEEEEecccccchHHHHHHHHHHHHHHHHHhc---CCCceeeEeeeecc--
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-D-GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQI---NHRNVVKLLGCCLE-- 235 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~-- 235 (468)
.++|++.+.||+|+||+||+|++. + ++.||||+++...... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc--hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 478999999999999999999963 3 6779999986543221 1122455677766655 89999999999853
Q ss_pred ---CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEE
Q 012214 236 ---TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAK 312 (468)
Q Consensus 236 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~k 312 (468)
....++++||++++++...... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~k 156 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIK 156 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred cccCceEEEEEEeccCCchhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCee
Confidence 3467899999988766544432 2235899999999999999999999999 99999999999999999999
Q ss_pred EEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHH
Q 012214 313 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVH 392 (468)
Q Consensus 313 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 392 (468)
|+|||+++...... ......||+.|+|||++.+.+++.++||||+||++|||++|+.||... . ..........
T Consensus 157 l~dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~--~---~~~~~~~i~~ 229 (305)
T d1blxa_ 157 LADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS--S---DVDQLGKILD 229 (305)
T ss_dssp ECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--S---HHHHHHHHHH
T ss_pred ecchhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC--C---HHHHHHHHHH
Confidence 99999987654332 234467999999999999999999999999999999999999998531 1 1111111111
Q ss_pred Hhhccccchhc------ch-------HHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhccc
Q 012214 393 SMRKNRLHDIL------DD-------QLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME--LNGIRG 449 (468)
Q Consensus 393 ~~~~~~~~~~~------d~-------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~~ 449 (468)
.........+. .. ..........++.+.+|+.+||+.||++|||+.|+++. ++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred hhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 11100000000 00 00011122344578899999999999999999999863 555543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=359.29 Aligned_cols=244 Identities=27% Similarity=0.427 Sum_probs=195.1
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchH--HHHHHHHHHHHHHHHHhcC--CCceeeEeeeeccCC
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDE--ELLKLEEFINEIVILSQIN--HRNVVKLLGCCLETE 237 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~~~ 237 (468)
.++|++.+.||+|+||+||+|+.. +|+.||||++....... .......+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 367999999999999999999964 78999999876432110 0011234668999999996 899999999999999
Q ss_pred cceeEeeecCC-CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCC-CcEEEEe
Q 012214 238 VPLLVYEFIPN-GTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQR-YRAKVAD 315 (468)
Q Consensus 238 ~~~lV~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~-~~~kl~D 315 (468)
..++||||+.+ +++.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECc
Confidence 99999999976 57777776532 4899999999999999999999999 9999999999999854 7999999
Q ss_pred cCCcccccCCCceeeecccccCCccCccccccCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
||+|+..... ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||.. .+ ...
T Consensus 155 FG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-----~~---------~i~ 217 (273)
T d1xwsa_ 155 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-----DE---------EII 217 (273)
T ss_dssp CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS-----HH---------HHH
T ss_pred cccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC-----ch---------HHh
Confidence 9999865432 2334579999999999988765 5678999999999999999999843 00 001
Q ss_pred hccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 395 RKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 395 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
+. .. ..+...++++.+|+.+||+.||++|||+.|+++
T Consensus 218 ~~-~~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 218 RG-QV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HC-CC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hc-cc----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 10 00 011223457899999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-44 Score=350.90 Aligned_cols=262 Identities=19% Similarity=0.261 Sum_probs=198.8
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCce-eeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNV-VKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~ 240 (468)
.++|++.+.||+|+||.||+|++ .+|+.||||++...... +++..|+++++.++|+|+ +.+.++..+.+..+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC------HHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 46799999999999999999996 46899999987654322 347789999999976665 45556667778889
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC---CCcEEEEecC
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ---RYRAKVADFG 317 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~---~~~~kl~DfG 317 (468)
+||||+ +++|...+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||
T Consensus 80 ivme~~-~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp EEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred EEEEEc-CCchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccC
Confidence 999999 567777665422 35899999999999999999999999 999999999999864 5679999999
Q ss_pred CcccccCCCce------eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHH
Q 012214 318 TSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFV 391 (468)
Q Consensus 318 la~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~ 391 (468)
+|+.+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ........
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~--~~~~~~~~ 229 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--RQKYERIS 229 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---------HHHHH
T ss_pred cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHH--HHHHHHhh
Confidence 99977543322 23345799999999999999999999999999999999999999854221111 11110000
Q ss_pred HHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 392 HSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
......... ......++++.+++.+||+.+|++||++.++.+.|+.+..
T Consensus 230 ~~~~~~~~~---------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 230 EKKMSTPIE---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHHSCHH---------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred cccCCCChh---------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 000000000 0112344578999999999999999999999999887643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=356.14 Aligned_cols=264 Identities=21% Similarity=0.287 Sum_probs=195.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC----
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 237 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~---- 237 (468)
+++|++.++||+|+||+||+|.. .+|+.||||++...... ...+.+.+|+.++++++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ---TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH---HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh---HHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 46799999999999999999986 47999999998754333 44567899999999999999999999986543
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFG 317 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfG 317 (468)
..+++++++.+|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG 154 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 154 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccC
Confidence 234556667799999999652 4899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCce--eeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 318 TSKFIAMDQTH--VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 318 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
+++........ ......||+.|+|||.+.. ..++.++||||+||++|||++|+.||.... . ...........
T Consensus 155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~--~---~~~~~~~~~~~ 229 (345)
T d1pmea_ 155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH--Y---LDQLNHILGIL 229 (345)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS--H---HHHHHHHHHHH
T ss_pred ceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC--H---HHHHHHHhhhc
Confidence 99876443222 1334569999999999855 567889999999999999999999985311 1 10111111100
Q ss_pred hccccch---hcchHH--------------hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 012214 395 RKNRLHD---ILDDQL--------------MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME 443 (468)
Q Consensus 395 ~~~~~~~---~~d~~l--------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 443 (468)
....... ...... ........+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 000000 000011223468899999999999999999999973
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=355.92 Aligned_cols=265 Identities=21% Similarity=0.265 Sum_probs=193.2
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc------
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE------ 235 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------ 235 (468)
.++|++.++||+|+||+||+|+. .+|+.||||++....... ...+.+.+|+.++++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT--SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 37899999999999999999996 479999999886543221 234568899999999999999999998855
Q ss_pred --CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEE
Q 012214 236 --TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKV 313 (468)
Q Consensus 236 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl 313 (468)
....++||||+.++.+...... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl 158 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKL 158 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEE
T ss_pred ccCceEEEEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEe
Confidence 3457899999987666544432 235889999999999999999999999 999999999999999999999
Q ss_pred EecCCcccccCCCcee---eecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHH
Q 012214 314 ADFGTSKFIAMDQTHV---TTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAY 389 (468)
Q Consensus 314 ~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~ 389 (468)
+|||+++......... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||... ........
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~-----~~~~~~~~ 233 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-----TEQHQLAL 233 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHH
T ss_pred eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC-----CHHHHHHH
Confidence 9999998765433221 2234699999999998764 6899999999999999999999998531 11111111
Q ss_pred HHHHhhc---cccchhcchH--------------Hh-hhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 390 FVHSMRK---NRLHDILDDQ--------------LM-KLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 390 ~~~~~~~---~~~~~~~d~~--------------l~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
....... .......... .. ........+.+.+|+.+||+.||++|||++|+++
T Consensus 234 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 1111110 0000000000 00 0001122346789999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=355.71 Aligned_cols=264 Identities=22% Similarity=0.300 Sum_probs=195.7
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCC----
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETE---- 237 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~---- 237 (468)
.++|++.+.||+|+||+||+|... +|+.||||+++...... ...+.+.+|+.++++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE--LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH--HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcCh--HHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 478999999999999999999964 69999999987543332 34567899999999999999999999997654
Q ss_pred --cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 012214 238 --VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVAD 315 (468)
Q Consensus 238 --~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~D 315 (468)
..++||||+ +.+|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~D 164 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILD 164 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred cceEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccc
Confidence 468999999 5677776654 24999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh
Q 012214 316 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM 394 (468)
Q Consensus 316 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 394 (468)
||+|+..... .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||... .............
T Consensus 165 fg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~-----~~~~~~~~~~~~~ 235 (346)
T d1cm8a_ 165 FGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS-----DHLDQLKEIMKVT 235 (346)
T ss_dssp CTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHHH
T ss_pred ccceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC-----ChHHHHHHHHhcc
Confidence 9999865433 234569999999999876 45789999999999999999999998531 1111111111100
Q ss_pred hccc------------------cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhcc
Q 012214 395 RKNR------------------LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSME--LNGIR 448 (468)
Q Consensus 395 ~~~~------------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~i~ 448 (468)
.... ........+ .......++.+.+|+.+||+.||++|||+.|+++. |+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCcHHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000 000000000 00112334578899999999999999999999973 65554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-44 Score=346.70 Aligned_cols=262 Identities=17% Similarity=0.224 Sum_probs=205.5
Q ss_pred hcCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCC-CceeeEeeeeccCCcce
Q 012214 163 TNHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH-RNVVKLLGCCLETEVPL 240 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~ 240 (468)
.++|++.+.||+|+||+||+|++. +|+.||||++...... ..+.+|++.++.++| +|++.+++++.+....+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 478999999999999999999965 6899999987653222 346678889999865 89999999999999999
Q ss_pred eEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcC-----CCcEEEEe
Q 012214 241 LVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQ-----RYRAKVAD 315 (468)
Q Consensus 241 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~-----~~~~kl~D 315 (468)
+||||+ +++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|
T Consensus 78 ~vme~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp EEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred EEEEec-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcc
Confidence 999999 689999886532 25899999999999999999999999 999999999999974 57899999
Q ss_pred cCCcccccCCCce------eeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHH
Q 012214 316 FGTSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAY 389 (468)
Q Consensus 316 fGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~ 389 (468)
||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~--~~~~~ 227 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK--QKYER 227 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH--HHHHH
T ss_pred cceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH--HHHHH
Confidence 9999876543221 133457999999999999999999999999999999999999999542221111 11111
Q ss_pred HHHHhhccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhccc
Q 012214 390 FVHSMRKNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSMELNGIRG 449 (468)
Q Consensus 390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 449 (468)
...........+ + ....++++.+++..|++.+|++||+++.+.+.|+++..
T Consensus 228 i~~~~~~~~~~~-----l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 228 IGEKKQSTPLRE-----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHHHHHHSCHHH-----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHhccCCCChHH-----h----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 111111111111 1 12344579999999999999999999999988877643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-45 Score=350.93 Aligned_cols=264 Identities=22% Similarity=0.287 Sum_probs=203.6
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeeccCCcceeE
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 242 (468)
++|++.+.||+|+||+||+|++. +++.||||+++...... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST--THHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCCh--HHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 57899999999999999999964 78999999986543322 3457789999999999999999999999999999999
Q ss_pred eeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012214 243 YEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGTSKFI 322 (468)
Q Consensus 243 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGla~~~ 322 (468)
+|++.+++|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++..
T Consensus 80 ~~~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~ 151 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF 151 (292)
T ss_dssp EECCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eeeccccccccccccc-----cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcc
Confidence 9999998888777543 25889999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCceeeecccccCCccCccccccCC-CCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhccc---
Q 012214 323 AMDQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRKNR--- 398 (468)
Q Consensus 323 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 398 (468)
...... .....++..|+|||.+.+.. ++.++|||||||++|||++|+.||.... ...+ ....+........
T Consensus 152 ~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~-~~~~---~~~~~~~~~~~~~~~~ 226 (292)
T d1unla_ 152 GIPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDD---QLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp CSCCSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-SHHH---HHHHHHHHHCCCCTTT
T ss_pred cCCCcc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC-CHHH---HHHHHHhhcCCCChhh
Confidence 543332 23345778899999887754 6899999999999999999999985322 1111 1111111111100
Q ss_pred cch---h---------cchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 399 LHD---I---------LDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 399 ~~~---~---------~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
... . .............++.+.+|+.+||+.||.+|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0 0000001112234457889999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=357.41 Aligned_cols=265 Identities=25% Similarity=0.314 Sum_probs=194.3
Q ss_pred CCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc------CC
Q 012214 165 HFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE------TE 237 (468)
Q Consensus 165 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------~~ 237 (468)
.|+..++||+|+||+||+|++. +|+.||||++...... +.+|+.++++++||||+++++++.. ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 5778889999999999999975 6899999998654321 3479999999999999999999843 23
Q ss_pred cceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC-cEEEEec
Q 012214 238 VPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY-RAKVADF 316 (468)
Q Consensus 238 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~-~~kl~Df 316 (468)
..++||||++++. .+.+.... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 93 ~~~lv~Ey~~~~~-~~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DF 167 (350)
T d1q5ka_ 93 YLNLVLDYVPETV-YRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDF 167 (350)
T ss_dssp EEEEEEECCSEEH-HHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCC
T ss_pred EEEEEEeccCCcc-HHHHHhhh-hccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecc
Confidence 4689999997654 44443221 12236999999999999999999999999 99999999999999775 8999999
Q ss_pred CCcccccCCCceeeecccccCCccCcccccc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
|+++....... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||.... ....... ......
T Consensus 168 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~----~~~~l~~-i~~~~g 240 (350)
T d1q5ka_ 168 GSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS----GVDQLVE-IIKVLG 240 (350)
T ss_dssp TTCEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS----HHHHHHH-HHHHHC
T ss_pred cchhhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC----HHHHHHH-HHHHhC
Confidence 99987654332 233568999999998775 578999999999999999999999985311 1111111 111000
Q ss_pred ---------------ccccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhccc
Q 012214 396 ---------------KNRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGIRG 449 (468)
Q Consensus 396 ---------------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i~~ 449 (468)
....................++.+.+|+.+||+.||++|||+.|+++ .++.++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred CChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 00000000000011112234557899999999999999999999986 3555543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=357.94 Aligned_cols=256 Identities=27% Similarity=0.327 Sum_probs=201.6
Q ss_pred cCCCCCceeeecCcEEEEEEEec----CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCC-CceeeEeeeeccCCc
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE----DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINH-RNVVKLLGCCLETEV 238 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~ 238 (468)
++|++.+.||+|+||+||+|... +|+.||||+++......+....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 4789999988643221111223567899999999965 899999999999999
Q ss_pred ceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 012214 239 PLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADFGT 318 (468)
Q Consensus 239 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~DfGl 318 (468)
.++++||+.+|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccc
Confidence 999999999999999997743 3778899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCceeeecccccCCccCccccccC--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhhc
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMRK 396 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 396 (468)
++.+............|++.|+|||.+.+. .++.++|||||||+||||++|+.||....... ...........
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~----~~~~i~~~~~~- 250 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISRRILK- 250 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHHHHHH-
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhccc-
Confidence 987755544444556799999999998764 46789999999999999999999985422111 11111111111
Q ss_pred cccchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 012214 397 NRLHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPT-----MEEVSM 442 (468)
Q Consensus 397 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 442 (468)
... ..+...++.+.+|+.+||+.||++||| ++|+++
T Consensus 251 ~~~----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 SEP----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCC----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCC----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 110 112344568999999999999999994 788764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.7e-44 Score=352.49 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=195.2
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeecc--CCcc
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLE--TEVP 239 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~--~~~~ 239 (468)
++|++.++||+|+||+||+|+. .+|+.||||+++... .+.+.+|+.+++.++ ||||+++++++.. ....
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 6799999999999999999996 478999999987532 246789999999995 9999999999864 4568
Q ss_pred eeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCC-cEEEEecCC
Q 012214 240 LLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRY-RAKVADFGT 318 (468)
Q Consensus 240 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~-~~kl~DfGl 318 (468)
++||||+++++|..+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 108 ~~v~e~~~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp EEEEECCCSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred eEEEeecCCCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeeccccc
Confidence 99999999999876642 4899999999999999999999999 99999999999998654 699999999
Q ss_pred cccccCCCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHH--------
Q 012214 319 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAY-------- 389 (468)
Q Consensus 319 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~-------- 389 (468)
|+....... .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||................
T Consensus 177 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~ 254 (328)
T d3bqca1 177 AEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254 (328)
T ss_dssp CEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred ceeccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhh
Confidence 987654332 3345689999999998775 57999999999999999999999985422211100000000
Q ss_pred HHHHhhccc---cchhc--------chHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 390 FVHSMRKNR---LHDIL--------DDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 390 ~~~~~~~~~---~~~~~--------d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
......... ..... ............++++.+|+.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000 00000 000011112234567899999999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=349.00 Aligned_cols=259 Identities=21% Similarity=0.286 Sum_probs=189.6
Q ss_pred cCCCCCceeeecCcEEEEEEEec-CCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc------C
Q 012214 164 NHFNANRILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE------T 236 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------~ 236 (468)
++|++.++||+|+||+||+|.+. +|+.||||++....... .....+.+|+.++++++||||+++++++.. .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCH--HHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 67999999999999999999965 69999999987644332 345678899999999999999999999864 3
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...++||||+.++ +.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++||
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp CEEEEEEECCSEE-HHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred ceeEEEEeccchH-HHHhhhc-------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeech
Confidence 5779999999664 4444432 4899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHh--
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSM-- 394 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~-- 394 (468)
|+++...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||.... ............
T Consensus 164 ~~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~-----~~~~~~~i~~~~~~ 236 (355)
T d2b1pa1 164 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-----YIDQWNKVIEQLGT 236 (355)
T ss_dssp CC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCC
T ss_pred hhhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC-----HHHHHHHHHHhccC
Confidence 9987654322 2344568999999999999999999999999999999999999985311 111111110000
Q ss_pred -----------------hcc------ccchhcchHH---hhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 012214 395 -----------------RKN------RLHDILDDQL---MKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM 442 (468)
Q Consensus 395 -----------------~~~------~~~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 442 (468)
... .......... ........+..+.+|+.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0000000000 01112345678899999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=346.06 Aligned_cols=265 Identities=20% Similarity=0.271 Sum_probs=197.3
Q ss_pred hcCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCceeeEeeeecc-----C
Q 012214 163 TNHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNVVKLLGCCLE-----T 236 (468)
Q Consensus 163 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-----~ 236 (468)
.++|++.+.||+|+||+||+|+. .+|+.||||++....... ...+.+.+|+.++++++|||++++++++.. .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI--IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 46899999999999999999996 479999999987643332 445678899999999999999999999853 3
Q ss_pred CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 012214 237 EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAKVADF 316 (468)
Q Consensus 237 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~kl~Df 316 (468)
...+++++++.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++||
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~df 165 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF 165 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccccccccccccc
Confidence 345677788889999999854 24999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCceeeecccccCCccCccccccC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCccchhchHHHHHHHhh
Q 012214 317 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQENVSLAAYFVHSMR 395 (468)
Q Consensus 317 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 395 (468)
|++...... .....||..|+|||.+.+. .++.++|||||||++|+|++|+.||... +.............
T Consensus 166 g~a~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~-----~~~~~~~~i~~~~~ 236 (348)
T d2gfsa1 166 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-----DHIDQLKLILRLVG 236 (348)
T ss_dssp ----CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHHHC
T ss_pred chhcccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC-----CHHHHHHHHHHhcC
Confidence 998754322 2335689999999987765 4688999999999999999999998531 11111111111110
Q ss_pred ccc------------------cchhcchHHhhhchHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhcc
Q 012214 396 KNR------------------LHDILDDQLMKLGVKNQIMTFANLAKRCLDLNGKKRPTMEEVSM--ELNGIR 448 (468)
Q Consensus 396 ~~~------------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~--~L~~i~ 448 (468)
... ........+. ......++.+.+|+.+||+.||++|||+.|+++ .+.++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 237 TPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CCCHHHHTTCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCChHHhhhccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 000 0000000000 001123457889999999999999999999997 455443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-38 Score=313.65 Aligned_cols=265 Identities=21% Similarity=0.229 Sum_probs=188.1
Q ss_pred cCCCCCceeeecCcEEEEEEEe-cCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-----------CCceeeEee
Q 012214 164 NHFNANRILGQGGQGTVYKGML-EDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-----------HRNVVKLLG 231 (468)
Q Consensus 164 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~g 231 (468)
++|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 3589999999999999999996 479999999987532 22356778888888775 578999998
Q ss_pred eeccC--CcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCEEecCCCCCCEEEcCC
Q 012214 232 CCLET--EVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHS-ATSSPIYHRDIKSTNILLDQR 308 (468)
Q Consensus 232 ~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiH~DLkp~NILl~~~ 308 (468)
++... ...+++++++..+......... .....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIV 162 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEE
T ss_pred Eeeeccccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeecc
Confidence 87643 3456666666554433333221 233468999999999999999999998 77 9999999999999866
Q ss_pred C------cEEEEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCcc-
Q 012214 309 Y------RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFWAGNTSQ- 381 (468)
Q Consensus 309 ~------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll~el~tG~~p~~~~~~~~~- 381 (468)
+ .++++|||.+...... .....||+.|+|||.+.+..++.++||||+||++++|++|+.||........
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcccccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 5 4999999998754322 2345699999999999999999999999999999999999999853211111
Q ss_pred chhchHHHHHHHhhcc----------------------ccchh----cch--HHhhhchHHHHHHHHHHHHHhhccCCCC
Q 012214 382 ENVSLAAYFVHSMRKN----------------------RLHDI----LDD--QLMKLGVKNQIMTFANLAKRCLDLNGKK 433 (468)
Q Consensus 382 ~~~~~~~~~~~~~~~~----------------------~~~~~----~d~--~l~~~~~~~~~~~l~~li~~cl~~dp~~ 433 (468)
................ .+... ... ..........++.+.+|+.+||+.||.+
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 318 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence 0000011110100000 00000 000 0112234566778999999999999999
Q ss_pred CCCHHHHHH
Q 012214 434 RPTMEEVSM 442 (468)
Q Consensus 434 RPt~~evl~ 442 (468)
|||++|+++
T Consensus 319 Rpta~e~L~ 327 (362)
T d1q8ya_ 319 RADAGGLVN 327 (362)
T ss_dssp CBCHHHHHT
T ss_pred CcCHHHHhc
Confidence 999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=9.7e-24 Score=189.08 Aligned_cols=173 Identities=18% Similarity=0.184 Sum_probs=120.9
Q ss_pred CCCceeeecCcEEEEEEEecCCcEEEEEecccccch--------------HHHHHHHHHHHHHHHHHhcCCCceeeEeee
Q 012214 167 NANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDD--------------EELLKLEEFINEIVILSQINHRNVVKLLGC 232 (468)
Q Consensus 167 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--------------~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~ 232 (468)
.+.++||+|+||+||+|...+|+.||||+++..... ........+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356789999999999999888999999986532110 011122345678899999999999988866
Q ss_pred eccCCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCEEecCCCCCCEEEcCCCcEE
Q 012214 233 CLETEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSATSSPIYHRDIKSTNILLDQRYRAK 312 (468)
Q Consensus 233 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiH~DLkp~NILl~~~~~~k 312 (468)
. ..+++|||+++..+.. ++......++.|++.+|.|||+++ |+||||||+|||++++ .++
T Consensus 83 ~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp E----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEE
T ss_pred c----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEE
Confidence 4 2479999998755422 233445678999999999999999 9999999999999965 589
Q ss_pred EEecCCcccccCCCceeeecccccCCccCccccccCCCCCcccHHHHHHHH
Q 012214 313 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVL 363 (468)
Q Consensus 313 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvll 363 (468)
|+|||+|........... ...+... -.+.+ ...|+.++|+||..--+
T Consensus 143 liDFG~a~~~~~~~~~~~--l~rd~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREI--LERDVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHHHH--HHHHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcHHH--HHHHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 999999875543221100 0000000 01111 35678899999976544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.36 E-value=4.9e-07 Score=82.58 Aligned_cols=149 Identities=16% Similarity=0.126 Sum_probs=97.9
Q ss_pred HHHHHHhcCCCCCceeeecCcEEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC-CCceeeEeeeecc
Q 012214 157 KELDKATNHFNANRILGQGGQGTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN-HRNVVKLLGCCLE 235 (468)
Q Consensus 157 ~ei~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~ 235 (468)
+++......|+..+..+.++.+.||+... +++.+.+|+....... ....+.+|...+..+. +--+.+++.+..+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~----~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~ 81 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFERH 81 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc----chhhHHHHHHHHHHHhccCCCCcEEEEEec
Confidence 45556566777665544445578998865 4556778876543211 1224567888877763 4445677777777
Q ss_pred CCcceeEeeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------
Q 012214 236 TEVPLLVYEFIPNGTLYQHLHDRHQNEEFPLTWEMRLRIATEVAGALAYLHSAT-------------------------- 289 (468)
Q Consensus 236 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------------------------- 289 (468)
.+..++||+++++.++.+..... .. ...++.++++.+..||+..
T Consensus 82 ~~~~~lv~~~l~G~~~~~~~~~~-------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T d1j7la_ 82 DGWSNLLMSEADGVLCSEEYEDE-------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHTTTC-------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred CCceEEEEEeccccccccccccc-------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhh
Confidence 88889999999998876544220 11 2234555666666666421
Q ss_pred ------------------------------CCCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 290 ------------------------------SSPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 290 ------------------------------~~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
...++|+|+.|.|||+++++.+-|.||+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1227999999999999987777799999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.96 E-value=1.1e-05 Score=72.94 Aligned_cols=74 Identities=18% Similarity=0.162 Sum_probs=51.5
Q ss_pred eeecCc-EEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcC--CCceeeEeeeeccCCcceeEeeecCC
Q 012214 172 LGQGGQ-GTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQIN--HRNVVKLLGCCLETEVPLLVYEFIPN 248 (468)
Q Consensus 172 LG~G~f-G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~~~~~~lV~E~~~~ 248 (468)
+..|.. +.||+...+++..+++|....... ..+..|+..++.+. .-.+.++++++.+.+..++||+++++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT-------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH-------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 455553 679999888888889997654321 23456777776663 33356678887888888999999988
Q ss_pred CChh
Q 012214 249 GTLY 252 (468)
Q Consensus 249 gsL~ 252 (468)
.++.
T Consensus 91 ~~~~ 94 (255)
T d1nd4a_ 91 QDLL 94 (255)
T ss_dssp EETT
T ss_pred cccc
Confidence 6653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.29 E-value=0.00029 Score=67.77 Aligned_cols=80 Identities=19% Similarity=0.190 Sum_probs=46.1
Q ss_pred ceeeecCcEEEEEEEec-CCcEEEEEecccccc--hH-HHHHHHHHHHHHHHHHhcC-C--CceeeEeeeeccCCcceeE
Q 012214 170 RILGQGGQGTVYKGMLE-DGRIIAVKKSKLTVD--DE-ELLKLEEFINEIVILSQIN-H--RNVVKLLGCCLETEVPLLV 242 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~-~~~~~~~~~~Ei~~l~~l~-h--~niv~l~g~~~~~~~~~lV 242 (468)
+.||.|....||+.... +++.++||.-..... .. .....+....|...++.+. + ..+.+++.+. .+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 45899999999999865 467889985322100 00 0011123345777776652 2 3455566553 4566899
Q ss_pred eeecCCCCh
Q 012214 243 YEFIPNGTL 251 (468)
Q Consensus 243 ~E~~~~gsL 251 (468)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.29 E-value=0.0061 Score=56.45 Aligned_cols=69 Identities=16% Similarity=0.107 Sum_probs=42.1
Q ss_pred EEEEEEEecCCcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCce--eeEeee-----eccCCcceeEeeecCCCC
Q 012214 178 GTVYKGMLEDGRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRNV--VKLLGC-----CLETEVPLLVYEFIPNGT 250 (468)
Q Consensus 178 G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni--v~l~g~-----~~~~~~~~lV~E~~~~gs 250 (468)
-.||++..++|+.+++|+....... .+++..|...+..+...++ +..+.. .......+.++++++|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s-----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWT-----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSC-----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCC-----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 4799999999999999987653222 2345667777776642222 111111 123445678889887654
Q ss_pred h
Q 012214 251 L 251 (468)
Q Consensus 251 L 251 (468)
+
T Consensus 111 ~ 111 (325)
T d1zyla1 111 F 111 (325)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.01 E-value=0.0097 Score=56.62 Aligned_cols=72 Identities=18% Similarity=0.235 Sum_probs=45.9
Q ss_pred ceeeecCcEEEEEEEecC--------CcEEEEEecccccchHHHHHHHHHHHHHHHHHhcCCCc-eeeEeeeeccCCcce
Q 012214 170 RILGQGGQGTVYKGMLED--------GRIIAVKKSKLTVDDEELLKLEEFINEIVILSQINHRN-VVKLLGCCLETEVPL 240 (468)
Q Consensus 170 ~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~~~~ 240 (468)
+.|+.|-.=.+|+....+ .+.|.+++.-..... ....+|..+++.+.-.+ ..++++++.+ .
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~------idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE------SHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH------HHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh------hHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 457778778899988653 345677665422111 23446888888774333 3477887753 6
Q ss_pred eEeeecCCCCh
Q 012214 241 LVYEFIPNGTL 251 (468)
Q Consensus 241 lV~E~~~~gsL 251 (468)
+|+||+++.+|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 88999987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.78 E-value=0.027 Score=51.38 Aligned_cols=30 Identities=17% Similarity=0.193 Sum_probs=26.6
Q ss_pred CCEEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012214 291 SPIYHRDIKSTNILLDQRYRAKVADFGTSK 320 (468)
Q Consensus 291 ~~iiH~DLkp~NILl~~~~~~kl~DfGla~ 320 (468)
..+||+|+.++||+++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 349999999999999998877899999874
|